1	Toxicol	NNP	O	Toxicol	_	0	SENT_1	[p1l6t3187r71b3491],
2	.	.	O	.	_	0	SENT_1	[p1l6t3187r71b3491],

1	2009.49:3	CD	NUMBER	2009.49:3	num	2	SENT_2	[p1l6t2787r72b3155],
2	77-394	CD	NUMBER	77-394	_	0	SENT_2	[p1l6t2491r72b2770],
3	.	.	O	.	_	0	SENT_2	[p1l6t2491r72b2770],

1	Downloaded	VBN	O	download	_	0	SENT_3	[p1l6t1986r71b2460],
2	from	IN	O	from	_	0	SENT_3	[p1l6t1781r71b1960],
3	wwW.annua1reViews.org	NN	O	www.annua1reviews.org	prep_from	1	SENT_3	[p1l6t848r90b1756],
4	of	IN	O	of	_	0	SENT_3	[p1l99t3395r164b3476],
5	Wisconsin	NNP	LOCATION	Wisconsin	nn	7	SENT_3	[p1l99t2985r165b3377],
6	—	NNP	O	—	nn	7	SENT_3	[p1l139t2933r145b2957],
7	Madison	NNP	O	Madison	prep_of	3	SENT_3	[p1l99t2571r164b2905],
8	on	IN	O	on	_	0	SENT_3	[p1l119t2455r164b2544],
9	01/05/14	CD	DATE	01/05/14	prep_on	7	SENT_3	[p1l99t2083r165b2429],
10	.	.	O	.	_	0	SENT_3	[p1l99t2083r165b2429],

1	For	IN	O	for	_	0	SENT_4	[p1l101t1923r164b2053],
2	personal	JJ	O	personal	amod	3	SENT_4	[p1l99t1586r184b1900],
3	use	NN	O	use	pobj	1	SENT_4	[p1l119t1438r164b1560],
4	only	RB	O	only	advmod	3	SENT_4	[p1l100t1229r184b1410],
5	.	.	O	.	_	0	SENT_4	[p1l100t1229r184b1410],

1	ANNUAL	JJ	SET	annual	amod	2	SENT_5	[p1l818t249r1096b301],
2	REVIEWS	NNS	O	review	dep	3	SENT_5	[p1l820t321r1094b374],
3	FU	VBP	O	fu	_	0	SENT_5	[p1l1134t251r1298b372],
4	rt	NN	O	rt	dobj	3	SENT_5	[p1l1325t262r1443b372],
5	'	''	O	'	_	0	SENT_5	[p1l1464t244r1541b370],
6	1	CD	NUMBER	1	num	8	SENT_5	[p1l1464t244r1541b370],
7	e	LS	O	e	dep	8	SENT_5	[p1l1563t282r1641b372],
8	r	NN	O	r	nsubj	3	SENT_5	[p1l1663t282r1712b370],

1	Click	VB	O	click	_	0	SENT_6	[p1l819t447r978b507],
2	here	RB	O	here	advmod	1	SENT_6	[p1l1000t447r1146b507],
3	for	IN	O	for	_	0	SENT_6	[p1l1166t447r1252b507],
4	quick	JJ	O	quick	amod	5	SENT_6	[p1l1273t447r1447b523],
5	links	NNS	O	link	prep_for	1	SENT_6	[p1l1470t447r1604b507],
6	to	TO	O	to	_	0	SENT_6	[p1l1626t458r1691b507],
7	Annual	JJ	SET	annual	amod	8	SENT_6	[p1l819t545r1044b605],
8	Reviews	NNS	MISC	review	prep_to	5	SENT_6	[p1l1074t548r1329b605],
9	content	JJ	O	content	dep	10	SENT_6	[p1l1353t556r1606b605],
10	online	NN	O	online	amod	8	SENT_6	[p1l1629t545r1842b615],
11	,	,	O	,	_	0	SENT_6	[p1l1629t545r1842b615],
12	including	VBG	O	include	partmod	8	SENT_6	[p1l822t643r1136b719],
13	:	:	O	:	_	0	SENT_6	[p1l822t643r1136b719],

1	-	:	O	-	_	0	SENT_7	[p1l804t807r820b822],
2	Other	JJ	O	other	amod	3	SENT_7	[p1l842t777r1028b837],
3	articles	NNS	O	article	_	0	SENT_7	[p1l1049t777r1273b837],
4	in	IN	O	in	_	0	SENT_7	[p1l1299t781r1349b836],
5	this	DT	O	this	det	6	SENT_7	[p1l1374t777r1486b837],
6	volume	NN	O	volume	prep_in	3	SENT_7	[p1l1508t777r1751b837],
7	-	:	O	-	_	0	SENT_7	[p1l804t878r954b950],
8	Top	JJ	O	top	nsubj	9	SENT_7	[p1l804t878r954b950],
9	cited	VBD	O	cite	dep	6	SENT_7	[p1l978t875r1132b935],
10	articles	NNS	O	article	dobj	9	SENT_7	[p1l1158t875r1381b935],
11	-	:	O	-	_	0	SENT_7	[p1l804t976r954b1048],
12	Top	JJ	O	top	dep	6	SENT_7	[p1l804t976r954b1048],
13	downloaded	VBN	O	download	partmod	12	SENT_7	[p1l978t973r1385b1033],
14	articles	NNS	O	article	dobj	13	SENT_7	[p1l1412t973r1636b1033],
15	-	:	O	-	_	0	SENT_7	[p1l804t1100r820b1116],
16	Our	PRP$	O	we	poss	18	SENT_7	[p1l842t1073r961b1130],
17	comprehensive	JJ	O	comprehensive	amod	18	SENT_7	[p1l983t1071r1482b1146],
18	search	NN	O	search	dep	14	SENT_7	[p1l1507t1071r1708b1130],

1	Annu	NNP	PERSON	Annu	_	0	SENT_8	[p2l411t312r617b373],
2	.	.	O	.	_	0	SENT_8	[p2l411t312r617b373],

1	Rev.	NNP	O	Rev.	nn	2	SENT_9	[p2l646t313r785b373],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_9	[p2l812t309r1198b373],
3	.	.	O	.	_	0	SENT_9	[p2l812t309r1198b373],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_10	[p2l1223t310r1493b373],
2	.	.	O	.	_	0	SENT_10	[p2l1223t310r1493b373],

1	2009	CD	DATE	2009	_	0	SENT_11	[p2l1522t314r1705b374],
2	.	.	O	.	_	0	SENT_11	[p2l1522t314r1705b374],

1	49377-94	CD	NUMBER	49377-94	_	0	SENT_12	[p2l1731t312r2088b374],

1	by	IN	O	by	_	0	SENT_13	[p2l99t429r184b521],
2	University	NNP	O	University	pobj	1	SENT_13	[p2l99t13r184b403],

1	First	JJ	ORDINAL	first	advmod	2	SENT_14	[p2l414t487r575b547],
2	published	VBN	O	publish	_	0	SENT_14	[p2l595t484r926b567],
3	online	NN	O	online	dep	2	SENT_14	[p2l951t484r1164b547],
4	as	IN	O	as	_	0	SENT_14	[p2l1189t508r1251b547],
5	a	DT	O	a	det	6	SENT_14	[p2l1277t508r1309b547],
6	Review	NN	O	review	prep_as	2	SENT_14	[p2l1334t487r1583b547],
7	in	IN	O	in	_	0	SENT_14	[p2l1603t487r1670b546],
8	Advance	NNP	O	Advance	prep_in	6	SENT_14	[p2l1690t484r1981b547],
9	on	IN	O	on	_	0	SENT_14	[p2l2006t508r2091b547],
10	October	NNP	DATE	October	prep_on	2	SENT_14	[p2l416t589r700b652],
11	17	CD	DATE	17	num	10	SENT_14	[p2l731t591r822b665],
12	,	,	DATE	,	_	0	SENT_14	[p2l731t591r822b665],
13	2008	CD	DATE	2008	num	10	SENT_14	[p2l850t593r1012b651],

1	Annu	NNP	PERSON	Annu	_	0	SENT_15	[p2l6t675r71b898],
2	.	.	O	.	_	0	SENT_15	[p2l6t675r71b898],

1	Rev.	NNP	O	Rev.	nn	2	SENT_16	[p2l7t477r72b644],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_16	[p2l6t32r71b447],
3	.	.	O	.	_	0	SENT_16	[p2l6t32r71b447],

1	The	DT	O	the	det	3	SENT_17	[p2l412t763r557b826],
2	Annual	JJ	SET	annual	amod	3	SENT_17	[p2l573t764r824b826],
3	Review	NN	O	review	nsubj	13	SENT_17	[p2l840t766r1066b826],
4	of	IN	O	of	_	0	SENT_17	[p2l1091t764r1161b847],
5	Pharmacology	NNP	O	Pharmacology	prep_of	3	SENT_17	[p2l1164t765r1607b848],
6	and	CC	O	and	_	0	SENT_17	[p2l1627t765r1748b826],
7	Ybxicology	NNP	PERSON	Ybxicology	prep_of	3	SENT_17	[p2l1771t765r2083b848],
8	is	VBZ	O	be	cop	13	SENT_17	[p2l2104t767r2154b826],
9	online	NN	O	online	dep	13	SENT_17	[p2l415t868r628b931],
10	at	IN	O	at	_	0	SENT_17	[p2l653t886r715b931],
11	pharmtox.annualreViews.org	NN	O	pharmtox.annualreviews.org	prep_at	13	SENT_17	[p2l736t868r1710b952],
12	This	DT	O	this	det	13	SENT_17	[p2l412t1041r571b1104],
13	article	NN	O	article	_	0	SENT_17	[p2l597t1041r848b1104],
14	’s	POS	O	’s	possessive	13	SENT_17	[p2l597t1041r848b1104],
15	doi	FW	O	doi	dep	13	SENT_17	[p2l875t1041r998b1104],
16	:	:	O	:	_	0	SENT_17	[p2l875t1041r998b1104],
17	10.1146	CD	NUMBER	10.1146	dep	13	SENT_17	[p2l422t1146r1798b1229],
18	/	:	O	/	punct	19	SENT_17	[p2l422t1146r1798b1229],
19	annurev	NN	O	annurev	dep	17	SENT_17	[p2l422t1146r1798b1229],
20	.	.	O	.	_	0	SENT_17	[p2l422t1146r1798b1229],

1	pharmtoX	NN	O	pharmtox	_	0	SENT_18	[p2l422t1146r1798b1229],
2	.	.	O	.	_	0	SENT_18	[p2l422t1146r1798b1229],

1	Ol1O08	JJ	O	ol1o08	amod	4	SENT_19	[p2l422t1146r1798b1229],
2	.1455	CD	NUMBER	.1455	number	3	SENT_19	[p2l422t1146r1798b1229],
3	53	CD	NUMBER	53	dep	1	SENT_19	[p2l1810t1149r1880b1210],
4	Copyright	NN	O	copyright	_	0	SENT_19	[p2l416t1321r771b1405],
5	©	CD	NUMBER	©	num	6	SENT_19	[p2l794t1324r868b1400],
6	2009	CD	DATE	2009	dep	4	SENT_19	[p2l895t1325r1059b1384],
7	by	IN	O	by	_	0	SENT_19	[p2l1084t1321r1168b1405],
8	Annual	JJ	SET	annual	amod	9	SENT_19	[p2l1186t1321r1433b1384],
9	Reviews	NNS	O	review	prep_by	6	SENT_19	[p2l1458t1324r1751b1384],
10	.	.	O	.	_	0	SENT_19	[p2l1458t1324r1751b1384],

1	All	DT	O	all	det	2	SENT_20	[p2l411t1423r510b1486],
2	rights	NNS	O	rights	nsubj	3	SENT_20	[p2l534t1423r730b1507],
3	reserved	VBD	O	reserve	_	0	SENT_20	[p2l754t1423r1039b1486],
4	0362-1642/09	CD	DURATION	0362-1642/09	dobj	3	SENT_20	[p2l415t1595r1525b1664],
5	/	:	O	/	punct	6	SENT_20	[p2l415t1595r1525b1664],
6	0210	CD	DATE	0210	dep	4	SENT_20	[p2l415t1595r1525b1664],
7	.	.	O	.	_	0	SENT_20	[p2l415t1595r1525b1664],

1	—	NN	O	—	_	0	SENT_21	[p2l415t1595r1525b1664],
2	.	.	O	.	_	0	SENT_21	[p2l415t1595r1525b1664],

1	O377	CD	NUMBER	o377	_	0	SENT_22	[p2l415t1595r1525b1664],
2	$	$	MONEY	$	dep	1	SENT_22	[p2l415t1595r1525b1664],
3	20.00	CD	MONEY	20.00	num	2	SENT_22	[p2l415t1595r1525b1664],

1	Emerging	VBG	O	emerge	_	0	SENT_23	[p2l15t1806r680b1961],
2	Pharmacology	NNP	O	Pharmacology	dobj	1	SENT_23	[p2l724t1799r1711b1961],
3	:	:	O	:	_	0	SENT_23	[p2l724t1799r1711b1961],
4	Inhibitors	NNS	O	inhibitor	dep	2	SENT_23	[p2l13t1994r668b2115],
5	of	IN	O	of	_	0	SENT_23	[p2l721t1995r863b2115],
6	Human	JJ	O	human	amod	9	SENT_23	[p2l893t2000r1398b2115],
7	Immunodeﬁciency	NN	O	immunodeﬁciency	nn	9	SENT_23	[p2l13t2187r1261b2349],
8	Virus	NN	O	virus	nn	9	SENT_23	[p2l7t2389r362b2504],
9	Integration	NN	O	integration	prep_of	4	SENT_23	[p2l412t2389r1160b2544],

1	Daria	NNP	PERSON	Daria	nn	5	SENT_24	[p2l13t2661r224b2727],
2	Hazuda	NNP	PERSON	Hazuda	nn	5	SENT_24	[p2l251t2658r563b2743],
3	,	,	O	,	_	0	SENT_24	[p2l251t2658r563b2743],
4	Marian	NNP	PERSON	Marian	appos	5	SENT_24	[p2l590t2661r867b2727],
5	Iwamoto	NNP	PERSON	Iwamoto	_	0	SENT_24	[p2l893t2661r1249b2743],
6	,	,	O	,	_	0	SENT_24	[p2l893t2661r1249b2743],
7	and	CC	O	and	_	0	SENT_24	[p2l1280t2658r1414b2727],
8	Larissa	NNP	ORGANIZATION	Larissa	nn	12	SENT_24	[p2l1441t2661r1706b2728],
9	Wenning	NNP	ORGANIZATION	Wenning	nn	12	SENT_24	[p2l1731t2661r2086b2750],
10	Merck	NNP	ORGANIZATION	Merck	nn	12	SENT_24	[p2l9t2813r157b2853],
11	Research	NNP	ORGANIZATION	Research	nn	12	SENT_24	[p2l171t2813r370b2853],
12	Labs	NNPS	ORGANIZATION	Labs	conj_and	5	SENT_24	[p2l385t2813r502b2862],
13	,	,	O	,	_	0	SENT_24	[p2l385t2813r502b2862],
14	West	NNP	LOCATION	West	nn	15	SENT_24	[p2l518t2815r633b2853],
15	Point	NNP	LOCATION	Point	appos	12	SENT_24	[p2l647t2815r780b2862],
16	,	,	O	,	_	0	SENT_24	[p2l647t2815r780b2862],
17	Pennsylvania	NNP	LOCATION	Pennsylvania	appos	12	SENT_24	[p2l797t2813r1086b2867],
18	19486	CD	NUMBER	19486	num	17	SENT_24	[p2l1106t2815r1247b2862],
19	;	:	O	;	_	0	SENT_24	[p2l1106t2815r1247b2862],
20	email	NN	O	email	dep	5	SENT_24	[p2l1266t2813r1395b2853],
21	:	:	O	:	_	0	SENT_24	[p2l1266t2813r1395b2853],
22	daria_hazuda@merck.com	NNP	O	daria_hazuda@merck.com	dep	20	SENT_24	[p2l1414t2813r1986b2853],

1	Key	NN	O	key	nn	2	SENT_25	[p2l11t3006r149b3081],
2	Words	NNS	MISC	word	_	0	SENT_25	[p2l167t3003r391b3061],
3	AIDS	NN	MISC	aid	nn	9	SENT_25	[p2l9t3095r188b3158],
4	,	,	O	,	_	0	SENT_25	[p2l9t3095r188b3158],
5	HIV	NN	MISC	hiv	dep	9	SENT_25	[p2l210t3096r357b3157],
6	,	,	O	,	_	0	SENT_25	[p2l210t3096r357b3157],
7	antiretrovirals	NNS	O	antiretroviral	dep	9	SENT_25	[p2l381t3093r794b3157],
8	,	,	O	,	_	0	SENT_25	[p2l381t3093r794b3157],
9	integrase	NN	O	integrase	dep	2	SENT_25	[p2l816t3096r1072b3163],
10	Abstract	JJ	O	abstract	dep	2	SENT_25	[p2l8t3172r299b3231],

1	The	DT	O	the	det	4	SENT_26	[p3l10t23r130b76],
2	ﬁrst	JJ	O	ﬁrst	amod	4	SENT_26	[p3l150t24r262b76],
3	integrase	NN	O	integrase	nn	4	SENT_26	[p3l278t26r534b94],
4	inhibitor	NN	O	inhibitor	nsubj	5	SENT_26	[p3l553t24r805b76],
5	licensed	VBD	O	license	_	0	SENT_26	[p3l822t23r1049b76],
6	to	TO	O	to	aux	7	SENT_26	[p3l1069t38r1124b76],
7	treat	VB	O	treat	xcomp	5	SENT_26	[p3l1144t38r1275b76],
8	HIV-1	NN	MISC	hiv-1	nn	9	SENT_26	[p3l1293t26r1474b76],
9	infection	NN	O	infection	nsubjpass	11	SENT_26	[p3l1498t24r1751b76],
10	was	VBD	O	be	auxpass	11	SENT_26	[p3l1768t44r1869b76],
11	approved	VBN	O	approve	ccomp	7	SENT_26	[p3l1890t24r2150b93],
12	in	IN	O	in	_	0	SENT_26	[p3l11t112r66b161],
13	late	JJ	DATE	late	amod	14	SENT_26	[p3l83t109r183b161],
14	2007	CD	DATE	2007	prep_in	11	SENT_26	[p3l202t111r354b173],
15	,	,	O	,	_	0	SENT_26	[p3l202t111r354b173],
16	more	JJR	DURATION	more	mwe	17	SENT_26	[p3l374t129r522b161],
17	than	IN	DURATION	than	quantmod	18	SENT_26	[p3l541t109r666b161],
18	a	DT	DURATION	a	num	19	SENT_26	[p3l684t129r711b161],
19	decade	NN	DURATION	decade	appos	14	SENT_26	[p3l730t109r921b161],
20	after	IN	O	after	_	0	SENT_26	[p3l940t110r1069b161],
21	the	DT	O	the	det	22	SENT_26	[p3l1086t109r1174b161],
22	introduction	NN	O	introduction	prep_after	11	SENT_26	[p3l1192t109r1550b161],
23	of	IN	O	of	_	0	SENT_26	[p3l1568t110r1630b161],
24	the	DT	O	the	det	26	SENT_26	[p3l1641t109r1729b161],
25	ﬁrst	NN	O	ﬁrst	nn	26	SENT_26	[p3l1747t110r1859b161],
26	inhibitors	NNS	O	inhibitor	prep_of	22	SENT_26	[p3l1875t109r2150b161],
27	of	IN	O	of	_	0	SENT_26	[p3l12t193r74b245],
28	the	DT	O	the	det	31	SENT_26	[p3l81t193r169b245],
29	HIV-1	NN	MISC	hiv-1	nn	31	SENT_26	[p3l183t195r364b245],
30	reverse	JJ	O	reverse	amod	31	SENT_26	[p3l383t213r584b245],
31	transcriptase	NN	O	transcriptase	prep_of	26	SENT_26	[p3l598t196r957b262],
32	and	CC	O	and	_	0	SENT_26	[p3l972t193r1072b245],
33	protease	NN	O	protease	prep_of	26	SENT_26	[p3l1086t208r1337b262],
34	.	.	O	.	_	0	SENT_26	[p3l1086t208r1337b262],

1	The	DT	O	the	det	6	SENT_27	[p3l1352t193r1472b245],
2	unique	JJ	O	unique	amod	6	SENT_27	[p3l1485t196r1680b262],
3	biochemical	JJ	O	biochemical	amod	6	SENT_27	[p3l1694t193r2036b245],
4	and	CC	O	and	_	0	SENT_27	[p3l2050t193r2150b245],
5	molecular	JJ	O	molecular	amod	6	SENT_27	[p3l11t278r294b331],
6	mechanism	NN	O	mechanism	nsubj	19	SENT_27	[p3l315t278r637b331],
7	of	IN	O	of	_	0	SENT_27	[p3l659t279r721b331],
8	action	NN	O	action	prep_of	6	SENT_27	[p3l737t281r909b331],
9	of	IN	O	of	_	0	SENT_27	[p3l932t279r994b331],
10	this	DT	O	this	det	12	SENT_27	[p3l1009t278r1109b331],
11	novel	JJ	O	novel	amod	12	SENT_27	[p3l1132t278r1285b331],
12	class	NN	O	class	prep_of	8	SENT_27	[p3l1308t278r1433b331],
13	of	IN	O	of	_	0	SENT_27	[p3l1457t279r1519b331],
14	antiretroviral	JJ	O	antiretroviral	amod	15	SENT_27	[p3l1535t278r1908b331],
15	drugs	NNS	O	drug	prep_of	12	SENT_27	[p3l1932t278r2086b348],
16	is	VBZ	O	be	cop	19	SENT_27	[p3l2109t281r2150b331],
17	the	DT	O	the	det	19	SENT_27	[p3l12t363r100b416],
18	fundamental	JJ	O	fundamental	amod	19	SENT_27	[p3l119t363r475b416],
19	basis	NN	O	basis	_	0	SENT_27	[p3l493t363r624b416],
20	for	IN	O	for	_	0	SENT_27	[p3l644t363r726b416],
21	their	PRP$	O	they	poss	22	SENT_27	[p3l744t363r879b416],
22	activity	NN	O	activity	prep_for	19	SENT_27	[p3l897t366r1103b433],
23	in	IN	O	in	_	0	SENT_27	[p3l1117t366r1173b415],
24	treating	VBG	O	treat	prepc_in	22	SENT_27	[p3l1191t366r1414b433],
25	multidrug-resistant	JJ	O	multidrug-resistant	amod	27	SENT_27	[p3l1430t363r1982b433],
26	HIV1	NN	O	hiv1	nn	27	SENT_27	[p3l1998t366r2149b416, p3l18t452r38b500],
27	infection	NN	O	infection	dobj	24	SENT_27	[p3l64t449r317b501],
28	and	CC	O	and	_	0	SENT_27	[p3l337t449r437b501],
29	is	VBZ	O	be	cop	30	SENT_27	[p3l457t451r498b501],
30	important	JJ	O	important	conj_and	19	SENT_27	[p3l518t451r805b518],
31	for	IN	O	for	_	0	SENT_27	[p3l823t449r906b501],
32	understanding	VBG	O	understand	prepc_for	30	SENT_27	[p3l924t448r1335b519],
33	both	CC	O	both	preconj	39	SENT_27	[p3l1353t448r1483b501],
34	the	DT	O	the	det	39	SENT_27	[p3l1504t449r1591b501],
35	cellular	JJ	O	cellular	nn	39	SENT_27	[p3l1613t448r1821b501],
36	and	CC	O	and	cc	35	SENT_27	[p3l1841t449r1941b501],
37	in	FW	O	in	nn	38	SENT_27	[p3l1961t451r2016b500],
38	vivo	FW	O	vivo	advmod	35	SENT_27	[p3l2033t451r2150b501],
39	pharmacology	NN	O	pharmacology	dobj	32	SENT_27	[p3l11t533r418b603],
40	and	CC	O	and	_	0	SENT_27	[p3l438t533r538b586],
41	metabolism	NN	O	metabolism	dobj	32	SENT_27	[p3l561t533r891b586],
42	of	IN	O	of	_	0	SENT_27	[p3l914t534r976b586],
43	these	DT	O	these	det	44	SENT_27	[p3l991t533r1135b586],
44	agents	NNS	O	agent	prep_of	41	SENT_27	[p3l1159t548r1351b603],
45	.	.	O	.	_	0	SENT_27	[p3l1159t548r1351b603],

1	In	IN	O	in	_	0	SENT_28	[p3l1377t536r1437b585],
2	addition	NN	O	addition	prep_in	31	SENT_28	[p3l1460t533r1709b597],
3	,	,	O	,	_	0	SENT_28	[p3l1460t533r1709b597],
4	available	JJ	O	available	amod	5	SENT_28	[p3l1735t533r1976b586],
5	pharmacokinetic	JJ	O	pharmacokinetic	amod	9	SENT_28	[p3l1999t533r2149b602, p3l11t618r355b671],
6	and	CC	O	and	_	0	SENT_28	[p3l382t618r482b671],
7	drug	NN	O	drug	amod	9	SENT_28	[p3l511t618r642b688],
8	interaction	NN	O	interaction	nn	9	SENT_28	[p3l667t621r977b671],
9	data	NNS	O	datum	nsubjpass	31	SENT_28	[p3l1004t618r1119b671],
10	for	IN	O	for	_	0	SENT_28	[p3l1146t618r1228b671],
11	raltegravir	NN	O	raltegravir	prep_for	9	SENT_28	[p3l1253t618r1549b688],
12	and	CC	O	and	_	0	SENT_28	[p3l1575t618r1676b671],
13	elvitegravir	NN	O	elvitegravir	prep_for	9	SENT_28	[p3l1704t618r2033b688],
14	,	,	O	,	_	0	SENT_28	[p3l1704t618r2033b688],
15	the	DT	O	the	det	18	SENT_28	[p3l2062t618r2150b671],
16	two	CD	NUMBER	two	num	18	SENT_28	[p3l12t718r115b756],
17	integrase	NN	O	integrase	nn	18	SENT_28	[p3l135t706r391b774],
18	inhibitors	NNS	O	inhibitor	appos	9	SENT_28	[p3l411t704r686b756],
19	that	WDT	O	that	nsubjpass	23	SENT_28	[p3l707t703r819b756],
20	are	VBP	O	be	auxpass	23	SENT_28	[p3l838t723r921b756],
21	the	DT	O	the	dobj	23	SENT_28	[p3l943t704r1031b756],
22	most	RBS	O	most	advmod	21	SENT_28	[p3l1051t718r1191b756],
23	advanced	VBN	O	advance	rcmod	18	SENT_28	[p3l1210t703r1469b756],
24	in	IN	O	in	_	0	SENT_28	[p3l1489t706r1544b755],
25	clinical	JJ	O	clinical	amod	26	SENT_28	[p3l1564t704r1764b756],
26	development	NN	O	development	prep_in	23	SENT_28	[p3l1785t703r2152b773],
27	to	TO	O	to	_	0	SENT_28	[p3l12t804r67b841],
28	date	NN	O	date	prep_to	26	SENT_28	[p3l89t789r221b852],
29	,	,	O	,	_	0	SENT_28	[p3l89t789r221b852],
30	are	VBP	O	be	auxpass	31	SENT_28	[p3l244t809r328b841],
31	reviewed	VBN	O	review	_	0	SENT_28	[p3l348t789r615b841],
32	.	.	O	.	_	0	SENT_28	[p3l348t789r615b841],

1	INTRODUCTION	NN	O	introduction	_	0	SENT_29	[p3l582t1102r962b1134],

1	Background	NN	O	background	_	0	SENT_30	[p3l583t1184r812b1227],
2	and	CC	O	and	_	0	SENT_30	[p3l825t1184r892b1217],
3	Medical	JJ	O	medical	amod	4	SENT_30	[p3l903t1184r1055b1217],
4	Need	NNP	O	Need	conj_and	1	SENT_30	[p3l1066t1184r1169b1217],
5	Since	IN	O	since	_	0	SENT_30	[p3l584t1236r667b1265],
6	the	DT	O	the	det	8	SENT_30	[p3l677t1235r725b1265],
7	ﬁrst	NN	O	ﬁrst	nn	8	SENT_30	[p3l735t1235r797b1265],
8	reports	NNS	O	report	prep_since	26	SENT_30	[p3l805t1244r916b1274],
9	of	IN	O	of	_	0	SENT_30	[p3l926t1235r960b1265],
10	Acquired	VBN	MISC	acquire	prepc_of	8	SENT_30	[p3l964t1235r1108b1274],
11	Immune	JJ	MISC	immune	amod	16	SENT_30	[p3l1117t1237r1250b1265],
12	Deﬁciency	NNP	MISC	Deﬁciency	nn	16	SENT_30	[p3l1260t1235r1429b1274],
13	Syndrome	NN	MISC	syndrome	nn	16	SENT_30	[p3l1438t1235r1597b1274],
14	(	CD	NUMBER	(	num	16	SENT_30	[p3l1608t1236r1719b1272],
15	AIDS	NNP	MISC	AIDS	nn	16	SENT_30	[p3l1608t1236r1719b1272],
16	)	NN	O	)	dobj	10	SENT_30	[p3l1608t1236r1719b1272],
17	in	IN	O	in	_	0	SENT_30	[p3l1729t1237r1759b1264],
18	the	DT	DATE	the	det	20	SENT_30	[p3l1768t1235r1817b1265],
19	early	JJ	DATE	early	amod	20	SENT_30	[p3l1827t1235r1903b1274],
20	1980s	CD	DATE	1980s	prep_in	16	SENT_30	[p3l1915t1237r2009b1271],
21	,	,	O	,	_	0	SENT_30	[p3l1915t1237r2009b1271],
22	there	EX	O	there	expl	26	SENT_30	[p3l2020t1235r2101b1265],
23	has	VBZ	O	have	aux	26	SENT_30	[p3l582t1283r632b1312],
24	been	VBN	O	be	cop	26	SENT_30	[p3l643t1283r717b1312],
25	signiﬁcant	JJ	O	signiﬁcant	amod	26	SENT_30	[p3l728t1283r890b1322],
26	progress	NN	O	progress	rcmod	1	SENT_30	[p3l900t1294r1031b1322],
27	in	IN	O	in	_	0	SENT_30	[p3l1042t1285r1072b1312],
28	the	DT	O	the	det	29	SENT_30	[p3l1083t1283r1132b1312],
29	treatment	NN	O	treatment	prep_in	26	SENT_30	[p3l1143t1291r1297b1312],
30	of	IN	O	of	_	0	SENT_30	[p3l1307t1283r1342b1312],
31	HIV-1	NN	O	hiv-1	nn	32	SENT_30	[p3l1348t1284r1448b1312],
32	infection	NN	O	infection	prep_of	29	SENT_30	[p3l1462t1283r1609b1312],
33	.	.	O	.	_	0	SENT_30	[p3l1462t1283r1609b1312],

1	The	DT	O	the	det	2	SENT_31	[p3l1620t1283r1687b1312],
2	identiﬁcation	NN	O	identiﬁcation	nsubj	11	SENT_31	[p3l1698t1283r1906b1312],
3	of	IN	O	of	_	0	SENT_31	[p3l1917t1283r1951b1312],
4	HIV-1	NN	O	hiv-1	prep_of	2	SENT_31	[p3l1958t1284r2058b1312],
5	as	IN	O	as	_	0	SENT_31	[p3l2072t1294r2101b1312],
6	the	DT	O	the	det	8	SENT_31	[p3l583t1331r632b1360],
7	causative	JJ	O	causative	amod	8	SENT_31	[p3l642t1333r781b1360],
8	agent	NN	O	agent	prep_as	4	SENT_31	[p3l791t1340r877b1370],
9	of	IN	O	of	_	0	SENT_31	[p3l886t1331r921b1360],
10	AIDS	NNP	MISC	AIDS	prep_of	8	SENT_31	[p3l925t1332r1014b1360],
11	catalyzed	VBD	O	catalyze	_	0	SENT_31	[p3l1025t1331r1168b1370],
12	efforts	NNS	O	effort	dobj	11	SENT_31	[p3l1179t1331r1278b1360],
13	to	TO	O	to	aux	14	SENT_31	[p3l1288t1340r1319b1360],
14	develop	VB	O	develop	xcomp	11	SENT_31	[p3l1329t1331r1449b1369],
15	antiviral	JJ	O	antiviral	amod	16	SENT_31	[p3l1460t1331r1587b1360],
16	agents	NNS	O	agent	dobj	14	SENT_31	[p3l1598t1339r1696b1370],
17	directed	VBN	O	direct	partmod	16	SENT_31	[p3l1707t1331r1833b1360],
18	against	IN	O	against	_	0	SENT_31	[p3l1843t1333r1953b1370],
19	the	DT	O	the	det	20	SENT_31	[p3l1961t1331r2010b1360],
20	three	CD	NUMBER	three	prep_against	17	SENT_31	[p3l2020t1331r2101b1360],
21	virally	RB	O	virally	advmod	22	SENT_31	[p3l581t1379r681b1418],
22	encoded	VBN	O	encode	partmod	20	SENT_31	[p3l692t1379r822b1408],
23	enzymes	NNS	O	enzyme	dobj	22	SENT_31	[p3l835t1390r967b1418],
24	that	WDT	O	that	nsubj	26	SENT_31	[p3l979t1379r1041b1408],
25	are	VBP	O	be	cop	26	SENT_31	[p3l1053t1390r1099b1408],
26	essential	JJ	O	essential	rcmod	23	SENT_31	[p3l1112t1379r1243b1408],
27	for	IN	O	for	_	0	SENT_31	[p3l1255t1379r1300b1408],
28	HIV-1	NN	O	hiv-1	nn	29	SENT_31	[p3l1312t1380r1412b1408],
29	replication	NN	O	replication	prep_for	26	SENT_31	[p3l1427t1379r1604b1418],
30	:	:	O	:	_	0	SENT_31	[p3l1427t1379r1604b1418],
31	reverse	JJ	O	reverse	amod	32	SENT_31	[p3l1617t1390r1728b1408],
32	transcriptase	NN	O	transcriptase	conj_and	16	SENT_31	[p3l1740t1381r1947b1418],
33	,	,	O	,	_	0	SENT_31	[p3l1740t1381r1947b1418],
34	protease	NN	O	protease	appos	32	SENT_31	[p3l1961t1387r2100b1418],
35	,	,	O	,	_	0	SENT_31	[p3l1961t1387r2100b1418],
36	and	CC	O	and	_	0	SENT_31	[p3l583t1427r639b1456],
37	integrase	NN	O	integrase	conj_and	16	SENT_31	[p3l647t1428r796b1466],
38	.	.	O	.	_	0	SENT_31	[p3l647t1428r796b1466],

1	These	DT	O	these	det	2	SENT_32	[p3l805t1427r903b1456],
2	efforts	NNS	O	effort	nsubj	4	SENT_32	[p3l912t1427r1011b1456],
3	quickly	RB	O	quickly	advmod	4	SENT_32	[p3l1021t1427r1135b1466],
4	resulted	VBD	O	result	_	0	SENT_32	[p3l1141t1427r1266b1456],
5	in	IN	O	in	mark	18	SENT_32	[p3l1274t1428r1304b1456],
6	the	DT	O	the	det	7	SENT_32	[p3l1312t1427r1361b1456],
7	identiﬁcation	NN	O	identiﬁcation	nsubj	18	SENT_32	[p3l1369t1427r1578b1456],
8	and	CC	O	and	_	0	SENT_32	[p3l1587t1427r1642b1456],
9	development	NN	O	development	nsubj	18	SENT_32	[p3l1651t1427r1854b1466],
10	of	IN	O	of	_	0	SENT_32	[p3l1862t1427r1896b1456],
11	two	CD	NUMBER	two	num	13	SENT_32	[p3l1900t1435r1957b1456],
12	different	JJ	O	different	amod	13	SENT_32	[p3l1967t1427r2102b1456],
13	classes	NNS	O	class	prep_of	7	SENT_32	[p3l583t1475r683b1505],
14	of	IN	O	of	_	0	SENT_32	[p3l692t1475r726b1505],
15	reverse	JJ	O	reverse	amod	17	SENT_32	[p3l729t1486r839b1505],
16	transcriptase	NN	O	transcriptase	nn	17	SENT_32	[p3l847t1477r1045b1514],
17	inhibitors	NNS	O	inhibitor	prep_of	13	SENT_32	[p3l1053t1475r1205b1505],
18	(	VBP	O	(	advcl	4	SENT_32	[p3l1213t1475r1273b1512],
19	the	DT	O	the	det	20	SENT_32	[p3l1213t1475r1273b1512],
20	nucleosides	NNS	O	nucleoside	dobj	18	SENT_32	[p3l1280t1475r1460b1505],
21	and	CC	O	and	_	0	SENT_32	[p3l1468t1475r1523b1505],
22	nonnucleosides	NNS	O	nonnucleoside	dobj	18	SENT_32	[p3l1530t1475r1783b1512],
23	)	CD	NUMBER	)	dep	20	SENT_32	[p3l1530t1475r1783b1512],
24	and	CC	O	and	_	0	SENT_32	[p3l1792t1475r1847b1505],
25	inhibitors	NNS	O	inhibitor	conj_and	20	SENT_32	[p3l1854t1475r2006b1505],
26	of	IN	O	of	_	0	SENT_32	[p3l2015t1475r2049b1505],
27	the	DT	O	the	det	29	SENT_32	[p3l2052t1475r2101b1505],
28	viral	JJ	O	viral	amod	29	SENT_32	[p3l581t1523r651b1552],
29	protease	NN	O	protease	prep_of	25	SENT_32	[p3l661t1531r800b1562],
30	.	.	O	.	_	0	SENT_32	[p3l661t1531r800b1562],

1	As	IN	O	as	mark	7	SENT_33	[p3l810t1524r848b1552],
2	an	DT	O	a	det	3	SENT_33	[p3l860t1534r895b1552],
3	understanding	NN	O	understanding	nsubj	7	SENT_33	[p3l905t1523r1132b1562],
4	of	IN	O	of	_	0	SENT_33	[p3l1142t1523r1176b1552],
5	HIV-1	NN	O	hiv-1	nn	6	SENT_33	[p3l1182t1524r1282b1552],
6	replication	NN	O	replication	prep_of	3	SENT_33	[p3l1295t1523r1464b1562],
7	elucidated	VBD	O	elucidate	advcl	22	SENT_33	[p3l1475t1523r1634b1552],
8	the	DT	O	the	det	10	SENT_33	[p3l1644t1523r1693b1552],
9	molecular	JJ	O	molecular	amod	10	SENT_33	[p3l1703t1523r1860b1552],
10	mechanisms	NNS	O	mechanism	dobj	7	SENT_33	[p3l1869t1523r2060b1552],
11	of	IN	O	of	_	0	SENT_33	[p3l2071t1523r2105b1552],
12	viral	JJ	O	viral	amod	13	SENT_33	[p3l581t1571r650b1600],
13	fusion	NN	O	fusion	prep_of	10	SENT_33	[p3l659t1571r754b1600],
14	and	CC	O	and	_	0	SENT_33	[p3l763t1571r819b1600],
15	entry	NN	O	entry	prep_of	10	SENT_33	[p3l828t1579r914b1610],
16	,	,	O	,	_	0	SENT_33	[p3l828t1579r914b1610],
17	inhibitors	NNS	O	inhibitor	nsubjpass	22	SENT_33	[p3l923t1571r1075b1600],
18	preventing	VBG	O	prevent	partmod	17	SENT_33	[p3l1084t1572r1254b1610],
19	these	DT	O	these	det	20	SENT_33	[p3l1261t1571r1341b1600],
20	processes	NNS	O	process	dobj	18	SENT_33	[p3l1350t1582r1495b1610],
21	were	VBD	O	be	auxpass	22	SENT_33	[p3l1503t1582r1578b1600],
22	identiﬁed	VBN	O	identiﬁed	_	0	SENT_33	[p3l1586t1571r1743b1600],
23	.	.	O	.	_	0	SENT_33	[p3l1586t1571r1743b1600],

1	By	IN	O	by	_	0	SENT_34	[p3l1754t1572r1796b1610],
2	2007	CD	DATE	2007	agent	17	SENT_34	[p3l1803t1572r1887b1607],
3	,	,	O	,	_	0	SENT_34	[p3l1803t1572r1887b1607],
4	more	JJR	O	more	mwe	5	SENT_34	[p3l1896t1582r1978b1600],
5	than	IN	O	than	quantmod	6	SENT_34	[p3l1986t1571r2055b1600],
6	21	CD	NUMBER	21	num	8	SENT_34	[p3l2064t1573r2097b1600],
7	different	JJ	O	different	amod	8	SENT_34	[p3l583t1621r719b1650],
8	agents	NNS	O	agent	nsubjpass	17	SENT_34	[p3l728t1629r826b1660],
9	targeting	VBG	O	target	partmod	8	SENT_34	[p3l836t1623r979b1660],
10	the	DT	O	the	det	13	SENT_34	[p3l987t1621r1036b1650],
11	viral	JJ	O	viral	amod	13	SENT_34	[p3l1044t1621r1114b1650],
12	reverse	JJ	O	reverse	amod	13	SENT_34	[p3l1123t1632r1233b1650],
13	transcriptase	NN	O	transcriptase	dobj	9	SENT_34	[p3l1243t1623r1442b1660],
14	and	CC	O	and	_	0	SENT_34	[p3l1452t1621r1507b1650],
15	protease	NN	O	protease	dobj	9	SENT_34	[p3l1517t1630r1647b1660],
16	were	VBD	O	be	auxpass	17	SENT_34	[p3l1656t1632r1731b1650],
17	licensed	VBN	O	license	_	0	SENT_34	[p3l1741t1621r1866b1650],
18	to	TO	O	to	aux	19	SENT_34	[p3l1876t1629r1906b1650],
19	treat	VB	O	treat	xcomp	17	SENT_34	[p3l1916t1629r1989b1650],
20	HIV-1	NN	MISC	hiv-1	nn	21	SENT_34	[p3l1997t1623r2097b1651],
21	infection	NN	O	infection	dobj	19	SENT_34	[p3l582t1672r730b1707],
22	,	,	O	,	_	0	SENT_34	[p3l582t1672r730b1707],
23	and	CC	O	and	_	0	SENT_34	[p3l741t1671r796b1700],
24	T20	NN	TIME	t20	nsubj	36	SENT_34	[p3l804t1672r880b1707],
25	,	,	O	,	_	0	SENT_34	[p3l804t1672r880b1707],
26	an	DT	O	a	det	29	SENT_34	[p3l890t1682r926b1700],
27	injectable	JJ	O	injectable	amod	29	SENT_34	[p3l934t1671r1084b1710],
28	peptide	NN	O	peptide	nn	29	SENT_34	[p3l1093t1671r1209b1710],
29	inhibitor	NN	O	inhibitor	appos	24	SENT_34	[p3l1218t1671r1357b1700],
30	of	IN	O	of	_	0	SENT_34	[p3l1366t1672r1400b1700],
31	viral	JJ	O	viral	amod	32	SENT_34	[p3l1403t1672r1472b1700],
32	fusion	NN	O	fusion	prep_of	29	SENT_34	[p3l1481t1672r1585b1707],
33	,	,	O	,	_	0	SENT_34	[p3l1481t1672r1585b1707],
34	had	VBD	O	have	aux	36	SENT_34	[p3l1594t1671r1651b1700],
35	been	VBN	O	be	cop	36	SENT_34	[p3l1659t1671r1734b1700],
36	available	JJ	O	available	conj_and	17	SENT_34	[p3l1743t1671r1876b1700],
37	for	IN	O	for	_	0	SENT_34	[p3l1885t1672r1931b1700],
38	four	CD	DURATION	four	num	39	SENT_34	[p3l1939t1672r2004b1700],
39	years	NNS	NUMBER	year	prep_for	36	SENT_34	[p3l2011t1682r2099b1710],
40	.	.	O	.	_	0	SENT_34	[p3l2011t1682r2099b1710],

1	The	DT	DATE	the	det	2	SENT_35	[p3l582t1721r648b1750],
2	year	NN	DATE	year	tmod	4	SENT_35	[p3l659t1732r726b1760],
3	2007	CD	DATE	2007	nsubj	4	SENT_35	[p3l738t1722r812b1751],
4	marked	VBD	O	mark	_	0	SENT_35	[p3l825t1721r942b1750],
5	a	DT	O	a	det	7	SENT_35	[p3l955t1732r970b1750],
6	signiﬁcant	JJ	O	signiﬁcant	amod	7	SENT_35	[p3l982t1721r1144b1760],
7	milestone	NN	O	milestone	dobj	4	SENT_35	[p3l1155t1721r1307b1750],
8	in	IN	O	in	_	0	SENT_35	[p3l1319t1723r1349b1750],
9	the	DT	O	the	det	10	SENT_35	[p3l1361t1721r1410b1750],
10	history	NN	O	history	prep_in	4	SENT_35	[p3l1422t1721r1532b1760],
11	of	IN	O	of	_	0	SENT_35	[p3l1543t1721r1577b1750],
12	antiretroviral	JJ	O	antiretroviral	amod	14	SENT_35	[p3l1586t1721r1792b1750],
13	drug	NN	O	drug	nn	14	SENT_35	[p3l1805t1721r1878b1760],
14	development	NN	O	development	prep_of	10	SENT_35	[p3l1889t1721r2100b1760],
15	;	:	O	;	_	0	SENT_35	[p3l1889t1721r2100b1760],
16	after	IN	O	after	_	0	SENT_35	[p3l583t1771r655b1800],
17	more	JJR	DURATION	more	mwe	18	SENT_35	[p3l663t1782r745b1800],
18	than	IN	DURATION	than	quantmod	19	SENT_35	[p3l755t1771r824b1800],
19	a	DT	DURATION	a	num	20	SENT_35	[p3l834t1782r848b1800],
20	decade	NN	DURATION	decade	prep_after	48	SENT_35	[p3l859t1771r964b1800],
21	since	IN	O	since	_	0	SENT_35	[p3l974t1773r1051b1800],
22	the	DT	O	the	det	23	SENT_35	[p3l1061t1771r1110b1800],
23	introduction	NN	O	introduction	prep_since	20	SENT_35	[p3l1119t1771r1317b1800],
24	of	IN	O	of	_	0	SENT_35	[p3l1327t1771r1361b1800],
25	the	DT	O	the	det	26	SENT_35	[p3l1366t1771r1415b1800],
26	concept	NN	O	concept	prep_of	23	SENT_35	[p3l1425t1779r1548b1810],
27	of	IN	O	of	_	0	SENT_35	[p3l1557t1771r1591b1800],
28	three-drug	JJ	O	three-drug	amod	30	SENT_35	[p3l1596t1771r1767b1810],
29	combination	NN	O	combination	nn	30	SENT_35	[p3l1776t1771r1973b1800],
30	therapy	NN	O	therapy	prep_of	26	SENT_35	[p3l1983t1771r2103b1810],
31	or	CC	O	or	_	0	SENT_35	[p3l583t1832r617b1850],
32	highly	RB	O	highly	advmod	33	SENT_35	[p3l630t1821r730b1860],
33	active	JJ	O	active	amod	35	SENT_35	[p3l742t1823r831b1850],
34	antiretroviral	JJ	O	antiretroviral	amod	35	SENT_35	[p3l845t1821r1052b1850],
35	therapy	NN	O	therapy	prep_after	48	SENT_35	[p3l1066t1821r1186b1860],
36	(	CD	NUMBER	(	num	37	SENT_35	[p3l1199t1822r1364b1857],
37	HAART	NNP	O	HAART	dep	35	SENT_35	[p3l1199t1822r1364b1857],
38	)	CD	NUMBER	)	num	37	SENT_35	[p3l1199t1822r1364b1857],
39	,	,	O	,	_	0	SENT_35	[p3l1199t1822r1364b1857],
40	two	CD	NUMBER	two	num	43	SENT_35	[p3l1379t1829r1436b1850],
41	entirely	RB	O	entirely	advmod	42	SENT_35	[p3l1451t1821r1572b1860],
42	new	JJ	O	new	amod	43	SENT_35	[p3l1584t1832r1648b1850],
43	classes	NNS	O	class	nsubj	48	SENT_35	[p3l1662t1821r1762b1850],
44	of	IN	O	of	_	0	SENT_35	[p3l1776t1821r1811b1850],
45	oral	JJ	O	oral	amod	47	SENT_35	[p3l1821t1821r1880b1850],
46	antiretroviral	JJ	O	antiretroviral	amod	47	SENT_35	[p3l1895t1821r2101b1850],
47	agents	NNS	O	agent	prep_of	43	SENT_35	[p3l583t1879r681b1910],
48	received	VBD	O	receive	parataxis	4	SENT_35	[p3l691t1871r820b1900],
49	FDA	NNP	ORGANIZATION	FDA	nn	50	SENT_35	[p3l829t1872r909b1900],
50	approval	NN	O	approval	dobj	48	SENT_35	[p3l916t1871r1058b1909],
51	:	:	O	:	_	0	SENT_35	[p3l916t1871r1058b1909],
52	Maraviroc	NNP	PERSON	Maraviroc	dep	50	SENT_35	[p3l1067t1872r1238b1906],
53	,	,	O	,	_	0	SENT_35	[p3l1067t1872r1238b1906],
54	a	DT	O	a	det	57	SENT_35	[p3l1249t1882r1263b1900],
55	CCR5	NN	O	ccr5	nn	57	SENT_35	[p3l1273t1872r1371b1900],
56	receptor	NN	O	receptor	nn	57	SENT_35	[p3l1382t1879r1515b1909],
57	antagonist	NN	O	antagonist	appos	52	SENT_35	[p3l1523t1873r1686b1910],
58	that	WDT	O	that	nsubj	59	SENT_35	[p3l1694t1871r1756b1900],
59	blocks	VBZ	O	block	rcmod	57	SENT_35	[p3l1764t1871r1861b1900],
60	viral	JJ	O	viral	amod	61	SENT_35	[p3l1869t1871r1939b1900],
61	entry	NN	O	entry	dobj	59	SENT_35	[p3l1948t1879r2035b1910],
62	,	,	O	,	_	0	SENT_35	[p3l1948t1879r2035b1910],
63	and	CC	O	and	_	0	SENT_35	[p3l2045t1871r2101b1900],
64	raltegravir	NN	O	raltegravir	dobj	48	SENT_35	[p3l583t1921r751b1960],
65	,	,	O	,	_	0	SENT_35	[p3l583t1921r751b1960],
66	the	DT	O	the	det	68	SENT_35	[p3l764t1921r813b1950],
67	ﬁrst	NN	O	ﬁrst	nn	68	SENT_35	[p3l824t1921r886b1950],
68	inhibitor	NN	O	inhibitor	appos	64	SENT_35	[p3l896t1921r1035b1950],
69	of	IN	O	of	_	0	SENT_35	[p3l1046t1921r1080b1950],
70	HIV-1	NN	MISC	hiv-1	nn	71	SENT_35	[p3l1087t1922r1187b1950],
71	integrase	NN	O	integrase	prep_of	68	SENT_35	[p3l1201t1923r1351b1960],
72	.	.	O	.	_	0	SENT_35	[p3l1201t1923r1351b1960],

1	The	DT	O	the	det	2	SENT_36	[p3l632t1971r698b2000],
2	advent	NN	O	advent	nsubj	17	SENT_36	[p3l716t1971r819b2000],
3	of	IN	O	of	_	0	SENT_36	[p3l836t1971r870b2000],
4	HAART	NNP	O	HAART	prep_of	2	SENT_36	[p3l882t1972r1018b1999],
5	as	IN	O	as	_	0	SENT_36	[p3l1034t1982r1062b2000],
6	the	DT	O	the	det	7	SENT_36	[p3l1080t1971r1128b2000],
7	standard	NN	O	standard	prep_as	4	SENT_36	[p3l1146t1971r1279b2000],
8	of	IN	O	of	_	0	SENT_36	[p3l1296t1971r1331b2000],
9	care	NN	O	care	prep_of	7	SENT_36	[p3l1344t1982r1407b2000],
10	for	IN	O	for	_	0	SENT_36	[p3l1424t1971r1469b2000],
11	the	DT	O	the	det	12	SENT_36	[p3l1486t1971r1534b2000],
12	treatment	NN	O	treatment	prep_for	9	SENT_36	[p3l1552t1979r1706b2000],
13	of	IN	O	of	_	0	SENT_36	[p3l1722t1971r1757b2000],
14	HIV-1	NN	MISC	hiv-1	nn	15	SENT_36	[p3l1769t1972r1869b2000],
15	infection	NN	O	infection	prep_of	12	SENT_36	[p3l1889t1971r2029b2000],
16	was	VBD	O	be	cop	17	SENT_36	[p3l2044t1982r2101b2000],
17	seminal	JJ	O	seminal	_	0	SENT_36	[p3l583t2021r702b2050],
18	in	IN	O	in	_	0	SENT_36	[p3l711t2022r742b2049],
19	reducing	VBG	O	reduce	prepc_in	17	SENT_36	[p3l751t2021r890b2059],
20	the	DT	O	the	det	21	SENT_36	[p3l899t2021r948b2050],
21	morbidity	NN	O	morbidity	dobj	19	SENT_36	[p3l958t2021r1116b2059],
22	and	CC	O	and	_	0	SENT_36	[p3l1124t2021r1180b2050],
23	mortality	NN	O	mortality	conj_and	21	SENT_36	[p3l1190t2021r1336b2059],
24	associated	VBN	O	associate	partmod	21	SENT_36	[p3l1345t2021r1500b2050],
25	with	IN	O	with	_	0	SENT_36	[p3l1509t2021r1579b2050],
26	HIV-1	NN	MISC	hiv-1	nn	27	SENT_36	[p3l1589t2022r1689b2050],
27	infection	NN	O	infection	prep_with	24	SENT_36	[p3l1702t2021r1842b2050],
28	and	CC	O	and	_	0	SENT_36	[p3l1852t2021r1907b2050],
29	progression	NN	O	progression	conj_and	27	SENT_36	[p3l1917t2022r2101b2059],
30	to	TO	O	to	_	0	SENT_36	[p3l583t2079r613b2100],
31	AIDS	NNP	MISC	AIDS	nn	32	SENT_36	[p3l622t2072r711b2100],
32	(	NN	O	(	prep_to	24	SENT_36	[p3l722t2072r760b2107],
33	1	CD	NUMBER	1	num	32	SENT_36	[p3l722t2072r760b2107],
34	,	,	O	,	_	0	SENT_36	[p3l722t2072r760b2107],
35	2	CD	NUMBER	2	num	36	SENT_36	[p3l770t2072r808b2107],
36	)	NN	O	)	appos	32	SENT_36	[p3l770t2072r808b2107],
37	.	.	O	.	_	0	SENT_36	[p3l770t2072r808b2107],

1	Combination	NN	O	combination	nn	3	SENT_37	[p3l820t2071r1029b2100],
2	antiretroviral	JJ	O	antiretroviral	amod	3	SENT_37	[p3l1038t2071r1244b2100],
3	therapy	NN	O	therapy	nsubj	9	SENT_37	[p3l1254t2071r1374b2110],
4	dramatically	RB	O	dramatically	advmod	5	SENT_37	[p3l1382t2071r1575b2110],
5	suppresses	VBZ	O	suppress	_	0	SENT_37	[p3l1583t2082r1745b2109],
6	HIV-1	NN	MISC	hiv-1	nn	7	SENT_37	[p3l1755t2072r1855b2100],
7	replication	NN	O	replication	dobj	5	SENT_37	[p3l1868t2071r2036b2109],
8	and	CC	O	and	_	0	SENT_37	[p3l2045t2071r2101b2100],
9	aded	VBD	O	ade	conj_and	5	SENT_37	[p3l55t2050r78b2113],
10	from	IN	O	from	_	0	SENT_37	[p3l55t1977r78b2041],
11	www.annua]reviews.org	NN	O	www.annua]reviews.org	prep_from	9	SENT_37	[p3l55t1643r85b1968],
12	4	CD	NUMBER	4	num	11	SENT_37	[p3l88t2085r112b2108],
13	.	.	O	.	_	0	SENT_37	[p3l88t2085r112b2108],

1	For	IN	O	for	_	0	SENT_38	[p3l89t2028r112b2074],
2	personal	JJ	O	personal	amod	3	SENT_38	[p3l88t1907r119b2019],
3	use	NN	O	use	pobj	1	SENT_38	[p3l96t1854r112b1898],
4	only	RB	O	only	advmod	3	SENT_38	[p3l88t1780r119b1845],
5	.	.	O	.	_	0	SENT_38	[p3l88t1780r119b1845],

1	reduces	VBZ	O	reduce	_	0	SENT_39	[p3l582t2178r701b2207],
2	the	DT	O	the	det	6	SENT_39	[p3l712t2178r760b2207],
3	plasma	NN	O	plasma	nn	6	SENT_39	[p3l770t2178r878b2216],
4	HIV-1	NN	MISC	hiv-1	nn	6	SENT_39	[p3l888t2179r988b2207],
5	viral	JJ	O	viral	amod	6	SENT_39	[p3l1000t2178r1070b2207],
6	load	NN	O	load	dobj	1	SENT_39	[p3l1080t2178r1154b2213],
7	,	,	O	,	_	0	SENT_39	[p3l1080t2178r1154b2213],
8	resulting	VBG	O	result	partmod	1	SENT_39	[p3l1165t2178r1305b2216],
9	in	IN	O	in	_	0	SENT_39	[p3l1313t2179r1344b2206],
10	signiﬁcant	JJ	O	signiﬁcant	amod	11	SENT_39	[p3l1354t2178r1516b2216],
11	reconstitution	NN	O	reconstitution	prep_in	8	SENT_39	[p3l1525t2179r1746b2207],
12	of	IN	O	of	_	0	SENT_39	[p3l1757t2178r1791b2207],
13	the	DT	O	the	det	15	SENT_39	[p3l1797t2178r1846b2207],
14	immune	JJ	O	immune	amod	15	SENT_39	[p3l1856t2179r1985b2207],
15	system	NN	O	system	prep_of	11	SENT_39	[p3l1996t2186r2101b2216],
16	(	CD	NUMBER	(	num	18	SENT_39	[p3l584t2229r670b2264],
17	3-7	CD	NUMBER	3-7	num	18	SENT_39	[p3l584t2229r670b2264],
18	)	NN	O	)	dobj	8	SENT_39	[p3l584t2229r670b2264],
19	.	.	O	.	_	0	SENT_39	[p3l584t2229r670b2264],

1	Combination	NN	O	combination	nn	2	SENT_40	[p3l683t2228r892b2257],
2	therapy	NN	O	therapy	nsubj	13	SENT_40	[p3l902t2228r1022b2266],
3	using	VBG	O	use	partmod	2	SENT_40	[p3l1029t2229r1114b2266],
4	agents	NNS	O	agent	dobj	3	SENT_40	[p3l1124t2236r1222b2266],
5	directed	VBN	O	direct	partmod	4	SENT_40	[p3l1233t2227r1359b2257],
6	against	IN	O	against	_	0	SENT_40	[p3l1370t2229r1479b2266],
7	at	IN	O	at	quantmod	9	SENT_40	[p3l1488t2236r1517b2257],
8	least	JJS	O	least	mwe	7	SENT_40	[p3l1525t2228r1596b2257],
9	two	CD	NUMBER	two	num	12	SENT_40	[p3l1605t2236r1662b2257],
10	distinct	JJ	O	distinct	amod	12	SENT_40	[p3l1673t2228r1789b2257],
11	molecular	JJ	O	molecular	amod	12	SENT_40	[p3l1797t2227r1954b2257],
12	targets	NNS	O	target	prep_against	5	SENT_40	[p3l1963t2236r2068b2266],
13	is	VBZ	O	be	_	0	SENT_40	[p3l2078t2229r2101b2257],

1	Downlo	NNP	O	Downlo	_	0	SENT_41	[p3l55t2171r78b2277],
2	01/05/1	CD	NUMBER	01/05/1	dep	1	SENT_41	[p3l88t2170r112b2266],

1	also	RB	O	also	_	0	SENT_42	[p3l583t2335r642b2364],
2	the	DT	O	the	det	4	SENT_42	[p3l654t2335r702b2364],
3	underlying	VBG	O	underlie	amod	4	SENT_42	[p3l713t2335r885b2374],
4	basis	NN	O	basis	dep	1	SENT_42	[p3l895t2335r968b2364],
5	for	IN	O	for	_	0	SENT_42	[p3l980t2335r1026b2364],
6	forestalling	VBG	O	forestall	amod	8	SENT_42	[p3l1037t2335r1214b2374],
7	drug	NN	O	drug	nn	8	SENT_42	[p3l1225t2335r1298b2374],
8	resistance	NN	O	resistance	prep_for	4	SENT_42	[p3l1308t2337r1469b2364],
9	.	.	O	.	_	0	SENT_42	[p3l1308t2337r1469b2364],

1	However	RB	O	however	advmod	15	SENT_43	[p3l1481t2337r1631b2371],
2	,	,	O	,	_	0	SENT_43	[p3l1481t2337r1631b2371],
3	despite	IN	O	despite	_	0	SENT_43	[p3l1645t2335r1754b2374],
4	the	DT	O	the	det	6	SENT_43	[p3l1766t2335r1814b2364],
5	many	JJ	O	many	amod	6	SENT_43	[p3l1826t2346r1913b2374],
6	advances	NNS	O	advance	prep_despite	15	SENT_43	[p3l1923t2335r2059b2364],
7	in	IN	O	in	_	0	SENT_43	[p3l2071t2337r2101b2364],
8	diagnosis	NN	O	diagnosis	prep_in	6	SENT_43	[p3l583t2385r726b2424],
9	and	CC	O	and	_	0	SENT_43	[p3l739t2385r795b2414],
10	treatment	NN	O	treatment	conj_and	8	SENT_43	[p3l807t2394r969b2420],
11	,	,	O	,	_	0	SENT_43	[p3l807t2394r969b2420],
12	the	DT	O	the	det	13	SENT_43	[p3l983t2385r1032b2414],
13	HIV-1	NN	MISC	hiv-1	nsubj	15	SENT_43	[p3l1044t2387r1144b2414],
14	epidemic	JJ	O	epidemic	amod	13	SENT_43	[p3l1161t2385r1302b2423],
15	continues	VBZ	O	continue	_	0	SENT_43	[p3l1314t2387r1473b2414],
16	.	.	O	.	_	0	SENT_43	[p3l1314t2387r1473b2414],

1	It	PRP	O	it	nsubjpass	3	SENT_44	[p3l1486t2387r1513b2414],
2	is	VBZ	O	be	auxpass	3	SENT_44	[p3l1523t2387r1546b2414],
3	estimated	VBN	O	estimate	_	0	SENT_44	[p3l1559t2385r1709b2414],
4	that	IN	O	that	complm	10	SENT_44	[p3l1721t2385r1783b2414],
5	39.5	CD	NUMBER	39.5	number	6	SENT_44	[p3l1796t2387r1858b2414],
6	million	CD	NUMBER	million	num	7	SENT_44	[p3l1873t2385r1985b2414],
7	people	NNS	O	people	nsubjpass	10	SENT_44	[p3l1997t2385r2101b2424],
8	are	VBP	O	be	auxpass	10	SENT_44	[p3l583t2446r629b2464],
9	currently	RB	DATE	currently	advmod	10	SENT_44	[p3l640t2435r785b2474],
10	infected	VBN	O	infect	ccomp	3	SENT_44	[p3l793t2435r918b2464],
11	worldwide	RB	O	worldwide	advmod	10	SENT_44	[p3l927t2435r1101b2464],
12	.	.	O	.	_	0	SENT_44	[p3l927t2435r1101b2464],

1	With	IN	O	with	_	0	SENT_45	[p3l1111t2435r1194b2464],
2	4.3	CD	NUMBER	4.3	number	3	SENT_45	[p3l1204t2437r1248b2464],
3	million	CD	NUMBER	million	num	5	SENT_45	[p3l1262t2435r1374b2464],
4	new	JJ	O	new	amod	5	SENT_45	[p3l1383t2446r1448b2464],
5	infections	NNS	O	infection	prep_with	14	SENT_45	[p3l1457t2435r1609b2464],
6	and	CC	O	and	_	0	SENT_45	[p3l1621t2435r1676b2464],
7	2.9	CD	NUMBER	2.9	number	8	SENT_45	[p3l1687t2437r1733b2464],
8	million	CD	NUMBER	million	num	9	SENT_45	[p3l1743t2435r1856b2464],
9	deaths	NNS	O	death	prep_with	14	SENT_45	[p3l1866t2435r1965b2464],
10	in	IN	O	in	_	0	SENT_45	[p3l1975t2437r2005b2464],
11	2006	CD	DATE	2006	prep_in	9	SENT_45	[p3l2016t2437r2100b2470],
12	,	,	O	,	_	0	SENT_45	[p3l2016t2437r2100b2470],
13	HIV/AIDS	NN	O	hiv/aids	nsubj	14	SENT_45	[p3l583t2486r759b2514],
14	remains	VBZ	O	remain	_	0	SENT_45	[p3l773t2486r896b2514],
15	one	CD	NUMBER	one	nsubj	24	SENT_45	[p3l910t2496r966b2514],
16	of	IN	O	of	_	0	SENT_45	[p3l980t2485r1014b2514],
17	the	DT	O	the	det	19	SENT_45	[p3l1023t2485r1072b2514],
18	leading	VBG	O	lead	amod	19	SENT_45	[p3l1085t2485r1200b2523],
19	causes	NNS	O	cause	prep_of	15	SENT_45	[p3l1212t2496r1308b2514],
20	of	IN	O	of	_	0	SENT_45	[p3l1322t2485r1357b2514],
21	infectious	JJ	O	infectious	amod	23	SENT_45	[p3l1365t2485r1517b2514],
22	disease	NN	O	disease	nn	23	SENT_45	[p3l1532t2485r1766b2514],
23	—	NN	O	—	prep_of	19	SENT_45	[p3l1532t2485r1766b2514],
24	related	JJ	O	related	ccomp	14	SENT_45	[p3l1532t2485r1766b2514],
25	mortality	NN	O	mortality	nn	27	SENT_45	[p3l1779t2485r1925b2523],
26	worldwide	JJ	O	worldwide	amod	27	SENT_45	[p3l1936t2485r2101b2514],
27	(	NN	O	(	dobj	24	SENT_45	[p3l584t2536r632b2571, p3l631t2584r780b2623],
28	3	CD	NUMBER	3	num	29	SENT_45	[p3l584t2536r632b2571, p3l631t2584r780b2623],
29	)	NN	O	)	dep	34	SENT_45	[p3l584t2536r632b2571, p3l631t2584r780b2623],
30	Although	IN	O	although	dep	34	SENT_45	[p3l584t2536r632b2571, p3l631t2584r780b2623],
31	HAART	NN	O	haart	nsubj	34	SENT_45	[p3l795t2585r931b2613],
32	has	VBZ	O	have	aux	34	SENT_45	[p3l945t2584r995b2613],
33	signiﬁcantly	RB	O	signiﬁcantly	advmod	34	SENT_45	[p3l1012t2584r1202b2623],
34	improved	VBN	O	improve	advcl	65	SENT_45	[p3l1216t2584r1366b2623],
35	morbidity	NN	O	morbidity	dobj	34	SENT_45	[p3l1382t2584r1539b2623],
36	and	CC	O	and	_	0	SENT_45	[p3l1554t2584r1609b2613],
37	mortality	NN	O	mortality	dobj	34	SENT_45	[p3l1625t2584r1775b2623],
38	,	,	O	,	_	0	SENT_45	[p3l1625t2584r1775b2623],
39	because	IN	O	because	mark	45	SENT_45	[p3l1792t2584r1912b2613],
40	HIV-1	NN	O	hiv-1	nsubj	45	SENT_45	[p3l1928t2586r2028b2613],
41	is	VBZ	O	be	cop	45	SENT_45	[p3l2047t2586r2070b2613],
42	a	DT	O	a	det	45	SENT_45	[p3l2086t2596r2101b2613],
43	chronic	JJ	O	chronic	amod	45	SENT_45	[p3l583t2634r701b2663],
44	viral	JJ	O	viral	amod	45	SENT_45	[p3l711t2634r781b2663],
45	infection	NN	O	infection	advcl	34	SENT_45	[p3l792t2634r932b2663],
46	and	CC	O	and	_	0	SENT_45	[p3l944t2634r999b2663],
47	there	EX	O	there	expl	48	SENT_45	[p3l1011t2634r1092b2663],
48	is	VBZ	O	be	advcl	34	SENT_45	[p3l1103t2636r1126b2663],
49	currently	RB	DATE	currently	advmod	48	SENT_45	[p3l1139t2634r1283b2673],
50	no	DT	O	no	det	51	SENT_45	[p3l1293t2645r1332b2663],
51	cure	NN	O	cure	nsubj	48	SENT_45	[p3l1345t2645r1420b2670],
52	,	,	O	,	_	0	SENT_45	[p3l1345t2645r1420b2670],
53	the	DT	O	the	det	54	SENT_45	[p3l1433t2634r1482b2663],
54	prospective	JJ	O	prospective	nsubj	65	SENT_45	[p3l1493t2636r1672b2673],
55	of	IN	O	of	_	0	SENT_45	[p3l1684t2634r1719b2663],
56	maintaining	VBG	O	maintain	prepc_of	54	SENT_45	[p3l1726t2636r1915b2673],
57	therapy	NN	O	therapy	dobj	56	SENT_45	[p3l1926t2634r2046b2673],
58	for	IN	O	for	_	0	SENT_45	[p3l2056t2634r2102b2663],
59	the	DT	O	the	det	60	SENT_45	[p3l583t2684r632b2713],
60	lifetime	NN	O	lifetime	prep_for	56	SENT_45	[p3l648t2684r767b2713],
61	of	IN	O	of	_	0	SENT_45	[p3l784t2684r818b2713],
62	a	DT	O	a	det	63	SENT_45	[p3l830t2695r845b2713],
63	patient	NN	O	patient	prep_of	60	SENT_45	[p3l860t2686r970b2722],
64	also	RB	O	also	advmod	65	SENT_45	[p3l985t2684r1044b2713],
65	presents	VBZ	O	present	rcmod	27	SENT_45	[p3l1060t2692r1188b2722],
66	signiﬁcant	JJ	O	signiﬁcant	amod	67	SENT_45	[p3l1205t2684r1367b2723],
67	challenges	NNS	O	challenge	dobj	65	SENT_45	[p3l1382t2684r1551b2723],
68	.	.	O	.	_	0	SENT_45	[p3l1382t2684r1551b2723],

1	The	DT	O	the	det	2	SENT_46	[p3l1568t2684r1634b2713],
2	potential	NN	O	potential	nsubj	12	SENT_46	[p3l1650t2684r1789b2722],
3	for	IN	O	for	_	0	SENT_46	[p3l1805t2684r1851b2713],
4	persistent	JJ	O	persistent	amod	6	SENT_46	[p3l1866t2686r2019b2722],
5	viral	JJ	O	viral	amod	6	SENT_46	[p3l2032t2684r2101b2713],
6	replication	NN	O	replication	prep_for	2	SENT_46	[p3l583t2734r751b2772],
7	in	IN	O	in	_	0	SENT_46	[p3l763t2736r794b2762],
8	compartments	NNS	O	compartment	prep_in	6	SENT_46	[p3l807t2742r1031b2772],
9	and	CC	O	and	_	0	SENT_46	[p3l1045t2734r1100b2763],
10	reservoirs	NNS	O	reservoir	prep_in	6	SENT_46	[p3l1113t2735r1265b2763],
11	may	MD	O	may	aux	12	SENT_46	[p3l1278t2745r1344b2772],
12	continue	VB	O	continue	_	0	SENT_46	[p3l1355t2735r1491b2763],
13	to	TO	O	to	aux	14	SENT_46	[p3l1505t2742r1535b2763],
14	drive	VB	O	drive	xcomp	12	SENT_46	[p3l1549t2734r1626b2763],
15	pathogenic	JJ	O	pathogenic	amod	17	SENT_46	[p3l1639t2734r1812b2772],
16	disease	NN	O	disease	nn	17	SENT_46	[p3l1825t2734r1932b2763],
17	processes	NNS	O	process	dobj	14	SENT_46	[p3l1945t2745r2099b2772],
18	.	.	O	.	_	0	SENT_46	[p3l1945t2745r2099b2772],

1	Adverse	JJ	MISC	adverse	amod	2	SENT_47	[p3l581t2784r706b2813],
2	effects	NNS	O	effect	nsubj	11	SENT_47	[p3l718t2784r816b2813],
3	and	CC	O	and	_	0	SENT_47	[p3l828t2784r883b2813],
4	poor	JJ	O	poor	amod	5	SENT_47	[p3l893t2794r967b2822],
5	tolerability	NN	O	tolerability	conj_and	2	SENT_47	[p3l978t2784r1150b2822],
6	associated	VBN	O	associate	partmod	5	SENT_47	[p3l1160t2784r1315b2813],
7	with	IN	O	with	_	0	SENT_47	[p3l1325t2784r1395b2813],
8	therapy	NN	O	therapy	prep_with	6	SENT_47	[p3l1405t2784r1525b2822],
9	are	VBP	O	be	cop	11	SENT_47	[p3l1534t2795r1580b2813],
10	still	RB	O	still	advmod	11	SENT_47	[p3l1591t2784r1647b2813],
11	issues	NNS	O	issue	_	0	SENT_47	[p3l1657t2785r1745b2813],
12	for	IN	O	for	_	0	SENT_47	[p3l1756t2784r1801b2813],
13	some	DT	O	some	det	14	SENT_47	[p3l1811t2795r1892b2813],
14	patients	NNS	O	patient	prep_for	11	SENT_47	[p3l1902t2785r2033b2822],
15	,	,	O	,	_	0	SENT_47	[p3l1902t2785r2033b2822],
16	and	CC	O	and	_	0	SENT_47	[p3l2045t2784r2101b2813],
17	suboptimal	JJ	O	suboptimal	amod	18	SENT_47	[p3l583t2834r756b2872],
18	pharmacokinetics	NNS	O	pharmacokinetic	nsubj	33	SENT_47	[p3l771t2834r1046b2872],
19	and	CC	O	and	_	0	SENT_47	[p3l1061t2834r1116b2863],
20	drug	NN	O	drug	nn	21	SENT_47	[p3l1131t2833r1204b2872],
21	interactions	NNS	O	interaction	conj_and	18	SENT_47	[p3l1217t2835r1402b2863],
22	with	IN	O	with	_	0	SENT_47	[p3l1415t2834r1485b2863],
23	antiretroviral	JJ	O	antiretroviral	amod	24	SENT_47	[p3l1500t2834r1706b2863],
24	agents	NNS	O	agent	prep_with	18	SENT_47	[p3l1721t2842r1819b2872],
25	and/or	JJ	O	and/or	amod	27	SENT_47	[p3l1834t2834r1939b2863],
26	concomitant	JJ	O	concomitant	amod	27	SENT_47	[p3l1953t2835r2100b2863, p3l583t2892r645b2912],
27	medications	NNS	O	medication	nsubj	30	SENT_47	[p3l655t2883r843b2912],
28	can	MD	O	can	aux	30	SENT_47	[p3l856t2894r909b2912],
29	also	RB	O	also	advmod	30	SENT_47	[p3l921t2883r979b2912],
30	impact	VB	O	impact	rcmod	24	SENT_47	[p3l992t2885r1099b2922],
31	clinical	JJ	O	clinical	amod	32	SENT_47	[p3l1110t2883r1220b2912],
32	outcomes	NNS	O	outcome	dobj	30	SENT_47	[p3l1233t2892r1382b2912],
33	(	VBP	O	(	conj_and	11	SENT_47	[p3l1395t2884r1444b2920],
34	9	CD	NUMBER	9	num	35	SENT_47	[p3l1395t2884r1444b2920],
35	)	NN	O	)	dobj	33	SENT_47	[p3l1395t2884r1444b2920],
36	.	.	O	.	_	0	SENT_47	[p3l1395t2884r1444b2920],

1	In	IN	O	in	_	0	SENT_48	[p3l1457t2885r1491b2912],
2	addition	NN	O	addition	prep_in	19	SENT_48	[p3l1503t2883r1641b2919],
3	,	,	O	,	_	0	SENT_48	[p3l1503t2883r1641b2919],
4	for	IN	O	for	_	0	SENT_48	[p3l1654t2884r1700b2912],
5	all	DT	O	all	prep_for	19	SENT_48	[p3l1712t2883r1747b2912],
6	commonly	RB	O	commonly	advmod	7	SENT_48	[p3l1759t2883r1927b2922],
7	prescribed	VBN	O	prescribe	partmod	5	SENT_48	[p3l1938t2883r2101b2922],
8	by	IN	O	by	_	0	SENT_48	[p3l88t2854r119b2887],
9	University	NNP	ORGANIZATION	University	agent	7	SENT_48	[p3l88t2705r119b2845],
10	of	IN	ORGANIZATION	of	_	0	SENT_48	[p3l88t2667r112b2695],
11	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	9	SENT_48	[p3l88t2520r112b2660],
12	-	:	O	-	_	0	SENT_48	[p3l102t2501r105b2510],
13	Madison	NNP	PERSON	Madison	dep	5	SENT_48	[p3l88t2375r112b2491],
14	on	IN	O	on	_	0	SENT_48	[p3l96t2335r112b2366],
15	antiretroviral	JJ	O	antiretroviral	amod	16	SENT_48	[p3l583t2933r789b2962],
16	agents	NNS	O	agent	prep_on	13	SENT_48	[p3l804t2941r911b2972],
17	,	,	O	,	_	0	SENT_48	[p3l804t2941r911b2972],
18	both	DT	O	both	nsubj	19	SENT_48	[p3l926t2933r998b2962],
19	evolved	VBD	O	evolve	_	0	SENT_48	[p3l1012t2933r1130b2962],
20	and	CC	O	and	_	0	SENT_48	[p3l1144t2933r1200b2962],
21	transmitted	VBD	O	transmit	conj_and	19	SENT_48	[p3l1213t2933r1394b2962],
22	drug	NN	O	drug	nn	23	SENT_48	[p3l1408t2933r1481b2972],
23	resistance	NN	O	resistance	nsubj	26	SENT_48	[p3l1494t2935r1646b2962],
24	is	VBZ	O	be	cop	26	SENT_48	[p3l1660t2935r1682b2962],
25	a	DT	O	a	det	26	SENT_48	[p3l1697t2944r1712b2962],
26	reality	NN	O	reality	ccomp	21	SENT_48	[p3l1725t2933r1829b2972],
27	.	.	O	.	_	0	SENT_48	[p3l1725t2933r1829b2972],

1	For	IN	O	for	_	0	SENT_49	[p3l1844t2935r1901b2962],
2	example	NN	O	example	pobj	1	SENT_49	[p3l1914t2933r2050b2971],
3	,	,	O	,	_	0	SENT_49	[p3l1914t2933r2050b2971],
4	an	DT	O	a	appos	2	SENT_49	[p3l2066t2944r2101b2962],

1	Annu	NNP	PERSON	Annu	_	0	SENT_50	[p3l55t2942r78b3022],
2	.	.	O	.	_	0	SENT_50	[p3l55t2942r78b3022],

1	Rev.	NNP	O	Rev.	nn	2	SENT_51	[p3l55t2871r78b2931],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_51	[p3l55t2712r78b2861],
3	.	.	O	.	_	0	SENT_51	[p3l55t2712r78b2861],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_52	[p3l55t2592r78b2701],
2	.	.	O	.	_	0	SENT_52	[p3l55t2592r78b2701],

1	2009.49:377	CD	NUMBER	2009.49:377	num	2	SENT_53	[p3l55t2346r79b2580],
2	-394	CD	NUMBER	-394	_	0	SENT_53	[p3l55t2346r79b2580],
3	.	.	O	.	_	0	SENT_53	[p3l55t2346r79b2580],

1	analysis	NN	O	analysis	nsubj	21	SENT_54	[p3l583t2983r701b3022],
2	of	IN	O	of	_	0	SENT_54	[p3l715t2983r750b3012],
3	viremic	JJ	O	viremic	amod	4	SENT_54	[p3l757t2985r875b3012],
4	patients	NNS	O	patient	prep_of	1	SENT_54	[p3l888t2985r1010b3022],
5	receiving	VBG	O	receive	partmod	4	SENT_54	[p3l1023t2985r1167b3022],
6	treatment	NN	O	treatment	dobj	5	SENT_54	[p3l1179t2991r1334b3012],
7	for	IN	O	for	_	0	SENT_54	[p3l1346t2983r1392b3012],
8	HIV-1	NN	O	hiv-1	nn	9	SENT_54	[p3l1404t2984r1504b3012],
9	infection	NN	O	infection	prep_for	5	SENT_54	[p3l1521t2983r1660b3012],
10	in	IN	O	in	_	0	SENT_54	[p3l1673t2985r1703b3012],
11	urban	JJ	O	urban	amod	12	SENT_54	[p3l1716t2983r1807b3012],
12	centers	NNS	O	center	prep_in	9	SENT_54	[p3l1821t2991r1931b3012],
13	across	IN	O	across	_	0	SENT_54	[p3l1945t2994r2038b3012],
14	the	DT	O	the	det	16	SENT_54	[p3l2052t2983r2101b3012],
15	United	NNP	LOCATION	United	nn	16	SENT_54	[p3l583t3031r693b3060],
16	States	NNPS	LOCATION	States	prep_across	5	SENT_54	[p3l705t3032r796b3060],
17	in	IN	O	in	_	0	SENT_54	[p3l807t3033r837b3060],
18	the	DT	DATE	the	det	20	SENT_54	[p3l847t3031r896b3060],
19	late	JJ	DATE	late	amod	20	SENT_54	[p3l907t3031r962b3060],
20	1990s	CD	DATE	1990s	prep_in	5	SENT_54	[p3l977t3033r1063b3060],
21	revealed	VBD	O	reveal	_	0	SENT_54	[p3l1074t3031r1203b3060],
22	the	DT	O	the	det	23	SENT_54	[p3l1214t3031r1263b3060],
23	incidence	NN	O	incidence	dobj	21	SENT_54	[p3l1274t3031r1422b3060],
24	of	IN	O	of	_	0	SENT_54	[p3l1434t3031r1468b3060],
25	three-class	JJ	O	three-class	amod	27	SENT_54	[p3l1475t3031r1641b3060],
26	drug	NN	O	drug	nn	27	SENT_54	[p3l1653t3031r1726b3070],
27	resistance	NN	O	resistance	prep_of	23	SENT_54	[p3l1735t3033r1887b3060],
28	to	TO	O	to	aux	34	SENT_54	[p3l1898t3040r1929b3060],
29	be	VB	O	be	cop	34	SENT_54	[p3l1940t3031r1976b3060],
30	slightly	RB	O	slightly	quantmod	33	SENT_54	[p3l1987t3031r2103b3070],
31	more	JJR	O	more	quantmod	33	SENT_54	[p3l583t3090r664b3108],
32	than	IN	O	than	quantmod	33	SENT_54	[p3l681t3079r750b3108],
33	13	CD	PERCENT	13	num	34	SENT_54	[p3l770t3081r848b3115],
34	%	NN	PERCENT	%	xcomp	21	SENT_54	[p3l770t3081r848b3115],
35	,	,	O	,	_	0	SENT_54	[p3l770t3081r848b3115],
36	and	CC	O	and	_	0	SENT_54	[p3l866t3079r922b3108],
37	in	IN	O	in	_	0	SENT_54	[p3l938t3081r968b3108],
38	several	JJ	O	several	amod	39	SENT_54	[p3l985t3079r1091b3108],
39	studies	NNS	O	study	prep_in	56	SENT_54	[p3l1108t3079r1213b3108],
40	the	DT	O	the	det	41	SENT_54	[p3l1231t3079r1279b3108],
41	prevalence	NN	O	prevalence	npadvmod	42	SENT_54	[p3l1296t3079r1463b3118],
42	of	IN	O	of	advmod	43	SENT_54	[p3l1480t3079r1514b3108],
43	transmitted	VBN	O	transmit	partmod	39	SENT_54	[p3l1527t3079r1707b3108],
44	drug	NN	O	drug	nn	45	SENT_54	[p3l1725t3079r1798b3118],
45	resistance	NN	O	resistance	dobj	43	SENT_54	[p3l1813t3081r1965b3108],
46	that	WDT	O	that	nsubj	47	SENT_54	[p3l1982t3079r2044b3108],
47	affected	VBD	O	affect	rcmod	45	SENT_54	[p3l2060t3079r2100b3108, p3l583t3127r677b3156],
48	susceptibility	NN	O	susceptibility	dobj	47	SENT_54	[p3l688t3127r894b3166],
49	to	TO	O	to	_	0	SENT_54	[p3l903t3135r933b3156],
50	one	CD	NUMBER	one	prep_to	47	SENT_54	[p3l945t3138r1001b3156],
51	or	CC	O	or	_	0	SENT_54	[p3l1012t3138r1046b3156],
52	more	JJR	O	more	prep_to	47	SENT_54	[p3l1055t3138r1137b3156],
53	antiretroviral	JJ	O	antiretroviral	amod	54	SENT_54	[p3l1148t3127r1355b3156],
54	agents	NNS	O	agent	nsubjpass	56	SENT_54	[p3l1366t3135r1464b3166],
55	was	VBD	O	be	auxpass	56	SENT_54	[p3l1474t3138r1530b3156],
56	estimated	VBN	O	estimate	conj_and	21	SENT_54	[p3l1541t3127r1691b3156],
57	to	TO	O	to	aux	58	SENT_54	[p3l1701t3135r1732b3156],
58	be	VB	O	be	xcomp	56	SENT_54	[p3l1743t3127r1779b3156],
59	in	IN	O	in	_	0	SENT_54	[p3l1789t3128r1819b3156],
60	the	DT	O	the	det	61	SENT_54	[p3l1830t3127r1879b3156],
61	range	NN	O	range	prep_in	58	SENT_54	[p3l1889t3138r1976b3166],
62	of	IN	O	of	_	0	SENT_54	[p3l1988t3127r2022b3156],
63	23	CD	PERCENT	23	num	64	SENT_54	[p3l2029t3129r2098b3156],
64	%	NN	PERCENT	%	prep_of	61	SENT_54	[p3l2029t3129r2098b3156],
65	(	CD	NUMBER	(	num	67	SENT_54	[p3l584t3176r709b3212],
66	10-12	CD	NUMBER	10-12	num	67	SENT_54	[p3l584t3176r709b3212],
67	)	NN	O	)	dep	64	SENT_54	[p3l584t3176r709b3212],
68	.	.	O	.	_	0	SENT_54	[p3l584t3176r709b3212],

1	Transmitted	VBN	O	transmit	csubj	5	SENT_55	[p3l727t3175r919b3205],
2	drug	NN	O	drug	nn	3	SENT_55	[p3l937t3175r1010b3214],
3	resistance	NN	O	resistance	dobj	1	SENT_55	[p3l1026t3177r1178b3205],
4	can	MD	O	can	aux	5	SENT_55	[p3l1196t3186r1248b3205],
5	have	VB	O	have	_	0	SENT_55	[p3l1264t3175r1335b3205],
6	both	DT	O	both	preconj	7	SENT_55	[p3l1352t3175r1424b3205],
7	immediate	JJ	O	immediate	amod	11	SENT_55	[p3l1440t3175r1606b3205],
8	and	CC	O	and	_	0	SENT_55	[p3l1623t3175r1679b3205],
9	long-term	JJ	O	long-term	amod	11	SENT_55	[p3l1696t3175r1855b3214],
10	clinical	JJ	O	clinical	amod	11	SENT_55	[p3l1872t3175r1982b3205],
11	consequences	NNS	O	consequence	dobj	5	SENT_55	[p3l2000t3186r2100b3205, p3l583t3236r715b3264],
12	.	.	O	.	_	0	SENT_55	[p3l2000t3186r2100b3205, p3l583t3236r715b3264],

1	Transmitted	VBN	O	transmit	_	0	SENT_56	[p3l727t3225r920b3254],
2	drug	NN	O	drug	nn	3	SENT_56	[p3l931t3225r1004b3264],
3	resistance	NN	O	resistance	dobj	1	SENT_56	[p3l1013t3227r1165b3254],
4	is	VBZ	O	be	auxpass	5	SENT_56	[p3l1176t3227r1199b3254],
5	associated	VBN	O	associate	auxpass	1	SENT_56	[p3l1210t3225r1366b3254],
6	with	IN	O	with	_	0	SENT_56	[p3l1376t3225r1446b3254],
7	decreased	VBN	O	decrease	amod	9	SENT_56	[p3l1457t3225r1608b3254],
8	treatment	NN	O	treatment	nn	9	SENT_56	[p3l1619t3233r1773b3254],
9	responses	NNS	O	response	prep_with	5	SENT_56	[p3l1783t3236r1942b3264],
10	,	,	O	,	_	0	SENT_56	[p3l1783t3236r1942b3264],
11	including	VBG	O	include	_	0	SENT_56	[p3l1953t3225r2102b3264],
12	both	CC	O	both	dep	15	SENT_56	[p3l583t3273r655b3302],
13	a	DT	O	a	det	15	SENT_56	[p3l667t3284r681b3302],
14	prolonged	JJ	O	prolonged	amod	15	SENT_56	[p3l693t3273r854b3312],
15	time	NN	O	time	prep_including	9	SENT_56	[p3l866t3274r935b3302],
16	to	TO	O	to	_	0	SENT_56	[p3l947t3281r978b3302],
17	virologic	JJ	O	virologic	amod	18	SENT_56	[p3l988t3273r1128b3312],
18	suppression	NN	O	suppression	prep_to	5	SENT_56	[p3l1139t3274r1323b3312],
19	following	VBG	O	follow	_	0	SENT_56	[p3l1334t3273r1483b3312],
20	the	DT	O	the	det	21	SENT_56	[p3l1494t3273r1543b3302],
21	initiation	NN	O	initiation	prep_following	18	SENT_56	[p3l1554t3274r1698b3302],
22	of	IN	O	of	_	0	SENT_56	[p3l1710t3273r1744b3302],
23	therapy	NN	O	therapy	prep_of	21	SENT_56	[p3l1751t3273r1871b3312],
24	and	CC	O	and	_	0	SENT_56	[p3l1882t3273r1937b3302],
25	decreased	VBD	O	decrease	auxpass	1	SENT_56	[p3l1950t3273r2101b3302],
26	durability	NN	O	durability	dobj	25	SENT_56	[p3l583t3321r736b3360],
27	of	IN	O	of	_	0	SENT_56	[p3l745t3321r779b3351],
28	the	DT	O	the	det	31	SENT_56	[p3l785t3321r834b3351],
29	therapeutic	JJ	O	therapeutic	amod	31	SENT_56	[p3l845t3321r1022b3360],
30	response	NN	O	response	nn	31	SENT_56	[p3l1032t3332r1168b3360],
31	(	NN	O	(	prep_of	26	SENT_56	[p3l1179t3322r1236b3358],
32	12	CD	NUMBER	12	nsubjpass	1	SENT_56	[p3l1179t3322r1236b3358],
33	,	,	O	,	_	0	SENT_56	[p3l1179t3322r1236b3358],
34	13	CD	NUMBER	13	num	35	SENT_56	[p3l1251t3322r1305b3358],
35	)	NN	O	)	appos	32	SENT_56	[p3l1251t3322r1305b3358],
36	.	.	O	.	_	0	SENT_56	[p3l1251t3322r1305b3358],

1	If	IN	O	if	mark	7	SENT_57	[p3l1316t3321r1345b3350],
2	undiagnosed	JJ	O	undiagnosed	amod	5	SENT_57	[p3l1350t3321r1557b3360],
3	,	,	O	,	_	0	SENT_57	[p3l1350t3321r1557b3360],
4	transmitted	JJ	O	transmitted	amod	5	SENT_57	[p3l1569t3321r1749b3351],
5	resistance	NN	O	resistance	nsubj	7	SENT_57	[p3l1759t3323r1912b3351],
6	also	RB	O	also	advmod	7	SENT_57	[p3l1923t3321r1981b3351],
7	has	VBZ	O	have	csubj	17	SENT_57	[p3l1991t3321r2041b3351],
8	the	DT	O	the	det	9	SENT_57	[p3l2052t3321r2101b3351],
9	potential	JJ	O	potential	dobj	7	SENT_57	[p3l583t3369r722b3408],
10	to	TO	O	to	aux	11	SENT_57	[p3l732t3377r763b3398],
11	facilitate	VB	O	facilitate	dep	9	SENT_57	[p3l774t3369r907b3398],
12	the	DT	O	the	det	13	SENT_57	[p3l918t3369r967b3398],
13	development	NN	O	development	dobj	11	SENT_57	[p3l978t3369r1181b3408],
14	of	IN	O	of	_	0	SENT_57	[p3l1191t3369r1225b3398],
15	collateral	NN	O	collateral	nn	16	SENT_57	[p3l1232t3369r1375b3398],
16	multi	NNS	O	multus	prep_of	13	SENT_57	[p3l1386t3369r1554b3398],
17	—	VBP	O	—	_	0	SENT_57	[p3l1386t3369r1554b3398],
18	class	NN	O	class	nn	20	SENT_57	[p3l1386t3369r1554b3398],
19	drug	NN	O	drug	nn	20	SENT_57	[p3l1566t3369r1639b3408],
20	resistance	NN	O	resistance	dobj	17	SENT_57	[p3l1648t3371r1800b3398],
21	affecting	VBG	O	affect	partmod	20	SENT_57	[p3l1811t3369r1948b3408],
22	any	DT	O	any	dobj	21	SENT_57	[p3l1957t3380r2013b3408],
23	or	CC	O	or	_	0	SENT_57	[p3l2022t3380r2055b3398],
24	all	DT	O	all	conj_or	22	SENT_57	[p3l2066t3369r2101b3398],
25	of	IN	O	of	_	0	SENT_57	[p3l583t3419r617b3448],
26	the	DT	O	the	det	28	SENT_57	[p3l624t3419r673b3448],
27	concomitant	JJ	O	concomitant	amod	28	SENT_57	[p3l685t3421r882b3448],
28	agents	NNS	O	agent	prep_of	22	SENT_57	[p3l893t3428r990b3458],
29	in	IN	O	in	_	0	SENT_57	[p3l1002t3421r1032b3448],
30	the	DT	O	the	det	31	SENT_57	[p3l1043t3419r1092b3448],
31	regimen	NN	O	regimen	prep_in	28	SENT_57	[p3l1103t3421r1241b3458],
32	.	.	O	.	_	0	SENT_57	[p3l1103t3421r1241b3458],

1	In	IN	O	in	_	0	SENT_58	[p3l632t3468r666b3496],
2	light	NN	O	light	prep_in	27	SENT_58	[p3l677t3467r750b3506],
3	of	IN	O	of	_	0	SENT_58	[p3l760t3467r795b3496],
4	the	DT	O	the	det	5	SENT_58	[p3l802t3467r850b3496],
5	lin1itations	NNS	O	lin1itation	prep_of	2	SENT_58	[p3l862t3467r1029b3496],
6	of	IN	O	of	_	0	SENT_58	[p3l1041t3467r1075b3496],
7	current	JJ	DATE	current	amod	9	SENT_58	[p3l1082t3476r1198b3496],
8	HIV-1	NN	MISC	hiv-1	nn	9	SENT_58	[p3l1208t3468r1308b3496],
9	therapies	NNS	O	therapy	prep_of	5	SENT_58	[p3l1323t3467r1473b3506],
10	,	,	O	,	_	0	SENT_58	[p3l1323t3467r1473b3506],
11	particularly	RB	O	particularly	advmod	27	SENT_58	[p3l1485t3467r1666b3506],
12	in	IN	O	in	_	0	SENT_58	[p3l1675t3469r1705b3496],
13	patients	NNS	O	patient	prep_in	27	SENT_58	[p3l1716t3469r1838b3506],
14	with	IN	O	with	_	0	SENT_58	[p3l1849t3467r1919b3496],
15	multidrugresistant	JJ	O	multidrugresistant	amod	16	SENT_58	[p3l1929t3467r2100b3506, p3l583t3517r714b3544],
16	infections	NNS	O	infection	prep_with	13	SENT_58	[p3l726t3515r888b3551],
17	,	,	O	,	_	0	SENT_58	[p3l726t3515r888b3551],
18	approval	NN	O	approval	nsubjpass	27	SENT_58	[p3l903t3515r1037b3554],
19	of	IN	O	of	_	0	SENT_58	[p3l1050t3515r1085b3544],
20	the	DT	O	the	det	23	SENT_58	[p3l1094t3515r1143b3544],
21	ﬁrst	JJ	O	ﬁrst	amod	23	SENT_58	[p3l1156t3515r1218b3544],
22	integrase	NN	O	integrase	nn	23	SENT_58	[p3l1230t3516r1371b3554],
23	inhibitors	NNS	O	inhibitor	prep_of	18	SENT_58	[p3l1384t3515r1536b3544],
24	has	VBZ	O	have	aux	27	SENT_58	[p3l1550t3515r1599b3544],
25	been	VBN	O	be	auxpass	27	SENT_58	[p3l1613t3515r1687b3544],
26	eagerly	RB	O	eagerly	advmod	27	SENT_58	[p3l1701t3515r1814b3554],
27	anticipated	VBN	O	anticipate	_	0	SENT_58	[p3l1826t3515r2006b3554],
28	.	.	O	.	_	0	SENT_58	[p3l1826t3515r2006b3554],

1	Here	RB	O	here	_	0	SENT_59	[p3l2021t3516r2101b3544],

1	378	CD	NUMBER	378	num	4	SENT_60	[p3l487t3616r532b3644],
2	Httzuda	NN	O	httzuda	nn	4	SENT_60	[p3l582t3615r674b3637],
3	o	NN	O	o	nn	4	SENT_60	[p3l689t3623r699b3633],
4	I71/amato	NN	O	i71/amato	_	0	SENT_60	[p3l713t3615r810b3637],
5	-	:	O	-	_	0	SENT_60	[p3l826t3623r835b3633],
6	Wenning	NNP	PERSON	Wenning	dep	4	SENT_60	[p3l854t3615r955b3645],
7	if	IN	O	if	_	0	SENT_60	[p4l56t2884r79b2931],
8	=	JJ	O	=	amod	9	SENT_60	[p4l56t2884r79b2931],
9	W	NN	O	w	prep_if	6	SENT_60	[p4l56t2884r79b2931],
10	50f	CD	NUMBER	50f	num	12	SENT_60	[p4l63t2820r79b2868],
11	g	NN	O	g	nn	12	SENT_60	[p4l63t2790r86b2805],
12	Annu	NNP	PERSON	Annu	dep	6	SENT_60	[p4l60t1742r83b1822],
13	.	.	O	.	_	0	SENT_60	[p4l60t1742r83b1822],

1	Rev.	NNP	O	Rev.	nn	2	SENT_61	[p4l60t1671r83b1731],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_61	[p4l60t1512r83b1661],
3	.	.	O	.	_	0	SENT_61	[p4l60t1512r83b1661],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_62	[p4l60t1392r83b1501],
2	.	.	O	.	_	0	SENT_62	[p4l60t1392r83b1501],

1	2009.49:377	CD	NUMBER	2009.49:377	num	2	SENT_63	[p4l60t1146r84b1380],
2	-394	CD	NUMBER	-394	_	0	SENT_63	[p4l60t1146r84b1380],
3	.	.	O	.	_	0	SENT_63	[p4l60t1146r84b1380],

1	Downloaded	VBN	O	download	_	0	SENT_64	[p4l60t966r83b1136],
2	from	IN	O	from	_	0	SENT_64	[p4l60t892r83b957],
3	www.annua1reviews.org	NN	O	www.annua1reviews.org	prep_from	1	SENT_64	[p4l60t559r90b884],
4	by	IN	O	by	_	0	SENT_64	[p4l93t1654r124b1687],
5	University	NNP	ORGANIZATION	University	dep	9	SENT_64	[p4l93t1505r124b1645],
6	of	IN	ORGANIZATION	of	_	0	SENT_64	[p4l93t1467r117b1495],
7	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	5	SENT_64	[p4l93t1320r117b1460],
8	-	:	O	-	_	0	SENT_64	[p4l107t1301r110b1310],
9	Madison	NNP	O	Madison	prep_by	1	SENT_64	[p4l93t1175r117b1291],
10	on	IN	O	on	_	0	SENT_64	[p4l101t1134r117b1166],
11	01/05/14	CD	DATE	01/05/14	prep_on	1	SENT_64	[p4l93t1000r117b1124],
12	.	.	O	.	_	0	SENT_64	[p4l93t1000r117b1124],

1	For	IN	O	for	_	0	SENT_65	[p4l94t943r117b990],
2	personal	JJ	O	personal	amod	3	SENT_65	[p4l93t823r124b935],
3	use	NN	O	use	pobj	1	SENT_65	[p4l101t770r117b814],
4	only	RB	O	only	advmod	3	SENT_65	[p4l93t696r124b760],
5	.	.	O	.	_	0	SENT_65	[p4l93t696r124b760],

1	we	PRP	O	we	nsubj	2	SENT_66	[p4l205t55r248b74],
2	review	VBP	O	review	_	0	SENT_66	[p4l260t46r363b74],
3	the	DT	O	the	det	4	SENT_66	[p4l374t44r423b74],
4	role	NN	O	role	dobj	2	SENT_66	[p4l435t44r496b74],
5	of	IN	O	of	_	0	SENT_66	[p4l509t44r544b74],
6	integrase	NN	O	integrase	prep_of	4	SENT_66	[p4l551t46r692b83],
7	in	IN	O	in	_	0	SENT_66	[p4l704t46r735b73],
8	HIV-1	NN	O	hiv-1	nn	9	SENT_66	[p4l747t46r847b74],
9	replication	NN	O	replication	prep_in	6	SENT_66	[p4l863t44r1031b83],
10	and	CC	O	and	_	0	SENT_66	[p4l1044t44r1099b74],
11	the	DT	O	the	det	13	SENT_66	[p4l1112t44r1160b74],
12	unique	JJ	O	unique	amod	13	SENT_66	[p4l1172t46r1280b83],
13	mechanism	NN	O	mechanism	prep_of	4	SENT_66	[p4l1292t44r1470b74],
14	of	IN	O	of	_	0	SENT_66	[p4l1482t44r1517b74],
15	action	NN	O	action	prep_of	13	SENT_66	[p4l1525t46r1620b74],
16	of	IN	O	of	_	0	SENT_66	[p4l1633t44r1667b74],
17	the	DT	O	the	det	18	SENT_66	[p4l1675t44r1724b74],
18	class	NN	O	class	prep_of	4	SENT_66	[p4l206t91r275b120],
19	of	IN	O	of	_	0	SENT_66	[p4l291t91r325b120],
20	integrase	NN	O	integrase	nn	21	SENT_66	[p4l335t93r476b130],
21	inhibitors	NNS	O	inhibitor	prep_of	18	SENT_66	[p4l490t91r643b120],
22	known	VBN	O	know	partmod	21	SENT_66	[p4l657t91r763b120],
23	as	IN	O	as	_	0	SENT_66	[p4l778t102r806b120],
24	strand	NN	O	strand	nn	26	SENT_66	[p4l821t91r918b120],
25	transfer	NN	O	transfer	nn	26	SENT_66	[p4l932t91r1054b120],
26	inhibitors	NNS	O	inhibitor	prep_as	22	SENT_66	[p4l1067t91r1228b120],
27	.	.	O	.	_	0	SENT_66	[p4l1067t91r1228b120],

1	The	DT	O	the	det	3	SENT_67	[p4l1243t91r1309b120],
2	drug	NN	O	drug	nn	3	SENT_67	[p4l1325t91r1398b130],
3	metabolism	NN	O	metabolism	nsubj	4	SENT_67	[p4l1411t91r1593b120],
4	proﬁles	VBZ	O	proﬁles	_	0	SENT_67	[p4l1608t91r1724b130],
5	as	RB	O	as	_	0	SENT_67	[p4l206t150r234b168],
6	well	RB	O	well	cc	9	SENT_67	[p4l245t139r309b168],
7	as	IN	O	as	_	0	SENT_67	[p4l322t150r350b168],
8	available	JJ	O	available	amod	9	SENT_67	[p4l362t139r496b168],
9	drug	NN	O	drug	dobj	4	SENT_67	[p4l509t139r582b178],
10	interaction	NN	O	interaction	nn	11	SENT_67	[p4l592t140r763b168],
11	data	NNS	O	datum	nsubjpass	13	SENT_67	[p4l775t139r839b168],
12	are	VBP	O	be	auxpass	13	SENT_67	[p4l851t150r898b168],
13	summarized	VBN	O	summarize	rcmod	9	SENT_67	[p4l910t139r1100b168],
14	for	IN	O	for	_	0	SENT_67	[p4l1112t139r1157b168],
15	raltegravir	NN	O	raltegravir	prep_for	13	SENT_67	[p4l1168t139r1332b178],
16	and	CC	O	and	_	0	SENT_67	[p4l1343t139r1398b168],
17	elvitegravir	NN	O	elvitegravir	prep_for	13	SENT_67	[p4l1411t139r1593b178],
18	,	,	O	,	_	0	SENT_67	[p4l1411t139r1593b178],
19	the	DT	O	the	det	22	SENT_67	[p4l1606t139r1655b168],
20	two	CD	NUMBER	two	num	22	SENT_67	[p4l1667t147r1724b168],
21	integrase	NN	O	integrase	nn	22	SENT_67	[p4l205t188r347b225],
22	strand	NN	O	strand	nn	24	SENT_67	[p4l358t186r455b215],
23	transfer	NN	O	transfer	nn	24	SENT_67	[p4l466t186r587b215],
24	inhibitors	NNS	O	inhibitor	dep	9	SENT_67	[p4l597t186r749b215],
25	that	WDT	O	that	nsubjpass	29	SENT_67	[p4l761t186r823b215],
26	are	VBP	O	be	auxpass	29	SENT_67	[p4l833t197r879b215],
27	the	DT	O	the	dobj	29	SENT_67	[p4l891t186r940b215],
28	most	RBS	O	most	advmod	27	SENT_67	[p4l951t194r1028b215],
29	advanced	VBN	O	advance	rcmod	24	SENT_67	[p4l1039t186r1182b215],
30	in	IN	O	in	_	0	SENT_67	[p4l1193t188r1223b215],
31	clinical	JJ	O	clinical	amod	32	SENT_67	[p4l1234t186r1345b215],
32	development	NN	O	development	prep_in	29	SENT_67	[p4l1356t186r1560b225],
33	to	TO	O	to	_	0	SENT_67	[p4l1570t194r1600b215],
34	date	NN	O	date	prep_to	32	SENT_67	[p4l1612t186r1685b215],
35	.	.	O	.	_	0	SENT_67	[p4l1612t186r1685b215],

1	HIV	NN	O	hiv	nn	2	SENT_68	[p4l205t302r292b333],
2	Replication	NN	O	replication	nsubj	35	SENT_68	[p4l302t300r519b343],
3	and	CC	O	and	_	0	SENT_68	[p4l531t300r598b333],
4	Antiretroviral	JJ	O	antiretroviral	amod	5	SENT_68	[p4l609t300r870b333],
5	Therapies	NNS	O	therapy	conj_and	2	SENT_68	[p4l881t300r1074b343],
6	Although	IN	O	although	mark	11	SENT_68	[p4l205t351r353b390],
7	the	DT	O	the	det	10	SENT_68	[p4l363t351r411b380],
8	HIV-1	NN	MISC	hiv-1	nn	10	SENT_68	[p4l421t352r521b380],
9	life	NN	O	life	nn	10	SENT_68	[p4l534t351r582b380],
10	cycle	NN	O	cycle	nsubj	11	SENT_68	[p4l592t351r669b390],
11	presents	VBZ	O	present	advcl	24	SENT_68	[p4l679t359r807b390],
12	many	JJ	O	many	amod	14	SENT_68	[p4l817t362r904b390],
13	potential	JJ	O	potential	amod	14	SENT_68	[p4l911t351r1050b390],
14	opportunities	NNS	O	opportunity	dobj	11	SENT_68	[p4l1060t353r1271b390],
15	for	IN	O	for	_	0	SENT_68	[p4l1280t351r1326b380],
16	therapeutic	JJ	O	therapeutic	amod	17	SENT_68	[p4l1335t351r1512b390],
17	intervention	NN	O	intervention	prep_for	14	SENT_68	[p4l1521t353r1723b387],
18	,	,	O	,	_	0	SENT_68	[p4l1521t353r1723b387],
19	current	JJ	DATE	current	amod	22	SENT_68	[p4l206t407r322b428],
20	drug	NN	O	drug	nn	22	SENT_68	[p4l338t399r411b438],
21	discovery	NN	O	discovery	nn	22	SENT_68	[p4l427t399r574b438],
22	efforts	NNS	O	effort	nsubj	24	SENT_68	[p4l590t399r689b428],
23	have	VBP	O	have	aux	24	SENT_68	[p4l706t399r776b428],
24	focused	VBN	O	focus	rcmod	5	SENT_68	[p4l793t399r911b428],
25	on	IN	O	on	prep	24	SENT_68	[p4l928t410r967b428],
26	and	CC	O	and	_	0	SENT_68	[p4l984t399r1039b428],
27	exploited	VBN	O	exploit	rcmod	5	SENT_68	[p4l1056t399r1199b438],
28	only	RB	O	only	advmod	31	SENT_68	[p4l1216t399r1285b438],
29	a	DT	O	a	det	31	SENT_68	[p4l1300t410r1315b428],
30	limited	JJ	O	limited	amod	31	SENT_68	[p4l1331t399r1442b428],
31	number	NN	O	number	dobj	27	SENT_68	[p4l1458t399r1581b428],
32	of	IN	O	of	_	0	SENT_68	[p4l1597t399r1632b428],
33	these	DT	O	these	det	34	SENT_68	[p4l1644t399r1724b428],
34	processes	NNS	O	process	prep_of	31	SENT_68	[p4l206t457r351b485],
35	(	VBP	O	(	_	0	SENT_68	[p4l364t446r514b483],
36	reviewed	VBN	O	review	dep	35	SENT_68	[p4l364t446r514b483],
37	in	IN	O	in	_	0	SENT_68	[p4l524t448r555b475],
38	14	CD	NUMBER	14	number	42	SENT_68	[p4l569t448r604b476],
39	and	CC	O	and	_	0	SENT_68	[p4l615t446r670b475],
40	15	CD	NUMBER	15	conj_and	42	SENT_68	[p4l685t447r730b483],
41	)	CD	NUMBER	)	number	42	SENT_68	[p4l685t447r730b483],
42	(	CD	NUMBER	(	num	43	SENT_68	[p4l742t447r864b485],
43	Figure	NN	O	figure	prep_in	36	SENT_68	[p4l742t447r864b485],
44	1	CD	NUMBER	1	num	45	SENT_68	[p4l880t447r916b483],
45	)	NN	O	)	dep	43	SENT_68	[p4l880t447r916b483],
46	.	.	O	.	_	0	SENT_68	[p4l880t447r916b483],

1	Figure	NNP	O	Figure	_	0	SENT_69	[p4l205t2029r304b2062],
2	1	CD	NUMBER	1	dep	1	SENT_69	[p4l318t2029r330b2053],

1	Reverse	JJ	O	reverse	amod	2	SENT_70	[p4l717t710r822b733],
2	transcriptase	NN	O	transcriptase	_	0	SENT_70	[p4l830t710r1008b740],
3	Viral	JJ	O	viral	amod	4	SENT_70	[p4l714t763r772b788],
4	RNA	NN	O	rna	dep	2	SENT_70	[p4l784t764r841b788],

1	integrase	NN	O	integrase	_	0	SENT_71	[p4l716t819r842b849],

1	Viral	JJ	O	viral	amod	3	SENT_72	[p4l779t913r837b938],
2	attachment	NN	O	attachment	nn	3	SENT_72	[p4l730t949r890b974],
3	C.	NN	O	c.	_	0	SENT_72	[p4l1048t934r1202b975],
4	°	CD	NUMBER	°	num	5	SENT_72	[p4l1048t934r1202b975],
5	re	NN	O	re	dep	3	SENT_72	[p4l1048t934r1202b975],
6	.	.	O	.	_	0	SENT_72	[p4l1048t934r1202b975],

1	Ce	NN	O	ce	_	0	SENT_73	[p4l1048t934r1202b975],
2	.	.	O	.	_	0	SENT_73	[p4l1048t934r1202b975],

1	pt	NN	O	pt	nn	4	SENT_74	[p4l1048t934r1202b975],
2	°	NN	O	°	nn	4	SENT_74	[p4l1048t934r1202b975],
3	r	NN	O	r	nn	4	SENT_74	[p4l1048t934r1202b975],
4	inhibitors	NNS	O	inhibitor	_	0	SENT_74	[p4l1066t970r1195b994],

1	Fusion	NN	O	fusion	nn	2	SENT_75	[p4l841t1093r929b1117],
2	inhibitors	NNS	O	inhibitor	_	0	SENT_75	[p4l940t1092r1070b1117],

1	Budding	VBG	O	bud	_	0	SENT_76	[p4l1467t949r1581b980],

1	Reverse	NN	O	reverse	_	0	SENT_77	[p4l949t1191r1054b1214],

1	_	NN	O	_	nn	3	SENT_78	[p4l649t1254r653b1258],
2	transcriptase	NN	O	transcriptase	nn	3	SENT_78	[p4l911t1227r1089b1256],
3	Protease	NN	O	protease	_	0	SENT_78	[p4l1294t1222r1410b1246],
4	Virus-Ce	JJ	O	virus-ce	amod	6	SENT_78	[p4l629t1253r753b1277],
5	"	``	O	"	punct	6	SENT_78	[p4l629t1253r753b1277],
6	inhibitors	NNS	O	inhibitor	dep	3	SENT_78	[p4l936t1262r1065b1287],
7	inhibitors	NNS	O	inhibitor	dep	6	SENT_78	[p4l1287t1258r1417b1282],
8	5	CD	NUMBER	5	number	9	SENT_78	[p4l1503t1245r1672b1287],
9	‘	CD	NUMBER	‘	dep	3	SENT_78	[p4l1503t1245r1672b1287],
10	5	CD	NUMBER	5	dep	9	SENT_78	[p4l1503t1245r1672b1287],
11	"	``	O	"	punct	10	SENT_78	[p4l1503t1245r1672b1287],
12	.	.	O	.	_	0	SENT_78	[p4l1503t1245r1672b1287],

1	—	NN	O	—	_	0	SENT_79	[p4l1503t1245r1672b1287],
2	.	.	O	.	_	0	SENT_79	[p4l1503t1245r1672b1287],

1	”‘	NN	O	”‘	dep	7	SENT_80	[p4l1503t1245r1672b1287],
2	b	NN	O	b	dep	1	SENT_80	[p4l1503t1245r1672b1287],
3	'	''	O	'	_	0	SENT_80	[p4l1503t1245r1672b1287],
4	V.	NNP	O	V.	dep	7	SENT_80	[p4l1503t1245r1672b1287],
5	°	FW	O	°	nn	7	SENT_80	[p4l1503t1245r1672b1287],
6	f	FW	O	f	nn	7	SENT_80	[p4l1503t1245r1672b1287],
7	fusion	NN	O	fusion	_	0	SENT_80	[p4l649t1289r733b1314],
8	viral	JJ	O	viral	amod	9	SENT_80	[p4l1497t1281r1553b1306],
9	proteins	NNS	O	protein	dep	7	SENT_80	[p4l1564t1285r1676b1312],
10	and	CC	O	and	_	0	SENT_80	[p4l1527t1318r1578b1342],
11	RNA	NN	O	rna	dep	7	SENT_80	[p4l1589t1319r1646b1342],

1	lntegrase	NN	O	lntegrase	nn	2	SENT_81	[p4l1103t1343r1257b1376],
2	inhibitors	NNS	O	inhibitor	_	0	SENT_81	[p4l1100t1386r1260b1414],

1	Reverse	JJ	O	reverse	amod	3	SENT_82	[p4l779t1438r884b1461],
2	_	NN	O	_	nn	3	SENT_82	[p4l1569t1470r1573b1474],
3	transcriptase	NN	O	transcriptase	_	0	SENT_82	[p4l741t1474r919b1504],
4	F’roteo	NNP	O	F’roteo	dep	3	SENT_82	[p4l1443t1468r1589b1500],
5	|	CD	NUMBER	|	num	4	SENT_82	[p4l1443t1468r1589b1500],
6	Yt	NNP	O	Yt	rcmod	4	SENT_82	[p4l1443t1468r1589b1500],
7	|	CD	NUMBER	|	num	6	SENT_82	[p4l1443t1468r1589b1500],
8	C	NN	O	c	prep	6	SENT_82	[p4l1443t1468r1589b1500],
9	processing	NN	O	processing	nn	10	SENT_82	[p4l1442t1506r1589b1536],
10	gm	NN	O	gm	dep	8	SENT_82	[p4l1466t1554r1576b1663],
11	lntegrase	NN	O	lntegrase	nn	12	SENT_82	[p4l824t1635r979b1668],
12	Integration	NN	O	integration	dep	6	SENT_82	[p4l1184t1640r1335b1670],
13	l	NN	O	l	tmod	12	SENT_82	[p4l1556t1638r1574b1662],
14	+	CC	O	+	_	0	SENT_82	[p4l1556t1638r1574b1662],
15	I	PRP	O	I	conj_+	12	SENT_82	[p4l1596t1671r1599b1672],
16	+	CC	O	+	_	0	SENT_82	[p4l1642t1656r1652b1663],
17	‘	CD	NUMBER	‘	conj_+	12	SENT_82	[p4l1670t1639r1678b1650],
18	"	``	O	"	punct	20	SENT_82	[p4l1670t1639r1678b1650],
19	(	NN	O	(	nn	20	SENT_82	[p4l1151t1675r1245b1703],
20	strand	NN	O	strand	rcmod	17	SENT_82	[p4l1151t1675r1245b1703],
21	transfer	NN	O	transfer	prep	20	SENT_82	[p4l1254t1674r1368b1703],
22	)	CD	NUMBER	)	dep	21	SENT_82	[p4l1254t1674r1368b1703],
23	/	:	O	/	dep	20	SENT_82	[p4l1470t1663r1582b1747],
24	'	''	O	'	_	0	SENT_82	[p4l1616t1674r1618b1676],
25	'	''	O	'	_	0	SENT_82	[p4l1630t1676r1632b1678],
26	'	''	O	'	_	0	SENT_82	[p4l1646t1676r1648b1678],

1	PIC	NN	O	pic	_	0	SENT_83	[p4l692t1726r734b1749],

1	P	NN	O	p	nn	3	SENT_84	[p4l1556t1740r1570b1763],
2	t	NN	O	t	nn	3	SENT_84	[p4l1600t1743r1610b1763],
3	formation	NN	O	formation	_	0	SENT_84	[p4l644t1729r884b1785],
4	\	CD	NUMBER	\	num	5	SENT_84	[p4l644t1729r884b1785],
5	ro	NN	O	ro	dep	3	SENT_84	[p4l1573t1746r1598b1763],
6	ease	NN	O	ease	nn	7	SENT_84	[p4l1612t1746r1672b1763],
7	processing	NN	O	processing	dep	3	SENT_84	[p4l773t1832r920b1862],

1	The	DT	O	the	det	2	SENT_85	[p4l205t2080r264b2107],
2	HIV-1	NN	MISC	hiv-1	_	0	SENT_85	[p4l274t2082r363b2107],
3	life	NN	O	life	dep	2	SENT_85	[p4l376t2080r419b2107],
4	cycle	NN	O	cycle	dep	3	SENT_85	[p4l429t2080r497b2115],
5	and	CC	O	and	_	0	SENT_85	[p4l508t2080r557b2107],
6	antiretroviral	JJ	O	antiretroviral	amod	7	SENT_85	[p4l568t2080r751b2107],
7	agents	NNS	O	agent	dep	3	SENT_85	[p4l761t2088r856b2115],
8	.	.	O	.	_	0	SENT_85	[p4l761t2088r856b2115],
9	"	''	O	"	punct	4	SENT_85	[p4l1133t2190r1406b2220],

1	ww	NN	O	ww	poss	3	SENT_86	[p4l1133t2190r1406b2220],
2	'	POS	O	'	_	0	SENT_86	[p4l1133t2190r1406b2220],
3	w.	NN	O	w.	nsubj	4	SENT_86	[p4l1133t2190r1406b2220],
4	annmzlreview	NN	O	annmzlreview	_	0	SENT_86	[p4l1133t2190r1406b2220],
5	:	:	O	:	_	0	SENT_86	[p4l1133t2190r1406b2220],
6	.	.	O	.	_	0	SENT_86	[p4l1133t2190r1406b2220],

1	org	NN	O	org	nn	2	SENT_87	[p4l1133t2190r1406b2220],
2	o	NN	O	o	_	0	SENT_87	[p4l1420t2198r1430b2208],
3	Emerging	VBG	O	emerge	dep	2	SENT_87	[p4l1445t2190r1560b2220],
4	Plmrmatology	NN	O	plmrmatology	pobj	3	SENT_87	[p4l1567t2190r1725b2220],
5	379	CD	NUMBER	379	num	4	SENT_87	[p4l1774t2198r1818b2219],

1	The	DT	O	the	det	3	SENT_88	[p4l632t2231r699b2261],
2	ﬁrst	JJ	O	ﬁrst	amod	3	SENT_88	[p4l713t2231r775b2261],
3	step	NN	O	step	nsubj	11	SENT_88	[p4l788t2239r850b2270],
4	in	IN	O	in	_	0	SENT_88	[p4l864t2233r895b2260],
5	the	DT	O	the	det	8	SENT_88	[p4l908t2231r957b2261],
6	HIV-1	NN	MISC	hiv-1	nn	8	SENT_88	[p4l971t2233r1071b2261],
7	life	NN	O	life	nn	8	SENT_88	[p4l1089t2231r1137b2261],
8	cycle	NN	O	cycle	prep_in	3	SENT_88	[p4l1152t2231r1229b2270],
9	is	VBZ	O	be	cop	11	SENT_88	[p4l1242t2233r1265b2261],
10	viral	JJ	O	viral	amod	11	SENT_88	[p4l1278t2231r1348b2261],
11	entry	NN	O	entry	_	0	SENT_88	[p4l1362t2240r1448b2270],
12	,	,	O	,	_	0	SENT_88	[p4l1362t2240r1448b2270],
13	the	DT	O	the	det	14	SENT_88	[p4l1464t2231r1513b2261],
14	target	NN	O	target	appos	11	SENT_88	[p4l1527t2239r1619b2270],
15	for	IN	O	for	_	0	SENT_88	[p4l1632t2231r1678b2261],
16	two	CD	NUMBER	two	num	18	SENT_88	[p4l1691t2239r1748b2261],
17	distinct	JJ	O	distinct	amod	18	SENT_88	[p4l1763t2231r1879b2261],
18	classes	NNS	O	class	prep_for	14	SENT_88	[p4l1893t2231r1993b2261],
19	of	IN	O	of	_	0	SENT_88	[p4l2008t2231r2042b2261],
20	antiretroviral	JJ	O	antiretroviral	amod	21	SENT_88	[p4l2052t2242r2101b2261, p4l584t2279r753b2308],
21	agents	NNS	O	agent	prep_of	18	SENT_88	[p4l765t2287r871b2318],
22	:	:	O	:	_	0	SENT_88	[p4l765t2287r871b2318],
23	the	DT	O	the	det	25	SENT_88	[p4l884t2279r933b2308],
24	CCR5	NN	O	ccr5	nn	25	SENT_88	[p4l945t2280r1043b2309],
25	antagonists	NNS	O	antagonist	dep	14	SENT_88	[p4l1057t2281r1231b2318],
26	and	CC	O	and	_	0	SENT_88	[p4l1243t2279r1299b2308],
27	fusion	NN	O	fusion	nn	28	SENT_88	[p4l1310t2279r1406b2308],
28	inhibitors	NNS	O	inhibitor	dep	14	SENT_88	[p4l1416t2279r1577b2308],
29	.	.	O	.	_	0	SENT_88	[p4l1416t2279r1577b2308],

1	The	DT	O	the	det	2	SENT_89	[p4l1588t2279r1655b2308],
2	HIV-1	NN	MISC	hiv-1	nsubj	5	SENT_89	[p4l1666t2280r1766b2308],
3	envelop	VB	O	envelop	dep	2	SENT_89	[p4l1782t2279r1902b2318],
4	gp120/gp41	NN	O	gp120/gp41	dobj	3	SENT_89	[p4l1914t2280r2098b2318],
5	has	VBZ	O	have	_	0	SENT_89	[p4l583t2327r633b2356],
6	afﬁnity	NN	O	afﬁnity	dobj	5	SENT_89	[p4l647t2327r758b2366],
7	for	IN	O	for	_	0	SENT_89	[p4l769t2327r815b2356],
8	the	DT	O	the	det	10	SENT_89	[p4l827t2327r876b2356],
9	CD4	NN	O	cd4	nn	10	SENT_89	[p4l890t2328r967b2356],
10	receptor	NN	O	receptor	prep_for	6	SENT_89	[p4l979t2335r1112b2366],
11	and	CC	O	and	_	0	SENT_89	[p4l1124t2327r1180b2356],
12	targets	NNS	O	target	nn	13	SENT_89	[p4l1193t2336r1297b2366],
13	HIV-1	NN	O	hiv-1	conj_and	10	SENT_89	[p4l1310t2329r1411b2356],
14	to	TO	O	to	_	0	SENT_89	[p4l1427t2335r1458b2356],
15	CD4	NN	O	cd4	prep_to	5	SENT_89	[p4l1472t2328r1577b2359],
16	+	CC	O	+	_	0	SENT_89	[p4l1472t2328r1577b2359],
17	immune	JJ	O	immune	amod	18	SENT_89	[p4l1590t2329r1720b2356],
18	cells	NNS	O	cell	conj_+	15	SENT_89	[p4l1733t2327r1808b2356],
19	.	.	O	.	_	0	SENT_89	[p4l1733t2327r1808b2356],

1	Interaction	NN	O	interaction	nsubjpass	9	SENT_90	[p4l1822t2329r1997b2356],
2	of	IN	O	of	_	0	SENT_90	[p4l2010t2327r2044b2356],
3	the	DT	O	the	det	5	SENT_90	[p4l2053t2327r2102b2356],
4	HIV-1	NN	MISC	hiv-1	nn	5	SENT_90	[p4l584t2375r684b2403],
5	envelope	NN	O	envelope	prep_of	1	SENT_90	[p4l704t2374r842b2413],
6	with	IN	O	with	_	0	SENT_90	[p4l857t2374r927b2403],
7	CD4	NN	O	cd4	prep_with	5	SENT_90	[p4l943t2375r1020b2404],
8	is	VBZ	O	be	auxpass	9	SENT_90	[p4l1035t2376r1058b2403],
9	followed	VBN	O	follow	_	0	SENT_90	[p4l1074t2374r1209b2403],
10	by	IN	O	by	_	0	SENT_90	[p4l1224t2374r1263b2413],
11	binding	VBG	O	bind	agent	9	SENT_90	[p4l1277t2374r1398b2413],
12	to	TO	O	to	_	0	SENT_90	[p4l1413t2382r1444b2403],
13	an	DT	O	a	det	15	SENT_90	[p4l1460t2385r1496b2403],
14	additional	JJ	O	additional	amod	15	SENT_90	[p4l1512t2374r1668b2403],
15	coreceptor	NN	O	coreceptor	prep_to	11	SENT_90	[p4l1684t2382r1858b2413],
16	,	,	O	,	_	0	SENT_90	[p4l1684t2382r1858b2413],
17	either	CC	O	either	preconj	11	SENT_90	[p4l1875t2374r1967b2403],
18	the	DT	O	the	det	22	SENT_90	[p4l1982t2374r2031b2403],
19	CC	NN	O	cc	nn	22	SENT_90	[p4l2047t2375r2101b2403],
20	chemokine	NN	O	chemokine	nn	22	SENT_90	[p4l584t2422r755b2451],
21	receptor	NN	O	receptor	nn	22	SENT_90	[p4l769t2430r901b2460],
22	CCR5	NN	O	ccr5	conj	11	SENT_90	[p4l915t2423r1013b2451],
23	or	CC	O	or	_	0	SENT_90	[p4l1029t2433r1062b2451],
24	the	DT	O	the	det	28	SENT_90	[p4l1075t2422r1124b2451],
25	CXC	NN	O	cxc	nn	28	SENT_90	[p4l1138t2423r1219b2451],
26	chemokine	NN	O	chemokine	nn	28	SENT_90	[p4l1234t2422r1404b2451],
27	receptor	NN	O	receptor	nn	28	SENT_90	[p4l1418t2430r1550b2460],
28	CXCR4	NN	O	cxcr4	conj_or	22	SENT_90	[p4l1564t2423r1699b2451],
29	.	.	O	.	_	0	SENT_90	[p4l1564t2423r1699b2451],

1	The	DT	O	the	det	2	SENT_91	[p4l1713t2422r1780b2451],
2	disposition	NN	O	disposition	nsubj	25	SENT_91	[p4l1794t2422r1965b2460],
3	of	IN	O	of	_	0	SENT_91	[p4l1978t2422r2013b2451],
4	these	DT	O	these	det	5	SENT_91	[p4l2022t2422r2102b2451],
5	coreceptors	NNS	O	coreceptor	prep_of	2	SENT_91	[p4l584t2479r765b2510],
6	on	IN	O	on	_	0	SENT_91	[p4l775t2482r814b2500],
7	the	DT	O	the	det	8	SENT_91	[p4l822t2471r871b2500],
8	surface	NN	O	surface	prep_on	5	SENT_91	[p4l880t2471r989b2500],
9	of	IN	O	of	_	0	SENT_91	[p4l998t2471r1033b2500],
10	lymphocytes	NNS	O	lymphocyte	prep_of	8	SENT_91	[p4l1037t2471r1234b2510],
11	as	RB	O	as	_	0	SENT_91	[p4l1243t2482r1271b2500],
12	well	RB	O	well	_	0	SENT_91	[p4l1279t2471r1343b2500],
13	as	IN	O	as	_	0	SENT_91	[p4l1352t2482r1380b2500],
14	the	DT	O	the	det	15	SENT_91	[p4l1389t2471r1438b2500],
15	surface	NN	O	surface	prep_on	5	SENT_91	[p4l1447t2471r1556b2500],
16	of	IN	O	of	_	0	SENT_91	[p4l1565t2471r1600b2500],
17	monocyte/macrophages	NNS	O	monocyte/macrophages	prep_of	15	SENT_91	[p4l1604t2471r1979b2510],
18	and	CC	O	and	_	0	SENT_91	[p4l1989t2471r2044b2500],
19	the	DT	O	the	det	20	SENT_91	[p4l2053t2471r2102b2500],
20	sequence	NN	O	sequence	prep_of	2	SENT_91	[p4l584t2529r725b2557],
21	of	IN	O	of	_	0	SENT_91	[p4l738t2518r772b2547],
22	the	DT	O	the	det	24	SENT_91	[p4l779t2518r828b2547],
23	viral	JJ	O	viral	amod	24	SENT_91	[p4l839t2518r908b2547],
24	envelope	NN	O	envelope	prep_of	20	SENT_91	[p4l920t2518r1059b2557],
25	determine	VB	O	determine	_	0	SENT_91	[p4l1071t2518r1230b2547],
26	the	DT	O	the	det	27	SENT_91	[p4l1242t2518r1291b2547],
27	tropism	NN	O	tropism	dobj	25	SENT_91	[p4l1303t2520r1424b2557],
28	of	IN	O	of	_	0	SENT_91	[p4l1436t2518r1470b2547],
29	the	DT	O	the	det	30	SENT_91	[p4l1478t2518r1527b2547],
30	virus	NN	O	virus	prep_of	27	SENT_91	[p4l1537t2520r1613b2547],
31	for	IN	O	for	_	0	SENT_91	[p4l1625t2518r1671b2547],
32	different	JJ	O	different	amod	34	SENT_91	[p4l1682t2518r1818b2547],
33	cell	NN	O	cell	nn	34	SENT_91	[p4l1829t2518r1882b2547],
34	types	NNS	O	type	prep_for	30	SENT_91	[p4l1893t2526r1973b2557],
35	and	CC	O	and	_	0	SENT_91	[p4l1986t2518r2041b2547],
36	the	DT	O	the	det	37	SENT_91	[p4l2053t2518r2102b2547],
37	susceptibility	NN	O	susceptibility	prep_of	27	SENT_91	[p4l584t2566r790b2605],
38	of	IN	O	of	_	0	SENT_91	[p4l801t2566r835b2595],
39	infection	NN	O	infection	prep_of	37	SENT_91	[p4l842t2566r982b2595],
40	to	TO	O	to	_	0	SENT_91	[p4l993t2574r1024b2595],
41	inhibition	NN	O	inhibition	prep_to	25	SENT_91	[p4l1035t2566r1191b2595],
42	by	IN	O	by	_	0	SENT_91	[p4l1203t2566r1241b2605],
43	CCR5	NN	O	ccr5	nn	44	SENT_91	[p4l1252t2567r1350b2595],
44	antagonists	NNS	O	antagonist	prep_by	25	SENT_91	[p4l1364t2567r1547b2605],
45	.	.	O	.	_	0	SENT_91	[p4l1364t2567r1547b2605],

1	These	DT	O	these	det	5	SENT_92	[p4l1560t2566r1657b2595],
2	sequential	JJ	O	sequential	amod	5	SENT_92	[p4l1669t2566r1827b2605],
3	receptor	NN	O	receptor	nn	5	SENT_92	[p4l1838t2574r1971b2605],
4	binding	NN	O	binding	nn	5	SENT_92	[p4l1982t2566r2103b2605],
5	events	NNS	O	event	nsubj	6	SENT_92	[p4l584t2624r681b2646],
6	induce	VBP	O	induce	_	0	SENT_92	[p4l693t2616r797b2646],
7	conformational	JJ	O	conformational	amod	8	SENT_92	[p4l810t2616r1051b2646],
8	changes	NNS	O	change	dobj	6	SENT_92	[p4l1063t2616r1186b2655],
9	in	IN	O	in	_	0	SENT_92	[p4l1199t2618r1229b2645],
10	the	DT	O	the	det	12	SENT_92	[p4l1241t2616r1290b2646],
11	viral	JJ	O	viral	amod	12	SENT_92	[p4l1301t2616r1370b2646],
12	envelope	NN	O	envelope	prep_in	8	SENT_92	[p4l1383t2616r1530b2655],
13	,	,	O	,	_	0	SENT_92	[p4l1383t2616r1530b2655],
14	exposing	VBG	O	expose	partmod	6	SENT_92	[p4l1544t2618r1682b2655],
15	a	DT	O	a	det	17	SENT_92	[p4l1693t2627r1708b2646],
16	hydrophobic	JJ	O	hydrophobic	amod	17	SENT_92	[p4l1720t2616r1921b2655],
17	domain	NN	O	domain	dobj	14	SENT_92	[p4l1933t2616r2051b2646],
18	on	IN	O	on	_	0	SENT_92	[p4l2063t2627r2102b2646],
19	gp41	NN	O	gp41	prep_on	17	SENT_92	[p4l584t2666r657b2703],
20	that	WDT	O	that	nsubj	23	SENT_92	[p4l673t2664r735b2693],
21	is	VBZ	O	be	cop	23	SENT_92	[p4l746t2666r769b2693],
22	principally	RB	O	principally	advmod	23	SENT_92	[p4l781t2664r950b2703],
23	responsible	JJ	O	responsible	rcmod	17	SENT_92	[p4l960t2664r1138b2703],
24	for	IN	O	for	_	0	SENT_92	[p4l1150t2664r1196b2693],
25	mediating	VBG	O	mediate	prepc_for	23	SENT_92	[p4l1207t2664r1366b2703],
26	viral	JJ	O	viral	amod	27	SENT_92	[p4l1376t2664r1445b2693],
27	fusion	NN	O	fusion	dobj	25	SENT_92	[p4l1457t2664r1553b2693],
28	and	CC	O	and	_	0	SENT_92	[p4l1566t2664r1621b2693],
29	the	DT	O	the	det	30	SENT_92	[p4l1634t2664r1683b2693],
30	target	NN	O	target	nsubj	34	SENT_92	[p4l1695t2672r1788b2703],
31	of	IN	O	of	_	0	SENT_92	[p4l1799t2664r1834b2693],
32	fusion	NN	O	fusion	nn	33	SENT_92	[p4l1842t2664r1938b2693],
33	inhibitors	NNS	O	inhibitor	prep_of	30	SENT_92	[p4l1949t2664r2102b2693],
34	(	VBP	O	(	conj_and	6	SENT_92	[p4l585t2713r661b2748],
35	T20	NN	TIME	t20	nn	38	SENT_92	[p4l585t2713r661b2748],
36	or	CC	O	or	_	0	SENT_92	[p4l673t2723r706b2741],
37	enfuvirtide	NN	O	enfuvirtide	nn	38	SENT_92	[p4l717t2712r907b2748],
38	)	NN	O	)	dobj	34	SENT_92	[p4l717t2712r907b2748],
39	.	.	O	.	_	0	SENT_92	[p4l717t2712r907b2748],

1	Fusion	NN	O	fusion	nsubj	11	SENT_93	[p4l919t2714r1026b2741],
2	of	IN	O	of	_	0	SENT_93	[p4l1037t2712r1071b2741],
3	the	DT	O	the	det	5	SENT_93	[p4l1077t2712r1126b2741],
4	viral	JJ	O	viral	amod	5	SENT_93	[p4l1135t2712r1205b2741],
5	envelope	NN	O	envelope	prep_of	1	SENT_93	[p4l1216t2712r1354b2751],
6	to	TO	O	to	_	0	SENT_93	[p4l1365t2721r1396b2741],
7	the	DT	O	the	det	10	SENT_93	[p4l1407t2712r1455b2741],
8	host	NN	O	host	nn	10	SENT_93	[p4l1466t2712r1533b2741],
9	cell	NN	O	cell	nn	10	SENT_93	[p4l1543t2712r1596b2741],
10	membrane	NN	O	membrane	prep_to	5	SENT_93	[p4l1606t2712r1773b2741],
11	allows	VBZ	O	allow	_	0	SENT_93	[p4l1785t2712r1880b2741],
12	for	IN	O	for	_	0	SENT_93	[p4l1891t2712r1936b2741],
13	uncoating	VBG	O	uncoat	prepc_for	11	SENT_93	[p4l1946t2714r2103b2751],
14	of	IN	O	of	_	0	SENT_93	[p4l584t2762r618b2791],
15	the	DT	O	the	det	17	SENT_93	[p4l625t2762r674b2791],
16	viral	JJ	O	viral	amod	17	SENT_93	[p4l684t2762r753b2791],
17	core	NN	O	core	prep_of	13	SENT_93	[p4l765t2773r831b2791],
18	and	CC	O	and	_	0	SENT_93	[p4l843t2762r899b2791],
19	the	DT	O	the	det	20	SENT_93	[p4l910t2762r959b2791],
20	release	NN	O	release	prep_of	13	SENT_93	[p4l970t2762r1075b2791],
21	of	IN	O	of	_	0	SENT_93	[p4l1087t2762r1121b2791],
22	the	DT	O	the	det	24	SENT_93	[p4l1128t2762r1177b2791],
23	viral	JJ	O	viral	amod	24	SENT_93	[p4l1187t2762r1256b2791],
24	enzymes	NNS	O	enzyme	prep_of	20	SENT_93	[p4l1268t2773r1401b2801],
25	and	CC	O	and	_	0	SENT_93	[p4l1412t2762r1468b2791],
26	RNA	NN	O	rna	prep_of	20	SENT_93	[p4l1479t2763r1570b2791],
27	.	.	O	.	_	0	SENT_93	[p4l1479t2763r1570b2791],

1	The	DT	O	the	det	4	SENT_94	[p4l633t2826r699b2855],
2	HIV-1	NN	MISC	hiv-1	nn	4	SENT_94	[p4l712t2827r812b2855],
3	reverse	JJ	O	reverse	amod	4	SENT_94	[p4l828t2837r938b2855],
4	transcriptase	NN	O	transcriptase	nsubj	7	SENT_94	[p4l951t2827r1149b2865],
5	is	VBZ	O	be	cop	7	SENT_94	[p4l1162t2827r1184b2855],
6	the	DT	O	the	det	7	SENT_94	[p4l1197t2826r1246b2855],
7	target	NN	O	target	ccomp	18	SENT_94	[p4l1259t2834r1351b2865],
8	for	IN	O	for	_	0	SENT_94	[p4l1363t2826r1408b2855],
9	two	CD	NUMBER	two	num	10	SENT_94	[p4l1420t2834r1477b2855],
10	classes	NNS	O	class	prep_for	7	SENT_94	[p4l1490t2826r1590b2855],
11	of	IN	O	of	_	0	SENT_94	[p4l1604t2826r1638b2855],
12	antiretroviral	JJ	O	antiretroviral	amod	13	SENT_94	[p4l1647t2826r1853b2855],
13	agents	NNS	O	agent	prep_of	10	SENT_94	[p4l1866t2834r1973b2865],
14	,	,	O	,	_	0	SENT_94	[p4l1866t2834r1973b2865],
15	the	DT	O	the	det	17	SENT_94	[p4l1987t2826r2035b2855],
16	nucleoside	NN	O	nucleoside	nn	17	SENT_94	[p4l2048t2837r2101b2855, p4l584t2890r708b2919],
17	inhibitors	NNS	O	inhibitor	nsubj	18	SENT_94	[p4l720t2890r872b2919],
18	(	VBP	O	(	_	0	SENT_94	[p4l885t2890r1019b2926],
19	NRTIS	NN	O	nrti	nn	20	SENT_94	[p4l885t2890r1019b2926],
20	)	NN	O	)	nsubj	24	SENT_94	[p4l885t2890r1019b2926],
21	and	CC	O	and	_	0	SENT_94	[p4l1032t2890r1088b2919],
22	non-nucleoside	JJ	O	non-nucleoside	amod	23	SENT_94	[p4l1100t2890r1341b2919],
23	inhibitors	NNS	O	inhibitor	conj_and	20	SENT_94	[p4l1353t2890r1505b2919],
24	(	VBP	O	(	ccomp	18	SENT_94	[p4l1518t2890r1694b2927],
25	NNRTIS	NNS	ORGANIZATION	nnrti	dobj	24	SENT_94	[p4l1518t2890r1694b2927],
26	)	CD	NUMBER	)	tmod	24	SENT_94	[p4l1518t2890r1694b2927],
27	.	.	O	.	_	0	SENT_94	[p4l1518t2890r1694b2927],

1	Reverse	JJ	O	reverse	amod	2	SENT_95	[p4l1708t2891r1830b2919],
2	transcriptase	NN	O	transcriptase	nsubj	4	SENT_95	[p4l1842t2891r2040b2929],
3	is	VBZ	O	be	cop	4	SENT_95	[p4l2052t2891r2075b2919],
4	a	DT	O	a	_	0	SENT_95	[p4l2087t2901r2102b2919],

1	Annu	NNP	PERSON	Annu	_	0	SENT_96	[p5l56t1076r79b1156],
2	.	.	O	.	_	0	SENT_96	[p5l56t1076r79b1156],

1	Rev.	NNP	O	Rev.	nn	2	SENT_97	[p5l56t1005r79b1065],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_97	[p5l56t846r79b995],
3	.	.	O	.	_	0	SENT_97	[p5l56t846r79b995],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_98	[p5l56t726r79b835],
2	.	.	O	.	_	0	SENT_98	[p5l56t726r79b835],

1	2009.49:377	CD	NUMBER	2009.49:377	num	2	SENT_99	[p5l56t480r80b714],
2	-394	CD	NUMBER	-394	_	0	SENT_99	[p5l56t480r80b714],
3	.	.	O	.	_	0	SENT_99	[p5l56t480r80b714],

1	Downloaded	VBN	O	download	_	0	SENT_100	[p5l56t300r79b470],
2	from	IN	O	from	_	0	SENT_100	[p5l56t226r79b291],
3	www	NN	O	www	prep_from	1	SENT_100	[p5l56t7r79b217],
4	.	.	O	.	_	0	SENT_100	[p5l56t7r79b217],

1	annua1rev	NN	O	annua1rev	_	0	SENT_101	[p5l56t7r79b217],
2	by	IN	O	by	_	0	SENT_101	[p5l89t988r120b1020],
3	University	NNP	ORGANIZATION	University	prep_by	1	SENT_101	[p5l89t839r120b979],
4	of	IN	ORGANIZATION	of	_	0	SENT_101	[p5l89t800r113b829],
5	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	3	SENT_101	[p5l89t653r113b794],
6	-	:	O	-	_	0	SENT_101	[p5l103t635r106b644],
7	Madison	NNP	O	Madison	dep	1	SENT_101	[p5l89t509r113b625],
8	on	IN	O	on	_	0	SENT_101	[p5l97t468r113b500],
9	01/05/14	CD	DATE	01/05/14	prep_on	7	SENT_101	[p5l89t334r113b458],
10	.	.	O	.	_	0	SENT_101	[p5l89t334r113b458],

1	For	IN	O	for	_	0	SENT_102	[p5l90t277r113b324],
2	personal	JJ	O	personal	amod	3	SENT_102	[p5l89t157r120b269],
3	use	NN	O	use	pobj	1	SENT_102	[p5l97t104r113b148],
4	only	RB	O	only	advmod	3	SENT_102	[p5l89t30r120b94],
5	.	.	O	.	_	0	SENT_102	[p5l89t30r120b94],

1	iew	NN	O	iew	nn	2	SENT_103	[p5l201t2466r224b2513],
2	s.org	NN	O	s.org	nn	4	SENT_103	[p5l208t2387r231b2451],
3	multifunctional	JJ	O	multifunctional	amod	4	SENT_103	[p5l583t14r827b44],
4	enzyme	NN	O	enzyme	nsubj	30	SENT_103	[p5l835t25r954b53],
5	with	IN	O	with	_	0	SENT_103	[p5l961t15r1031b44],
6	RNA	NN	MISC	rna	nn	7	SENT_103	[p5l1039t14r1303b53],
7	—	NN	O	—	prep_with	4	SENT_103	[p5l1039t14r1303b53],
8	dependent	JJ	O	dependent	amod	7	SENT_103	[p5l1039t14r1303b53],
9	DNA	NN	O	dna	nn	10	SENT_103	[p5l1310t16r1399b43],
10	polymerase	NN	O	polymerase	tmod	8	SENT_103	[p5l1405t15r1591b53],
11	,	,	O	,	_	0	SENT_103	[p5l1405t15r1591b53],
12	RNase-H	NN	O	rnase-h	appos	10	SENT_103	[p5l1601t16r1761b50],
13	,	,	O	,	_	0	SENT_103	[p5l1601t16r1761b50],
14	and	CC	O	and	_	0	SENT_103	[p5l1771t14r1826b44],
15	DNA-dependent	JJ	O	dna-dependent	amod	18	SENT_103	[p5l1835t14r2103b53],
16	DNA	NN	O	dna	nn	18	SENT_103	[p5l584t66r673b93],
17	polymerase	NN	O	polymerase	nn	18	SENT_103	[p5l685t64r862b103],
18	activities	NNS	O	activity	conj_and	7	SENT_103	[p5l877t66r1021b100],
19	,	,	O	,	_	0	SENT_103	[p5l877t66r1021b100],
20	all	DT	O	all	dep	21	SENT_103	[p5l1036t64r1072b93],
21	of	IN	O	of	nsubjpass	24	SENT_103	[p5l1086t64r1120b93],
22	which	WDT	O	which	pobj	21	SENT_103	[p5l1129t64r1223b93],
23	are	VBP	O	be	auxpass	24	SENT_103	[p5l1238t75r1284b93],
24	required	VBN	O	require	rcmod	18	SENT_103	[p5l1298t64r1431b103],
25	to	TO	O	to	aux	26	SENT_103	[p5l1445t73r1475b93],
26	convert	VB	O	convert	xcomp	24	SENT_103	[p5l1490t73r1608b93],
27	the	DT	O	the	det	29	SENT_103	[p5l1621t64r1670b93],
28	single	JJ	O	single	amod	29	SENT_103	[p5l1684t64r1924b103],
29	—	NN	O	—	dobj	26	SENT_103	[p5l1684t64r1924b103],
30	stranded	VBD	O	strand	_	0	SENT_103	[p5l1684t64r1924b103],
31	viral	JJ	O	viral	amod	32	SENT_103	[p5l1937t64r2006b93],
32	RNA	NN	O	rna	dobj	30	SENT_103	[p5l2020t65r2104b93],
33	into	IN	O	into	_	0	SENT_103	[p5l584t116r646b143],
34	double	JJ	O	double	amod	37	SENT_103	[p5l659t114r915b143],
35	—	JJ	O	—	amod	37	SENT_103	[p5l659t114r915b143],
36	stranded	JJ	O	stranded	amod	37	SENT_103	[p5l659t114r915b143],
37	DNA	NN	O	dna	prep_into	30	SENT_103	[p5l928t115r1023b143],
38	.	.	O	.	_	0	SENT_103	[p5l928t115r1023b143],

1	Although	IN	O	although	mark	3	SENT_104	[p5l1036t114r1185b153],
2	they	PRP	O	they	nsubj	3	SENT_104	[p5l1198t114r1266b153],
3	differ	VBP	O	differ	advcl	21	SENT_104	[p5l1278t114r1362b143],
4	with	IN	O	with	_	0	SENT_104	[p5l1373t114r1443b143],
5	respect	NN	O	respect	prep_with	3	SENT_104	[p5l1455t122r1567b152],
6	to	TO	O	to	_	0	SENT_104	[p5l1579t123r1609b143],
7	their	PRP$	O	they	poss	8	SENT_104	[p5l1623t114r1697b143],
8	site	NN	O	site	prep_to	3	SENT_104	[p5l1709t116r1761b143],
9	of	IN	O	of	_	0	SENT_104	[p5l1775t114r1809b143],
10	interaction	NN	O	interaction	prep_of	8	SENT_104	[p5l1817t116r1988b143],
11	on	IN	O	on	_	0	SENT_104	[p5l2001t125r2040b143],
12	the	DT	O	the	det	13	SENT_104	[p5l2053t114r2102b143],
13	enzyme	NN	O	enzyme	prep_on	10	SENT_104	[p5l584t175r703b202],
14	and	CC	O	and	_	0	SENT_104	[p5l714t164r770b193],
15	molecular	JJ	O	molecular	amod	16	SENT_104	[p5l780t164r936b193],
16	mechanism	NN	O	mechanism	prep_on	10	SENT_104	[p5l946t164r1131b199],
17	,	,	O	,	_	0	SENT_104	[p5l946t164r1131b199],
18	NRTIS	NN	O	nrti	nsubj	21	SENT_104	[p5l1142t165r1255b193],
19	and	CC	O	and	_	0	SENT_104	[p5l1266t164r1321b193],
20	NNRTIS	NN	ORGANIZATION	nnrti	conj_and	18	SENT_104	[p5l1331t165r1476b193],
21	affect	VBP	O	affect	_	0	SENT_104	[p5l1487t164r1573b193],
22	the	DT	O	the	det	24	SENT_104	[p5l1582t164r1631b193],
23	polymerization	NN	O	polymerization	nn	24	SENT_104	[p5l1641t164r1879b203],
24	activity	NN	O	activity	dobj	21	SENT_104	[p5l1890t166r2004b203],
25	of	IN	O	of	_	0	SENT_104	[p5l2013t164r2047b193],
26	the	DT	O	the	det	30	SENT_104	[p5l2053t164r2102b193],
27	enzyme	NN	O	enzyme	nn	30	SENT_104	[p5l584t225r703b252],
28	and	CC	O	and	_	0	SENT_104	[p5l717t214r772b243],
29	block	NN	O	block	nn	30	SENT_104	[p5l785t214r871b243],
30	formation	NN	O	formation	prep_of	24	SENT_104	[p5l882t214r1039b243],
31	of	IN	O	of	_	0	SENT_104	[p5l1052t214r1086b243],
32	full	JJ	O	full	amod	34	SENT_104	[p5l1095t214r1262b252],
33	—	NN	O	—	nn	34	SENT_104	[p5l1095t214r1262b252],
34	length	NN	O	length	prep_of	30	SENT_104	[p5l1095t214r1262b252],
35	viral	JJ	O	viral	amod	36	SENT_104	[p5l1273t214r1342b243],
36	DNA	NN	O	dna	dep	34	SENT_104	[p5l1355t215r1450b243],
37	.	.	O	.	_	0	SENT_104	[p5l1355t215r1450b243],

1	The	DT	O	the	det	2	SENT_105	[p5l1463t214r1530b243],
2	completion	NN	O	completion	nsubjpass	7	SENT_105	[p5l1543t214r1721b252],
3	of	IN	O	of	_	0	SENT_105	[p5l1734t214r1768b243],
4	reverse	JJ	O	reverse	amod	5	SENT_105	[p5l1776t225r1887b243],
5	transcription	NN	O	transcription	prep_of	2	SENT_105	[p5l1900t215r2102b252],
6	is	VBZ	O	be	auxpass	7	SENT_105	[p5l583t265r606b293],
7	required	VBN	O	require	_	0	SENT_105	[p5l619t264r752b302],
8	for	IN	O	for	_	0	SENT_105	[p5l765t264r810b293],
9	formation	NN	O	formation	prep_for	7	SENT_105	[p5l822t264r978b293],
10	of	IN	O	of	_	0	SENT_105	[p5l991t264r1025b293],
11	the	DT	O	the	det	14	SENT_105	[p5l1034t264r1082b293],
12	viral	JJ	O	viral	amod	14	SENT_105	[p5l1094t264r1163b292],
13	preintegration	NN	O	preintegration	nn	14	SENT_105	[p5l1175t265r1401b302],
14	complex	NN	O	complex	prep_of	9	SENT_105	[p5l1414t264r1545b302],
15	(	CD	NUMBER	(	num	17	SENT_105	[p5l1558t265r1653b300],
16	PIC	NN	O	pic	nn	17	SENT_105	[p5l1558t265r1653b300],
17	)	NN	O	)	dep	14	SENT_105	[p5l1558t265r1653b300],
18	.	.	O	.	_	0	SENT_105	[p5l1558t265r1653b300],

1	Integrase	NN	O	integrase	nn	2	SENT_106	[p5l1667t265r1811b302],
2	inhibitors	NNS	O	inhibitor	nsubj	16	SENT_106	[p5l1823t263r1976b293],
3	bind	VBP	O	bind	_	0	SENT_106	[p5l1988t263r2058b293],
4	to	TO	O	to	_	0	SENT_106	[p5l2071t272r2102b293],
5	the	DT	O	the	det	6	SENT_106	[p5l584t313r633b342],
6	enzyme	NN	O	enzyme	prep_to	3	SENT_106	[p5l644t324r763b352],
7	in	IN	O	in	_	0	SENT_106	[p5l773t315r804b342],
8	the	DT	O	the	det	9	SENT_106	[p5l814t313r863b342],
9	context	NN	O	context	prep_in	6	SENT_106	[p5l874t322r989b342],
10	of	IN	O	of	_	0	SENT_106	[p5l999t313r1033b342],
11	the	DT	O	the	det	13	SENT_106	[p5l1040t313r1088b342],
12	viral	JJ	O	viral	amod	13	SENT_106	[p5l1098t313r1167b342],
13	PIC	NN	O	pic	prep_of	9	SENT_106	[p5l1177t314r1241b342],
14	and	CC	O	and	_	0	SENT_106	[p5l1253t313r1308b342],
15	therefore	RB	O	therefore	advmod	16	SENT_106	[p5l1319t313r1463b342],
16	need	VBP	O	need	conj_and	3	SENT_106	[p5l1473t313r1548b342],
17	to	TO	O	to	aux	19	SENT_106	[p5l1558t322r1589b342],
18	be	VB	O	be	cop	19	SENT_106	[p5l1600t313r1636b342],
19	present	JJ	DATE	present	xcomp	16	SENT_106	[p5l1646t322r1762b352],
20	only	RB	O	only	advmod	27	SENT_106	[p5l1772t313r1841b352],
21	after	IN	O	after	dep	27	SENT_106	[p5l1850t313r1922b342],
22	the	DT	O	the	det	25	SENT_106	[p5l1932t313r1981b342],
23	reverse	JJ	O	reverse	amod	25	SENT_106	[p5l1991t324r2102b342],
24	transcription	NN	O	transcription	nn	25	SENT_106	[p5l584t365r786b402],
25	process	NN	O	process	nsubj	27	SENT_106	[p5l797t374r911b401],
26	is	VBZ	O	be	cop	27	SENT_106	[p5l923t365r945b392],
27	complete	JJ	O	complete	ccomp	19	SENT_106	[p5l958t363r1109b401],
28	.	.	O	.	_	0	SENT_106	[p5l958t363r1109b401],

1	Integrase	NN	O	integrase	nn	2	SENT_107	[p5l1122t365r1266b402],
2	inhibitors	NNS	O	inhibitor	nsubj	3	SENT_107	[p5l1278t363r1430b392],
3	prevent	VBP	O	prevent	_	0	SENT_107	[p5l1441t372r1561b402],
4	the	DT	O	the	det	5	SENT_107	[p5l1571t363r1620b392],
5	insertion	NN	O	insertion	dobj	3	SENT_107	[p5l1631t365r1771b392],
6	or	CC	O	or	_	0	SENT_107	[p5l1782t374r1816b392],
7	integration	NN	O	integration	dobj	3	SENT_107	[p5l1826t365r2000b402],
8	of	IN	O	of	_	0	SENT_107	[p5l2012t363r2046b392],
9	the	DT	O	the	det	11	SENT_107	[p5l2053t363r2102b392],
10	viral	JJ	O	viral	amod	11	SENT_107	[p5l582t413r652b442],
11	DNA	NN	O	dna	prep_of	5	SENT_107	[p5l665t414r754b442],
12	into	IN	O	into	_	0	SENT_107	[p5l765t415r827b442],
13	the	DT	O	the	det	15	SENT_107	[p5l841t413r889b442],
14	cellular	JJ	O	cellular	amod	15	SENT_107	[p5l903t413r1018b442],
15	DNA	NN	O	dna	prep_into	3	SENT_107	[p5l1031t414r1126b442],
16	.	.	O	.	_	0	SENT_107	[p5l1031t414r1126b442],

1	Integration	NN	O	integration	nsubj	15	SENT_108	[p5l1141t414r1318b452],
2	is	VBZ	O	be	auxpass	3	SENT_108	[p5l1331t415r1354b442],
3	required	VBN	O	require	_	0	SENT_108	[p5l1367t413r1500b451],
4	to	TO	O	to	aux	5	SENT_108	[p5l1514t421r1544b442],
5	maintain	VB	O	maintain	xcomp	3	SENT_108	[p5l1558t415r1696b442],
6	the	DT	O	the	det	8	SENT_108	[p5l1709t413r1758b442],
7	viral	JJ	O	viral	amod	8	SENT_108	[p5l1770t413r1839b442],
8	DNA	NN	O	dna	dobj	5	SENT_108	[p5l1852t414r1941b442],
9	in	IN	O	in	_	0	SENT_108	[p5l1952t415r1982b442],
10	the	DT	O	the	det	12	SENT_108	[p5l1995t413r2044b442],
11	infected	JJ	O	infected	amod	12	SENT_108	[p5l2058t415r2101b442, p5l584t463r678b492],
12	cell	NN	O	cell	prep_in	5	SENT_108	[p5l690t463r742b492],
13	and	CC	O	and	_	0	SENT_108	[p5l754t463r810b492],
14	is	VBZ	O	be	cop	15	SENT_108	[p5l821t464r844b492],
15	essential	JJ	O	essential	conj_and	3	SENT_108	[p5l856t463r987b492],
16	for	IN	O	for	_	0	SENT_108	[p5l998t463r1044b492],
17	expression	NN	O	expression	prep_for	15	SENT_108	[p5l1055t464r1218b501],
18	of	IN	O	of	_	0	SENT_108	[p5l1230t463r1264b492],
19	HIV-1	NN	MISC	hiv-1	nn	21	SENT_108	[p5l1271t464r1371b492],
20	messenger	NN	O	messenger	nn	21	SENT_108	[p5l1385t474r1550b501],
21	RNA	NN	MISC	rna	prep_of	17	SENT_108	[p5l1561t464r1652b498],
22	,	,	O	,	_	0	SENT_108	[p5l1561t464r1652b498],
23	viral	JJ	O	viral	amod	24	SENT_108	[p5l1663t463r1732b492],
24	proteins	NNS	O	protein	conj_and	21	SENT_108	[p5l1743t464r1880b501],
25	,	,	O	,	_	0	SENT_108	[p5l1743t464r1880b501],
26	and	CC	O	and	_	0	SENT_108	[p5l1893t463r1948b492],
27	new	JJ	O	new	amod	30	SENT_108	[p5l1959t474r2024b492],
28	viral	JJ	O	viral	amod	30	SENT_108	[p5l2033t463r2102b492],
29	RNA	NN	O	rna	nn	30	SENT_108	[p5l584t513r668b541],
30	genomes	NNS	O	genome	conj_and	21	SENT_108	[p5l678t523r824b551],
31	.	.	O	.	_	0	SENT_108	[p5l678t523r824b551],

1	Viral	JJ	O	viral	amod	2	SENT_109	[p5l835t512r913b541],
2	proteins	NNS	O	protein	nsubjpass	4	SENT_109	[p5l924t514r1052b550],
3	are	VBP	O	be	auxpass	4	SENT_109	[p5l1065t523r1111b541],
4	assembled	VBN	O	assemble	_	0	SENT_109	[p5l1123t512r1282b541],
5	and	CC	O	and	_	0	SENT_109	[p5l1293t512r1349b541],
6	transported	VBN	O	transport	conj_and	4	SENT_109	[p5l1360t512r1542b550],
7	to	TO	O	to	_	0	SENT_109	[p5l1553t520r1584b541],
8	the	DT	O	the	det	10	SENT_109	[p5l1596t512r1644b541],
9	cell	NN	O	cell	nn	10	SENT_109	[p5l1657t512r1709b541],
10	surface	NN	O	surface	prep_to	4	SENT_109	[p5l1721t512r1838b547],
11	,	,	O	,	_	0	SENT_109	[p5l1721t512r1838b547],
12	where	WRB	O	where	advmod	18	SENT_109	[p5l1850t512r1946b541],
13	the	DT	O	the	det	16	SENT_109	[p5l1957t512r2006b541],
14	HIV1-encoded	JJ	O	hiv1-encoded	amod	16	SENT_109	[p5l2018t514r2101b541, p5l587t562r748b591],
15	protease	NN	O	protease	nn	16	SENT_109	[p5l759t570r890b600],
16	enzyme	NN	O	enzyme	nsubj	18	SENT_109	[p5l902t573r1021b601],
17	is	VBZ	O	be	cop	18	SENT_109	[p5l1032t564r1054b591],
18	responsible	JJ	O	responsible	rcmod	10	SENT_109	[p5l1066t562r1242b600],
19	for	IN	O	for	_	0	SENT_109	[p5l1254t562r1299b591],
20	the	DT	O	the	det	21	SENT_109	[p5l1310t562r1359b591],
21	maturation	NN	O	maturation	prep_for	18	SENT_109	[p5l1370t564r1544b591],
22	of	IN	O	of	_	0	SENT_109	[p5l1555t562r1589b591],
23	the	DT	O	the	det	25	SENT_109	[p5l1596t562r1645b591],
24	viral	JJ	O	viral	amod	25	SENT_109	[p5l1655t562r1724b591],
25	particles	NNS	O	particle	prep_of	21	SENT_109	[p5l1735t562r1865b600],
26	into	IN	O	into	_	0	SENT_109	[p5l1876t564r1938b591],
27	infectious	JJ	O	infectious	amod	28	SENT_109	[p5l1950t562r2102b591],
28	virions	NNS	O	virion	prep_into	18	SENT_109	[p5l582t613r698b641],
29	.	.	O	.	_	0	SENT_109	[p5l582t613r698b641],

1	Protease	NN	O	protease	nn	2	SENT_110	[p5l711t613r845b641],
2	inhibitors	NNS	O	inhibitor	nsubj	10	SENT_110	[p5l856t612r1009b641],
3	block	VBP	O	block	_	0	SENT_110	[p5l1021t612r1107b641],
4	processing	NN	O	processing	dobj	3	SENT_110	[p5l1116t613r1283b651],
5	of	IN	O	of	_	0	SENT_110	[p5l1294t612r1328b641],
6	the	DT	O	the	det	8	SENT_110	[p5l1336t612r1384b641],
7	viral	JJ	O	viral	amod	8	SENT_110	[p5l1395t612r1464b641],
8	polyprotein	NN	O	polyprotein	prep_of	4	SENT_110	[p5l1476t612r1659b650],
9	and	CC	O	and	_	0	SENT_110	[p5l1671t612r1726b641],
10	prevent	VB	O	prevent	conj_and	3	SENT_110	[p5l1737t620r1857b650],
11	the	DT	O	the	det	12	SENT_110	[p5l1868t612r1916b641],
12	production	NN	O	production	dobj	10	SENT_110	[p5l1928t612r2102b650],
13	of	IN	O	of	_	0	SENT_110	[p5l584t662r618b691],
14	infectious	JJ	O	infectious	amod	16	SENT_110	[p5l625t662r777b691],
15	viral	JJ	O	viral	amod	16	SENT_110	[p5l787t662r856b691],
16	particles	NNS	O	particle	prep_of	12	SENT_110	[p5l867t662r1006b700],
17	.	.	O	.	_	0	SENT_110	[p5l867t662r1006b700],

1	As	IN	O	as	mark	2	SENT_111	[p5l632t713r670b741],
2	outlined	VBN	O	outline	advcl	7	SENT_111	[p5l686t711r815b741],
3	above	IN	O	above	prep	2	SENT_111	[p5l830t712r928b747],
4	,	,	O	,	_	0	SENT_111	[p5l830t712r928b747],
5	integrase	NN	O	integrase	nn	6	SENT_111	[p5l943t713r1084b750],
6	inhibitors	NNS	O	inhibitor	nsubj	7	SENT_111	[p5l1098t712r1250b741],
7	act	VBP	O	act	_	0	SENT_111	[p5l1266t720r1310b741],
8	on	IN	O	on	_	0	SENT_111	[p5l1324t723r1363b741],
9	a	DT	O	a	det	12	SENT_111	[p5l1378t723r1392b741],
10	distinct	JJ	O	distinct	amod	12	SENT_111	[p5l1407t712r1523b741],
11	viral	JJ	O	viral	amod	12	SENT_111	[p5l1535t711r1604b741],
12	target	NN	O	target	prep_on	7	SENT_111	[p5l1618t720r1710b750],
13	at	IN	O	at	_	0	SENT_111	[p5l1724t720r1752b741],
14	a	DT	O	a	det	15	SENT_111	[p5l1766t723r1780b741],
15	point	NN	O	point	prep_at	12	SENT_111	[p5l1795t713r1878b750],
16	in	IN	O	in	_	0	SENT_111	[p5l1891t713r1921b740],
17	the	DT	O	the	det	20	SENT_111	[p5l1935t712r1984b741],
18	HIV-1	NN	MISC	hiv-1	nn	20	SENT_111	[p5l1998t713r2099b741],
19	replication	NN	O	replication	nn	20	SENT_111	[p5l584t761r752b800],
20	cycle	NN	O	cycle	prep_in	15	SENT_111	[p5l764t762r840b800],
21	that	WDT	O	that	nsubj	22	SENT_111	[p5l852t762r914b791],
22	differs	VBZ	O	differ	rcmod	12	SENT_111	[p5l925t762r1022b791],
23	from	IN	O	from	_	0	SENT_111	[p5l1034t762r1110b791],
24	all	DT	O	all	det	26	SENT_111	[p5l1121t761r1157b791],
25	other	JJ	O	other	amod	26	SENT_111	[p5l1169t761r1252b791],
26	classes	NNS	O	class	prep_from	22	SENT_111	[p5l1264t761r1364b791],
27	of	IN	O	of	_	0	SENT_111	[p5l1376t762r1410b790],
28	antiretroviral	JJ	O	antiretroviral	amod	29	SENT_111	[p5l1418t761r1624b791],
29	drugs	NNS	O	drug	prep_of	26	SENT_111	[p5l1636t762r1730b800],
30	.	.	O	.	_	0	SENT_111	[p5l1636t762r1730b800],

1	Moreover	RB	O	moreover	advmod	32	SENT_112	[p5l1741t763r1905b797],
2	,	,	O	,	_	0	SENT_112	[p5l1741t763r1905b797],
3	as	IN	O	as	mark	4	SENT_112	[p5l1918t773r1946b791],
4	discussed	VBN	O	discuss	advcl	32	SENT_112	[p5l1958t761r2102b791],
5	further	RB	O	further	advmod	4	SENT_112	[p5l584t811r694b840],
6	below	IN	O	below	prep	4	SENT_112	[p5l703t811r801b847],
7	,	,	O	,	_	0	SENT_112	[p5l703t811r801b847],
8	the	DT	O	the	det	10	SENT_112	[p5l811t811r860b840],
9	biological	JJ	O	biological	amod	10	SENT_112	[p5l870t811r1023b850],
10	mechanism	NN	O	mechanism	nsubj	32	SENT_112	[p5l1031t811r1209b840],
11	of	IN	O	of	_	0	SENT_112	[p5l1218t812r1253b840],
12	action	NN	O	action	nn	15	SENT_112	[p5l1258t813r1353b840],
13	and	CC	O	and	_	0	SENT_112	[p5l1362t811r1418b840],
14	molecular	JJ	O	molecular	nn	15	SENT_112	[p5l1427t811r1583b840],
15	properties	NNS	O	property	prep_of	10	SENT_112	[p5l1592t813r1750b850],
16	of	IN	O	of	_	0	SENT_112	[p5l1760t812r1795b840],
17	integrase	NN	O	integrase	nn	18	SENT_112	[p5l1799t813r1940b850],
18	inhibitors	NNS	O	inhibitor	prep_of	15	SENT_112	[p5l1949t811r2102b840],
19	such	JJ	O	such	_	0	SENT_112	[p5l584t861r654b890],
20	as	IN	O	as	_	0	SENT_112	[p5l665t872r693b890],
21	raltegravir	NN	O	raltegravir	prep_such_as	18	SENT_112	[p5l705t861r874b900],
22	,	,	O	,	_	0	SENT_112	[p5l705t861r874b900],
23	the	DT	O	the	det	27	SENT_112	[p5l887t861r935b890],
24	most	RBS	O	most	advmod	26	SENT_112	[p5l947t869r1024b890],
25	well	RB	O	well	advmod	26	SENT_112	[p5l1033t861r1097b890],
26	studied	VBN	O	study	amod	27	SENT_112	[p5l1109t861r1221b890],
27	compound	NN	O	compound	appos	21	SENT_112	[p5l1233t861r1400b900],
28	in	IN	O	in	_	0	SENT_112	[p5l1411t863r1441b890],
29	the	DT	O	the	det	30	SENT_112	[p5l1453t861r1501b890],
30	class	NN	O	class	prep_in	27	SENT_112	[p5l1514t861r1591b897],
31	,	,	O	,	_	0	SENT_112	[p5l1514t861r1591b897],
32	have	VBP	O	have	_	0	SENT_112	[p5l1604t861r1674b890],
33	important	JJ	O	important	amod	34	SENT_112	[p5l1686t863r1844b900],
34	implications	NNS	O	implication	dobj	32	SENT_112	[p5l1854t861r2045b900],
35	for	IN	O	for	_	0	SENT_112	[p5l2057t861r2103b890],
36	understanding	VBG	O	understand	prepc_for	34	SENT_112	[p5l583t911r810b950],
37	the	DT	O	the	det	38	SENT_112	[p5l821t911r869b940],
38	pharmacology	NN	O	pharmacology	dobj	36	SENT_112	[p5l880t911r1105b950],
39	and	CC	O	and	_	0	SENT_112	[p5l1115t911r1170b940],
40	pharmacodynamics	NNS	O	pharmacodynamic	dobj	36	SENT_112	[p5l1181t911r1484b950],
41	of	IN	O	of	_	0	SENT_112	[p5l1496t911r1530b940],
42	these	DT	O	these	det	43	SENT_112	[p5l1537t911r1616b940],
43	agents	NNS	O	agent	prep_of	38	SENT_112	[p5l1628t919r1735b950],
44	.	.	O	.	_	0	SENT_112	[p5l1628t919r1735b950],

1	INTEGRASE	NNP	O	INTEGRASE	nn	2	SENT_113	[p5l583t1054r847b1086],
2	INHIBITORS	NNS	O	inhibitor	_	0	SENT_113	[p5l859t1054r1135b1086],

1	Integrase	NNP	O	Integrase	nn	2	SENT_114	[p5l583t1138r760b1180],
2	Biology	NNP	O	Biology	dep	24	SENT_114	[p5l774t1137r919b1180],
3	and	CC	O	and	_	0	SENT_114	[p5l931t1137r998b1169],
4	Biochemistry	NNP	O	Biochemistry	conj_and	2	SENT_114	[p5l1011t1137r1263b1180],
5	In	IN	O	in	_	0	SENT_114	[p5l584t1189r617b1217],
6	contrast	NN	O	contrast	prep_in	24	SENT_114	[p5l628t1196r755b1217],
7	to	TO	O	to	_	0	SENT_114	[p5l764t1196r795b1217],
8	the	DT	O	the	det	10	SENT_114	[p5l806t1188r855b1217],
9	early	JJ	O	early	amod	10	SENT_114	[p5l866t1188r943b1227],
10	discovery	NN	O	discovery	prep_to	6	SENT_114	[p5l953t1188r1100b1227],
11	and	CC	O	and	_	0	SENT_114	[p5l1110t1188r1165b1217],
12	subsequent	JJ	O	subsequent	amod	15	SENT_114	[p5l1176t1188r1351b1227],
13	rapid	JJ	O	rapid	amod	15	SENT_114	[p5l1361t1188r1441b1227],
14	clinical	JJ	O	clinical	amod	15	SENT_114	[p5l1452t1188r1563b1217],
15	development	NN	O	development	conj_and	6	SENT_114	[p5l1574t1188r1777b1227],
16	of	IN	O	of	_	0	SENT_114	[p5l1787t1188r1821b1217],
17	reverse	JJ	O	reverse	amod	18	SENT_114	[p5l1827t1199r1938b1217],
18	transcriptase	NN	O	transcriptase	prep_of	15	SENT_114	[p5l1949t1190r2101b1227, p5l584t1244r642b1265],
19	and	CC	O	and	_	0	SENT_114	[p5l654t1236r709b1265],
20	protease	NN	O	protease	nn	21	SENT_114	[p5l720t1244r850b1275],
21	inhibitors	NNS	O	inhibitor	conj_and	18	SENT_114	[p5l861t1236r1022b1271],
22	,	,	O	,	_	0	SENT_114	[p5l861t1236r1022b1271],
23	integrase	NN	O	integrase	nsubj	24	SENT_114	[p5l1034t1236r1263b1275],
24	—	VBD	O	—	dep	37	SENT_114	[p5l1034t1236r1263b1275],
25	the	DT	O	the	det	26	SENT_114	[p5l1034t1236r1263b1275],
26	third	JJ	ORDINAL	third	dobj	24	SENT_114	[p5l1274t1236r1350b1265],
27	of	IN	O	of	_	0	SENT_114	[p5l1362t1236r1396b1265],
28	the	DT	O	the	det	31	SENT_114	[p5l1402t1236r1451b1265],
29	three	CD	NUMBER	three	num	31	SENT_114	[p5l1462t1236r1543b1265],
30	major	JJ	O	major	amod	31	SENT_114	[p5l1554t1237r1645b1275],
31	enzymes	NNS	O	enzyme	prep_of	26	SENT_114	[p5l1656t1247r1788b1275],
32	required	VBN	O	require	partmod	31	SENT_114	[p5l1799t1236r1932b1275],
33	for	IN	O	for	_	0	SENT_114	[p5l1943t1236r1988b1265],
34	HIV-1	NN	MISC	hiv-1	nn	36	SENT_114	[p5l1998t1237r2098b1265],
35	replication	NN	O	replication	nn	36	SENT_114	[p5l584t1284r925b1323],
36	—	NN	O	—	prep_for	32	SENT_114	[p5l584t1284r925b1323],
37	followed	VBD	O	follow	_	0	SENT_114	[p5l584t1284r925b1323],
38	the	DT	O	the	det	41	SENT_114	[p5l940t1284r989b1314],
39	ﬁrst	JJ	O	ﬁrst	amod	41	SENT_114	[p5l1003t1284r1065b1314],
40	ARV	NN	ORGANIZATION	arv	nn	41	SENT_114	[p5l1077t1285r1156b1314],
41	agents	NNS	O	agent	dobj	37	SENT_114	[p5l1168t1293r1266b1323],
42	after	IN	O	after	_	0	SENT_114	[p5l1281t1284r1352b1314],
43	more	JJR	DURATION	more	quantmod	44	SENT_114	[p5l1365t1295r1447b1314],
44	than	IN	DURATION	than	num	47	SENT_114	[p5l1462t1284r1531b1314],
45	a	DT	DURATION	a	det	46	SENT_114	[p5l1545t1295r1560b1314],
46	decade	NN	DURATION	decade	dep	44	SENT_114	[p5l1575t1284r1680b1314],
47	(	CD	NUMBER	(	prep_after	37	SENT_114	[p5l1695t1285r1821b1321],
48	16-19	CD	NUMBER	16-19	num	49	SENT_114	[p5l1695t1285r1821b1321],
49	)	NN	O	)	nsubj	37	SENT_114	[p5l1695t1285r1821b1321],
50	.	.	O	.	_	0	SENT_114	[p5l1695t1285r1821b1321],

1	Although	IN	O	although	mark	5	SENT_115	[p5l1836t1284r1985b1323],
2	HIV-1	NN	O	hiv-1	nn	3	SENT_115	[p5l1998t1286r2099b1314],
3	integrase	NN	O	integrase	nsubjpass	5	SENT_115	[p5l583t1334r725b1371],
4	is	VBZ	O	be	auxpass	5	SENT_115	[p5l739t1334r761b1361],
5	known	VBN	O	know	advcl	36	SENT_115	[p5l775t1332r881b1361],
6	to	TO	O	to	aux	7	SENT_115	[p5l895t1340r925b1361],
7	inﬂuence	VB	O	inﬂuence	xcomp	5	SENT_115	[p5l939t1332r1083b1361],
8	several	JJ	O	several	amod	9	SENT_115	[p5l1097t1332r1202b1361],
9	stages	NNS	O	stage	dobj	7	SENT_115	[p5l1217t1340r1308b1371],
10	of	IN	O	of	_	0	SENT_115	[p5l1323t1332r1357b1361],
11	the	DT	O	the	det	14	SENT_115	[p5l1367t1332r1415b1361],
12	HIV-1	NN	MISC	hiv-1	nn	14	SENT_115	[p5l1429t1333r1530b1361],
13	replication	NN	O	replication	nn	14	SENT_115	[p5l1547t1332r1715b1371],
14	cycle	NN	O	cycle	prep_of	9	SENT_115	[p5l1729t1332r1815b1371],
15	,	,	O	,	_	0	SENT_115	[p5l1729t1332r1815b1371],
16	including	VBG	O	include	_	0	SENT_115	[p5l1830t1332r1978b1371],
17	reverse	JJ	O	reverse	amod	18	SENT_115	[p5l1991t1343r2102b1361],
18	transcription	NN	O	transcription	prep_including	5	SENT_115	[p5l584t1381r794b1419],
19	,	,	O	,	_	0	SENT_115	[p5l584t1381r794b1419],
20	integration	NN	O	integration	conj_and	18	SENT_115	[p5l805t1381r988b1419],
21	,	,	O	,	_	0	SENT_115	[p5l805t1381r988b1419],
22	and	CC	O	and	_	0	SENT_115	[p5l1000t1380r1055b1409],
23	viral	JJ	O	viral	amod	24	SENT_115	[p5l1064t1380r1133b1409],
24	assembly	NN	O	assembly	conj_and	18	SENT_115	[p5l1144t1380r1285b1419],
25	(	CD	NUMBER	(	number	26	SENT_115	[p5l1294t1381r1351b1416],
26	20	CD	NUMBER	20	dep	24	SENT_115	[p5l1294t1381r1351b1416],
27	,	,	O	,	_	0	SENT_115	[p5l1294t1381r1351b1416],
28	21	CD	NUMBER	21	num	29	SENT_115	[p5l1363t1381r1420b1417],
29	)	NN	O	)	nsubj	36	SENT_115	[p5l1363t1381r1420b1417],
30	,	,	O	,	_	0	SENT_115	[p5l1363t1381r1420b1417],
31	the	DT	O	the	det	32	SENT_115	[p5l1432t1380r1481b1409],
32	enzyme	NN	O	enzyme	poss	35	SENT_115	[p5l1492t1381r1630b1419],
33	’s	POS	O	’s	_	0	SENT_115	[p5l1492t1381r1630b1419],
34	primary	JJ	O	primary	amod	35	SENT_115	[p5l1640t1381r1766b1419],
35	role	NN	O	role	appos	29	SENT_115	[p5l1774t1380r1835b1409],
36	is	VBZ	O	be	_	0	SENT_115	[p5l1845t1381r1868b1409],
37	in	IN	O	in	_	0	SENT_115	[p5l1878t1381r1908b1409],
38	integration	NN	O	integration	prep_in	36	SENT_115	[p5l1918t1381r2101b1419],
39	,	,	O	,	_	0	SENT_115	[p5l1918t1381r2101b1419],
40	the	DT	O	the	det	41	SENT_115	[p5l584t1428r633b1458],
41	process	NN	O	process	appos	38	SENT_115	[p5l648t1439r763b1467],
42	wherein	WRB	O	wherein	advmod	48	SENT_115	[p5l777t1428r905b1458],
43	the	DT	O	the	det	45	SENT_115	[p5l920t1428r969b1457],
44	viral	JJ	O	viral	amod	45	SENT_115	[p5l983t1428r1052b1458],
45	DNA	NN	MISC	dna	nsubjpass	48	SENT_115	[p5l1068t1429r1157b1457],
46	is	VBZ	O	be	auxpass	48	SENT_115	[p5l1170t1430r1192b1458],
47	irreversibly	RB	O	irreversibly	advmod	48	SENT_115	[p5l1208t1428r1387b1467],
48	inserted	VBN	O	insert	rcmod	41	SENT_115	[p5l1400t1428r1526b1458],
49	into	IN	O	into	_	0	SENT_115	[p5l1541t1430r1603b1458],
50	the	DT	O	the	det	52	SENT_115	[p5l1619t1428r1668b1458],
51	cellular	JJ	O	cellular	amod	52	SENT_115	[p5l1684t1428r1799b1458],
52	DNA	NN	O	dna	prep_into	48	SENT_115	[p5l1814t1429r1903b1457],
53	of	IN	O	of	_	0	SENT_115	[p5l1917t1428r1951b1458],
54	the	DT	O	the	det	55	SENT_115	[p5l1962t1428r2011b1458],
55	host	NN	O	host	prep_of	52	SENT_115	[p5l2026t1428r2100b1458],
56	.	.	O	.	_	0	SENT_115	[p5l2026t1428r2100b1458],

1	Integrase	NNP	O	Integrase	nsubjpass	3	SENT_116	[p5l584t1479r728b1517],
2	is	VBZ	O	be	auxpass	3	SENT_116	[p5l738t1480r761b1507],
3	required	VBN	O	require	_	0	SENT_116	[p5l771t1478r904b1517],
4	for	IN	O	for	_	0	SENT_116	[p5l915t1478r960b1507],
5	each	DT	O	each	prep_for	3	SENT_116	[p5l970t1478r1040b1507],
6	of	IN	O	of	_	0	SENT_116	[p5l1050t1478r1084b1507],
7	the	DT	O	the	det	10	SENT_116	[p5l1090t1478r1139b1507],
8	three	CD	NUMBER	three	num	10	SENT_116	[p5l1150t1478r1230b1507],
9	sequence-speciﬁc	NN	O	sequence-speciﬁc	nn	10	SENT_116	[p5l1241t1478r1513b1517],
10	events	NNS	O	event	prep_of	5	SENT_116	[p5l1524t1486r1620b1507],
11	critical	JJ	O	critical	amod	10	SENT_116	[p5l1631t1478r1737b1507],
12	for	IN	O	for	_	0	SENT_116	[p5l1748t1478r1793b1507],
13	integration	NN	O	integration	prep_for	11	SENT_116	[p5l1802t1480r1984b1517],
14	:	:	O	:	_	0	SENT_116	[p5l1802t1480r1984b1517],
15	assembly	NN	O	assembly	conj_and	5	SENT_116	[p5l1997t1489r2101b1507, p5l584t1526r632b1565],
16	with	IN	O	with	_	0	SENT_116	[p5l643t1526r712b1555],
17	the	DT	O	the	det	19	SENT_116	[p5l725t1526r774b1555],
18	viral	JJ	O	viral	amod	19	SENT_116	[p5l786t1526r855b1555],
19	DNA	NN	MISC	dna	prep_with	15	SENT_116	[p5l869t1527r964b1562],
20	,	,	O	,	_	0	SENT_116	[p5l869t1527r964b1562],
21	3	CD	NUMBER	3	num	22	SENT_116	[p5l980t1528r1003b1555],
22	’	NN	O	’	prep_for	3	SENT_116	[p5l980t1528r1003b1555],
23	endonucleolytic	JJ	O	endonucleolytic	amod	24	SENT_116	[p5l1019t1526r1268b1565],
24	processing	NN	O	processing	dep	22	SENT_116	[p5l1281t1528r1454b1565],
25	,	,	O	,	_	0	SENT_116	[p5l1281t1528r1454b1565],
26	and	CC	O	and	_	0	SENT_116	[p5l1469t1526r1525b1555],
27	strand	NN	O	strand	nn	28	SENT_116	[p5l1538t1526r1635b1555],
28	transfer	NN	O	transfer	conj_and	5	SENT_116	[p5l1648t1526r1774b1555],
29	.	.	O	.	_	0	SENT_116	[p5l1648t1526r1774b1555],

1	In	IN	O	in	_	0	SENT_117	[p5l1788t1528r1822b1555],
2	the	DT	O	the	det	6	SENT_117	[p5l1835t1526r1884b1555],
3	3	CD	NUMBER	3	num	6	SENT_117	[p5l1899t1528r1922b1555],
4	’	NN	O	’	nn	6	SENT_117	[p5l1899t1528r1922b1555],
5	processing	NN	O	processing	nn	6	SENT_117	[p5l1936t1528r2103b1565],
6	reaction	NN	O	reaction	prep_in	9	SENT_117	[p5l584t1575r719b1609],
7	,	,	O	,	_	0	SENT_117	[p5l584t1575r719b1609],
8	integrase	NN	O	integrase	nsubj	9	SENT_117	[p5l735t1575r876b1612],
9	removes	VBZ	O	remove	_	0	SENT_117	[p5l891t1584r1020b1602],
10	the	DT	O	the	det	14	SENT_117	[p5l1035t1573r1084b1602],
11	terminal	JJ	O	terminal	amod	14	SENT_117	[p5l1099t1573r1231b1602],
12	3	CD	NUMBER	3	tmod	11	SENT_117	[p5l1247t1575r1271b1603],
13	’	NN	O	’	nn	14	SENT_117	[p5l1247t1575r1271b1603],
14	dinucleotide	NN	O	dinucleotide	dobj	9	SENT_117	[p5l1288t1573r1481b1602],
15	from	IN	O	from	_	0	SENT_117	[p5l1496t1573r1572b1602],
16	each	DT	O	each	det	17	SENT_117	[p5l1587t1573r1656b1602],
17	end	NN	O	end	prep_from	9	SENT_117	[p5l1671t1573r1727b1602],
18	of	IN	O	of	_	0	SENT_117	[p5l1742t1573r1777b1602],
19	the	DT	O	the	det	20	SENT_117	[p5l1787t1573r1836b1602],
20	DNA	NN	MISC	dna	prep_of	17	SENT_117	[p5l1851t1574r1946b1609],
21	,	,	O	,	_	0	SENT_117	[p5l1851t1574r1946b1609],
22	leaving	VBG	O	leave	partmod	9	SENT_117	[p5l1961t1573r2073b1612],
23	a	DT	O	a	det	25	SENT_117	[p5l2087t1584r2102b1602],
24	recessed-3	NN	O	recessed-3	nn	25	SENT_117	[p5l584t1621r834b1650],
25	’	NN	O	’	dobj	22	SENT_117	[p5l584t1621r834b1650],
26	.	.	O	.	_	0	SENT_117	[p5l584t1621r834b1650],

1	—	NN	O	—	_	0	SENT_118	[p5l584t1621r834b1650],
2	.	.	O	.	_	0	SENT_118	[p5l584t1621r834b1650],

1	OH	NN	O	oh	_	0	SENT_119	[p5l584t1621r834b1650],
2	at	IN	O	at	_	0	SENT_119	[p5l849t1629r877b1650],
3	both	DT	O	both	det	4	SENT_119	[p5l891t1621r963b1650],
4	termini	NNS	O	terminus	prep_at	1	SENT_119	[p5l977t1622r1101b1650],
5	.	.	O	.	_	0	SENT_119	[p5l977t1622r1101b1650],

1	In	IN	O	in	_	0	SENT_120	[p5l1117t1622r1150b1650],
2	the	DT	O	the	det	5	SENT_120	[p5l1165t1621r1214b1650],
3	strand	NN	O	strand	nn	5	SENT_120	[p5l1229t1621r1325b1650],
4	transfer	NN	O	transfer	nn	5	SENT_120	[p5l1340t1621r1461b1650],
5	reaction	NN	O	reaction	pobj	1	SENT_120	[p5l1475t1623r1611b1657],
6	,	,	O	,	_	0	SENT_120	[p5l1475t1623r1611b1657],
7	integrase	NN	O	integrase	nn	8	SENT_120	[p5l1626t1622r1767b1660],
8	nicks	NNS	O	nick	appos	5	SENT_120	[p5l1782t1621r1861b1650],
9	the	DT	O	the	det	10	SENT_120	[p5l1876t1621r1925b1650],
10	cellular	JJ	O	cellular	dep	8	SENT_120	[p5l1940t1621r2055b1650],
11	or	CC	O	or	cc	10	SENT_120	[p5l2069t1632r2103b1650],

1	Httzuda	NN	PERSON	httzuda	nn	3	SENT_121	[p5l583t1728r675b1750],
2	o	NN	O	o	nn	3	SENT_121	[p5l690t1736r700b1746],
3	Izmmato	NNP	PERSON	Izmmato	_	0	SENT_121	[p5l714t1728r811b1750],
4	-	:	O	-	_	0	SENT_121	[p5l827t1736r836b1746],
5	Wenning	NNP	PERSON	Wenning	nn	7	SENT_121	[p5l855t1728r956b1758],
6	target	NN	O	target	nn	7	SENT_121	[p5l347t1841r439b1872],
7	DNA	NN	O	dna	dep	3	SENT_121	[p5l450t1834r539b1862],
8	once	RB	DATE	once	advmod	18	SENT_121	[p5l548t1844r621b1863],
9	on	IN	O	on	_	0	SENT_121	[p5l633t1844r672b1863],
10	each	DT	O	each	det	11	SENT_121	[p5l684t1833r753b1863],
11	strand	NN	O	strand	nn	14	SENT_121	[p5l765t1833r861b1863],
12	and	CC	O	and	cc	11	SENT_121	[p5l873t1833r928b1863],
13	covalently	RB	O	covalently	advmod	11	SENT_121	[p5l940t1833r1100b1872],
14	links	NNS	O	link	prep_on	8	SENT_121	[p5l1109t1833r1182b1863],
15	each	DT	O	each	det	18	SENT_121	[p5l1194t1833r1264b1863],
16	5	CD	NUMBER	5	num	18	SENT_121	[p5l1276t1835r1300b1863],
17	’	NN	O	’	nn	18	SENT_121	[p5l1276t1835r1300b1863],
18	phosphate	NN	O	phosphate	rcmod	7	SENT_121	[p5l1313t1833r1473b1872],
19	to	TO	O	to	_	0	SENT_121	[p5l1485t1842r1515b1863],
20	one	CD	NUMBER	one	prep_to	18	SENT_121	[p5l1528t1844r1583b1863],
21	of	IN	O	of	_	0	SENT_121	[p5l1596t1833r1630b1863],
22	the	DT	O	the	det	24	SENT_121	[p5l1637t1833r1686b1863],
23	recessed	VBN	O	recess	amod	24	SENT_121	[p5l1697t1833r1826b1863],
24	3	CD	NUMBER	3	prep_of	20	SENT_121	[p5l1840t1835r1863b1863],
25	’	NN	O	’	nn	26	SENT_121	[p5l1840t1835r1863b1863],
26	ends	NNS	O	end	npadvmod	24	SENT_121	[p5l347t1881r417b1910],
27	of	IN	O	of	_	0	SENT_121	[p5l431t1881r465b1910],
28	the	DT	O	the	det	30	SENT_121	[p5l474t1881r523b1910],
29	viral	JJ	O	viral	amod	30	SENT_121	[p5l535t1881r604b1910],
30	DNA	NN	O	dna	prep_of	24	SENT_121	[p5l618t1882r713b1910],
31	.	.	O	.	_	0	SENT_121	[p5l618t1882r713b1910],

1	In	IN	O	in	_	0	SENT_122	[p5l727t1882r761b1910],
2	the	DT	O	the	det	6	SENT_122	[p5l774t1881r823b1910],
3	ﬁnal	JJ	O	ﬁnal	amod	6	SENT_122	[p5l836t1881r912b1917],
4	,	,	O	,	_	0	SENT_122	[p5l836t1881r912b1917],
5	nonspeciﬁc	JJ	O	nonspeciﬁc	amod	6	SENT_122	[p5l926t1881r1104b1920],
6	step	NN	O	step	prep_in	12	SENT_122	[p5l1117t1889r1187b1920],
7	,	,	O	,	_	0	SENT_122	[p5l1117t1889r1187b1920],
8	the	DT	O	the	det	10	SENT_122	[p5l1202t1881r1250b1910],
9	integrated	VBN	O	integrate	amod	10	SENT_122	[p5l1264t1881r1424b1920],
10	intermediate	NN	O	intermediate	nsubjpass	12	SENT_122	[p5l1437t1881r1636b1910],
11	is	VBZ	O	be	auxpass	12	SENT_122	[p5l1649t1883r1672b1910],
12	repaired	VBN	O	repair	_	0	SENT_122	[p5l1685t1881r1815b1920],
13	by	IN	O	by	_	0	SENT_122	[p5l1828t1881r1866b1920],
14	cellular	JJ	O	cellular	amod	15	SENT_122	[p5l347t1929r462b1958],
15	enzymes	NNS	O	enzyme	agent	12	SENT_122	[p5l471t1940r603b1968],
16	to	TO	O	to	aux	17	SENT_122	[p5l612t1937r643b1958],
17	create	VB	O	create	xcomp	12	SENT_122	[p5l652t1938r745b1958],
18	the	DT	O	the	det	21	SENT_122	[p5l754t1929r802b1958],
19	intact	JJ	O	intact	amod	21	SENT_122	[p5l811t1931r900b1958],
20	double	JJ	O	double	amod	21	SENT_122	[p5l908t1929r1164b1958],
21	—	NN	O	—	nsubj	22	SENT_122	[p5l908t1929r1164b1958],
22	stranded	VBD	O	strand	ccomp	17	SENT_122	[p5l908t1929r1164b1958],
23	product	NN	O	product	dobj	22	SENT_122	[p5l1173t1929r1303b1968],
24	.	.	O	.	_	0	SENT_122	[p5l1173t1929r1303b1968],

1	In	IN	O	in	_	0	SENT_123	[p5l1313t1931r1347b1958],
2	the	DT	O	the	det	3	SENT_123	[p5l1355t1929r1404b1958],
3	context	NN	O	context	prep_in	10	SENT_123	[p5l1413t1937r1528b1958],
4	of	IN	O	of	_	0	SENT_123	[p5l1536t1929r1571b1958],
5	HIV-1	NN	MISC	hiv-1	nn	6	SENT_123	[p5l1575t1931r1675b1958],
6	replication	NN	O	replication	prep_of	3	SENT_123	[p5l1687t1929r1863b1968],
7	,	,	O	,	_	0	SENT_123	[p5l1687t1929r1863b1968],
8	these	DT	O	these	det	9	SENT_123	[p5l347t1979r427b2008],
9	events	NNS	O	event	nsubj	10	SENT_123	[p5l440t1987r536b2008],
10	proceed	VBP	O	proceed	_	0	SENT_123	[p5l549t1979r673b2018],
11	in	IN	O	in	_	0	SENT_123	[p5l685t1981r715b2008],
12	a	DT	O	a	det	14	SENT_123	[p5l727t1990r742b2008],
13	stepwise	JJ	O	stepwise	amod	14	SENT_123	[p5l754t1981r884b2018],
14	manner	NN	O	manner	prep_in	10	SENT_123	[p5l896t1990r1022b2015],
15	,	,	O	,	_	0	SENT_123	[p5l896t1990r1022b2015],
16	with	IN	O	with	_	0	SENT_123	[p5l1034t1979r1104b2008],
17	the	DT	O	the	det	19	SENT_123	[p5l1116t1979r1165b2008],
18	rate-limiting	JJ	O	rate-limiting	amod	19	SENT_123	[p5l1177t1979r1377b2018],
19	event	NN	O	event	nsubj	22	SENT_123	[p5l1389t1987r1473b2008],
20	being	VBG	O	be	cop	22	SENT_123	[p5l1484t1979r1572b2018],
21	strand	NN	O	strand	nn	22	SENT_123	[p5l1583t1979r1679b2008],
22	transfer	NN	O	transfer	prepc_with	10	SENT_123	[p5l1692t1979r1818b2008],
23	.	.	O	.	_	0	SENT_123	[p5l1692t1979r1818b2008],

1	In	IN	O	in	_	0	SENT_124	[p5l1831t1980r1865b2008],
2	activated	VBN	O	activate	amod	3	SENT_124	[p5l347t2027r485b2056],
3	cells	NNS	O	cell	prep_in	14	SENT_124	[p5l499t2027r574b2062],
4	,	,	O	,	_	0	SENT_124	[p5l499t2027r574b2062],
5	within	IN	O	within	_	0	SENT_124	[p5l587t2027r688b2056],
6	several	JJ	DURATION	several	amod	7	SENT_124	[p5l702t2027r807b2056],
7	hours	NNS	DURATION	hour	prep_within	14	SENT_124	[p5l820t2027r908b2056],
8	after	IN	O	after	_	0	SENT_124	[p5l922t2027r994b2056],
9	infection	NN	O	infection	prep_after	7	SENT_124	[p5l1006t2027r1154b2062],
10	,	,	O	,	_	0	SENT_124	[p5l1006t2027r1154b2062],
11	reverse	JJ	O	reverse	amod	12	SENT_124	[p5l1168t2038r1279b2056],
12	transcription	NN	O	transcription	nsubjpass	14	SENT_124	[p5l1293t2028r1495b2065],
13	is	VBZ	O	be	auxpass	14	SENT_124	[p5l1507t2028r1530b2056],
14	completed	VBN	O	complete	_	0	SENT_124	[p5l1544t2027r1708b2065],
15	and	CC	O	and	_	0	SENT_124	[p5l1722t2027r1777b2056],
16	integrase	NN	O	integrase	nsubj	19	SENT_124	[p5l1790t2028r1864b2056, p5l347t2085r427b2113],
17	binds	VBZ	O	bind	conj_and	14	SENT_124	[p5l440t2074r523b2103],
18	and	CC	O	and	_	0	SENT_124	[p5l537t2074r592b2103],
19	processes	VBZ	O	process	conj_and	17	SENT_124	[p5l605t2085r750b2113],
20	the	DT	O	the	det	22	SENT_124	[p5l764t2074r812b2103],
21	viral	JJ	O	viral	amod	22	SENT_124	[p5l824t2074r893b2103],
22	DNA	NN	O	dna	dobj	17	SENT_124	[p5l906t2075r1001b2103],
23	.	.	O	.	_	0	SENT_124	[p5l906t2075r1001b2103],

1	The	DT	O	the	det	3	SENT_125	[p5l1014t2074r1081b2103],
2	subsequent	JJ	O	subsequent	amod	3	SENT_125	[p5l1094t2074r1269b2113],
3	reaction	NN	O	reaction	nsubj	8	SENT_125	[p5l1281t2076r1416b2110],
4	,	,	O	,	_	0	SENT_125	[p5l1281t2076r1416b2110],
5	strand	NN	O	strand	nn	6	SENT_125	[p5l1431t2074r1527b2103],
6	transfer	NN	O	transfer	appos	3	SENT_125	[p5l1540t2074r1666b2110],
7	,	,	O	,	_	0	SENT_125	[p5l1540t2074r1666b2110],
8	occurs	VBZ	O	occur	_	0	SENT_125	[p5l1681t2085r1780b2103],
9	after	IN	O	after	mark	14	SENT_125	[p5l1794t2074r1865b2103],
10	the	DT	O	the	det	11	SENT_125	[p5l347t2121r396b2150],
11	PIC	NNP	ORGANIZATION	PIC	nsubjpass	14	SENT_125	[p5l407t2122r471b2150],
12	has	VBZ	O	have	aux	14	SENT_125	[p5l482t2121r532b2150],
13	been	VBN	O	be	auxpass	14	SENT_125	[p5l543t2121r617b2150],
14	transported	VBN	O	transport	advcl	8	SENT_125	[p5l628t2121r809b2159],
15	into	IN	O	into	_	0	SENT_125	[p5l820t2123r882b2150],
16	the	DT	O	the	det	17	SENT_125	[p5l894t2121r943b2150],
17	nucleus	NN	O	nucleus	prep_into	14	SENT_125	[p5l954t2121r1080b2150],
18	.	.	O	.	_	0	SENT_125	[p5l954t2121r1080b2150],

1	To	TO	O	to	_	0	SENT_126	[p5l396t2169r437b2197],
2	date	NN	O	date	prep_to	9	SENT_126	[p5l447t2168r519b2204],
3	,	,	O	,	_	0	SENT_126	[p5l447t2168r519b2204],
4	HIV-1	NN	O	hiv-1	nn	5	SENT_126	[p5l529t2169r629b2197],
5	integrase	NN	O	integrase	nsubj	9	SENT_126	[p5l641t2169r782b2207],
6	is	VBZ	O	be	cop	9	SENT_126	[p5l791t2169r813b2197],
7	the	DT	O	the	det	9	SENT_126	[p5l823t2168r871b2197],
8	only	JJ	O	only	amod	9	SENT_126	[p5l881t2168r950b2207],
9	protein	NN	O	protein	_	0	SENT_126	[p5l956t2169r1071b2207],
10	known	VBN	O	know	partmod	9	SENT_126	[p5l1079t2168r1184b2197],
11	to	TO	O	to	aux	14	SENT_126	[p5l1193t2176r1224b2197],
12	be	VB	O	be	auxpass	14	SENT_126	[p5l1233t2168r1268b2197],
13	absolutely	RB	O	absolutely	advmod	14	SENT_126	[p5l1277t2168r1436b2207],
14	required	VBN	O	require	xcomp	10	SENT_126	[p5l1443t2168r1576b2207],
15	to	TO	O	to	aux	16	SENT_126	[p5l1585t2176r1615b2197],
16	catalyze	VB	O	catalyze	xcomp	14	SENT_126	[p5l1625t2168r1747b2207],
17	each	DT	O	each	dobj	16	SENT_126	[p5l1757t2168r1826b2197],
18	of	IN	O	of	_	0	SENT_126	[p5l1835t2168r1869b2197],
19	the	DT	O	the	det	22	SENT_126	[p5l347t2216r396b2246],
20	three	CD	NUMBER	three	num	22	SENT_126	[p5l403t2216r484b2246],
21	speciﬁc	NN	O	speciﬁc	nn	22	SENT_126	[p5l492t2216r606b2255],
22	steps	NNS	O	step	prep_of	17	SENT_126	[p5l614t2225r689b2255],
23	in	IN	O	in	_	0	SENT_126	[p5l697t2218r727b2245],
24	integration	NN	O	integration	prep_in	22	SENT_126	[p5l734t2218r916b2255],
25	,	,	O	,	_	0	SENT_126	[p5l734t2218r916b2255],
26	and	CC	O	and	_	0	SENT_126	[p5l925t2216r981b2246],
27	is	VBZ	O	be	cop	28	SENT_126	[p5l988t2218r1010b2246],
28	sufﬁcient	JJ	O	sufﬁcient	xcomp	10	SENT_126	[p5l1019t2216r1162b2246],
29	to	TO	O	to	aux	30	SENT_126	[p5l1169t2225r1199b2246],
30	perform	VB	O	perform	xcomp	28	SENT_126	[p5l1207t2216r1336b2255],
31	these	DT	O	these	det	32	SENT_126	[p5l1343t2216r1422b2246],
32	activities	NNS	O	activity	dobj	30	SENT_126	[p5l1431t2218r1566b2246],
33	in	FW	O	in	nn	34	SENT_126	[p5l1573t2218r1604b2245],
34	vitro	FW	O	vitro	advmod	30	SENT_126	[p5l1609t2218r1692b2246],
35	.	.	O	.	_	0	SENT_126	[p5l1609t2218r1692b2246],

1	The	DT	O	the	det	2	SENT_127	[p5l1700t2216r1766b2246],
2	structure	NN	O	structure	nsubj	10	SENT_127	[p5l1774t2224r1864b2246, p5l347t2272r409b2293],
3	of	IN	O	of	_	0	SENT_127	[p5l422t2264r457b2293],
4	the	DT	O	the	det	9	SENT_127	[p5l465t2264r513b2293],
5	full	JJ	O	full	amod	9	SENT_127	[p5l526t2264r693b2303],
6	—	NN	O	—	nn	9	SENT_127	[p5l526t2264r693b2303],
7	length	NN	O	length	nn	9	SENT_127	[p5l526t2264r693b2303],
8	integrase	NN	O	integrase	nn	9	SENT_127	[p5l704t2266r846b2303],
9	enzyme	NN	O	enzyme	prep_of	2	SENT_127	[p5l859t2275r977b2303],
10	has	VBZ	O	have	_	0	SENT_127	[p5l990t2264r1039b2293],
11	yet	RB	O	yet	advmod	10	SENT_127	[p5l1050t2272r1099b2303],
12	to	TO	O	to	aux	14	SENT_127	[p5l1110t2272r1141b2293],
13	be	VB	O	be	auxpass	14	SENT_127	[p5l1154t2264r1189b2293],
14	determined	VBN	O	determine	xcomp	10	SENT_127	[p5l1202t2264r1390b2300],
15	;	:	O	;	_	0	SENT_127	[p5l1202t2264r1390b2300],
16	however	RB	O	however	advmod	18	SENT_127	[p5l1403t2264r1542b2300],
17	,	,	O	,	_	0	SENT_127	[p5l1403t2264r1542b2300],
18	in	IN	O	in	ccomp	34	SENT_127	[p5l1555t2266r1585b2293],
19	conjunction	NN	O	conjunction	pobj	18	SENT_127	[p5l1598t2266r1784b2303],
20	with	IN	O	with	_	0	SENT_127	[p5l1795t2264r1865b2293],
21	biochemical	JJ	O	biochemical	amod	22	SENT_127	[p5l347t2312r536b2341],
22	analyses	NNS	O	analysis	prep_with	19	SENT_127	[p5l544t2312r677b2351],
23	,	,	O	,	_	0	SENT_127	[p5l544t2312r677b2351],
24	the	DT	O	the	det	25	SENT_127	[p5l687t2312r735b2341],
25	structures	NNS	O	structure	nsubj	34	SENT_127	[p5l743t2320r897b2341],
26	of	IN	O	of	_	0	SENT_127	[p5l906t2312r940b2341],
27	each	DT	O	each	prep_of	25	SENT_127	[p5l944t2312r1013b2341],
28	of	IN	O	of	_	0	SENT_127	[p5l1021t2312r1055b2341],
29	the	DT	O	the	det	31	SENT_127	[p5l1059t2312r1107b2341],
30	three	CD	NUMBER	three	num	31	SENT_127	[p5l1116t2312r1196b2341],
31	subdomains	NNS	O	subdomain	prep_of	27	SENT_127	[p5l1204t2312r1389b2341],
32	have	VBP	O	have	aux	34	SENT_127	[p5l1397t2312r1467b2341],
33	substantially	RB	O	substantially	advmod	34	SENT_127	[p5l1475t2312r1671b2351],
34	advanced	VBN	O	advance	parataxis	10	SENT_127	[p5l1678t2312r1821b2341],
35	an	DT	O	a	det	36	SENT_127	[p5l1829t2323r1865b2341],
36	understanding	NN	O	understanding	dobj	34	SENT_127	[p5l346t2359r573b2398],
37	of	IN	O	of	_	0	SENT_127	[p5l583t2359r617b2388],
38	enzymatic	JJ	O	enzymatic	amod	39	SENT_127	[p5l624t2361r782b2398],
39	function	NN	O	function	prep_of	36	SENT_127	[p5l793t2359r924b2388],
40	and	CC	O	and	_	0	SENT_127	[p5l935t2359r990b2388],
41	mechanism	NN	O	mechanism	nn	42	SENT_127	[p5l1001t2359r1178b2388],
42	(	NN	O	(	conj_and	39	SENT_127	[p5l1189t2359r1339b2395],
43	reviewed	VBN	O	review	partmod	39	SENT_127	[p5l1189t2359r1339b2395],
44	in	IN	O	in	_	0	SENT_127	[p5l1350t2361r1380b2388],
45	21	CD	NUMBER	21	prep_in	43	SENT_127	[p5l1391t2361r1424b2388],
46	and	CC	O	and	_	0	SENT_127	[p5l1438t2359r1494b2388],
47	22	CD	NUMBER	22	num	48	SENT_127	[p5l1505t2360r1562b2395],
48	)	NN	O	)	prep_in	43	SENT_127	[p5l1505t2360r1562b2395],
49	.	.	O	.	_	0	SENT_127	[p5l1505t2360r1562b2395],

1	In	IN	O	in	_	0	SENT_128	[p5l1574t2360r1607b2388],
2	the	DT	O	the	det	3	SENT_128	[p5l1618t2359r1666b2388],
3	absence	NN	O	absence	prep_in	9	SENT_128	[p5l1678t2359r1798b2388],
4	of	IN	O	of	_	0	SENT_128	[p5l1809t2359r1843b2388],
5	a	DT	O	a	det	8	SENT_128	[p5l1850t2370r1865b2388],
6	relevant	JJ	O	relevant	amod	8	SENT_128	[p5l347t2409r473b2438],
7	inhibitor	NN	O	inhibitor	nn	8	SENT_128	[p5l482t2409r734b2438],
8	—	NN	O	—	prep_of	3	SENT_128	[p5l482t2409r734b2438],
9	bound	VBD	O	bind	_	0	SENT_128	[p5l482t2409r734b2438],
10	complex	NN	O	complex	dobj	9	SENT_128	[p5l745t2409r876b2448],
11	for	IN	O	for	_	0	SENT_128	[p5l885t2409r930b2438],
12	either	CC	O	either	preconj	13	SENT_128	[p5l940t2409r1032b2438],
13	raltegravir	NN	O	raltegravir	prep_for	10	SENT_128	[p5l1041t2409r1204b2448],
14	or	CC	O	or	_	0	SENT_128	[p5l1214t2420r1247b2438],
15	elvitegravir	NN	O	elvitegravir	prep_for	10	SENT_128	[p5l1257t2409r1439b2448],
16	,	,	O	,	_	0	SENT_128	[p5l1257t2409r1439b2448],
17	the	DT	O	the	det	20	SENT_128	[p5l1450t2409r1499b2438],
18	unliganded	JJ	O	unliganded	amod	20	SENT_128	[p5l1508t2409r1683b2448],
19	subdomain	NN	O	subdomain	nn	20	SENT_128	[p5l1693t2409r1865b2438],
20	structure	NN	O	structure	appos	10	SENT_128	[p5l347t2480r487b2501],
21	of	IN	O	of	_	0	SENT_128	[p5l497t2472r532b2501],
22	the	DT	O	the	det	25	SENT_128	[p5l537t2472r586b2501],
23	catalytic	JJ	O	catalytic	amod	25	SENT_128	[p5l597t2472r725b2511],
24	core	NN	O	core	nn	25	SENT_128	[p5l735t2483r801b2501],
25	domain	NN	O	domain	prep_of	20	SENT_128	[p5l812t2472r929b2501],
26	(	CD	NUMBER	(	num	28	SENT_128	[p5l940t2473r1048b2508],
27	amino	NN	O	amino	nn	28	SENT_128	[p5l940t2473r1048b2508],
28	acids	NNS	O	acid	nsubj	9	SENT_128	[p5l1058t2472r1134b2501],
29	51-212	CD	NUMBER	51-212	nsubj	36	SENT_128	[p5l1146t2473r1255b2501],
30	in	IN	O	in	_	0	SENT_128	[p5l1268t2473r1298b2501],
31	HIV-1	NN	MISC	hiv-1	nn	33	SENT_128	[p5l1307t2473r1407b2501],
32	integrase	NN	O	integrase	nn	33	SENT_128	[p5l1421t2473r1573b2511],
33	)	NN	O	)	prep_in	29	SENT_128	[p5l1421t2473r1573b2511],
34	has	VBZ	O	have	aux	36	SENT_128	[p5l1583t2472r1633b2501],
35	also	RB	O	also	advmod	36	SENT_128	[p5l1644t2472r1702b2501],
36	suggested	VBN	O	suggest	rcmod	28	SENT_128	[p5l1713t2472r1865b2511],

1	Annu	NNP	PERSON	Annu	_	0	SENT_129	[p6l201t1076r224b1156],
2	.	.	O	.	_	0	SENT_129	[p6l201t1076r224b1156],

1	Rev.	NNP	O	Rev.	nn	2	SENT_130	[p6l201t1006r224b1065],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_130	[p6l201t846r224b995],
3	.	.	O	.	_	0	SENT_130	[p6l201t846r224b995],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_131	[p6l201t726r224b836],
2	.	.	O	.	_	0	SENT_131	[p6l201t726r224b836],

1	2009.49:377	CD	NUMBER	2009.49:377	num	2	SENT_132	[p6l201t481r225b715],
2	-394	CD	NUMBER	-394	_	0	SENT_132	[p6l201t481r225b715],
3	.	.	O	.	_	0	SENT_132	[p6l201t481r225b715],

1	Downloaded	VBN	O	download	_	0	SENT_133	[p6l201t300r224b470],
2	from	IN	O	from	_	0	SENT_133	[p6l201t227r224b291],
3	www	NN	O	www	prep_from	1	SENT_133	[p6l201t7r224b218],
4	.	.	O	.	_	0	SENT_133	[p6l201t7r224b218],

1	annua1rev	NN	O	annua1rev	_	0	SENT_134	[p6l201t7r224b218],
2	by	IN	O	by	_	0	SENT_134	[p6l234t989r265b1021],
3	University	NNP	ORGANIZATION	University	prep_by	1	SENT_134	[p6l234t839r265b979],
4	of	IN	ORGANIZATION	of	_	0	SENT_134	[p6l234t801r258b830],
5	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	3	SENT_134	[p6l234t654r258b794],
6	-	:	O	-	_	0	SENT_134	[p6l248t635r251b644],
7	Madison	NNP	O	Madison	dep	1	SENT_134	[p6l234t509r258b625],
8	on	IN	O	on	_	0	SENT_134	[p6l242t468r258b500],
9	01/05/14	CD	DATE	01/05/14	prep_on	7	SENT_134	[p6l234t335r258b459],
10	.	.	O	.	_	0	SENT_134	[p6l234t335r258b459],

1	For	IN	O	for	_	0	SENT_135	[p6l235t278r258b324],
2	personal	JJ	O	personal	amod	3	SENT_135	[p6l234t157r265b269],
3	use	NN	O	use	pobj	1	SENT_135	[p6l242t104r258b148],
4	only	RB	O	only	advmod	3	SENT_135	[p6l234t30r265b94],
5	.	.	O	.	_	0	SENT_135	[p6l234t30r265b94],

1	Annu	NNP	PERSON	Annu	_	0	SENT_136	[p6l55t3556r78b3636],
2	.	.	O	.	_	0	SENT_136	[p6l55t3556r78b3636],

1	Rev.	NNP	O	Rev.	nn	2	SENT_137	[p6l55t3486r78b3545],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_137	[p6l55t3327r78b3475],
3	.	.	O	.	_	0	SENT_137	[p6l55t3327r78b3475],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_138	[p6l55t3206r78b3316],
2	.	.	O	.	_	0	SENT_138	[p6l55t3206r78b3316],

1	2009.49:377	CD	NUMBER	2009.49:377	num	2	SENT_139	[p6l55t2961r79b3195],
2	-394	CD	NUMBER	-394	_	0	SENT_139	[p6l55t2961r79b3195],
3	.	.	O	.	_	0	SENT_139	[p6l55t2961r79b3195],

1	Downloaded	VBN	O	download	_	0	SENT_140	[p6l55t2781r78b2951],
2	from	IN	O	from	_	0	SENT_140	[p6l55t2707r78b2772],
3	www	NN	O	www	prep_from	1	SENT_140	[p6l55t2440r78b2698],
4	.	.	O	.	_	0	SENT_140	[p6l55t2440r78b2698],

1	annua1review	NN	O	annua1review	nn	2	SENT_141	[p6l55t2440r78b2698],
2	s.org	NN	O	s.org	_	0	SENT_141	[p6l62t2360r85b2424],
3	by	IN	O	by	_	0	SENT_141	[p6l88t3469r119b3501],
4	University	NNP	ORGANIZATION	University	prep_by	2	SENT_141	[p6l88t3320r119b3460],
5	of	IN	ORGANIZATION	of	_	0	SENT_141	[p6l88t3281r112b3310],
6	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	4	SENT_141	[p6l88t3134r112b3275],
7	-	:	O	-	_	0	SENT_141	[p6l102t3116r105b3125],
8	Madison	NNP	O	Madison	dep	2	SENT_141	[p6l88t2990r112b3106],
9	on	IN	O	on	_	0	SENT_141	[p6l96t2949r112b2981],
10	01/05/14	CD	DATE	01/05/14	prep_on	8	SENT_141	[p6l88t2815r112b2939],
11	.	.	O	.	_	0	SENT_141	[p6l88t2815r112b2939],

1	For	IN	O	for	_	0	SENT_142	[p6l89t2758r112b2805],
2	personal	JJ	O	personal	amod	3	SENT_142	[p6l88t2638r119b2750],
3	use	NN	O	use	pobj	1	SENT_142	[p6l96t2585r112b2629],
4	only	RB	O	only	advmod	3	SENT_142	[p6l88t2511r119b2575],
5	.	.	O	.	_	0	SENT_142	[p6l88t2511r119b2575],

1	implications	NNS	O	implication	_	0	SENT_143	[p6l346t15r538b53],
2	relevant	JJ	O	relevant	amod	1	SENT_143	[p6l552t14r678b44],
3	for	IN	O	for	_	0	SENT_143	[p6l691t15r736b44],
4	understanding	VBG	O	understand	prepc_for	2	SENT_143	[p6l749t14r976b53],
5	integrase	NN	O	integrase	nn	7	SENT_143	[p6l988t16r1129b53],
6	inhibitor	NN	O	inhibitor	nn	7	SENT_143	[p6l1143t15r1282b44],
7	mechanism	NN	O	mechanism	dobj	4	SENT_143	[p6l1295t15r1473b44],
8	and	CC	O	and	_	0	SENT_143	[p6l1487t14r1542b44],
9	pharmacology	NN	O	pharmacology	dobj	4	SENT_143	[p6l1556t14r1784b53],
10	.	.	O	.	_	0	SENT_143	[p6l1556t14r1784b53],

1	The	DT	O	the	det	4	SENT_144	[p6l1798t14r1864b44],
2	catalytic	JJ	O	catalytic	amod	4	SENT_144	[p6l347t64r476b103],
3	core	NN	O	core	nn	4	SENT_144	[p6l487t75r553b93],
4	domain	NN	O	domain	nsubj	5	SENT_144	[p6l565t64r683b93],
5	includes	VBZ	O	include	_	0	SENT_144	[p6l693t64r821b93],
6	the	DT	O	the	det	10	SENT_144	[p6l833t64r881b93],
7	critical	JJ	O	critical	amod	10	SENT_144	[p6l893t64r999b93],
8	active	JJ	O	active	amod	10	SENT_144	[p6l1011t66r1099b93],
9	site	NN	O	site	nn	10	SENT_144	[p6l1111t66r1163b93],
10	residues	NNS	O	residue	nsubj	11	SENT_144	[p6l1174t64r1300b93],
11	aspartates	VBZ	O	aspartate	ccomp	5	SENT_144	[p6l1312t73r1464b103],
12	D64	NN	O	d64	dobj	11	SENT_144	[p6l1476t66r1544b94],
13	and	CC	O	and	_	0	SENT_144	[p6l1556t64r1611b93],
14	D116	NN	O	d116	dobj	11	SENT_144	[p6l1623t66r1710b93],
15	as	RB	O	as	_	0	SENT_144	[p6l1722t76r1750b93],
16	well	RB	O	well	_	0	SENT_144	[p6l1761t64r1824b93],
17	as	IN	O	as	_	0	SENT_144	[p6l1836t75r1864b93],
18	glutamate	JJ	O	glutamate	amod	19	SENT_144	[p6l347t114r501b153],
19	E152	NN	O	e152	conj_and	12	SENT_144	[p6l515t115r606b149],
20	,	,	O	,	_	0	SENT_144	[p6l515t115r606b149],
21	which	WDT	O	which	nsubjpass	23	SENT_144	[p6l620t114r714b143],
22	are	VBP	O	be	auxpass	23	SENT_144	[p6l728t125r774b143],
23	conserved	VBN	O	conserve	rcmod	19	SENT_144	[p6l789t114r944b143],
24	among	IN	O	among	_	0	SENT_144	[p6l959t125r1066b153],
25	all	DT	O	all	det	27	SENT_144	[p6l1079t114r1114b143],
26	retroviral	JJ	O	retroviral	amod	27	SENT_144	[p6l1127t114r1274b143],
27	integrases	NNS	O	integrase	prep_among	23	SENT_144	[p6l1287t116r1451b153],
28	.	.	O	.	_	0	SENT_144	[p6l1287t116r1451b153],

1	This	DT	O	this	det	3	SENT_145	[p6l1465t114r1538b143],
2	DDE	NN	O	dde	nn	3	SENT_145	[p6l1552t116r1639b143],
3	motif	NN	O	motif	nsubj	4	SENT_145	[p6l1652t114r1741b143],
4	coordinates	VBZ	O	coordinate	_	0	SENT_145	[p6l1750t114r1864b143, p6l346t172r426b193],
5	the	DT	O	the	det	10	SENT_145	[p6l437t164r486b193],
6	divalent	JJ	O	divalent	amod	10	SENT_145	[p6l497t164r621b193],
7	metal	NN	O	metal	nn	10	SENT_145	[p6l631t164r717b193],
8	ion	NN	O	ion	nn	10	SENT_145	[p6l728t166r778b193],
9	cofactor	NN	O	cofactor	nn	10	SENT_145	[p6l789t164r952b201],
10	(	NN	O	(	nsubj	12	SENT_145	[p6l789t164r952b201],
11	s	VBZ	O	s	cop	12	SENT_145	[p6l789t164r952b201],
12	)	NN	O	)	ccomp	4	SENT_145	[p6l789t164r952b201],
13	required	VBN	O	require	partmod	12	SENT_145	[p6l963t164r1096b203],
14	for	IN	O	for	_	0	SENT_145	[p6l1107t164r1153b193],
15	the	DT	O	the	det	23	SENT_145	[p6l1163t164r1211b193],
16	phosphodiester	NN	O	phosphodiester	nn	19	SENT_145	[p6l1222t164r1463b202],
17	bond	NN	O	bond	nn	19	SENT_145	[p6l1473t164r1552b193],
18	cleavage/formation	JJ	O	cleavage/formation	amod	19	SENT_145	[p6l1564t164r1865b203],
19	reactions	NNS	O	reaction	dep	23	SENT_145	[p6l347t216r487b243],
20	of	IN	O	of	_	0	SENT_145	[p6l500t214r534b243],
21	3	CD	NUMBER	3	num	22	SENT_145	[p6l544t216r567b243],
22	’	NN	O	’	prep_of	19	SENT_145	[p6l544t216r567b243],
23	processing	NN	O	processing	prep_for	13	SENT_145	[p6l581t216r747b253],
24	and	CC	O	and	_	0	SENT_145	[p6l759t214r814b243],
25	strand	NN	O	strand	nn	26	SENT_145	[p6l826t214r923b243],
26	transfer	NN	O	transfer	conj_and	23	SENT_145	[p6l935t214r1056b243],
27	(	CD	NUMBER	(	number	28	SENT_145	[p6l1068t215r1125b250],
28	23	CD	NUMBER	23	num	23	SENT_145	[p6l1068t215r1125b250],
29	,	,	O	,	_	0	SENT_145	[p6l1068t215r1125b250],
30	24	CD	NUMBER	24	num	31	SENT_145	[p6l1138t215r1195b250],
31	)	NN	O	)	appos	23	SENT_145	[p6l1138t215r1195b250],
32	.	.	O	.	_	0	SENT_145	[p6l1138t215r1195b250],

1	The	DT	O	the	det	4	SENT_146	[p6l1208t214r1274b243],
2	metal	NN	O	metal	nn	4	SENT_146	[p6l1286t214r1373b243],
3	binding	NN	O	binding	nn	4	SENT_146	[p6l1385t214r1506b253],
4	architecture	NN	O	architecture	nsubj	13	SENT_146	[p6l1517t214r1705b243],
5	of	IN	O	of	_	0	SENT_146	[p6l1717t214r1752b243],
6	the	DT	O	the	det	9	SENT_146	[p6l1759t214r1808b243],
7	integrase	NN	O	integrase	nn	9	SENT_146	[p6l1820t216r1864b243, p6l347t272r456b303],
8	active	JJ	O	active	amod	9	SENT_146	[p6l469t266r558b293],
9	site	NN	O	site	prep_of	4	SENT_146	[p6l570t266r622b293],
10	is	VBZ	O	be	cop	13	SENT_146	[p6l634t266r657b293],
11	a	DT	O	a	det	13	SENT_146	[p6l670t275r685b293],
12	common	JJ	O	common	amod	13	SENT_146	[p6l697t275r835b293],
13	feature	NN	O	feature	_	0	SENT_146	[p6l847t264r955b293],
14	of	IN	O	of	_	0	SENT_146	[p6l968t264r1002b293],
15	many	JJ	O	many	amod	17	SENT_146	[p6l1010t275r1097b303],
16	magnesium-dependent	JJ	O	magnesium-dependent	amod	17	SENT_146	[p6l1107t264r1468b303],
17	phosphotransferases	NNS	O	phosphotransferase	prep_of	13	SENT_146	[p6l1479t264r1796b302],
18	and	CC	O	and	_	0	SENT_146	[p6l1809t264r1865b293],
19	is	VBZ	O	be	cop	23	SENT_146	[p6l346t315r369b343],
20	the	DT	O	the	det	23	SENT_146	[p6l381t314r430b343],
21	key	JJ	O	key	amod	23	SENT_146	[p6l441t314r495b353],
22	structural	JJ	O	structural	amod	23	SENT_146	[p6l505t314r655b343],
23	element	NN	O	element	conj_and	13	SENT_146	[p6l667t314r792b343],
24	exploited	VBN	O	exploit	partmod	23	SENT_146	[p6l803t314r946b352],
25	in	IN	O	in	_	0	SENT_146	[p6l957t315r987b342],
26	the	DT	O	the	det	27	SENT_146	[p6l998t314r1047b343],
27	mechanism	NN	O	mechanism	prep_in	24	SENT_146	[p6l1058t314r1236b343],
28	of	IN	O	of	_	0	SENT_146	[p6l1247t314r1281b343],
29	action	NN	O	action	prep_of	27	SENT_146	[p6l1289t315r1384b343],
30	of	IN	O	of	_	0	SENT_146	[p6l1396t314r1430b343],
31	all	DT	O	all	det	35	SENT_146	[p6l1437t314r1473b343],
32	integrase	NN	O	integrase	nn	35	SENT_146	[p6l1484t315r1625b352],
33	strand	NN	O	strand	nn	35	SENT_146	[p6l1636t314r1733b343],
34	transfer	NN	O	transfer	nn	35	SENT_146	[p6l1744t314r1865b343],
35	inhibitors	NNS	O	inhibitor	prep_of	29	SENT_146	[p6l346t364r507b393],
36	.	.	O	.	_	0	SENT_146	[p6l346t364r507b393],

1	Inhibitor	NNP	O	Inhibitor	_	0	SENT_147	[p6l346t494r518b527],
2	Mechanism	NN	O	mechanism	dep	1	SENT_147	[p6l528t494r748b527],

1	The	DT	O	the	det	3	SENT_148	[p6l346t564r412b593],
2	4-aryl-2	JJ	O	4-aryl-2	amod	3	SENT_148	[p6l424t564r830b603],
3	,4	NN	O	,4	_	0	SENT_148	[p6l424t564r830b603],
4	-	:	O	-	_	0	SENT_148	[p6l424t564r830b603],
5	diketobutanoic	JJ	O	diketobutanoic	amod	6	SENT_148	[p6l424t564r830b603],
6	acids	NNS	O	acid	dep	3	SENT_148	[p6l842t564r917b593],
7	(	CD	NUMBER	(	dep	6	SENT_148	[p6l930t565r975b601],
8	or	CC	O	or	_	0	SENT_148	[p6l930t565r975b601],
9	diketo	JJ	O	diketo	amod	10	SENT_148	[p6l986t564r1083b593],
10	acids	NNS	O	acid	dep	3	SENT_148	[p6l1095t564r1182b601],
11	)	CD	NUMBER	)	nsubj	19	SENT_148	[p6l1095t564r1182b601],
12	exempliﬁed	VBN	O	exempliﬁed	partmod	11	SENT_148	[p6l1195t564r1375b603],
13	by	IN	O	by	_	0	SENT_148	[p6l1387t564r1425b603],
14	L-731988	NN	O	l-731988	nn	16	SENT_148	[p6l1435t565r1589b594],
15	(	CD	NUMBER	(	num	16	SENT_148	[p6l1603t565r1725b603],
16	Figure	NNP	O	Figure	agent	12	SENT_148	[p6l1603t565r1725b603],
17	2a	FW	O	2a	nn	18	SENT_148	[p6l1738t565r1787b601],
18	)	FW	O	)	amod	16	SENT_148	[p6l1738t565r1787b601],
19	represent	VBP	O	represent	rcmod	10	SENT_148	[p6l1799t575r1864b603, p6l347t622r443b643],
20	the	DT	O	the	det	21	SENT_148	[p6l452t614r501b643],
21	prototype	NN	O	prototype	nsubj	27	SENT_148	[p6l511t622r664b653],
22	for	IN	O	for	_	0	SENT_148	[p6l675t614r720b643],
23	integrase	NN	O	integrase	nn	26	SENT_148	[p6l730t616r871b653],
24	strand	NN	O	strand	nn	26	SENT_148	[p6l881t614r978b643],
25	transfer	NN	O	transfer	nn	26	SENT_148	[p6l988t614r1109b643],
26	inhibitors	NNS	O	inhibitor	prep_for	21	SENT_148	[p6l1118t614r1270b643],
27	(	VBP	O	(	ccomp	19	SENT_148	[p6l1282t615r1308b650],
28	2	CD	NUMBER	2	number	29	SENT_148	[p6l1282t615r1308b650],
29	5	CD	NUMBER	5	num	30	SENT_148	[p6l1314t615r1350b650],
30	)	NN	O	)	dobj	27	SENT_148	[p6l1314t615r1350b650],
31	.	.	O	.	_	0	SENT_148	[p6l1314t615r1350b650],

1	These	DT	O	these	det	2	SENT_149	[p6l1361t614r1458b643],
2	compounds	NNS	O	compound	nsubj	6	SENT_149	[p6l1469t614r1650b652],
3	were	VBD	O	be	cop	6	SENT_149	[p6l1659t625r1734b643],
4	the	DT	O	the	det	6	SENT_149	[p6l1745t614r1793b643],
5	ﬁrst	JJ	O	ﬁrst	amod	6	SENT_149	[p6l1804t614r1866b643],
6	integrase	NN	O	integrase	_	0	SENT_149	[p6l346t665r487b703],
7	inhibitors	NNS	O	inhibitor	nsubj	8	SENT_149	[p6l500t664r652b693],
8	demonstrated	VBD	O	demonstrate	rcmod	6	SENT_149	[p6l665t664r879b693],
9	to	TO	O	to	aux	10	SENT_149	[p6l892t672r922b693],
10	have	VB	O	have	xcomp	8	SENT_149	[p6l935t664r1005b693],
11	antiviral	JJ	O	antiviral	amod	12	SENT_149	[p6l1018t664r1146b693],
12	activity	NN	O	activity	dobj	10	SENT_149	[p6l1159t665r1272b703],
13	directly	RB	O	directly	advmod	10	SENT_149	[p6l1284t664r1403b703],
14	as	IN	O	as	_	0	SENT_149	[p6l1414t675r1442b693],
15	a	DT	O	a	det	16	SENT_149	[p6l1455t675r1470b693],
16	consequence	NN	O	consequence	prep_as	10	SENT_149	[p6l1483t675r1681b702],
17	of	IN	O	of	_	0	SENT_149	[p6l1694t664r1728b693],
18	their	PRP$	O	they	poss	19	SENT_149	[p6l1736t664r1811b693],
19	effect	NN	O	effect	prep_of	16	SENT_149	[p6l1823t664r1864b693, p6l347t714r405b743],
20	on	IN	O	on	_	0	SENT_149	[p6l419t725r458b743],
21	HIV-1	NN	O	hiv-1	nn	22	SENT_149	[p6l472t715r572b743],
22	integration	NN	O	integration	prep_on	19	SENT_149	[p6l590t715r772b752],
23	.	.	O	.	_	0	SENT_149	[p6l590t715r772b752],

1	In	IN	O	in	_	0	SENT_150	[p6l788t715r822b742],
2	biochemical	JJ	O	biochemical	amod	3	SENT_150	[p6l836t714r1025b743],
3	assays	NNS	O	assay	prep_in	10	SENT_150	[p6l1040t725r1130b752],
4	and	CC	O	and	_	0	SENT_150	[p6l1146t714r1201b743],
5	in	IN	O	in	conj_and	3	SENT_150	[p6l1216t715r1246b742],
6	cells	NNS	O	cell	pobj	5	SENT_150	[p6l1261t714r1336b749],
7	,	,	O	,	_	0	SENT_150	[p6l1261t714r1336b749],
8	these	DT	O	these	det	9	SENT_150	[p6l1352t714r1432b743],
9	compounds	NNS	O	compound	nsubj	10	SENT_150	[p6l1447t714r1628b752],
10	inhibit	VBP	O	inhibit	_	0	SENT_150	[p6l1642t714r1748b743],
11	HIV-1	NN	MISC	hiv-1	nn	13	SENT_150	[p6l1761t715r1861b743],
12	strand	NN	O	strand	nn	13	SENT_150	[p6l347t764r443b793],
13	transfer	NN	O	transfer	dobj	10	SENT_150	[p6l455t764r575b793],
14	and	CC	O	and	_	0	SENT_150	[p6l586t764r641b793],
15	integration	NN	O	integration	conj_and	13	SENT_150	[p6l652t765r826b802],
16	without	IN	O	without	_	0	SENT_150	[p6l836t763r959b793],
17	affecting	VBG	O	affect	prepc_without	10	SENT_150	[p6l969t764r1105b802],
18	either	CC	O	either	prep	17	SENT_150	[p6l1116t764r1207b793],
19	assembly	NN	O	assembly	dep	18	SENT_150	[p6l1218t763r1359b802],
20	or	CC	O	or	_	0	SENT_150	[p6l1368t774r1402b793],
21	processing	NN	O	processing	dep	18	SENT_150	[p6l1412t765r1578b802],
22	of	IN	O	of	_	0	SENT_150	[p6l1589t764r1623b793],
23	the	DT	O	the	det	25	SENT_150	[p6l1630t763r1678b793],
24	viral	JJ	O	viral	amod	25	SENT_150	[p6l1688t764r1757b793],
25	DNA	NN	O	dna	prep_of	19	SENT_150	[p6l1768t765r1863b793],
26	.	.	O	.	_	0	SENT_150	[p6l1768t765r1863b793],

1	Studies	NNS	O	study	nsubj	12	SENT_151	[p6l348t813r460b842],
2	to	TO	O	to	aux	3	SENT_151	[p6l473t822r504b842],
3	understand	VB	O	understand	infmod	1	SENT_151	[p6l517t813r692b842],
4	the	DT	O	the	det	8	SENT_151	[p6l705t813r754b842],
5	biochemical	JJ	O	biochemical	amod	8	SENT_151	[p6l767t813r956b842],
6	and	CC	O	and	_	0	SENT_151	[p6l969t813r1025b842],
7	molecular	JJ	O	molecular	amod	8	SENT_151	[p6l1038t813r1194b842],
8	basis	NN	O	basis	dobj	3	SENT_151	[p6l1206t813r1279b842],
9	of	IN	O	of	_	0	SENT_151	[p6l1293t814r1327b842],
10	inhibition	NN	O	inhibition	prep_of	8	SENT_151	[p6l1336t813r1491b842],
11	have	VBP	O	have	aux	12	SENT_151	[p6l1504t813r1574b842],
12	identiﬁed	VBN	O	identiﬁed	_	0	SENT_151	[p6l1587t813r1736b842],
13	distinct	JJ	O	distinct	amod	15	SENT_151	[p6l1750t813r1866b842],
14	a	DT	O	a	det	15	SENT_151	[p6l353t911r375b937],
15	b	NN	O	b	dobj	12	SENT_151	[p6l1083t901r1109b937],

1	Hydrophobic	JJ	O	hydrophobic	_	0	SENT_152	[p6l1085t972r1278b1003],
2	/	:	O	/	punct	5	SENT_152	[p6l604t1009r632b1047],
3	|	CD	NUMBER	|	num	5	SENT_152	[p6l672t1024r675b1068],
4	OH	NN	O	oh	nn	5	SENT_152	[p6l880t1010r921b1034],
5	binding	NN	O	binding	dep	1	SENT_152	[p6l1163t1012r1277b1043],
6	surfaces	NNS	O	surface	dep	1	SENT_152	[p6l1150t1052r1271b1077],

1	N	NN	O	n	_	0	SENT_153	[p6l616t1084r634b1107],
2	\	CD	NUMBER	\	num	3	SENT_153	[p6l788t1087r830b1113],
3	O	NN	O	o	dep	1	SENT_153	[p6l929t1092r950b1116],

1	F	NN	O	f	_	0	SENT_154	[p6l354t1136r366b1159],
2	<	JJR	O	<	dep	1	SENT_154	[p6l418t1114r435b1179],
3	>	JJR	O	>	amod	5	SENT_154	[p6l520t1114r537b1178],
4	o	NN	O	o	nn	5	SENT_154	[p6l724t1152r745b1176],
5	OH	NN	O	oh	dep	1	SENT_154	[p6l829t1153r871b1177],

1	L-731988	NN	O	l-731988	_	0	SENT_155	[p6l545t1228r697b1254],

1	D64	NN	O	d64	_	0	SENT_156	[p6l1572t1496r1632b1523],
2	,	,	O	,	_	0	SENT_156	[p6l1572t1496r1632b1523],
3	D116	NN	O	d116	appos	1	SENT_156	[p6l1643t1496r1720b1523],
4	,	,	O	,	_	0	SENT_156	[p6l1643t1496r1720b1523],
5	E152	NN	O	e152	appos	1	SENT_156	[p6l1730t1496r1794b1519],

1	Figure	NN	O	figure	dep	19	SENT_157	[p6l346t1569r445b1602],
2	2	CD	NUMBER	2	num	1	SENT_157	[p6l457t1569r472b1593],
3	A	DT	O	a	det	10	SENT_157	[p6l346t1620r369b1644],
4	prototypical	JJ	O	prototypical	amod	10	SENT_157	[p6l377t1619r547b1653],
5	integrase	NN	O	integrase	nn	10	SENT_157	[p6l556t1620r682b1653],
6	strand	NN	O	strand	nn	10	SENT_157	[p6l692t1619r778b1645],
7	transfer	NN	O	transfer	nn	10	SENT_157	[p6l788t1619r895b1645],
8	inhibitor	NN	O	inhibitor	nn	10	SENT_157	[p6l904t1619r1028b1645],
9	(	NN	O	(	nn	10	SENT_157	[p6l1038t1620r1151b1651],
10	InSTI	NN	O	instus	dep	1	SENT_157	[p6l1038t1620r1151b1651],
11	)	CD	NUMBER	)	num	13	SENT_157	[p6l1038t1620r1151b1651],
12	:	:	O	:	_	0	SENT_157	[p6l1038t1620r1151b1651],
13	(	CD	NUMBER	(	dep	10	SENT_157	[p6l1163t1620r1197b1651],
14	a	DT	O	a	det	15	SENT_157	[p6l1163t1620r1197b1651],
15	)	NN	O	)	dep	19	SENT_157	[p6l1163t1620r1197b1651],
16	the	DT	O	the	det	19	SENT_157	[p6l1208t1619r1251b1645],
17	diketo	JJ	O	diketo	amod	19	SENT_157	[p6l1262t1619r1347b1645],
18	acid	NN	O	acid	nn	19	SENT_157	[p6l1358t1619r1413b1645],
19	L-731988	NN	O	l-731988	_	0	SENT_157	[p6l1423t1620r1559b1645],
20	and	CC	O	and	_	0	SENT_157	[p6l1571t1619r1620b1645],
21	(	NN	O	(	conj_and	19	SENT_157	[p6l1631t1620r1663b1651],
22	17	CD	NUMBER	17	number	23	SENT_157	[p6l1631t1620r1663b1651],
23	)	CD	NUMBER	)	dep	19	SENT_157	[p6l1631t1620r1663b1651],
24	a	DT	O	a	det	25	SENT_157	[p6l1674t1629r1687b1645],
25	model	NN	O	model	dep	23	SENT_157	[p6l1697t1619r1784b1645],
26	for	IN	O	for	dep	19	SENT_157	[p6l1794t1619r1834b1645],
27	InSTI	NNP	O	InSTI	nn	30	SENT_157	[p6l346t1660r433b1685],
28	active	JJ	O	active	amod	30	SENT_157	[p6l443t1661r522b1685],
29	site	NN	O	site	nn	30	SENT_157	[p6l532t1661r578b1685],
30	interaction	NN	O	interaction	pobj	26	SENT_157	[p6l588t1661r747b1685],
31	.	.	O	.	_	0	SENT_157	[p6l588t1661r747b1685],
32	'	''	O	'	_	0	SENT_157	[p6l1273t1760r1546b1790],

1	www.zmnmtlreviewr.org	NN	O	www.zmnmtlreviewr.org	nn	2	SENT_158	[p6l1273t1760r1546b1790],
2	o	NN	O	o	_	0	SENT_158	[p6l1561t1768r1571b1778],
3	Emerging	VBG	O	emerge	dep	2	SENT_158	[p6l1586t1760r1701b1790],
4	P/mmmmlogy	NN	O	p/mmmmlogy	pobj	3	SENT_158	[p6l1707t1760r1865b1790],
5	381	CD	NUMBER	381	num	4	SENT_158	[p6l1915t1761r1958b1789],

1	biochemical	JJ	O	biochemical	amod	4	SENT_159	[p6l583t1801r772b1831],
2	and	CC	O	and	_	0	SENT_159	[p6l786t1801r841b1831],
3	biological	JJ	O	biological	conj_and	1	SENT_159	[p6l855t1801r1008b1840],
4	properties	NNS	O	property	_	0	SENT_159	[p6l1022t1803r1181b1840],
5	that	WDT	O	that	nsubj	6	SENT_159	[p6l1195t1801r1257b1831],
6	characterize	VBP	O	characterize	rcmod	4	SENT_159	[p6l1270t1801r1458b1831],
7	compounds	NNS	O	compound	dobj	6	SENT_159	[p6l1473t1801r1653b1840],
8	with	IN	O	with	_	0	SENT_159	[p6l1666t1801r1736b1831],
9	this	DT	O	this	det	10	SENT_159	[p6l1750t1801r1805b1831],
10	mechanism	NN	O	mechanism	prep_with	6	SENT_159	[p6l1819t1801r1997b1831],
11	of	IN	O	of	_	0	SENT_159	[p6l2011t1801r2045b1831],
12	action	NN	O	action	prep_of	10	SENT_159	[p6l2055t1812r2100b1831, p6l583t1851r653b1878],
13	.	.	O	.	_	0	SENT_159	[p6l2055t1812r2100b1831, p6l583t1851r653b1878],

1	These	DT	O	these	det	2	SENT_160	[p6l666t1849r764b1878],
2	inhibitors	NNS	O	inhibitor	nsubj	4	SENT_160	[p6l777t1849r929b1878],
3	only	RB	O	only	advmod	4	SENT_160	[p6l943t1849r1012b1888],
4	bind	VBP	O	bind	_	0	SENT_160	[p6l1023t1849r1092b1878],
5	with	IN	O	with	_	0	SENT_160	[p6l1104t1849r1174b1878],
6	high	JJ	O	high	amod	7	SENT_160	[p6l1186t1849r1257b1888],
7	afﬁnity	NN	O	afﬁnity	prep_with	4	SENT_160	[p6l1270t1849r1381b1888],
8	to	TO	O	to	aux	9	SENT_160	[p6l1392t1857r1423b1878],
9	integrase	VB	O	integrase	xcomp	4	SENT_160	[p6l1435t1851r1577b1888],
10	when	WRB	O	when	advmod	13	SENT_160	[p6l1588t1849r1674b1878],
11	the	DT	O	the	det	12	SENT_160	[p6l1686t1849r1735b1878],
12	enzyme	NN	O	enzyme	nsubj	13	SENT_160	[p6l1749t1860r1867b1888],
13	is	VBZ	O	be	advcl	9	SENT_160	[p6l1880t1851r1903b1878],
14	in	IN	O	in	_	0	SENT_160	[p6l1916t1851r1946b1878],
15	a	DT	O	a	det	17	SENT_160	[p6l1959t1860r1973b1878],
16	speciﬁc	NN	O	speciﬁc	nn	17	SENT_160	[p6l1986t1849r2101b1888],
17	complex	NN	O	complex	prep_in	13	SENT_160	[p6l583t1897r715b1936],
18	with	IN	O	with	_	0	SENT_160	[p6l722t1897r792b1927],
19	viral	JJ	O	viral	amod	21	SENT_160	[p6l800t1897r870b1927],
20	DNA	NN	O	dna	nn	21	SENT_160	[p6l880t1898r969b1926],
21	(	NN	O	(	prep_with	17	SENT_160	[p6l977t1898r1003b1934],
22	2	CD	NUMBER	2	number	23	SENT_160	[p6l977t1898r1003b1934],
23	6	CD	NUMBER	6	num	24	SENT_160	[p6l1008t1898r1045b1934],
24	)	NN	O	)	dobj	4	SENT_160	[p6l1008t1898r1045b1934],
25	.	.	O	.	_	0	SENT_160	[p6l1008t1898r1045b1934],

1	The	DT	O	the	det	3	SENT_161	[p6l1056t1897r1122b1927],
2	inhibitor-bound	JJ	O	inhibitor-bound	amod	3	SENT_161	[p6l1132t1897r1385b1927],
3	complex	NN	O	complex	nsubj	6	SENT_161	[p6l1395t1897r1527b1936],
4	is	VBZ	O	be	cop	6	SENT_161	[p6l1535t1899r1558b1927],
5	not	RB	O	not	neg	6	SENT_161	[p6l1568t1906r1621b1927],
6	competent	JJ	O	competent	_	0	SENT_161	[p6l1630t1906r1798b1936],
7	to	TO	O	to	aux	8	SENT_161	[p6l1807t1906r1837b1927],
8	bind	VB	O	bind	xcomp	6	SENT_161	[p6l1847t1897r1917b1927],
9	the	DT	O	the	dep	10	SENT_161	[p6l1927t1897r1976b1927],
10	cellular	JJ	O	cellular	dobj	8	SENT_161	[p6l1987t1897r2102b1927],
11	or	CC	O	or	_	0	SENT_161	[p6l583t1956r617b1974],
12	target	NN	O	target	nn	14	SENT_161	[p6l627t1953r719b1984],
13	DNA	NN	MISC	dna	nn	14	SENT_161	[p6l730t1946r818b1974],
14	substrate	NN	O	substrate	conj_or	10	SENT_161	[p6l828t1945r975b1981],
15	,	,	O	,	_	0	SENT_161	[p6l828t1945r975b1981],
16	and	CC	O	and	_	0	SENT_161	[p6l988t1945r1044b1974],
17	the	DT	O	the	det	19	SENT_161	[p6l1055t1945r1104b1974],
18	net	JJ	O	net	amod	19	SENT_161	[p6l1114t1953r1165b1974],
19	result	NN	O	result	nsubj	22	SENT_161	[p6l1175t1945r1263b1974],
20	is	VBZ	O	be	cop	22	SENT_161	[p6l1273t1947r1296b1974],
21	selective	JJ	O	selective	amod	22	SENT_161	[p6l1307t1945r1438b1974],
22	inhibition	NN	O	inhibition	conj_and	6	SENT_161	[p6l1449t1945r1605b1974],
23	of	IN	O	of	_	0	SENT_161	[p6l1616t1945r1650b1974],
24	strand	NN	O	strand	nn	25	SENT_161	[p6l1657t1945r1754b1974],
25	transfer	NN	O	transfer	prep_of	22	SENT_161	[p6l1765t1945r1891b1974],
26	.	.	O	.	_	0	SENT_161	[p6l1765t1945r1891b1974],

1	In	IN	O	in	_	0	SENT_162	[p6l1904t1946r1937b1974],
2	biological	JJ	O	biological	amod	3	SENT_162	[p6l1948t1945r2101b1984],
3	systems	NNS	O	system	prep_in	10	SENT_162	[p6l583t2001r710b2032],
4	,	,	O	,	_	0	SENT_162	[p6l583t2001r710b2032],
5	blocking	VBG	O	block	csubj	10	SENT_162	[p6l720t1993r856b2032],
6	strand	NN	O	strand	nn	7	SENT_162	[p6l864t1993r961b2022],
7	transfer	NN	O	transfer	dobj	5	SENT_162	[p6l970t1993r1091b2022],
8	and	CC	O	and	_	0	SENT_162	[p6l1100t1993r1155b2022],
9	integration	NN	O	integration	dobj	5	SENT_162	[p6l1164t1994r1338b2032],
10	allows	VBZ	O	allow	_	0	SENT_162	[p6l1347t1993r1443b2022],
11	the	DT	O	the	det	13	SENT_162	[p6l1452t1993r1501b2022],
12	viral	JJ	O	viral	amod	13	SENT_162	[p6l1509t1993r1578b2022],
13	DNA	NN	O	dna	dobj	10	SENT_162	[p6l1587t1994r1676b2022],
14	to	TO	O	to	aux	16	SENT_162	[p6l1683t2001r1714b2022],
15	be	VB	O	be	auxpass	16	SENT_162	[p6l1723t1993r1758b2022],
16	metabolized	VBN	O	metabolize	infmod	13	SENT_162	[p6l1768t1993r1959b2022],
17	by	IN	O	by	_	0	SENT_162	[p6l1968t1993r2006b2032],
18	cellular	JJ	O	cellular	amod	19	SENT_162	[p6l2014t1993r2100b2022, p6l583t2041r623b2070],
19	enzymes	NNS	O	enzyme	agent	16	SENT_162	[p6l634t2052r775b2080],
20	.	.	O	.	_	0	SENT_162	[p6l634t2052r775b2080],

1	Although	IN	O	although	mark	10	SENT_163	[p6l785t2041r934b2080],
2	most	JJS	O	most	nsubjpass	10	SENT_163	[p6l944t2050r1021b2070],
3	of	IN	O	of	_	0	SENT_163	[p6l1031t2041r1065b2070],
4	the	DT	O	the	det	7	SENT_163	[p6l1071t2041r1120b2070],
5	unintegrated	JJ	O	unintegrated	amod	7	SENT_163	[p6l1129t2041r1331b2080],
6	viral	JJ	O	viral	amod	7	SENT_163	[p6l1339t2041r1409b2070],
7	DNA	NN	MISC	dna	prep_of	2	SENT_163	[p6l1419t2042r1508b2070],
8	may	MD	O	may	aux	10	SENT_163	[p6l1516t2052r1582b2080],
9	be	VB	O	be	auxpass	10	SENT_163	[p6l1590t2041r1626b2070],
10	degraded	VBN	O	degrade	advcl	19	SENT_163	[p6l1637t2041r1789b2080],
11	,	,	O	,	_	0	SENT_163	[p6l1637t2041r1789b2080],
12	alternate	JJ	O	alternate	amod	14	SENT_163	[p6l1801t2041r1937b2070],
13	metabolic	JJ	O	metabolic	amod	14	SENT_163	[p6l1947t2041r2101b2070],
14	pathways	NNS	O	pathway	nsubj	19	SENT_163	[p6l583t2089r725b2128],
15	involving	VBG	O	involve	_	0	SENT_163	[p6l735t2089r881b2128],
16	recombination	NN	O	recombination	prep_involving	14	SENT_163	[p6l889t2089r1120b2118],
17	and	CC	O	and	_	0	SENT_163	[p6l1129t2089r1184b2118],
18	repair	NN	O	repair	prep_involving	14	SENT_163	[p6l1193t2091r1286b2128],
19	produce	VBP	O	produce	_	0	SENT_163	[p6l1295t2089r1422b2128],
20	1	CD	NUMBER	1	dobj	19	SENT_163	[p6l1435t2091r1446b2118],
21	and	CC	O	and	_	0	SENT_163	[p6l1459t2089r1514b2118],
22	2	CD	NUMBER	2	num	27	SENT_163	[p6l1524t2091r1539b2118],
23	long	JJ	O	long	amod	27	SENT_163	[p6l1550t2089r1621b2128],
24	terminal	JJ	O	terminal	amod	27	SENT_163	[p6l1629t2089r1761b2118],
25	repeat	NN	O	repeat	nn	27	SENT_163	[p6l1770t2097r1868b2128],
26	(	NN	O	(	nn	27	SENT_163	[p6l1877t2090r1973b2126],
27	LTR	NN	O	ltr	conj_and	20	SENT_163	[p6l1877t2090r1973b2126],
28	)	CD	NUMBER	)	num	31	SENT_163	[p6l1877t2090r1973b2126],
29	circular	JJ	O	circular	amod	31	SENT_163	[p6l1983t2089r2102b2118],
30	DNA	NN	O	dna	nn	31	SENT_163	[p6l583t2138r672b2166],
31	by-products	NNS	O	by-product	dep	27	SENT_163	[p6l686t2137r883b2176],
32	.	.	O	.	_	0	SENT_163	[p6l686t2137r883b2176],

1	The	DT	O	the	det	3	SENT_164	[p6l899t2137r965b2166],
2	net	JJ	O	net	amod	3	SENT_164	[p6l981t2145r1032b2166],
3	result	NN	O	result	nsubj	10	SENT_164	[p6l1046t2137r1135b2166],
4	of	IN	O	of	prep	3	SENT_164	[p6l1150t2137r1184b2166],
5	either	CC	O	either	prep	3	SENT_164	[p6l1196t2137r1288b2166],
6	process	NN	O	process	dep	5	SENT_164	[p6l1303t2148r1417b2176],
7	is	VBZ	O	be	cop	10	SENT_164	[p6l1433t2139r1456b2166],
8	an	DT	O	a	det	10	SENT_164	[p6l1473t2148r1508b2166],
9	irreversible	JJ	O	irreversible	amod	10	SENT_164	[p6l1524t2137r1700b2166],
10	block	NN	O	block	_	0	SENT_164	[p6l1716t2137r1802b2166],
11	of	IN	O	of	_	0	SENT_164	[p6l1817t2137r1851b2166],
12	HIV-1	NN	O	hiv-1	nn	13	SENT_164	[p6l1863t2138r1963b2166],
13	replication	NN	O	replication	prep_of	10	SENT_164	[p6l1982t2137r2100b2176, p6l583t2187r653b2215],
14	.	.	O	.	_	0	SENT_164	[p6l1982t2137r2100b2176, p6l583t2187r653b2215],

1	LTR	NN	O	ltr	nn	2	SENT_165	[p6l666t2186r741b2214],
2	circles	NNS	O	circle	nsubj	7	SENT_165	[p6l751t2185r848b2215],
3	have	VBP	O	have	aux	7	SENT_165	[p6l859t2185r930b2215],
4	become	VBN	O	become	cop	7	SENT_165	[p6l941t2185r1062b2215],
5	a	DT	O	a	det	7	SENT_165	[p6l1074t2196r1089b2215],
6	deﬁning	VBG	O	deﬁning	amod	7	SENT_165	[p6l1100t2185r1229b2224],
7	feature	NN	O	feature	_	0	SENT_165	[p6l1240t2185r1348b2215],
8	of	IN	O	of	_	0	SENT_165	[p6l1360t2185r1394b2215],
9	integrase	NN	O	integrase	nn	12	SENT_165	[p6l1400t2187r1541b2224],
10	strand	NN	O	strand	nn	12	SENT_165	[p6l1553t2185r1649b2215],
11	transfer	NN	O	transfer	nn	12	SENT_165	[p6l1661t2185r1782b2215],
12	inhibitors	NNS	O	inhibitor	prep_of	7	SENT_165	[p6l1792t2185r1952b2221],
13	,	,	O	,	_	0	SENT_165	[p6l1792t2185r1952b2221],
14	but	CC	O	but	_	0	SENT_165	[p6l1965t2185r2017b2215],
15	were	VBD	O	be	cop	16	SENT_165	[p6l2026t2196r2101b2215],
16	ﬁrst	JJ	O	ﬁrst	conj_but	7	SENT_165	[p6l583t2235r645b2264],
17	noted	VBN	O	note	ccomp	16	SENT_165	[p6l654t2235r743b2264],
18	with	IN	O	with	_	0	SENT_165	[p6l753t2235r822b2264],
19	integration-defective	JJ	O	integration-defective	amod	20	SENT_165	[p6l832t2235r1161b2274],
20	viruses	NNS	O	virus	prep_with	17	SENT_165	[p6l1170t2237r1277b2264],
21	containing	VBG	O	contain	partmod	20	SENT_165	[p6l1289t2237r1456b2274],
22	mutations	NNS	O	mutation	dobj	21	SENT_165	[p6l1465t2237r1621b2264],
23	in	IN	O	in	_	0	SENT_165	[p6l1632t2237r1662b2264],
24	the	DT	O	the	det	27	SENT_165	[p6l1673t2235r1721b2264],
25	integrase	NN	O	integrase	nn	27	SENT_165	[p6l1732t2237r1873b2274],
26	coding	VBG	O	code	amod	27	SENT_165	[p6l1884t2235r1991b2274],
27	region	NN	O	region	prep_in	22	SENT_165	[p6l2000t2237r2101b2274],
28	(	CD	NUMBER	(	num	29	SENT_165	[p6l584t2286r640b2321],
29	27	CD	NUMBER	27	nsubj	16	SENT_165	[p6l584t2286r640b2321],
30	,	,	O	,	_	0	SENT_165	[p6l584t2286r640b2321],
31	28	CD	NUMBER	28	num	32	SENT_165	[p6l653t2286r710b2321],
32	)	NN	O	)	appos	29	SENT_165	[p6l653t2286r710b2321],
33	.	.	O	.	_	0	SENT_165	[p6l653t2286r710b2321],

1	The	DT	O	the	det	5	SENT_166	[p6l632t2332r698b2361],
2	biological	JJ	O	biological	amod	5	SENT_166	[p6l706t2332r859b2371],
3	and	CC	O	and	_	0	SENT_166	[p6l867t2332r923b2361],
4	biochemical	JJ	O	biochemical	conj_and	2	SENT_166	[p6l931t2332r1120b2361],
5	action	NN	O	action	nsubj	11	SENT_166	[p6l1128t2334r1223b2361],
6	of	IN	O	of	_	0	SENT_166	[p6l1231t2332r1265b2361],
7	integrase	NN	O	integrase	nn	10	SENT_166	[p6l1269t2334r1410b2371],
8	strand	NN	O	strand	nn	10	SENT_166	[p6l1418t2332r1515b2361],
9	transfer	NN	O	transfer	nn	10	SENT_166	[p6l1523t2332r1644b2361],
10	inhibitors	NNS	O	inhibitor	prep_of	5	SENT_166	[p6l1651t2332r1803b2361],
11	distinguishes	VBZ	O	distinguish	_	0	SENT_166	[p6l1812t2332r2013b2371],
12	them	PRP	O	they	dep	13	SENT_166	[p6l2021t2332r2101b2361],
13	functionally	RB	O	functionally	dep	11	SENT_166	[p6l583t2382r771b2421],
14	and	CC	O	and	_	0	SENT_166	[p6l780t2382r836b2411],
15	mechanistically	RB	O	mechanistically	advmod	16	SENT_166	[p6l846t2382r1088b2421],
16	from	IN	O	from	dep	11	SENT_166	[p6l1097t2382r1173b2411],
17	other	JJ	O	other	amod	19	SENT_166	[p6l1183t2382r1267b2411],
18	antiretroviral	JJ	O	antiretroviral	amod	19	SENT_166	[p6l1277t2382r1483b2411],
19	agents	NNS	O	agent	pobj	16	SENT_166	[p6l1494t2390r1600b2421],
20	.	.	O	.	_	0	SENT_166	[p6l1494t2390r1600b2421],

1	As	IN	O	as	mark	4	SENT_167	[p6l1611t2383r1649b2411],
2	these	DT	O	these	det	3	SENT_167	[p6l1660t2382r1739b2411],
3	inhibitors	NNS	O	inhibitor	nsubj	4	SENT_167	[p6l1750t2382r1902b2411],
4	bind	VBP	O	bind	advcl	18	SENT_167	[p6l1912t2382r1982b2411],
5	only	RB	O	only	advmod	4	SENT_167	[p6l1993t2382r2061b2421],
6	to	TO	O	to	_	0	SENT_167	[p6l2070t2390r2101b2411],
7	the	DT	O	the	det	8	SENT_167	[p6l583t2446r632b2475],
8	enzyme	NN	O	enzyme	prep_to	4	SENT_167	[p6l645t2457r763b2485],
9	in	IN	O	in	_	0	SENT_167	[p6l775t2447r806b2475],
10	complex	NN	O	complex	prep_in	8	SENT_167	[p6l818t2446r949b2485],
11	with	IN	O	with	_	0	SENT_167	[p6l959t2446r1029b2475],
12	viral	JJ	O	viral	amod	13	SENT_167	[p6l1039t2446r1109b2475],
13	DNA	NN	MISC	dna	prep_with	4	SENT_167	[p6l1121t2447r1216b2481],
14	,	,	O	,	_	0	SENT_167	[p6l1121t2447r1216b2481],
15	they	PRP	O	they	nsubjpass	18	SENT_167	[p6l1230t2446r1298b2485],
16	are	VBP	O	be	auxpass	18	SENT_167	[p6l1309t2457r1356b2475],
17	not	RB	O	not	neg	18	SENT_167	[p6l1368t2454r1421b2475],
18	involved	VBN	O	involve	_	0	SENT_167	[p6l1432t2446r1564b2475],
19	until	IN	O	until	_	0	SENT_167	[p6l1575t2446r1649b2475],
20	several	JJ	DURATION	several	amod	21	SENT_167	[p6l1661t2446r1767b2475],
21	hours	NNS	DURATION	hour	prep_until	18	SENT_167	[p6l1779t2446r1866b2475],
22	after	IN	O	after	_	0	SENT_167	[p6l1879t2446r1950b2475],
23	infection	NN	O	infection	prep_after	18	SENT_167	[p6l1962t2446r2101b2475],
24	when	WRB	O	when	advmod	31	SENT_167	[p6l582t2495r667b2524],
25	the	DT	O	the	det	26	SENT_167	[p6l683t2495r731b2525],
26	process	NN	O	process	nsubj	31	SENT_167	[p6l747t2506r862b2534],
27	of	IN	O	of	_	0	SENT_167	[p6l878t2496r913b2525],
28	reverse	JJ	O	reverse	amod	29	SENT_167	[p6l924t2506r1035b2525],
29	transcription	NN	O	transcription	prep_of	26	SENT_167	[p6l1051t2497r1253b2534],
30	is	VBZ	O	be	cop	31	SENT_167	[p6l1268t2497r1291b2525],
31	complete	JJ	O	complete	advcl	18	SENT_167	[p6l1308t2496r1459b2534],
32	.	.	O	.	_	0	SENT_167	[p6l1308t2496r1459b2534],

1	However	RB	O	however	advmod	6	SENT_168	[p6l1476t2497r1627b2531],
2	,	,	O	,	_	0	SENT_168	[p6l1476t2497r1627b2531],
3	inhibition	NN	O	inhibition	nsubj	6	SENT_168	[p6l1643t2495r1799b2525],
4	is	VBZ	O	be	cop	6	SENT_168	[p6l1814t2497r1837b2525],
5	functionally	RB	O	functionally	advmod	6	SENT_168	[p6l1854t2495r2042b2534],
6	reversible	JJ	O	reversible	_	0	SENT_168	[p6l2056t2506r2100b2525, p6l581t2545r711b2574],
7	.	.	O	.	_	0	SENT_168	[p6l2056t2506r2100b2525, p6l581t2545r711b2574],

1	Together	RB	O	together	advmod	6	SENT_169	[p6l720t2545r870b2584],
2	,	,	O	,	_	0	SENT_169	[p6l720t2545r870b2584],
3	these	DT	O	these	det	5	SENT_169	[p6l881t2545r961b2574],
4	two	CD	NUMBER	two	num	5	SENT_169	[p6l970t2554r1027b2574],
5	characteristics	NNS	O	characteristic	nsubj	6	SENT_169	[p6l1037t2545r1258b2574],
6	suggest	VBP	O	suggest	_	0	SENT_169	[p6l1268t2554r1383b2584],
7	such	JJ	O	such	amod	8	SENT_169	[p6l1392t2545r1461b2574],
8	compounds	NNS	O	compound	nsubj	10	SENT_169	[p6l1471t2545r1651b2584],
9	may	MD	O	may	aux	10	SENT_169	[p6l1660t2556r1727b2584],
10	have	VB	O	have	ccomp	6	SENT_169	[p6l1734t2545r1804b2574],
11	to	TO	O	to	aux	14	SENT_169	[p6l1814t2554r1844b2574],
12	be	VB	O	be	cop	14	SENT_169	[p6l1854t2545r1890b2574],
13	continuously	RB	O	continuously	advmod	14	SENT_169	[p6l1899t2545r2103b2584],
14	present	JJ	DATE	present	xcomp	10	SENT_169	[p6l583t2604r699b2633],
15	to	TO	O	to	aux	17	SENT_169	[p6l709t2604r739b2624],
16	be	VB	O	be	cop	17	SENT_169	[p6l751t2595r787b2624],
17	effective	JJ	O	effective	xcomp	14	SENT_169	[p6l799t2595r937b2624],
18	.	.	O	.	_	0	SENT_169	[p6l799t2595r937b2624],

1	Medicinal	JJ	O	medicinal	amod	2	SENT_170	[p6l582t2724r770b2757],
2	Chemistry	NNP	O	Chemistry	_	0	SENT_170	[p6l783t2724r983b2767],

1	Binding	NN	O	binding	_	0	SENT_171	[p6l583t2794r708b2833],
2	of	IN	O	of	_	0	SENT_171	[p6l721t2794r755b2823],
3	integrase	NN	O	integrase	nn	6	SENT_171	[p6l764t2796r905b2833],
4	strand	NN	O	strand	nn	6	SENT_171	[p6l919t2794r1015b2823],
5	transfer	NN	O	transfer	nn	6	SENT_171	[p6l1029t2794r1150b2823],
6	inhibitors	NNS	O	inhibitor	prep_of	1	SENT_171	[p6l1162t2794r1314b2823],
7	to	TO	O	to	_	0	SENT_171	[p6l1328t2803r1359b2823],
8	the	DT	O	the	det	9	SENT_171	[p6l1372t2794r1421b2823],
9	integrase	NN	O	integrase	prep_to	1	SENT_171	[p6l1434t2795r1681b2833],
10	.	.	O	.	_	0	SENT_171	[p6l1434t2795r1681b2833],

1	—	NN	O	—	_	0	SENT_172	[p6l1434t2795r1681b2833],
2	.	.	O	.	_	0	SENT_172	[p6l1434t2795r1681b2833],

1	DNA	NN	O	dna	nn	2	SENT_173	[p6l1434t2795r1681b2833],
2	complex	NN	O	complex	nsubj	5	SENT_173	[p6l1692t2794r1824b2833],
3	is	VBZ	O	be	cop	5	SENT_173	[p6l1836t2796r1858b2823],
4	strictly	RB	O	strictly	advmod	5	SENT_173	[p6l1872t2794r1981b2833],
5	dependent	JJ	O	dependent	_	0	SENT_173	[p6l1993t2794r2100b2833, p6l583t2844r653b2873],
6	on	IN	O	on	_	0	SENT_173	[p6l666t2855r705b2873],
7	divalent	JJ	O	divalent	amod	8	SENT_173	[p6l719t2844r843b2873],
8	metal	NN	O	metal	prep_on	5	SENT_173	[p6l855t2844r950b2873],
9	.	.	O	.	_	0	SENT_173	[p6l855t2844r950b2873],

1	The	DT	O	the	det	4	SENT_174	[p6l964t2844r1031b2873],
2	speciﬁc	JJ	O	speciﬁc	amod	4	SENT_174	[p6l1044t2844r1159b2882],
3	chemical	NN	O	chemical	nn	4	SENT_174	[p6l1173t2844r1311b2873],
4	nature	NN	O	nature	nsubjpass	10	SENT_174	[p6l1324t2853r1424b2873],
5	of	IN	O	of	_	0	SENT_174	[p6l1438t2844r1473b2873],
6	the	DT	O	the	det	7	SENT_174	[p6l1482t2844r1531b2873],
7	pharmacophore	NN	O	pharmacophore	prep_of	4	SENT_174	[p6l1544t2844r1792b2883],
8	has	VBZ	O	have	aux	10	SENT_174	[p6l1805t2844r1855b2873],
9	been	VBN	O	be	auxpass	10	SENT_174	[p6l1869t2844r1943b2873],
10	shown	VBN	O	show	_	0	SENT_174	[p6l1956t2844r2057b2873],
11	to	TO	O	to	aux	12	SENT_174	[p6l2070t2853r2101b2873],
12	affect	VB	O	affect	xcomp	10	SENT_174	[p6l583t2894r669b2923],
13	relative	JJ	O	relative	amod	14	SENT_174	[p6l681t2894r795b2923],
14	activity	NN	O	activity	dobj	12	SENT_174	[p6l809t2896r923b2933],
15	in	IN	O	in	_	0	SENT_174	[p6l934t2896r964b2923],
16	biochemical	JJ	O	biochemical	amod	17	SENT_174	[p6l977t2894r1166b2923],
17	assays	NNS	O	assay	prep_in	14	SENT_174	[p6l1180t2905r1270b2933],
18	depending	VBG	O	depend	_	0	SENT_174	[p6l1284t2894r1449b2933],
19	on	IN	O	on	prepc_depending_on	12	SENT_174	[p6l1461t2905r1501b2923],
20	whether	IN	O	whether	complm	25	SENT_174	[p6l1512t2894r1642b2923],
21	magnesium	NN	O	magnesium	nsubjpass	25	SENT_174	[p6l1654t2896r1834b2933],
22	or	CC	O	or	_	0	SENT_174	[p6l1847t2905r1881b2923],
23	manganese	NN	O	manganese	conj_or	21	SENT_174	[p6l1893t2905r2065b2933],
24	is	VBZ	O	be	auxpass	25	SENT_174	[p6l2078t2896r2101b2923],
25	used	VBN	O	use	pcomp	12	SENT_174	[p6l582t2944r652b2973],
26	in	IN	O	in	_	0	SENT_174	[p6l664t2945r694b2972],
27	the	DT	O	the	det	28	SENT_174	[p6l706t2944r755b2973],
28	reaction	NN	O	reaction	prep_in	25	SENT_174	[p6l767t2945r902b2973],
29	.	.	O	.	_	0	SENT_174	[p6l767t2945r902b2973],

1	Importantly	RB	O	importantly	advmod	19	SENT_175	[p6l916t2944r1110b2982],
2	,	,	O	,	_	0	SENT_175	[p6l916t2944r1110b2982],
3	although	IN	O	although	mark	7	SENT_175	[p6l1123t2944r1262b2982],
4	nonacid	JJ	O	nonacid	amod	6	SENT_175	[p6l1273t2944r1398b2973],
5	pharmacophore	NN	O	pharmacophore	nn	6	SENT_175	[p6l1409t2944r1657b2982],
6	replacements	NNS	O	replacement	nsubj	7	SENT_175	[p6l1669t2944r1876b2982],
7	exhibit	VBP	O	exhibit	advcl	19	SENT_175	[p6l1889t2944r1996b2973],
8	only	RB	O	only	advmod	11	SENT_175	[p6l2007t2944r2076b2982],
9	a	DT	O	a	det	11	SENT_175	[p6l2086t2955r2101b2973],
10	modest	JJ	O	modest	amod	11	SENT_175	[p6l583t2993r697b3022],
11	loss	NN	O	loss	dobj	7	SENT_175	[p6l711t2993r767b3022],
12	in	IN	O	in	_	0	SENT_175	[p6l781t2995r811b3022],
13	binding	NN	O	binding	nn	14	SENT_175	[p6l825t2993r947b3032],
14	afﬁnity	NN	O	afﬁnity	prep_in	11	SENT_175	[p6l961t2993r1076b3032],
15	,	,	O	,	_	0	SENT_175	[p6l961t2993r1076b3032],
16	such	JJ	O	such	amod	17	SENT_175	[p6l1091t2993r1161b3022],
17	compounds	NNS	O	compound	nsubj	19	SENT_175	[p6l1176t2993r1356b3031],
18	are	VBP	O	be	cop	19	SENT_175	[p6l1371t3004r1418b3022],
19	inactive	JJ	O	inactive	_	0	SENT_175	[p6l1432t2995r1552b3022],
20	as	IN	O	as	_	0	SENT_175	[p6l1567t3004r1596b3022],
21	inhibitors	NNS	O	inhibitor	prep_as	19	SENT_175	[p6l1610t2993r1771b3022],
22	.	.	O	.	_	0	SENT_175	[p6l1610t2993r1771b3022],

1	Thus	RB	O	thus	advmod	13	SENT_176	[p6l1785t2993r1877b3028],
2	,	,	O	,	_	0	SENT_176	[p6l1785t2993r1877b3028],
3	sequestration	NN	O	sequestration	nsubj	13	SENT_176	[p6l1893t2995r2101b3031],
4	of	IN	O	of	_	0	SENT_176	[p6l583t3043r617b3072],
5	the	DT	O	the	det	8	SENT_176	[p6l627t3043r676b3072],
6	active	JJ	O	active	amod	8	SENT_176	[p6l691t3045r779b3072],
7	site	NN	O	site	nn	8	SENT_176	[p6l794t3045r846b3072],
8	metals	NNS	O	metal	prep_of	3	SENT_176	[p6l860t3043r960b3072],
9	by	IN	O	by	_	0	SENT_176	[p6l974t3043r1013b3082],
10	the	DT	O	the	det	11	SENT_176	[p6l1025t3043r1074b3072],
11	pharmacophore	NN	O	pharmacophore	prep_by	8	SENT_176	[p6l1087t3043r1335b3081],
12	is	VBZ	O	be	cop	13	SENT_176	[p6l1349t3045r1372b3072],
13	critical	JJ	O	critical	_	0	SENT_176	[p6l1387t3043r1493b3072],
14	for	IN	O	for	_	0	SENT_176	[p6l1507t3043r1552b3072],
15	inhibition	NN	O	inhibition	prep_for	13	SENT_176	[p6l1565t3043r1729b3078],
16	,	,	O	,	_	0	SENT_176	[p6l1565t3043r1729b3078],
17	whereas	IN	O	whereas	mark	25	SENT_176	[p6l1743t3043r1869b3072],
18	the	DT	O	the	det	19	SENT_176	[p6l1884t3043r1932b3072],
19	affinity	NN	O	affinity	nsubj	25	SENT_176	[p6l1947t3043r2058b3082],
20	of	IN	O	of	_	0	SENT_176	[p6l2071t3043r2105b3072],
21	integrase	NN	O	integrase	nn	24	SENT_176	[p6l582t3094r724b3131],
22	strand	NN	O	strand	nn	24	SENT_176	[p6l738t3093r835b3122],
23	transfer	NN	O	transfer	nn	24	SENT_176	[p6l849t3093r970b3122],
24	inhibitors	NNS	O	inhibitor	prep_of	19	SENT_176	[p6l983t3093r1136b3122],
25	appears	VBZ	O	appear	advcl	13	SENT_176	[p6l1151t3104r1268b3131],
26	to	TO	O	to	aux	28	SENT_176	[p6l1282t3101r1313b3122],
27	be	VB	O	be	auxpass	28	SENT_176	[p6l1327t3093r1363b3122],
28	determined	VBN	O	determine	xcomp	25	SENT_176	[p6l1378t3093r1557b3122],
29	largely	RB	O	largely	advmod	30	SENT_176	[p6l1572t3093r1679b3131],
30	(	JJ	O	(	acomp	28	SENT_176	[p6l1692t3093r1842b3131],
31	although	IN	O	although	mark	39	SENT_176	[p6l1692t3093r1842b3131],
32	not	RB	O	not	dep	33	SENT_176	[p6l1856t3101r1909b3122],
33	exclusively	RB	O	exclusively	advmod	39	SENT_176	[p6l1923t3093r2100b3131],
34	)	CD	NUMBER	)	nsubj	39	SENT_176	[p6l1923t3093r2100b3131],
35	by	IN	O	by	_	0	SENT_176	[p6l583t3143r621b3181],
36	the	DT	O	the	det	38	SENT_176	[p6l634t3143r683b3172],
37	pendant	NN	O	pendant	nn	38	SENT_176	[p6l698t3143r826b3181],
38	substituents	NNS	O	substituent	prep_by	34	SENT_176	[p6l840t3143r1025b3172],
39	(	VBP	O	(	advcl	28	SENT_176	[p6l1041t3144r1109b3179],
40	29	CD	NUMBER	29	num	41	SENT_176	[p6l1041t3144r1109b3179],
41	)	CD	NUMBER	)	dobj	39	SENT_176	[p6l1041t3144r1109b3179],
42	.	.	O	.	_	0	SENT_176	[p6l1041t3144r1109b3179],

1	On	IN	O	on	_	0	SENT_177	[p6l1127t3144r1177b3172],
2	the	DT	O	the	det	3	SENT_177	[p6l1191t3143r1240b3172],
3	basis	NN	O	basis	prep_on	50	SENT_177	[p6l1255t3142r1328b3172],
4	of	IN	O	of	_	0	SENT_177	[p6l1344t3143r1378b3172],
5	these	DT	O	these	det	6	SENT_177	[p6l1389t3142r1468b3172],
6	observations	NNS	O	observation	prep_of	3	SENT_177	[p6l1484t3143r1679b3172],
7	as	RB	O	as	_	0	SENT_177	[p6l1695t3154r1723b3172],
8	well	RB	O	well	_	0	SENT_177	[p6l1737t3142r1801b3171],
9	as	IN	O	as	_	0	SENT_177	[p6l1816t3154r1844b3172],
10	structure	NN	O	structure	nn	12	SENT_177	[p6l1860t3151r1999b3172],
11	activity	NN	O	activity	nn	12	SENT_177	[p6l2015t3144r2100b3172, p6l582t3194r624b3231],
12	analyses	NNS	O	analysis	prep_on	50	SENT_177	[p6l639t3193r764b3231],
13	of	IN	O	of	_	0	SENT_177	[p6l781t3193r815b3221],
14	inhibitors	NNS	O	inhibitor	prep_of	12	SENT_177	[p6l827t3192r979b3221],
15	and	CC	O	and	_	0	SENT_177	[p6l996t3192r1051b3221],
16	information	NN	O	information	conj_and	14	SENT_177	[p6l1067t3193r1255b3221],
17	derived	VBN	O	derive	partmod	12	SENT_177	[p6l1272t3192r1387b3221],
18	from	IN	O	from	_	0	SENT_177	[p6l1403t3193r1479b3221],
19	X	NN	O	x	prep_from	17	SENT_177	[p6l1494t3194r1586b3231],
20	—	CD	NUMBER	—	num	23	SENT_177	[p6l1494t3194r1586b3231],
21	ray	NN	O	ray	nn	23	SENT_177	[p6l1494t3194r1586b3231],
22	crystallography	NN	O	crystallography	nn	23	SENT_177	[p6l1601t3192r1843b3231],
23	studies	NNS	O	study	nsubjpass	50	SENT_177	[p6l1858t3192r1964b3221],
24	of	IN	O	of	_	0	SENT_177	[p6l1981t3193r2015b3221],
25	integrase	NN	O	integrase	prep_of	23	SENT_177	[p6l2027t3194r2100b3221, p6l583t3253r663b3281],
26	and	CC	O	and	_	0	SENT_177	[p6l678t3242r733b3271],
27	other	JJ	O	other	amod	30	SENT_177	[p6l748t3242r832b3271],
28	metal-dependent	JJ	O	metal-dependent	amod	30	SENT_177	[p6l845t3242r1113b3280],
29	phosphotransferase	NN	O	phosphotransferase	nn	30	SENT_177	[p6l1126t3242r1430b3281],
30	enzymes	NNS	O	enzyme	prep_of	23	SENT_177	[p6l1445t3253r1586b3281],
31	,	,	O	,	_	0	SENT_177	[p6l1445t3253r1586b3281],
32	a	DT	O	a	det	33	SENT_177	[p6l1602t3253r1617b3271],
33	model	NN	O	model	prep_of	23	SENT_177	[p6l1631t3242r1729b3271],
34	for	IN	O	for	_	0	SENT_177	[p6l1743t3242r1789b3271],
35	the	DT	O	the	det	36	SENT_177	[p6l1802t3242r1851b3271],
36	interaction	NN	O	interaction	prep_for	33	SENT_177	[p6l1865t3244r2036b3271],
37	between	IN	O	between	_	0	SENT_177	[p6l2050t3242r2100b3271, p6l583t3300r676b3321],
38	the	DT	O	the	det	40	SENT_177	[p6l686t3292r735b3321],
39	inhibitor	NN	O	inhibitor	nn	40	SENT_177	[p6l746t3292r885b3321],
40	pharmacophore	NN	O	pharmacophore	prep_between	36	SENT_177	[p6l895t3292r1143b3330],
41	and	CC	O	and	_	0	SENT_177	[p6l1154t3292r1210b3321],
42	the	DT	O	the	det	43	SENT_177	[p6l1221t3292r1269b3321],
43	metals	NNS	O	metal	conj_and	25	SENT_177	[p6l1280t3292r1380b3321],
44	at	IN	O	at	_	0	SENT_177	[p6l1392t3300r1420b3321],
45	the	DT	O	the	det	48	SENT_177	[p6l1430t3292r1479b3321],
46	integrase	NN	O	integrase	nn	48	SENT_177	[p6l1489t3294r1631b3331],
47	active	JJ	O	active	amod	48	SENT_177	[p6l1642t3294r1730b3321],
48	site	NN	O	site	prep_at	43	SENT_177	[p6l1742t3294r1794b3321],
49	was	VBD	O	be	auxpass	50	SENT_177	[p6l1804t3303r1860b3321],
50	developed	VBN	O	develop	_	0	SENT_177	[p6l1872t3292r2029b3330],
51	(	NN	O	(	dobj	50	SENT_177	[p6l2041t3293r2067b3328],
52	2	CD	NUMBER	2	number	53	SENT_177	[p6l2041t3293r2067b3328],
53	9	CD	NUMBER	9	num	54	SENT_177	[p6l2072t3293r2100b3328],
54	)	NN	O	)	dep	51	SENT_177	[p6l2072t3293r2100b3328],
55	(	CD	NUMBER	(	num	58	SENT_177	[p6l584t3343r706b3380],
56	Figure	NNP	O	Figure	nn	58	SENT_177	[p6l584t3343r706b3380],
57	2b	NN	O	2b	nn	58	SENT_177	[p6l718t3343r776b3378],
58	)	NN	O	)	dep	54	SENT_177	[p6l718t3343r776b3378],
59	.	.	O	.	_	0	SENT_177	[p6l718t3343r776b3378],

1	The	DT	O	the	det	3	SENT_178	[p6l788t3342r854b3371],
2	bond	NN	O	bond	nn	3	SENT_178	[p6l866t3342r945b3371],
3	lengths	NNS	O	length	nsubjpass	16	SENT_178	[p6l956t3342r1069b3380],
4	and	CC	O	and	_	0	SENT_178	[p6l1082t3342r1137b3371],
5	angles	NNS	O	angle	nsubjpass	16	SENT_178	[p6l1149t3342r1245b3380],
6	for	IN	O	for	_	0	SENT_178	[p6l1257t3342r1302b3371],
7	the	DT	O	the	det	10	SENT_178	[p6l1313t3342r1361b3371],
8	diketo	JJ	O	diketo	amod	10	SENT_178	[p6l1374t3342r1470b3371],
9	acid	NN	O	acid	nn	10	SENT_178	[p6l1482t3342r1544b3371],
10	pharmacophore	NN	O	pharmacophore	prep_for	3	SENT_178	[p6l1555t3342r1802b3380],
11	used	VBN	O	use	partmod	10	SENT_178	[p6l1813t3342r1884b3371],
12	in	IN	O	in	_	0	SENT_178	[p6l1895t3343r1925b3370],
13	this	DT	O	this	det	14	SENT_178	[p6l1936t3342r1992b3371],
14	model	NN	O	model	prep_in	11	SENT_178	[p6l2003t3342r2101b3371],
15	were	VBD	O	be	auxpass	16	SENT_178	[p6l582t3403r656b3421],
16	derived	VBN	O	derive	_	0	SENT_178	[p6l672t3392r786b3421],
17	from	IN	O	from	_	0	SENT_178	[p6l801t3392r877b3421],
18	the	DT	O	the	det	20	SENT_178	[p6l891t3392r940b3421],
19	crystal	NN	O	crystal	nn	20	SENT_178	[p6l954t3392r1055b3430],
20	structure	NN	O	structure	prep_from	16	SENT_178	[p6l1069t3400r1209b3421],
21	of	IN	O	of	_	0	SENT_178	[p6l1224t3392r1258b3421],
22	5	CD	NUMBER	5	prep_of	20	SENT_178	[p6l1270t3392r1421b3421],
23	.	.	O	.	_	0	SENT_178	[p6l1270t3392r1421b3421],

1	—	NN	O	—	_	0	SENT_179	[p6l1270t3392r1421b3421],
2	.	.	O	.	_	0	SENT_179	[p6l1270t3392r1421b3421],

1	CITEP	NN	O	citep	dep	9	SENT_180	[p6l1270t3392r1421b3421],
2	[	CD	NUMBER	[	num	3	SENT_180	[p6l1438t3392r2100b3430, p6l583t3441r996b3480],
3	1	CD	NUMBER	1	dep	1	SENT_180	[p6l1438t3392r2100b3430, p6l583t3441r996b3480],
4	—	NN	O	—	dep	9	SENT_180	[p6l1438t3392r2100b3430, p6l583t3441r996b3480],
5	(	CD	NUMBER	(	num	4	SENT_180	[p6l1438t3392r2100b3430, p6l583t3441r996b3480],
6	5chloroindol3	NN	O	5chloroindol3	nn	9	SENT_180	[p6l1438t3392r2100b3430, p6l583t3441r996b3480],
7	—	CD	NUMBER	—	num	9	SENT_180	[p6l1438t3392r2100b3430, p6l583t3441r996b3480],
8	yl	NN	O	yl	nn	9	SENT_180	[p6l1438t3392r2100b3430, p6l583t3441r996b3480],
9	)	NN	O	)	dep	12	SENT_180	[p6l1438t3392r2100b3430, p6l583t3441r996b3480],
10	3hydroxy3	CD	NUMBER	3hydroxy3	num	11	SENT_180	[p6l1438t3392r2100b3430, p6l583t3441r996b3480],
11	(	CD	NUMBER	(	dep	9	SENT_180	[p6l1438t3392r2100b3430, p6l583t3441r996b3480],
12	2Htetrazol	NN	O	2htetrazol	dep	16	SENT_180	[p6l1438t3392r2100b3430, p6l583t3441r996b3480],
13	—	CD	NUMBER	—	num	12	SENT_180	[p6l1438t3392r2100b3430, p6l583t3441r996b3480],
14	5	CD	NUMBER	5	num	16	SENT_180	[p6l1438t3392r2100b3430, p6l583t3441r996b3480],
15	—	NN	O	—	nn	16	SENT_180	[p6l1438t3392r2100b3430, p6l583t3441r996b3480],
16	yl	NN	O	yl	_	0	SENT_180	[p6l1438t3392r2100b3430, p6l583t3441r996b3480],
17	)	SYM	O	)	dep	21	SENT_180	[p6l1438t3392r2100b3430, p6l583t3441r996b3480],
18	-	:	O	-	_	0	SENT_180	[p6l1438t3392r2100b3430, p6l583t3441r996b3480],
19	propenone	NN	O	propenone	nn	21	SENT_180	[p6l1438t3392r2100b3430, p6l583t3441r996b3480],
20	)	CD	NUMBER	)	num	21	SENT_180	[p6l1438t3392r2100b3430, p6l583t3441r996b3480],
21	]	NN	O	]	dep	16	SENT_180	[p6l1438t3392r2100b3430, p6l583t3441r996b3480],
22	and	CC	O	and	_	0	SENT_180	[p6l1013t3441r1068b3470],
23	structural	JJ	O	structural	amod	24	SENT_180	[p6l1081t3442r1231b3470],
24	information	NN	O	information	conj_and	21	SENT_180	[p6l1244t3442r1432b3470],
25	based	VBN	O	base	partmod	21	SENT_180	[p6l1444t3441r1531b3470],
26	on	IN	O	on	_	0	SENT_180	[p6l1544t3452r1584b3470],
27	the	DT	O	the	det	31	SENT_180	[p6l1596t3441r1645b3470],
28	two	CD	NUMBER	two	num	31	SENT_180	[p6l1658t3450r1715b3470],
29	active	JJ	O	active	amod	31	SENT_180	[p6l1729t3443r1818b3470],
30	site	NN	O	site	nn	31	SENT_180	[p6l1831t3443r1883b3470],
31	metals	NNS	O	metal	prep_on	25	SENT_180	[p6l1896t3441r1996b3470],
32	in	IN	O	in	_	0	SENT_180	[p6l2009t3443r2039b3470],
33	the	DT	O	the	det	35	SENT_180	[p6l2052t3441r2101b3470],
34	crystal	NN	O	crystal	nn	35	SENT_180	[p6l583t3491r684b3530],
35	structure	NN	O	structure	prep_in	31	SENT_180	[p6l694t3499r833b3520],
36	of	IN	O	of	_	0	SENT_180	[p6l844t3491r878b3520],
37	ASV	NNP	ORGANIZATION	ASV	nn	39	SENT_180	[p6l882t3492r958b3520],
38	integrase	NN	O	integrase	nn	39	SENT_180	[p6l965t3493r1106b3530],
39	(	NN	O	(	prep_of	35	SENT_180	[p6l1116t3492r1185b3527],
40	30	CD	NUMBER	30	num	41	SENT_180	[p6l1116t3492r1185b3527],
41	)	NN	O	)	dep	39	SENT_180	[p6l1116t3492r1185b3527],
42	.	.	O	.	_	0	SENT_180	[p6l1116t3492r1185b3527],

1	This	DT	O	this	det	2	SENT_181	[p6l1195t3491r1268b3520],
2	model	NN	O	model	nsubj	5	SENT_181	[p6l1278t3491r1375b3520],
3	is	VBZ	O	be	cop	5	SENT_181	[p6l1385t3493r1407b3520],
4	also	RB	O	also	advmod	5	SENT_181	[p6l1418t3491r1477b3520],
5	consistent	JJ	O	consistent	_	0	SENT_181	[p6l1487t3493r1645b3520],
6	with	IN	O	with	_	0	SENT_181	[p6l1652t3491r1722b3520],
7	the	DT	O	the	det	8	SENT_181	[p6l1731t3491r1780b3520],
8	observation	NN	O	observation	prep_with	5	SENT_181	[p6l1790t3491r1972b3520],
9	that	IN	O	that	complm	24	SENT_181	[p6l1982t3491r2043b3520],
10	the	DT	O	the	det	12	SENT_181	[p6l2052t3491r2101b3520],
11	resistance	NN	O	resistance	nn	12	SENT_181	[p6l583t3543r735b3570],
12	mutations	NNS	O	mutation	nsubj	24	SENT_181	[p6l747t3543r903b3570],
13	that	WDT	O	that	nsubjpass	15	SENT_181	[p6l916t3541r978b3570],
14	are	VBP	O	be	auxpass	15	SENT_181	[p6l990t3552r1037b3570],
15	selected	VBN	O	select	rcmod	12	SENT_181	[p6l1049t3541r1173b3570],
16	with	IN	O	with	_	0	SENT_181	[p6l1185t3541r1254b3570],
17	a	DT	O	a	det	18	SENT_181	[p6l1267t3552r1282b3570],
18	variety	NN	O	variety	prep_with	15	SENT_181	[p6l1293t3543r1401b3580],
19	of	IN	O	of	_	0	SENT_181	[p6l1413t3541r1447b3570],
20	integrase	NN	O	integrase	nn	23	SENT_181	[p6l1455t3543r1596b3580],
21	strand	NN	O	strand	nn	23	SENT_181	[p6l1609t3541r1706b3570],
22	transfer	NN	O	transfer	nn	23	SENT_181	[p6l1718t3541r1839b3570],
23	inhibitors	NNS	O	inhibitor	prep_of	18	SENT_181	[p6l1851t3541r2003b3570],
24	affect	VBP	O	affect	ccomp	5	SENT_181	[p6l2016t3541r2102b3570],
25	residues	NNS	O	residue	dobj	24	SENT_181	[p6l583t3591r708b3620],
26	that	WDT	O	that	nsubj	28	SENT_181	[p6l720t3591r782b3620],
27	are	VBP	O	be	cop	28	SENT_181	[p6l792t3602r839b3620],
28	proximal	JJ	O	proximal	rcmod	25	SENT_181	[p6l850t3591r988b3629],
29	to	TO	O	to	_	0	SENT_181	[p6l1000t3599r1030b3620],
30	those	DT	O	those	prep_to	28	SENT_181	[p6l1042t3591r1125b3620],
31	that	WDT	O	that	nsubj	32	SENT_181	[p6l1136t3591r1198b3620],
32	coordinate	VBP	O	coordinate	rcmod	30	SENT_181	[p6l1208t3591r1375b3620],
33	the	DT	O	the	det	35	SENT_181	[p6l1387t3591r1435b3620],
34	metal	NN	O	metal	nn	35	SENT_181	[p6l1447t3591r1533b3620],
35	cofactors	NNS	O	cofactor	dobj	32	SENT_181	[p6l1545t3591r1685b3620],
36	at	IN	O	at	_	0	SENT_181	[p6l1697t3599r1725b3620],
37	the	DT	O	the	det	40	SENT_181	[p6l1736t3591r1784b3620],
38	integrase	NN	O	integrase	nn	40	SENT_181	[p6l1795t3593r1937b3630],
39	active	JJ	O	active	amod	40	SENT_181	[p6l1949t3593r2037b3620],
40	site	NN	O	site	prep_at	35	SENT_181	[p6l2049t3593r2101b3620],
41	(	CD	NUMBER	(	num	42	SENT_181	[p6l584t3642r640b3677],
42	31	CD	NUMBER	31	tmod	32	SENT_181	[p6l584t3642r640b3677],
43	,	,	O	,	_	0	SENT_181	[p6l584t3642r640b3677],
44	32	CD	NUMBER	32	num	45	SENT_181	[p6l654t3642r710b3677],
45	)	NN	O	)	appos	42	SENT_181	[p6l654t3642r710b3677],
46	.	.	O	.	_	0	SENT_181	[p6l654t3642r710b3677],

1	Subsequent	JJ	O	subsequent	_	0	SENT_182	[p6l634t3689r815b3728],
2	to	TO	O	to	_	0	SENT_182	[p6l823t3697r853b3718],
3	the	DT	O	the	det	4	SENT_182	[p6l863t3689r911b3718],
4	identiﬁcation	NN	O	identiﬁcation	prep_subsequent_to	10	SENT_182	[p6l920t3689r1129b3718],
5	of	IN	O	of	_	0	SENT_182	[p6l1138t3689r1172b3718],
6	the	DT	O	the	det	8	SENT_182	[p6l1177t3689r1226b3718],
7	ﬁrst	JJ	O	ﬁrst	amod	8	SENT_182	[p6l1235t3689r1297b3718],
8	strand	NN	O	strand	prep_of	4	SENT_182	[p6l1305t3689r1401b3718],
9	transfer	NN	O	transfer	nn	10	SENT_182	[p6l1411t3689r1531b3718],
10	inhibitors	NNS	O	inhibitor	nsubjpass	28	SENT_182	[p6l1539t3689r1700b3725],
11	,	,	O	,	_	0	SENT_182	[p6l1539t3689r1700b3725],
12	many	JJ	O	many	amod	15	SENT_182	[p6l1710t3700r1797b3728],
13	structurally	RB	O	structurally	advmod	14	SENT_182	[p6l1805t3689r1984b3728],
14	diverse	JJ	O	diverse	amod	15	SENT_182	[p6l1992t3689r2101b3718],
15	analogs	NNS	O	analog	appos	10	SENT_182	[p6l583t3737r699b3776],
16	elaborating	VBG	O	elaborate	partmod	10	SENT_182	[p6l713t3737r891b3776],
17	novel	JJ	O	novel	amod	20	SENT_182	[p6l903t3737r996b3773],
18	,	,	O	,	_	0	SENT_182	[p6l903t3737r996b3773],
19	isosteric	JJ	O	isosteric	amod	20	SENT_182	[p6l1011t3738r1139b3766],
20	replacements	NNS	O	replacement	dobj	16	SENT_182	[p6l1153t3737r1359b3776],
21	for	IN	O	for	_	0	SENT_182	[p6l1373t3737r1419b3766],
22	the	DT	O	the	det	25	SENT_182	[p6l1432t3737r1481b3766],
23	diketo	JJ	O	diketo	amod	25	SENT_182	[p6l1495t3737r1592b3766],
24	acid	NN	O	acid	nn	25	SENT_182	[p6l1606t3737r1668b3766],
25	pharmacophore	NN	O	pharmacophore	prep_for	20	SENT_182	[p6l1681t3737r1929b3776],
26	have	VBP	O	have	aux	28	SENT_182	[p6l1943t3737r2013b3766],
27	been	VBN	O	be	auxpass	28	SENT_182	[p6l2027t3737r2101b3766],
28	reported	VBN	O	report	_	0	SENT_182	[p6l583t3787r718b3826],
29	(	CD	NUMBER	(	dobj	28	SENT_182	[p6l730t3787r880b3824],
30	reviewed	VBN	O	review	partmod	29	SENT_182	[p6l730t3787r880b3824],
31	in	IN	O	in	_	0	SENT_182	[p6l891t3789r921b3816],
32	33	CD	NUMBER	33	num	33	SENT_182	[p6l934t3788r990b3824],
33	)	NN	O	)	prep_in	30	SENT_182	[p6l934t3788r990b3824],
34	.	.	O	.	_	0	SENT_182	[p6l934t3788r990b3824],

1	These	DT	O	these	det	2	SENT_183	[p6l1002t3787r1099b3817],
2	analogs	NNS	O	analog	nsubjpass	5	SENT_183	[p6l1112t3787r1227b3826],
3	have	VBP	O	have	aux	5	SENT_183	[p6l1238t3787r1309b3817],
4	been	VBN	O	be	auxpass	5	SENT_183	[p6l1321t3787r1395b3817],
5	designed	VBN	O	design	_	0	SENT_183	[p6l1407t3787r1544b3826],
6	not	RB	O	not	dep	7	SENT_183	[p6l1555t3795r1608b3817],
7	only	RB	O	only	advmod	5	SENT_183	[p6l1619t3787r1688b3826],
8	to	TO	O	to	aux	9	SENT_183	[p6l1698t3795r1729b3817],
9	improve	VB	O	improve	xcomp	5	SENT_183	[p6l1740t3789r1870b3826],
10	upon	IN	O	upon	_	0	SENT_183	[p6l1881t3798r1961b3826],
11	intrinsic	JJ	O	intrinsic	prep_upon	9	SENT_183	[p6l1972t3789r2101b3817],

1	Annu	NNP	PERSON	Annu	_	0	SENT_184	[p7l201t2285r224b2365],
2	.	.	O	.	_	0	SENT_184	[p7l201t2285r224b2365],

1	Rev.	NNP	O	Rev.	nn	2	SENT_185	[p7l201t2215r224b2274],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_185	[p7l201t2056r224b2204],
3	.	.	O	.	_	0	SENT_185	[p7l201t2056r224b2204],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_186	[p7l201t1936r224b2045],
2	.	.	O	.	_	0	SENT_186	[p7l201t1936r224b2045],

1	2009.49:3	CD	NUMBER	2009.49:3	num	2	SENT_187	[p7l201t1792r225b1924],
2	77-394	CD	NUMBER	77-394	_	0	SENT_187	[p7l201t1686r225b1786],
3	.	.	O	.	_	0	SENT_187	[p7l201t1686r225b1786],

1	Downloaded	VBN	O	download	_	0	SENT_188	[p7l201t1505r224b1675],
2	from	IN	O	from	_	0	SENT_188	[p7l201t1431r224b1495],
3	www	NN	O	www	prep_from	1	SENT_188	[p7l209t1351r224b1422],
4	.	.	O	.	_	0	SENT_188	[p7l201t1087r231b1338],

1	annualreviews.org	NN	O	annualreviews.org	_	0	SENT_189	[p7l201t1087r231b1338],
2	by	IN	O	by	_	0	SENT_189	[p7l234t2198r265b2230],
3	University	NNP	ORGANIZATION	University	prep_by	1	SENT_189	[p7l234t2049r265b2189],
4	of	IN	ORGANIZATION	of	_	0	SENT_189	[p7l234t2010r258b2039],
5	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	3	SENT_189	[p7l234t1864r258b2004],
6	-	:	O	-	_	0	SENT_189	[p7l248t1845r251b1854],
7	Madison	NNP	O	Madison	dep	1	SENT_189	[p7l234t1714r258b1835],
8	on	IN	O	on	_	0	SENT_189	[p7l242t1673r258b1705],
9	01/05/14	CD	DATE	01/05/14	prep_on	7	SENT_189	[p7l234t1539r258b1664],
10	.	.	O	.	_	0	SENT_189	[p7l234t1539r258b1664],

1	For	IN	O	for	_	0	SENT_190	[p7l235t1482r258b1528],
2	personal	JJ	O	personal	amod	3	SENT_190	[p7l234t1361r265b1473],
3	use	NN	O	use	pobj	1	SENT_190	[p7l242t1298r258b1341],
4	only	RB	O	only	advmod	3	SENT_190	[p7l234t1223r265b1288],
5	.	.	O	.	_	0	SENT_190	[p7l234t1223r265b1288],

1	potency	NN	O	potency	_	0	SENT_191	[p7l583t20r708b51],
2	and	CC	O	and	_	0	SENT_191	[p7l717t12r773b41],
3	antiviral	JJ	O	antiviral	amod	4	SENT_191	[p7l783t12r911b41],
4	efficacy	NN	O	efficacy	conj_and	1	SENT_191	[p7l922t12r1040b51],
5	but	CC	O	but	cc	6	SENT_191	[p7l1048t12r1100b41],
6	also	RB	O	also	dep	8	SENT_191	[p7l1110t12r1169b41],
7	to	TO	O	to	aux	8	SENT_191	[p7l1179t20r1210b41],
8	obviate	VB	O	obviate	dep	1	SENT_191	[p7l1221t12r1333b41],
9	pharmacologic	JJ	O	pharmacologic	amod	10	SENT_191	[p7l1344t12r1576b51],
10	liabilities	NNS	O	liability	dobj	8	SENT_191	[p7l1585t12r1726b41],
11	such	JJ	O	such	_	0	SENT_191	[p7l1737t12r1807b41],
12	as	IN	O	as	_	0	SENT_191	[p7l1817t23r1846b41],
13	cell	NN	O	cell	nn	14	SENT_191	[p7l1857t12r1909b41],
14	penetration	NN	O	penetration	prep_such_as	10	SENT_191	[p7l1920t14r2101b51],
15	and	CC	O	and	_	0	SENT_191	[p7l583t60r639b89],
16	protein	NN	O	protein	nn	17	SENT_191	[p7l654t62r769b99],
17	binding	NN	O	binding	prep_such_as	10	SENT_191	[p7l784t60r913b99],
18	.	.	O	.	_	0	SENT_191	[p7l784t60r913b99],

1	Notable	JJ	O	notable	dep	8	SENT_192	[p7l929t60r1058b89],
2	among	IN	O	among	_	0	SENT_192	[p7l1074t71r1181b99],
3	these	DT	O	these	det	4	SENT_192	[p7l1196t60r1276b89],
4	compounds	NNS	O	compound	prep_among	1	SENT_192	[p7l1293t60r1473b99],
5	are	VBP	O	be	cop	8	SENT_192	[p7l1489t71r1536b89],
6	the	DT	O	the	det	8	SENT_192	[p7l1552t60r1601b89],
7	8-hydroxy	JJ	O	8-hydroxy	amod	8	SENT_192	[p7l1618t60r2101b99],
8	—	NN	O	—	_	0	SENT_192	[p7l1618t60r2101b99],
9	(	CD	NUMBER	(	number	10	SENT_192	[p7l1618t60r2101b99],
10	1,6	CD	NUMBER	1,6	dep	8	SENT_192	[p7l1618t60r2101b99],
11	)	SYM	O	)	dep	8	SENT_192	[p7l1618t60r2101b99],
12	-	:	O	-	_	0	SENT_192	[p7l1618t60r2101b99],
13	naphthyridine	NN	O	naphthyridine	nn	14	SENT_192	[p7l1618t60r2101b99],
14	carboxamides	NNS	O	carboxamide	dobj	8	SENT_192	[p7l583t108r803b143],
15	,	,	O	,	_	0	SENT_192	[p7l583t108r803b143],
16	L-870810	NN	O	l-870810	conj_and	14	SENT_192	[p7l820t109r975b137],
17	and	CC	O	and	_	0	SENT_192	[p7l991t108r1047b137],
18	L-870812	NN	O	l-870812	conj_and	14	SENT_192	[p7l1062t109r1215b137],
19	(	CD	NUMBER	(	num	20	SENT_192	[p7l1234t109r1290b144],
20	31	CD	NUMBER	31	nsubj	8	SENT_192	[p7l1234t109r1290b144],
21	,	,	O	,	_	0	SENT_192	[p7l1234t109r1290b144],
22	34	CD	NUMBER	34	appos	20	SENT_192	[p7l1309t110r1353b143],
23	,	,	O	,	_	0	SENT_192	[p7l1309t110r1353b143],
24	35	CD	NUMBER	35	num	25	SENT_192	[p7l1372t109r1427b144],
25	)	NN	O	)	appos	22	SENT_192	[p7l1372t109r1427b144],
26	,	,	O	,	_	0	SENT_192	[p7l1372t109r1427b144],
27	which	WDT	O	which	nsubj	28	SENT_192	[p7l1443t108r1538b137],
28	provided	VBD	O	provide	rcmod	22	SENT_192	[p7l1553t108r1691b146],
29	proof	NN	O	proof	dobj	28	SENT_192	[p7l1707t108r1796b146],
30	of	IN	O	of	_	0	SENT_192	[p7l1808t108r1842b137],
31	concept	NN	O	concept	prep_of	29	SENT_192	[p7l1854t116r1977b146],
32	for	IN	O	for	_	0	SENT_192	[p7l1992t108r2037b137],
33	the	DT	O	the	det	34	SENT_192	[p7l2052t108r2101b137],
34	efﬁcacy	NN	O	efﬁcacy	prep_for	28	SENT_192	[p7l583t156r701b195],
35	of	IN	O	of	_	0	SENT_192	[p7l713t156r748b185],
36	integrase	NN	O	integrase	nn	39	SENT_192	[p7l756t158r897b195],
37	strand	NN	O	strand	nn	39	SENT_192	[p7l911t156r1008b185],
38	transfer	NN	O	transfer	nn	39	SENT_192	[p7l1021t156r1142b185],
39	inhibitors	NNS	O	inhibitor	prep_of	34	SENT_192	[p7l1154t156r1306b185],
40	as	IN	O	as	_	0	SENT_192	[p7l1321t167r1349b185],
41	antiretroviral	JJ	O	antiretroviral	amod	42	SENT_192	[p7l1363t156r1569b185],
42	agents	NNS	O	agent	prep_as	28	SENT_192	[p7l1583t164r1681b195],
43	in	FW	O	in	prep	42	SENT_192	[p7l1694t158r1725b185],
44	vivo	FW	O	vivo	pobj	43	SENT_192	[p7l1736t158r1809b185],
45	.	.	O	.	_	0	SENT_192	[p7l1736t158r1809b185],

1	Raltegravir	NNP	O	Raltegravir	nn	3	SENT_193	[p7l1825t156r1999b195],
2	(	CD	NUMBER	(	num	3	SENT_193	[p7l2013t157r2100b193, p7l583t206r618b233],
3	MK05	NN	O	mk05	nsubj	32	SENT_193	[p7l2013t157r2100b193, p7l583t206r618b233],
4	18	CD	NUMBER	18	num	5	SENT_193	[p7l625t205r670b240],
5	)	NN	O	)	dep	3	SENT_193	[p7l625t205r670b240],
6	and	CC	O	and	_	0	SENT_193	[p7l680t204r735b233],
7	elvitegravir	NN	O	elvitegravir	nn	9	SENT_193	[p7l745t204r921b243],
8	(	CD	NUMBER	(	num	9	SENT_193	[p7l930t205r1241b240],
9	GS	NN	O	g	conj_and	3	SENT_193	[p7l930t205r1241b240],
10	—	CD	NUMBER	—	num	11	SENT_193	[p7l930t205r1241b240],
11	9l37	NN	O	9l37	dep	9	SENT_193	[p7l930t205r1241b240],
12	,	,	O	,	_	0	SENT_193	[p7l930t205r1241b240],
13	JTK303	NN	O	jtk303	nn	14	SENT_193	[p7l930t205r1241b240],
14	)	NN	O	)	appos	11	SENT_193	[p7l930t205r1241b240],
15	are	VBP	O	be	cop	32	SENT_193	[p7l1252t215r1298b233],
16	the	DT	O	the	det	32	SENT_193	[p7l1307t204r1356b233],
17	two	CD	NUMBER	two	num	18	SENT_193	[p7l1365t213r1422b233],
18	integrase	NN	O	integrase	amod	32	SENT_193	[p7l1431t206r1572b243],
19	strand	NN	O	strand	nn	21	SENT_193	[p7l1581t204r1678b233],
20	transfer	NN	O	transfer	nn	21	SENT_193	[p7l1687t204r1808b233],
21	inhibitors	NNS	O	inhibitor	dep	18	SENT_193	[p7l1815t204r1968b233],
22	to	TO	O	to	aux	23	SENT_193	[p7l1977t213r2007b233],
23	reach	VB	O	reach	infmod	21	SENT_193	[p7l2017t204r2101b233],
24	advanced	JJ	O	advanced	amod	29	SENT_193	[p7l583t252r727b281],
25	clinical	JJ	O	clinical	amod	29	SENT_193	[p7l743t252r853b281],
26	development	NN	O	development	nn	29	SENT_193	[p7l870t252r1074b290],
27	(	CD	NUMBER	(	number	28	SENT_193	[p7l1089t253r1172b288],
28	36	CD	NUMBER	36	num	29	SENT_193	[p7l1089t253r1172b288],
29	—	NN	O	—	dobj	23	SENT_193	[p7l1089t253r1172b288],
30	3	CD	NUMBER	3	number	31	SENT_193	[p7l1089t253r1172b288],
31	8	CD	NUMBER	8	num	32	SENT_193	[p7l1179t253r1215b288],
32	)	NN	O	)	_	0	SENT_193	[p7l1179t253r1215b288],
33	.	.	O	.	_	0	SENT_193	[p7l1179t253r1215b288],

1	These	DT	O	these	det	2	SENT_194	[p7l1232t252r1330b281],
2	compounds	NNS	O	compound	nsubj	4	SENT_194	[p7l1346t252r1527b290],
3	are	VBP	O	be	cop	4	SENT_194	[p7l1544t263r1590b281],
4	distinct	JJ	O	distinct	_	0	SENT_194	[p7l1607t252r1723b281],
5	from	IN	O	from	_	0	SENT_194	[p7l1738t252r1815b281],
6	either	CC	O	either	preconj	9	SENT_194	[p7l1831t252r1923b281],
7	the	DT	O	the	det	9	SENT_194	[p7l1938t252r1987b281],
8	diketo	JJ	O	diketo	amod	9	SENT_194	[p7l2004t252r2101b281],
9	acids	NNS	O	acid	prep_from	4	SENT_194	[p7l583t300r658b329],
10	or	CC	O	or	_	0	SENT_194	[p7l674t311r707b329],
11	the	DT	O	the	det	12	SENT_194	[p7l721t300r770b329],
12	naphthyridines	NNS	O	naphthyridine	prep_from	4	SENT_194	[p7l784t300r1028b339],
13	,	,	O	,	_	0	SENT_194	[p7l784t300r1028b339],
14	and	CC	O	and	_	0	SENT_194	[p7l1045t300r1100b329],
15	each	DT	O	each	nsubj	23	SENT_194	[p7l1116t300r1185b329],
16	is	VBZ	O	be	cop	23	SENT_194	[p7l1199t301r1222b329],
17	from	IN	O	from	_	0	SENT_194	[p7l1237t300r1313b329],
18	a	DT	O	a	det	20	SENT_194	[p7l1328t311r1342b329],
19	different	JJ	O	different	amod	20	SENT_194	[p7l1358t300r1493b329],
20	chemical	NN	O	chemical	prep_from	23	SENT_194	[p7l1507t300r1645b329],
21	series	NN	O	series	nn	23	SENT_194	[p7l1660t301r1745b329],
22	(	CD	NUMBER	(	num	23	SENT_194	[p7l1761t301r1883b339],
23	Figure	NNP	O	Figure	conj_and	4	SENT_194	[p7l1761t301r1883b339],
24	3	CD	NUMBER	3	num	25	SENT_194	[p7l1899t301r1937b336],
25	)	NN	O	)	dep	23	SENT_194	[p7l1899t301r1937b336],
26	.	.	O	.	_	0	SENT_194	[p7l1899t301r1937b336],

1	Although	IN	O	although	_	0	SENT_195	[p7l1953t300r2101b339],

1	382	CD	NUMBER	382	num	4	SENT_196	[p7l487t408r530b436],
2	Httzuda	NN	O	httzuda	nn	4	SENT_196	[p7l582t407r674b429],
3	o	NN	O	o	nn	4	SENT_196	[p7l689t415r699b425],
4	I71/amato	NN	O	i71/amato	_	0	SENT_196	[p7l713t407r810b429],
5	-	:	O	-	_	0	SENT_196	[p7l826t415r835b425],
6	Wenning	NN	PERSON	wenning	dep	4	SENT_196	[p7l854t407r955b437],

1	>	JJR	O	>	amod	14	SENT_197	[p7l642t512r723b607],
2	/	:	O	/	punct	5	SENT_197	[p7l642t512r723b607],
3	\	NN	O	\	nn	5	SENT_197	[p7l642t512r723b607],
4	o	NN	O	o	nn	5	SENT_197	[p7l642t512r723b607],
5	N	NN	O	n	dep	1	SENT_197	[p7l626t610r651b648],
6	‘	CD	NUMBER	‘	dep	5	SENT_197	[p7l626t610r651b648],
7	/	:	O	/	punct	5	SENT_197	[p7l680t640r711b652],
8	H	NN	O	h	dep	5	SENT_197	[p7l816t612r833b635],
9	N	NN	O	n	dep	10	SENT_197	[p7l653t652r670b675],
10	J	NN	O	j	amod	12	SENT_197	[p7l684t612r808b719],
11	\	NN	O	\	nn	12	SENT_197	[p7l684t612r808b719],
12	H	NN	O	h	dep	8	SENT_197	[p7l684t612r808b719],
13	/	:	O	/	punct	5	SENT_197	[p7l684t612r808b719],
14	N	NN	O	n	_	0	SENT_197	[p7l816t643r833b666],
15	f	FW	O	f	nn	16	SENT_197	[p7l840t620r935b758],
16	|	FW	O	|	amod	14	SENT_197	[p7l1371t665r1374b706],
17	OH	NN	O	oh	dep	14	SENT_197	[p7l1668t655r1709b678],

1	H	NN	O	h	nn	4	SENT_198	[p7l712t796r729b819],
2	OH	NN	O	oh	nn	4	SENT_198	[p7l1719t807r1761b830],
3	N	NN	O	n	nn	4	SENT_198	[p7l712t826r729b849],
4	O	NN	O	o	_	0	SENT_198	[p7l736t792r985b899],
5	Q	NNP	O	Q	dep	4	SENT_198	[p7l1142t836r1166b861],

1	o	NN	O	o	_	0	SENT_199	[p7l762t903r783b927],
2	OH	NN	O	oh	nn	5	SENT_199	[p7l868t905r909b929],
3	F	NN	O	f	nn	5	SENT_199	[p7l1262t894r1275b917],
4	O	NN	O	o	nn	5	SENT_199	[p7l1570t892r1591b915],
5	O	NN	O	o	dep	1	SENT_199	[p7l1674t892r1695b915],

1	MK-0518	NN	O	mk-0518	nn	2	SENT_200	[p7l669t970r817b996],
2	JTK-303	NN	O	jtk-303	_	0	SENT_200	[p7l1309t971r1536b999],
3	/	:	O	/	punct	4	SENT_200	[p7l1309t971r1536b999],
4	G591	NN	O	g591	dep	2	SENT_200	[p7l1309t971r1536b999],
5	37	CD	NUMBER	37	num	4	SENT_200	[p7l1543t972r1582b998],

1	Figure	NNP	O	Figure	_	0	SENT_201	[p7l347t1049r445b1082],
2	3	CD	NUMBER	3	num	4	SENT_201	[p7l457t1050r471b1073],
3	Chemical	NNP	O	Chemical	nn	4	SENT_201	[p7l347t1100r480b1126],
4	structures	NNS	O	structure	dep	1	SENT_201	[p7l490t1107r627b1126],
5	of	IN	O	of	_	0	SENT_201	[p7l637t1100r668b1126],
6	raltegravir	NN	O	raltegravir	nn	9	SENT_201	[p7l674t1100r819b1134],
7	(	CD	NUMBER	(	num	9	SENT_201	[p7l829t1101r986b1132],
8	MK-0518	NN	O	mk-0518	nn	9	SENT_201	[p7l829t1101r986b1132],
9	)	NN	O	)	prep_of	4	SENT_201	[p7l829t1101r986b1132],
10	and	CC	O	and	_	0	SENT_201	[p7l997t1100r1046b1126],
11	elvitegravir	NN	O	elvitegravir	nn	12	SENT_201	[p7l1057t1100r1214b1135],
12	OTK-303	NN	O	otk-303	prep_of	4	SENT_201	[p7l1224t1101r1505b1132],
13	/	:	O	/	punct	1	SENT_201	[p7l1224t1101r1505b1132],
14	GS9137	NN	O	gs9137	nn	15	SENT_201	[p7l1224t1101r1505b1132],
15	)	NN	O	)	dep	1	SENT_201	[p7l1224t1101r1505b1132],
16	.	.	O	.	_	0	SENT_201	[p7l1224t1101r1505b1132],

1	these	DT	O	these	det	2	SENT_202	[p7l347t1194r427b1223],
2	inhibitors	NNS	O	inhibitor	nsubj	3	SENT_202	[p7l442t1194r594b1223],
3	exhibit	VBP	O	exhibit	_	0	SENT_202	[p7l611t1194r718b1223],
4	a	DT	O	a	det	5	SENT_202	[p7l733t1205r747b1223],
5	range	NN	O	range	dobj	3	SENT_202	[p7l763t1205r850b1233],
6	of	IN	O	of	_	0	SENT_202	[p7l866t1194r900b1223],
7	chemical	NN	O	chemical	nn	8	SENT_202	[p7l912t1194r1049b1223],
8	diversity	NN	O	diversity	prep_of	5	SENT_202	[p7l1066t1194r1203b1233],
9	,	,	O	,	_	0	SENT_202	[p7l1066t1194r1203b1233],
10	in	IN	O	in	_	0	SENT_202	[p7l1220t1196r1250b1223],
11	each	DT	O	each	det	12	SENT_202	[p7l1266t1194r1335b1223],
12	case	NN	O	case	prep_in	3	SENT_202	[p7l1351t1205r1413b1223],
13	the	DT	O	the	det	15	SENT_202	[p7l1429t1194r1478b1223],
14	critical	JJ	O	critical	amod	15	SENT_202	[p7l1494t1194r1600b1223],
15	elements	NNS	O	element	nsubjpass	30	SENT_202	[p7l1616t1194r1754b1223],
16	of	IN	O	of	_	0	SENT_202	[p7l1770t1194r1804b1223],
17	the	DT	O	the	det	21	SENT_202	[p7l1816t1194r1864b1223],
18	metal	NN	O	metal	nn	21	SENT_202	[p7l347t1244r571b1283],
19	—	NN	O	—	nn	21	SENT_202	[p7l347t1244r571b1283],
20	binding	NN	O	binding	nn	21	SENT_202	[p7l347t1244r571b1283],
21	pharmacophore	NN	O	pharmacophore	prep_of	15	SENT_202	[p7l581t1244r828b1283],
22	encompassed	VBN	O	encompass	partmod	21	SENT_202	[p7l840t1244r1046b1283],
23	in	IN	O	in	_	0	SENT_202	[p7l1056t1246r1087b1273],
24	the	DT	O	the	det	28	SENT_202	[p7l1098t1244r1146b1273],
25	original	JJ	O	original	amod	28	SENT_202	[p7l1158t1244r1279b1283],
26	diketo	JJ	O	diketo	amod	28	SENT_202	[p7l1291t1244r1387b1273],
27	acid	NN	O	acid	nn	28	SENT_202	[p7l1399t1244r1461b1273],
28	series	NN	O	series	prep_in	22	SENT_202	[p7l1472t1246r1558b1273],
29	are	VBP	O	be	auxpass	30	SENT_202	[p7l1570t1255r1616b1273],
30	preserved	VBN	O	preserve	rcmod	12	SENT_202	[p7l1627t1244r1786b1283],
31	.	.	O	.	_	0	SENT_202	[p7l1627t1244r1786b1283],

1	The	DT	O	the	det	2	SENT_203	[p7l1798t1244r1864b1273],
2	conservation	NN	O	conservation	nsubj	32	SENT_203	[p7l347t1296r546b1324],
3	of	IN	O	of	_	0	SENT_203	[p7l561t1294r596b1324],
4	the	DT	O	the	det	6	SENT_203	[p7l606t1294r655b1324],
5	metal	NN	O	metal	nn	6	SENT_203	[p7l670t1294r757b1324],
6	pharmacophore	NN	O	pharmacophore	prep_of	2	SENT_203	[p7l771t1294r1019b1333],
7	in	IN	O	in	_	0	SENT_203	[p7l1034t1296r1064b1323],
8	these	DT	O	these	det	9	SENT_203	[p7l1079t1294r1159b1324],
9	compounds	NNS	O	compound	prep_in	6	SENT_203	[p7l1174t1294r1363b1333],
10	,	,	O	,	_	0	SENT_203	[p7l1174t1294r1363b1333],
11	particularly	RB	O	particularly	advmod	14	SENT_203	[p7l1379t1294r1560b1333],
12	as	IN	O	as	dep	14	SENT_203	[p7l1574t1305r1602b1324],
13	it	PRP	O	it	nsubj	14	SENT_203	[p7l1617t1296r1640b1324],
14	relates	VBZ	O	relate	dep	2	SENT_203	[p7l1653t1294r1754b1324],
15	to	TO	O	to	_	0	SENT_203	[p7l1770t1303r1800b1324],
16	the	DT	O	the	det	19	SENT_203	[p7l1816t1294r1864b1324],
17	apparent	JJ	O	apparent	amod	19	SENT_203	[p7l347t1363r485b1393],
18	invariant	JJ	O	invariant	amod	19	SENT_203	[p7l500t1356r640b1384],
19	need	NN	O	need	prep_to	14	SENT_203	[p7l655t1354r729b1384],
20	for	IN	O	for	_	0	SENT_203	[p7l746t1355r792b1384],
21	a	DT	O	a	det	23	SENT_203	[p7l808t1366r823b1384],
22	primary	JJ	O	primary	amod	23	SENT_203	[p7l839t1356r965b1394],
23	hydroxyl	NN	O	hydroxyl	prep_for	19	SENT_203	[p7l980t1354r1117b1394],
24	in	IN	O	in	_	0	SENT_203	[p7l1133t1356r1164b1384],
25	all	DT	O	all	det	27	SENT_203	[p7l1181t1354r1216b1384],
26	potent	JJ	O	potent	amod	27	SENT_203	[p7l1233t1363r1336b1393],
27	inhibitors	NNS	O	inhibitor	prep_in	23	SENT_203	[p7l1351t1355r1503b1384],
28	with	IN	O	with	_	0	SENT_203	[p7l1519t1355r1589b1384],
29	this	DT	O	this	det	30	SENT_203	[p7l1605t1355r1661b1384],
30	mechanism	NN	O	mechanism	prep_with	27	SENT_203	[p7l1678t1354r1863b1390],
31	,	,	O	,	_	0	SENT_203	[p7l1678t1354r1863b1390],
32	makes	VBZ	O	make	_	0	SENT_203	[p7l347t1405r442b1434],
33	all	DT	O	all	det	37	SENT_203	[p7l453t1405r489b1434],
34	integrase	NN	O	integrase	nn	37	SENT_203	[p7l498t1406r639b1443],
35	strand	NN	O	strand	nn	37	SENT_203	[p7l650t1405r746b1434],
36	transfer	NN	O	transfer	nn	37	SENT_203	[p7l756t1405r877b1434],
37	inhibitors	NNS	O	inhibitor	dobj	32	SENT_203	[p7l886t1405r1038b1434],
38	subject	JJ	O	subject	amod	37	SENT_203	[p7l1049t1405r1158b1443],
39	to	TO	O	to	_	0	SENT_203	[p7l1167t1413r1197b1434],
40	extensive	JJ	O	extensive	amod	41	SENT_203	[p7l1208t1406r1349b1434],
41	metabolism	NN	O	metabolism	prep_to	38	SENT_203	[p7l1359t1405r1542b1434],
42	via	IN	O	via	_	0	SENT_203	[p7l1550t1406r1594b1434],
43	glucuronidation	NN	O	glucuronidation	prep_via	41	SENT_203	[p7l1604t1405r1863b1443],
44	.	.	O	.	_	0	SENT_203	[p7l1604t1405r1863b1443],

1	PHARMACOKINETICS	NNS	O	pharmacokinetic	_	0	SENT_204	[p7l346t1531r832b1563],
2	AND	CC	O	and	_	0	SENT_204	[p7l844t1531r944b1563],
3	DRUG	NN	O	drug	conj_and	1	SENT_204	[p7l958t1531r1093b1563],
4	METABOLISM	NN	O	metabolism	dep	1	SENT_204	[p7l1104t1531r1412b1563],

1	The	DT	O	the	det	3	SENT_205	[p7l346t1600r412b1629],
2	clinical	JJ	O	clinical	amod	3	SENT_205	[p7l420t1600r530b1629],
3	pharmacokinetics	NNS	O	pharmacokinetic	nsubj	8	SENT_205	[p7l538t1600r813b1639],
4	of	IN	O	of	_	0	SENT_205	[p7l821t1600r855b1629],
5	raltegravir	NN	O	raltegravir	prep_of	3	SENT_205	[p7l858t1600r1022b1639],
6	and	CC	O	and	_	0	SENT_205	[p7l1029t1600r1084b1629],
7	elvitegravir	NN	O	elvitegravir	prep_of	3	SENT_205	[p7l1093t1600r1269b1639],
8	differ	VBP	O	differ	_	0	SENT_205	[p7l1276t1600r1361b1629],
9	based	VBN	O	base	_	0	SENT_205	[p7l1367t1600r1454b1629],
10	on	IN	O	on	prepc_based_on	8	SENT_205	[p7l1462t1611r1501b1629],
11	the	DT	O	the	det	13	SENT_205	[p7l1508t1600r1557b1629],
12	distinct	JJ	O	distinct	amod	13	SENT_205	[p7l1565t1600r1681b1629],
13	absorption	NN	O	absorption	pobj	8	SENT_205	[p7l1688t1600r1863b1639],
14	,	,	O	,	_	0	SENT_205	[p7l1688t1600r1863b1639],
15	distribution	NN	O	distribution	pobj	8	SENT_205	[p7l347t1650r539b1685],
16	,	,	O	,	_	0	SENT_205	[p7l347t1650r539b1685],
17	metabolism	NN	O	metabolism	pobj	8	SENT_205	[p7l549t1650r739b1686],
18	,	,	O	,	_	0	SENT_205	[p7l549t1650r739b1686],
19	and	CC	O	and	_	0	SENT_205	[p7l750t1650r805b1679],
20	excretion	NN	O	excretion	nn	21	SENT_205	[p7l815t1652r959b1679],
21	pathways	NNS	O	pathway	pobj	8	SENT_205	[p7l967t1650r1110b1689],
22	of	IN	O	of	_	0	SENT_205	[p7l1119t1650r1154b1679],
23	the	DT	O	the	det	25	SENT_205	[p7l1158t1650r1207b1679],
24	two	CD	NUMBER	two	num	25	SENT_205	[p7l1216t1658r1273b1679],
25	compounds	NNS	O	compound	prep_of	21	SENT_205	[p7l1282t1650r1463b1689],
26	and	CC	O	and	_	0	SENT_205	[p7l1472t1650r1528b1679],
27	thus	RB	O	thus	advmod	30	SENT_205	[p7l1537t1650r1602b1679],
28	will	MD	O	will	aux	30	SENT_205	[p7l1610t1650r1667b1679],
29	be	VB	O	be	auxpass	30	SENT_205	[p7l1675t1650r1711b1679],
30	discussed	VBN	O	discuss	conj_and	8	SENT_205	[p7l1721t1650r1865b1679],
31	separately	RB	O	separately	advmod	30	SENT_205	[p7l347t1700r504b1738],
32	below	IN	O	below	prep	30	SENT_205	[p7l513t1699r611b1729],
33	.	.	O	.	_	0	SENT_205	[p7l513t1699r611b1729],

1	Raltegravir	NNP	O	Raltegravir	nn	3	SENT_206	[p7l346t1833r557b1876],
2	Pharmacokinetics	NNP	O	Pharmacokinetics	nn	3	SENT_206	[p7l569t1833r905b1866],
3	Raltegravir	NNP	O	Raltegravir	nsubj	8	SENT_206	[p7l347t1903r522b1942],
4	is	VBZ	O	be	cop	8	SENT_206	[p7l534t1905r557b1932],
5	an	DT	O	a	det	8	SENT_206	[p7l571t1914r607b1932],
6	orally	RB	O	orally	advmod	7	SENT_206	[p7l620t1903r710b1942],
7	administered	VBN	O	administer	amod	8	SENT_206	[p7l722t1903r925b1932],
8	drug	NN	O	drug	_	0	SENT_206	[p7l939t1903r1012b1942],
9	that	WDT	O	that	nsubjpass	12	SENT_206	[p7l1025t1903r1086b1932],
10	is	VBZ	O	be	auxpass	12	SENT_206	[p7l1098t1905r1121b1932],
11	rapidly	RB	O	rapidly	advmod	12	SENT_206	[p7l1135t1903r1245b1942],
12	absorbed	VBN	O	absorb	ccomp	8	SENT_206	[p7l1257t1903r1398b1932],
13	with	IN	O	with	_	0	SENT_206	[p7l1410t1903r1480b1932],
14	a	DT	O	a	det	15	SENT_206	[p7l1494t1914r1508b1932],
15	time	NN	O	time	prep_with	12	SENT_206	[p7l1522t1905r1591b1932],
16	to	TO	O	to	_	0	SENT_206	[p7l1605t1912r1636b1932],
17	maximal	JJ	O	maximal	amod	18	SENT_206	[p7l1649t1903r1781b1932],
18	concentration	NN	O	concentration	prep_to	12	SENT_206	[p7l1795t1914r1864b1932, p7l347t1954r507b1982],
19	of	IN	O	of	_	0	SENT_206	[p7l521t1953r555b1982],
20	approximately	RB	O	approximately	quantmod	21	SENT_206	[p7l565t1953r789b1992],
21	three	CD	DURATION	three	num	22	SENT_206	[p7l801t1953r881b1982],
22	hours	NNS	NUMBER	hour	prep_of	18	SENT_206	[p7l894t1953r982b1982],
23	when	WRB	O	when	advmod	24	SENT_206	[p7l995t1953r1080b1982],
24	administered	VBN	O	administer	advcl	12	SENT_206	[p7l1093t1953r1296b1982],
25	in	IN	O	in	_	0	SENT_206	[p7l1309t1954r1340b1981],
26	the	DT	O	the	det	28	SENT_206	[p7l1353t1953r1401b1982],
27	fasted	JJ	O	fasted	amod	28	SENT_206	[p7l1415t1953r1506b1982],
28	state	NN	O	state	prep_in	24	SENT_206	[p7l1519t1961r1598b1982],
29	.	.	O	.	_	0	SENT_206	[p7l1519t1961r1598b1982],

1	Raltegravir	NNP	O	Raltegravir	nn	2	SENT_207	[p7l1614t1953r1788b1992],
2	area	NN	O	area	_	0	SENT_207	[p7l1802t1964r1865b1982],
3	under	IN	O	under	_	0	SENT_207	[p7l346t2003r439b2032],
4	the	DT	O	the	det	9	SENT_207	[p7l449t2003r498b2032],
5	concentration-time	JJ	O	concentration-time	amod	9	SENT_207	[p7l509t2004r812b2032],
6	curve	NN	O	curve	nn	9	SENT_207	[p7l824t2014r907b2032],
7	(	CD	NUMBER	(	num	9	SENT_207	[p7l919t2004r1024b2039],
8	AUC	NN	O	auc	nn	9	SENT_207	[p7l919t2004r1024b2039],
9	)	NN	O	)	prep_under	2	SENT_207	[p7l919t2004r1024b2039],
10	and	CC	O	and	_	0	SENT_207	[p7l1036t2003r1092b2032],
11	maximal	JJ	O	maximal	amod	17	SENT_207	[p7l1102t2003r1234b2032],
12	concentration	NN	O	concentration	nn	17	SENT_207	[p7l1245t2004r1463b2032],
13	(	NN	O	(	nn	17	SENT_207	[p7l1474t2004r1568b2039],
14	Cmax	NN	O	cmax	nn	17	SENT_207	[p7l1474t2004r1568b2039],
15	)	CD	NUMBER	)	num	17	SENT_207	[p7l1474t2004r1568b2039],
16	increase	NN	O	increase	nn	17	SENT_207	[p7l1579t2004r1705b2032],
17	dose	NN	O	dose	prep_under	2	SENT_207	[p7l1717t2003r1786b2032],
18	proportionally	RB	O	proportionally	advmod	2	SENT_207	[p7l1797t2014r1864b2041, p7l347t2052r521b2091],
19	from	IN	O	from	_	0	SENT_207	[p7l530t2052r606b2081],
20	100	CD	NUMBER	100	number	22	SENT_207	[p7l621t2054r674b2081],
21	to	TO	O	to	dep	22	SENT_207	[p7l685t2061r716b2081],
22	1600	CD	DATE	1600	num	23	SENT_207	[p7l731t2054r803b2081],
23	mg	NN	O	mg	prep_from	2	SENT_207	[p7l815t2063r872b2091],
24	.	.	O	.	_	0	SENT_207	[p7l815t2063r872b2091],

1	Raltegravir	NN	O	raltegravir	nn	3	SENT_208	[p7l885t2052r1060b2091],
2	trough	NN	O	trough	nn	3	SENT_208	[p7l1070t2052r1176b2091],
3	concentration	NN	O	concentration	nsubj	24	SENT_208	[p7l1188t2054r1405b2081],
4	or	CC	O	or	_	0	SENT_208	[p7l1417t2063r1450b2081],
5	concentration	NN	O	concentration	conj_or	3	SENT_208	[p7l1461t2054r1679b2081],
6	at	IN	O	at	_	0	SENT_208	[p7l1690t2061r1718b2081],
7	12	CD	DURATION	12	num	8	SENT_208	[p7l1732t2054r1763b2081],
8	hours	NNS	NUMBER	hour	npadvmod	9	SENT_208	[p7l1776t2052r1864b2081],
9	postdose	JJ	O	postdose	amod	13	SENT_208	[p7l347t2102r483b2140],
10	(	NN	O	(	nn	13	SENT_208	[p7l493t2103r555b2138],
11	C12	NN	O	c12	nn	13	SENT_208	[p7l493t2103r555b2138],
12	hr	NN	DURATION	hr	nn	13	SENT_208	[p7l562t2103r598b2138],
13	)	NN	O	)	prep_at	5	SENT_208	[p7l562t2103r598b2138],
14	increases	VBZ	O	increase	_	0	SENT_208	[p7l607t2104r747b2131],
15	dose	NN	O	dose	dobj	14	SENT_208	[p7l757t2102r826b2131],
16	proportionally	RB	O	proportionally	advmod	14	SENT_208	[p7l835t2102r1064b2141],
17	from	IN	O	from	_	0	SENT_208	[p7l1072t2102r1148b2131],
18	100	CD	NUMBER	100	number	20	SENT_208	[p7l1161t2104r1213b2131],
19	to	TO	NUMBER	to	dep	20	SENT_208	[p7l1223t2110r1254b2131],
20	800	CD	NUMBER	800	num	21	SENT_208	[p7l1265t2104r1319b2131],
21	mg	NN	O	mg	prep_from	14	SENT_208	[p7l1329t2113r1379b2141],
22	and	CC	O	and	_	0	SENT_208	[p7l1388t2102r1444b2131],
23	slightly	RB	O	slightly	advmod	24	SENT_208	[p7l1453t2102r1569b2141],
24	less	JJR	O	less	conj_and	14	SENT_208	[p7l1576t2102r1630b2131],
25	than	IN	O	than	_	0	SENT_208	[p7l1639t2102r1709b2131],
26	dose	NN	O	dose	prep_than	24	SENT_208	[p7l1718t2102r1787b2131],
27	proportionally	RB	O	proportionally	advmod	24	SENT_208	[p7l1797t2113r1864b2140, p7l346t2152r521b2191],
28	from	IN	O	from	_	0	SENT_208	[p7l531t2152r607b2181],
29	100	CD	NUMBER	100	number	31	SENT_208	[p7l622t2154r674b2181],
30	to	TO	O	to	dep	31	SENT_208	[p7l687t2160r717b2181],
31	1600	CD	DATE	1600	num	32	SENT_208	[p7l733t2154r805b2181],
32	mg	NN	O	mg	prep_from	24	SENT_208	[p7l817t2163r874b2191],
33	.	.	O	.	_	0	SENT_208	[p7l817t2163r874b2191],

1	The	DT	O	the	det	4	SENT_209	[p7l887t2152r953b2181],
2	apparent	JJ	O	apparent	amod	3	SENT_209	[p7l965t2160r1103b2190],
3	terminal	JJ	O	terminal	amod	4	SENT_209	[p7l1114t2152r1246b2181],
4	half-life	NN	O	half-life	nsubj	10	SENT_209	[p7l1257t2152r1379b2181],
5	of	IN	O	of	_	0	SENT_209	[p7l1392t2152r1426b2181],
6	raltegravir	NN	O	raltegravir	prep_of	4	SENT_209	[p7l1433t2152r1597b2191],
7	is	VBZ	O	be	cop	10	SENT_209	[p7l1607t2154r1630b2181],
8	approximately	RB	O	approximately	quantmod	9	SENT_209	[p7l1642t2152r1866b2191],
9	nine	CD	DURATION	nine	num	10	SENT_209	[p7l346t2203r414b2231],
10	hours	NNS	NUMBER	hour	_	0	SENT_209	[p7l424t2202r520b2237],
11	,	,	O	,	_	0	SENT_209	[p7l424t2202r520b2237],
12	with	IN	O	with	_	0	SENT_209	[p7l530t2202r600b2231],
13	a	DT	O	a	det	16	SENT_209	[p7l609t2213r624b2231],
14	shorter	JJR	O	shorter	amod	16	SENT_209	[p7l633t2202r746b2231],
15	oc-phase	NN	O	oc-phase	nn	16	SENT_209	[p7l757t2202r881b2240],
16	half-life	NN	O	half-life	prep_with	10	SENT_209	[p7l890t2202r1012b2231],
17	of	IN	O	of	_	0	SENT_209	[p7l1023t2202r1057b2231],
18	approximately	RB	O	approximately	quantmod	19	SENT_209	[p7l1062t2202r1286b2240],
19	one	CD	DURATION	one	num	21	SENT_209	[p7l1294t2213r1350b2231],
20	hour	NN	NUMBER	hour	nn	21	SENT_209	[p7l1360t2202r1435b2231],
21	accounting	NN	O	accounting	prep_of	16	SENT_209	[p7l1444t2203r1617b2240],
22	for	IN	O	for	_	0	SENT_209	[p7l1625t2202r1671b2231],
23	much	JJ	O	much	amod	30	SENT_209	[p7l1679t2202r1767b2231],
24	of	IN	O	of	_	0	SENT_209	[p7l1776t2202r1811b2231],
25	the	DT	O	the	det	27	SENT_209	[p7l1816t2202r1864b2231],
26	AUC	NN	O	auc	nn	27	SENT_209	[p7l345t2253r429b2281],
27	(	NN	O	(	prep_of	23	SENT_209	[p7l440t2252r465b2288],
28	3	CD	NUMBER	3	number	29	SENT_209	[p7l440t2252r465b2288],
29	9	CD	NUMBER	9	amod	30	SENT_209	[p7l471t2253r508b2288],
30	)	NN	O	)	prep_for	21	SENT_209	[p7l471t2253r508b2288],
31	.	.	O	.	_	0	SENT_209	[p7l471t2253r508b2288],

1	Typical	JJ	O	typical	amod	3	SENT_210	[p7l518t2252r633b2290],
2	concentration-time	JJ	O	concentration-time	amod	3	SENT_210	[p7l643t2253r946b2281],
3	proﬁles	NNS	O	proﬁles	nsubjpass	12	SENT_210	[p7l955t2252r1071b2290],
4	following	VBG	O	follow	_	0	SENT_210	[p7l1081t2251r1230b2290],
5	single	JJ	O	single	amod	8	SENT_210	[p7l1239t2251r1414b2290],
6	—	NN	O	—	nn	8	SENT_210	[p7l1239t2251r1414b2290],
7	dose	NN	O	dose	nn	8	SENT_210	[p7l1239t2251r1414b2290],
8	administration	NN	O	administration	prep_following	3	SENT_210	[p7l1425t2251r1653b2281],
9	of	IN	O	of	_	0	SENT_210	[p7l1663t2252r1697b2281],
10	raltegravir	NN	O	raltegravir	prep_of	8	SENT_210	[p7l1702t2252r1865b2290],
11	are	VBP	O	be	auxpass	12	SENT_210	[p7l347t2312r393b2330],
12	shown	VBN	O	show	_	0	SENT_210	[p7l403t2301r503b2330],
13	in	IN	O	in	_	0	SENT_210	[p7l512t2303r542b2330],
14	Figure	NNP	O	Figure	prep_in	12	SENT_210	[p7l551t2303r662b2340],
15	4	CD	NUMBER	4	num	14	SENT_210	[p7l672t2303r700b2330],
16	.	.	O	.	_	0	SENT_210	[p7l672t2303r700b2330],

1	The	DT	O	the	det	3	SENT_211	[p7l709t2301r776b2330],
2	therapeutic	JJ	O	therapeutic	amod	3	SENT_211	[p7l786t2301r963b2340],
3	dose	NN	O	dose	nsubj	8	SENT_211	[p7l972t2301r1041b2330],
4	and	CC	O	and	_	0	SENT_211	[p7l1051t2301r1106b2330],
5	schedule	NN	O	schedule	conj_and	3	SENT_211	[p7l1116t2301r1250b2330],
6	is	VBZ	O	be	cop	8	SENT_211	[p7l1259t2303r1282b2330],
7	400	CD	NUMBER	400	num	8	SENT_211	[p7l1291t2303r1348b2331],
8	mg	NN	O	mg	_	0	SENT_211	[p7l1357t2312r1408b2340],
9	administered	VBN	O	administer	partmod	8	SENT_211	[p7l1416t2301r1619b2330],
10	twice	RB	O	twice	advmod	9	SENT_211	[p7l1628t2303r1709b2330],
11	daily	RB	SET	daily	advmod	9	SENT_211	[p7l1720t2301r1798b2340],
12	,	,	O	,	_	0	SENT_211	[p7l1720t2301r1798b2340],
13	and	CC	O	and	_	0	SENT_211	[p7l1809t2301r1865b2330],
14	steady	JJ	O	steady	amod	15	SENT_211	[p7l347t2351r445b2390],
15	state	NN	O	state	nsubjpass	17	SENT_211	[p7l452t2360r523b2380],
16	is	VBZ	O	be	auxpass	17	SENT_211	[p7l531t2353r554b2380],
17	achieved	VBN	O	achieve	conj_and	8	SENT_211	[p7l563t2351r697b2380],
18	rapidly	RB	O	rapidly	advmod	17	SENT_211	[p7l705t2351r816b2390],
19	within	IN	O	within	_	0	SENT_211	[p7l821t2351r922b2380],
20	approximately	RB	O	approximately	quantmod	21	SENT_211	[p7l931t2351r1155b2390],
21	two	CD	DURATION	two	num	22	SENT_211	[p7l1161t2359r1218b2380],
22	days	NNS	NUMBER	day	prep_within	17	SENT_211	[p7l1228t2351r1302b2390],
23	.	.	O	.	_	0	SENT_211	[p7l1228t2351r1302b2390],

1	There	EX	O	there	expl	2	SENT_212	[p7l1311t2351r1409b2380],
2	is	VBZ	O	be	_	0	SENT_212	[p7l1418t2353r1440b2380],
3	little	JJ	O	little	acomp	2	SENT_212	[p7l1449t2351r1521b2380],
4	to	TO	O	to	_	0	SENT_212	[p7l1529t2359r1560b2380],
5	no	DT	O	no	det	6	SENT_212	[p7l1568t2362r1608b2380],
6	accumulation	NN	O	accumulation	prep_to	3	SENT_212	[p7l1617t2351r1827b2380],
7	in	IN	O	in	_	0	SENT_212	[p7l1835t2353r1865b2380],
8	AUC	NN	O	auc	nn	11	SENT_212	[p7l346t2401r429b2429],
9	and	CC	O	and	_	0	SENT_212	[p7l440t2400r495b2429],
10	Cm	NN	O	cm	nn	11	SENT_212	[p7l506t2401r585b2435],
11	”	NN	O	”	prep_in	6	SENT_212	[p7l506t2401r585b2435],
12	,	,	O	,	_	0	SENT_212	[p7l506t2401r585b2435],
13	and	CC	O	and	_	0	SENT_212	[p7l596t2400r652b2429],
14	modest	JJ	O	modest	amod	15	SENT_212	[p7l661t2400r776b2429],
15	accumulation	NN	O	accumulation	conj_and	6	SENT_212	[p7l785t2400r995b2429],
16	in	IN	O	in	_	0	SENT_212	[p7l1004t2402r1034b2429],
17	C121	NN	O	c121	prep_in	15	SENT_212	[p7l1044t2401r1125b2434],
18	,	,	O	,	_	0	SENT_212	[p7l1044t2401r1125b2434],
19	,	,	O	,	_	0	SENT_212	[p7l1044t2401r1125b2434],
20	(	CD	PERCENT	(	number	21	SENT_212	[p7l1136t2401r1221b2436],
21	3	CD	PERCENT	3	num	22	SENT_212	[p7l1136t2401r1221b2436],
22	%	NN	PERCENT	%	appos	6	SENT_212	[p7l1136t2401r1221b2436],
23	)	CD	NUMBER	)	tmod	3	SENT_212	[p7l1136t2401r1221b2436],
24	.	.	O	.	_	0	SENT_212	[p7l1136t2401r1221b2436],

1	In	IN	O	in	_	0	SENT_213	[p7l1232t2401r1266b2429],
2	HIV-1-infected	JJ	O	hiv-1-infected	amod	3	SENT_213	[p7l1275t2400r1520b2429],
3	patients	NNS	O	patient	pobj	1	SENT_213	[p7l1529t2402r1651b2438],
4	administered	VBN	O	administer	partmod	3	SENT_213	[p7l1662t2400r1865b2429],
5	400	CD	NUMBER	400	num	7	SENT_213	[p7l346t2451r403b2478],
6	mg	NN	O	mg	nn	7	SENT_213	[p7l411t2460r461b2488],
7	raltegravir	NN	O	raltegravir	dobj	4	SENT_213	[p7l472t2449r635b2488],
8	twice	RB	O	twice	advmod	4	SENT_213	[p7l647t2450r728b2478],
9	daily	RB	SET	daily	advmod	4	SENT_213	[p7l741t2449r816b2488],
10	as	IN	O	as	_	0	SENT_213	[p7l827t2460r855b2478],
11	monotherapy	NN	O	monotherapy	prep_as	4	SENT_213	[p7l867t2449r1083b2488],
12	,	,	O	,	_	0	SENT_213	[p7l867t2449r1083b2488],
13	a	DT	O	a	det	17	SENT_213	[p7l1097t2460r1111b2478],
14	geometric	JJ	O	geometric	amod	17	SENT_213	[p7l1124t2450r1281b2488],
15	mean	NN	O	mean	nn	17	SENT_213	[p7l1293t2460r1378b2478],
16	AUC0_12	NN	O	auc0_12	nn	17	SENT_213	[p7l1388t2450r1529b2484],
17	hr	NN	DURATION	hr	dobj	4	SENT_213	[p7l1536t2464r1559b2483],
18	of	IN	O	of	_	0	SENT_213	[p7l1573t2449r1607b2478],
19	14.3	CD	NUMBER	14.3	num	20	SENT_213	[p7l1619t2451r1678b2478],
20	|	NN	O	|	prep_of	17	SENT_213	[p7l1696t2449r1797b2485],
21	.	.	O	.	_	0	SENT_213	[p7l1696t2449r1797b2485],

1	LM-hr	NN	O	lm-hr	nn	4	SENT_214	[p7l1696t2449r1797b2485],
2	and	CC	O	and	_	0	SENT_214	[p7l1809t2449r1865b2478],
3	C12	NN	O	c12	nn	4	SENT_214	[p7l348t2499r398b2533],
4	hr	NN	DURATION	hr	nsubjpass	9	SENT_214	[p7l405t2513r428b2533],
5	of	IN	O	of	_	0	SENT_214	[p7l441t2498r475b2528],
6	142	CD	NUMBER	142	num	7	SENT_214	[p7l486t2500r536b2528],
7	nl\/I	NN	O	nl\/i	prep_of	4	SENT_214	[p7l549t2500r606b2527],
8	were	VBD	O	be	auxpass	9	SENT_214	[p7l615t2509r690b2528],
9	characterized	VBN	O	characterize	_	0	SENT_214	[p7l702t2498r910b2528],
10	(	NN	O	(	nn	12	SENT_214	[p7l922t2499r990b2535],
11	38	CD	NUMBER	38	num	12	SENT_214	[p7l922t2499r990b2535],
12	)	NN	O	)	dobj	9	SENT_214	[p7l922t2499r990b2535],
13	.	.	O	.	_	0	SENT_214	[p7l922t2499r990b2535],

1	Raltegravir	NNP	O	Raltegravir	nsubjpass	3	SENT_215	[p7l397t2548r571b2587],
2	is	VBZ	O	be	auxpass	3	SENT_215	[p7l585t2550r607b2577],
3	administered	VBN	O	administer	_	0	SENT_215	[p7l623t2548r825b2577],
4	without	IN	O	without	_	0	SENT_215	[p7l839t2548r962b2577],
5	regard	NN	O	regard	prep_without	3	SENT_215	[p7l975t2548r1076b2587],
6	to	TO	O	to	_	0	SENT_215	[p7l1090t2556r1121b2577],
7	food	NN	O	food	prep_to	3	SENT_215	[p7l1135t2548r1214b2584],
8	,	,	O	,	_	0	SENT_215	[p7l1135t2548r1214b2584],
9	although	IN	O	although	mark	13	SENT_215	[p7l1230t2548r1369b2587],
10	food	NN	O	food	nsubjpass	13	SENT_215	[p7l1383t2548r1453b2577],
11	has	VBZ	O	have	aux	13	SENT_215	[p7l1467t2548r1517b2577],
12	been	VBN	O	be	auxpass	13	SENT_215	[p7l1532t2548r1606b2577],
13	shown	VBN	O	show	advcl	3	SENT_215	[p7l1620t2548r1720b2577],
14	to	TO	O	to	aux	15	SENT_215	[p7l1734t2556r1765b2577],
15	affect	VB	O	affect	xcomp	13	SENT_215	[p7l1780t2548r1866b2577],
16	the	DT	O	the	det	21	SENT_215	[p7l347t2597r396b2626],
17	pharmacokinetic	JJ	O	pharmacokinetic	amod	21	SENT_215	[p7l412t2597r674b2636],
18	proﬁle	NN	O	proﬁle	nn	21	SENT_215	[p7l689t2597r792b2636],
19	(	NN	O	(	nn	21	SENT_215	[p7l809t2598r877b2634],
20	41	CD	NUMBER	41	num	21	SENT_215	[p7l809t2598r877b2634],
21	)	NN	O	)	dobj	15	SENT_215	[p7l809t2598r877b2634],
22	.	.	O	.	_	0	SENT_215	[p7l809t2598r877b2634],

1	Varying	JJ	O	varying	amod	3	SENT_216	[p7l893t2599r1018b2636],
2	meal	NN	O	meal	nn	3	SENT_216	[p7l1033t2597r1107b2626],
3	types	NNS	O	type	nsubj	9	SENT_216	[p7l1124t2606r1203b2636],
4	differing	VBG	O	differ	partmod	3	SENT_216	[p7l1220t2597r1356b2636],
5	in	IN	O	in	_	0	SENT_216	[p7l1371t2599r1401b2626],
6	fat	JJ	O	fat	amod	7	SENT_216	[p7l1417t2597r1457b2626],
7	content	NN	O	content	prep_in	4	SENT_216	[p7l1473t2606r1592b2626],
8	have	VBP	O	have	aux	9	SENT_216	[p7l1607t2597r1678b2626],
9	resulted	VBN	O	result	dep	18	SENT_216	[p7l1694t2597r1819b2626],
10	in	IN	O	in	_	0	SENT_216	[p7l1835t2599r1865b2626],
11	increases	NNS	O	increase	prep_in	9	SENT_216	[p7l346t2648r486b2676],
12	and	CC	O	and	_	0	SENT_216	[p7l498t2646r553b2676],
13	decreases	VBZ	O	decrease	conj_and	9	SENT_216	[p7l565t2646r710b2676],
14	in	IN	O	in	_	0	SENT_216	[p7l721t2648r752b2675],
15	raltegravir	NN	O	raltegravir	nn	17	SENT_216	[p7l763t2646r926b2685],
16	plasma	NN	O	plasma	nn	17	SENT_216	[p7l936t2646r1044b2685],
17	concentrations	NNS	O	concentration	prep_in	13	SENT_216	[p7l1055t2648r1286b2676],
18	(	VBP	O	(	_	0	SENT_216	[p7l1298t2647r1393b2683],
19	D.M.	NNP	PERSON	D.M.	nn	20	SENT_216	[p7l1298t2647r1393b2683],
20	Brainard	NNP	PERSON	Brainard	nsubj	18	SENT_216	[p7l1406t2646r1550b2682],
21	,	,	O	,	_	0	SENT_216	[p7l1406t2646r1550b2682],
22	L.A.	NNP	PERSON	L.A.	nn	23	SENT_216	[p7l1563t2647r1630b2675],
23	Wenning	NNP	PERSON	Wenning	nsubj	18	SENT_216	[p7l1641t2648r1796b2685],
24	,	,	O	,	_	0	SENT_216	[p7l1641t2648r1796b2685],
25	and	CC	O	and	_	0	SENT_216	[p7l1809t2646r1864b2676],
26	M.	NNP	PERSON	M.	nn	27	SENT_216	[p7l345t2697r389b2725],
27	Iwamoto	NNP	PERSON	Iwamoto	conj_and	20	SENT_216	[p7l403t2697r550b2731],
28	,	,	O	,	_	0	SENT_216	[p7l403t2697r550b2731],
29	unpublished	JJ	O	unpublished	amod	31	SENT_216	[p7l563t2696r756b2734],
30	data	NNS	O	datum	nn	31	SENT_216	[p7l768t2696r852b2732],
31	)	NN	O	)	appos	27	SENT_216	[p7l768t2696r852b2732],
32	.	.	O	.	_	0	SENT_216	[p7l768t2696r852b2732],

1	Overall	RB	O	overall	advmod	8	SENT_217	[p7l866t2696r990b2731],
2	,	,	O	,	_	0	SENT_217	[p7l866t2696r990b2731],
3	the	DT	O	the	det	5	SENT_217	[p7l1003t2696r1052b2725],
4	food-effect	JJ	O	food-effect	amod	5	SENT_217	[p7l1064t2696r1237b2725],
5	studies	NNS	O	study	nsubj	8	SENT_217	[p7l1248t2696r1354b2725],
6	have	VBP	O	have	aux	8	SENT_217	[p7l1366t2696r1436b2725],
7	not	RB	O	not	neg	8	SENT_217	[p7l1448t2704r1502b2725],
8	resulted	VBN	O	result	_	0	SENT_217	[p7l1512t2696r1637b2725],
9	in	IN	O	in	_	0	SENT_217	[p7l1648t2698r1679b2725],
10	predictable	JJ	O	predictable	amod	11	SENT_217	[p7l1690t2696r1864b2734],
11	changes	NNS	O	change	prep_in	8	SENT_217	[p7l347t2745r470b2784],
12	secondary	JJ	O	secondary	amod	11	SENT_217	[p7l483t2745r640b2784],
13	to	TO	O	to	_	0	SENT_217	[p7l650t2754r681b2774],
14	food	NN	O	food	prep_to	12	SENT_217	[p7l693t2745r772b2774],
15	.	.	O	.	_	0	SENT_217	[p7l693t2745r772b2774],

1	In	IN	O	in	_	0	SENT_218	[p7l785t2747r818b2774],
2	the	DT	O	the	det	4	SENT_218	[p7l830t2745r879b2774],
3	pivotal	JJ	O	pivotal	amod	4	SENT_218	[p7l891t2745r997b2784],
4	phase	NN	O	phase	prep_in	10	SENT_218	[p7l1008t2745r1095b2784],
5	III	CD	NUMBER	iii	num	6	SENT_218	[p7l1107t2747r1148b2774],
6	studies	NNS	O	study	dep	4	SENT_218	[p7l1159t2745r1274b2780],
7	,	,	O	,	_	0	SENT_218	[p7l1159t2745r1274b2780],
8	raltegravir	NN	O	raltegravir	nsubjpass	10	SENT_218	[p7l1287t2745r1450b2784],
9	was	VBD	O	be	auxpass	10	SENT_218	[p7l1460t2756r1516b2774],
10	administered	VBN	O	administer	_	0	SENT_218	[p7l1529t2745r1732b2774],
11	without	IN	O	without	_	0	SENT_218	[p7l1742t2745r1866b2774],
12	regard	NN	O	regard	prep_without	10	SENT_218	[p7l347t2794r448b2833],
13	to	TO	O	to	_	0	SENT_218	[p7l459t2802r490b2823],
14	food	NN	O	food	prep_to	10	SENT_218	[p7l501t2794r580b2823],
15	.	.	O	.	_	0	SENT_218	[p7l501t2794r580b2823],

1	Overall	RB	O	overall	advmod	16	SENT_219	[p7l593t2794r717b2830],
2	,	,	O	,	_	0	SENT_219	[p7l593t2794r717b2830],
3	the	DT	O	the	det	5	SENT_219	[p7l729t2794r778b2823],
4	pharmacokinetic	JJ	O	pharmacokinetic	amod	5	SENT_219	[p7l789t2794r1051b2833],
5	variability	NN	O	variability	nsubjpass	16	SENT_219	[p7l1061t2794r1219b2833],
6	resulting	VBG	O	result	partmod	5	SENT_219	[p7l1229t2794r1367b2833],
7	from	IN	O	from	_	0	SENT_219	[p7l1378t2794r1454b2823],
8	ingestion	NN	O	ingestion	prep_from	6	SENT_219	[p7l1464t2796r1609b2833],
9	with	IN	O	with	_	0	SENT_219	[p7l1619t2794r1688b2823],
10	or	CC	O	or	_	0	SENT_219	[p7l1700t2805r1733b2823],
11	without	IN	O	without	_	0	SENT_219	[p7l1742t2794r1866b2823],
12	food	NN	O	food	prep_without	6	SENT_219	[p7l347t2844r417b2873],
13	has	VBZ	O	have	aux	16	SENT_219	[p7l428t2844r478b2873],
14	not	RB	O	not	neg	16	SENT_219	[p7l489t2852r542b2873],
15	been	VBN	O	be	auxpass	16	SENT_219	[p7l552t2844r626b2873],
16	shown	VBN	O	show	_	0	SENT_219	[p7l638t2844r738b2873],
17	to	TO	O	to	aux	18	SENT_219	[p7l749t2852r779b2873],
18	result	VB	O	result	xcomp	16	SENT_219	[p7l791t2844r879b2873],
19	in	IN	O	in	_	0	SENT_219	[p7l889t2845r919b2873],
20	clinically	RB	O	clinically	advmod	21	SENT_219	[p7l930t2844r1071b2883],
21	meaningful	JJ	O	meaningful	amod	22	SENT_219	[p7l1080t2844r1257b2883],
22	differences	NNS	O	difference	prep_in	18	SENT_219	[p7l1269t2844r1438b2873],
23	in	IN	O	in	_	0	SENT_219	[p7l1449t2845r1479b2873],
24	efﬁcacy	NN	O	efﬁcacy	prep_in	22	SENT_219	[p7l1491t2844r1612b2883],
25	.	.	O	.	_	0	SENT_219	[p7l1491t2844r1612b2883],
26	'	''	O	'	_	0	SENT_219	[p7l1273t2958r1506b2980],

1	www	NN	O	www	_	0	SENT_220	[p7l1273t2958r1506b2980],
2	.	.	O	.	_	0	SENT_220	[p7l1273t2958r1506b2980],

1	zmnualrem	NN	O	zmnualrem	_	0	SENT_221	[p7l1273t2958r1506b2980],
2	'	''	O	'	_	0	SENT_221	[p7l1273t2958r1506b2980],
3	e	SYM	O	e	dep	7	SENT_221	[p7l1273t2958r1506b2980],
4	'	''	O	'	_	0	SENT_221	[p7l1273t2958r1506b2980],
5	w.v.	FW	O	w.v.	nn	7	SENT_221	[p7l1273t2958r1506b2980],
6	org	FW	O	org	nn	7	SENT_221	[p7l1510t2966r1546b2988],
7	o	NN	O	o	rcmod	1	SENT_221	[p7l1561t2966r1571b2976],
8	Emerging	VBG	O	emerge	partmod	7	SENT_221	[p7l1586t2958r1701b2988],
9	Plmmmmlogy	NN	O	plmmmmlogy	dobj	8	SENT_221	[p7l1707t2958r1865b2988],
10	3	CD	NUMBER	3	number	9	SENT_221	[p7l1915t2966r1928b2987],
11	8	CD	NUMBER	8	number	9	SENT_221	[p7l1932t2959r1945b2980],
12	3	CD	NUMBER	3	number	9	SENT_221	[p7l1945t2966r1958b2987],

1	Downloaded	VBN	O	download	dep	6	SENT_222	[p8l63t3482r86b3652],
2	from	IN	O	from	_	0	SENT_222	[p8l63t3409r86b3473],
3	wwwannualrevievx	NN	O	wwwannualrevievx	nn	4	SENT_222	[p8l63t3146r86b3400],
4	rs.org	NN	O	rs.org	prep_from	1	SENT_222	[p8l70t3063r93b3134],
5	I	PRP	O	I	nsubj	6	SENT_222	[p8l56t1809r78b1820],
6	Xnnu	VBP	O	xnnu	_	0	SENT_222	[p8l55t1729r78b1798],
7	.	.	O	.	_	0	SENT_222	[p8l55t1729r78b1798],

1	Rev.	NNP	O	Rev.	nn	2	SENT_223	[p8l55t1659r78b1718],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_223	[p8l55t1499r78b1648],
3	.	.	O	.	_	0	SENT_223	[p8l55t1499r78b1648],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_224	[p8l55t1379r78b1488],
2	.	.	O	.	_	0	SENT_224	[p8l55t1379r78b1488],

1	2009.49:377	CD	NUMBER	2009.49:377	num	2	SENT_225	[p8l55t1133r79b1367],
2	-394	CD	NUMBER	-394	_	0	SENT_225	[p8l55t1133r79b1367],
3	.	.	O	.	_	0	SENT_225	[p8l55t1133r79b1367],

1	Downloaded	VBN	O	download	_	0	SENT_226	[p8l55t953r78b1123],
2	from	IN	O	from	_	0	SENT_226	[p8l55t879r78b944],
3	www.annua1reviews.org	NN	O	www.annua1reviews.org	prep_from	1	SENT_226	[p8l55t546r85b870],
4	by	IN	O	by	_	0	SENT_226	[p8l88t1641r119b1674],
5	University	NNP	ORGANIZATION	University	prep_by	1	SENT_226	[p8l89t1492r119b1632],
6	of	IN	ORGANIZATION	of	_	0	SENT_226	[p8l88t1453r112b1482],
7	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	5	SENT_226	[p8l88t1307r112b1447],
8	-	:	O	-	_	0	SENT_226	[p8l102t1289r105b1298],
9	Madison	NNP	O	Madison	dep	5	SENT_226	[p8l88t1162r112b1279],
10	on	IN	O	on	_	0	SENT_226	[p8l96t1121r112b1153],
11	01/05/14	NN	DATE	01/05/14	prep_on	9	SENT_226	[p8l88t994r112b1111],
12	For	IN	O	for	_	0	SENT_226	[p8l89t930r112b977],
13	personal	JJ	O	personal	amod	14	SENT_226	[p8l88t810r119b922],
14	use	NN	O	use	prep_for	1	SENT_226	[p8l96t757r112b801],
15	only	RB	O	only	advmod	1	SENT_226	[p8l88t689r119b747],

1	01/05/14	NN	DATE	01/05/14	_	0	SENT_227	[p8l96t3517r120b3642],
2	.	.	O	.	_	0	SENT_227	[p8l96t3517r120b3642],

1	For	IN	O	for	_	0	SENT_228	[p8l97t3460r120b3506],
2	personal	JJ	O	personal	amod	3	SENT_228	[p8l96t3339r127b3451],
3	use	NN	O	use	pobj	1	SENT_228	[p8l104t3287r120b3330],
4	only	RB	O	only	advmod	3	SENT_228	[p8l96t3212r127b3277],
5	.	.	O	.	_	0	SENT_228	[p8l96t3212r127b3277],

1	uunuul	NN	O	uunuul	nn	3	SENT_229	[p8l2009t278r2027b347],
2	unmml	NN	O	unmml	nn	3	SENT_229	[p8l2009t182r2027b251],
3	numml	NN	O	numml	_	0	SENT_229	[p8l2009t85r2027b155],
4	|	CD	NUMBER	|	num	5	SENT_229	[p8l2015t13r2027b59],
5	IIL	NN	O	iil	dep	3	SENT_229	[p8l2015t13r2027b59],

1	Raltegravir	NN	O	raltegravir	nn	3	SENT_230	[p8l648t636r683b819],
2	plasma	NN	O	plasma	nn	3	SENT_230	[p8l648t509r683b626],
3	concentration	NN	O	concentration	_	0	SENT_230	[p8l649t268r676b498],
4	(	CD	NUMBER	(	num	6	SENT_230	[p8l649t183r680b256],
5	nM	NN	O	nm	nn	6	SENT_230	[p8l649t183r680b256],
6	)	NN	O	)	dep	3	SENT_230	[p8l649t183r680b256],

1	Time	NNP	O	Time	nn	3	SENT_231	[p8l1334t946r1415b973],
2	(	CD	NUMBER	(	num	3	SENT_231	[p8l1426t946r1467b978],
3	h	NN	O	h	nsubj	8	SENT_231	[p8l1426t946r1467b978],
4	)	CD	NUMBER	)	num	7	SENT_231	[p8l1426t946r1467b978],
5	Figure	NNP	O	Figure	nn	7	SENT_231	[p8l582t1025r681b1058],
6	4	CD	NUMBER	4	num	7	SENT_231	[p8l692t1025r710b1049],
7	Arithmetic	NNP	O	Arithmetic	dep	3	SENT_231	[p8l581t1076r734b1102],
8	mean	VB	O	mean	ccomp	34	SENT_231	[p8l743t1086r818b1102],
9	raltegravir	JJ	O	raltegravir	amod	12	SENT_231	[p8l828t1076r973b1110],
10	plasma	NN	O	plasma	nn	12	SENT_231	[p8l982t1076r1078b1110],
11	concentration	NN	O	concentration	nn	12	SENT_231	[p8l1088t1077r1282b1102],
12	proﬁles	NNS	O	proﬁles	dobj	8	SENT_231	[p8l1291t1076r1394b1110],
13	following	VBG	O	follow	_	0	SENT_231	[p8l1404t1076r1537b1110],
14	single-dose	JJ	O	single-dose	amod	15	SENT_231	[p8l1546t1076r1703b1110],
15	administration	NN	O	administration	prep_following	12	SENT_231	[p8l1713t1076r1916b1102],
16	of	IN	O	of	_	0	SENT_231	[p8l1926t1076r1957b1102],
17	100	CD	NUMBER	100	prep_of	15	SENT_231	[p8l1966t1078r2021b1107],
18	,	,	O	,	_	0	SENT_231	[p8l1966t1078r2021b1107],
19	200	CD	NUMBER	200	nsubj	34	SENT_231	[p8l2032t1078r2090b1107],
20	,	,	O	,	_	0	SENT_231	[p8l2032t1078r2090b1107],
21	400	CD	NUMBER	400	conj_or	19	SENT_231	[p8l582t1119r641b1149],
22	,	,	O	,	_	0	SENT_231	[p8l582t1119r641b1149],
23	800	CD	NUMBER	800	conj_or	19	SENT_231	[p8l653t1119r710b1149],
24	,	,	O	,	_	0	SENT_231	[p8l653t1119r710b1149],
25	or	CC	O	or	_	0	SENT_231	[p8l721t1127r751b1143],
26	1600	CD	DATE	1600	num	27	SENT_231	[p8l763t1119r827b1143],
27	mg	NN	O	mg	conj_or	19	SENT_231	[p8l837t1127r882b1152],
28	to	TO	O	to	_	0	SENT_231	[p8l891t1125r918b1143],
29	healthy	JJ	O	healthy	amod	33	SENT_231	[p8l928t1117r1032b1152],
30	male	NN	O	male	amod	33	SENT_231	[p8l1040t1117r1106b1143],
31	and	CC	O	and	_	0	SENT_231	[p8l1117t1117r1166b1143],
32	female	JJ	O	female	amod	33	SENT_231	[p8l1176t1117r1267b1143],
33	subjects	NNS	O	subject	prep_to	27	SENT_231	[p8l1277t1117r1386b1152],
34	(	VBP	O	(	_	0	SENT_231	[p8l1397t1118r1449b1150],
35	40	CD	NUMBER	40	number	36	SENT_231	[p8l1397t1118r1449b1150],
36	)	CD	NUMBER	)	num	38	SENT_231	[p8l1397t1118r1449b1150],
37	(	NN	O	(	nn	38	SENT_231	[p8l1461t1118r1499b1150],
38	N	NN	O	n	dobj	34	SENT_231	[p8l1461t1118r1499b1150],
39	=	JJ	O	=	amod	38	SENT_231	[p8l1511t1130r1534b1139],
40	20	CD	NUMBER	20	tmod	39	SENT_231	[p8l1551t1119r1591b1149],
41	;	:	O	;	_	0	SENT_231	[p8l1551t1119r1591b1149],
42	inset	NNP	O	inset	dep	38	SENT_231	[p8l1602t1119r1674b1143],
43	:	:	O	:	_	0	SENT_231	[p8l1602t1119r1674b1143],
44	semilog	NN	O	semilog	nn	46	SENT_231	[p8l1686t1117r1794b1152],
45	scale	NN	O	scale	nn	46	SENT_231	[p8l1803t1117r1886b1150],
46	)	NN	O	)	dep	42	SENT_231	[p8l1803t1117r1886b1150],
47	.	.	O	.	_	0	SENT_231	[p8l1803t1117r1886b1150],

1	Raltegravir	NNP	O	Raltegravir	nn	2	SENT_232	[p8l582t1236r793b1279],
2	Metabolism	NNP	O	Metabolism	dep	9	SENT_232	[p8l804t1236r1030b1268],
3	In	IN	O	in	_	0	SENT_232	[p8l582t1307r616b1334],
4	preclinical	JJ	O	preclinical	amod	5	SENT_232	[p8l635t1305r798b1344],
5	studies	NNS	O	study	prep_in	9	SENT_232	[p8l817t1305r931b1341],
6	,	,	O	,	_	0	SENT_232	[p8l817t1305r931b1341],
7	raltegravir	NN	O	raltegravir	nsubjpass	9	SENT_232	[p8l952t1305r1115b1344],
8	was	VBD	O	be	auxpass	9	SENT_232	[p8l1132t1317r1188b1334],
9	metabolized	VBN	O	metabolize	_	0	SENT_232	[p8l1207t1305r1399b1334],
10	predominantly	RB	O	predominantly	advmod	9	SENT_232	[p8l1417t1305r1650b1344],
11	in	IN	O	in	_	0	SENT_232	[p8l1667t1307r1698b1334],
12	the	DT	O	the	det	13	SENT_232	[p8l1717t1305r1765b1334],
13	liver	NN	O	liver	prep_in	9	SENT_232	[p8l1784t1305r1854b1334],
14	via	IN	O	via	_	0	SENT_232	[p8l1871t1307r1915b1334],
15	the	DT	O	the	det	16	SENT_232	[p8l1934t1306r1983b1334],
16	UDPglucuronosyltransferase	NN	O	udpglucuronosyltransferase	prep_via	13	SENT_232	[p8l2002t1307r2100b1334, p8l583t1355r955b1394],
17	(	CD	NUMBER	(	num	18	SENT_232	[p8l971t1355r1244b1392],
18	UGT	NNP	ORGANIZATION	UGT	dep	16	SENT_232	[p8l971t1355r1244b1392],
19	)	CD	NUMBER	)	num	18	SENT_232	[p8l971t1355r1244b1392],
20	.	.	O	.	_	0	SENT_232	[p8l971t1355r1244b1392],

1	—	NN	O	—	_	0	SENT_233	[p8l971t1355r1244b1392],
2	.	.	O	.	_	0	SENT_233	[p8l971t1355r1244b1392],

1	mediated	JJ	O	mediated	amod	2	SENT_234	[p8l971t1355r1244b1392],
2	pathway	NN	O	pathway	_	0	SENT_234	[p8l1259t1355r1394b1394],
3	.	.	O	.	_	0	SENT_234	[p8l1259t1355r1394b1394],

1	In	IN	O	in	_	0	SENT_235	[p8l1411t1357r1445b1384],
2	Vivo	NNP	O	Vivo	nn	6	SENT_235	[p8l1459t1357r1523b1384],
3	and	CC	O	and	cc	2	SENT_235	[p8l1540t1355r1595b1384],
4	in	FW	O	in	nn	5	SENT_235	[p8l1611t1357r1641b1384],
5	vitro	FW	O	vitro	advmod	2	SENT_235	[p8l1655t1357r1729b1384],
6	studies	NNS	O	study	nsubj	7	SENT_235	[p8l1746t1355r1851b1384],
7	using	VBG	O	use	prepc_in	16	SENT_235	[p8l1867t1357r1951b1394],
8	isoform	NN	O	isoform	dobj	7	SENT_235	[p8l1966t1355r2100b1384],
9	—	CD	NUMBER	—	num	12	SENT_235	[p8l1966t1355r2100b1384],
10	selective	JJ	O	selective	amod	12	SENT_235	[p8l583t1405r714b1434],
11	chemical	NN	O	chemical	nn	12	SENT_235	[p8l728t1405r866b1434],
12	inhibitors	NNS	O	inhibitor	nsubj	16	SENT_235	[p8l879t1405r1031b1434],
13	and	CC	O	and	_	0	SENT_235	[p8l1045t1405r1101b1434],
14	CDNA-expressed	JJ	O	cdna-expressed	amod	15	SENT_235	[p8l1114t1405r1383b1443],
15	UGTs	NNS	O	ugt	conj_and	12	SENT_235	[p8l1396t1406r1494b1434],
16	showed	VBD	O	show	_	0	SENT_235	[p8l1508t1405r1624b1434],
17	that	IN	O	that	complm	33	SENT_235	[p8l1638t1405r1700b1434],
18	UGT1Al	NN	O	ugt1al	nsubj	33	SENT_235	[p8l1712t1406r1862b1434],
19	is	VBZ	O	be	cop	33	SENT_235	[p8l1879t1407r1901b1434],
20	the	DT	O	the	det	33	SENT_235	[p8l1915t1405r1964b1434],
21	primary	JJ	O	primary	amod	33	SENT_235	[p8l1977t1407r2103b1444],
22	enzyme	NN	O	enzyme	nn	33	SENT_235	[p8l583t1465r702b1493],
23	responsible	JJ	O	responsible	amod	33	SENT_235	[p8l718t1454r895b1493],
24	for	IN	O	for	_	0	SENT_235	[p8l910t1455r956b1483],
25	the	DT	O	the	det	26	SENT_235	[p8l971t1454r1020b1483],
26	formation	NN	O	formation	prep_for	23	SENT_235	[p8l1035t1455r1192b1483],
27	of	IN	O	of	_	0	SENT_235	[p8l1207t1455r1242b1483],
28	raltegravir	NN	O	raltegravir	nn	30	SENT_235	[p8l1252t1454r1618b1493],
29	—	NN	O	—	nn	30	SENT_235	[p8l1252t1454r1618b1493],
30	glucuronide	NN	O	glucuronide	prep_of	26	SENT_235	[p8l1252t1454r1618b1493],
31	(	CD	NUMBER	(	number	32	SENT_235	[p8l1634t1456r1702b1491],
32	40	CD	NUMBER	40	num	30	SENT_235	[p8l1634t1456r1702b1491],
33	)	NN	O	)	ccomp	16	SENT_235	[p8l1634t1456r1702b1491],
34	.	.	O	.	_	0	SENT_235	[p8l1634t1456r1702b1491],

1	In	FW	O	in	nn	2	SENT_236	[p8l1719t1456r1753b1483],
2	vitro	FW	O	vitro	amod	3	SENT_236	[p8l1767t1456r1841b1483],
3	studies	NNS	O	study	nsubj	4	SENT_236	[p8l1857t1454r1963b1484],
4	demonstrate	VBP	O	demonstrate	_	0	SENT_236	[p8l1979t1454r2100b1484, p8l583t1513r668b1533],
5	that	IN	O	that	complm	17	SENT_236	[p8l679t1504r741b1533],
6	raltegravir	NN	O	raltegravir	nsubj	17	SENT_236	[p8l750t1504r913b1543],
7	is	VBZ	O	be	cop	17	SENT_236	[p8l922t1506r945b1533],
8	not	RB	O	not	neg	17	SENT_236	[p8l955t1513r1009b1533],
9	a	DT	O	a	det	10	SENT_236	[p8l1019t1515r1033b1533],
10	substrate	NN	O	substrate	pobj	8	SENT_236	[p8l1044t1504r1183b1533],
11	for	IN	O	for	_	0	SENT_236	[p8l1194t1504r1239b1533],
12	cytochrome	NN	O	cytochrome	nn	13	SENT_236	[p8l1249t1504r1435b1543],
13	P450	NN	O	p450	prep_for	8	SENT_236	[p8l1445t1506r1525b1534],
14	(	CD	NUMBER	(	num	17	SENT_236	[p8l1536t1505r1634b1541],
15	CYP	NN	O	cyp	nn	17	SENT_236	[p8l1536t1505r1634b1541],
16	)	NN	O	)	nn	17	SENT_236	[p8l1536t1505r1634b1541],
17	enzymes	NNS	O	enzyme	ccomp	4	SENT_236	[p8l1646t1515r1778b1543],
18	and	CC	O	and	_	0	SENT_236	[p8l1789t1504r1845b1533],
19	does	VBZ	O	do	aux	21	SENT_236	[p8l1856t1504r1924b1533],
20	not	RB	O	not	neg	21	SENT_236	[p8l1935t1513r1988b1533],
21	inhibit	VB	O	inhibit	conj_and	4	SENT_236	[p8l1997t1504r2102b1533],
22	CYP1A2	NN	O	cyp1a2	dobj	21	SENT_236	[p8l584t1555r730b1590],
23	,	,	O	,	_	0	SENT_236	[p8l584t1555r730b1590],
24	2B6	NN	O	2b6	appos	22	SENT_236	[p8l745t1556r814b1590],
25	,	,	O	,	_	0	SENT_236	[p8l745t1556r814b1590],
26	2C8	NN	O	2c8	appos	22	SENT_236	[p8l829t1555r903b1590],
27	,	,	O	,	_	0	SENT_236	[p8l829t1555r903b1590],
28	2C9	NN	O	2c9	appos	22	SENT_236	[p8l918t1555r991b1590],
29	,	,	O	,	_	0	SENT_236	[p8l918t1555r991b1590],
30	2Cl9	NN	O	2cl9	appos	22	SENT_236	[p8l1006t1555r1099b1590],
31	,	,	O	,	_	0	SENT_236	[p8l1006t1555r1099b1590],
32	2D6	NN	O	2d6	appos	22	SENT_236	[p8l1114t1556r1190b1590],
33	,	,	O	,	_	0	SENT_236	[p8l1114t1556r1190b1590],
34	or	CC	O	or	_	0	SENT_236	[p8l1205t1565r1238b1583],
35	3A	NN	O	3a	appos	22	SENT_236	[p8l1252t1555r1295b1584],
36	or	CC	O	or	_	0	SENT_236	[p8l1307t1565r1340b1583],
37	induce	VB	O	induce	conj_or	21	SENT_236	[p8l1352t1554r1456b1583],
38	3A4	NN	O	3a4	nn	39	SENT_236	[p8l1471t1555r1532b1584],
39	(	NN	O	(	dobj	37	SENT_236	[p8l1545t1555r1614b1591],
40	43	CD	NUMBER	43	num	41	SENT_236	[p8l1545t1555r1614b1591],
41	)	NN	O	)	dobj	21	SENT_236	[p8l1545t1555r1614b1591],
42	.	.	O	.	_	0	SENT_236	[p8l1545t1555r1614b1591],

1	Similarly	RB	O	similarly	advmod	7	SENT_237	[p8l1629t1554r1775b1593],
2	,	,	O	,	_	0	SENT_237	[p8l1629t1554r1775b1593],
3	raltegravir	NN	O	raltegravir	nsubj	7	SENT_237	[p8l1789t1554r1952b1593],
4	is	VBZ	O	be	cop	7	SENT_237	[p8l1964t1556r1987b1583],
5	not	RB	O	not	neg	7	SENT_237	[p8l2000t1563r2053b1583],
6	an	DT	O	a	det	7	SENT_237	[p8l2066t1565r2101b1583],
7	inhibitor	NN	O	inhibitor	_	0	SENT_237	[p8l582t1604r722b1633],
8	of	IN	O	of	_	0	SENT_237	[p8l733t1604r767b1633],
9	UGTs	NNS	O	ugt	prep_of	7	SENT_237	[p8l774t1605r872b1633],
10	(	CD	NUMBER	(	num	11	SENT_237	[p8l884t1605r1045b1641],
11	UGTlA1	NN	O	ugtla1	dep	9	SENT_237	[p8l884t1605r1045b1641],
12	and	CC	O	and	_	0	SENT_237	[p8l1060t1604r1116b1633],
13	UGTZB7	NN	O	ugtzb7	conj_and	9	SENT_237	[p8l1126t1605r1291b1640],
14	)	CD	NUMBER	)	num	13	SENT_237	[p8l1126t1605r1291b1640],
15	or	CC	O	or	_	0	SENT_237	[p8l1303t1615r1336b1633],
16	P	NN	O	p	nn	18	SENT_237	[p8l1347t1604r1584b1643],
17	—	CD	NUMBER	—	num	18	SENT_237	[p8l1347t1604r1584b1643],
18	glycoprotein	NN	O	glycoprotein	conj_or	13	SENT_237	[p8l1347t1604r1584b1643],
19	(	CD	NUMBER	(	num	20	SENT_237	[p8l1595t1604r1854b1643],
20	P-gp	NN	O	p-gp	nsubj	23	SENT_237	[p8l1595t1604r1854b1643],
21	)	SYM	O	)	dep	23	SENT_237	[p8l1595t1604r1854b1643],
22	-	:	O	-	_	0	SENT_237	[p8l1595t1604r1854b1643],
23	mediated	VBN	O	mediate	rcmod	7	SENT_237	[p8l1595t1604r1854b1643],
24	transport	NN	O	transport	dobj	23	SENT_237	[p8l1865t1612r2010b1643],
25	(	CD	NUMBER	(	num	24	SENT_237	[p8l2021t1605r2089b1641],
26	40	CD	NUMBER	40	num	27	SENT_237	[p8l2021t1605r2089b1641],
27	)	NN	O	)	dep	24	SENT_237	[p8l2021t1605r2089b1641],
28	.	.	O	.	_	0	SENT_237	[p8l2021t1605r2089b1641],

1	In	IN	O	in	_	0	SENT_238	[p8l632t1656r666b1683],
2	clinical	JJ	O	clinical	amod	3	SENT_238	[p8l675t1655r785b1684],
3	studies	NNS	O	study	prep_in	9	SENT_238	[p8l794t1655r909b1690],
4	,	,	O	,	_	0	SENT_238	[p8l794t1655r909b1690],
5	metabolism	NN	O	metabolism	nsubj	9	SENT_238	[p8l919t1655r1101b1684],
6	via	IN	O	via	_	0	SENT_238	[p8l1108t1656r1153b1684],
7	UGTlAl	NN	O	ugtlal	nn	8	SENT_238	[p8l1161t1655r1475b1684],
8	—	NN	O	—	prep_via	5	SENT_238	[p8l1161t1655r1475b1684],
9	mediated	VBD	O	mediate	_	0	SENT_238	[p8l1161t1655r1475b1684],
10	glucuronidation	NN	O	glucuronidation	nsubj	14	SENT_238	[p8l1484t1655r1735b1693],
11	is	VBZ	O	be	cop	14	SENT_238	[p8l1743t1656r1766b1684],
12	the	DT	O	the	det	14	SENT_238	[p8l1775t1655r1824b1684],
13	major	JJ	O	major	amod	14	SENT_238	[p8l1833t1656r1924b1693],
14	pathway	NN	O	pathway	ccomp	9	SENT_238	[p8l1932t1655r2063b1693],
15	of	IN	O	of	_	0	SENT_238	[p8l2071t1655r2105b1684],
16	elimination	NN	O	elimination	prep_of	14	SENT_238	[p8l583t1704r762b1733],
17	of	IN	O	of	_	0	SENT_238	[p8l774t1705r808b1733],
18	raltegravir	NN	O	raltegravir	prep_of	16	SENT_238	[p8l815t1704r984b1743],
19	,	,	O	,	_	0	SENT_238	[p8l815t1704r984b1743],
20	with	IN	O	with	mark	35	SENT_238	[p8l996t1704r1066b1733],
21	a	DT	O	a	det	23	SENT_238	[p8l1077t1716r1092b1733],
22	minor	JJ	O	minor	amod	23	SENT_238	[p8l1103t1706r1199b1733],
23	component	NN	O	component	nsubj	35	SENT_238	[p8l1211t1713r1389b1743],
24	of	IN	O	of	_	0	SENT_238	[p8l1400t1705r1434b1733],
25	elimination	NN	O	elimination	prep_of	23	SENT_238	[p8l1442t1704r1621b1733],
26	via	IN	O	via	_	0	SENT_238	[p8l1631t1706r1675b1733],
27	kidney	NN	O	kidney	nn	29	SENT_238	[p8l1686t1704r1792b1743],
28	(	CD	NUMBER	(	num	29	SENT_238	[p8l1803t1705r1893b1741],
29	~	NN	O	~	prep_via	25	SENT_238	[p8l1803t1705r1893b1741],
30	9	CD	PERCENT	9	number	31	SENT_238	[p8l1803t1705r1893b1741],
31	%	NN	PERCENT	%	amod	29	SENT_238	[p8l1803t1705r1893b1741],
32	of	IN	O	of	_	0	SENT_238	[p8l1908t1705r1942b1733],
33	total	JJ	O	total	amod	34	SENT_238	[p8l1949t1704r2020b1733],
34	dose	NN	O	dose	prep_of	29	SENT_238	[p8l2032t1705r2101b1733],
35	excreted	VBD	O	excrete	advcl	14	SENT_238	[p8l583t1754r713b1783],
36	unchanged	JJ	O	unchanged	acomp	35	SENT_238	[p8l720t1754r891b1793],
37	into	IN	O	into	_	0	SENT_238	[p8l898t1756r960b1783],
38	urine	NN	O	urine	nn	39	SENT_238	[p8l967t1755r1069b1790],
39	)	NN	O	)	prep_into	35	SENT_238	[p8l967t1755r1069b1790],
40	.	.	O	.	_	0	SENT_238	[p8l967t1755r1069b1790],

1	The	DT	O	the	det	3	SENT_239	[p8l1077t1754r1143b1783],
2	only	JJ	O	only	amod	3	SENT_239	[p8l1151t1754r1220b1793],
3	metabolite	NN	O	metabolite	nsubj	11	SENT_239	[p8l1225t1754r1392b1783],
4	detected	VBN	O	detect	partmod	3	SENT_239	[p8l1400t1754r1531b1783],
5	in	IN	O	in	_	0	SENT_239	[p8l1538t1755r1568b1783],
6	humans	NNS	O	human	prep_in	4	SENT_239	[p8l1575t1754r1696b1783],
7	was	VBD	O	be	cop	11	SENT_239	[p8l1703t1765r1759b1783],
8	the	DT	O	the	det	11	SENT_239	[p8l1766t1754r1815b1783],
9	phenolic	JJ	O	phenolic	amod	11	SENT_239	[p8l1822t1754r1957b1793],
10	hydroxyl	NN	O	hydroxyl	nn	11	SENT_239	[p8l1964t1754r2101b1793],
11	glucuronide	NN	O	glucuronide	_	0	SENT_239	[p8l583t1815r779b1854],
12	,	,	O	,	_	0	SENT_239	[p8l583t1815r779b1854],
13	and	CC	O	and	_	0	SENT_239	[p8l797t1815r852b1845],
14	this	DT	O	this	det	15	SENT_239	[p8l868t1815r924b1845],
15	metabolite	NN	O	metabolite	nsubj	18	SENT_239	[p8l940t1815r1106b1845],
16	does	VBZ	O	do	aux	18	SENT_239	[p8l1123t1815r1192b1845],
17	not	RB	O	not	neg	18	SENT_239	[p8l1207t1824r1261b1845],
18	have	VB	O	have	conj_and	11	SENT_239	[p8l1275t1815r1346b1845],
19	antiviral	JJ	O	antiviral	amod	20	SENT_239	[p8l1362t1815r1490b1845],
20	activity	NN	O	activity	dobj	18	SENT_239	[p8l1506t1817r1620b1854],
21	(	CD	NUMBER	(	num	23	SENT_239	[p8l1635t1816r1703b1852],
22	42	CD	NUMBER	42	num	23	SENT_239	[p8l1635t1816r1703b1852],
23	)	NN	O	)	dep	20	SENT_239	[p8l1635t1816r1703b1852],
24	.	.	O	.	_	0	SENT_239	[p8l1635t1816r1703b1852],

1	In	IN	O	in	_	0	SENT_240	[p8l1720t1817r1754b1844],
2	a	DT	O	a	det	4	SENT_240	[p8l1770t1826r1784b1845],
3	human	JJ	O	human	amod	4	SENT_240	[p8l1800t1815r1908b1845],
4	absorption	NN	O	absorption	prep_in	24	SENT_240	[p8l1924t1815r2100b1854],
5	,	,	O	,	_	0	SENT_240	[p8l1924t1815r2100b1854],
6	distribution	NN	O	distribution	nsubj	24	SENT_240	[p8l583t1865r775b1901],
7	,	,	O	,	_	0	SENT_240	[p8l583t1865r775b1901],
8	metabolism	NN	O	metabolism	nsubj	24	SENT_240	[p8l785t1865r976b1901],
9	,	,	O	,	_	0	SENT_240	[p8l785t1865r976b1901],
10	and	CC	O	and	_	0	SENT_240	[p8l986t1865r1042b1894],
11	excretion	NN	O	excretion	nsubj	24	SENT_240	[p8l1052t1867r1196b1894],
12	(	CD	NUMBER	(	num	13	SENT_240	[p8l1205t1866r1343b1902],
13	ADME	NN	O	adme	dep	6	SENT_240	[p8l1205t1866r1343b1902],
14	)	CD	NUMBER	)	num	15	SENT_240	[p8l1205t1866r1343b1902],
15	study	NN	O	study	dep	6	SENT_240	[p8l1353t1865r1441b1904],
16	,	,	O	,	_	0	SENT_240	[p8l1353t1865r1441b1904],
17	~	NN	O	~	dep	6	SENT_240	[p8l1453t1866r1515b1895],
18	51	CD	NUMBER	51	num	17	SENT_240	[p8l1453t1866r1515b1895],
19	and	CC	O	and	_	0	SENT_240	[p8l1528t1865r1583b1894],
20	32	CD	PERCENT	32	num	21	SENT_240	[p8l1594t1867r1662b1894],
21	%	NN	PERCENT	%	dep	6	SENT_240	[p8l1594t1867r1662b1894],
22	of	IN	O	of	advmod	24	SENT_240	[p8l1674t1865r1708b1894],
23	a	DT	O	a	dep	22	SENT_240	[p8l1714t1876r1728b1894],
24	radiolabeled	VBN	O	radiolabele	_	0	SENT_240	[p8l1737t1865r1929b1894],
25	raltegravir	NN	O	raltegravir	nn	28	SENT_240	[p8l1938t1865r2102b1904],
26	dose	NN	O	dose	nn	28	SENT_240	[p8l583t1914r652b1943],
27	(	NN	O	(	nn	28	SENT_240	[p8l661t1915r773b1953],
28	parent	NN	O	parent	dobj	24	SENT_240	[p8l661t1915r773b1953],
29	and	CC	O	and	_	0	SENT_240	[p8l779t1914r835b1943],
30	metabolite	NN	O	metabolite	nn	31	SENT_240	[p8l842t1914r1020b1950],
31	)	NN	O	)	conj_and	28	SENT_240	[p8l842t1914r1020b1950],
32	was	VBD	O	be	auxpass	33	SENT_240	[p8l1027t1925r1083b1943],
33	excreted	VBN	O	excrete	rcmod	28	SENT_240	[p8l1091t1914r1221b1943],
34	in	IN	O	in	_	0	SENT_240	[p8l1228t1916r1258b1943],
35	the	DT	O	the	det	36	SENT_240	[p8l1265t1914r1314b1943],
36	feces	NNS	O	fece	prep_in	33	SENT_240	[p8l1322t1914r1396b1943],
37	and	CC	O	and	_	0	SENT_240	[p8l1404t1914r1460b1943],
38	urine	NN	O	urine	prep_in	33	SENT_240	[p8l1467t1916r1557b1950],
39	,	,	O	,	_	0	SENT_240	[p8l1467t1916r1557b1950],
40	respectively	RB	O	respectively	advmod	33	SENT_240	[p8l1566t1914r1755b1953],
41	.	.	O	.	_	0	SENT_240	[p8l1566t1914r1755b1953],

1	The	DT	O	the	det	2	SENT_241	[p8l1762t1914r1829b1943],
2	major	JJ	O	major	nsubj	11	SENT_241	[p8l1836t1916r1928b1953],
3	circulating	VBG	O	circulate	partmod	2	SENT_241	[p8l1935t1914r2102b1953],
4	entity	NN	O	entity	dobj	3	SENT_241	[p8l583t1965r674b2002],
5	in	IN	O	in	_	0	SENT_241	[p8l687t1965r717b1992],
6	plasma	NN	O	plasma	prep_in	4	SENT_241	[p8l731t1963r838b2002],
7	was	VBD	O	be	cop	11	SENT_241	[p8l852t1974r908b1992],
8	the	DT	O	the	det	11	SENT_241	[p8l923t1963r972b1992],
9	parent	NN	O	parent	nn	11	SENT_241	[p8l986t1972r1088b2002],
10	compound	NN	O	compound	nn	11	SENT_241	[p8l1102t1963r1268b2002],
11	(	NN	O	(	_	0	SENT_241	[p8l1284t1964r1364b2000],
12	69	CD	PERCENT	69	number	13	SENT_241	[p8l1284t1964r1364b2000],
13	%	NN	PERCENT	%	amod	11	SENT_241	[p8l1284t1964r1364b2000],
14	of	IN	O	of	_	0	SENT_241	[p8l1382t1963r1417b1992],
15	the	DT	O	the	det	18	SENT_241	[p8l1427t1963r1476b1992],
16	total	JJ	O	total	amod	18	SENT_241	[p8l1491t1963r1561b1992],
17	drug-related	JJ	O	drug-related	amod	18	SENT_241	[p8l1576t1963r1771b2002],
18	material	NN	O	material	prep_of	11	SENT_241	[p8l1785t1963r1914b1992],
19	in	IN	O	in	_	0	SENT_241	[p8l1928t1965r1958b1992],
20	plasma	NN	O	plasma	nn	21	SENT_241	[p8l1972t1963r2100b2002],
21	)	NN	O	)	prep_in	18	SENT_241	[p8l1972t1963r2100b2002],
22	,	,	O	,	_	0	SENT_241	[p8l1972t1963r2100b2002],
23	whereas	IN	O	whereas	mark	32	SENT_241	[p8l582t2013r708b2042],
24	most	JJS	O	most	nsubjpass	32	SENT_241	[p8l716t2021r793b2042],
25	of	IN	O	of	_	0	SENT_241	[p8l801t2013r835b2042],
26	the	DT	O	the	det	28	SENT_241	[p8l840t2013r888b2042],
27	drug-related	JJ	O	drug-related	amod	28	SENT_241	[p8l898t2013r1093b2052],
28	material	NN	O	material	prep_of	24	SENT_241	[p8l1101t2013r1229b2042],
29	in	IN	O	in	_	0	SENT_241	[p8l1237t2014r1267b2042],
30	urine	NN	O	urine	prep_in	28	SENT_241	[p8l1275t2014r1357b2042],
31	was	VBD	O	be	auxpass	32	SENT_241	[p8l1364t2024r1420b2042],
32	accounted	VBN	O	account	advcl	11	SENT_241	[p8l1430t2013r1588b2042],
33	for	IN	O	for	dep	32	SENT_241	[p8l1597t2013r1642b2042],
34	by	IN	O	by	_	0	SENT_241	[p8l1650t2013r1688b2052],
35	the	DT	O	the	det	38	SENT_241	[p8l1695t2013r1744b2042],
36	glucuronide	NN	O	glucuronide	nn	38	SENT_241	[p8l1753t2013r1940b2052],
37	derivative	JJ	O	derivative	amod	38	SENT_241	[p8l1950t2013r2101b2042],
38	(	NN	O	(	agent	32	SENT_241	[p8l584t2063r664b2099],
39	72	CD	PERCENT	72	num	40	SENT_241	[p8l584t2063r664b2099],
40	%	NN	PERCENT	%	npadvmod	38	SENT_241	[p8l584t2063r664b2099],
41	of	IN	O	of	_	0	SENT_241	[p8l679t2062r714b2092],
42	the	DT	O	the	det	46	SENT_241	[p8l721t2062r770b2092],
43	drug	NN	O	drug	nn	46	SENT_241	[p8l782t2062r977b2101],
44	—	RB	O	—	advmod	45	SENT_241	[p8l782t2062r977b2101],
45	related	JJ	O	related	amod	46	SENT_241	[p8l782t2062r977b2101],
46	material	NN	O	material	prep_of	38	SENT_241	[p8l989t2062r1117b2092],
47	in	IN	O	in	_	0	SENT_241	[p8l1128t2064r1159b2091],
48	urine	NN	O	urine	nn	49	SENT_241	[p8l1169t2063r1271b2099],
49	)	NN	O	)	prep_in	46	SENT_241	[p8l1169t2063r1271b2099],
50	.	.	O	.	_	0	SENT_241	[p8l1169t2063r1271b2099],

1	In	IN	O	in	_	0	SENT_242	[p8l1284t2064r1318b2091],
2	feces	NNS	O	fece	prep_in	8	SENT_242	[p8l1330t2062r1413b2098],
3	,	,	O	,	_	0	SENT_242	[p8l1330t2062r1413b2098],
4	only	RB	O	only	advmod	6	SENT_242	[p8l1427t2062r1496b2101],
5	parent	JJ	O	parent	amod	6	SENT_242	[p8l1505t2071r1607b2101],
6	compound	NN	O	compound	nsubjpass	8	SENT_242	[p8l1618t2062r1785b2101],
7	was	VBD	O	be	auxpass	8	SENT_242	[p8l1795t2073r1851b2092],
8	detected	VBN	O	detect	_	0	SENT_242	[p8l1864t2062r2004b2098],
9	,	,	O	,	_	0	SENT_242	[p8l1864t2062r2004b2098],
10	but	CC	O	but	_	0	SENT_242	[p8l2017t2062r2069b2092],
11	it	PRP	O	it	nsubj	13	SENT_242	[p8l2079t2064r2102b2092],
12	is	VBZ	O	be	cop	13	SENT_242	[p8l582t2114r605b2141],
13	likely	JJ	O	likely	conj_but	8	SENT_242	[p8l617t2112r703b2151],
14	that	IN	O	that	complm	25	SENT_242	[p8l713t2112r775b2141],
15	a	DT	O	a	det	17	SENT_242	[p8l787t2123r801b2141],
16	good	JJ	O	good	amod	17	SENT_242	[p8l814t2112r891b2151],
17	fraction	NN	O	fraction	nsubjpass	25	SENT_242	[p8l904t2112r1025b2141],
18	of	IN	O	of	_	0	SENT_242	[p8l1038t2112r1072b2141],
19	the	DT	O	the	det	20	SENT_242	[p8l1080t2112r1129b2141],
20	raltegravir	NN	O	raltegravir	prep_of	17	SENT_242	[p8l1141t2112r1304b2151],
21	detected	VBN	O	detect	partmod	20	SENT_242	[p8l1316t2112r1447b2141],
22	in	IN	O	in	_	0	SENT_242	[p8l1459t2114r1489b2141],
23	feces	NNS	O	fece	prep_in	21	SENT_242	[p8l1501t2112r1576b2141],
24	is	VBZ	O	be	auxpass	25	SENT_242	[p8l1588t2114r1611b2141],
25	derived	VBN	O	derive	ccomp	13	SENT_242	[p8l1624t2112r1739b2141],
26	from	IN	O	from	_	0	SENT_242	[p8l1751t2112r1827b2141],
27	hydrolysis	NN	O	hydrolysis	prep_from	25	SENT_242	[p8l1839t2112r1997b2151],
28	of	IN	O	of	_	0	SENT_242	[p8l2010t2112r2044b2141],
29	the	DT	O	the	det	30	SENT_242	[p8l2052t2112r2101b2141],
30	glucuronide	NN	O	glucuronide	prep_of	27	SENT_242	[p8l583t2162r771b2201],
31	derivative	JJ	O	derivative	amod	30	SENT_242	[p8l783t2162r934b2191],
32	secreted	VBN	O	secrete	partmod	30	SENT_242	[p8l946t2162r1073b2191],
33	in	IN	O	in	_	0	SENT_242	[p8l1084t2163r1114b2191],
34	bile	NN	O	bile	prep_in	32	SENT_242	[p8l1125t2162r1182b2191],
35	as	IN	O	as	mark	40	SENT_242	[p8l1194t2173r1222b2191],
36	observed	VBN	O	observe	csubj	40	SENT_242	[p8l1234t2162r1372b2191],
37	in	IN	O	in	_	0	SENT_242	[p8l1383t2163r1413b2191],
38	preclinical	JJ	O	preclinical	amod	39	SENT_242	[p8l1424t2162r1587b2201],
39	species	NNS	O	species	prep_in	36	SENT_242	[p8l1598t2163r1705b2201],
40	(	VBP	O	(	advcl	32	SENT_242	[p8l1718t2163r1786b2199],
41	42	CD	NUMBER	42	number	42	SENT_242	[p8l1718t2163r1786b2199],
42	)	CD	NUMBER	)	dobj	40	SENT_242	[p8l1718t2163r1786b2199],
43	.	.	O	.	_	0	SENT_242	[p8l1718t2163r1786b2199],

1	Effects	NNS	O	effect	nsubjpass	14	SENT_243	[p8l633t2211r740b2241],
2	of	IN	O	of	_	0	SENT_243	[p8l754t2211r789b2241],
3	intrinsic	JJ	O	intrinsic	amod	7	SENT_243	[p8l797t2213r927b2241],
4	and	CC	O	and	_	0	SENT_243	[p8l940t2211r996b2241],
5	extrinsic	JJ	O	extrinsic	amod	7	SENT_243	[p8l1010t2213r1141b2241],
6	demographic	JJ	O	demographic	amod	7	SENT_243	[p8l1155t2211r1360b2250],
7	factors	NNS	O	factor	prep_of	1	SENT_243	[p8l1373t2211r1477b2241],
8	on	IN	O	on	_	0	SENT_243	[p8l1491t2222r1530b2241],
9	the	DT	O	the	det	10	SENT_243	[p8l1544t2211r1592b2241],
10	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	7	SENT_243	[p8l1606t2211r1881b2250],
11	of	IN	O	of	_	0	SENT_243	[p8l1895t2211r1929b2241],
12	raltegravir	NN	O	raltegravir	prep_of	10	SENT_243	[p8l1938t2211r2102b2250],
13	were	VBD	O	be	auxpass	14	SENT_243	[p8l582t2272r656b2290],
14	evaluated	VBN	O	evaluate	_	0	SENT_243	[p8l672t2261r826b2290],
15	.	.	O	.	_	0	SENT_243	[p8l672t2261r826b2290],

1	Results	NNS	O	result	nsubj	5	SENT_244	[p8l842t2261r954b2290],
2	from	IN	O	from	_	0	SENT_244	[p8l968t2261r1045b2290],
3	the	DT	O	the	det	4	SENT_244	[p8l1059t2261r1107b2290],
4	analyses	NNS	O	analysis	prep_from	1	SENT_244	[p8l1122t2261r1247b2300],
5	indicate	VBP	O	indicate	_	0	SENT_244	[p8l1261t2261r1384b2290],
6	that	IN	O	that	complm	15	SENT_244	[p8l1399t2261r1461b2290],
7	the	DT	O	the	det	9	SENT_244	[p8l1474t2261r1523b2290],
8	demographic	JJ	O	demographic	amod	9	SENT_244	[p8l1538t2261r1743b2300],
9	factors	NNS	O	factor	nsubj	15	SENT_244	[p8l1757t2261r1861b2290],
10	of	IN	O	of	_	0	SENT_244	[p8l1876t2261r1910b2290],
11	gender	NN	O	gender	prep_of	9	SENT_244	[p8l1920t2261r2034b2300],
12	,	,	O	,	_	0	SENT_244	[p8l1920t2261r2034b2300],
13	age	NN	O	age	appos	11	SENT_244	[p8l2050t2272r2101b2300],
14	(	CD	NUMBER	(	num	15	SENT_244	[p8l584t2310r686b2346],
15	adults	NNS	O	adult	ccomp	5	SENT_244	[p8l584t2310r686b2346],
16	:65	CD	NUMBER	:65	num	17	SENT_244	[p8l706t2312r767b2344],
17	years	NNS	NUMBER	year	tmod	18	SENT_244	[p8l784t2311r885b2349],
18	)	RB	O	)	amod	15	SENT_244	[p8l784t2311r885b2349],
19	,	,	O	,	_	0	SENT_244	[p8l784t2311r885b2349],
20	body	NN	O	body	nn	22	SENT_244	[p8l903t2310r982b2349],
21	mass	NN	O	mass	nn	22	SENT_244	[p8l997t2321r1070b2339],
22	index	NN	O	index	appos	15	SENT_244	[p8l1087t2310r1180b2346],
23	,	,	O	,	_	0	SENT_244	[p8l1087t2310r1180b2346],
24	hepatic	JJ	O	hepatic	amod	29	SENT_244	[p8l1198t2310r1311b2348],
25	function	NN	O	function	nn	29	SENT_244	[p8l1328t2310r1459b2339],
26	impairment	NN	O	impairment	nn	29	SENT_244	[p8l1476t2312r1661b2349],
27	(	CD	NUMBER	(	num	29	SENT_244	[p8l1677t2310r1856b2347],
28	moderate	JJ	O	moderate	amod	29	SENT_244	[p8l1677t2310r1856b2347],
29	)	NN	O	)	nn	32	SENT_244	[p8l1677t2310r1856b2347],
30	,	,	O	,	_	0	SENT_244	[p8l1677t2310r1856b2347],
31	renal	JJ	O	renal	amod	32	SENT_244	[p8l1874t2310r1953b2339],
32	function	NN	O	function	dobj	15	SENT_244	[p8l1970t2310r2101b2339],

1	Hazuda	NNP	PERSON	Hazuda	nn	3	SENT_245	[p8l582t2424r674b2446],
2	o	NN	O	o	nn	3	SENT_245	[p8l689t2432r699b2442],
3	Iwamato	NNP	O	Iwamato	_	0	SENT_245	[p8l713t2424r810b2446],
4	-	:	O	-	_	0	SENT_245	[p8l826t2432r835b2442],
5	Wenning	NN	PERSON	wenning	nn	6	SENT_245	[p8l854t2424r955b2454],
6	impairment	NN	O	impairment	dep	3	SENT_245	[p8l208t2531r393b2568],
7	(	CD	NUMBER	(	num	9	SENT_245	[p8l405t2530r532b2566],
8	severe	JJ	O	severe	amod	9	SENT_245	[p8l405t2530r532b2566],
9	)	NN	O	)	nsubj	19	SENT_245	[p8l405t2530r532b2566],
10	,	,	O	,	_	0	SENT_245	[p8l405t2530r532b2566],
11	race	NN	O	race	nsubj	19	SENT_245	[p8l546t2540r618b2565],
12	,	,	O	,	_	0	SENT_245	[p8l546t2540r618b2565],
13	and	CC	O	and	_	0	SENT_245	[p8l632t2529r688b2559],
14	HIV	NN	MISC	hiv	nn	16	SENT_245	[p8l700t2531r775b2559],
15	infection	NN	O	infection	nn	16	SENT_245	[p8l785t2529r924b2559],
16	status	NN	O	status	nsubj	19	SENT_245	[p8l937t2537r1024b2559],
17	do	VBP	O	do	aux	19	SENT_245	[p8l1037t2529r1075b2559],
18	not	RB	O	not	neg	19	SENT_245	[p8l1087t2537r1140b2559],
19	have	VB	O	have	rcmod	6	SENT_245	[p8l1151t2529r1222b2559],
20	clinically	RB	O	clinically	advmod	21	SENT_245	[p8l1235t2529r1375b2568],
21	meaningful	JJ	O	meaningful	amod	22	SENT_245	[p8l1386t2529r1563b2568],
22	effects	NNS	O	effect	dobj	19	SENT_245	[p8l1576t2529r1674b2559],
23	on	IN	O	on	_	0	SENT_245	[p8l1688t2540r1727b2559],
24	the	DT	O	the	det	25	SENT_245	[p8l209t2576r258b2605],
25	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	22	SENT_245	[p8l271t2576r546b2615],
26	of	IN	O	of	_	0	SENT_245	[p8l560t2576r595b2605],
27	raltegravir	NN	O	raltegravir	prep_of	25	SENT_245	[p8l604t2576r772b2615],
28	,	,	O	,	_	0	SENT_245	[p8l604t2576r772b2615],
29	and	CC	O	and	_	0	SENT_245	[p8l788t2576r843b2605],
30	no	DT	O	no	det	32	SENT_245	[p8l856t2587r896b2605],
31	dose	NN	O	dose	nn	32	SENT_245	[p8l910t2576r979b2605],
32	adjustment	NN	O	adjustment	nsubjpass	34	SENT_245	[p8l993t2576r1167b2615],
33	is	VBZ	O	be	auxpass	34	SENT_245	[p8l1179t2578r1201b2605],
34	warranted	VBN	O	warrant	conj_and	19	SENT_245	[p8l1214t2576r1373b2605],
35	for	IN	O	for	mark	38	SENT_245	[p8l1386t2576r1432b2605],
36	these	DT	O	these	det	37	SENT_245	[p8l1445t2576r1525b2605],
37	factors	NNS	O	factor	nsubj	38	SENT_245	[p8l1538t2576r1642b2605],
38	(	VBP	O	(	advcl	34	SENT_245	[p8l1657t2577r1725b2613],
39	41	CD	NUMBER	41	num	40	SENT_245	[p8l1657t2577r1725b2613],
40	)	CD	NUMBER	)	dobj	38	SENT_245	[p8l1657t2577r1725b2613],
41	.	.	O	.	_	0	SENT_245	[p8l1657t2577r1725b2613],

1	Additionally	RB	O	additionally	advmod	4	SENT_246	[p8l208t2623r407b2662],
2	,	,	O	,	_	0	SENT_246	[p8l208t2623r407b2662],
3	there	EX	O	there	expl	4	SENT_246	[p8l425t2623r506b2652],
4	is	VBZ	O	be	dep	16	SENT_246	[p8l522t2625r545b2652],
5	no	DT	O	no	det	6	SENT_246	[p8l561t2634r601b2652],
6	evidence	NN	O	evidence	nsubj	4	SENT_246	[p8l618t2623r753b2652],
7	that	IN	O	that	complm	9	SENT_246	[p8l769t2623r831b2652],
8	the	DT	O	the	det	9	SENT_246	[p8l847t2623r895b2652],
9	UGT1Al	NN	O	ugt1al	dep	6	SENT_246	[p8l912t2624r1062b2652],
10	*	CD	NUMBER	*	num	11	SENT_246	[p8l1083t2625r1201b2652],
11	28	CD	NUMBER	28	dep	9	SENT_246	[p8l1083t2625r1201b2652],
12	/	:	O	/	punct	9	SENT_246	[p8l1083t2625r1201b2652],
13	*	CD	NUMBER	*	num	14	SENT_246	[p8l1083t2625r1201b2652],
14	28	CD	NUMBER	28	dep	9	SENT_246	[p8l1083t2625r1201b2652],
15	polymorphism	NN	O	polymorphism	dep	14	SENT_246	[p8l1218t2623r1448b2662],
16	alters	VBZ	O	alter	_	0	SENT_246	[p8l1465t2623r1547b2652],
17	raltegravir	NN	O	raltegravir	nn	18	SENT_246	[p8l1564t2623r1727b2662],
18	pharmacokinetics	NNS	O	pharmacokinetic	dobj	16	SENT_246	[p8l209t2670r484b2709],
19	to	TO	O	to	_	0	SENT_246	[p8l495t2678r526b2699],
20	a	DT	O	a	det	23	SENT_246	[p8l538t2681r552b2699],
21	clinically	RB	O	clinically	advmod	22	SENT_246	[p8l564t2670r704b2709],
22	meaningful	JJ	O	meaningful	amod	23	SENT_246	[p8l713t2670r891b2709],
23	extent	NN	O	extent	prep_to	16	SENT_246	[p8l903t2678r998b2699],
24	(	CD	NUMBER	(	num	26	SENT_246	[p8l1009t2671r1094b2707],
25	42a	NN	O	42a	nn	26	SENT_246	[p8l1009t2671r1094b2707],
26	)	NN	O	)	nsubj	16	SENT_246	[p8l1009t2671r1094b2707],
27	.	.	O	.	_	0	SENT_246	[p8l1009t2671r1094b2707],

1	Raltegravir	NNP	O	Raltegravir	nn	2	SENT_247	[p8l208t2784r419b2827],
2	Drug-Drug	NNP	O	Drug-Drug	nsubjpass	28	SENT_247	[p8l431t2786r650b2827],
3	Interactions	NNS	O	interaction	dep	2	SENT_247	[p8l661t2785r890b2816],
4	The	DT	O	the	det	5	SENT_247	[p8l208t2839r274b2869],
5	effect	NN	O	effect	dep	2	SENT_247	[p8l283t2839r369b2869],
6	of	IN	O	of	_	0	SENT_247	[p8l376t2839r410b2869],
7	raltegravir	NN	O	raltegravir	prep_of	5	SENT_247	[p8l413t2839r576b2878],
8	on	IN	O	on	_	0	SENT_247	[p8l584t2850r623b2869],
9	the	DT	O	the	det	10	SENT_247	[p8l630t2839r679b2869],
10	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	7	SENT_247	[p8l687t2839r962b2878],
11	of	IN	O	of	_	0	SENT_247	[p8l970t2839r1004b2869],
12	other	JJ	O	other	amod	13	SENT_247	[p8l1008t2839r1092b2869],
13	agents	NNS	O	agent	prep_of	10	SENT_247	[p8l1099t2847r1197b2878],
14	as	RB	O	as	_	0	SENT_247	[p8l1206t2850r1234b2869],
15	well	RB	O	well	_	0	SENT_247	[p8l1241t2839r1305b2868],
16	as	IN	O	as	_	0	SENT_247	[p8l1313t2850r1341b2869],
17	the	DT	O	the	det	18	SENT_247	[p8l1349t2839r1398b2869],
18	effect	NN	O	effect	conj_and	10	SENT_247	[p8l1406t2839r1492b2869],
19	of	IN	O	of	_	0	SENT_247	[p8l1499t2839r1533b2869],
20	other	JJ	O	other	amod	21	SENT_247	[p8l1537t2839r1621b2869],
21	agents	NNS	O	agent	prep_of	18	SENT_247	[p8l1628t2848r1726b2878],
22	on	IN	O	on	_	0	SENT_247	[p8l209t2900r248b2918],
23	the	DT	O	the	det	24	SENT_247	[p8l260t2889r309b2918],
24	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	21	SENT_247	[p8l321t2889r596b2928],
25	of	IN	O	of	_	0	SENT_247	[p8l608t2889r642b2918],
26	raltegravir	NN	O	raltegravir	prep_of	24	SENT_247	[p8l650t2889r813b2928],
27	were	VBD	O	be	auxpass	28	SENT_247	[p8l823t2900r898b2918],
28	examined	VBN	O	examine	_	0	SENT_247	[p8l911t2889r1067b2918],
29	.	.	O	.	_	0	SENT_247	[p8l911t2889r1067b2918],

1	On	IN	O	on	_	0	SENT_248	[p8l1081t2890r1131b2918],
2	the	DT	O	the	det	3	SENT_248	[p8l1143t2889r1191b2918],
3	basis	NN	O	basis	prep_on	14	SENT_248	[p8l1203t2889r1276b2918],
4	of	IN	O	of	_	0	SENT_248	[p8l1289t2889r1323b2918],
5	the	DT	O	the	det	7	SENT_248	[p8l1331t2889r1379b2918],
6	metabolic	JJ	O	metabolic	amod	7	SENT_248	[p8l1391t2889r1545b2918],
7	proﬁle	NN	O	proﬁle	prep_of	3	SENT_248	[p8l1556t2889r1659b2928],
8	and	CC	O	and	_	0	SENT_248	[p8l1671t2889r1727b2918],
9	preclinical	JJ	O	preclinical	amod	11	SENT_248	[p8l209t2939r371b2978],
10	interaction	NN	O	interaction	nn	11	SENT_248	[p8l380t2940r551b2968],
11	data	NNS	O	datum	prep_of	3	SENT_248	[p8l561t2939r633b2975],
12	,	,	O	,	_	0	SENT_248	[p8l561t2939r633b2975],
13	raltegravir	NN	O	raltegravir	nsubj	14	SENT_248	[p8l643t2939r806b2978],
14	has	VBZ	O	have	_	0	SENT_248	[p8l814t2939r864b2968],
15	a	DT	O	a	det	17	SENT_248	[p8l874t2950r888b2968],
16	low	JJ	O	low	amod	17	SENT_248	[p8l897t2939r954b2968],
17	propensity	NN	O	propensity	dobj	14	SENT_248	[p8l962t2940r1129b2978],
18	to	TO	O	to	aux	20	SENT_248	[p8l1137t2947r1167b2968],
19	be	VB	O	be	auxpass	20	SENT_248	[p8l1177t2939r1212b2968],
20	involved	VBN	O	involve	infmod	17	SENT_248	[p8l1221t2939r1354b2968],
21	in	IN	O	in	_	0	SENT_248	[p8l1363t2940r1393b2968],
22	clinically	RB	O	clinically	advmod	23	SENT_248	[p8l1402t2939r1542b2978],
23	meaningful	JJ	O	meaningful	amod	25	SENT_248	[p8l1549t2939r1727b2978],
24	drug	NN	O	drug	nn	25	SENT_248	[p8l209t2988r282b3027],
25	interactions	NNS	O	interaction	prep_in	20	SENT_248	[p8l292t2990r485b3018],
26	.	.	O	.	_	0	SENT_248	[p8l292t2990r485b3018],

1	Effect	NN	O	effect	_	0	SENT_249	[p8l208t3093r311b3121],
2	of	IN	O	of	_	0	SENT_249	[p8l327t3093r364b3121],
3	raltegravir	NN	O	raltegravir	prep_of	1	SENT_249	[p8l376t3092r554b3131],
4	on	IN	O	on	_	0	SENT_249	[p8l570t3103r612b3121],
5	coadministered	JJ	O	coadministered	amod	6	SENT_249	[p8l629t3092r890b3121],
6	drugs	NNS	O	drug	prep_on	1	SENT_249	[p8l907t3092r1010b3131],
7	.	.	O	.	_	0	SENT_249	[p8l907t3092r1010b3131],

1	In	FW	O	in	nn	2	SENT_250	[p8l1032t3094r1065b3121],
2	vitro	FW	O	vitro	nsubj	4	SENT_250	[p8l1080t3094r1154b3122],
3	results	VBZ	O	result	dep	2	SENT_250	[p8l1171t3092r1271b3122],
4	indicated	VBD	O	indicate	_	0	SENT_250	[p8l1288t3092r1431b3122],
5	that	IN	O	that	complm	10	SENT_250	[p8l1448t3092r1510b3122],
6	raltegravir	NN	O	raltegravir	nsubjpass	10	SENT_250	[p8l1525t3093r1688b3131],
7	is	VBZ	O	be	auxpass	10	SENT_250	[p8l1703t3094r1726b3122],
8	generally	RB	O	generally	advmod	10	SENT_250	[p8l209t3154r354b3193],
9	not	RB	O	not	neg	10	SENT_250	[p8l363t3163r416b3184],
10	expected	VBN	O	expect	ccomp	4	SENT_250	[p8l428t3154r563b3193],
11	to	TO	O	to	aux	12	SENT_250	[p8l575t3163r605b3184],
12	alter	VB	O	alter	xcomp	10	SENT_250	[p8l618t3154r688b3184],
13	the	DT	O	the	det	14	SENT_250	[p8l699t3154r748b3184],
14	pharmacokinetics	NNS	O	pharmacokinetic	dobj	12	SENT_250	[p8l759t3154r1034b3193],
15	of	IN	O	of	_	0	SENT_250	[p8l1047t3155r1081b3184],
16	coadministered	JJ	O	coadministered	amod	17	SENT_250	[p8l1089t3154r1328b3184],
17	drugs	NNS	O	drug	prep_of	14	SENT_250	[p8l1340t3154r1434b3193],
18	.	.	O	.	_	0	SENT_250	[p8l1340t3154r1434b3193],

1	At	IN	O	at	_	0	SENT_251	[p8l1446t3156r1484b3184],
2	concentrations	NNS	O	concentration	prep_at	12	SENT_251	[p8l1495t3156r1726b3184],
3	up	IN	O	up	advmod	2	SENT_251	[p8l208t3216r247b3243],
4	to	TO	O	to	_	0	SENT_251	[p8l257t3213r288b3234],
5	100	CD	NUMBER	100	num	6	SENT_251	[p8l302t3207r354b3234],
6	uM	NN	O	um	prep_to	3	SENT_251	[p8l367t3206r430b3241],
7	,	,	O	,	_	0	SENT_251	[p8l367t3206r430b3241],
8	raltegravir	NN	O	raltegravir	nsubj	12	SENT_251	[p8l441t3205r605b3243],
9	is	VBZ	O	be	cop	12	SENT_251	[p8l613t3206r636b3234],
10	not	RB	O	not	neg	12	SENT_251	[p8l646t3213r699b3234],
11	an	DT	O	a	det	12	SENT_251	[p8l708t3216r744b3234],
12	inhibitor	NN	O	inhibitor	_	0	SENT_251	[p8l753t3205r892b3234],
13	of	IN	O	of	_	0	SENT_251	[p8l902t3205r936b3234],
14	the	DT	O	the	det	17	SENT_251	[p8l942t3205r990b3234],
15	major	JJ	O	major	amod	17	SENT_251	[p8l1000t3206r1092b3243],
16	CYP450	NN	O	cyp450	nn	17	SENT_251	[p8l1102t3206r1234b3234],
17	isozymes	NNS	O	isozyme	prep_of	12	SENT_251	[p8l1244t3206r1392b3243],
18	,	,	O	,	_	0	SENT_251	[p8l1244t3206r1392b3243],
19	several	JJ	O	several	amod	21	SENT_251	[p8l1403t3205r1509b3234],
20	major	JJ	O	major	amod	21	SENT_251	[p8l1518t3206r1610b3243],
21	UGTS	NNS	O	ugt	prep_of	12	SENT_251	[p8l1619t3205r1725b3240],
22	,	,	O	,	_	0	SENT_251	[p8l1619t3205r1725b3240],
23	or	CC	O	or	_	0	SENT_251	[p8l209t3265r243b3284],
24	P-gp	NN	O	p-gp	prep_of	12	SENT_251	[p8l252t3256r336b3293],
25	.	.	O	.	_	0	SENT_251	[p8l252t3256r336b3293],

1	Additionally	RB	O	additionally	advmod	6	SENT_252	[p8l347t3254r547b3293],
2	,	,	O	,	_	0	SENT_252	[p8l347t3254r547b3293],
3	raltegravir	NN	O	raltegravir	nsubjpass	6	SENT_252	[p8l558t3255r721b3293],
4	was	VBD	O	be	auxpass	6	SENT_252	[p8l730t3266r786b3284],
5	not	RB	O	not	neg	6	SENT_252	[p8l796t3263r850b3284],
6	found	VBN	O	find	_	0	SENT_252	[p8l859t3255r950b3284],
7	to	TO	O	to	aux	13	SENT_252	[p8l961t3263r991b3284],
8	be	VB	O	be	cop	13	SENT_252	[p8l1002t3255r1037b3284],
9	a	DT	O	a	det	13	SENT_252	[p8l1048t3266r1063b3284],
10	time	NN	O	time	nn	13	SENT_252	[p8l1074t3254r1325b3293],
11	—	NN	O	—	nn	13	SENT_252	[p8l1074t3254r1325b3293],
12	dependent	JJ	O	dependent	amod	13	SENT_252	[p8l1074t3254r1325b3293],
13	inhibitor	NN	O	inhibitor	xcomp	6	SENT_252	[p8l1334t3254r1473b3284],
14	of	IN	O	of	_	0	SENT_252	[p8l1483t3255r1517b3284],
15	CYP3A4	NN	O	cyp3a4	prep_of	13	SENT_252	[p8l1524t3256r1663b3284],
16	nor	CC	O	nor	_	0	SENT_252	[p8l1672t3265r1727b3284],
17	an	DT	O	a	det	18	SENT_252	[p8l209t3315r245b3333],
18	inducer	NN	O	inducer	xcomp	6	SENT_252	[p8l255t3304r375b3333],
19	of	IN	O	of	_	0	SENT_252	[p8l386t3304r420b3333],
20	CYP3A4	NN	O	cyp3a4	prep_of	18	SENT_252	[p8l428t3305r566b3334],
21	(	CD	NUMBER	(	num	20	SENT_252	[p8l578t3305r646b3341],
22	43	CD	NUMBER	43	num	23	SENT_252	[p8l578t3305r646b3341],
23	)	NN	O	)	dep	18	SENT_252	[p8l578t3305r646b3341],
24	.	.	O	.	_	0	SENT_252	[p8l578t3305r646b3341],

1	Clinical	JJ	O	clinical	amod	3	SENT_253	[p8l259t3354r381b3383],
2	interaction	NN	O	interaction	nn	3	SENT_253	[p8l389t3356r560b3383],
3	studies	NNS	O	study	nsubjpass	5	SENT_253	[p8l569t3354r675b3383],
4	were	VBD	O	be	auxpass	5	SENT_253	[p8l682t3365r757b3383],
5	conducted	VBN	O	conduct	_	0	SENT_253	[p8l767t3354r928b3383],
6	with	IN	O	with	_	0	SENT_253	[p8l936t3354r1005b3383],
7	midazolam	NN	O	midazolam	prep_with	5	SENT_253	[p8l1014t3354r1194b3389],
8	,	,	O	,	_	0	SENT_253	[p8l1014t3354r1194b3389],
9	tenofovir	NN	O	tenofovir	conj_and	7	SENT_253	[p8l1204t3354r1353b3389],
10	,	,	O	,	_	0	SENT_253	[p8l1204t3354r1353b3389],
11	etravirine	NN	O	etravirine	conj_and	7	SENT_253	[p8l1363t3356r1521b3389],
12	,	,	O	,	_	0	SENT_253	[p8l1363t3356r1521b3389],
13	and	CC	O	and	_	0	SENT_253	[p8l1531t3354r1587b3383],
14	a	DT	O	a	det	17	SENT_253	[p8l1596t3365r1610b3383],
15	t1	NN	O	t1	nn	17	SENT_253	[p8l1619t3354r1726b3392],
16	“	NN	O	“	nn	17	SENT_253	[p8l1619t3354r1726b3392],
17	ipha	NN	O	ipha	conj_and	7	SENT_253	[p8l1619t3354r1726b3392],
18	—	CD	NUMBER	—	num	19	SENT_253	[p8l1619t3354r1726b3392],
19	sic	NN	O	sic	dep	17	SENT_253	[p8l209t3406r248b3433],
20	oral	JJ	O	oral	amod	21	SENT_253	[p8l260t3404r320b3433],
21	contraceptive	NN	O	contraceptive	tmod	5	SENT_253	[p8l332t3406r551b3442],
22	,	,	O	,	_	0	SENT_253	[p8l332t3406r551b3442],
23	which	WDT	O	which	nsubj	24	SENT_253	[p8l563t3404r657b3433],
24	demonstrated	VBD	O	demonstrate	rcmod	21	SENT_253	[p8l669t3404r884b3433],
25	minimal	JJ	O	minimal	amod	26	SENT_253	[p8l895t3404r1025b3433],
26	effects	NNS	O	effect	nsubj	33	SENT_253	[p8l1037t3404r1136b3433],
27	of	IN	O	of	_	0	SENT_253	[p8l1148t3404r1182b3433],
28	raltegravir	NN	O	raltegravir	prep_of	26	SENT_253	[p8l1190t3404r1353b3443],
29	on	IN	O	on	_	0	SENT_253	[p8l1364t3415r1404b3433],
30	the	DT	O	the	det	32	SENT_253	[p8l1415t3404r1464b3433],
31	respective	JJ	O	respective	amod	32	SENT_253	[p8l1476t3406r1631b3442],
32	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	28	SENT_253	[p8l1643t3404r1726b3442, p8l208t3454r412b3483],
33	(	VBP	O	(	ccomp	24	SENT_253	[p8l424t3453r530b3490],
34	Table	NNP	O	Table	dobj	33	SENT_253	[p8l424t3453r530b3490],
35	1	CD	NUMBER	1	num	34	SENT_253	[p8l545t3455r572b3490],
36	)	CD	NUMBER	)	number	37	SENT_253	[p8l545t3455r572b3490],
37	(	CD	NUMBER	(	dep	34	SENT_253	[p8l585t3455r710b3490],
38	43-46	CD	NUMBER	43-46	num	39	SENT_253	[p8l585t3455r710b3490],
39	)	NN	O	)	dep	37	SENT_253	[p8l585t3455r710b3490],
40	.	.	O	.	_	0	SENT_253	[p8l585t3455r710b3490],

1	Effect	NN	O	effect	_	0	SENT_254	[p8l208t3558r310b3587],
2	of	IN	O	of	_	0	SENT_254	[p8l325t3558r363b3587],
3	coadministered	JJ	O	coadministered	amod	4	SENT_254	[p8l374t3558r635b3587],
4	drugs	NNS	O	drug	prep_of	1	SENT_254	[p8l651t3558r745b3597],
5	on	IN	O	on	_	0	SENT_254	[p8l761t3568r804b3587],
6	raltegravir	NN	O	raltegravir	prep_on	1	SENT_254	[p8l819t3558r1002b3597],
7	.	.	O	.	_	0	SENT_254	[p8l819t3558r1002b3597],

1	There	EX	O	there	expl	2	SENT_255	[p8l1023t3558r1121b3587],
2	is	VBZ	O	be	_	0	SENT_255	[p8l1136t3559r1159b3587],
3	low	JJ	O	low	amod	4	SENT_255	[p8l1175t3558r1231b3587],
4	propensity	NN	O	propensity	nsubj	2	SENT_255	[p8l1245t3559r1413b3597],
5	for	IN	O	for	_	0	SENT_255	[p8l1427t3558r1472b3587],
6	coadministered	JJ	O	coadministered	amod	7	SENT_255	[p8l1487t3558r1726b3587],
7	drugs	NNS	O	drug	prep_for	4	SENT_255	[p8l209t3608r295b3647],
8	to	TO	O	to	aux	10	SENT_255	[p8l304t3616r334b3637],
9	meaningfully	RB	O	meaningfully	advmod	10	SENT_255	[p8l343t3608r550b3647],
10	alter	VB	O	alter	infmod	4	SENT_255	[p8l558t3608r628b3637],
11	the	DT	O	the	det	12	SENT_255	[p8l636t3608r684b3637],
12	pharmacokinetics	NNS	O	pharmacokinetic	dobj	10	SENT_255	[p8l693t3608r968b3646],
13	of	IN	O	of	_	0	SENT_255	[p8l977t3608r1011b3637],
14	raltegravir	NN	O	raltegravir	prep_of	12	SENT_255	[p8l1016t3608r1184b3647],
15	.	.	O	.	_	0	SENT_255	[p8l1016t3608r1184b3647],

1	Raltegravir	NNP	O	Raltegravir	nsubjpass	3	SENT_256	[p8l1195t3608r1369b3647],
2	is	VBZ	O	be	auxpass	3	SENT_256	[p8l1377t3609r1399b3637],
3	eliminated	VBN	O	eliminate	_	0	SENT_256	[p8l1409t3608r1573b3637],
4	primarily	RB	O	primarily	advmod	3	SENT_256	[p8l1582t3608r1728b3647],

1	Annu	NNP	PERSON	Annu	_	0	SENT_257	[p9l55t3120r78b3200],
2	.	.	O	.	_	0	SENT_257	[p9l55t3120r78b3200],

1	Rev.	NNP	O	Rev.	nn	2	SENT_258	[p9l55t3049r78b3109],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_258	[p9l55t2890r78b3039],
3	.	.	O	.	_	0	SENT_258	[p9l55t2890r78b3039],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_259	[p9l55t2770r78b2879],
2	.	.	O	.	_	0	SENT_259	[p9l55t2770r78b2879],

1	2009.49:377	CD	NUMBER	2009.49:377	num	2	SENT_260	[p9l55t2524r79b2758],
2	-394	CD	NUMBER	-394	_	0	SENT_260	[p9l55t2524r79b2758],
3	.	.	O	.	_	0	SENT_260	[p9l55t2524r79b2758],

1	Downloaded	VBN	O	download	_	0	SENT_261	[p9l55t2343r78b2513],
2	from	IN	O	from	_	0	SENT_261	[p9l55t2270r78b2334],
3	www.annua1reviews.org	NN	O	www.annua1reviews.org	nn	4	SENT_261	[p9l55t1936r85b2261],
4	Annu	NN	PERSON	annu	prep_from	1	SENT_261	[p9l63t644r86b724],
5	.	.	O	.	_	0	SENT_261	[p9l63t644r86b724],

1	Rev.	NNP	O	Rev.	nn	2	SENT_262	[p9l63t573r86b633],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_262	[p9l63t414r86b563],
3	.	.	O	.	_	0	SENT_262	[p9l63t414r86b563],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_263	[p9l63t294r86b403],
2	.	.	O	.	_	0	SENT_263	[p9l63t294r86b403],

1	2009.49:377	CD	NUMBER	2009.49:377	num	2	SENT_264	[p9l63t48r87b282],
2	-394	CD	NUMBER	-394	_	0	SENT_264	[p9l63t48r87b282],
3	.	.	O	.	_	0	SENT_264	[p9l63t48r87b282],

1	by	IN	O	by	dep	6	SENT_265	[p9l88t3032r119b3064],
2	University	NNP	ORGANIZATION	University	pobj	1	SENT_265	[p9l88t2883r119b3023],
3	of	IN	ORGANIZATION	of	_	0	SENT_265	[p9l88t2845r112b2873],
4	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	2	SENT_265	[p9l88t2698r112b2838],
5	-	:	O	-	_	0	SENT_265	[p9l102t2679r105b2688],
6	Madison	NNP	O	Madison	_	0	SENT_265	[p9l88t2553r112b2669],
7	on	IN	O	on	_	0	SENT_265	[p9l96t2511r112b2544],
8	01/05/14	CD	DATE	01/05/14	prep_on	6	SENT_265	[p9l88t2378r112b2502],
9	.	.	O	.	_	0	SENT_265	[p9l88t2378r112b2502],

1	For	IN	O	for	_	0	SENT_266	[p9l89t2321r112b2367],
2	personal	JJ	O	personal	amod	3	SENT_266	[p9l88t2200r119b2313],
3	use	NN	O	use	pobj	1	SENT_266	[p9l96t2148r112b2191],
4	only	RB	O	only	advmod	3	SENT_266	[p9l88t2073r119b2137],
5	.	.	O	.	_	0	SENT_266	[p9l88t2073r119b2137],

1	by	IN	O	by	_	0	SENT_267	[p9l96t556r127b589],
2	University	NNP	ORGANIZATION	University	agent	16	SENT_267	[p9l96t407r127b547],
3	of	IN	ORGANIZATION	of	_	0	SENT_267	[p9l96t369r120b397],
4	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	2	SENT_267	[p9l96t222r120b362],
5	-	:	O	-	_	0	SENT_267	[p9l110t203r113b212],
6	Madison	NNP	O	Madison	agent	16	SENT_267	[p9l96t77r120b193],
7	on	IN	O	on	prep	6	SENT_267	[p9l104t36r120b67],
8	by	IN	O	by	pcomp	7	SENT_267	[p9l209t42r247b81],
9	metabolism	NN	O	metabolism	pobj	8	SENT_267	[p9l259t42r441b71],
10	via	IN	O	via	_	0	SENT_267	[p9l454t43r498b71],
11	UGTIAI	NNP	LOCATION	UGTIAI	prep_via	9	SENT_267	[p9l512t43r674b77],
12	,	,	O	,	_	0	SENT_267	[p9l512t43r674b77],
13	and	CC	O	and	_	0	SENT_267	[p9l690t42r745b71],
14	studies	NNS	O	study	conj_and	2	SENT_267	[p9l759t42r865b71],
15	were	VBD	O	be	auxpass	16	SENT_267	[p9l878t53r953b71],
16	conducted	VBN	O	conduct	_	0	SENT_267	[p9l968t42r1130b71],
17	evaluating	VBG	O	evaluate	xcomp	16	SENT_267	[p9l1145t42r1305b81],
18	the	DT	O	the	det	19	SENT_267	[p9l1318t42r1366b71],
19	effect	NN	O	effect	dobj	17	SENT_267	[p9l1381t42r1467b71],
20	of	IN	O	of	_	0	SENT_267	[p9l1481t42r1515b71],
21	inducers	NNS	O	inducer	prep_of	19	SENT_267	[p9l1524t42r1656b71],
22	and	CC	O	and	_	0	SENT_267	[p9l1671t42r1726b71],
23	inhibitors	NNS	O	inhibitor	prep_of	19	SENT_267	[p9l209t92r361b121],
24	of	IN	O	of	_	0	SENT_267	[p9l374t92r408b121],
25	drug	NN	O	drug	nn	27	SENT_267	[p9l417t92r490b131],
26	metabolizing	VBG	O	metabolize	amod	27	SENT_267	[p9l502t92r707b131],
27	enzymes	NNS	O	enzyme	prep_of	19	SENT_267	[p9l719t103r852b131],
28	(	CD	NUMBER	(	nsubjpass	16	SENT_267	[p9l865t92r1025b131],
29	including	VBG	O	include	_	0	SENT_267	[p9l865t92r1025b131],
30	UGTIAI	NNP	O	UGTIAI	prep_including	28	SENT_267	[p9l1036t93r1201b128],
31	)	CD	NUMBER	)	num	30	SENT_267	[p9l1036t93r1201b128],
32	on	IN	O	on	_	0	SENT_267	[p9l1215t103r1254b121],
33	raltegravir	NN	O	raltegravir	nn	34	SENT_267	[p9l1266t92r1430b131],
34	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	30	SENT_267	[p9l1441t92r1725b130],
35	.	.	O	.	_	0	SENT_267	[p9l1441t92r1725b130],

1	Results	NNS	O	result	nsubjpass	3	SENT_268	[p9l209t142r321b171],
2	are	VBP	O	be	auxpass	3	SENT_268	[p9l333t153r379b171],
3	summarized	VBN	O	summarize	_	0	SENT_268	[p9l391t142r581b171],
4	in	IN	O	in	_	0	SENT_268	[p9l592t144r622b171],
5	Table	NNP	O	Table	prep_in	3	SENT_268	[p9l632t142r728b171],
6	2	CD	NUMBER	2	num	5	SENT_268	[p9l740t144r767b171],
7	.	.	O	.	_	0	SENT_268	[p9l740t144r767b171],

1	As	IN	O	as	mark	2	SENT_269	[p9l257t193r295b221],
2	anticipated	VBN	O	anticipate	advcl	8	SENT_269	[p9l311t192r491b230],
3	,	,	O	,	_	0	SENT_269	[p9l311t192r491b230],
4	raltegravir	NN	O	raltegravir	nn	6	SENT_269	[p9l507t192r670b230],
5	plasma	NN	O	plasma	nn	6	SENT_269	[p9l684t192r791b230],
6	levels	NNS	O	level	nsubjpass	8	SENT_269	[p9l805t192r890b221],
7	were	VBD	O	be	auxpass	8	SENT_269	[p9l904t203r979b221],
8	increased	VBN	O	increase	_	0	SENT_269	[p9l993t192r1139b221],
9	with	IN	O	with	_	0	SENT_269	[p9l1153t192r1223b221],
10	coadministration	NN	O	coadministration	prep_with	8	SENT_269	[p9l1238t192r1503b221],
11	of	IN	O	of	_	0	SENT_269	[p9l1518t192r1552b221],
12	atazanavir	NN	O	atazanavir	prep_of	10	SENT_269	[p9l1563t193r1725b227],
13	,	,	O	,	_	0	SENT_269	[p9l1563t193r1725b227],
14	consistent	JJ	O	consistent	amod	26	SENT_269	[p9l209t243r367b271],
15	with	IN	O	with	_	0	SENT_269	[p9l372t242r442b271],
16	the	DT	O	the	det	19	SENT_269	[p9l448t242r497b271],
17	known	JJ	O	known	amod	19	SENT_269	[p9l504t242r610b271],
18	inhibitory	JJ	O	inhibitory	amod	19	SENT_269	[p9l616t242r774b280],
19	effect	NN	O	effect	prep_with	14	SENT_269	[p9l780t242r866b271],
20	of	IN	O	of	_	0	SENT_269	[p9l873t242r907b271],
21	atazanavir	NN	O	atazanavir	prep_of	19	SENT_269	[p9l910t243r1067b271],
22	on	IN	O	on	_	0	SENT_269	[p9l1074t253r1113b271],
23	UGT1A1	NN	O	ugt1a1	prep_on	21	SENT_269	[p9l1120t242r1270b271],
24	(	CD	NUMBER	(	num	23	SENT_269	[p9l1281t243r1349b278],
25	47	CD	NUMBER	47	tmod	14	SENT_269	[p9l1281t243r1349b278],
26	)	NN	O	)	appos	12	SENT_269	[p9l1281t243r1349b278],
27	.	.	O	.	_	0	SENT_269	[p9l1281t243r1349b278],

1	The	DT	O	the	det	2	SENT_270	[p9l1357t242r1423b271],
2	increases	NNS	O	increase	nsubj	6	SENT_270	[p9l1430t243r1579b277],
3	,	,	O	,	_	0	SENT_270	[p9l1430t243r1579b277],
4	however	RB	O	however	advmod	6	SENT_270	[p9l1587t242r1725b277],
5	,	,	O	,	_	0	SENT_270	[p9l1587t242r1725b277],
6	were	VBD	O	be	_	0	SENT_270	[p9l208t302r282b320],
7	on	IN	O	on	dep	6	SENT_270	[p9l297t302r336b320],
8	the	DT	O	the	det	10	SENT_270	[p9l349t291r398b320],
9	whole	JJ	O	whole	amod	10	SENT_270	[p9l410t291r504b320],
10	modest	JJ	O	modest	pobj	7	SENT_270	[p9l518t292r632b320],
11	and	CC	O	and	_	0	SENT_270	[p9l645t291r701b320],
12	not	RB	O	not	dep	6	SENT_270	[p9l713t300r767b320],
13	considered	VBN	O	consider	dep	7	SENT_270	[p9l780t291r949b320],
14	clinically	RB	O	clinically	advmod	15	SENT_270	[p9l962t291r1103b330],
15	meaningful	JJ	O	meaningful	acomp	13	SENT_270	[p9l1114t291r1291b330],
16	based	VBN	O	base	_	0	SENT_270	[p9l1305t291r1391b320],
17	on	IN	O	on	prepc_based_on	13	SENT_270	[p9l1405t302r1444b320],
18	the	DT	O	the	det	22	SENT_270	[p9l1457t291r1506b320],
19	overall	JJ	O	overall	amod	22	SENT_270	[p9l1520t291r1625b320],
20	safety	NN	O	safety	nn	22	SENT_270	[p9l1638t292r1728b330],
21	database	NN	O	database	nn	22	SENT_270	[p9l209t341r341b370],
22	inclusive	NN	O	inclusive	pobj	13	SENT_270	[p9l352t341r487b370],
23	of	IN	O	of	_	0	SENT_270	[p9l499t341r533b370],
24	patients	NNS	O	patient	prep_of	22	SENT_270	[p9l540t343r662b380],
25	receiving	VBG	O	receive	partmod	24	SENT_270	[p9l673t343r817b380],
26	raltegravir	NN	O	raltegravir	dobj	25	SENT_270	[p9l827t341r990b380],
27	in	IN	O	in	_	0	SENT_270	[p9l1001t343r1031b370],
28	conjunction	NN	O	conjunction	prep_in	26	SENT_270	[p9l1042t343r1229b380],
29	with	IN	O	with	_	0	SENT_270	[p9l1238t341r1308b370],
30	atazanavir	NN	O	atazanavir	prep_with	25	SENT_270	[p9l1320t343r1477b370],
31	(	CD	NUMBER	(	number	32	SENT_270	[p9l1488t342r1556b378],
32	41	CD	NUMBER	41	num	33	SENT_270	[p9l1488t342r1556b378],
33	)	NN	O	)	dep	25	SENT_270	[p9l1488t342r1556b378],
34	.	.	O	.	_	0	SENT_270	[p9l1488t342r1556b378],

1	Both	DT	O	both	det	3	SENT_271	[p9l259t391r335b420],
2	ritonavir-boosted	JJ	O	ritonavir-boosted	amod	3	SENT_271	[p9l346t391r618b420],
3	tipranavir	NN	O	tipranavir	nsubj	6	SENT_271	[p9l630t393r782b429],
4	and	CC	O	and	_	0	SENT_271	[p9l793t391r849b420],
5	rifampin	NN	O	rifampin	conj_and	3	SENT_271	[p9l860t391r994b429],
6	decreased	VBD	O	decrease	_	0	SENT_271	[p9l1006t391r1157b420],
7	plasma	NN	O	plasma	nn	8	SENT_271	[p9l1168t391r1276b429],
8	levels	NNS	O	level	dobj	6	SENT_271	[p9l1287t391r1371b420],
9	of	IN	O	of	_	0	SENT_271	[p9l1383t391r1417b420],
10	raltegravir	NN	O	raltegravir	prep_of	8	SENT_271	[p9l1424t391r1587b430],
11	(	CD	NUMBER	(	num	12	SENT_271	[p9l1599t392r1655b427],
12	48	CD	NUMBER	48	tmod	6	SENT_271	[p9l1599t392r1655b427],
13	,	,	O	,	_	0	SENT_271	[p9l1599t392r1655b427],
14	49	CD	NUMBER	49	num	15	SENT_271	[p9l1668t392r1725b427],
15	)	NN	O	)	appos	12	SENT_271	[p9l1668t392r1725b427],
16	.	.	O	.	_	0	SENT_271	[p9l1668t392r1725b427],

1	The	DT	O	the	det	2	SENT_272	[p9l208t441r274b470],
2	interaction	NN	O	interaction	nsubj	5	SENT_272	[p9l285t442r457b470],
3	is	VBZ	O	be	cop	5	SENT_272	[p9l467t442r490b470],
4	likely	JJ	O	likely	amod	5	SENT_272	[p9l502t441r587b479],
5	secondary	JJ	O	secondary	_	0	SENT_272	[p9l597t441r755b479],
6	to	TO	O	to	_	0	SENT_272	[p9l764t449r795b470],
7	a	DT	O	a	det	10	SENT_272	[p9l807t452r822b470],
8	modest	JJ	O	modest	amod	10	SENT_272	[p9l833t441r947b470],
9	inductive	JJ	O	inductive	amod	10	SENT_272	[p9l957t441r1101b470],
10	effect	NN	O	effect	prep_to	5	SENT_272	[p9l1113t441r1199b470],
11	of	IN	O	of	_	0	SENT_272	[p9l1210t441r1244b470],
12	tipranavir	NN	O	tipranavir	prep_of	10	SENT_272	[p9l1251t442r1404b479],
13	and	CC	O	and	_	0	SENT_272	[p9l1415t441r1470b470],
14	rifampin	NN	O	rifampin	conj_and	12	SENT_272	[p9l1481t441r1616b479],
15	on	IN	O	on	_	0	SENT_272	[p9l1627t452r1667b470],
16	the	DT	O	the	det	17	SENT_272	[p9l1678t441r1726b470],
17	metabolism	NN	O	metabolism	prep_on	5	SENT_272	[p9l208t491r391b520],
18	of	IN	O	of	_	0	SENT_272	[p9l398t491r433b520],
19	raltegravir	NN	O	raltegravir	prep_of	17	SENT_272	[p9l435t491r604b529],
20	.	.	O	.	_	0	SENT_272	[p9l435t491r604b529],

1	In	IN	O	in	_	0	SENT_273	[p9l612t492r646b519],
2	both	DT	O	both	det	3	SENT_273	[p9l653t491r725b520],
3	cases	NNS	O	case	prep_in	11	SENT_273	[p9l732t502r817b526],
4	,	,	O	,	_	0	SENT_273	[p9l732t502r817b526],
5	raltegravir	NN	O	raltegravir	nn	6	SENT_273	[p9l825t491r988b529],
6	C12	NN	O	c12	nsubjpass	11	SENT_273	[p9l996t492r1046b525],
7	hr	NN	DURATION	hr	nn	8	SENT_273	[p9l1053t506r1076b525],
8	value	NN	O	value	dep	6	SENT_273	[p9l1083t491r1164b520],
9	was	VBD	O	be	auxpass	11	SENT_273	[p9l1171t502r1227b520],
10	most	RBS	O	most	advmod	11	SENT_273	[p9l1234t499r1312b520],
11	impacted	VBN	O	impact	_	0	SENT_273	[p9l1317t491r1469b529],
12	.	.	O	.	_	0	SENT_273	[p9l1317t491r1469b529],

1	The	DT	O	the	det	4	SENT_274	[p9l1476t491r1543b520],
2	prescribing	VBG	O	prescribe	amod	4	SENT_274	[p9l1550t491r1728b529],
3	information	NN	O	information	nn	4	SENT_274	[p9l208t541r397b570],
4	states	NNS	O	state	nsubjpass	9	SENT_274	[p9l407t549r491b570],
5	that	WDT	O	that	nsubj	6	SENT_274	[p9l502t541r564b570],
6	caution	VBP	O	caution	rcmod	4	SENT_274	[p9l574t542r689b570],
7	should	MD	O	should	aux	9	SENT_274	[p9l699t540r803b570],
8	be	VB	O	be	auxpass	9	SENT_274	[p9l813t540r849b570],
9	used	VBN	O	use	_	0	SENT_274	[p9l859t540r929b570],
10	when	WRB	O	when	advmod	11	SENT_274	[p9l939t540r1024b570],
11	coadministering	VBG	O	coadminister	advcl	9	SENT_274	[p9l1034t540r1288b579],
12	raltegravir	NN	O	raltegravir	dobj	11	SENT_274	[p9l1297t541r1460b579],
13	with	IN	O	with	_	0	SENT_274	[p9l1469t541r1539b569],
14	rifampin	NN	O	rifampin	prep_with	12	SENT_274	[p9l1549t541r1683b579],
15	or	CC	O	or	_	0	SENT_274	[p9l1694t551r1727b570],
16	other	JJ	O	other	amod	18	SENT_274	[p9l209t590r293b619],
17	strong	JJ	O	strong	amod	18	SENT_274	[p9l302t599r402b629],
18	inducers	NNS	O	inducer	conj_or	12	SENT_274	[p9l409t590r541b619],
19	of	IN	O	of	_	0	SENT_274	[p9l551t591r585b619],
20	UGT1A1	NN	O	ugt1a1	prep_of	18	SENT_274	[p9l590t591r752b619],
21	.	.	O	.	_	0	SENT_274	[p9l590t591r752b619],

1	For	IN	O	for	_	0	SENT_275	[p9l762t592r819b619],
2	tipranavir	NN	O	tipranavir	prep_for	8	SENT_275	[p9l827t592r985b629],
3	,	,	O	,	_	0	SENT_275	[p9l827t592r985b629],
4	the	DT	O	the	det	5	SENT_275	[p9l995t590r1044b619],
5	decreases	NNS	O	decrease	nsubjpass	8	SENT_275	[p9l1054t590r1199b619],
6	are	VBP	O	be	auxpass	8	SENT_275	[p9l1209t601r1255b619],
7	not	RB	O	not	neg	8	SENT_275	[p9l1263t599r1317b619],
8	considered	VBN	O	consider	_	0	SENT_275	[p9l1325t590r1494b619],
9	to	TO	O	to	aux	12	SENT_275	[p9l1503t599r1534b619],
10	be	VB	O	be	cop	12	SENT_275	[p9l1543t590r1578b619],
11	clinically	RB	O	clinically	advmod	12	SENT_275	[p9l1588t590r1728b629],
12	meaningful	JJ	O	meaningful	xcomp	8	SENT_275	[p9l209t640r386b679],
13	based	VBN	O	base	_	0	SENT_275	[p9l393t640r479b669],
14	on	IN	O	on	prepc_based_on	12	SENT_275	[p9l487t651r526b669],
15	the	DT	O	the	det	18	SENT_275	[p9l533t640r582b669],
16	clinical	JJ	O	clinical	amod	18	SENT_275	[p9l590t640r700b669],
17	efﬁcacy	NN	O	efﬁcacy	nn	18	SENT_275	[p9l707t640r825b679],
18	database	NN	O	database	pobj	12	SENT_275	[p9l831t640r962b669],
19	(	CD	NUMBER	(	number	20	SENT_275	[p9l971t641r1039b676],
20	40	CD	NUMBER	40	num	21	SENT_275	[p9l971t641r1039b676],
21	)	NN	O	)	dep	18	SENT_275	[p9l971t641r1039b676],
22	.	.	O	.	_	0	SENT_275	[p9l971t641r1039b676],

1	Clinical	JJ	O	clinical	amod	3	SENT_276	[p9l1048t640r1170b669],
2	efﬁcacy	NN	O	efﬁcacy	nn	3	SENT_276	[p9l1178t640r1295b679],
3	data	NNS	O	datum	nsubj	5	SENT_276	[p9l1301t640r1365b669],
4	are	VBP	O	be	cop	5	SENT_276	[p9l1373t651r1419b669],
5	available	JJ	O	available	_	0	SENT_276	[p9l1427t640r1560b669],
6	in	IN	O	in	_	0	SENT_276	[p9l1567t642r1597b669],
7	patients	NNS	O	patient	prep_in	5	SENT_276	[p9l1604t642r1726b678],

1	Table	NNP	O	Table	dep	121	SENT_277	[p9l212t729r297b755],
2	1	CD	NUMBER	1	dep	121	SENT_277	[p9l311t731r322b754],
3	Summary	NNP	O	Summary	dep	121	SENT_277	[p9l360t730r504b763],
4	of	IN	O	of	dep	121	SENT_277	[p9l514t729r546b755],
5	raltegravir	NN	O	raltegravir	dep	121	SENT_277	[p9l553t729r711b763],
6	drug-drug	NN	O	drug-drug	dep	121	SENT_277	[p9l720t729r877b763],
7	interactions	NNS	O	interaction	dep	121	SENT_277	[p9l886t730r1073b755],
8	:	:	O	:	_	0	SENT_277	[p9l886t730r1073b755],
9	effect	NN	O	effect	dep	121	SENT_277	[p9l1085t729r1169b755],
10	of	IN	O	of	dep	121	SENT_277	[p9l1179t729r1212b755],
11	raltegravir	NN	O	raltegravir	dep	121	SENT_277	[p9l1218t729r1376b763],
12	on	IN	O	on	dep	121	SENT_277	[p9l1385t739r1423b755],
13	coadministered	JJ	O	coadministered	dep	121	SENT_277	[p9l1433t729r1665b755],
14	agent	NN	O	agent	dep	121	SENT_277	[p9l1676t736r1759b763],
15	pharmacokinetics	NNS	O	pharmacokinetic	dep	121	SENT_277	[p9l1768t729r2033b763],
16	Coadministered	JJ	O	coadministered	dep	121	SENT_277	[p9l213t793r455b819],
17	agent	NN	O	agent	dep	121	SENT_277	[p9l466t800r549b828],
18	AUC	NN	O	auc	dep	121	SENT_277	[p9l790t794r880b819],
19	”	CD	NUMBER	”	dep	121	SENT_277	[p9l790t794r880b819],
20	GMR	NNP	O	GMR	dep	121	SENT_277	[p9l893t794r979b819],
21	(	CD	PERCENT	(	dep	121	SENT_277	[p9l989t794r1064b825],
22	90	CD	PERCENT	90	dep	121	SENT_277	[p9l989t794r1064b825],
23	%	NN	PERCENT	%	dep	121	SENT_277	[p9l989t794r1064b825],
24	CI	NN	O	ci	dep	121	SENT_277	[p9l1077t794r1126b825],
25	)	CD	NUMBER	)	dep	121	SENT_277	[p9l1077t794r1126b825],
26	Cm	NN	O	cm	dep	121	SENT_277	[p9l1265t794r1337b824],
27	“	CD	NUMBER	“	dep	121	SENT_277	[p9l1265t794r1337b824],
28	GMR	NNP	O	GMR	dep	121	SENT_277	[p9l1349t794r1435b819],
29	(	CD	PERCENT	(	dep	121	SENT_277	[p9l1445t794r1521b826],
30	90	CD	PERCENT	90	dep	121	SENT_277	[p9l1445t794r1521b826],
31	%	NN	PERCENT	%	dep	121	SENT_277	[p9l1445t794r1521b826],
32	CI	NN	O	ci	dep	121	SENT_277	[p9l1534t794r1583b826],
33	)	CD	NUMBER	)	dep	121	SENT_277	[p9l1534t794r1583b826],
34	Cmmghb	NNP	O	Cmmghb	dep	121	SENT_277	[p9l1709t787r1823b833],
35	GMR	NNP	O	GMR	dep	121	SENT_277	[p9l1836t794r1922b819],
36	(	CD	PERCENT	(	dep	121	SENT_277	[p9l1932t794r2008b826],
37	90	CD	PERCENT	90	dep	121	SENT_277	[p9l1932t794r2008b826],
38	%	NN	PERCENT	%	dep	121	SENT_277	[p9l1932t794r2008b826],
39	CI	NN	O	ci	dep	121	SENT_277	[p9l2021t794r2069b826],
40	)	CD	NUMBER	)	dep	121	SENT_277	[p9l2021t794r2069b826],
41	Ethinyl	NNP	O	Ethinyl	dep	121	SENT_277	[p9l213t845r317b879],
42	Estradiol	NNP	O	Estradiol	dep	121	SENT_277	[p9l327t845r453b871],
43	0.98	CD	NUMBER	0.98	dep	121	SENT_277	[p9l847t846r904b871],
44	(	CD	NUMBER	(	dep	121	SENT_277	[p9l916t845r992b877],
45	0.93	CD	NUMBER	0.93	dep	121	SENT_277	[p9l916t845r992b877],
46	,	,	O	,	_	0	SENT_277	[p9l916t845r992b877],
47	1.04	CD	NUMBER	1.04	dep	121	SENT_277	[p9l1006t845r1072b877],
48	)	NN	O	)	dep	121	SENT_277	[p9l1006t845r1072b877],
49	1.06	CD	NUMBER	1.06	dep	121	SENT_277	[p9l1314t846r1370b870],
50	(	CD	NUMBER	(	dep	121	SENT_277	[p9l1381t846r1457b877],
51	0.98	CD	NUMBER	0.98	dep	121	SENT_277	[p9l1381t846r1457b877],
52	,	,	O	,	_	0	SENT_277	[p9l1381t846r1457b877],
53	1.14	CD	NUMBER	1.14	dep	121	SENT_277	[p9l1471t846r1537b877],
54	)	CD	NUMBER	)	dep	121	SENT_277	[p9l1471t846r1537b877],
55	—	NN	O	—	dep	121	SENT_277	[p9l1881t861r1898b863],
56	Etravirine	NN	O	etravirine	dep	121	SENT_277	[p9l213t897r353b922],
57	1.10	CD	NUMBER	1.10	dep	121	SENT_277	[p9l850t898r905b922],
58	(	NN	O	(	dep	121	SENT_277	[p9l916t897r992b929],
59	1.03	CD	NUMBER	1.03	dep	121	SENT_277	[p9l916t897r992b929],
60	,	,	O	,	_	0	SENT_277	[p9l916t897r992b929],
61	1.16	CD	NUMBER	1.16	dep	121	SENT_277	[p9l1006t897r1072b929],
62	)	NN	O	)	dep	121	SENT_277	[p9l1006t897r1072b929],
63	1.04	CD	NUMBER	1.04	dep	121	SENT_277	[p9l1315t897r1457b929],
64	(	CD	NUMBER	(	dep	121	SENT_277	[p9l1315t897r1457b929],
65	0.97	CD	NUMBER	0.97	dep	121	SENT_277	[p9l1315t897r1457b929],
66	,	,	O	,	_	0	SENT_277	[p9l1315t897r1457b929],
67	1.12	CD	NUMBER	1.12	dep	121	SENT_277	[p9l1471t897r1537b929],
68	)	CD	NUMBER	)	dep	121	SENT_277	[p9l1471t897r1537b929],
69	1.17	CD	NUMBER	1.17	dep	121	SENT_277	[p9l1779t897r1834b923],
70	(	NN	O	(	dep	121	SENT_277	[p9l1846t897r1922b929],
71	1.10	CD	NUMBER	1.10	dep	121	SENT_277	[p9l1846t897r1922b929],
72	,	,	O	,	_	0	SENT_277	[p9l1846t897r1922b929],
73	1.26	CD	NUMBER	1.26	dep	121	SENT_277	[p9l1936t897r2002b929],
74	)	CD	NUMBER	)	dep	121	SENT_277	[p9l1936t897r2002b929],
75	Midazolam	NNP	O	Midazolam	dep	121	SENT_277	[p9l212t948r370b974],
76	0.92	CD	NUMBER	0.92	dep	121	SENT_277	[p9l847t949r903b974],
77	(	CD	NUMBER	(	dep	121	SENT_277	[p9l916t949r992b980],
78	0.82	CD	NUMBER	0.82	dep	121	SENT_277	[p9l916t949r992b980],
79	,	,	O	,	_	0	SENT_277	[p9l916t949r992b980],
80	1.03	CD	NUMBER	1.03	dep	121	SENT_277	[p9l1006t949r1072b980],
81	)	NN	O	)	dep	121	SENT_277	[p9l1006t949r1072b980],
82	1.03	CD	NUMBER	1.03	dep	121	SENT_277	[p9l1314t949r1367b974],
83	(	CD	NUMBER	(	dep	121	SENT_277	[p9l1381t949r1457b980],
84	0.87	CD	NUMBER	0.87	dep	121	SENT_277	[p9l1381t949r1457b980],
85	,	,	O	,	_	0	SENT_277	[p9l1381t949r1457b980],
86	1.22	CD	NUMBER	1.22	dep	121	SENT_277	[p9l1471t949r1537b980],
87	)	CD	NUMBER	)	dep	121	SENT_277	[p9l1471t949r1537b980],
88	—	NN	O	—	dep	121	SENT_277	[p9l1881t964r1898b966],
89	Norelgestromin	JJ	O	norelgestromin	dep	121	SENT_277	[p9l212t999r438b1034],
90	1.14	CD	NUMBER	1.14	dep	121	SENT_277	[p9l849t1001r906b1025],
91	(	CD	NUMBER	(	dep	121	SENT_277	[p9l916t1000r992b1032],
92	1.08	CD	NUMBER	1.08	dep	121	SENT_277	[p9l916t1000r992b1032],
93	,	,	O	,	_	0	SENT_277	[p9l916t1000r992b1032],
94	1.21	CD	NUMBER	1.21	dep	121	SENT_277	[p9l1006t1000r1072b1032],
95	)	CD	NUMBER	)	dep	121	SENT_277	[p9l1006t1000r1072b1032],
96	1.29	CD	NUMBER	1.29	dep	121	SENT_277	[p9l1315t1001r1370b1025],
97	(	NN	O	(	dep	121	SENT_277	[p9l1381t1000r1457b1032],
98	1.23	CD	NUMBER	1.23	dep	121	SENT_277	[p9l1381t1000r1457b1032],
99	,	,	O	,	_	0	SENT_277	[p9l1381t1000r1457b1032],
100	1.37	CD	NUMBER	1.37	dep	121	SENT_277	[p9l1471t1000r1537b1032],
101	)	CD	NUMBER	)	dep	121	SENT_277	[p9l1471t1000r1537b1032],
102	—	CD	NUMBER	—	dep	121	SENT_277	[p9l1881t1016r1898b1018],
103	Tenofovir	NNP	O	Tenofovir	dep	121	SENT_277	[p9l212t1051r349b1077],
104	0.90	CD	NUMBER	0.90	dep	121	SENT_277	[p9l847t1053r905b1077],
105	(	CD	NUMBER	(	dep	121	SENT_277	[p9l916t1052r992b1083],
106	0.82	CD	NUMBER	0.82	dep	121	SENT_277	[p9l916t1052r992b1083],
107	,	,	O	,	_	0	SENT_277	[p9l916t1052r992b1083],
108	0.99	CD	NUMBER	0.99	dep	121	SENT_277	[p9l1004t1052r1072b1083],
109	)	CD	NUMBER	)	dep	121	SENT_277	[p9l1004t1052r1072b1083],
110	0.77	CD	NUMBER	0.77	dep	121	SENT_277	[p9l1312t1052r1369b1077],
111	(	NN	O	(	dep	121	SENT_277	[p9l1381t1052r1457b1083],
112	0.69	CD	NUMBER	0.69	dep	121	SENT_277	[p9l1381t1052r1457b1083],
113	,	,	O	,	_	0	SENT_277	[p9l1381t1052r1457b1083],
114	0.85	CD	NUMBER	0.85	dep	121	SENT_277	[p9l1469t1052r1537b1083],
115	)	CD	NUMBER	)	dep	121	SENT_277	[p9l1469t1052r1537b1083],
116	0.87	CD	NUMBER	0.87	dep	121	SENT_277	[p9l1777t1052r1834b1077],
117	(	NN	O	(	dep	121	SENT_277	[p9l1846t1052r1922b1083],
118	0.74	CD	NUMBER	0.74	dep	121	SENT_277	[p9l1846t1052r1922b1083],
119	,	,	O	,	_	0	SENT_277	[p9l1846t1052r1922b1083],
120	1.02	CD	NUMBER	1.02	dep	121	SENT_277	[p9l1936t1052r2002b1083],
121	)	NN	O	)	_	0	SENT_277	[p9l1936t1052r2002b1083],

1	“	NN	O	“	nn	2	SENT_278	[p9l213t1143r332b1168],
2	AUCo-oo	NN	O	auco-oo	_	0	SENT_278	[p9l213t1143r332b1168],
3	for	IN	O	for	_	0	SENT_278	[p9l343t1142r378b1164],
4	midazolam	NN	O	midazolam	prep_for	2	SENT_278	[p9l386t1142r526b1169],
5	;	:	O	;	_	0	SENT_278	[p9l386t1142r526b1169],
6	AUC0_z4	NN	O	auc0_z4	nn	7	SENT_278	[p9l535t1143r644b1169],
7	h	NN	O	h	dep	2	SENT_278	[p9l648t1153r668b1169],
8	,	,	O	,	_	0	SENT_278	[p9l648t1153r668b1169],
9	for	IN	O	for	_	0	SENT_278	[p9l678t1142r713b1164],
10	tenofovir	NN	O	tenofovir	nn	13	SENT_278	[p9l721t1142r837b1169],
11	,	,	O	,	_	0	SENT_278	[p9l721t1142r837b1169],
12	ethinyl	NN	O	ethinyl	conj_and	13	SENT_278	[p9l848t1142r932b1172],
13	estradiol	NN	O	estradiol	prep_for	7	SENT_278	[p9l941t1142r1044b1164],
14	and	CC	O	and	_	0	SENT_278	[p9l1053t1142r1096b1164],
15	norelgestromin	NN	O	norelgestromin	conj_and	13	SENT_278	[p9l1105t1142r1300b1172],
16	;	:	O	;	_	0	SENT_278	[p9l1105t1142r1300b1172],
17	AUC0_1	NN	O	auc0_1	dep	2	SENT_278	[p9l1308t1143r1416b1169],
18	;	:	O	;	_	0	SENT_278	[p9l1308t1143r1416b1169],
19	h	NN	O	h	dep	17	SENT_278	[p9l1422t1153r1441b1169],
20	,	,	O	,	_	0	SENT_278	[p9l1422t1153r1441b1169],
21	for	IN	O	for	_	0	SENT_278	[p9l1451t1142r1487b1164],
22	etravirine	NN	O	etravirine	prep_for	19	SENT_278	[p9l1495t1143r1618b1164],
23	.	.	O	.	_	0	SENT_278	[p9l1495t1143r1618b1164],

1	l’C12	NN	O	l’c12	_	0	SENT_279	[p9l213t1174r267b1206],
2	1	CD	NUMBER	1	dep	1	SENT_279	[p9l273t1189r292b1206],
3	,	,	O	,	_	0	SENT_279	[p9l273t1189r292b1206],
4	,	,	O	,	_	0	SENT_279	[p9l273t1189r292b1206],
5	for	IN	O	for	mark	6	SENT_279	[p9l303t1178r338b1201],
6	etravirine	NN	O	etravirine	dep	1	SENT_279	[p9l346t1180r469b1206],
7	;	:	O	;	_	0	SENT_279	[p9l346t1180r469b1206],
8	C24h	NN	O	c24h	dep	6	SENT_279	[p9l479t1179r545b1206],
9	,	,	O	,	_	0	SENT_279	[p9l479t1179r545b1206],
10	for	IN	O	for	_	0	SENT_279	[p9l555t1178r590b1201],
11	tenofovir	NN	O	tenofovir	prep_for	1	SENT_279	[p9l599t1178r717b1206],
12	;	:	O	;	_	0	SENT_279	[p9l599t1178r717b1206],
13	“	CD	NUMBER	“	dep	1	SENT_279	[p9l727t1179r772b1206],
14	.	.	O	.	_	0	SENT_279	[p9l727t1179r772b1206],

1	—	NN	O	—	_	0	SENT_280	[p9l727t1179r772b1206],
2	.	.	O	.	_	0	SENT_280	[p9l727t1179r772b1206],

1	”	NN	O	”	_	0	SENT_281	[p9l727t1179r772b1206],
2	,	,	O	,	_	0	SENT_281	[p9l727t1179r772b1206],
3	not	RB	O	not	neg	4	SENT_281	[p9l781t1185r823b1201],
4	done	VBN	O	do	partmod	1	SENT_281	[p9l831t1178r897b1201],
5	.	.	O	.	_	0	SENT_281	[p9l831t1178r897b1201],

1	GMR	NNP	ORGANIZATION	GMR	_	0	SENT_282	[p9l213t1217r291b1243],
2	,	,	O	,	_	0	SENT_282	[p9l213t1217r291b1243],
3	Geometric	JJ	O	geometric	appos	1	SENT_282	[p9l301t1217r432b1238],
4	mean	NN	O	mean	rcmod	3	SENT_282	[p9l441t1224r507b1238],
5	ratio	NN	O	ratio	dobj	4	SENT_282	[p9l515t1217r578b1243],
6	;	:	O	;	_	0	SENT_282	[p9l515t1217r578b1243],
7	CI	NN	O	ci	dep	5	SENT_282	[p9l588t1217r626b1243],
8	,	,	O	,	_	0	SENT_282	[p9l588t1217r626b1243],
9	Conﬁdence	NN	O	conﬁdence	nn	10	SENT_282	[p9l636t1216r776b1238],
10	interval	NN	O	interval	appos	5	SENT_282	[p9l785t1216r883b1238],
11	.	.	O	.	_	0	SENT_282	[p9l785t1216r883b1238],
12	'	''	O	'	_	0	SENT_282	[p9l1135t1318r1408b1348],

1	www.zmnmtlrew'ew.v.org	NN	O	www.zmnmtlrew'ew.v.org	nn	2	SENT_283	[p9l1135t1318r1408b1348],
2	o	NN	O	o	_	0	SENT_283	[p9l1423t1326r1433b1336],
3	Emerging	VBG	O	emerge	dep	2	SENT_283	[p9l1448t1318r1563b1348],
4	Plmmmmlogy	NN	O	plmmmmlogy	dobj	3	SENT_283	[p9l1569t1318r1727b1348],

1	Table	NNP	O	Table	_	0	SENT_284	[p9l582t1362r667b1388],
2	2	CD	NUMBER	2	num	1	SENT_284	[p9l678t1364r693b1387],
3	Summary	NNP	O	Summary	dep	1	SENT_284	[p9l730t1363r874b1396],
4	of	IN	O	of	_	0	SENT_284	[p9l884t1362r916b1388],
5	raltegravir	NN	O	raltegravir	nn	7	SENT_284	[p9l923t1362r1080b1396],
6	drug-drug	NN	O	drug-drug	nn	7	SENT_284	[p9l1090t1362r1247b1396],
7	interactions	NNS	O	interaction	prep_of	3	SENT_284	[p9l1256t1363r1443b1388],
8	:	:	O	:	_	0	SENT_284	[p9l1256t1363r1443b1388],
9	effect	NN	O	effect	dep	3	SENT_284	[p9l1455t1362r1539b1388],
10	of	IN	O	of	_	0	SENT_284	[p9l1549t1362r1582b1388],
11	coadministered	JJ	O	coadministered	amod	12	SENT_284	[p9l1588t1362r1820b1388],
12	agent	NN	O	agent	prep_of	9	SENT_284	[p9l1831t1369r1913b1396],
13	on	IN	O	on	_	0	SENT_284	[p9l1923t1372r1961b1388],
14	raltegravir	NN	O	raltegravir	nn	15	SENT_284	[p9l583t1408r740b1443],
15	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	12	SENT_284	[p9l750t1408r1015b1443],

1	Coadministered	JJ	O	coadministered	dep	200	SENT_285	[p9l583t1473r825b1499],
2	agent	NN	O	agent	dep	200	SENT_285	[p9l836t1480r919b1508],
3	AUC	NN	O	auc	dep	200	SENT_285	[p9l992t1474r1082b1499],
4	“	CD	NUMBER	“	dep	200	SENT_285	[p9l992t1474r1082b1499],
5	GMR	NNP	O	GMR	dep	200	SENT_285	[p9l1095t1474r1181b1499],
6	(	CD	PERCENT	(	dep	200	SENT_285	[p9l1191t1474r1266b1506],
7	90	CD	PERCENT	90	dep	200	SENT_285	[p9l1191t1474r1266b1506],
8	%	NN	PERCENT	%	dep	200	SENT_285	[p9l1191t1474r1266b1506],
9	CI	NN	O	ci	dep	200	SENT_285	[p9l1279t1474r1328b1506],
10	)	CD	NUMBER	)	dep	200	SENT_285	[p9l1279t1474r1328b1506],
11	Cmax	NNP	O	Cmax	dep	200	SENT_285	[p9l1395t1474r1466b1504],
12	GMR	NNP	O	GMR	dep	200	SENT_285	[p9l1479t1474r1565b1499],
13	(	CD	PERCENT	(	dep	200	SENT_285	[p9l1574t1474r1650b1506],
14	90	CD	PERCENT	90	dep	200	SENT_285	[p9l1574t1474r1650b1506],
15	%	NN	PERCENT	%	dep	200	SENT_285	[p9l1574t1474r1650b1506],
16	CI	NN	O	ci	dep	200	SENT_285	[p9l1663t1474r1712b1506],
17	)	CD	NUMBER	)	dep	200	SENT_285	[p9l1663t1474r1712b1506],
18	C121	NN	O	c121	dep	200	SENT_285	[p9l1771t1474r1854b1505],
19	,	,	O	,	_	0	SENT_285	[p9l1771t1474r1854b1505],
20	,	,	O	,	_	0	SENT_285	[p9l1771t1474r1854b1505],
21	GMR	NNP	ORGANIZATION	GMR	dep	200	SENT_285	[p9l1866t1474r1952b1499],
22	(	CD	PERCENT	(	dep	200	SENT_285	[p9l1962t1474r2038b1506],
23	90	CD	PERCENT	90	dep	200	SENT_285	[p9l1962t1474r2038b1506],
24	%	NN	PERCENT	%	dep	200	SENT_285	[p9l1962t1474r2038b1506],
25	CI	NN	O	ci	dep	200	SENT_285	[p9l2051t1474r2100b1506],
26	)	CD	NUMBER	)	dep	200	SENT_285	[p9l2051t1474r2100b1506],
27	Atazanavir	NNP	O	Atazanavir	dep	200	SENT_285	[p9l581t1526r741b1551],
28	“	CD	NUMBER	“	dep	200	SENT_285	[p9l581t1526r741b1551],
29	1.72	CD	NUMBER	1.72	dep	200	SENT_285	[p9l1051t1526r1105b1551],
30	(	NN	O	(	dep	200	SENT_285	[p9l1118t1526r1194b1557],
31	1.47	CD	NUMBER	1.47	dep	200	SENT_285	[p9l1118t1526r1194b1557],
32	,	,	O	,	_	0	SENT_285	[p9l1118t1526r1194b1557],
33	2.02	CD	NUMBER	2.02	dep	200	SENT_285	[p9l1205t1526r1274b1557],
34	)	CD	NUMBER	)	dep	200	SENT_285	[p9l1205t1526r1274b1557],
35	1.53	CD	NUMBER	1.53	dep	200	SENT_285	[p9l1444t1526r1496b1551],
36	(	NN	O	(	dep	200	SENT_285	[p9l1510t1526r1586b1557],
37	1.11	CD	NUMBER	1.11	dep	200	SENT_285	[p9l1510t1526r1586b1557],
38	,	,	O	,	_	0	SENT_285	[p9l1510t1526r1586b1557],
39	2.12	CD	NUMBER	2.12	dep	200	SENT_285	[p9l1598t1526r1666b1557],
40	)	CD	NUMBER	)	dep	200	SENT_285	[p9l1598t1526r1666b1557],
41	1.95	CD	NUMBER	1.95	dep	200	SENT_285	[p9l1826t1526r1880b1551],
42	(	NN	O	(	dep	200	SENT_285	[p9l1892t1526r1968b1557],
43	1.30	CD	NUMBER	1.30	dep	200	SENT_285	[p9l1892t1526r1968b1557],
44	,	,	O	,	_	0	SENT_285	[p9l1892t1526r1968b1557],
45	2.92	CD	NUMBER	2.92	dep	200	SENT_285	[p9l1980t1526r2048b1557],
46	)	CD	NUMBER	)	dep	200	SENT_285	[p9l1980t1526r2048b1557],
47	Atazanavir/ritonavirb	NN	O	atazanavir/ritonavirb	dep	200	SENT_285	[p9l582t1570r877b1602],
48	1.41	CD	NUMBER	1.41	dep	200	SENT_285	[p9l1051t1578r1104b1602],
49	(	NN	O	(	dep	200	SENT_285	[p9l1118t1577r1194b1608],
50	1.12	CD	NUMBER	1.12	dep	200	SENT_285	[p9l1118t1577r1194b1608],
51	,	,	O	,	_	0	SENT_285	[p9l1118t1577r1194b1608],
52	1.78	CD	NUMBER	1.78	dep	200	SENT_285	[p9l1208t1577r1274b1609],
53	)	NN	O	)	dep	200	SENT_285	[p9l1208t1577r1274b1609],
54	1.24	CD	NUMBER	1.24	dep	200	SENT_285	[p9l1444t1578r1500b1602],
55	(	CD	NUMBER	(	dep	200	SENT_285	[p9l1510t1577r1586b1608],
56	0.87	CD	NUMBER	0.87	dep	200	SENT_285	[p9l1510t1577r1586b1608],
57	,	,	O	,	_	0	SENT_285	[p9l1510t1577r1586b1608],
58	1.77	CD	NUMBER	1.77	dep	200	SENT_285	[p9l1601t1577r1666b1609],
59	)	CD	NUMBER	)	dep	200	SENT_285	[p9l1601t1577r1666b1609],
60	1.77	CD	NUMBER	1.77	dep	200	SENT_285	[p9l1826t1577r1880b1602],
61	(	NN	O	(	dep	200	SENT_285	[p9l1892t1577r1968b1609],
62	1.39	CD	NUMBER	1.39	dep	200	SENT_285	[p9l1892t1577r1968b1609],
63	,	,	O	,	_	0	SENT_285	[p9l1892t1577r1968b1609],
64	2.25	CD	NUMBER	2.25	dep	200	SENT_285	[p9l1980t1577r2048b1609],
65	)	CD	NUMBER	)	dep	200	SENT_285	[p9l1980t1577r2048b1609],
66	Efavirenza	NN	O	efavirenza	dep	200	SENT_285	[p9l583t1628r727b1654],
67	0.64	CD	NUMBER	0.64	dep	200	SENT_285	[p9l1049t1629r1108b1654],
68	(	CD	NUMBER	(	dep	200	SENT_285	[p9l1118t1629r1194b1660],
69	0.52	CD	NUMBER	0.52	dep	200	SENT_285	[p9l1118t1629r1194b1660],
70	,	,	O	,	_	0	SENT_285	[p9l1118t1629r1194b1660],
71	0.80	CD	NUMBER	0.80	dep	200	SENT_285	[p9l1205t1629r1274b1660],
72	)	CD	NUMBER	)	dep	200	SENT_285	[p9l1205t1629r1274b1660],
73	0.64	CD	NUMBER	0.64	dep	200	SENT_285	[p9l1441t1629r1500b1654],
74	(	NN	O	(	dep	200	SENT_285	[p9l1510t1629r1586b1660],
75	0.41	CD	NUMBER	0.41	dep	200	SENT_285	[p9l1510t1629r1586b1660],
76	,	,	O	,	_	0	SENT_285	[p9l1510t1629r1586b1660],
77	0.98	CD	NUMBER	0.98	dep	200	SENT_285	[p9l1598t1629r1666b1660],
78	)	CD	NUMBER	)	dep	200	SENT_285	[p9l1598t1629r1666b1660],
79	0.79	CD	NUMBER	0.79	dep	200	SENT_285	[p9l1823t1629r1881b1654],
80	(	NN	O	(	dep	200	SENT_285	[p9l1892t1629r1968b1660],
81	0.49	CD	NUMBER	0.49	dep	200	SENT_285	[p9l1892t1629r1968b1660],
82	,	,	O	,	_	0	SENT_285	[p9l1892t1629r1968b1660],
83	1.28	CD	NUMBER	1.28	dep	200	SENT_285	[p9l1983t1629r2048b1660],
84	)	CD	NUMBER	)	dep	200	SENT_285	[p9l1983t1629r2048b1660],
85	Etravirineb	NN	O	etravirineb	dep	200	SENT_285	[p9l583t1674r737b1705],
86	0.90	CD	NUMBER	0.90	dep	200	SENT_285	[p9l1049t1681r1107b1705],
87	(	CD	NUMBER	(	dep	200	SENT_285	[p9l1118t1680r1194b1711],
88	0.68	CD	NUMBER	0.68	dep	200	SENT_285	[p9l1118t1680r1194b1711],
89	,	,	O	,	_	0	SENT_285	[p9l1118t1680r1194b1711],
90	1.18	CD	NUMBER	1.18	dep	200	SENT_285	[p9l1208t1680r1274b1711],
91	)	CD	NUMBER	)	dep	200	SENT_285	[p9l1208t1680r1274b1711],
92	0.89	CD	NUMBER	0.89	dep	200	SENT_285	[p9l1441t1681r1499b1705],
93	(	NN	O	(	dep	200	SENT_285	[p9l1510t1680r1586b1711],
94	0.68	CD	NUMBER	0.68	dep	200	SENT_285	[p9l1510t1680r1586b1711],
95	,	,	O	,	_	0	SENT_285	[p9l1510t1680r1586b1711],
96	1.15	CD	NUMBER	1.15	dep	200	SENT_285	[p9l1601t1680r1666b1711],
97	)	CD	NUMBER	)	dep	200	SENT_285	[p9l1601t1680r1666b1711],
98	0.66	CD	NUMBER	0.66	dep	200	SENT_285	[p9l1823t1681r1881b1705],
99	(	NN	O	(	dep	200	SENT_285	[p9l1892t1680r1968b1711],
100	0.34	CD	NUMBER	0.34	dep	200	SENT_285	[p9l1892t1680r1968b1711],
101	,	,	O	,	_	0	SENT_285	[p9l1892t1680r1968b1711],
102	1.26	CD	NUMBER	1.26	dep	200	SENT_285	[p9l1983t1680r2048b1711],
103	)	CD	NUMBER	)	dep	200	SENT_285	[p9l1983t1680r2048b1711],
104	Omeprazolea	NNP	O	Omeprazolea	dep	200	SENT_285	[p9l583t1731r766b1765],
105	3.12	CD	NUMBER	3.12	dep	200	SENT_285	[p9l1050t1732r1105b1757],
106	(	CD	NUMBER	(	dep	200	SENT_285	[p9l1118t1732r1194b1763],
107	2.13	CD	NUMBER	2.13	dep	200	SENT_285	[p9l1118t1732r1194b1763],
108	,	,	O	,	_	0	SENT_285	[p9l1118t1732r1194b1763],
109	4.56	CD	NUMBER	4.56	dep	200	SENT_285	[p9l1205t1732r1274b1763],
110	)	CD	NUMBER	)	dep	200	SENT_285	[p9l1205t1732r1274b1763],
111	4.15	CD	NUMBER	4.15	dep	200	SENT_285	[p9l1440t1732r1498b1757],
112	(	NN	O	(	dep	200	SENT_285	[p9l1510t1732r1586b1763],
113	2.82	CD	NUMBER	2.82	dep	200	SENT_285	[p9l1510t1732r1586b1763],
114	,	,	O	,	_	0	SENT_285	[p9l1510t1732r1586b1763],
115	6.10	CD	NUMBER	6.10	dep	200	SENT_285	[p9l1598t1732r1666b1763],
116	)	CD	NUMBER	)	dep	200	SENT_285	[p9l1598t1732r1666b1763],
117	1.46	CD	NUMBER	1.46	dep	200	SENT_285	[p9l1826t1732r1881b1757],
118	(	NN	O	(	dep	200	SENT_285	[p9l1892t1732r1968b1763],
119	1.10	CD	NUMBER	1.10	dep	200	SENT_285	[p9l1892t1732r1968b1763],
120	,	,	O	,	_	0	SENT_285	[p9l1892t1732r1968b1763],
121	1.93	CD	NUMBER	1.93	dep	200	SENT_285	[p9l1983t1732r2048b1763],
122	)	CD	NUMBER	)	dep	200	SENT_285	[p9l1983t1732r2048b1763],
123	Rifampin	NNP	O	Rifampin	dep	200	SENT_285	[p9l583t1782r724b1816],
124	“	CD	NUMBER	“	dep	200	SENT_285	[p9l583t1782r724b1816],
125	0.60	CD	NUMBER	0.60	dep	200	SENT_285	[p9l1049t1784r1107b1808],
126	(	NN	O	(	dep	200	SENT_285	[p9l1118t1783r1194b1814],
127	0.39	CD	NUMBER	0.39	dep	200	SENT_285	[p9l1118t1783r1194b1814],
128	,	,	O	,	_	0	SENT_285	[p9l1118t1783r1194b1814],
129	0.91	CD	NUMBER	0.91	dep	200	SENT_285	[p9l1205t1783r1274b1814],
130	)	CD	NUMBER	)	dep	200	SENT_285	[p9l1205t1783r1274b1814],
131	0.62	CD	NUMBER	0.62	dep	200	SENT_285	[p9l1441t1784r1497b1808],
132	(	NN	O	(	dep	200	SENT_285	[p9l1510t1783r1586b1814],
133	0.37	CD	NUMBER	0.37	dep	200	SENT_285	[p9l1510t1783r1586b1814],
134	,	,	O	,	_	0	SENT_285	[p9l1510t1783r1586b1814],
135	1.04	CD	NUMBER	1.04	dep	200	SENT_285	[p9l1601t1783r1666b1814],
136	)	CD	NUMBER	)	dep	200	SENT_285	[p9l1601t1783r1666b1814],
137	0.39	CD	NUMBER	0.39	dep	200	SENT_285	[p9l1823t1784r1881b1808],
138	(	NN	O	(	dep	200	SENT_285	[p9l1892t1783r1968b1814],
139	0.30	CD	NUMBER	0.30	dep	200	SENT_285	[p9l1892t1783r1968b1814],
140	,	,	O	,	_	0	SENT_285	[p9l1892t1783r1968b1814],
141	0.51	CD	NUMBER	0.51	dep	200	SENT_285	[p9l1980t1783r2048b1814],
142	)	CD	NUMBER	)	dep	200	SENT_285	[p9l1980t1783r2048b1814],
143	Ritonavir	NNP	O	Ritonavir	dep	200	SENT_285	[p9l583t1835r725b1859],
144	“	CD	NUMBER	“	dep	200	SENT_285	[p9l583t1835r725b1859],
145	0.84	CD	NUMBER	0.84	dep	200	SENT_285	[p9l1049t1835r1108b1860],
146	(	NN	O	(	dep	200	SENT_285	[p9l1118t1835r1194b1866],
147	0.70	CD	NUMBER	0.70	dep	200	SENT_285	[p9l1118t1835r1194b1866],
148	,	,	O	,	_	0	SENT_285	[p9l1118t1835r1194b1866],
149	1.01	CD	NUMBER	1.01	dep	200	SENT_285	[p9l1208t1835r1274b1866],
150	)	CD	NUMBER	)	dep	200	SENT_285	[p9l1208t1835r1274b1866],
151	0.76	CD	NUMBER	0.76	dep	200	SENT_285	[p9l1441t1835r1499b1860],
152	(	NN	O	(	dep	200	SENT_285	[p9l1510t1835r1586b1866],
153	0.55	CD	NUMBER	0.55	dep	200	SENT_285	[p9l1510t1835r1586b1866],
154	,	,	O	,	_	0	SENT_285	[p9l1510t1835r1586b1866],
155	1.04	CD	NUMBER	1.04	dep	200	SENT_285	[p9l1601t1835r1666b1866],
156	)	CD	NUMBER	)	dep	200	SENT_285	[p9l1601t1835r1666b1866],
157	0.99	CD	NUMBER	0.99	dep	200	SENT_285	[p9l1823t1835r1881b1860],
158	(	NN	O	(	dep	200	SENT_285	[p9l1892t1835r1968b1866],
159	0.70	CD	NUMBER	0.70	dep	200	SENT_285	[p9l1892t1835r1968b1866],
160	,	,	O	,	_	0	SENT_285	[p9l1892t1835r1968b1866],
161	1.40	CD	NUMBER	1.40	dep	200	SENT_285	[p9l1983t1835r2048b1866],
162	)	NN	O	)	dep	200	SENT_285	[p9l1983t1835r2048b1866],
163	Tenofovirb	NN	O	tenofovirb	dep	200	SENT_285	[p9l582t1879r732b1911],
164	1.49	CD	NUMBER	1.49	dep	200	SENT_285	[p9l1051t1887r1107b1911],
165	(	NN	O	(	dep	200	SENT_285	[p9l1118t1886r1194b1917],
166	1.15	CD	NUMBER	1.15	dep	200	SENT_285	[p9l1118t1886r1194b1917],
167	,	,	O	,	_	0	SENT_285	[p9l1118t1886r1194b1917],
168	1.94	CD	NUMBER	1.94	dep	200	SENT_285	[p9l1208t1886r1274b1917],
169	)	CD	NUMBER	)	dep	200	SENT_285	[p9l1208t1886r1274b1917],
170	1.64	CD	NUMBER	1.64	dep	200	SENT_285	[p9l1444t1887r1500b1911],
171	(	NN	O	(	dep	200	SENT_285	[p9l1510t1886r1586b1917],
172	1.16	CD	NUMBER	1.16	dep	200	SENT_285	[p9l1510t1886r1586b1917],
173	,	,	O	,	_	0	SENT_285	[p9l1510t1886r1586b1917],
174	2.32	CD	NUMBER	2.32	dep	200	SENT_285	[p9l1598t1886r1666b1917],
175	)	NN	O	)	dep	200	SENT_285	[p9l1598t1886r1666b1917],
176	1.03	CD	NUMBER	1.03	dep	200	SENT_285	[p9l1826t1887r1878b1911],
177	(	CD	NUMBER	(	dep	200	SENT_285	[p9l1892t1886r1968b1917],
178	0.73	CD	NUMBER	0.73	dep	200	SENT_285	[p9l1892t1886r1968b1917],
179	,	,	O	,	_	0	SENT_285	[p9l1892t1886r1968b1917],
180	1.45	CD	NUMBER	1.45	dep	200	SENT_285	[p9l1983t1886r2048b1917],
181	)	CD	NUMBER	)	dep	200	SENT_285	[p9l1983t1886r2048b1917],
182	Tipranavir/ritonavirb	NN	O	tipranavir/ritonavirb	dep	200	SENT_285	[p9l582t1931r879b1971],
183	0.76	CD	NUMBER	0.76	dep	200	SENT_285	[p9l1049t1938r1107b1963],
184	(	CD	NUMBER	(	dep	200	SENT_285	[p9l1118t1937r1194b1969],
185	0.49	CD	NUMBER	0.49	dep	200	SENT_285	[p9l1118t1937r1194b1969],
186	,	,	O	,	_	0	SENT_285	[p9l1118t1937r1194b1969],
187	1.19	CD	NUMBER	1.19	dep	200	SENT_285	[p9l1208t1937r1274b1969],
188	)	CD	NUMBER	)	dep	200	SENT_285	[p9l1208t1937r1274b1969],
189	0.82	CD	NUMBER	0.82	dep	200	SENT_285	[p9l1441t1938r1497b1962],
190	(	NN	O	(	dep	200	SENT_285	[p9l1510t1937r1586b1969],
191	0.46	CD	NUMBER	0.46	dep	200	SENT_285	[p9l1510t1937r1586b1969],
192	,	,	O	,	_	0	SENT_285	[p9l1510t1937r1586b1969],
193	1.46	CD	NUMBER	1.46	dep	200	SENT_285	[p9l1601t1937r1666b1969],
194	)	CD	NUMBER	)	dep	200	SENT_285	[p9l1601t1937r1666b1969],
195	0.45	CD	NUMBER	0.45	dep	200	SENT_285	[p9l1823t1938r1880b1963],
196	(	NN	O	(	dep	200	SENT_285	[p9l1892t1937r1968b1969],
197	0.31	CD	NUMBER	0.31	dep	200	SENT_285	[p9l1892t1937r1968b1969],
198	,	,	O	,	_	0	SENT_285	[p9l1892t1937r1968b1969],
199	0.66	CD	NUMBER	0.66	dep	200	SENT_285	[p9l1980t1937r2048b1969],
200	)	NN	O	)	_	0	SENT_285	[p9l1980t1937r2048b1969],

1	“	NN	O	“	_	0	SENT_286	[p9l583t2027r699b2058],
2	Multiple	JJ	O	multiple	amod	3	SENT_286	[p9l583t2027r699b2058],
3	doses	NNS	O	dose	dep	1	SENT_286	[p9l708t2027r773b2050],
4	of	IN	O	of	_	0	SENT_286	[p9l782t2028r809b2050],
5	concomitant	JJ	O	concomitant	amod	6	SENT_286	[p9l814t2029r968b2050],
6	medication	NN	O	medication	prep_of	3	SENT_286	[p9l975t2027r1111b2050],
7	plus	CC	O	plus	_	0	SENT_286	[p9l1120t2027r1168b2058],
8	single	JJ	O	single	amod	9	SENT_286	[p9l1177t2027r1248b2058],
9	dose	NN	O	dose	conj_plus	3	SENT_286	[p9l1257t2027r1310b2050],
10	of	IN	O	of	_	0	SENT_286	[p9l1320t2028r1346b2050],
11	raltegravir	NN	O	raltegravir	prep_of	9	SENT_286	[p9l1351t2027r1483b2058],
12	.	.	O	.	_	0	SENT_286	[p9l1351t2027r1483b2058],

1	l’Multiple	NN	O	l’multiple	nn	2	SENT_287	[p9l582t2065r701b2099],
2	doses	NNS	O	dose	_	0	SENT_287	[p9l710t2069r775b2092],
3	of	IN	O	of	_	0	SENT_287	[p9l784t2070r811b2092],
4	concomitant	JJ	O	concomitant	amod	5	SENT_287	[p9l816t2071r970b2092],
5	medication	NN	O	medication	prep_of	2	SENT_287	[p9l977t2069r1113b2092],
6	plus	CC	O	plus	prep	2	SENT_287	[p9l1121t2069r1170b2099],
7	multiple	JJ	O	multiple	amod	8	SENT_287	[p9l1179t2069r1281b2099],
8	doses	NNS	O	dose	dep	6	SENT_287	[p9l1290t2069r1354b2092],
9	of	IN	O	of	_	0	SENT_287	[p9l1363t2070r1390b2092],
10	raltegravir	NN	O	raltegravir	prep_of	2	SENT_287	[p9l1395t2070r1527b2099],
11	.	.	O	.	_	0	SENT_287	[p9l1395t2070r1527b2099],

1	°	NN	O	°	_	0	SENT_288	[p9l583t2112r701b2138],
2	AUCo	SYM	O	auco	dep	16	SENT_288	[p9l583t2112r701b2138],
3	-	:	O	-	_	0	SENT_288	[p9l583t2112r701b2138],
4	¢	NN	O	¢	npadvmod	16	SENT_288	[p9l583t2112r701b2138],
5	,	,	O	,	_	0	SENT_288	[p9l583t2112r701b2138],
6	o	NN	O	o	appos	4	SENT_288	[p9l583t2112r701b2138],
7	for	IN	O	for	_	0	SENT_288	[p9l713t2111r748b2134],
8	single	JJ	O	single	amod	9	SENT_288	[p9l756t2111r826b2141],
9	doses	NNS	O	dose	prep_for	6	SENT_288	[p9l836t2111r900b2134],
10	of	IN	O	of	_	0	SENT_288	[p9l909t2111r936b2134],
11	raltegravir	NN	O	raltegravir	prep_of	9	SENT_288	[p9l941t2111r1074b2141],
12	;	:	O	;	_	0	SENT_288	[p9l941t2111r1074b2141],
13	AUCo_12	NN	O	auco_12	nn	14	SENT_288	[p9l1083t2112r1191b2138],
14	h	NN	O	h	dep	6	SENT_288	[p9l1196t2122r1216b2138],
15	,	,	O	,	_	0	SENT_288	[p9l1196t2122r1216b2138],
16	for	IN	O	for	dep	1	SENT_288	[p9l1226t2111r1261b2134],
17	multiple	JJ	O	multiple	amod	18	SENT_288	[p9l1269t2111r1371b2141],
18	doses	NNS	O	dose	pobj	16	SENT_288	[p9l1380t2111r1445b2134],
19	of	IN	O	of	_	0	SENT_288	[p9l1454t2111r1480b2134],
20	raltegravir	NN	O	raltegravir	prep_of	18	SENT_288	[p9l1485t2111r1617b2141],
21	.	.	O	.	_	0	SENT_288	[p9l1485t2111r1617b2141],

1	GMR	NNP	ORGANIZATION	GMR	_	0	SENT_289	[p9l583t2154r661b2180],
2	,	,	O	,	_	0	SENT_289	[p9l583t2154r661b2180],
3	Geometric	JJ	O	geometric	amod	5	SENT_289	[p9l671t2154r802b2176],
4	mean	NN	O	mean	nn	5	SENT_289	[p9l811t2161r877b2175],
5	ratio	NN	O	ratio	appos	1	SENT_289	[p9l885t2154r948b2180],
6	;	:	O	;	_	0	SENT_289	[p9l885t2154r948b2180],
7	CI	NN	O	ci	dep	1	SENT_289	[p9l958t2154r996b2180],
8	,	,	O	,	_	0	SENT_289	[p9l958t2154r996b2180],
9	Conﬁdence	NN	O	conﬁdence	nn	10	SENT_289	[p9l1006t2153r1146b2176],
10	interval	NN	O	interval	appos	7	SENT_289	[p9l1155t2153r1247b2175],
11	(	CD	NUMBER	(	number	12	SENT_289	[p9l1256t2154r1301b2181],
12	41	CD	NUMBER	41	dep	10	SENT_289	[p9l1256t2154r1301b2181],
13	,	,	O	,	_	0	SENT_289	[p9l1256t2154r1301b2181],
14	45	CD	NUMBER	45	appos	1	SENT_289	[p9l1310t2154r1346b2180],
15	,	,	O	,	_	0	SENT_289	[p9l1310t2154r1346b2180],
16	46a	CD	NUMBER	46a	num	17	SENT_289	[p9l1355t2154r1413b2181],
17	)	NN	O	)	appos	1	SENT_289	[p9l1355t2154r1413b2181],
18	.	.	O	.	_	0	SENT_289	[p9l1355t2154r1413b2181],

1	coadministered	VBN	O	coadminister	_	0	SENT_290	[p9l583t2242r823b2271],
2	tipranavir	NN	O	tipranavir	dobj	1	SENT_290	[p9l836t2243r989b2280],
3	in	IN	O	in	_	0	SENT_290	[p9l1001t2243r1031b2270],
4	conjunction	NN	O	conjunction	prep_in	1	SENT_290	[p9l1045t2243r1231b2280],
5	with	IN	O	with	_	0	SENT_290	[p9l1243t2242r1313b2271],
6	raltegravir	NN	O	raltegravir	prep_with	1	SENT_290	[p9l1325t2242r1489b2280],
7	and	CC	O	and	_	0	SENT_290	[p9l1502t2242r1557b2271],
8	no	DT	O	no	det	9	SENT_290	[p9l1570t2253r1609b2271],
9	difference	NN	O	difference	nsubjpass	13	SENT_290	[p9l1623t2242r1779b2271],
10	in	IN	O	in	_	0	SENT_290	[p9l1792t2243r1822b2270],
11	efﬁcacy	NN	O	efﬁcacy	prep_in	9	SENT_290	[p9l1836t2242r1953b2280],
12	was	VBD	O	be	auxpass	13	SENT_290	[p9l1964t2253r2020b2271],
13	seen	VBN	O	see	conj_and	1	SENT_290	[p9l2033t2253r2101b2271],
14	relative	JJ	O	relative	advmod	13	SENT_290	[p9l583t2291r697b2321],
15	to	TO	O	to	_	0	SENT_290	[p9l710t2300r740b2321],
16	the	DT	O	the	det	18	SENT_290	[p9l753t2291r801b2321],
17	complementary	JJ	O	complementary	amod	18	SENT_290	[p9l814t2292r1060b2330],
18	cohort	NN	O	cohort	prep_to	13	SENT_290	[p9l1071t2291r1181b2321],
19	.	.	O	.	_	0	SENT_290	[p9l1071t2291r1181b2321],

1	No	DT	O	no	det	2	SENT_291	[p9l1194t2293r1245b2320],
2	data	NNS	O	datum	nsubj	4	SENT_291	[p9l1259t2291r1322b2321],
3	are	VBP	O	be	cop	4	SENT_291	[p9l1335t2302r1381b2320],
4	available	JJ	O	available	_	0	SENT_291	[p9l1393t2291r1527b2321],
5	in	IN	O	in	_	0	SENT_291	[p9l1539t2293r1569b2320],
6	patients	NNS	O	patient	prep_in	4	SENT_291	[p9l1580t2293r1703b2330],
7	coadministered	VBN	O	coadminister	partmod	6	SENT_291	[p9l1715t2292r1955b2321],
8	rifampin	NN	O	rifampin	dobj	7	SENT_291	[p9l1966t2292r2101b2330],
9	and	CC	O	and	_	0	SENT_291	[p9l583t2341r639b2370],
10	raltegravir	NN	O	raltegravir	dobj	7	SENT_291	[p9l650t2341r821b2380],
11	;	:	O	;	_	0	SENT_291	[p9l650t2341r821b2380],
12	as	IN	O	as	_	0	SENT_291	[p9l834t2352r862b2370],
13	such	JJ	O	such	prep_such_as	18	SENT_291	[p9l874t2341r951b2377],
14	,	,	O	,	_	0	SENT_291	[p9l874t2341r951b2377],
15	caution	NN	O	caution	nsubjpass	18	SENT_291	[p9l964t2343r1080b2370],
16	should	MD	O	should	aux	18	SENT_291	[p9l1091t2341r1194b2370],
17	be	VB	O	be	auxpass	18	SENT_291	[p9l1205t2341r1241b2370],
18	used	VBN	O	use	parataxis	4	SENT_291	[p9l1252t2341r1322b2370],
19	with	IN	O	with	_	0	SENT_291	[p9l1332t2341r1402b2370],
20	coadministration	NN	O	coadministration	prep_with	18	SENT_291	[p9l1413t2341r1679b2370],
21	(	CD	NUMBER	(	number	22	SENT_291	[p9l1691t2342r1759b2378],
22	41	CD	NUMBER	41	num	23	SENT_291	[p9l1691t2342r1759b2378],
23	)	NN	O	)	dep	18	SENT_291	[p9l1691t2342r1759b2378],
24	.	.	O	.	_	0	SENT_291	[p9l1691t2342r1759b2378],

1	Raltegravir	NNP	O	Raltegravir	nsubj	4	SENT_292	[p9l633t2391r808b2430],
2	is	VBZ	O	be	cop	4	SENT_292	[p9l820t2393r842b2420],
3	sparingly	RB	O	sparingly	advmod	4	SENT_292	[p9l856t2391r1000b2430],
4	soluble	JJ	O	soluble	_	0	SENT_292	[p9l1011t2391r1121b2420],
5	in	IN	O	in	_	0	SENT_292	[p9l1134t2393r1164b2420],
6	media	NNS	O	media	prep_in	4	SENT_292	[p9l1177t2391r1271b2420],
7	with	IN	O	with	_	0	SENT_292	[p9l1282t2391r1352b2420],
8	low	JJ	O	low	amod	9	SENT_292	[p9l1365t2391r1421b2420],
9	pH	NN	O	ph	prep_with	6	SENT_292	[p9l1433t2393r1492b2429],
10	,	,	O	,	_	0	SENT_292	[p9l1433t2393r1492b2429],
11	and	CC	O	and	_	0	SENT_292	[p9l1507t2391r1563b2420],
12	solubility	NN	O	solubility	nn	13	SENT_292	[p9l1576t2391r1722b2430],
13	increases	NNS	O	increase	prep_in	4	SENT_292	[p9l1732t2393r1872b2420],
14	at	IN	O	at	_	0	SENT_292	[p9l1886t2399r1914b2420],
15	higher	JJR	O	higher	amod	16	SENT_292	[p9l1925t2391r2028b2430],
16	pH.	NN	O	ph.	prep_at	13	SENT_292	[p9l2040t2392r2099b2429],
17	.	.	O	.	_	0	SENT_292	[p9l2040t2392r2099b2429],

1	An	DT	O	a	det	4	SENT_293	[p9l582t2442r627b2470],
2	omeprazole	NN	O	omeprazole	nn	4	SENT_293	[p9l639t2441r821b2479],
3	interaction	NN	O	interaction	nn	4	SENT_293	[p9l833t2443r1005b2470],
4	study	NN	O	study	nsubj	8	SENT_293	[p9l1017t2441r1101b2480],
5	in	IN	O	in	_	0	SENT_293	[p9l1111t2443r1141b2470],
6	healthy	JJ	O	healthy	amod	7	SENT_293	[p9l1153t2441r1269b2480],
7	subjects	NNS	O	subject	prep_in	4	SENT_293	[p9l1280t2441r1402b2480],
8	resulted	VBD	O	result	_	0	SENT_293	[p9l1414t2441r1538b2470],
9	in	IN	O	in	_	0	SENT_293	[p9l1550t2443r1580b2470],
10	increased	VBN	O	increase	amod	12	SENT_293	[p9l1592t2441r1738b2470],
11	plasma	NN	O	plasma	nn	12	SENT_293	[p9l1750t2441r1857b2479],
12	concentrations	NNS	O	concentration	prep_in	8	SENT_293	[p9l1870t2443r2101b2470],
13	of	IN	O	of	_	0	SENT_293	[p9l583t2491r617b2520],
14	raltegravir	NN	O	raltegravir	prep_of	12	SENT_293	[p9l622t2491r785b2529],
15	likely	JJ	O	likely	amod	16	SENT_293	[p9l794t2491r879b2529],
16	secondary	JJ	O	secondary	amod	14	SENT_293	[p9l887t2491r1045b2529],
17	to	TO	O	to	_	0	SENT_293	[p9l1052t2499r1083b2520],
18	the	DT	O	the	det	20	SENT_293	[p9l1092t2491r1141b2520],
19	pH-altering	JJ	O	ph-altering	amod	20	SENT_293	[p9l1150t2491r1339b2529],
20	effects	NNS	O	effect	prep_to	8	SENT_293	[p9l1348t2491r1446b2520],
21	of	IN	O	of	_	0	SENT_293	[p9l1456t2491r1490b2520],
22	omeprazole	NN	O	omeprazole	nn	25	SENT_293	[p9l1496t2491r1677b2529],
23	(	CD	NUMBER	(	num	25	SENT_293	[p9l1688t2492r1773b2527],
24	46a	NN	O	46a	nn	25	SENT_293	[p9l1688t2492r1773b2527],
25	)	NN	O	)	prep_of	20	SENT_293	[p9l1688t2492r1773b2527],
26	.	.	O	.	_	0	SENT_293	[p9l1688t2492r1773b2527],

1	A	DT	O	a	det	3	SENT_294	[p9l1782t2492r1809b2519],
2	high	JJ	O	high	amod	3	SENT_294	[p9l1815t2491r1886b2530],
3	prevalence	NN	O	prevalence	nsubjpass	8	SENT_294	[p9l1895t2491r2061b2529],
4	of	IN	O	of	_	0	SENT_294	[p9l2071t2491r2105b2520],
5	achlorhydria	NN	O	achlorhydrium	prep_of	3	SENT_294	[p9l583t2541r781b2579],
6	has	VBZ	O	have	aux	8	SENT_294	[p9l788t2541r837b2570],
7	been	VBN	O	be	auxpass	8	SENT_294	[p9l845t2541r920b2570],
8	reported	VBN	O	report	_	0	SENT_294	[p9l926t2541r1061b2579],
9	in	IN	O	in	_	0	SENT_294	[p9l1069t2542r1099b2569],
10	HIV-1	NN	MISC	hiv-1	prep_in	8	SENT_294	[p9l1106t2542r1206b2570],
11	infected	JJ	O	infected	amod	12	SENT_294	[p9l1217t2541r1342b2570],
12	individuals	NNS	O	individual	nsubj	13	SENT_294	[p9l1349t2541r1518b2570],
13	(	VBP	O	(	dep	8	SENT_294	[p9l1527t2542r1595b2577],
14	50	CD	NUMBER	50	number	15	SENT_294	[p9l1527t2542r1595b2577],
15	)	CD	NUMBER	)	dobj	13	SENT_294	[p9l1527t2542r1595b2577],
16	,	,	O	,	_	0	SENT_294	[p9l1527t2542r1595b2577],
17	and	CC	O	and	_	0	SENT_294	[p9l1604t2541r1660b2570],
18	as	IN	O	as	mark	25	SENT_294	[p9l1668t2552r1696b2570],
19	such	JJ	O	such	amod	21	SENT_294	[p9l1704t2541r1774b2570],
20	the	DT	O	the	det	21	SENT_294	[p9l1781t2541r1830b2570],
21	effect	NN	O	effect	nsubj	25	SENT_294	[p9l1838t2541r1924b2570],
22	of	IN	O	of	_	0	SENT_294	[p9l1931t2541r1965b2570],
23	omeprazole	NN	O	omeprazole	prep_of	21	SENT_294	[p9l1969t2552r2100b2579, p9l583t2591r645b2620],
24	may	MD	O	may	aux	25	SENT_294	[p9l660t2601r727b2629],
25	differ	VB	O	differ	conj_and	13	SENT_294	[p9l741t2591r825b2620],
26	in	IN	O	in	_	0	SENT_294	[p9l839t2592r869b2619],
27	this	DT	O	this	det	28	SENT_294	[p9l884t2591r940b2620],
28	population	NN	O	population	prep_in	25	SENT_294	[p9l955t2590r1133b2629],
29	.	.	O	.	_	0	SENT_294	[p9l955t2590r1133b2629],

1	Evaluation	NN	O	evaluation	nsubj	10	SENT_295	[p9l1150t2591r1319b2620],
2	of	IN	O	of	_	0	SENT_295	[p9l1334t2591r1368b2620],
3	population	NN	O	population	nn	4	SENT_295	[p9l1379t2591r1549b2629],
4	pharmacokinetics	NNS	O	pharmacokinetic	prep_of	1	SENT_295	[p9l1563t2590r1838b2629],
5	in	IN	O	in	_	0	SENT_295	[p9l1853t2592r1884b2619],
6	the	DT	O	the	det	7	SENT_295	[p9l1899t2590r1947b2620],
7	phase	NN	O	phase	prep_in	4	SENT_295	[p9l1963t2591r2050b2629],
8	III	CD	NUMBER	iii	num	9	SENT_295	[p9l2061t2592r2101b2619],
9	studies	NNS	O	study	dep	7	SENT_295	[p9l583t2640r689b2669],
10	revealed	VBD	O	reveal	_	0	SENT_295	[p9l699t2640r828b2669],
11	that	IN	O	that	complm	19	SENT_295	[p9l838t2640r899b2669],
12	the	DT	O	the	det	13	SENT_295	[p9l908t2640r957b2669],
13	pharmacokinetics	NNS	O	pharmacokinetic	nsubjpass	19	SENT_295	[p9l966t2640r1241b2679],
14	of	IN	O	of	_	0	SENT_295	[p9l1252t2641r1286b2669],
15	raltegravir	NN	O	raltegravir	prep_of	13	SENT_295	[p9l1291t2640r1454b2679],
16	was	VBD	O	be	auxpass	19	SENT_295	[p9l1462t2652r1518b2669],
17	not	RB	O	not	neg	19	SENT_295	[p9l1527t2649r1581b2669],
18	meaningfully	RB	O	meaningfully	advmod	19	SENT_295	[p9l1589t2640r1796b2679],
19	altered	VBN	O	alter	ccomp	10	SENT_295	[p9l1805t2640r1911b2669],
20	with	IN	O	with	_	0	SENT_295	[p9l1920t2640r1989b2669],
21	gastric	JJ	O	gastric	amod	22	SENT_295	[p9l1999t2642r2101b2679],
22	pH	NN	O	ph	prep_with	19	SENT_295	[p9l583t2692r634b2729],
23	altering	VBG	O	alter	partmod	22	SENT_295	[p9l644t2690r765b2729],
24	agents	NNS	O	agent	dobj	23	SENT_295	[p9l775t2699r873b2729],
25	(	CD	NUMBER	(	num	27	SENT_295	[p9l884t2691r962b2727],
26	L.A.	NNP	PERSON	L.A.	nn	27	SENT_295	[p9l884t2691r962b2727],
27	Wenning	NNP	PERSON	Wenning	tmod	23	SENT_295	[p9l973t2692r1127b2729],
28	,	,	O	,	_	0	SENT_295	[p9l973t2692r1127b2729],
29	unpublished	JJ	O	unpublished	amod	31	SENT_295	[p9l1138t2690r1331b2729],
30	data	NNS	O	datum	nn	31	SENT_295	[p9l1342t2690r1425b2726],
31	)	NN	O	)	appos	27	SENT_295	[p9l1342t2690r1425b2726],
32	.	.	O	.	_	0	SENT_295	[p9l1342t2690r1425b2726],

1	Furthermore	RB	O	furthermore	advmod	8	SENT_296	[p9l1437t2690r1649b2726],
2	,	,	O	,	_	0	SENT_296	[p9l1437t2690r1649b2726],
3	safety	NN	O	safety	nn	5	SENT_296	[p9l1661t2690r1751b2729],
4	subgroup	NN	O	subgroup	nn	5	SENT_296	[p9l1760t2690r1906b2729],
5	analyses	NNS	O	analysis	nsubj	8	SENT_296	[p9l1917t2690r2041b2729],
6	did	VBD	O	do	aux	8	SENT_296	[p9l2053t2690r2101b2719],
7	not	RB	O	not	neg	8	SENT_296	[p9l582t2749r636b2769],
8	reveal	VB	O	reveal	_	0	SENT_296	[p9l647t2740r739b2769],
9	a	DT	O	a	det	10	SENT_296	[p9l752t2751r766b2769],
10	difference	NN	O	difference	dobj	8	SENT_296	[p9l779t2740r935b2769],
11	in	IN	O	in	_	0	SENT_296	[p9l947t2742r977b2769],
12	the	DT	O	the	det	14	SENT_296	[p9l989t2740r1038b2769],
13	safety	NN	O	safety	nn	14	SENT_296	[p9l1051t2740r1141b2779],
14	proﬁle	NN	O	proﬁle	prep_in	10	SENT_296	[p9l1151t2740r1253b2778],
15	of	IN	O	of	_	0	SENT_296	[p9l1266t2740r1301b2769],
16	raltegravir	NN	O	raltegravir	prep_of	14	SENT_296	[p9l1308t2740r1472b2779],
17	with	IN	O	with	_	0	SENT_296	[p9l1482t2740r1552b2769],
18	coadministration	NN	O	coadministration	nn	21	SENT_296	[p9l1565t2740r1830b2769],
19	(	CD	NUMBER	(	num	21	SENT_296	[p9l1843t2741r1893b2776],
20	H.	NNP	PERSON	H.	nn	21	SENT_296	[p9l1843t2741r1893b2776],
21	Teppler	NNP	PERSON	Teppler	prep_with	8	SENT_296	[p9l1906t2740r2033b2778],
22	,	,	O	,	_	0	SENT_296	[p9l1906t2740r2033b2778],
23	unpublished	JJ	O	unpublished	amod	25	SENT_296	[p9l2046t2751r2100b2769, p9l582t2790r734b2828],
24	data	NNS	O	datum	nn	25	SENT_296	[p9l748t2790r831b2826],
25	)	NN	O	)	appos	21	SENT_296	[p9l748t2790r831b2826],
26	.	.	O	.	_	0	SENT_296	[p9l748t2790r831b2826],

1	Additional	JJ	O	additional	amod	2	SENT_297	[p9l845t2790r1011b2819],
2	investigation	NN	O	investigation	nsubjpass	4	SENT_297	[p9l1023t2792r1224b2829],
3	is	VBZ	O	be	auxpass	4	SENT_297	[p9l1237t2792r1259b2819],
4	warranted	VBN	O	warrant	_	0	SENT_297	[p9l1272t2790r1430b2819],
5	to	TO	O	to	aux	7	SENT_297	[p9l1444t2798r1474b2819],
6	fully	RB	O	fully	advmod	7	SENT_297	[p9l1488t2790r1558b2829],
7	evaluate	VB	O	evaluate	xcomp	4	SENT_297	[p9l1570t2790r1696b2819],
8	the	DT	O	the	det	9	SENT_297	[p9l1709t2790r1758b2819],
9	interaction	NN	O	interaction	dobj	7	SENT_297	[p9l1771t2792r1942b2819],
10	in	IN	O	in	_	0	SENT_297	[p9l1954t2792r1985b2819],
11	HIV-1	NN	MISC	hiv-1	nn	13	SENT_297	[p9l1997t2791r2097b2819],
12	infected	JJ	O	infected	amod	13	SENT_297	[p9l582t2840r708b2869],
13	patients	NNS	O	patient	prep_in	9	SENT_297	[p9l719t2841r850b2878],
14	.	.	O	.	_	0	SENT_297	[p9l719t2841r850b2878],

1	Other	JJ	O	other	amod	2	SENT_298	[p9l633t2889r728b2918],
2	drugs	NNS	O	drug	nsubj	4	SENT_298	[p9l741t2889r826b2928],
3	assessed	VBN	O	assess	partmod	2	SENT_298	[p9l840t2889r964b2918],
4	had	VBD	O	have	_	0	SENT_298	[p9l977t2889r1033b2918],
5	less	JJR	O	less	dobj	4	SENT_298	[p9l1046t2889r1099b2918],
6	of	IN	O	of	_	0	SENT_298	[p9l1113t2889r1147b2918],
7	an	DT	O	a	det	11	SENT_298	[p9l1156t2900r1192b2918],
8	inductive	JJ	O	inductive	amod	11	SENT_298	[p9l1204t2889r1348b2918],
9	or	CC	O	or	_	0	SENT_298	[p9l1362t2900r1395b2918],
10	inhibitory	JJ	O	inhibitory	amod	11	SENT_298	[p9l1407t2889r1565b2928],
11	effect	NN	O	effect	prep_of	5	SENT_298	[p9l1577t2889r1663b2918],
12	on	IN	O	on	_	0	SENT_298	[p9l1675t2900r1714b2918],
13	raltegravir	NN	O	raltegravir	nn	14	SENT_298	[p9l1727t2889r1890b2928],
14	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	11	SENT_298	[p9l1902t2889r2100b2928, p9l582t2941r681b2968],
15	.	.	O	.	_	0	SENT_298	[p9l1902t2889r2100b2928, p9l582t2941r681b2968],

1	Overall	RB	O	overall	advmod	5	SENT_299	[p9l696t2939r820b2974],
2	,	,	O	,	_	0	SENT_299	[p9l696t2939r820b2974],
3	the	DT	O	the	det	4	SENT_299	[p9l834t2939r883b2968],
4	data	NNS	O	datum	nsubj	5	SENT_299	[p9l896t2939r960b2968],
5	suggest	VBP	O	suggest	_	0	SENT_299	[p9l973t2947r1089b2978],
6	raltegravir	NN	O	raltegravir	dobj	5	SENT_299	[p9l1100t2939r1264b2978],
7	to	TO	O	to	aux	8	SENT_299	[p9l1276t2948r1306b2968],
8	have	VB	O	have	xcomp	5	SENT_299	[p9l1319t2939r1390b2968],
9	a	DT	O	a	det	12	SENT_299	[p9l1403t2950r1418b2968],
10	relatively	RB	O	relatively	advmod	11	SENT_299	[p9l1431t2939r1576b2978],
11	low	JJ	O	low	amod	12	SENT_299	[p9l1587t2939r1643b2968],
12	propensity	NN	O	propensity	dobj	8	SENT_299	[p9l1655t2941r1823b2978],
13	to	TO	O	to	aux	15	SENT_299	[p9l1834t2948r1864b2968],
14	be	VB	O	be	auxpass	15	SENT_299	[p9l1878t2939r1913b2968],
15	involved	VBN	O	involve	infmod	12	SENT_299	[p9l1926t2939r2058b2968],
16	in	IN	O	in	_	0	SENT_299	[p9l2071t2941r2101b2968],
17	clinically	RB	O	clinically	advmod	18	SENT_299	[p9l583t2989r723b3028],
18	meaningful	JJ	O	meaningful	amod	20	SENT_299	[p9l733t2989r910b3028],
19	drug	NN	O	drug	nn	20	SENT_299	[p9l922t2989r995b3028],
20	interactions	NNS	O	interaction	prep_in	15	SENT_299	[p9l1005t2991r1198b3018],
21	.	.	O	.	_	0	SENT_299	[p9l1005t2991r1198b3018],

1	Elvitegravir	NNP	O	Elvitegravir	nn	2	SENT_300	[p9l582t3135r804b3178],
2	Pharmacokinetics	NNPS	O	Pharmacokinetics	_	0	SENT_300	[p9l815t3135r1151b3167],
3	and	CC	O	and	_	0	SENT_300	[p9l1165t3135r1232b3167],
4	Metabolism	NN	O	metabolism	conj_and	2	SENT_300	[p9l1244t3135r1469b3167],

1	Elvitegravir	NNP	O	Elvitegravir	nsubj	6	SENT_301	[p9l583t3211r768b3250],
2	is	VBZ	O	be	cop	6	SENT_301	[p9l777t3213r800b3240],
3	an	DT	O	a	det	6	SENT_301	[p9l810t3222r846b3240],
4	orally	RB	O	orally	advmod	5	SENT_301	[p9l856t3211r946b3250],
5	administered	VBN	O	administer	amod	6	SENT_301	[p9l954t3211r1157b3240],
6	drug	NN	O	drug	_	0	SENT_301	[p9l1167t3211r1240b3250],
7	with	IN	O	with	_	0	SENT_301	[p9l1248t3211r1318b3240],
8	high	JJ	O	high	amod	9	SENT_301	[p9l1327t3211r1397b3250],
9	bioavailability	NN	O	bioavailability	prep_with	6	SENT_301	[p9l1407t3211r1627b3250],
10	and	CC	O	and	_	0	SENT_301	[p9l1636t3211r1691b3240],
11	low	JJ	O	low	amod	12	SENT_301	[p9l1701t3211r1758b3240],
12	clearance	NN	O	clearance	conj_and	9	SENT_301	[p9l1767t3211r1911b3240],
13	when	WRB	O	when	advmod	14	SENT_301	[p9l1920t3211r2005b3240],
14	coadministered	VBN	O	coadminister	advcl	6	SENT_301	[p9l2015t3211r2100b3240, p9l583t3258r749b3287],
15	with	IN	O	with	_	0	SENT_301	[p9l763t3258r832b3287],
16	boosting	VBG	O	boost	prepc_with	14	SENT_301	[p9l846t3258r983b3297],
17	doses	NNS	O	dose	dobj	16	SENT_301	[p9l997t3258r1080b3287],
18	of	IN	O	of	_	0	SENT_301	[p9l1095t3258r1129b3287],
19	ritonavir	NN	O	ritonavir	prep_of	17	SENT_301	[p9l1139t3260r1275b3287],
20	(	CD	NUMBER	(	num	19	SENT_301	[p9l1290t3259r1358b3295],
21	51	CD	NUMBER	51	num	22	SENT_301	[p9l1290t3259r1358b3295],
22	)	NN	O	)	dep	19	SENT_301	[p9l1290t3259r1358b3295],
23	.	.	O	.	_	0	SENT_301	[p9l1290t3259r1358b3295],

1	It	PRP	O	it	nsubjpass	4	SENT_302	[p9l1373t3259r1400b3287],
2	is	VBZ	O	be	auxpass	4	SENT_302	[p9l1412t3260r1435b3287],
3	rapidly	RB	O	rapidly	advmod	4	SENT_302	[p9l1450t3258r1560b3297],
4	absorbed	VBN	O	absorb	_	0	SENT_302	[p9l1573t3258r1714b3287],
5	with	IN	O	with	_	0	SENT_302	[p9l1727t3258r1797b3287],
6	a	DT	O	a	det	7	SENT_302	[p9l1811t3269r1826b3287],
7	time	NN	O	time	prep_with	4	SENT_302	[p9l1840t3260r1910b3287],
8	to	TO	O	to	_	0	SENT_302	[p9l1924t3266r1955b3287],
9	maximal	JJ	O	maximal	amod	10	SENT_302	[p9l1969t3258r2101b3287],
10	concentration	NN	O	concentration	prep_to	4	SENT_302	[p9l583t3306r801b3334],
11	of	IN	O	of	_	0	SENT_302	[p9l812t3305r846b3334],
12	approximately	RB	O	approximately	quantmod	13	SENT_302	[p9l853t3305r1077b3344],
13	three	CD	DURATION	three	num	14	SENT_302	[p9l1087t3305r1167b3334],
14	hours	NNS	NUMBER	hour	prep_of	10	SENT_302	[p9l1178t3305r1266b3334],
15	when	WRB	O	when	advmod	16	SENT_302	[p9l1276t3305r1361b3334],
16	administered	VBN	O	administer	advcl	4	SENT_302	[p9l1372t3305r1575b3334],
17	in	IN	O	in	_	0	SENT_302	[p9l1586t3306r1616b3334],
18	the	DT	O	the	det	20	SENT_302	[p9l1627t3305r1675b3334],
19	fasted	JJ	O	fasted	amod	20	SENT_302	[p9l1687t3305r1777b3334],
20	state	NN	O	state	prep_in	16	SENT_302	[p9l1788t3313r1867b3334],
21	.	.	O	.	_	0	SENT_302	[p9l1788t3313r1867b3334],

1	V1/hen	NN	O	v1/hen	nsubj	2	SENT_303	[p9l1879t3305r1978b3334],
2	administered	VBN	O	administer	partmod	6	SENT_303	[p9l1989t3305r2100b3334, p9l582t3352r687b3382],
3	alone	RB	O	alone	advmod	2	SENT_303	[p9l696t3352r788b3388],
4	,	,	O	,	_	0	SENT_303	[p9l696t3352r788b3388],
5	elvitegravir	NN	O	elvitegravir	nsubj	6	SENT_303	[p9l798t3352r974b3391],
6	demonstrates	VBZ	O	demonstrate	_	0	SENT_303	[p9l983t3352r1190b3382],
7	slightly	RB	O	slightly	advmod	8	SENT_303	[p9l1200t3352r1315b3391],
8	less	JJR	O	less	acomp	6	SENT_303	[p9l1322t3352r1375b3382],
9	than	IN	O	than	mark	13	SENT_303	[p9l1384t3352r1454b3382],
10	dose	NN	O	dose	nn	12	SENT_303	[p9l1462t3352r1531b3382],
11	proportional	JJ	O	proportional	amod	12	SENT_303	[p9l1540t3352r1738b3391],
12	pharmacokinetics	NNS	O	pharmacokinetic	nsubj	13	SENT_303	[p9l1747t3352r2022b3391],
13	(	VBP	O	(	ccomp	8	SENT_303	[p9l2031t3353r2099b3389],
14	52	CD	NUMBER	52	num	15	SENT_303	[p9l2031t3353r2099b3389],
15	)	CD	NUMBER	)	dobj	13	SENT_303	[p9l2031t3353r2099b3389],
16	.	.	O	.	_	0	SENT_303	[p9l2031t3353r2099b3389],

1	Ritonavir	NN	O	ritonavir	_	0	SENT_304	[p9l583t3400r731b3428],
2	boosting	VBG	O	boost	partmod	1	SENT_304	[p9l740t3399r876b3438],
3	signiﬁcantly	JJ	O	signiﬁcantly	amod	4	SENT_304	[p9l885t3399r1076b3438],
4	increases	NNS	O	increase	iobj	2	SENT_304	[p9l1083t3401r1223b3428],
5	plasma	NN	O	plasma	nn	6	SENT_304	[p9l1233t3399r1340b3438],
6	levels	NNS	O	level	dobj	2	SENT_304	[p9l1349t3399r1434b3428],
7	of	IN	O	of	_	0	SENT_304	[p9l1444t3399r1479b3428],
8	elvitegravir	NN	O	elvitegravir	prep_of	6	SENT_304	[p9l1485t3399r1666b3438],
9	.	.	O	.	_	0	SENT_304	[p9l1485t3399r1666b3438],

1	Effects	NNS	O	effect	nsubjpass	3	SENT_305	[p9l1677t3399r1785b3428],
2	are	VBP	O	be	auxpass	3	SENT_305	[p9l1795t3410r1841b3428],
3	seen	VBN	O	see	_	0	SENT_305	[p9l1851t3410r1919b3428],
4	at	IN	O	at	_	0	SENT_305	[p9l1929t3407r1957b3428],
5	ritonavir	NN	O	ritonavir	nn	6	SENT_305	[p9l1965t3401r2102b3428],
6	doses	NNS	O	dose	prep_at	3	SENT_305	[p9l583t3446r666b3475],
7	as	RB	O	as	quantmod	10	SENT_305	[p9l678t3457r706b3475],
8	low	JJ	O	low	quantmod	10	SENT_305	[p9l718t3446r774b3475],
9	as	IN	O	as	quantmod	10	SENT_305	[p9l785t3457r813b3475],
10	20	CD	NUMBER	20	num	11	SENT_305	[p9l825t3448r862b3475],
11	mg	NN	O	mg	dep	6	SENT_305	[p9l873t3457r931b3485],
12	,	,	O	,	_	0	SENT_305	[p9l873t3457r931b3485],
13	with	IN	O	with	_	0	SENT_305	[p9l942t3446r1012b3475],
14	maximal	JJ	O	maximal	amod	15	SENT_305	[p9l1023t3446r1155b3475],
15	increase	NN	O	increase	prep_with	6	SENT_305	[p9l1166t3448r1292b3475],
16	in	IN	O	in	_	0	SENT_305	[p9l1303t3448r1333b3475],
17	elvitegravir	JJ	O	elvitegravir	amod	18	SENT_305	[p9l1345t3446r1521b3485],
18	exposure	NN	O	exposure	prep_in	15	SENT_305	[p9l1532t3457r1670b3485],
19	at	IN	O	at	_	0	SENT_305	[p9l1682t3455r1710b3475],
20	100	CD	NUMBER	100	num	22	SENT_305	[p9l1724t3448r1776b3475],
21	mg	NN	O	mg	nn	22	SENT_305	[p9l1788t3457r1838b3485],
22	ritonavir	NN	O	ritonavir	prep_at	3	SENT_305	[p9l1848t3448r1990b3475],
23	.	.	O	.	_	0	SENT_305	[p9l1848t3448r1990b3475],

1	Coadministration	NN	O	coadministration	nsubj	4	SENT_306	[p9l2004t3446r2100b3475, p9l583t3495r775b3522],
2	with	IN	O	with	_	0	SENT_306	[p9l786t3493r855b3522],
3	ritonavir	NN	O	ritonavir	prep_with	1	SENT_306	[p9l867t3495r1003b3522],
4	results	VBZ	O	result	dep	25	SENT_306	[p9l1014t3493r1115b3522],
5	in	IN	O	in	_	0	SENT_306	[p9l1127t3495r1157b3522],
6	a	DT	O	a	det	9	SENT_306	[p9l1169t3504r1183b3522],
7	~	NN	O	~	nn	9	SENT_306	[p9l1196t3493r1338b3522],
8	20-fold	JJ	O	20-fold	amod	9	SENT_306	[p9l1196t3493r1338b3522],
9	increase	NN	O	increase	prep_in	4	SENT_306	[p9l1350t3495r1476b3522],
10	in	IN	O	in	_	0	SENT_306	[p9l1487t3495r1517b3522],
11	AUC	NN	O	auc	prep_in	9	SENT_306	[p9l1528t3494r1611b3522],
12	and	CC	O	and	_	0	SENT_306	[p9l1624t3493r1680b3522],
13	an	DT	O	a	det	14	SENT_306	[p9l1692t3504r1727b3522],
14	increase	NN	O	increase	prep_in	4	SENT_306	[p9l1739t3495r1864b3522],
15	in	IN	O	in	_	0	SENT_306	[p9l1876t3495r1906b3522],
16	the	DT	O	the	det	17	SENT_306	[p9l1918t3493r1967b3522],
17	half-life	NN	O	half-life	prep_in	14	SENT_306	[p9l1978t3493r2101b3522],
18	of	IN	O	of	_	0	SENT_306	[p9l583t3540r617b3569],
19	elimination	NN	O	elimination	prep_of	17	SENT_306	[p9l625t3540r804b3569],
20	from	IN	O	from	_	0	SENT_306	[p9l815t3540r891b3569],
21	three	CD	DURATION	three	number	23	SENT_306	[p9l902t3540r982b3569],
22	to	TO	DURATION	to	dep	23	SENT_306	[p9l994t3548r1025b3569],
23	ten	CD	DURATION	ten	num	24	SENT_306	[p9l1036t3548r1085b3569],
24	hours	NNS	NUMBER	hour	prep_from	4	SENT_306	[p9l1096t3540r1184b3569],
25	(	VBP	O	(	_	0	SENT_306	[p9l1196t3541r1253b3576],
26	51	CD	NUMBER	51	nsubj	25	SENT_306	[p9l1196t3541r1253b3576],
27	,	,	O	,	_	0	SENT_306	[p9l1196t3541r1253b3576],
28	5	CD	NUMBER	5	number	29	SENT_306	[p9l1267t3541r1281b3569],
29	3	CD	NUMBER	3	num	30	SENT_306	[p9l1286t3541r1322b3576],
30	)	NN	O	)	appos	26	SENT_306	[p9l1286t3541r1322b3576],
31	.	.	O	.	_	0	SENT_306	[p9l1286t3541r1322b3576],

1	Metabolism	NN	O	metabolism	nsubj	19	SENT_307	[p9l631t3587r819b3616],
2	via	IN	O	via	_	0	SENT_307	[p9l828t3589r872b3616],
3	oxidation	NN	O	oxidation	prep_via	1	SENT_307	[p9l883t3587r1028b3616],
4	by	IN	O	by	_	0	SENT_307	[p9l1038t3587r1077b3626],
5	CYP3A4	NN	O	cyp3a4	prep_by	3	SENT_307	[p9l1086t3588r1239b3616],
6	/	:	O	/	punct	7	SENT_307	[p9l1086t3588r1239b3616],
7	5	CD	NUMBER	5	dep	5	SENT_307	[p9l1241t3589r1255b3616],
8	and	CC	O	and	_	0	SENT_307	[p9l1268t3587r1323b3616],
9	secondarily	RB	O	secondarily	dep	5	SENT_307	[p9l1334t3587r1512b3626],
10	by	IN	O	by	_	0	SENT_307	[p9l1520t3587r1559b3626],
11	glucuronidation	NN	O	glucuronidation	prep_by	9	SENT_307	[p9l1568t3587r1819b3626],
12	via	IN	O	via	_	0	SENT_307	[p9l1827t3589r1871b3616],
13	UGT1A1	NN	O	ugt1a1	prep_via	11	SENT_307	[p9l1881t3588r2050b3616],
14	/	:	O	/	punct	7	SENT_307	[p9l1881t3588r2050b3616],
15	3	CD	NUMBER	3	dep	5	SENT_307	[p9l2052t3589r2065b3616],
16	is	VBZ	O	be	cop	19	SENT_307	[p9l2078t3589r2101b3616],
17	the	DT	O	the	det	19	SENT_307	[p9l583t3634r632b3663],
18	major	JJ	O	major	amod	19	SENT_307	[p9l639t3636r731b3673],
19	pathway	NN	O	pathway	_	0	SENT_307	[p9l737t3634r868b3673],
20	of	IN	O	of	_	0	SENT_307	[p9l875t3634r909b3663],
21	elimination	NN	O	elimination	prep_of	19	SENT_307	[p9l913t3634r1100b3670],
22	,	,	O	,	_	0	SENT_307	[p9l913t3634r1100b3670],
23	with	IN	O	with	_	0	SENT_307	[p9l1107t3634r1177b3663],
24	a	DT	O	a	det	26	SENT_307	[p9l1185t3645r1200b3663],
25	minor	JJ	O	minor	amod	26	SENT_307	[p9l1207t3636r1303b3663],
26	component	NN	O	component	prep_with	19	SENT_307	[p9l1311t3642r1489b3673],
27	of	IN	O	of	_	0	SENT_307	[p9l1496t3634r1530b3663],
28	elimination	NN	O	elimination	prep_of	26	SENT_307	[p9l1534t3634r1713b3663],
29	via	IN	O	via	_	0	SENT_307	[p9l1719t3636r1763b3663],
30	the	DT	O	the	det	32	SENT_307	[p9l1771t3634r1820b3663],
31	renal	JJ	O	renal	amod	32	SENT_307	[p9l1827t3634r1906b3663],
32	system	NN	O	system	prep_via	28	SENT_307	[p9l1913t3643r2026b3673],
33	.	.	O	.	_	0	SENT_307	[p9l1913t3643r2026b3673],

1	The	DT	O	the	det	4	SENT_308	[p9l2034t3634r2101b3663],
2	resulting	VBG	O	result	amod	4	SENT_308	[p9l583t3681r722b3720],
3	major	JJ	O	major	amod	4	SENT_308	[p9l730t3682r821b3720],
4	metabolites	NNS	O	metabolite	nsubj	6	SENT_308	[p9l831t3681r1011b3710],
5	have	VBP	O	have	aux	6	SENT_308	[p9l1021t3681r1091b3710],
6	reduced	VBN	O	reduce	_	0	SENT_308	[p9l1101t3681r1226b3710],
7	activity	NN	O	activity	dobj	6	SENT_308	[p9l1236t3682r1350b3720],
8	compared	VBN	O	compare	_	0	SENT_308	[p9l1359t3681r1513b3720],
9	with	IN	O	with	prepc_compared_with	6	SENT_308	[p9l1522t3681r1592b3710],
10	elvitegravir	NN	O	elvitegravir	pobj	6	SENT_308	[p9l1602t3681r1779b3720],
11	and	CC	O	and	_	0	SENT_308	[p9l1788t3681r1844b3710],
12	are	VBP	O	be	auxpass	14	SENT_308	[p9l1854t3692r1900b3710],
13	not	RB	O	not	neg	14	SENT_308	[p9l1910t3689r1963b3710],
14	believed	VBN	O	believe	conj_and	6	SENT_308	[p9l1972t3681r2101b3710],

1	7-394	CD	NUMBER	7-394	_	0	SENT_309	[p10l55t3736r79b3820],
2	.	.	O	.	_	0	SENT_309	[p10l55t3736r79b3820],

1	Downloaded	VBN	O	download	_	0	SENT_310	[p10l55t3556r78b3726],
2	from	IN	O	from	_	0	SENT_310	[p10l55t3482r78b3547],
3	www.annua1reviews.org	NN	O	www.annua1reviews.org	nn	4	SENT_310	[p10l55t3149r85b3473],
4	ison	NN	O	ison	prep_from	1	SENT_310	[p10l88t3765r112b3820],
5	on	IN	O	on	_	0	SENT_310	[p10l96t3724r112b3756],
6	01/05/14	CD	DATE	01/05/14	prep_on	4	SENT_310	[p10l88t3590r112b3714],
7	.	.	O	.	_	0	SENT_310	[p10l88t3590r112b3714],

1	For	IN	O	for	_	0	SENT_311	[p10l89t3533r112b3580],
2	personal	JJ	O	personal	amod	3	SENT_311	[p10l88t3413r119b3525],
3	use	NN	O	use	pobj	1	SENT_311	[p10l96t3360r112b3404],
4	only	RB	O	only	advmod	3	SENT_311	[p10l88t3286r119b3350],
5	.	.	O	.	_	0	SENT_311	[p10l88t3286r119b3350],

1	Annu	NNP	PERSON	Annu	_	0	SENT_312	[p10l60t1859r83b1939],
2	.	.	O	.	_	0	SENT_312	[p10l60t1859r83b1939],

1	Rev.	NNP	O	Rev.	nn	2	SENT_313	[p10l60t1789r83b1848],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_313	[p10l60t1630r83b1778],
3	.	.	O	.	_	0	SENT_313	[p10l60t1630r83b1778],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_314	[p10l60t1509r83b1619],
2	.	.	O	.	_	0	SENT_314	[p10l60t1509r83b1619],

1	2009.49:377	CD	NUMBER	2009.49:377	num	2	SENT_315	[p10l60t1264r84b1498],
2	-394	CD	NUMBER	-394	_	0	SENT_315	[p10l60t1264r84b1498],
3	.	.	O	.	_	0	SENT_315	[p10l60t1264r84b1498],

1	Downloaded	VBN	O	download	_	0	SENT_316	[p10l60t1083r83b1253],
2	from	IN	O	from	_	0	SENT_316	[p10l60t1010r83b1074],
3	www.annua]reviews.org	NN	O	www.annua]reviews.org	prep_from	1	SENT_316	[p10l60t676r90b1001],
4	by	IN	O	by	_	0	SENT_316	[p10l93t1772r124b1804],
5	Umversity	NN	O	umversity	prep_by	1	SENT_316	[p10l94t1623r124b1763],
6	of	IN	O	of	_	0	SENT_316	[p10l93t1584r117b1613],
7	Wisconsin	NNP	LOCATION	Wisconsin	prep_of	5	SENT_316	[p10l93t1437r117b1578],
8	-	:	O	-	_	0	SENT_316	[p10l107t1419r110b1428],
9	Madison	NNP	O	Madison	dep	5	SENT_316	[p10l93t1293r117b1409],
10	on	IN	O	on	_	0	SENT_316	[p10l101t1251r117b1283],
11	01/05/14	NN	DATE	01/05/14	prep_on	9	SENT_316	[p10l93t1125r117b1242],
12	For	IN	O	for	_	0	SENT_316	[p10l94t1061r117b1107],
13	personal	JJ	O	personal	amod	14	SENT_316	[p10l93t940r124b1052],
14	use	NN	O	use	prep_for	1	SENT_316	[p10l101t887r117b931],
15	only	RB	O	only	advmod	1	SENT_316	[p10l93t820r124b878],

1	386	CD	NUMBER	386	num	4	SENT_317	[p10l487t42r533b70],
2	Hazuda	NN	O	hazuda	nn	4	SENT_317	[p10l582t41r674b63],
3	o	NN	O	o	nn	4	SENT_317	[p10l689t49r699b59],
4	Iwamato	NNP	PERSON	Iwamato	_	0	SENT_317	[p10l713t41r810b63],
5	-	:	O	-	_	0	SENT_317	[p10l826t49r835b59],
6	Wenning	NNP	PERSON	Wenning	dep	4	SENT_317	[p10l854t41r955b71],
7	to	TO	O	to	aux	8	SENT_317	[p10l206t155r237b176],
8	contribute	VB	O	contribute	infmod	6	SENT_317	[p10l251t146r413b176],
9	signiﬁcantly	NN	O	signiﬁcantly	dobj	8	SENT_317	[p10l427t146r618b185],
10	to	TO	O	to	_	0	SENT_317	[p10l630t154r661b176],
11	antiviral	JJ	O	antiviral	amod	12	SENT_317	[p10l675t146r803b176],
12	activity	NN	O	activity	prep_to	8	SENT_317	[p10l817t148r931b185],
13	(	CD	NUMBER	(	number	14	SENT_317	[p10l943t147r1012b183],
14	54	CD	NUMBER	54	num	15	SENT_317	[p10l943t147r1012b183],
15	)	NN	O	)	dep	12	SENT_317	[p10l943t147r1012b183],
16	.	.	O	.	_	0	SENT_317	[p10l943t147r1012b183],

1	In	IN	O	in	_	0	SENT_318	[p10l1026t148r1060b175],
2	a	DT	O	a	det	5	SENT_318	[p10l1074t157r1089b175],
3	human	JJ	O	human	amod	5	SENT_318	[p10l1102t146r1210b176],
4	ADME	NN	ORGANIZATION	adme	nn	5	SENT_318	[p10l1222t147r1340b175],
5	study	NN	O	study	prep_in	23	SENT_318	[p10l1353t146r1438b185],
6	with	IN	O	with	_	0	SENT_318	[p10l1449t146r1518b176],
7	radiolabeled	VBN	O	radiolabele	prepc_with	5	SENT_318	[p10l1531t146r1724b176],
8	elvitegravir	NN	O	elvitegravir	dobj	7	SENT_318	[p10l207t194r383b233],
9	and	CC	O	and	_	0	SENT_318	[p10l391t194r447b223],
10	boosting	VBG	O	boost	prepc_with	5	SENT_318	[p10l455t194r592b233],
11	doses	NNS	O	dose	dobj	10	SENT_318	[p10l600t194r682b223],
12	of	IN	O	of	_	0	SENT_318	[p10l692t194r726b223],
13	ritonavir	NN	O	ritonavir	prep_of	11	SENT_318	[p10l730t196r872b230],
14	,	,	O	,	_	0	SENT_318	[p10l730t196r872b230],
15	>	JJR	O	>	nsubj	23	SENT_318	[p10l884t196r980b223],
16	90	CD	PERCENT	90	number	17	SENT_318	[p10l884t196r980b223],
17	%	NN	PERCENT	%	amod	15	SENT_318	[p10l884t196r980b223],
18	of	IN	O	of	_	0	SENT_318	[p10l992t194r1027b223],
19	the	DT	O	the	det	21	SENT_318	[p10l1031t194r1080b223],
20	circulating	VBG	O	circulate	amod	21	SENT_318	[p10l1089t194r1256b233],
21	plasma	NN	O	plasma	prep_of	15	SENT_318	[p10l1263t194r1371b233],
22	was	VBD	O	be	cop	23	SENT_318	[p10l1378t205r1434b223],
23	present	JJ	DATE	present	_	0	SENT_318	[p10l1443t202r1559b233],
24	as	IN	O	as	_	0	SENT_318	[p10l1567t205r1595b223],
25	the	DT	O	the	det	27	SENT_318	[p10l1604t194r1652b223],
26	parent	NN	O	parent	nn	27	SENT_318	[p10l1661t205r1723b233, p10l207t251r256b271],
27	compound	NN	O	compound	prep_as	23	SENT_318	[p10l265t242r440b281],
28	.	.	O	.	_	0	SENT_318	[p10l265t242r440b281],

1	Radiolabeled	VBN	O	radiolabele	_	0	SENT_319	[p10l451t242r655b271],
2	compound	NN	O	compound	nsubjpass	4	SENT_319	[p10l665t242r832b281],
3	was	VBD	O	be	auxpass	4	SENT_319	[p10l840t253r896b271],
4	excreted	VBN	O	excrete	ccomp	1	SENT_319	[p10l906t242r1036b271],
5	primarily	RB	O	primarily	advmod	4	SENT_319	[p10l1046t242r1192b281],
6	in	IN	O	in	_	0	SENT_319	[p10l1199t244r1229b271],
7	the	DT	O	the	det	8	SENT_319	[p10l1239t242r1288b271],
8	feces	NNS	O	fece	prep_in	4	SENT_319	[p10l1297t242r1372b271],
9	(	VBP	O	(	dep	1	SENT_319	[p10l1383t243r1515b278],
10	94.8	CD	PERCENT	94.8	num	11	SENT_319	[p10l1383t243r1515b278],
11	%	NN	PERCENT	%	dobj	9	SENT_319	[p10l1383t243r1515b278],
12	)	CD	NUMBER	)	nsubj	1	SENT_319	[p10l1383t243r1515b278],
13	,	,	O	,	_	0	SENT_319	[p10l1383t243r1515b278],
14	with	IN	O	with	mark	21	SENT_319	[p10l1525t242r1595b271],
15	a	DT	O	a	det	17	SENT_319	[p10l1605t253r1619b271],
16	minor	JJ	O	minor	amod	17	SENT_319	[p10l1628t244r1725b271],
17	amount	NN	O	amount	nsubj	21	SENT_319	[p10l206t297r326b318],
18	in	IN	O	in	_	0	SENT_319	[p10l339t291r369b318],
19	the	DT	O	the	det	20	SENT_319	[p10l383t289r431b318],
20	urine	NN	O	urine	prep_in	17	SENT_319	[p10l444t291r526b318],
21	(	VBP	O	(	dep	12	SENT_319	[p10l541t290r654b326],
22	6.7	CD	PERCENT	6.7	num	23	SENT_319	[p10l541t290r654b326],
23	%	NN	PERCENT	%	dobj	21	SENT_319	[p10l541t290r654b326],
24	)	CD	NUMBER	)	tmod	21	SENT_319	[p10l541t290r654b326],
25	.	.	O	.	_	0	SENT_319	[p10l541t290r654b326],

1	Fecal	JJ	O	fecal	amod	2	SENT_320	[p10l670t289r752b318],
2	radioactivity	NN	O	radioactivity	nsubj	3	SENT_320	[p10l765t289r961b328],
3	consisted	VBD	O	consist	_	0	SENT_320	[p10l974t289r1117b318],
4	primarily	RB	O	primarily	advmod	3	SENT_320	[p10l1131t289r1277b328],
5	of	IN	O	of	_	0	SENT_320	[p10l1289t289r1324b318],
6	parent	NN	O	parent	nn	8	SENT_320	[p10l1333t297r1434b328],
7	compound	NN	O	compound	nn	8	SENT_320	[p10l1447t289r1614b328],
8	(	NN	O	(	prep_of	3	SENT_320	[p10l1629t290r1723b326],
9	36	CD	PERCENT	36	number	10	SENT_320	[p10l1629t290r1723b326],
10	%	NN	PERCENT	%	amod	8	SENT_320	[p10l1629t290r1723b326],
11	)	CD	NUMBER	)	dep	8	SENT_320	[p10l1629t290r1723b326],
12	and	CC	O	and	_	0	SENT_320	[p10l206t337r262b366],
13	an	DT	O	a	det	16	SENT_320	[p10l272t348r308b366],
14	oxidative	JJ	O	oxidative	amod	16	SENT_320	[p10l318t337r457b366],
15	metabolite	NN	O	metabolite	nn	16	SENT_320	[p10l467t337r634b366],
16	(	NN	O	(	prep_of	3	SENT_320	[p10l645t338r748b373],
17	46	CD	PERCENT	46	number	18	SENT_320	[p10l645t338r748b373],
18	%	NN	PERCENT	%	amod	16	SENT_320	[p10l645t338r748b373],
19	)	CD	NUMBER	)	dep	16	SENT_320	[p10l645t338r748b373],
20	.	.	O	.	_	0	SENT_320	[p10l645t338r748b373],

1	Urine	NN	O	urine	nsubjpass	3	SENT_321	[p10l760t338r852b366],
2	was	VBD	O	be	auxpass	3	SENT_321	[p10l861t348r918b366],
3	comprised	VBN	O	comprise	dep	10	SENT_321	[p10l928t337r1090b375],
4	of	IN	O	of	_	0	SENT_321	[p10l1101t337r1135b366],
5	low	JJ	O	low	amod	6	SENT_321	[p10l1141t337r1197b366],
6	levels	NNS	O	level	prep_of	3	SENT_321	[p10l1206t337r1291b366],
7	of	IN	O	of	_	0	SENT_321	[p10l1302t337r1336b366],
8	various	JJ	O	various	amod	9	SENT_321	[p10l1340t338r1453b366],
9	metabolites	NNS	O	metabolite	prep_of	6	SENT_321	[p10l1463t337r1643b366],
10	(	VBP	O	(	_	0	SENT_321	[p10l1654t338r1681b373],
11	5	CD	NUMBER	5	dobj	10	SENT_321	[p10l1654t338r1681b373],
12	5	CD	NUMBER	5	num	13	SENT_321	[p10l1686t338r1722b373],
13	)	NN	O	)	nsubj	10	SENT_321	[p10l1686t338r1722b373],
14	.	.	O	.	_	0	SENT_321	[p10l1686t338r1722b373],

1	Elvitegravir	NNP	O	Elvitegravir	nn	2	SENT_322	[p10l205t450r427b493],
2	Drug-Drug	NNP	O	Drug-Drug	nsubjpass	28	SENT_322	[p10l439t452r658b493],
3	Interactions	NNS	O	interaction	dep	2	SENT_322	[p10l669t452r898b482],
4	The	DT	O	the	det	5	SENT_322	[p10l205t502r271b531],
5	effect	NN	O	effect	dep	2	SENT_322	[p10l285t502r372b531],
6	of	IN	O	of	_	0	SENT_322	[p10l384t502r419b531],
7	elvitegravir	NN	O	elvitegravir	prep_of	5	SENT_322	[p10l428t502r605b541],
8	on	IN	O	on	_	0	SENT_322	[p10l618t513r657b531],
9	the	DT	O	the	det	10	SENT_322	[p10l670t502r719b531],
10	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	7	SENT_322	[p10l732t502r1007b541],
11	of	IN	O	of	_	0	SENT_322	[p10l1022t502r1056b531],
12	other	JJ	O	other	amod	13	SENT_322	[p10l1065t502r1149b531],
13	agents	NNS	O	agent	prep_of	10	SENT_322	[p10l1162t510r1260b541],
14	as	RB	O	as	_	0	SENT_322	[p10l1275t513r1303b531],
15	well	RB	O	well	_	0	SENT_322	[p10l1315t502r1379b531],
16	as	IN	O	as	_	0	SENT_322	[p10l1393t513r1421b531],
17	the	DT	O	the	det	18	SENT_322	[p10l1435t502r1484b531],
18	effect	NN	O	effect	conj_and	10	SENT_322	[p10l1498t502r1584b531],
19	of	IN	O	of	_	0	SENT_322	[p10l1597t502r1631b531],
20	other	JJ	O	other	amod	21	SENT_322	[p10l1641t502r1725b531],
21	agents	NNS	O	agent	prep_of	18	SENT_322	[p10l206t559r304b590],
22	on	IN	O	on	_	0	SENT_322	[p10l321t562r361b581],
23	the	DT	O	the	det	24	SENT_322	[p10l377t551r425b581],
24	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	21	SENT_322	[p10l442t551r717b590],
25	of	IN	O	of	_	0	SENT_322	[p10l734t551r768b581],
26	elvitegravir	NN	O	elvitegravir	prep_of	24	SENT_322	[p10l781t551r957b590],
27	were	VBD	O	be	auxpass	28	SENT_322	[p10l971t562r1046b581],
28	examined	VBN	O	examine	_	0	SENT_322	[p10l1063t551r1219b581],
29	.	.	O	.	_	0	SENT_322	[p10l1063t551r1219b581],

1	On	IN	O	on	_	0	SENT_323	[p10l1238t552r1288b581],
2	the	DT	O	the	det	3	SENT_323	[p10l1304t551r1353b581],
3	basis	NN	O	basis	prep_on	14	SENT_323	[p10l1369t551r1442b581],
4	of	IN	O	of	_	0	SENT_323	[p10l1459t551r1493b581],
5	the	DT	O	the	det	7	SENT_323	[p10l1505t551r1554b581],
6	metabolic	JJ	O	metabolic	amod	7	SENT_323	[p10l1570t551r1724b581],
7	proﬁle	NN	O	proﬁle	prep_of	3	SENT_323	[p10l206t600r308b639],
8	and	CC	O	and	_	0	SENT_323	[p10l321t600r377b629],
9	preclinical	JJ	O	preclinical	amod	11	SENT_323	[p10l389t600r552b639],
10	interaction	NN	O	interaction	nn	11	SENT_323	[p10l564t602r736b629],
11	data	NNS	O	datum	prep_of	3	SENT_323	[p10l749t600r821b636],
12	,	,	O	,	_	0	SENT_323	[p10l749t600r821b636],
13	elvitegravir	NN	O	elvitegravir	nsubj	14	SENT_323	[p10l835t600r1012b639],
14	has	VBZ	O	have	_	0	SENT_323	[p10l1023t600r1073b629],
15	some	DT	O	some	det	17	SENT_323	[p10l1086t611r1167b629],
16	modest	JJ	O	modest	amod	17	SENT_323	[p10l1179t600r1294b629],
17	potential	NN	O	potential	dobj	14	SENT_323	[p10l1306t600r1445b639],
18	to	TO	O	to	aux	20	SENT_323	[p10l1457t608r1488b629],
19	be	VB	O	be	auxpass	20	SENT_323	[p10l1501t600r1537b629],
20	involved	VBN	O	involve	infmod	17	SENT_323	[p10l1549t600r1682b629],
21	in	IN	O	in	_	0	SENT_323	[p10l1694t602r1724b629],
22	clinically	RB	O	clinically	advmod	23	SENT_323	[p10l206t650r346b689],
23	meaningful	JJ	O	meaningful	amod	25	SENT_323	[p10l356t650r533b689],
24	drug	NN	O	drug	nn	25	SENT_323	[p10l545t650r618b689],
25	interactions	NNS	O	interaction	prep_in	20	SENT_323	[p10l628t652r821b680],
26	.	.	O	.	_	0	SENT_323	[p10l628t652r821b680],

1	Effect	NN	O	effect	_	0	SENT_324	[p10l205t753r308b782],
2	of	IN	O	of	_	0	SENT_324	[p10l316t753r354b782],
3	elvitegravir	NN	O	elvitegravir	prep_of	1	SENT_324	[p10l359t753r551b792],
4	on	IN	O	on	_	0	SENT_324	[p10l559t764r602b782],
5	coadministered	JJ	O	coadministered	amod	6	SENT_324	[p10l611t753r872b782],
6	drugs	NNS	O	drug	prep_on	1	SENT_324	[p10l882t753r985b792],
7	.	.	O	.	_	0	SENT_324	[p10l882t753r985b792],

1	Elvitegravir	NNP	O	Elvitegravir	nsubjpass	4	SENT_325	[p10l1007t753r1192b792],
2	has	VBZ	O	have	aux	4	SENT_325	[p10l1200t753r1250b782],
3	been	VBN	O	be	auxpass	4	SENT_325	[p10l1259t753r1333b782],
4	shown	VBN	O	show	_	0	SENT_325	[p10l1342t753r1443b782],
5	in	FW	O	in	nn	6	SENT_325	[p10l1451t755r1481b782],
6	vitro	FW	O	vitro	advmod	4	SENT_325	[p10l1489t755r1563b782],
7	to	TO	O	to	aux	8	SENT_325	[p10l1573t762r1603b782],
8	possess	VB	O	possess	xcomp	4	SENT_325	[p10l1613t764r1724b791],
9	the	DT	O	the	det	17	SENT_325	[p10l206t803r255b832],
10	potential	JJ	O	potential	amod	17	SENT_325	[p10l265t803r405b841],
11	to	TO	O	to	aux	12	SENT_325	[p10l415t811r446b832],
12	induce	VB	O	induce	xcomp	10	SENT_325	[p10l457t803r561b832],
13	CYP3A4	NN	O	cyp3a4	nn	14	SENT_325	[p10l572t804r711b832],
14	(	NN	O	(	dobj	12	SENT_325	[p10l722t804r749b839],
15	5	CD	NUMBER	5	number	16	SENT_325	[p10l722t804r749b839],
16	3	CD	NUMBER	3	num	17	SENT_325	[p10l754t804r790b839],
17	)	NN	O	)	dobj	8	SENT_325	[p10l754t804r790b839],
18	.	.	O	.	_	0	SENT_325	[p10l754t804r790b839],

1	Additionally	RB	O	additionally	advmod	10	SENT_326	[p10l801t803r1001b842],
2	,	,	O	,	_	0	SENT_326	[p10l801t803r1001b842],
3	the	DT	O	the	det	4	SENT_326	[p10l1013t803r1062b832],
4	majority	NN	O	majority	nsubj	10	SENT_326	[p10l1073t805r1206b842],
5	of	IN	O	of	_	0	SENT_326	[p10l1216t803r1250b832],
6	studies	NNS	O	study	prep_of	4	SENT_326	[p10l1256t803r1362b832],
7	conducted	VBN	O	conduct	partmod	6	SENT_326	[p10l1374t803r1536b832],
8	with	IN	O	with	_	0	SENT_326	[p10l1545t803r1615b832],
9	elvitegravir	NN	O	elvitegravir	prep_with	7	SENT_326	[p10l1626t803r1723b832, p10l206t854r298b892],
10	utilized	VBD	O	utilize	_	0	SENT_326	[p10l306t853r423b882],
11	boosting	VBG	O	boost	xcomp	10	SENT_326	[p10l433t853r569b892],
12	doses	NNS	O	dose	dobj	11	SENT_326	[p10l578t853r661b882],
13	of	IN	O	of	_	0	SENT_326	[p10l671t853r706b882],
14	ritonavir	NN	O	ritonavir	prep_of	12	SENT_326	[p10l711t854r853b888],
15	,	,	O	,	_	0	SENT_326	[p10l711t854r853b888],
16	which	WDT	O	which	nsubj	17	SENT_326	[p10l862t853r957b882],
17	possesses	VBZ	O	possess	rcmod	14	SENT_326	[p10l966t864r1108b891],
18	both	DT	O	both	det	22	SENT_326	[p10l1119t853r1191b882],
19	inhibitory	JJ	O	inhibitory	amod	22	SENT_326	[p10l1200t853r1358b891],
20	and	CC	O	and	_	0	SENT_326	[p10l1366t853r1422b882],
21	inductive	JJ	O	inductive	conj_and	19	SENT_326	[p10l1431t853r1575b882],
22	potential	NN	O	potential	dobj	17	SENT_326	[p10l1585t853r1724b891],
23	on	IN	O	on	_	0	SENT_326	[p10l206t914r246b932],
24	a	DT	O	a	det	25	SENT_326	[p10l259t914r273b932],
25	number	NN	O	number	prep_on	22	SENT_326	[p10l285t903r409b932],
26	of	IN	O	of	_	0	SENT_326	[p10l422t903r456b932],
27	drug-metabolizing	JJ	O	drug-metabolizing	amod	28	SENT_326	[p10l465t903r758b941],
28	enzymes	NNS	O	enzyme	prep_of	25	SENT_326	[p10l770t914r911b941],
29	.	.	O	.	_	0	SENT_326	[p10l770t914r911b941],

1	A	DT	O	a	det	2	SENT_327	[p10l924t904r951b931],
2	number	NN	O	number	nsubjpass	8	SENT_327	[p10l961t903r1085b932],
3	of	IN	O	of	_	0	SENT_327	[p10l1098t903r1132b932],
4	clinical	JJ	O	clinical	amod	6	SENT_327	[p10l1141t903r1251b932],
5	interaction	NN	O	interaction	nn	6	SENT_327	[p10l1263t904r1435b932],
6	studies	NNS	O	study	prep_of	2	SENT_327	[p10l1448t903r1554b932],
7	were	VBD	O	be	auxpass	8	SENT_327	[p10l1566t914r1640b932],
8	conducted	VBN	O	conduct	_	0	SENT_327	[p10l1654t914r1723b932, p10l206t953r311b982],
9	to	TO	O	to	aux	10	SENT_327	[p10l327t961r357b982],
10	assess	VB	O	assess	xcomp	8	SENT_327	[p10l373t964r460b982],
11	the	DT	O	the	det	12	SENT_327	[p10l476t953r524b982],
12	effect	NN	O	effect	dobj	10	SENT_327	[p10l541t953r627b982],
13	of	IN	O	of	_	0	SENT_327	[p10l641t953r676b982],
14	elvitegravir-ritonavir	NN	O	elvitegravir-ritonavir	prep_of	12	SENT_327	[p10l687t953r1014b991],
15	on	IN	O	on	_	0	SENT_327	[p10l1029t964r1068b982],
16	the	DT	O	the	det	17	SENT_327	[p10l1084t953r1132b982],
17	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	10	SENT_327	[p10l1148t953r1423b991],
18	of	IN	O	of	_	0	SENT_327	[p10l1439t953r1473b982],
19	coadministered	JJ	O	coadministered	amod	20	SENT_327	[p10l1485t953r1724b982],
20	drugs	NNS	O	drug	prep_of	17	SENT_327	[p10l206t1002r300b1041],
21	.	.	O	.	_	0	SENT_327	[p10l206t1002r300b1041],

1	Results	NNS	O	result	nsubjpass	3	SENT_328	[p10l316t1002r428b1032],
2	are	VBP	O	be	auxpass	3	SENT_328	[p10l442t1013r488b1031],
3	summarized	VBN	O	summarize	_	0	SENT_328	[p10l502t1002r692b1031],
4	in	IN	O	in	_	0	SENT_328	[p10l705t1004r736b1031],
5	Table	NNP	O	Table	prep_in	3	SENT_328	[p10l748t1002r844b1031],
6	3	CD	NUMBER	3	num	5	SENT_328	[p10l860t1004r886b1032],
7	.	.	O	.	_	0	SENT_328	[p10l860t1004r886b1032],

1	Overall	RB	O	overall	advmod	5	SENT_329	[p10l902t1002r1025b1038],
2	,	,	O	,	_	0	SENT_329	[p10l902t1002r1025b1038],
3	elvitegravir-ritonavir	JJ	O	elvitegravir-ritonavir	amod	4	SENT_329	[p10l1041t1002r1368b1041],
4	effects	NNS	O	effect	nsubj	5	SENT_329	[p10l1381t1003r1480b1031],
5	were	VBD	O	be	_	0	SENT_329	[p10l1492t1013r1567b1031],
6	relatively	RB	O	relatively	advmod	5	SENT_329	[p10l1581t1002r1726b1041],

1	Table	NNP	O	Table	dep	20	SENT_330	[p10l205t1093r290b1118],
2	3	CD	NUMBER	3	num	1	SENT_330	[p10l302t1095r315b1119],
3	Summary	NNP	O	Summary	dep	1	SENT_330	[p10l353t1094r497b1127],
4	of	IN	O	of	_	0	SENT_330	[p10l507t1093r539b1118],
5	elvitegravir	FW	O	elvitegravir	prep_of	3	SENT_330	[p10l546t1093r716b1127],
6	drug-drug	JJ	O	drug-drug	amod	7	SENT_330	[p10l726t1093r883b1127],
7	interactions	NNS	O	interaction	dep	3	SENT_330	[p10l892t1094r1079b1118],
8	:	:	O	:	_	0	SENT_330	[p10l892t1094r1079b1118],
9	effect	NN	O	effect	dep	3	SENT_330	[p10l1091t1093r1175b1118],
10	of	IN	O	of	_	0	SENT_330	[p10l1185t1093r1218b1118],
11	elvitegravir/ritonavir	NN	O	elvitegravir/ritonavir	prep_of	9	SENT_330	[p10l1224t1093r1538b1127],
12	on	IN	O	on	_	0	SENT_330	[p10l1548t1102r1586b1118],
13	coadministered	JJ	O	coadministered	amod	15	SENT_330	[p10l1596t1093r1827b1118],
14	agent	NN	O	agent	nn	15	SENT_330	[p10l1838t1100r1921b1127],
15	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	11	SENT_330	[p10l205t1143r471b1176],
16	Coadrninistered	JJ	MISC	coadrninistered	amod	17	SENT_330	[p10l206t1207r448b1233],
17	agent	NN	O	agent	dep	20	SENT_330	[p10l459t1214r542b1242],
18	AUC	NN	O	auc	nn	20	SENT_330	[p10l864t1208r954b1233],
19	”	CD	NUMBER	”	num	20	SENT_330	[p10l864t1208r954b1233],
20	GMR	NNP	O	GMR	dep	24	SENT_330	[p10l967t1208r1053b1233],
21	(	CD	PERCENT	(	num	23	SENT_330	[p10l1063t1208r1139b1239],
22	90	CD	PERCENT	90	num	23	SENT_330	[p10l1063t1208r1139b1239],
23	%	NN	PERCENT	%	dep	20	SENT_330	[p10l1063t1208r1139b1239],
24	CI	NN	O	ci	dep	28	SENT_330	[p10l1151t1208r1200b1239],
25	)	CD	NUMBER	)	num	24	SENT_330	[p10l1151t1208r1200b1239],
26	Cm	NN	O	cm	nn	28	SENT_330	[p10l1319t1208r1391b1238],
27	“	CD	NUMBER	“	num	28	SENT_330	[p10l1319t1208r1391b1238],
28	GMR	NNP	O	GMR	dep	33	SENT_330	[p10l1403t1208r1489b1233],
29	(	CD	PERCENT	(	num	31	SENT_330	[p10l1499t1208r1574b1239],
30	90	CD	PERCENT	90	num	31	SENT_330	[p10l1499t1208r1574b1239],
31	%	NN	PERCENT	%	dep	28	SENT_330	[p10l1499t1208r1574b1239],
32	CI	NN	O	ci	nn	33	SENT_330	[p10l1587t1208r1636b1240],
33	)	NN	O	)	_	0	SENT_330	[p10l1587t1208r1636b1240],

1	Ctroughb	NNP	O	Ctroughb	nn	2	SENT_331	[p10l1731t1201r1846b1247],
2	GMR	NNP	O	GMR	_	0	SENT_331	[p10l1858t1208r1944b1233],
3	(	CD	PERCENT	(	num	5	SENT_331	[p10l1954t1208r2030b1240],
4	90	CD	PERCENT	90	num	5	SENT_331	[p10l1954t1208r2030b1240],
5	%	NN	PERCENT	%	dep	2	SENT_331	[p10l1954t1208r2030b1240],
6	CI	NN	O	ci	nn	7	SENT_331	[p10l2043t1208r2092b1240],
7	)	NN	O	)	dep	2	SENT_331	[p10l2043t1208r2092b1240],

1	Abacavir	NNP	O	Abacavir	nn	2	SENT_332	[p10l204t1259r327b1284],
2	Amprenavir	NNP	O	Amprenavir	_	0	SENT_332	[p10l205t1311r372b1344],

1	Atazanavir	NNP	O	Atazanavir	nn	2	SENT_333	[p10l205t1363r353b1387],
2	(	NN	O	(	dep	9	SENT_333	[p10l363t1362r434b1394],
3	with	IN	O	with	_	0	SENT_333	[p10l363t1362r434b1394],
4	200	CD	NUMBER	200	num	5	SENT_333	[p10l444t1363r494b1387],
5	mg	NN	O	mg	prep_with	2	SENT_333	[p10l504t1371r549b1396],
6	elvitegravir	NN	O	elvitegravir	dep	9	SENT_333	[p10l558t1362r724b1396],
7	)	CD	NUMBER	)	num	6	SENT_333	[p10l558t1362r724b1396],
8	Atazanavir	NNP	O	Atazanavir	nn	9	SENT_333	[p10l205t1414r353b1439],
9	(	NN	O	(	_	0	SENT_333	[p10l363t1413r434b1445],
10	with	IN	O	with	_	0	SENT_333	[p10l363t1413r434b1445],
11	85	CD	NUMBER	85	num	14	SENT_333	[p10l445t1414r475b1439],
12	mg	NN	O	mg	nn	14	SENT_333	[p10l487t1423r531b1447],
13	elvitegravir	NN	O	elvitegravir	nn	14	SENT_333	[p10l541t1413r707b1447],
14	)	NN	O	)	prep_with	9	SENT_333	[p10l541t1413r707b1447],

1	Darunavir	NNP	PERSON	Darunavir	nn	2	SENT_334	[p10l206t1466r349b1490],
2	Didanosine	NNP	PERSON	Didanosine	_	0	SENT_334	[p10l206t1516r365b1542],

1	Emtricitabine	NNP	O	Emtricitabine	nn	2	SENT_335	[p10l206t1568r398b1593],
2	Etravirine	NNP	O	Etravirine	_	0	SENT_335	[p10l206t1620r346b1645],

1	Lopinavir	NNP	O	Lopinavir	nn	3	SENT_336	[p10l206t1672r344b1705],
2	Maraviroc	NNP	O	Maraviroc	nn	3	SENT_336	[p10l204t1723r349b1748],
3	Ritonavir	NNP	O	Ritonavir	_	0	SENT_336	[p10l206t1775r337b1799],
4	(	NN	O	(	dep	3	SENT_336	[p10l347t1773r418b1806],
5	with	IN	O	with	_	0	SENT_336	[p10l347t1773r418b1806],
6	darunavir	NN	O	darunavir	nn	7	SENT_336	[p10l428t1773r570b1806],
7	)	NN	O	)	prep_with	4	SENT_336	[p10l428t1773r570b1806],

1	Ritonavir	NNP	O	Ritonavir	_	0	SENT_337	[p10l206t1826r337b1851],
2	(	CD	NUMBER	(	num	1	SENT_337	[p10l347t1825r418b1857],
3	with	IN	O	with	_	0	SENT_337	[p10l347t1825r418b1857],
4	etravirine	NN	O	etravirine	prep_with	1	SENT_337	[p10l428t1826r571b1857],
5	)	CD	NUMBER	)	num	4	SENT_337	[p10l428t1826r571b1857],
6	Ritonavir	NNP	O	Ritonavir	dep	1	SENT_337	[p10l206t1878r337b1902],
7	(	CD	NUMBER	(	num	6	SENT_337	[p10l347t1876r418b1909],
8	with	IN	O	with	_	0	SENT_337	[p10l347t1876r418b1909],
9	fosamprenavir	JJ	O	fosamprenavir	amod	10	SENT_337	[p10l428t1877r636b1910],
10	)	NN	O	)	prep_with	6	SENT_337	[p10l428t1877r636b1910],

1	Ritonavir	NNP	O	Ritonavir	_	0	SENT_338	[p10l206t1929r337b1954],
2	(	CD	NUMBER	(	num	1	SENT_338	[p10l347t1928r418b1960],
3	with	IN	O	with	_	0	SENT_338	[p10l347t1928r418b1960],
4	maraviroc	NN	O	maraviroc	nn	7	SENT_338	[p10l427t1929r577b1960],
5	)	CD	NUMBER	)	num	7	SENT_338	[p10l427t1929r577b1960],
6	Ritonavir	NNP	O	Ritonavir	nn	7	SENT_338	[p10l206t1981r337b2005],
7	(	NN	O	(	prep_with	1	SENT_338	[p10l347t1979r418b2011],
8	with	IN	O	with	_	0	SENT_338	[p10l347t1979r418b2011],
9	tipranavir	NN	O	tipranavir	nn	10	SENT_338	[p10l428t1980r573b2013],
10	)	NN	O	)	prep_with	1	SENT_338	[p10l428t1980r573b2013],

1	Stavudine	NN	O	stavudine	dep	9	SENT_339	[p10l207t2031r343b2057],
2	1.07	CD	NUMBER	1.07	num	1	SENT_339	[p10l897t2032r952b2057],
3	(	NN	O	(	dep	1	SENT_339	[p10l964t2032r1040b2063],
4	1.05	CD	NUMBER	1.05	num	3	SENT_339	[p10l964t2032r1040b2063],
5	,	,	O	,	_	0	SENT_339	[p10l964t2032r1040b2063],
6	1.08	CD	NUMBER	1.08	number	7	SENT_339	[p10l1054t2032r1120b2063],
7	)	CD	NUMBER	)	appos	3	SENT_339	[p10l1054t2032r1120b2063],
8	0.996	CD	NUMBER	0.996	dep	9	SENT_339	[p10l1339t2032r1414b2057],
9	(	NN	O	(	dep	15	SENT_339	[p10l1426t2032r1519b2063],
10	0.934	CD	NUMBER	0.934	dep	9	SENT_339	[p10l1426t2032r1519b2063],
11	,	,	O	,	_	0	SENT_339	[p10l1426t2032r1519b2063],
12	1.06	CD	NUMBER	1.06	number	13	SENT_339	[p10l1533t2032r1599b2063],
13	)	CD	NUMBER	)	appos	10	SENT_339	[p10l1533t2032r1599b2063],
14	—	CD	NUMBER	—	num	15	SENT_339	[p10l1903t2047r1920b2049],
15	Tenofovir	NNP	O	Tenofovir	dep	32	SENT_339	[p10l205t2082r342b2108],
16	1.07	CD	NUMBER	1.07	num	15	SENT_339	[p10l898t2083r952b2108],
17	(	CD	NUMBER	(	num	18	SENT_339	[p10l964t2083r1040b2114],
18	1.03	CD	NUMBER	1.03	dep	15	SENT_339	[p10l964t2083r1040b2114],
19	,	,	O	,	_	0	SENT_339	[p10l964t2083r1040b2114],
20	1.12	CD	NUMBER	1.12	dep	26	SENT_339	[p10l1055t2083r1120b2115],
21	)	CD	NUMBER	)	num	22	SENT_339	[p10l1055t2083r1120b2115],
22	1.01	CD	NUMBER	1.01	dep	20	SENT_339	[p10l1342t2083r1582b2114],
23	(	NN	O	(	dep	26	SENT_339	[p10l1342t2083r1582b2114],
24	0.933,1.10	CD	NUMBER	0.933,1.10	num	23	SENT_339	[p10l1342t2083r1582b2114],
25	)	CD	NUMBER	)	num	26	SENT_339	[p10l1342t2083r1582b2114],
26	1.08	CD	NUMBER	1.08	dep	32	SENT_339	[p10l1785t2084r1839b2108],
27	(	NN	O	(	dep	26	SENT_339	[p10l1851t2083r1927b2115],
28	1.02	CD	NUMBER	1.02	num	27	SENT_339	[p10l1851t2083r1927b2115],
29	,	,	O	,	_	0	SENT_339	[p10l1851t2083r1927b2115],
30	1.15	CD	NUMBER	1.15	number	31	SENT_339	[p10l1941t2083r2007b2115],
31	)	CD	NUMBER	)	appos	27	SENT_339	[p10l1941t2083r2007b2115],
32	Tipranavir	NNP	O	Tipranavir	_	0	SENT_339	[p10l205t2134r355b2168],
33	0.889	CD	NUMBER	0.889	num	32	SENT_339	[p10l895t2135r970b2160],
34	(	CD	NUMBER	(	num	35	SENT_339	[p10l981t2135r1075b2166],
35	0.800	CD	NUMBER	0.800	nsubj	41	SENT_339	[p10l981t2135r1075b2166],
36	,	,	O	,	_	0	SENT_339	[p10l981t2135r1075b2166],
37	0.988	CD	NUMBER	0.988	number	38	SENT_339	[p10l1086t2135r1172b2166],
38	)	CD	NUMBER	)	appos	35	SENT_339	[p10l1086t2135r1172b2166],
39	0.916	CD	NUMBER	0.916	num	40	SENT_339	[p10l1339t2135r1414b2160],
40	(	NN	O	(	dep	38	SENT_339	[p10l1426t2135r1519b2166],
41	0.838	CD	NUMBER	0.838	rcmod	32	SENT_339	[p10l1426t2135r1519b2166],
42	,	,	O	,	_	0	SENT_339	[p10l1426t2135r1519b2166],
43	1.00	CD	NUMBER	1.00	number	44	SENT_339	[p10l1533t2135r1599b2166],
44	)	CD	NUMBER	)	appos	41	SENT_339	[p10l1533t2135r1599b2166],
45	0.889	CD	NUMBER	0.889	num	46	SENT_339	[p10l1773t2135r1848b2159],
46	(	NN	O	(	dep	44	SENT_339	[p10l1859t2135r1953b2166],
47	0.774	CD	NUMBER	0.774	dep	44	SENT_339	[p10l1859t2135r1953b2166],
48	,	,	O	,	_	0	SENT_339	[p10l1859t2135r1953b2166],
49	1.02	CD	NUMBER	1.02	num	51	SENT_339	[p10l1967t2135r2033b2166],
50	)	CD	NUMBER	)	num	51	SENT_339	[p10l1967t2135r2033b2166],
51	Zidovudine	NN	O	zidovudine	appos	41	SENT_339	[p10l206t2185r366b2211],
52	0.860	CD	NUMBER	0.860	number	53	SENT_339	[p10l895t2187r970b2211],
53	(	CD	NUMBER	(	dobj	41	SENT_339	[p10l981t2186r1075b2217],
54	0.798	CD	NUMBER	0.798	dep	53	SENT_339	[p10l981t2186r1075b2217],
55	,	,	O	,	_	0	SENT_339	[p10l981t2186r1075b2217],
56	0.926	CD	NUMBER	0.926	number	57	SENT_339	[p10l1086t2186r1172b2217],
57	)	CD	NUMBER	)	dobj	41	SENT_339	[p10l1086t2186r1172b2217],
58	0.881	CD	NUMBER	0.881	num	59	SENT_339	[p10l1339t2187r1412b2211],
59	(	NN	O	(	dep	57	SENT_339	[p10l1426t2186r1519b2217],
60	0.765	CD	NUMBER	0.765	dep	57	SENT_339	[p10l1426t2186r1519b2217],
61	,	,	O	,	_	0	SENT_339	[p10l1426t2186r1519b2217],
62	1.01	CD	NUMBER	1.01	number	63	SENT_339	[p10l1533t2186r1599b2217],
63	)	CD	NUMBER	)	num	64	SENT_339	[p10l1533t2186r1599b2217],
64	—	CD	NUMBER	—	appos	57	SENT_339	[p10l1903t2202r1920b2204],
65	"	''	O	"	punct	57	SENT_339	[p10l206t2277r324b2303],

1	‘	NN	O	‘	_	0	SENT_340	[p10l206t2277r324b2303],
2	AUC	NN	O	auc	rcmod	1	SENT_340	[p10l206t2277r324b2303],
3	(	CD	NUMBER	(	dep	2	SENT_340	[p10l206t2277r324b2303],
4	)	SYM	O	)	dep	2	SENT_340	[p10l206t2277r324b2303],
5	-	:	O	-	_	0	SENT_340	[p10l206t2277r324b2303],
6	¢	NN	O	¢	dep	1	SENT_340	[p10l206t2277r324b2303],
7	,	,	O	,	_	0	SENT_340	[p10l206t2277r324b2303],
8	o	NN	O	o	appos	6	SENT_340	[p10l206t2277r324b2303],
9	for	IN	O	for	_	0	SENT_340	[p10l336t2276r371b2299],
10	abacavir	NN	O	abacavir	prep_for	8	SENT_340	[p10l379t2276r483b2303],
11	,	,	O	,	_	0	SENT_340	[p10l379t2276r483b2303],
12	didanosine	NN	O	didanosine	prep_for	8	SENT_340	[p10l493t2276r630b2304],
13	,	,	O	,	_	0	SENT_340	[p10l493t2276r630b2304],
14	and	CC	O	and	_	0	SENT_340	[p10l640t2276r683b2299],
15	stavudine	NN	O	stavudine	prep_for	8	SENT_340	[p10l692t2276r813b2303],
16	;	:	O	;	_	0	SENT_340	[p10l692t2276r813b2303],
17	AUCg	SYM	O	aucg	dep	8	SENT_340	[p10l822t2277r932b2303],
18	-	:	O	-	_	0	SENT_340	[p10l822t2277r932b2303],
19	;	:	O	;	_	0	SENT_340	[p10l822t2277r932b2303],
20	4	CD	NUMBER	4	number	21	SENT_340	[p10l822t2277r932b2303],
21	1	CD	NUMBER	1	dep	1	SENT_340	[p10l935t2287r955b2303],
22	,	,	O	,	_	0	SENT_340	[p10l935t2287r955b2303],
23	,	,	O	,	_	0	SENT_340	[p10l935t2287r955b2303],
24	for	IN	O	for	dep	21	SENT_340	[p10l965t2276r1000b2299],
25	atazanavir	NN	O	atazanavir	pobj	24	SENT_340	[p10l1009t2277r1135b2303],
26	,	,	O	,	_	0	SENT_340	[p10l1009t2277r1135b2303],
27	emtricitabine	NN	O	emtricitabine	appos	25	SENT_340	[p10l1145t2276r1314b2303],
28	,	,	O	,	_	0	SENT_340	[p10l1145t2276r1314b2303],
29	ritonavir	NN	O	ritonavir	nn	30	SENT_340	[p10l1323t2277r1430b2299],
30	(	NN	O	(	appos	25	SENT_340	[p10l1438t2276r1500b2304],
31	with	IN	O	with	_	0	SENT_340	[p10l1438t2276r1500b2304],
32	maraviroc	NN	O	maraviroc	nn	33	SENT_340	[p10l1509t2277r1639b2304],
33	)	NN	O	)	prep_with	30	SENT_340	[p10l1509t2277r1639b2304],
34	and	CC	O	and	_	0	SENT_340	[p10l1648t2276r1692b2299],
35	tenofovir	NN	O	tenofovir	prep_with	30	SENT_340	[p10l1700t2276r1818b2304],
36	;	:	O	;	_	0	SENT_340	[p10l1700t2276r1818b2304],
37	AUCO_1z	NN	O	auco_1z	dep	25	SENT_340	[p10l1827t2277r1935b2303],
38	1	CD	NUMBER	1	num	37	SENT_340	[p10l1940t2287r1960b2303],
39	,	,	O	,	_	0	SENT_340	[p10l1940t2287r1960b2303],
40	,	,	O	,	_	0	SENT_340	[p10l1940t2287r1960b2303],
41	for	IN	O	for	_	0	SENT_340	[p10l1970t2276r2005b2299],
42	amprenavir	NN	O	amprenavir	prep_for	21	SENT_340	[p10l206t2318r349b2347],
43	,	,	O	,	_	0	SENT_340	[p10l206t2318r349b2347],
44	darunavir	NN	O	darunavir	nn	53	SENT_340	[p10l359t2317r479b2345],
45	,	,	O	,	_	0	SENT_340	[p10l359t2317r479b2345],
46	etravirine	NN	O	etravirine	dep	53	SENT_340	[p10l490t2318r612b2345],
47	,	,	O	,	_	0	SENT_340	[p10l490t2318r612b2345],
48	lopinavir	NN	O	lopinavir	dep	53	SENT_340	[p10l622t2317r735b2347],
49	,	,	O	,	_	0	SENT_340	[p10l622t2317r735b2347],
50	maraviroc	NN	O	maraviroc	dep	53	SENT_340	[p10l744t2318r873b2345],
51	,	,	O	,	_	0	SENT_340	[p10l744t2318r873b2345],
52	other	JJ	O	other	amod	53	SENT_340	[p10l883t2317r948b2340],
53	ritonavir	NN	O	ritonavir	appos	21	SENT_340	[p10l956t2318r1066b2345],
54	,	,	O	,	_	0	SENT_340	[p10l956t2318r1066b2345],
55	tipranavir	NN	O	tipranavir	conj_and	53	SENT_340	[p10l1076t2318r1199b2347],
56	,	,	O	,	_	0	SENT_340	[p10l1076t2318r1199b2347],
57	and	CC	O	and	_	0	SENT_340	[p10l1209t2317r1252b2340],
58	zidovudine	NN	O	zidovudine	appos	21	SENT_340	[p10l1261t2317r1401b2340],
59	.	.	O	.	_	0	SENT_340	[p10l1261t2317r1401b2340],

1	BCZ4	NN	O	bcz4	_	0	SENT_341	[p10l205t2349r262b2381],
2	1	CD	NUMBER	1	dep	1	SENT_341	[p10l266t2365r285b2381],
3	,	,	O	,	_	0	SENT_341	[p10l266t2365r285b2381],
4	,	,	O	,	_	0	SENT_341	[p10l266t2365r285b2381],
5	for	IN	O	for	dep	1	SENT_341	[p10l295t2354r331b2376],
6	atazanavir	NN	O	atazanavir	pobj	5	SENT_341	[p10l339t2355r466b2381],
7	,	,	O	,	_	0	SENT_341	[p10l339t2355r466b2381],
8	emtricitabine	NN	O	emtricitabine	appos	6	SENT_341	[p10l476t2353r644b2381],
9	,	,	O	,	_	0	SENT_341	[p10l476t2353r644b2381],
10	ritonavir	NN	O	ritonavir	nn	11	SENT_341	[p10l654t2355r760b2376],
11	(	NN	O	(	appos	6	SENT_341	[p10l769t2353r831b2382],
12	with	IN	O	with	_	0	SENT_341	[p10l769t2353r831b2382],
13	maraviroc	NN	O	maraviroc	nn	14	SENT_341	[p10l839t2354r976b2382],
14	)	NN	O	)	prep_with	11	SENT_341	[p10l839t2354r976b2382],
15	,	,	O	,	_	0	SENT_341	[p10l839t2354r976b2382],
16	and	CC	O	and	_	0	SENT_341	[p10l986t2353r1030b2376],
17	tenofovir	NN	O	tenofovir	conj_and	11	SENT_341	[p10l1038t2354r1156b2381],
18	;	:	O	;	_	0	SENT_341	[p10l1038t2354r1156b2381],
19	C1	NN	O	c1	dep	6	SENT_341	[p10l1166t2354r1207b2381],
20	;	:	O	;	_	0	SENT_341	[p10l1166t2354r1207b2381],
21	1	CD	NUMBER	1	dep	6	SENT_341	[p10l1213t2365r1232b2381],
22	,	,	O	,	_	0	SENT_341	[p10l1213t2365r1232b2381],
23	,	,	O	,	_	0	SENT_341	[p10l1213t2365r1232b2381],
24	for	IN	O	for	_	0	SENT_341	[p10l1242t2354r1278b2376],
25	amprenavir	NN	O	amprenavir	nn	34	SENT_341	[p10l1286t2355r1429b2383],
26	,	,	O	,	_	0	SENT_341	[p10l1286t2355r1429b2383],
27	darunavir	NN	O	darunavir	dep	34	SENT_341	[p10l1439t2353r1559b2381],
28	,	,	O	,	_	0	SENT_341	[p10l1439t2353r1559b2381],
29	etravirine	NN	O	etravirine	dep	34	SENT_341	[p10l1569t2355r1692b2381],
30	,	,	O	,	_	0	SENT_341	[p10l1569t2355r1692b2381],
31	lopinavir	NN	O	lopinavir	dep	34	SENT_341	[p10l1702t2353r1815b2383],
32	,	,	O	,	_	0	SENT_341	[p10l1702t2353r1815b2383],
33	other	JJ	O	other	amod	34	SENT_341	[p10l1825t2354r1890b2376],
34	ritonavir	NN	O	ritonavir	prep_for	1	SENT_341	[p10l1898t2355r2009b2381],
35	,	,	O	,	_	0	SENT_341	[p10l1898t2355r2009b2381],
36	and	CC	O	and	_	0	SENT_341	[p10l2018t2353r2062b2376],
37	tipranavir	NN	O	tipranavir	prep_for	1	SENT_341	[p10l206t2390r331b2419],
38	;	:	O	;	_	0	SENT_341	[p10l206t2390r331b2419],
39	“	CD	NUMBER	“	dep	1	SENT_341	[p10l341t2390r386b2417],
40	.	.	O	.	_	0	SENT_341	[p10l341t2390r386b2417],

1	—	NN	O	—	_	0	SENT_342	[p10l341t2390r386b2417],
2	.	.	O	.	_	0	SENT_342	[p10l341t2390r386b2417],

1	”	NN	O	”	_	0	SENT_343	[p10l341t2390r386b2417],
2	,	,	O	,	_	0	SENT_343	[p10l341t2390r386b2417],
3	not	RB	O	not	neg	4	SENT_343	[p10l395t2396r437b2412],
4	done	VBN	O	do	partmod	1	SENT_343	[p10l445t2389r511b2412],
5	.	.	O	.	_	0	SENT_343	[p10l445t2389r511b2412],

1	GMR	NNP	ORGANIZATION	GMR	_	0	SENT_344	[p10l206t2426r284b2452],
2	,	,	O	,	_	0	SENT_344	[p10l206t2426r284b2452],
3	Geometric	JJ	O	geometric	amod	5	SENT_344	[p10l294t2426r425b2448],
4	mean	NN	O	mean	nn	5	SENT_344	[p10l434t2433r500b2448],
5	ratio	NN	O	ratio	appos	1	SENT_344	[p10l508t2426r571b2452],
6	;	:	O	;	_	0	SENT_344	[p10l508t2426r571b2452],
7	CI	NN	O	ci	dep	1	SENT_344	[p10l581t2426r619b2452],
8	,	,	O	,	_	0	SENT_344	[p10l581t2426r619b2452],
9	Conﬁdence	NN	O	conﬁdence	nn	10	SENT_344	[p10l629t2425r769b2448],
10	interval	NN	O	interval	appos	7	SENT_344	[p10l778t2425r870b2448],
11	(	CD	NUMBER	(	number	12	SENT_344	[p10l879t2426r900b2453],
12	5	CD	NUMBER	5	num	13	SENT_344	[p10l879t2426r900b2453],
13	4	CD	NUMBER	4	dep	10	SENT_344	[p10l903t2426r924b2453],
14	,	,	O	,	_	0	SENT_344	[p10l903t2426r924b2453],
15	56-66	CD	NUMBER	56-66	num	16	SENT_344	[p10l934t2426r1022b2453],
16	)	NN	O	)	appos	7	SENT_344	[p10l934t2426r1022b2453],
17	.	.	O	.	_	0	SENT_344	[p10l934t2426r1022b2453],
18	"	''	O	"	punct	1	SENT_344	[p10l1133t2528r1406b2558],

1	ww	NN	O	ww	poss	3	SENT_345	[p10l1133t2528r1406b2558],
2	'	POS	O	'	_	0	SENT_345	[p10l1133t2528r1406b2558],
3	w.	NN	O	w.	nsubj	4	SENT_345	[p10l1133t2528r1406b2558],
4	annmzlreview	NN	O	annmzlreview	_	0	SENT_345	[p10l1133t2528r1406b2558],
5	:	:	O	:	_	0	SENT_345	[p10l1133t2528r1406b2558],
6	.	.	O	.	_	0	SENT_345	[p10l1133t2528r1406b2558],

1	org	NN	O	org	nn	2	SENT_346	[p10l1133t2528r1406b2558],
2	o	NN	O	o	_	0	SENT_346	[p10l1420t2536r1430b2546],
3	Emerging	VBG	O	emerge	dep	2	SENT_346	[p10l1445t2528r1560b2558],
4	Plmrmacology	NN	O	plmrmacology	dobj	3	SENT_346	[p10l1567t2528r1725b2558],

1	Table	NNP	O	Table	dep	148	SENT_347	[p10l208t2573r293b2599],
2	4	CD	NUMBER	4	dep	148	SENT_347	[p10l304t2575r321b2599],
3	Summary	NNP	O	Summary	dep	148	SENT_347	[p10l356t2574r500b2607],
4	of	IN	O	of	dep	148	SENT_347	[p10l510t2573r543b2599],
5	elvitegravir	FW	O	elvitegravir	dep	148	SENT_347	[p10l550t2573r720b2607],
6	drug-drug	JJ	O	drug-drug	dep	148	SENT_347	[p10l730t2573r886b2607],
7	interactions	NNS	O	interaction	dep	148	SENT_347	[p10l895t2574r1082b2599],
8	:	:	O	:	_	0	SENT_347	[p10l895t2574r1082b2599],
9	effect	NN	O	effect	dep	148	SENT_347	[p10l1095t2573r1178b2599],
10	of	IN	O	of	dep	148	SENT_347	[p10l1188t2573r1221b2599],
11	coadrrlinistered	JJ	O	coadrrlinistered	dep	148	SENT_347	[p10l1227t2573r1459b2599],
12	agent	NN	O	agent	dep	148	SENT_347	[p10l1470t2580r1553b2607],
13	on	IN	O	on	dep	148	SENT_347	[p10l1563t2582r1601b2599],
14	elvitegravir	NN	O	elvitegravir	dep	148	SENT_347	[p10l1611t2573r1781b2607],
15	pharmacokinetics	NNS	O	pharmacokinetic	dep	148	SENT_347	[p10l1790t2573r2056b2607],
16	Coadministered	JJ	O	coadministered	dep	148	SENT_347	[p10l209t2637r452b2663],
17	agent	NN	O	agent	dep	148	SENT_347	[p10l462t2644r545b2671],
18	AUC0_241	NN	O	auc0_241	dep	148	SENT_347	[p10l901t2638r1065b2669],
19	,	,	O	,	_	0	SENT_347	[p10l901t2638r1065b2669],
20	,	,	O	,	_	0	SENT_347	[p10l901t2638r1065b2669],
21	GMR	NNP	ORGANIZATION	GMR	dep	148	SENT_347	[p10l1077t2638r1163b2663],
22	(	CD	PERCENT	(	dep	148	SENT_347	[p10l1173t2638r1249b2669],
23	90	CD	PERCENT	90	dep	148	SENT_347	[p10l1173t2638r1249b2669],
24	%	NN	PERCENT	%	dep	148	SENT_347	[p10l1173t2638r1249b2669],
25	CI	NN	O	ci	dep	148	SENT_347	[p10l1261t2638r1311b2669],
26	)	CD	NUMBER	)	dep	148	SENT_347	[p10l1261t2638r1311b2669],
27	cm	NN	O	cm	dep	148	SENT_347	[p10l1389t2638r1461b2668],
28	GMR	NN	O	gmr	dep	148	SENT_347	[p10l1472t2638r1559b2663],
29	(	CD	PERCENT	(	dep	148	SENT_347	[p10l1568t2638r1644b2669],
30	90	CD	PERCENT	90	dep	148	SENT_347	[p10l1568t2638r1644b2669],
31	%	NN	PERCENT	%	dep	148	SENT_347	[p10l1568t2638r1644b2669],
32	CI	NN	O	ci	dep	148	SENT_347	[p10l1657t2638r1706b2669],
33	)	CD	NUMBER	)	dep	148	SENT_347	[p10l1657t2638r1706b2669],
34	C241	NN	O	c241	dep	148	SENT_347	[p10l1771t2638r1854b2669],
35	,	,	O	,	_	0	SENT_347	[p10l1771t2638r1854b2669],
36	,	,	O	,	_	0	SENT_347	[p10l1771t2638r1854b2669],
37	GMR	NNP	ORGANIZATION	GMR	dep	148	SENT_347	[p10l1866t2638r1952b2663],
38	(	CD	PERCENT	(	dep	148	SENT_347	[p10l1962t2638r2037b2669],
39	90	CD	PERCENT	90	dep	148	SENT_347	[p10l1962t2638r2037b2669],
40	%	NN	PERCENT	%	dep	148	SENT_347	[p10l1962t2638r2037b2669],
41	CI	NN	O	ci	dep	148	SENT_347	[p10l2050t2638r2099b2669],
42	)	CD	NUMBER	)	dep	148	SENT_347	[p10l2050t2638r2099b2669],
43	Abacavir/ritonavir	NN	O	abacavir/ritonavir	dep	148	SENT_347	[p10l208t2688r464b2714],
44	0.967	CD	NUMBER	0.967	dep	148	SENT_347	[p10l990t2690r1064b2715],
45	(	CD	NUMBER	(	dep	148	SENT_347	[p10l1076t2689r1170b2721],
46	0.925	CD	NUMBER	0.925	dep	148	SENT_347	[p10l1076t2689r1170b2721],
47	,	,	O	,	_	0	SENT_347	[p10l1076t2689r1170b2721],
48	1.01	CD	NUMBER	1.01	dep	148	SENT_347	[p10l1184t2689r1250b2721],
49	)	CD	NUMBER	)	dep	148	SENT_347	[p10l1184t2689r1250b2721],
50	0.950	CD	NUMBER	0.950	dep	148	SENT_347	[p10l1424t2690r1499b2714],
51	(	NN	O	(	dep	148	SENT_347	[p10l1510t2689r1604b2721],
52	0.897	CD	NUMBER	0.897	dep	148	SENT_347	[p10l1510t2689r1604b2721],
53	,	,	O	,	_	0	SENT_347	[p10l1510t2689r1604b2721],
54	1.01	CD	NUMBER	1.01	dep	148	SENT_347	[p10l1618t2689r1683b2721],
55	)	NN	O	)	dep	148	SENT_347	[p10l1618t2689r1683b2721],
56	1.06	CD	NUMBER	1.06	dep	148	SENT_347	[p10l1808t2690r1864b2714],
57	(	CD	NUMBER	(	dep	148	SENT_347	[p10l1875t2689r1951b2721],
58	1.01	CD	NUMBER	1.01	dep	148	SENT_347	[p10l1875t2689r1951b2721],
59	,	,	O	,	_	0	SENT_347	[p10l1875t2689r1951b2721],
60	1.13	CD	NUMBER	1.13	dep	148	SENT_347	[p10l1965t2689r2031b2721],
61	)	CD	NUMBER	)	dep	148	SENT_347	[p10l1965t2689r2031b2721],
62	Atazanavir/ritonavir	NN	O	atazanavir/ritonavir	dep	148	SENT_347	[p10l208t2741r491b2766],
63	2.00	CD	NUMBER	2.00	dep	148	SENT_347	[p10l990t2742r1048b2766],
64	(	NN	O	(	dep	148	SENT_347	[p10l1059t2741r1135b2772],
65	1.85	CD	NUMBER	1.85	dep	148	SENT_347	[p10l1059t2741r1135b2772],
66	,	,	O	,	_	0	SENT_347	[p10l1059t2741r1135b2772],
67	2.16	CD	NUMBER	2.16	dep	148	SENT_347	[p10l1147t2741r1215b2772],
68	)	NN	O	)	dep	148	SENT_347	[p10l1147t2741r1215b2772],
69	1.85	CD	NUMBER	1.85	dep	148	SENT_347	[p10l1426t2741r1480b2766],
70	(	CD	NUMBER	(	dep	148	SENT_347	[p10l1493t2741r1569b2772],
71	1.69	CD	NUMBER	1.69	dep	148	SENT_347	[p10l1493t2741r1569b2772],
72	,	,	O	,	_	0	SENT_347	[p10l1493t2741r1569b2772],
73	2.03	CD	NUMBER	2.03	dep	148	SENT_347	[p10l1580t2741r1649b2772],
74	)	CD	NUMBER	)	dep	148	SENT_347	[p10l1580t2741r1649b2772],
75	2.88	CD	NUMBER	2.88	dep	148	SENT_347	[p10l1806t2742r1863b2766],
76	(	NN	O	(	dep	148	SENT_347	[p10l1875t2741r1951b2772],
77	2.53	CD	NUMBER	2.53	dep	148	SENT_347	[p10l1875t2741r1951b2772],
78	,	,	O	,	_	0	SENT_347	[p10l1875t2741r1951b2772],
79	3.27	CD	NUMBER	3.27	dep	148	SENT_347	[p10l1964t2741r2031b2772],
80	)	CD	NUMBER	)	dep	148	SENT_347	[p10l1964t2741r2031b2772],
81	Atazanavir/ritonavir	NN	O	atazanavir/ritonavir	dep	148	SENT_347	[p10l208t2792r491b2817],
82	(	CD	NUMBER	(	dep	148	SENT_347	[p10l501t2792r542b2824],
83	85	CD	NUMBER	85	dep	148	SENT_347	[p10l501t2792r542b2824],
84	mg	NN	O	mg	dep	148	SENT_347	[p10l553t2801r598b2826],
85	elvitegravir	NN	O	elvitegravir	dep	148	SENT_347	[p10l608t2791r764b2826],
86	in	IN	O	in	dep	148	SENT_347	[p10l773t2793r800b2817],
87	1.07	CD	NUMBER	1.07	dep	148	SENT_347	[p10l993t2792r1047b2818],
88	(	CD	NUMBER	(	dep	148	SENT_347	[p10l1059t2792r1152b2824],
89	0.951	CD	NUMBER	0.951	dep	148	SENT_347	[p10l1059t2792r1152b2824],
90	,	,	O	,	_	0	SENT_347	[p10l1059t2792r1152b2824],
91	1.21	CD	NUMBER	1.21	dep	148	SENT_347	[p10l1167t2792r1232b2824],
92	)	CD	NUMBER	)	dep	148	SENT_347	[p10l1167t2792r1232b2824],
93	0.909	CD	NUMBER	0.909	dep	148	SENT_347	[p10l1424t2793r1499b2817],
94	(	NN	O	(	dep	148	SENT_347	[p10l1510t2792r1604b2824],
95	0.814	CD	NUMBER	0.814	dep	148	SENT_347	[p10l1510t2792r1604b2824],
96	,	,	O	,	_	0	SENT_347	[p10l1510t2792r1604b2824],
97	1.02	CD	NUMBER	1.02	dep	148	SENT_347	[p10l1618t2792r1683b2824],
98	)	CD	NUMBER	)	dep	148	SENT_347	[p10l1618t2792r1683b2824],
99	combination	NN	O	combination	dep	148	SENT_347	[p10l226t2837r402b2863],
100	versus	CC	O	versus	dep	148	SENT_347	[p10l410t2847r496b2863],
101	150	CD	NUMBER	150	dep	148	SENT_347	[p10l509t2838r556b2863],
102	mg	NN	O	mg	dep	148	SENT_347	[p10l566t2847r611b2871],
103	elvitegravir	NN	O	elvitegravir	dep	148	SENT_347	[p10l621t2837r777b2871],
104	control	NN	O	control	dep	148	SENT_347	[p10l226t2883r336b2915],
105	)	CD	NUMBER	)	dep	148	SENT_347	[p10l226t2883r336b2915],
106	Darunavir/ritonavir	NN	O	darunavir/ritonavir	dep	148	SENT_347	[p10l209t2935r486b2960],
107	1.11	CD	NUMBER	1.11	dep	148	SENT_347	[p10l993t2936r1045b2960],
108	(	CD	NUMBER	(	dep	148	SENT_347	[p10l1059t2935r1152b2966],
109	0.991	CD	NUMBER	0.991	dep	148	SENT_347	[p10l1059t2935r1152b2966],
110	,	,	O	,	_	0	SENT_347	[p10l1059t2935r1152b2966],
111	1.22	CD	NUMBER	1.22	dep	148	SENT_347	[p10l1167t2935r1232b2966],
112	)	CD	NUMBER	)	dep	148	SENT_347	[p10l1167t2935r1232b2966],
113	1.13	CD	NUMBER	1.13	dep	148	SENT_347	[p10l1427t2936r1479b2960],
114	(	NN	O	(	dep	148	SENT_347	[p10l1493t2935r1569b2966],
115	1.03	CD	NUMBER	1.03	dep	148	SENT_347	[p10l1493t2935r1569b2966],
116	,	,	O	,	_	0	SENT_347	[p10l1493t2935r1569b2966],
117	1.24	CD	NUMBER	1.24	dep	148	SENT_347	[p10l1583t2935r1649b2966],
118	)	CD	NUMBER	)	dep	148	SENT_347	[p10l1583t2935r1649b2966],
119	1.18	CD	NUMBER	1.18	dep	148	SENT_347	[p10l1809t2936r1863b2960],
120	(	NN	O	(	dep	148	SENT_347	[p10l1875t2935r1951b2966],
121	1.06	CD	NUMBER	1.06	dep	148	SENT_347	[p10l1875t2935r1951b2966],
122	,	,	O	,	_	0	SENT_347	[p10l1875t2935r1951b2966],
123	1.31	CD	NUMBER	1.31	dep	148	SENT_347	[p10l1965t2935r2031b2966],
124	)	CD	NUMBER	)	dep	148	SENT_347	[p10l1965t2935r2031b2966],
125	Didanosine/ritonavir	NN	O	didanosine/ritonavir	dep	148	SENT_347	[p10l209t2986r504b3011],
126	0.967	CD	NUMBER	0.967	dep	148	SENT_347	[p10l990t2987r1064b3012],
127	(	CD	NUMBER	(	dep	148	SENT_347	[p10l1076t2987r1170b3018],
128	0.925	CD	NUMBER	0.925	dep	148	SENT_347	[p10l1076t2987r1170b3018],
129	,	,	O	,	_	0	SENT_347	[p10l1076t2987r1170b3018],
130	1.01	CD	NUMBER	1.01	dep	148	SENT_347	[p10l1184t2987r1250b3018],
131	)	CD	NUMBER	)	dep	148	SENT_347	[p10l1184t2987r1250b3018],
132	0.950	CD	NUMBER	0.950	dep	148	SENT_347	[p10l1424t2987r1499b3012],
133	(	NN	O	(	dep	148	SENT_347	[p10l1510t2987r1604b3018],
134	0.897	CD	NUMBER	0.897	dep	148	SENT_347	[p10l1510t2987r1604b3018],
135	,	,	O	,	_	0	SENT_347	[p10l1510t2987r1604b3018],
136	1.01	CD	NUMBER	1.01	dep	148	SENT_347	[p10l1618t2987r1684b3018],
137	)	NN	O	)	dep	148	SENT_347	[p10l1618t2987r1684b3018],
138	1.06	CD	NUMBER	1.06	dep	148	SENT_347	[p10l1808t2987r1864b3011],
139	(	CD	NUMBER	(	dep	148	SENT_347	[p10l1875t2987r1951b3018],
140	1.01	CD	NUMBER	1.01	dep	148	SENT_347	[p10l1875t2987r1951b3018],
141	,	,	O	,	_	0	SENT_347	[p10l1875t2987r1951b3018],
142	1.13	CD	NUMBER	1.13	dep	148	SENT_347	[p10l1965t2987r2031b3018],
143	)	CD	NUMBER	)	dep	148	SENT_347	[p10l1965t2987r2031b3018],
144	Emtricitabine/tenfovir	NN	O	emtricitabine/tenfovir	dep	148	SENT_347	[p10l209t3037r526b3063],
145	disoproxil	NN	O	disoproxil	dep	148	SENT_347	[p10l536t3037r673b3071],
146	fumarate	NN	O	fumarate	dep	148	SENT_347	[p10l683t3037r819b3063],
147	/	:	O	/	dep	148	SENT_347	[p10l683t3037r819b3063],
148	ritonavir	NN	O	ritonavir	_	0	SENT_347	[p10l225t3084r347b3109],

1	Etravirine/ritonavir	NN	O	etravirine/ritonavir	_	0	SENT_348	[p10l209t3136r485b3160],
2	1.06	CD	NUMBER	1.06	num	1	SENT_348	[p10l993t3136r1048b3160],
3	(	CD	NUMBER	(	num	4	SENT_348	[p10l1059t3135r1135b3167],
4	1.00	CD	NUMBER	1.00	dep	1	SENT_348	[p10l1059t3135r1135b3167],
5	,	,	O	,	_	0	SENT_348	[p10l1059t3135r1135b3167],
6	1.13	CD	NUMBER	1.13	num	7	SENT_348	[p10l1150t3135r1215b3166],
7	)	NN	O	)	appos	4	SENT_348	[p10l1150t3135r1215b3166],
8	1.07	CD	NUMBER	1.07	number	9	SENT_348	[p10l1427t3135r1481b3160],
9	(	CD	NUMBER	(	num	10	SENT_348	[p10l1493t3135r1569b3167],
10	1.01	CD	NUMBER	1.01	dep	7	SENT_348	[p10l1493t3135r1569b3167],
11	,	,	O	,	_	0	SENT_348	[p10l1493t3135r1569b3167],
12	1.13	CD	NUMBER	1.13	num	13	SENT_348	[p10l1583t3135r1649b3167],
13	)	NN	O	)	appos	4	SENT_348	[p10l1583t3135r1649b3167],

1	Fosamprenavir/ritonavir	NN	O	fosamprenavir/ritonavir	_	0	SENT_349	[p10l209t3187r552b3220],
2	0.934	CD	NUMBER	0.934	num	1	SENT_349	[p10l990t3187r1066b3212],
3	(	CD	NUMBER	(	number	4	SENT_349	[p10l1076t3187r1170b3218],
4	0.879	CD	NUMBER	0.879	dep	1	SENT_349	[p10l1076t3187r1170b3218],
5	,	,	O	,	_	0	SENT_349	[p10l1076t3187r1170b3218],
6	0.992	CD	NUMBER	0.992	number	7	SENT_349	[p10l1181t3187r1267b3218],
7	)	CD	NUMBER	)	appos	1	SENT_349	[p10l1181t3187r1267b3218],
8	0.999	CD	NUMBER	0.999	num	9	SENT_349	[p10l1424t3187r1499b3212],
9	(	NN	O	(	dep	7	SENT_349	[p10l1510t3187r1604b3218],
10	0.906	CD	NUMBER	0.906	dep	1	SENT_349	[p10l1510t3187r1604b3218],
11	,	,	O	,	_	0	SENT_349	[p10l1510t3187r1604b3218],
12	1.10	CD	NUMBER	1.10	num	13	SENT_349	[p10l1618t3187r1684b3218],
13	)	NN	O	)	appos	10	SENT_349	[p10l1618t3187r1684b3218],

1	0.963	CD	NUMBER	0.963	dep	101	SENT_350	[p10l1806t3187r1878b3212],
2	(	CD	NUMBER	(	dep	101	SENT_350	[p10l1892t3187r1986b3218],
3	0.898	CD	NUMBER	0.898	dep	101	SENT_350	[p10l1892t3187r1986b3218],
4	,	,	O	,	_	0	SENT_350	[p10l1892t3187r1986b3218],
5	1.03	CD	NUMBER	1.03	dep	101	SENT_350	[p10l2000t3187r2065b3218],
6	)	CD	NUMBER	)	dep	101	SENT_350	[p10l2000t3187r2065b3218],
7	Lopinavir/ritonavir	NN	O	lopinavir/ritonavir	dep	101	SENT_350	[p10l209t3238r481b3271],
8	1.75	CD	NUMBER	1.75	dep	101	SENT_350	[p10l993t3238r1046b3263],
9	(	NN	O	(	dep	101	SENT_350	[p10l1059t3238r1135b3270],
10	1.50	CD	NUMBER	1.50	dep	101	SENT_350	[p10l1059t3238r1135b3270],
11	,	,	O	,	_	0	SENT_350	[p10l1059t3238r1135b3270],
12	2.04	CD	NUMBER	2.04	dep	101	SENT_350	[p10l1147t3238r1215b3270],
13	)	CD	NUMBER	)	dep	101	SENT_350	[p10l1147t3238r1215b3270],
14	1.52	CD	NUMBER	1.52	dep	101	SENT_350	[p10l1427t3238r1480b3263],
15	(	NN	O	(	dep	101	SENT_350	[p10l1493t3238r1569b3270],
16	1.29	CD	NUMBER	1.29	dep	101	SENT_350	[p10l1493t3238r1569b3270],
17	,	,	O	,	_	0	SENT_350	[p10l1493t3238r1569b3270],
18	1.79	CD	NUMBER	1.79	dep	101	SENT_350	[p10l1583t3238r1649b3270],
19	)	CD	NUMBER	)	dep	101	SENT_350	[p10l1583t3238r1649b3270],
20	2.38	CD	NUMBER	2.38	dep	101	SENT_350	[p10l1806t3239r1863b3263],
21	(	NN	O	(	dep	101	SENT_350	[p10l1875t3238r1951b3270],
22	1.81	CD	NUMBER	1.81	dep	101	SENT_350	[p10l1875t3238r1951b3270],
23	,	,	O	,	_	0	SENT_350	[p10l1875t3238r1951b3270],
24	3.13	CD	NUMBER	3.13	dep	101	SENT_350	[p10l1964t3238r2031b3270],
25	)	CD	NUMBER	)	dep	101	SENT_350	[p10l1964t3238r2031b3270],
26	Maraviroc/ritonavir	NN	O	maraviroc/ritonavir	dep	101	SENT_350	[p10l208t3290r487b3314],
27	1.07	CD	NUMBER	1.07	dep	101	SENT_350	[p10l992t3290r1047b3315],
28	(	CD	NUMBER	(	dep	101	SENT_350	[p10l1059t3290r1152b3321],
29	0.964	CD	NUMBER	0.964	dep	101	SENT_350	[p10l1059t3290r1152b3321],
30	,	,	O	,	_	0	SENT_350	[p10l1059t3290r1152b3321],
31	1.18	CD	NUMBER	1.18	dep	101	SENT_350	[p10l1167t3290r1232b3321],
32	)	CD	NUMBER	)	dep	101	SENT_350	[p10l1167t3290r1232b3321],
33	1.01	CD	NUMBER	1.01	dep	101	SENT_350	[p10l1426t3290r1586b3321],
34	(	NN	O	(	dep	101	SENT_350	[p10l1426t3290r1586b3321],
35	0.887	CD	NUMBER	0.887	dep	101	SENT_350	[p10l1426t3290r1586b3321],
36	,	,	O	,	_	0	SENT_350	[p10l1426t3290r1586b3321],
37	1.15	CD	NUMBER	1.15	dep	101	SENT_350	[p10l1601t3290r1666b3321],
38	)	CD	NUMBER	)	dep	101	SENT_350	[p10l1601t3290r1666b3321],
39	1.09	CD	NUMBER	1.09	dep	101	SENT_350	[p10l1808t3290r1864b3315],
40	(	NN	O	(	dep	101	SENT_350	[p10l1875t3290r1968b3321],
41	0.947	CD	NUMBER	0.947	dep	101	SENT_350	[p10l1875t3290r1968b3321],
42	,	,	O	,	_	0	SENT_350	[p10l1875t3290r1968b3321],
43	1.26	CD	NUMBER	1.26	dep	101	SENT_350	[p10l1983t3290r2048b3321],
44	)	CD	NUMBER	)	dep	101	SENT_350	[p10l1983t3290r2048b3321],
45	Stavudine/ritonavir	NN	O	stavudine/ritonavir	dep	101	SENT_350	[p10l210t3340r481b3366],
46	0.987	CD	NUMBER	0.987	dep	101	SENT_350	[p10l990t3341r1064b3366],
47	(	CD	NUMBER	(	dep	101	SENT_350	[p10l1076t3341r1170b3372],
48	0.939	CD	NUMBER	0.939	dep	101	SENT_350	[p10l1076t3341r1170b3372],
49	,	,	O	,	_	0	SENT_350	[p10l1076t3341r1170b3372],
50	1.04	CD	NUMBER	1.04	dep	101	SENT_350	[p10l1184t3341r1250b3372],
51	)	CD	NUMBER	)	dep	101	SENT_350	[p10l1184t3341r1250b3372],
52	0.960	CD	NUMBER	0.960	dep	101	SENT_350	[p10l1424t3342r1499b3366],
53	(	NN	O	(	dep	101	SENT_350	[p10l1510t3341r1604b3372],
54	0.899	CD	NUMBER	0.899	dep	101	SENT_350	[p10l1510t3341r1604b3372],
55	,	,	O	,	_	0	SENT_350	[p10l1510t3341r1604b3372],
56	1.03	CD	NUMBER	1.03	dep	101	SENT_350	[p10l1618t3341r1684b3372],
57	)	NN	O	)	dep	101	SENT_350	[p10l1618t3341r1684b3372],
58	1.24	CD	NUMBER	1.24	dep	101	SENT_350	[p10l1809t3342r1865b3366],
59	(	CD	NUMBER	(	dep	101	SENT_350	[p10l1875t3341r1951b3372],
60	1.17	CD	NUMBER	1.17	dep	101	SENT_350	[p10l1875t3341r1951b3372],
61	,	,	O	,	_	0	SENT_350	[p10l1875t3341r1951b3372],
62	1.33	CD	NUMBER	1.33	dep	101	SENT_350	[p10l1965t3341r2031b3372],
63	)	CD	NUMBER	)	dep	101	SENT_350	[p10l1965t3341r2031b3372],
64	Tipranavir/ritonavir	NN	O	tipranavir/ritonavir	dep	101	SENT_350	[p10l208t3392r493b3426],
65	0.924	CD	NUMBER	0.924	dep	101	SENT_350	[p10l990t3393r1066b3418],
66	(	CD	NUMBER	(	dep	101	SENT_350	[p10l1076t3393r1170b3424],
67	0.787	CD	NUMBER	0.787	dep	101	SENT_350	[p10l1076t3393r1170b3424],
68	,	,	O	,	_	0	SENT_350	[p10l1076t3393r1170b3424],
69	1.08	CD	NUMBER	1.08	dep	101	SENT_350	[p10l1184t3393r1250b3424],
70	)	NN	O	)	dep	101	SENT_350	[p10l1184t3393r1250b3424],
71	1.06	CD	NUMBER	1.06	dep	101	SENT_350	[p10l1426t3393r1482b3417],
72	(	CD	NUMBER	(	dep	101	SENT_350	[p10l1493t3393r1586b3424],
73	0.894	CD	NUMBER	0.894	dep	101	SENT_350	[p10l1493t3393r1586b3424],
74	,	,	O	,	_	0	SENT_350	[p10l1493t3393r1586b3424],
75	1.26	CD	NUMBER	1.26	dep	101	SENT_350	[p10l1601t3393r1666b3424],
76	)	CD	NUMBER	)	dep	101	SENT_350	[p10l1601t3393r1666b3424],
77	0.904	CD	NUMBER	0.904	dep	101	SENT_350	[p10l1806t3393r1882b3418],
78	(	NN	O	(	dep	101	SENT_350	[p10l1892t3393r1986b3424],
79	0.698	CD	NUMBER	0.698	dep	101	SENT_350	[p10l1892t3393r1986b3424],
80	,	,	O	,	_	0	SENT_350	[p10l1892t3393r1986b3424],
81	1.17	CD	NUMBER	1.17	dep	101	SENT_350	[p10l2000t3393r2065b3424],
82	)	CD	NUMBER	)	dep	101	SENT_350	[p10l2000t3393r2065b3424],
83	Zidovudine/ritonavir	NN	O	zidovudine/ritonavir	dep	101	SENT_350	[p10l209t3443r504b3469],
84	1.05	CD	NUMBER	1.05	dep	101	SENT_350	[p10l993t3445r1046b3469],
85	(	CD	NUMBER	(	dep	101	SENT_350	[p10l1059t3444r1152b3475],
86	0.993	CD	NUMBER	0.993	dep	101	SENT_350	[p10l1059t3444r1152b3475],
87	,	,	O	,	_	0	SENT_350	[p10l1059t3444r1152b3475],
88	1.11	CD	NUMBER	1.11	dep	101	SENT_350	[p10l1167t3444r1232b3475],
89	)	NN	O	)	dep	101	SENT_350	[p10l1167t3444r1232b3475],
90	1.05	CD	NUMBER	1.05	dep	101	SENT_350	[p10l1427t3444r1480b3469],
91	(	CD	NUMBER	(	dep	101	SENT_350	[p10l1493t3444r1586b3475],
92	0.983	CD	NUMBER	0.983	dep	101	SENT_350	[p10l1493t3444r1586b3475],
93	,	,	O	,	_	0	SENT_350	[p10l1493t3444r1586b3475],
94	1.13	CD	NUMBER	1.13	dep	101	SENT_350	[p10l1601t3444r1666b3475],
95	)	CD	NUMBER	)	dep	101	SENT_350	[p10l1601t3444r1666b3475],
96	1.15	CD	NUMBER	1.15	dep	101	SENT_350	[p10l1809t3444r1862b3469],
97	(	NN	O	(	dep	101	SENT_350	[p10l1875t3444r1951b3475],
98	1.04	CD	NUMBER	1.04	dep	101	SENT_350	[p10l1875t3444r1951b3475],
99	,	,	O	,	_	0	SENT_350	[p10l1875t3444r1951b3475],
100	1.26	CD	NUMBER	1.26	dep	101	SENT_350	[p10l1965t3444r2031b3475],
101	)	NN	O	)	_	0	SENT_350	[p10l1965t3444r2031b3475],

1	Multiple	JJ	O	multiple	amod	2	SENT_351	[p10l208t3534r314b3564],
2	doses	NNS	O	dose	_	0	SENT_351	[p10l323t3534r388b3557],
3	of	IN	O	of	_	0	SENT_351	[p10l397t3534r424b3557],
4	concomitant	JJ	O	concomitant	amod	5	SENT_351	[p10l429t3535r582b3557],
5	medication	NN	O	medication	prep_of	2	SENT_351	[p10l590t3534r726b3557],
6	plus	CC	O	plus	prep	2	SENT_351	[p10l734t3534r783b3564],
7	multiple	JJ	O	multiple	amod	8	SENT_351	[p10l791t3534r893b3564],
8	doses	NNS	O	dose	dep	6	SENT_351	[p10l902t3534r966b3557],
9	of	IN	O	of	_	0	SENT_351	[p10l976t3534r1002b3557],
10	elvitegravir	NN	O	elvitegravir	prep_of	2	SENT_351	[p10l1008t3534r1145b3564],
11	and	CC	O	and	_	0	SENT_351	[p10l1154t3534r1197b3557],
12	ritonavir	NN	O	ritonavir	conj_and	10	SENT_351	[p10l1205t3535r1311b3557],
13	with	IN	O	with	_	0	SENT_351	[p10l1318t3534r1373b3557],
14	the	DT	O	the	det	15	SENT_351	[p10l1381t3534r1419b3557],
15	exception	NN	O	exception	prep_with	2	SENT_351	[p10l1428t3535r1545b3564],
16	of	IN	O	of	_	0	SENT_351	[p10l1553t3534r1580b3557],
17	abacavir	NN	O	abacavir	nn	19	SENT_351	[p10l1585t3534r1689b3561],
18	,	,	O	,	_	0	SENT_351	[p10l1585t3534r1689b3561],
19	didanosine	NN	O	didanosine	prep_of	2	SENT_351	[p10l1699t3534r1836b3562],
20	,	,	O	,	_	0	SENT_351	[p10l1699t3534r1836b3562],
21	and	CC	O	and	_	0	SENT_351	[p10l1846t3534r1889b3557],
22	stavudine	NN	O	stavudine	conj_and	19	SENT_351	[p10l1898t3534r2019b3561],
23	,	,	O	,	_	0	SENT_351	[p10l1898t3534r2019b3561],
24	which	WDT	O	which	nsubjpass	26	SENT_351	[p10l2028t3534r2101b3557],
25	were	VBD	O	be	auxpass	26	SENT_351	[p10l208t3584r266b3598],
26	administered	VBN	O	administer	rcmod	19	SENT_351	[p10l275t3575r433b3598],
27	as	IN	O	as	_	0	SENT_351	[p10l442t3584r464b3598],
28	a	DT	O	a	det	30	SENT_351	[p10l473t3584r485b3598],
29	single	JJ	O	single	amod	30	SENT_351	[p10l494t3576r564b3606],
30	dose	NN	O	dose	prep_as	26	SENT_351	[p10l573t3576r633b3598],
31	.	.	O	.	_	0	SENT_351	[p10l573t3576r633b3598],

1	GMR	NNP	ORGANIZATION	GMR	_	0	SENT_352	[p10l644t3576r721b3603],
2	,	,	O	,	_	0	SENT_352	[p10l644t3576r721b3603],
3	Geometric	JJ	O	geometric	amod	5	SENT_352	[p10l731t3576r863b3598],
4	mean	NN	O	mean	nn	5	SENT_352	[p10l871t3584r937b3598],
5	ratio	NN	O	ratio	appos	1	SENT_352	[p10l945t3577r1009b3603],
6	;	:	O	;	_	0	SENT_352	[p10l945t3577r1009b3603],
7	CI	NN	O	ci	dep	1	SENT_352	[p10l1019t3576r1056b3603],
8	,	,	O	,	_	0	SENT_352	[p10l1019t3576r1056b3603],
9	Conﬁdence	NN	O	conﬁdence	nn	10	SENT_352	[p10l1067t3576r1207b3598],
10	interval	NN	O	interval	appos	7	SENT_352	[p10l1215t3576r1308b3598],
11	(	CD	NUMBER	(	number	12	SENT_352	[p10l1317t3576r1361b3604],
12	54	CD	NUMBER	54	dep	10	SENT_352	[p10l1317t3576r1361b3604],
13	,	,	O	,	_	0	SENT_352	[p10l1317t3576r1361b3604],
14	56-66	CD	NUMBER	56-66	num	15	SENT_352	[p10l1372t3576r1460b3604],
15	)	NN	O	)	appos	7	SENT_352	[p10l1372t3576r1460b3604],
16	.	.	O	.	_	0	SENT_352	[p10l1372t3576r1460b3604],

1	modest	JJ	O	modest	_	0	SENT_353	[p10l582t3666r704b3695],
2	.	.	O	.	_	0	SENT_353	[p10l582t3666r704b3695],

1	With	IN	O	with	_	0	SENT_354	[p10l714t3666r797b3695],
2	maraviroc	NN	O	maraviroc	nn	3	SENT_354	[p10l805t3667r962b3695],
3	coadministration	NN	O	coadministration	prep_with	9	SENT_354	[p10l971t3666r1244b3701],
4	,	,	O	,	_	0	SENT_354	[p10l971t3666r1244b3701],
5	maraviroc	NN	O	maraviroc	nn	7	SENT_354	[p10l1254t3667r1411b3695],
6	plasma	NN	O	plasma	nn	7	SENT_354	[p10l1419t3666r1527b3704],
7	levels	NNS	O	level	nsubjpass	9	SENT_354	[p10l1535t3666r1620b3695],
8	were	VBD	O	be	auxpass	9	SENT_354	[p10l1628t3677r1703b3695],
9	increased	VBN	O	increase	_	0	SENT_354	[p10l1712t3666r1858b3695],
10	consistent	JJ	O	consistent	acomp	9	SENT_354	[p10l1867t3667r2025b3695],
11	with	IN	O	with	_	0	SENT_354	[p10l2031t3666r2101b3695],
12	ritonavir	NN	O	ritonavir	nn	14	SENT_354	[p10l583t3717r719b3744],
13	CYP3A	NN	O	cyp3a	nn	14	SENT_354	[p10l727t3716r848b3745],
14	inhibition	NN	O	inhibition	prep_with	9	SENT_354	[p10l853t3715r1016b3744],
15	.	.	O	.	_	0	SENT_354	[p10l853t3715r1016b3744],

1	Atazanavir	NNP	O	Atazanavir	nn	2	SENT_355	[p10l1024t3717r1191b3744],
2	exposures	NNS	O	exposure	nsubj	14	SENT_355	[p10l1199t3726r1350b3754],
3	were	VBD	O	be	aux	5	SENT_355	[p10l1357t3726r1431b3744],
4	modestly	RB	O	modestly	advmod	5	SENT_355	[p10l1439t3715r1582b3754],
5	reduced	VBN	O	reduce	_	0	SENT_355	[p10l1588t3715r1713b3744],
6	with	IN	O	with	_	0	SENT_355	[p10l1719t3716r1789b3744],
7	2	CD	NUMBER	2	num	10	SENT_355	[p10l1797t3717r1811b3744],
8	oo	NN	O	oo	nn	10	SENT_355	[p10l1816t3717r1853b3744],
9	mg	NN	O	mg	nn	10	SENT_355	[p10l1860t3726r1911b3754],
10	elvitegravir	NN	O	elvitegravir	prep_with	5	SENT_355	[p10l1918t3715r2100b3754],
11	,	,	O	,	_	0	SENT_355	[p10l1918t3715r2100b3754],
12	but	CC	O	but	_	0	SENT_355	[p10l583t3765r635b3794],
13	not	RB	O	not	_	0	SENT_355	[p10l645t3773r698b3794],
14	affected	VBN	O	affect	conj_negcc	5	SENT_355	[p10l708t3765r830b3794],
15	with	IN	O	with	_	0	SENT_355	[p10l840t3765r910b3794],
16	an	DT	O	a	det	19	SENT_355	[p10l922t3776r957b3794],
17	85	CD	NUMBER	85	num	19	SENT_355	[p10l970t3766r1003b3794],
18	mg	NN	O	mg	nn	19	SENT_355	[p10l1016t3776r1067b3804],
19	dose	NN	O	dose	prep_with	14	SENT_355	[p10l1078t3765r1155b3794],
20	.	.	O	.	_	0	SENT_355	[p10l1078t3765r1155b3794],

1	Annu	NNP	PERSON	Annu	_	0	SENT_356	[p11l55t518r78b598],
2	.	.	O	.	_	0	SENT_356	[p11l55t518r78b598],

1	Rev.	NNP	O	Rev.	nn	2	SENT_357	[p11l55t448r78b507],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_357	[p11l55t289r78b437],
3	.	.	O	.	_	0	SENT_357	[p11l55t289r78b437],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_358	[p11l55t168r78b278],
2	.	.	O	.	_	0	SENT_358	[p11l55t168r78b278],

1	2009.49:37	CD	NUMBER	2009.49:37	_	0	SENT_359	[p11l55t8r79b157],
2	by	IN	O	by	_	0	SENT_359	[p11l88t431r119b463],
3	University	NNP	ORGANIZATION	University	prep_by	1	SENT_359	[p11l88t282r119b422],
4	of	IN	ORGANIZATION	of	_	0	SENT_359	[p11l88t243r112b272],
5	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	3	SENT_359	[p11l88t96r112b237],
6	-	:	O	-	_	0	SENT_359	[p11l102t78r105b87],
7	Mad	NNP	O	Mad	nn	8	SENT_359	[p11l88t7r112b68],
8	Annu	NNP	O	Annu	dep	1	SENT_359	[p11l201t3008r224b3088],
9	.	.	O	.	_	0	SENT_359	[p11l201t3008r224b3088],

1	Rev.	NNP	O	Rev.	nn	2	SENT_360	[p11l201t2938r224b2997],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_360	[p11l201t2779r224b2927],
3	.	.	O	.	_	0	SENT_360	[p11l201t2779r224b2927],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_361	[p11l201t2658r224b2768],
2	.	.	O	.	_	0	SENT_361	[p11l201t2658r224b2768],

1	2009.49:377	CD	NUMBER	2009.49:377	num	2	SENT_362	[p11l201t2413r225b2647],
2	-394	CD	NUMBER	-394	_	0	SENT_362	[p11l201t2413r225b2647],
3	.	.	O	.	_	0	SENT_362	[p11l201t2413r225b2647],

1	Downloaded	VBN	O	download	_	0	SENT_363	[p11l201t2233r224b2403],
2	from	IN	O	from	_	0	SENT_363	[p11l201t2159r224b2224],
3	www.annua1reviews.org	NN	O	www.annua1reviews.org	prep_from	1	SENT_363	[p11l201t1827r231b2150],
4	by	IN	O	by	_	0	SENT_363	[p11l234t2921r265b2953],
5	University	NNP	ORGANIZATION	University	dep	9	SENT_363	[p11l234t2772r265b2912],
6	of	IN	ORGANIZATION	of	_	0	SENT_363	[p11l234t2733r258b2762],
7	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	5	SENT_363	[p11l234t2586r258b2727],
8	-	:	O	-	_	0	SENT_363	[p11l248t2568r251b2577],
9	Madison	NNP	O	Madison	prep_by	1	SENT_363	[p11l234t2442r258b2558],
10	on	IN	O	on	_	0	SENT_363	[p11l242t2401r258b2433],
11	01/05/14	CD	DATE	01/05/14	prep_on	1	SENT_363	[p11l234t2267r258b2391],
12	.	.	O	.	_	0	SENT_363	[p11l234t2267r258b2391],

1	For	IN	O	for	_	0	SENT_364	[p11l235t2210r258b2257],
2	personal	JJ	O	personal	amod	3	SENT_364	[p11l234t2090r265b2202],
3	use	NN	O	use	pobj	1	SENT_364	[p11l242t2037r258b2081],
4	only	RB	O	only	advmod	3	SENT_364	[p11l234t1963r265b2027],
5	.	.	O	.	_	0	SENT_364	[p11l234t1963r265b2027],

1	Effect	NN	O	effect	_	0	SENT_365	[p11l582t53r684b82],
2	of	IN	O	of	_	0	SENT_365	[p11l696t53r733b82],
3	coadministered	JJ	O	coadministered	amod	4	SENT_365	[p11l741t53r1002b82],
4	drugs	NNS	O	drug	prep_of	1	SENT_365	[p11l1014t53r1108b92],
5	on	IN	O	on	_	0	SENT_365	[p11l1121t64r1164b82],
6	elvitegravir	NN	O	elvitegravir	prep_on	1	SENT_365	[p11l1176t53r1373b92],
7	.	.	O	.	_	0	SENT_365	[p11l1176t53r1373b92],

1	Elvitegravir	NNP	O	Elvitegravir	nn	2	SENT_366	[p11l1395t53r1580b92],
2	metabolism	NN	O	metabolism	nsubjpass	12	SENT_366	[p11l1591t53r1773b82],
3	is	VBZ	O	be	auxpass	4	SENT_366	[p11l1784t55r1807b82],
4	mediated	VBN	O	mediate	_	0	SENT_366	[p11l1819t53r1963b82],
5	through	IN	O	through	_	0	SENT_366	[p11l1974t53r2101b92],
6	CYP3A4/5	NN	O	cyp3a4/5	prep_through	4	SENT_366	[p11l584t104r753b132],
7	and	CC	O	and	_	0	SENT_366	[p11l770t103r826b132],
8	UGT1A1/3	NN	O	ugt1a1/3	prep_through	4	SENT_366	[p11l841t104r1024b132],
9	and	CC	O	and	_	0	SENT_366	[p11l1043t103r1099b132],
10	may	MD	O	may	aux	12	SENT_366	[p11l1113t114r1180b142],
11	be	VB	O	be	auxpass	12	SENT_366	[p11l1193t103r1228b132],
12	affected	VBN	O	affect	conj_and	4	SENT_366	[p11l1244t103r1366b132],
13	by	IN	O	by	_	0	SENT_366	[p11l1381t103r1419b142],
14	inducers	NNS	O	inducer	agent	12	SENT_366	[p11l1432t103r1564b132],
15	and	CC	O	and	_	0	SENT_366	[p11l1580t103r1635b132],
16	inhibitors	NNS	O	inhibitor	agent	12	SENT_366	[p11l1650t103r1802b132],
17	of	IN	O	of	_	0	SENT_366	[p11l1818t103r1852b132],
18	these	DT	O	these	det	19	SENT_366	[p11l1863t103r1943b132],
19	enzymes	NNS	O	enzyme	prep_of	14	SENT_366	[p11l1959t114r2099b142],
20	.	.	O	.	_	0	SENT_366	[p11l1959t114r2099b142],

1	Studies	NNS	O	study	nsubjpass	3	SENT_367	[p11l584t153r696b182],
2	were	VBD	O	be	auxpass	3	SENT_367	[p11l703t164r778b182],
3	conducted	VBN	O	conduct	_	0	SENT_367	[p11l787t153r949b182],
4	evaluating	VBG	O	evaluate	xcomp	3	SENT_367	[p11l958t153r1118b191],
5	various	JJ	O	various	amod	7	SENT_367	[p11l1123t154r1236b182],
6	antiretroviral	JJ	O	antiretroviral	amod	7	SENT_367	[p11l1245t153r1451b182],
7	agents	NNS	O	agent	dobj	4	SENT_367	[p11l1459t161r1557b191],
8	as	RB	O	as	_	0	SENT_367	[p11l1566t164r1594b182],
9	well	RB	O	well	_	0	SENT_367	[p11l1602t153r1666b182],
10	as	IN	O	as	_	0	SENT_367	[p11l1674t164r1702b182],
11	antacids	NNS	O	antacid	dobj	4	SENT_367	[p11l1711t153r1836b182],
12	and	CC	O	and	_	0	SENT_367	[p11l1845t153r1900b182],
13	omeprazole	NN	O	omeprazole	conj_and	11	SENT_367	[p11l1909t153r2099b191],
14	.	.	O	.	_	0	SENT_367	[p11l1909t153r2099b191],

1	Results	NNS	O	result	nsubjpass	3	SENT_368	[p11l583t203r695b232],
2	are	VBP	O	be	auxpass	3	SENT_368	[p11l711t213r757b232],
3	summarized	VBN	O	summarize	_	0	SENT_368	[p11l772t203r962b232],
4	in	IN	O	in	_	0	SENT_368	[p11l976t204r1006b231],
5	Table	NNP	O	Table	prep_in	3	SENT_368	[p11l1019t202r1115b231],
6	4	CD	NUMBER	4	num	5	SENT_368	[p11l1131t205r1158b232],
7	.	.	O	.	_	0	SENT_368	[p11l1131t205r1158b232],

1	Overall	RB	O	overall	advmod	10	SENT_369	[p11l1175t202r1299b238],
2	,	,	O	,	_	0	SENT_369	[p11l1175t202r1299b238],
3	the	DT	O	the	det	4	SENT_369	[p11l1315t203r1364b232],
4	effects	NNS	O	effect	nsubj	10	SENT_369	[p11l1379t203r1477b232],
5	on	IN	O	on	_	0	SENT_369	[p11l1493t214r1532b232],
6	elvitegravir	NN	O	elvitegravir	nn	7	SENT_369	[p11l1547t202r1723b241],
7	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	4	SENT_369	[p11l1737t203r2012b241],
8	were	VBD	O	be	cop	10	SENT_369	[p11l2026t213r2101b232],
9	relatively	RB	O	relatively	advmod	10	SENT_369	[p11l583t252r728b291],
10	modest	JJ	O	modest	_	0	SENT_369	[p11l737t252r858b281],
11	.	.	O	.	_	0	SENT_369	[p11l737t252r858b281],

1	Atazanavir	NNP	O	Atazanavir	nsubj	5	SENT_370	[p11l631t303r799b331],
2	and	CC	O	and	_	0	SENT_370	[p11l814t302r869b331],
3	lopinavir	JJ	O	lopinavir	amod	4	SENT_370	[p11l884t302r1024b340],
4	coadministration	NN	O	coadministration	conj_and	1	SENT_370	[p11l1039t302r1305b331],
5	increased	VBN	O	increase	_	0	SENT_370	[p11l1320t302r1466b331],
6	plasma	NN	O	plasma	nn	7	SENT_370	[p11l1481t302r1588b340],
7	levels	NNS	O	level	dobj	5	SENT_370	[p11l1603t302r1688b331],
8	of	IN	O	of	_	0	SENT_370	[p11l1704t302r1739b331],
9	elvitegravir	NN	O	elvitegravir	prep_of	7	SENT_370	[p11l1750t302r1927b341],
10	likely	JJ	O	likely	amod	11	SENT_370	[p11l1941t302r2027b341],
11	secondary	JJ	O	secondary	amod	9	SENT_370	[p11l2040t313r2100b331, p11l583t352r693b391],
12	to	TO	O	to	_	0	SENT_370	[p11l706t360r737b381],
13	inhibitory	JJ	O	inhibitory	amod	14	SENT_370	[p11l751t352r910b391],
14	effects	NNS	O	effect	prep_to	5	SENT_370	[p11l923t352r1022b381],
15	on	IN	O	on	_	0	SENT_370	[p11l1037t363r1076b381],
16	CYI	NN	O	cyus	nn	18	SENT_370	[p11l1091t353r1212b381],
17	’	CD	NUMBER	’	num	18	SENT_370	[p11l1091t353r1212b381],
18	3A	NN	O	3a	prep_on	5	SENT_370	[p11l1091t353r1212b381],
19	and	CC	O	and	_	0	SENT_370	[p11l1225t352r1281b381],
20	UGTIA	NN	O	ugtium	conj_and	18	SENT_370	[p11l1295t353r1438b381],
21	.	.	O	.	_	0	SENT_370	[p11l1295t353r1438b381],

1	A	DT	O	a	det	3	SENT_371	[p11l1452t353r1479b381],
2	reduced	VBN	O	reduce	amod	3	SENT_371	[p11l1491t352r1616b381],
3	dose	NN	O	dose	nsubjpass	7	SENT_371	[p11l1631t352r1700b381],
4	of	IN	O	of	_	0	SENT_371	[p11l1716t352r1750b381],
5	elvitegravir	NN	O	elvitegravir	prep_of	3	SENT_371	[p11l1761t352r1937b391],
6	is	VBZ	O	be	auxpass	7	SENT_371	[p11l1951t354r1973b381],
7	recommended	VBN	O	recommend	_	0	SENT_371	[p11l1988t363r2100b381, p11l582t402r708b431],
8	with	IN	O	with	_	0	SENT_371	[p11l723t402r793b431],
9	coadministration	NN	O	coadministration	prep_with	7	SENT_371	[p11l810t402r1076b431],
10	of	IN	O	of	_	0	SENT_371	[p11l1092t402r1127b431],
11	either	CC	O	either	prep	16	SENT_371	[p11l1140t402r1231b431],
12	atazanavir	NN	O	atazanavir	dep	11	SENT_371	[p11l1247t403r1404b431],
13	or	CC	O	or	_	0	SENT_371	[p11l1421t413r1454b431],
14	lopinavir	NN	O	lopinavir	dep	11	SENT_371	[p11l1470t402r1610b440],
15	(	CD	NUMBER	(	number	16	SENT_371	[p11l1627t403r1683b438],
16	57	CD	NUMBER	57	prep_of	9	SENT_371	[p11l1627t403r1683b438],
17	,	,	O	,	_	0	SENT_371	[p11l1627t403r1683b438],
18	64	CD	NUMBER	64	num	19	SENT_371	[p11l1702t403r1758b438],
19	)	NN	O	)	appos	16	SENT_371	[p11l1702t403r1758b438],
20	.	.	O	.	_	0	SENT_371	[p11l1702t403r1758b438],

1	Coadrninistration	NN	O	coadrninistration	_	0	SENT_372	[p11l1777t402r2054b431],
2	of	IN	O	of	_	0	SENT_372	[p11l2071t402r2105b431],
3	elvitegravir	NN	O	elvitegravir	prep_of	1	SENT_372	[p11l583t452r760b490],
4	with	IN	O	with	_	0	SENT_372	[p11l775t451r845b481],
5	Al	NNP	O	Al	prep_with	3	SENT_372	[p11l859t449r1217b490],
6	”	CD	NUMBER	”	num	5	SENT_372	[p11l859t449r1217b490],
7	/	:	O	/	punct	8	SENT_372	[p11l859t449r1217b490],
8	Mg	NN	O	mg	dep	3	SENT_372	[p11l859t449r1217b490],
9	“	SYM	O	“	dep	1	SENT_372	[p11l859t449r1217b490],
10	-	:	O	-	_	0	SENT_372	[p11l859t449r1217b490],
11	containing	VBG	O	contain	dep	1	SENT_372	[p11l859t449r1217b490],
12	antacids	NNS	O	antacid	nsubj	13	SENT_372	[p11l1233t452r1357b481],
13	resulted	VBD	O	result	ccomp	11	SENT_372	[p11l1374t452r1499b481],
14	in	IN	O	in	_	0	SENT_372	[p11l1515t453r1546b480],
15	decreased	VBN	O	decrease	amod	17	SENT_372	[p11l1562t452r1714b481],
16	plasma	NN	O	plasma	nn	17	SENT_372	[p11l1730t452r1838b490],
17	levels	NNS	O	level	prep_in	13	SENT_372	[p11l1854t452r1939b481],
18	of	IN	O	of	_	0	SENT_372	[p11l1956t452r1991b481],
19	elvitegravir	NN	O	elvitegravir	nn	20	SENT_372	[p11l2003t452r2100b481, p11l583t503r675b540],
20	~	NN	O	~	prep_of	17	SENT_372	[p11l688t503r753b531],
21	40	CD	NUMBER	40	number	23	SENT_372	[p11l688t503r753b531],
22	to	TO	O	to	dep	23	SENT_372	[p11l766t510r796b530],
23	50	CD	PERCENT	50	num	24	SENT_372	[p11l811t503r890b537],
24	%	NN	PERCENT	%	dobj	13	SENT_372	[p11l811t503r890b537],
25	,	,	O	,	_	0	SENT_372	[p11l811t503r890b537],
26	whereas	IN	O	whereas	mark	39	SENT_372	[p11l903t501r1029b530],
27	antacid	NN	O	antacid	nn	28	SENT_372	[p11l1042t501r1154b530],
28	administration	NN	O	administration	nsubj	39	SENT_372	[p11l1167t502r1396b530],
29	staggered	VBN	O	stagger	partmod	28	SENT_372	[p11l1408t501r1558b540],
30	by	IN	O	by	_	0	SENT_372	[p11l1570t501r1608b540],
31	two	CD	DURATION	two	num	32	SENT_372	[p11l1619t510r1676b530],
32	hours	NNS	NUMBER	hour	agent	29	SENT_372	[p11l1689t501r1777b530],
33	or	CC	O	or	_	0	SENT_372	[p11l1790t512r1823b530],
34	coadministration	NN	O	coadministration	agent	29	SENT_372	[p11l1836t501r2101b530],
35	with	IN	O	with	_	0	SENT_372	[p11l582t551r651b580],
36	omeprazole	NN	O	omeprazole	prep_with	29	SENT_372	[p11l662t551r843b589],
37	did	VBD	O	do	aux	39	SENT_372	[p11l854t551r903b580],
38	not	RB	O	not	neg	39	SENT_372	[p11l912t559r965b580],
39	have	VB	O	have	dep	24	SENT_372	[p11l974t551r1045b580],
40	a	DT	O	a	det	42	SENT_372	[p11l1055t562r1070b580],
41	meaningful	JJ	O	meaningful	amod	42	SENT_372	[p11l1079t551r1257b590],
42	effect	NN	O	effect	dobj	39	SENT_372	[p11l1267t551r1353b580],
43	on	IN	O	on	_	0	SENT_372	[p11l1363t562r1402b580],
44	elvitegravir	NN	O	elvitegravir	nn	45	SENT_372	[p11l1412t551r1589b590],
45	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	42	SENT_372	[p11l1598t551r1881b589],
46	.	.	O	.	_	0	SENT_372	[p11l1598t551r1881b589],

1	Thus	RB	O	thus	advmod	8	SENT_373	[p11l1892t551r1983b586],
2	,	,	O	,	_	0	SENT_373	[p11l1892t551r1983b586],
3	proton	NN	O	proton	nn	5	SENT_373	[p11l1994t559r2101b589],
4	pump	NN	O	pump	nn	5	SENT_373	[p11l583t610r672b638],
5	inhibitors	NNS	O	inhibitor	nsubjpass	8	SENT_373	[p11l687t599r839b628],
6	may	MD	O	may	aux	8	SENT_373	[p11l854t610r920b638],
7	be	VB	O	be	auxpass	8	SENT_373	[p11l933t599r968b628],
8	coadministered	VBN	O	coadminister	_	0	SENT_373	[p11l983t599r1223b628],
9	with	IN	O	with	_	0	SENT_373	[p11l1236t599r1306b628],
10	elvitegravir	NN	O	elvitegravir	prep_with	8	SENT_373	[p11l1321t599r1497b638],
11	but	CC	O	but	_	0	SENT_373	[p11l1511t599r1564b628],
12	antacid	NN	O	antacid	nn	13	SENT_373	[p11l1577t599r1689b628],
13	administration	NN	O	administration	nsubjpass	16	SENT_373	[p11l1704t599r1933b628],
14	should	MD	O	should	aux	16	SENT_373	[p11l1947t599r2050b628],
15	be	VB	O	be	auxpass	16	SENT_373	[p11l2065t599r2101b628],
16	staggered	VBN	O	stagger	conj_but	8	SENT_373	[p11l583t648r732b687],
17	by	IN	O	by	_	0	SENT_373	[p11l743t648r782b687],
18	at	IN	DURATION	at	quantmod	20	SENT_373	[p11l791t656r820b677],
19	least	JJS	DURATION	least	mwe	18	SENT_373	[p11l830t648r900b677],
20	two	CD	DURATION	two	num	21	SENT_373	[p11l910t656r967b677],
21	hours	NNS	NUMBER	hour	agent	16	SENT_373	[p11l978t648r1066b677],
22	(	VBP	O	(	rcmod	21	SENT_373	[p11l1078t649r1146b685],
23	67	CD	NUMBER	67	number	24	SENT_373	[p11l1078t649r1146b685],
24	)	CD	NUMBER	)	dobj	22	SENT_373	[p11l1078t649r1146b685],
25	.	.	O	.	_	0	SENT_373	[p11l1078t649r1146b685],

1	Pharmacokinetics	NNS	O	pharmacokinetic	nsubjpass	25	SENT_374	[p11l582t762r918b794],
2	and	CC	O	and	_	0	SENT_374	[p11l932t762r999b794],
3	Pharmacodynamics	NNS	O	pharmacodynamic	nsubjpass	25	SENT_374	[p11l1011t762r1377b805],
4	An	DT	O	a	det	8	SENT_374	[p11l582t813r627b841],
5	exposure	NN	O	exposure	nn	8	SENT_374	[p11l640t823r930b851],
6	—	NN	O	—	nn	8	SENT_374	[p11l640t823r930b851],
7	response	NN	O	response	nn	8	SENT_374	[p11l640t823r930b851],
8	relationship	NN	O	relationship	dep	1	SENT_374	[p11l943t812r1128b851],
9	between	IN	O	between	_	0	SENT_374	[p11l1142t812r1272b841],
10	drug	NN	O	drug	nn	12	SENT_374	[p11l1285t812r1358b851],
11	trough	NN	O	trough	nn	12	SENT_374	[p11l1369t812r1475b851],
12	concentrations	NNS	O	concentration	prep_between	8	SENT_374	[p11l1488t813r1719b841],
13	and	CC	O	and	_	0	SENT_374	[p11l1732t812r1788b841],
14	the	DT	O	the	det	15	SENT_374	[p11l1801t812r1849b841],
15	decline	NN	O	decline	nsubjpass	25	SENT_374	[p11l1863t812r1973b841],
16	in	IN	O	in	_	0	SENT_374	[p11l1986t813r2016b841],
17	HIV	NN	MISC	hiv	nn	18	SENT_374	[p11l2028t813r2103b841],
18	RNA	NN	MISC	rna	prep_in	15	SENT_374	[p11l583t861r667b889],
19	with	IN	O	with	_	0	SENT_374	[p11l674t860r744b890],
20	short-term	JJ	O	short-term	amod	22	SENT_374	[p11l754t860r925b890],
21	monotherapy	NN	O	monotherapy	nn	22	SENT_374	[p11l934t860r1147b899],
22	treatment	NN	O	treatment	prep_with	18	SENT_374	[p11l1155t868r1310b890],
23	has	VBZ	O	have	aux	25	SENT_374	[p11l1319t860r1368b890],
24	been	VBN	O	be	auxpass	25	SENT_374	[p11l1379t860r1454b890],
25	suggested	VBN	O	suggest	_	0	SENT_374	[p11l1464t860r1616b899],
26	for	IN	O	for	_	0	SENT_374	[p11l1626t860r1672b890],
27	both	DT	O	both	preconj	28	SENT_374	[p11l1681t860r1754b890],
28	raltegravir	NN	O	raltegravir	prep_for	25	SENT_374	[p11l1763t860r1927b899],
29	and	CC	O	and	_	0	SENT_374	[p11l1937t860r1992b890],
30	elvitegravir	NN	O	elvitegravir	prep_for	25	SENT_374	[p11l2003t860r2100b890, p11l583t912r680b949],
31	.	.	O	.	_	0	SENT_374	[p11l2003t860r2100b890, p11l583t912r680b949],

1	For	IN	O	for	_	0	SENT_375	[p11l695t911r752b939],
2	raltegravir	NN	O	raltegravir	prep_for	8	SENT_375	[p11l765t910r934b949],
3	,	,	O	,	_	0	SENT_375	[p11l765t910r934b949],
4	a	DT	O	a	det	6	SENT_375	[p11l949t921r964b939],
5	potential	JJ	O	potential	amod	6	SENT_375	[p11l978t910r1117b949],
6	association	NN	O	association	nsubjpass	8	SENT_375	[p11l1131t912r1301b939],
7	was	VBD	O	be	auxpass	8	SENT_375	[p11l1313t921r1369b939],
8	observed	VBN	O	observe	_	0	SENT_375	[p11l1384t910r1522b939],
9	between	IN	O	between	_	0	SENT_375	[p11l1536t910r1666b939],
10	raltegravir	NN	O	raltegravir	nn	15	SENT_375	[p11l1680t910r1843b949],
11	trough	NN	O	trough	nn	15	SENT_375	[p11l1856t910r1962b949],
12	concentration	NN	O	concentration	nn	15	SENT_375	[p11l1976t921r2100b939, p11l583t960r689b987],
13	(	CD	NUMBER	(	num	15	SENT_375	[p11l704t959r826b999],
14	Ctwugh	NNP	O	Ctwugh	nn	15	SENT_375	[p11l704t959r826b999],
15	)	NN	O	)	prep_between	8	SENT_375	[p11l704t959r826b999],
16	and	CC	O	and	_	0	SENT_375	[p11l842t958r898b987],
17	both	DT	O	both	det	26	SENT_375	[p11l912t958r984b987],
18	change	NN	O	change	dep	26	SENT_375	[p11l999t958r1108b997],
19	from	IN	O	from	_	0	SENT_375	[p11l1123t958r1199b987],
20	baseline	NN	O	baseline	prep_from	18	SENT_375	[p11l1213t958r1338b987],
21	in	IN	O	in	_	0	SENT_375	[p11l1353t960r1383b987],
22	lOg1	NN	O	log1	prep_in	20	SENT_375	[p11l1397t958r1471b997],
23	(	CD	NUMBER	(	number	24	SENT_375	[p11l1397t958r1471b997],
24	)	CD	NUMBER	)	num	22	SENT_375	[p11l1397t958r1471b997],
25	HIV	NN	O	hiv	nn	26	SENT_375	[p11l1488t960r1563b987],
26	RNA	NN	O	rna	prep_between	8	SENT_375	[p11l1575t959r1659b987],
27	and	CC	O	and	_	0	SENT_375	[p11l1672t958r1728b987],
28	the	DT	O	the	det	29	SENT_375	[p11l1742t958r1791b987],
29	slope	NN	O	slope	conj_and	15	SENT_375	[p11l1806t958r1886b997],
30	of	IN	O	of	_	0	SENT_375	[p11l1901t958r1935b987],
31	decline	NN	O	decline	prep_of	29	SENT_375	[p11l1946t958r2057b987],
32	in	IN	O	in	_	0	SENT_375	[p11l2071t960r2101b987],
33	HIV	NN	MISC	hiv	nn	34	SENT_375	[p11l583t1006r658b1034],
34	RNA	NN	MISC	rna	prep_in	8	SENT_375	[p11l665t1006r749b1034],
35	following	VBG	DATE	follow	_	0	SENT_375	[p11l756t1005r905b1044],
36	10	CD	DATE	10	num	37	SENT_375	[p11l917t1007r950b1034],
37	days	NNS	DATE	day	prep_following	34	SENT_375	[p11l960t1005r1026b1044],
38	of	IN	O	of	_	0	SENT_375	[p11l1036t1005r1070b1034],
39	monotherapy	NN	O	monotherapy	nn	40	SENT_375	[p11l1075t1005r1287b1044],
40	treatment	NN	O	treatment	prep_of	37	SENT_375	[p11l1295t1013r1449b1034],
41	with	IN	O	with	_	0	SENT_375	[p11l1456t1005r1526b1034],
42	various	JJ	O	various	amod	45	SENT_375	[p11l1533t1007r1646b1034],
43	twice-daily	JJ	O	twice-daily	amod	45	SENT_375	[p11l1655t1005r1829b1044],
44	dosing	NN	O	dosing	nn	45	SENT_375	[p11l1837t1005r1940b1044],
45	regimens	NNS	O	regimen	prep_with	40	SENT_375	[p11l1948t1007r2099b1044],
46	.	.	O	.	_	0	SENT_375	[p11l1948t1007r2099b1044],

1	Similar	JJ	O	similar	amod	2	SENT_376	[p11l584t1053r696b1082],
2	relationships	NNS	O	relationship	nsubjpass	5	SENT_376	[p11l711t1053r911b1092],
3	were	VBD	O	be	auxpass	5	SENT_376	[p11l925t1064r1000b1082],
4	not	RB	O	not	neg	5	SENT_376	[p11l1016t1061r1069b1082],
5	observed	VBN	O	observe	_	0	SENT_376	[p11l1084t1053r1223b1082],
6	with	IN	O	with	_	0	SENT_376	[p11l1237t1053r1307b1082],
7	raltegravir	NN	O	raltegravir	nn	8	SENT_376	[p11l1322t1053r1486b1092],
8	AUC	NN	O	auc	prep_with	5	SENT_376	[p11l1499t1054r1583b1082],
9	or	CC	O	or	_	0	SENT_376	[p11l1600t1064r1633b1082],
10	Cmax	NN	O	cmax	prep_with	5	SENT_376	[p11l1649t1054r1719b1088],
11	in	IN	O	in	_	0	SENT_376	[p11l1735t1054r1765b1082],
12	this	DT	O	this	det	13	SENT_376	[p11l1781t1053r1836b1082],
13	study	NN	O	study	prep_in	5	SENT_376	[p11l1853t1053r1937b1092],
14	(	CD	NUMBER	(	number	15	SENT_376	[p11l1952t1054r2020b1090],
15	40	CD	NUMBER	40	num	16	SENT_376	[p11l1952t1054r2020b1090],
16	)	NN	O	)	dep	5	SENT_376	[p11l1952t1054r2020b1090],
17	.	.	O	.	_	0	SENT_376	[p11l1952t1054r2020b1090],

1	In	IN	O	in	_	0	SENT_377	[p11l2037t1054r2070b1082],
2	a	DT	O	a	pobj	1	SENT_377	[p11l2086t1064r2101b1082],

1	388	CD	NUMBER	388	num	4	SENT_378	[p11l487t1161r532b1189],
2	Hazuda	NN	O	hazuda	nn	4	SENT_378	[p11l582t1160r674b1182],
3	o	NN	O	o	nn	4	SENT_378	[p11l689t1168r699b1178],
4	Iwamato	NN	O	iwamato	_	0	SENT_378	[p11l713t1160r810b1182],
5	-	:	O	-	_	0	SENT_378	[p11l826t1168r835b1178],
6	Wenning	NN	PERSON	wenning	dep	4	SENT_378	[p11l854t1160r955b1190],

1	10-day	JJ	DURATION	10-day	amod	2	SENT_379	[p11l350t1265r455b1304],
2	study	NN	O	study	nsubj	23	SENT_379	[p11l465t1265r550b1304],
3	containing	VBG	O	contain	partmod	2	SENT_379	[p11l560t1267r728b1304],
4	various	JJ	O	various	amod	5	SENT_379	[p11l737t1267r849b1295],
5	doses	NNS	O	dose	dobj	3	SENT_379	[p11l862t1265r945b1295],
6	of	IN	O	of	_	0	SENT_379	[p11l958t1265r992b1295],
7	once	RB	DATE	once	dep	13	SENT_379	[p11l1000t1276r1086b1295],
8	-	:	O	-	_	0	SENT_379	[p11l1000t1276r1086b1295],
9	or	CC	O	or	_	0	SENT_379	[p11l1100t1276r1133b1295],
10	twice	RB	O	twice	advmod	12	SENT_379	[p11l1144t1265r1317b1304],
11	—	RB	O	—	advmod	12	SENT_379	[p11l1144t1265r1317b1304],
12	daily	JJ	SET	daily	conj_or	7	SENT_379	[p11l1144t1265r1317b1304],
13	elvitegravir	NN	O	elvitegravir	prep_of	5	SENT_379	[p11l1328t1265r1504b1304],
14	with	IN	O	with	_	0	SENT_379	[p11l1515t1265r1584b1295],
15	or	CC	O	or	_	0	SENT_379	[p11l1596t1276r1630b1295],
16	without	IN	O	without	_	0	SENT_379	[p11l1640t1265r1763b1295],
17	ritonavir	NN	O	ritonavir	prep_without	3	SENT_379	[p11l1773t1267r1864b1295, p11l347t1317r405b1344],
18	boosting	VBG	O	boost	xcomp	3	SENT_379	[p11l416t1315r560b1354],
19	,	,	O	,	_	0	SENT_379	[p11l416t1315r560b1354],
20	elvitegravir	NN	O	elvitegravir	nn	22	SENT_379	[p11l574t1315r751b1354],
21	trough	NN	O	trough	nn	22	SENT_379	[p11l762t1315r868b1354],
22	concentrations	NNS	O	concentration	nsubj	23	SENT_379	[p11l880t1317r1111b1344],
23	appeared	VBD	O	appear	_	0	SENT_379	[p11l1124t1315r1265b1354],
24	to	TO	O	to	aux	26	SENT_379	[p11l1277t1323r1307b1344],
25	be	VB	O	be	auxpass	26	SENT_379	[p11l1320t1315r1355b1344],
26	related	VBN	O	relate	xcomp	23	SENT_379	[p11l1367t1315r1475b1344],
27	to	TO	O	to	aux	28	SENT_379	[p11l1487t1323r1518b1344],
28	change	VB	O	change	xcomp	26	SENT_379	[p11l1530t1315r1640b1354],
29	from	IN	O	from	_	0	SENT_379	[p11l1652t1315r1728b1344],
30	baseline	NN	O	baseline	prep_from	28	SENT_379	[p11l1740t1315r1865b1344],
31	(	CD	NUMBER	(	num	30	SENT_379	[p11l348t1364r444b1399],
32	CFB	NNP	O	CFB	dobj	28	SENT_379	[p11l348t1364r444b1399],
33	)	CD	NUMBER	)	num	32	SENT_379	[p11l348t1364r444b1399],
34	in	IN	O	in	_	0	SENT_379	[p11l454t1365r484b1392],
35	loglo	JJ	O	loglo	amod	37	SENT_379	[p11l494t1363r568b1402],
36	HIV	NN	O	hiv	nn	37	SENT_379	[p11l580t1365r655b1392],
37	RNA	NN	O	rna	prep_in	32	SENT_379	[p11l663t1364r747b1392],
38	according	VBG	O	accord	_	0	SENT_379	[p11l755t1363r910b1402],
39	to	TO	O	to	prepc_according_to	37	SENT_379	[p11l918t1372r949b1392],
40	a	DT	O	a	det	42	SENT_379	[p11l960t1374r975b1392],
41	simple	JJ	O	simple	amod	42	SENT_379	[p11l985t1363r1086b1402],
42	Ema	NN	O	ema	pobj	37	SENT_379	[p11l1096t1365r1164b1398],
43	,	,	O	,	_	0	SENT_379	[p11l1096t1365r1164b1398],
44	relationship	NN	O	relationship	nn	46	SENT_379	[p11l1175t1363r1361b1402],
45	[	CD	NUMBER	[	num	46	SENT_379	[p11l1374t1364r1456b1399],
46	CFB	NN	O	cfb	appos	42	SENT_379	[p11l1374t1364r1456b1399],
47	=	JJ	O	=	amod	48	SENT_379	[p11l1474t1378r1500b1388],
48	Ema	NN	O	ema	dep	46	SENT_379	[p11l1517t1365r1585b1398],
49	,	,	O	,	_	0	SENT_379	[p11l1517t1365r1585b1398],
50	*	CD	NUMBER	*	num	51	SENT_379	[p11l1597t1366r1607b1378],
51	Cmmgh	NN	O	cmmgh	prep_in	32	SENT_379	[p11l1620t1364r1825b1404],
52	/	:	O	/	punct	54	SENT_379	[p11l1620t1364r1825b1404],
53	(	CD	NUMBER	(	num	54	SENT_379	[p11l1620t1364r1825b1404],
54	EC5g	NN	O	ec5g	dep	51	SENT_379	[p11l1620t1364r1825b1404],
55	+	CC	O	+	_	0	SENT_379	[p11l1839t1369r1864b1395],
56	Cm	NN	O	cm	dep	51	SENT_379	[p11l348t1411r468b1451],
57	,	,	O	,	_	0	SENT_379	[p11l348t1411r468b1451],
58	ugh	NN	O	ugh	nn	60	SENT_379	[p11l348t1411r468b1451],
59	)	CD	NUMBER	)	num	60	SENT_379	[p11l348t1411r468b1451],
60	]	NN	O	]	conj_and	37	SENT_379	[p11l348t1411r468b1451],
61	with	IN	O	with	_	0	SENT_379	[p11l480t1410r550b1439],
62	an	DT	O	a	det	68	SENT_379	[p11l561t1421r597b1439],
63	Em	NN	O	em	nn	68	SENT_379	[p11l608t1411r676b1444],
64	”	NN	O	”	nn	68	SENT_379	[p11l608t1411r676b1444],
65	(	CD	NUMBER	(	num	68	SENT_379	[p11l688t1411r855b1446],
66	maximum	JJ	O	maximum	amod	68	SENT_379	[p11l688t1411r855b1446],
67	effect	NN	O	effect	nn	68	SENT_379	[p11l866t1410r963b1446],
68	)	NN	O	)	prep_with	60	SENT_379	[p11l866t1410r963b1446],
69	of	IN	O	of	_	0	SENT_379	[p11l975t1410r1009b1439],
70	2.32	CD	NUMBER	2.32	num	72	SENT_379	[p11l1016t1412r1079b1439],
71	loglo	JJ	O	loglo	amod	72	SENT_379	[p11l1092t1410r1167b1449],
72	change	NN	O	change	prep_of	68	SENT_379	[p11l1180t1410r1289b1449],
73	from	IN	O	from	_	0	SENT_379	[p11l1301t1410r1377b1439],
74	baseline	NN	O	baseline	prep_from	72	SENT_379	[p11l1387t1410r1512b1439],
75	and	CC	O	and	_	0	SENT_379	[p11l1524t1410r1579b1439],
76	an	DT	O	a	det	79	SENT_379	[p11l1591t1421r1626b1439],
77	EC5o	NN	O	ec5o	nn	79	SENT_379	[p11l1637t1411r1715b1445],
78	(	NN	O	(	nn	79	SENT_379	[p11l1729t1411r1864b1446, p11l347t1459r453b1486],
79	concentration	NN	O	concentration	prep_in	32	SENT_379	[p11l1729t1411r1864b1446, p11l347t1459r453b1486],
80	that	WDT	O	that	nsubj	81	SENT_379	[p11l463t1457r525b1486],
81	results	VBZ	O	result	rcmod	79	SENT_379	[p11l534t1457r635b1486],
82	in	IN	O	in	_	0	SENT_379	[p11l646t1459r676b1486],
83	50	CD	PERCENT	50	num	84	SENT_379	[p11l688t1458r756b1486],
84	%	NN	PERCENT	%	prep_in	81	SENT_379	[p11l688t1458r756b1486],
85	of	IN	O	of	_	0	SENT_379	[p11l770t1457r804b1486],
86	maximum	JJ	O	maximum	amod	88	SENT_379	[p11l810t1459r966b1486],
87	effect	NN	O	effect	nn	88	SENT_379	[p11l977t1457r1073b1494],
88	)	NN	O	)	prep_of	84	SENT_379	[p11l977t1457r1073b1494],
89	of	IN	O	of	_	0	SENT_379	[p11l1085t1457r1119b1486],
90	14.4	CD	NUMBER	14.4	num	93	SENT_379	[p11l1129t1459r1193b1487],
91	ng	NN	O	ng	nn	93	SENT_379	[p11l1202t1468r1242b1496],
92	ml	NN	O	ml	nn	93	SENT_379	[p11l1251t1454r1334b1486],
93	”	NN	O	”	prep_of	88	SENT_379	[p11l1251t1454r1334b1486],
94	.	.	O	.	_	0	SENT_379	[p11l1251t1454r1334b1486],

1	No	DT	O	no	det	3	SENT_380	[p11l1346t1458r1397b1486],
2	such	JJ	O	such	amod	3	SENT_380	[p11l1408t1457r1478b1486],
3	relationship	NN	O	relationship	nsubj	5	SENT_380	[p11l1488t1457r1674b1496],
4	was	VBD	O	be	cop	5	SENT_380	[p11l1684t1468r1740b1486],
5	evident	JJ	O	evident	conj_or	5	SENT_380	[p11l1752t1457r1866b1486],
6	for	IN	O	for	_	0	SENT_380	[p11l347t1505r392b1534],
7	either	CC	O	either	prep_for	5	SENT_380	[p11l406t1505r497b1534],
8	Cm	NN	O	cm	conj	5	SENT_380	[p11l510t1506r580b1540],
9	,	,	O	,	_	0	SENT_380	[p11l510t1506r580b1540],
10	or	CC	O	or	_	0	SENT_380	[p11l595t1516r628b1534],
11	AUC	NN	O	auc	npadvmod	5	SENT_380	[p11l639t1506r723b1534],
12	of	IN	O	of	_	0	SENT_380	[p11l737t1505r771b1534],
13	elvitegravir	NN	O	elvitegravir	prep_of	11	SENT_380	[p11l781t1505r957b1544],
14	in	IN	O	in	_	0	SENT_380	[p11l969t1507r1000b1534],
15	this	DT	O	this	det	17	SENT_380	[p11l1013t1505r1068b1534],
16	study	NN	O	study	nn	17	SENT_380	[p11l1082t1505r1166b1544],
17	(	NN	O	(	prep_in	5	SENT_380	[p11l1178t1506r1204b1541],
18	3	CD	NUMBER	3	number	19	SENT_380	[p11l1178t1506r1204b1541],
19	6	CD	NUMBER	6	num	20	SENT_380	[p11l1210t1506r1247b1541],
20	)	NN	O	)	dep	17	SENT_380	[p11l1210t1506r1247b1541],
21	.	.	O	.	_	0	SENT_380	[p11l1210t1506r1247b1541],

1	These	DT	O	these	det	2	SENT_381	[p11l1260t1505r1358b1534],
2	results	NNS	O	result	nsubj	3	SENT_381	[p11l1371t1505r1472b1534],
3	suggest	VBP	O	suggest	_	0	SENT_381	[p11l1486t1513r1601b1544],
4	that	IN	O	that	complm	11	SENT_381	[p11l1613t1505r1675b1534],
5	Ctwugh	NNP	PERSON	Ctwugh	nsubj	11	SENT_381	[p11l1688t1506r1786b1546],
6	may	MD	O	may	aux	11	SENT_381	[p11l1801t1516r1867b1544],
7	be	VB	O	be	cop	11	SENT_381	[p11l347t1555r382b1584],
8	a	DT	O	a	det	11	SENT_381	[p11l397t1566r412b1584],
9	sensitive	JJ	O	sensitive	amod	11	SENT_381	[p11l426t1557r557b1584],
10	pharmacokinetic	JJ	O	pharmacokinetic	amod	11	SENT_381	[p11l571t1555r833b1594],
11	parameter	NN	O	parameter	ccomp	3	SENT_381	[p11l847t1563r1006b1594],
12	to	TO	O	to	aux	13	SENT_381	[p11l1020t1563r1050b1584],
13	predict	VB	O	predict	infmod	11	SENT_381	[p11l1064t1555r1175b1594],
14	viral	JJ	O	viral	amod	15	SENT_381	[p11l1187t1555r1256b1584],
15	response	NN	O	response	dobj	13	SENT_381	[p11l1269t1566r1406b1594],
16	for	IN	O	for	_	0	SENT_381	[p11l1420t1555r1465b1584],
17	integrase	NN	O	integrase	nn	18	SENT_381	[p11l1478t1557r1619b1594],
18	inhibitors	NNS	O	inhibitor	prep_for	13	SENT_381	[p11l1633t1555r1794b1591],
19	,	,	O	,	_	0	SENT_381	[p11l1633t1555r1794b1591],
20	and	CC	O	and	_	0	SENT_381	[p11l1810t1555r1865b1584],
21	that	IN	O	that	complm	28	SENT_381	[p11l347t1603r409b1632],
22	at	IN	O	at	advmod	28	SENT_381	[p11l417t1611r445b1632],
23	least	JJS	O	least	pobj	22	SENT_381	[p11l454t1603r524b1632],
24	short-term	JJ	O	short-term	amod	25	SENT_381	[p11l532t1603r702b1632],
25	efﬁcacy	NN	O	efﬁcacy	nsubjpass	28	SENT_381	[p11l712t1603r830b1642],
26	may	MD	O	may	aux	28	SENT_381	[p11l837t1614r903b1642],
27	be	VB	O	be	auxpass	28	SENT_381	[p11l911t1603r946b1632],
28	associated	VBN	O	associate	ccomp	3	SENT_381	[p11l956t1603r1112b1632],
29	with	IN	O	with	_	0	SENT_381	[p11l1120t1603r1190b1632],
30	maintenance	NN	O	maintenance	prep_with	28	SENT_381	[p11l1199t1604r1398b1632],
31	of	IN	O	of	_	0	SENT_381	[p11l1408t1603r1442b1632],
32	therapeutic	JJ	O	therapeutic	amod	33	SENT_381	[p11l1447t1603r1624b1642],
33	concentrations	NNS	O	concentration	prep_of	30	SENT_381	[p11l1634t1604r1865b1632],
34	across	IN	O	across	_	0	SENT_381	[p11l347t1664r440b1683],
35	a	DT	O	a	det	37	SENT_381	[p11l452t1664r467b1683],
36	dosing	NN	O	dosing	nn	37	SENT_381	[p11l479t1653r582b1692],
37	interval	NN	O	interval	prep_across	28	SENT_381	[p11l592t1653r719b1683],
38	.	.	O	.	_	0	SENT_381	[p11l592t1653r719b1683],

1	The	DT	O	the	det	3	SENT_382	[p11l396t1701r462b1730],
2	clinical	JJ	O	clinical	amod	3	SENT_382	[p11l479t1701r589b1730],
3	signiﬁcance	NN	O	signiﬁcance	nsubj	25	SENT_382	[p11l606t1701r788b1740],
4	of	IN	O	of	_	0	SENT_382	[p11l805t1701r839b1730],
5	an	DT	O	a	det	6	SENT_382	[p11l852t1712r888b1730],
6	association	NN	O	association	prep_of	3	SENT_382	[p11l904t1703r1074b1730],
7	between	IN	O	between	_	0	SENT_382	[p11l1090t1701r1220b1730],
8	Ctrough	NNP	PERSON	Ctrough	prep_between	6	SENT_382	[p11l1238t1702r1335b1742],
9	and	CC	O	and	_	0	SENT_382	[p11l1354t1701r1410b1730],
10	viral	JJ	O	viral	amod	11	SENT_382	[p11l1424t1701r1494b1730],
11	response	NN	O	response	prep_of	3	SENT_382	[p11l1510t1712r1646b1740],
12	for	IN	O	for	_	0	SENT_382	[p11l1663t1701r1708b1730],
13	integrase	NN	O	integrase	nn	14	SENT_382	[p11l1724t1703r1865b1740],
14	inhibitors	NNS	O	inhibitor	prep_for	11	SENT_382	[p11l347t1749r499b1778],
15	following	VBG	O	follow	_	0	SENT_382	[p11l515t1749r665b1788],
16	short-term	JJ	O	short-term	amod	18	SENT_382	[p11l680t1749r850b1778],
17	monotherapy	NN	O	monotherapy	nn	18	SENT_382	[p11l866t1749r1079b1788],
18	treatment	NN	O	treatment	prep_following	14	SENT_382	[p11l1093t1758r1255b1785],
19	,	,	O	,	_	0	SENT_382	[p11l1093t1758r1255b1785],
20	however	RB	O	however	advmod	25	SENT_382	[p11l1273t1749r1411b1785],
21	,	,	O	,	_	0	SENT_382	[p11l1273t1749r1411b1785],
22	is	VBZ	O	be	cop	25	SENT_382	[p11l1429t1751r1451b1778],
23	not	RB	O	not	neg	25	SENT_382	[p11l1468t1757r1521b1778],
24	yet	RB	O	yet	advmod	25	SENT_382	[p11l1535t1758r1584b1788],
25	clear	JJ	O	clear	_	0	SENT_382	[p11l1600t1749r1674b1778],
26	for	IN	O	for	_	0	SENT_382	[p11l1690t1749r1735b1778],
27	longerterm	JJ	O	longerterm	amod	28	SENT_382	[p11l1751t1749r1864b1788, p11l347t1807r421b1828],
28	treatment	NN	O	treatment	prep_for	25	SENT_382	[p11l436t1807r591b1828],
29	with	IN	O	with	_	0	SENT_382	[p11l603t1799r673b1828],
30	combination	NN	O	combination	nn	31	SENT_382	[p11l689t1799r886b1828],
31	therapies	NNS	O	therapy	prep_with	25	SENT_382	[p11l901t1799r1051b1837],
32	.	.	O	.	_	0	SENT_382	[p11l901t1799r1051b1837],

1	For	IN	O	for	dep	113	SENT_383	[p11l1068t1800r1125b1828],
2	raltegravir	NN	O	raltegravir	dep	113	SENT_383	[p11l1139t1799r1308b1838],
3	,	,	O	,	_	0	SENT_383	[p11l1139t1799r1308b1838],
4	for	IN	O	for	dep	113	SENT_383	[p11l1324t1799r1370b1828],
5	example	NN	O	example	dep	113	SENT_383	[p11l1385t1799r1521b1837],
6	,	,	O	,	_	0	SENT_383	[p11l1385t1799r1521b1837],
7	no	DT	O	no	dep	113	SENT_383	[p11l1537t1810r1576b1828],
8	associations	NNS	O	association	dep	113	SENT_383	[p11l1592t1801r1776b1828],
9	were	VBD	O	be	dep	113	SENT_383	[p11l1790t1810r1865b1828],
10	observed	VBN	O	observe	dep	113	SENT_383	[p11l347t1848r486b1877],
11	between	IN	O	between	dep	113	SENT_383	[p11l499t1848r629b1877],
12	Cmugh	NNP	LOCATION	Cmugh	dep	113	SENT_383	[p11l642t1849r740b1889],
13	and	CC	O	and	dep	113	SENT_383	[p11l755t1848r810b1877],
14	a	DT	O	a	dep	113	SENT_383	[p11l824t1859r838b1877],
15	variety	NN	O	variety	dep	113	SENT_383	[p11l849t1850r958b1887],
16	of	IN	O	of	dep	113	SENT_383	[p11l969t1848r1003b1877],
17	measures	NNS	O	measure	dep	113	SENT_383	[p11l1011t1859r1154b1877],
18	of	IN	O	of	dep	113	SENT_383	[p11l1168t1848r1202b1877],
19	treatment	NN	O	treatment	dep	113	SENT_383	[p11l1211t1856r1365b1877],
20	outcome	NN	O	outcome	dep	113	SENT_383	[p11l1377t1856r1513b1877],
21	(	CD	NUMBER	(	dep	113	SENT_383	[p11l1527t1848r1686b1887],
22	including	VBG	O	include	dep	113	SENT_383	[p11l1527t1848r1686b1887],
23	HIV	NN	O	hiv	dep	113	SENT_383	[p11l1697t1849r1773b1877],
24	RNA	NN	O	rna	dep	113	SENT_383	[p11l1783t1849r1867b1877],
25	<	JJR	O	<	dep	113	SENT_383	[p11l350t1900r432b1927],
26	400	CD	NUMBER	400	dep	113	SENT_383	[p11l350t1900r432b1927],
27	copies	NNS	O	copy	dep	113	SENT_383	[p11l446t1899r542b1937],
28	ml	NN	O	ml	dep	113	SENT_383	[p11l554t1895r637b1933],
29	”	NN	O	”	dep	113	SENT_383	[p11l554t1895r637b1933],
30	,	,	O	,	_	0	SENT_383	[p11l554t1895r637b1933],
31	HIV	NN	O	hiv	dep	113	SENT_383	[p11l651t1899r726b1927],
32	RNA	NN	O	rna	dep	113	SENT_383	[p11l736t1899r820b1927],
33	<	JJR	O	<	dep	113	SENT_383	[p11l834t1899r897b1927],
34	50	CD	NUMBER	50	dep	113	SENT_383	[p11l834t1899r897b1927],
35	copies	NNS	O	copy	dep	113	SENT_383	[p11l910t1899r1006b1936],
36	ml	NN	O	ml	dep	113	SENT_383	[p11l1019t1895r1102b1933],
37	‘	NN	O	‘	dep	113	SENT_383	[p11l1019t1895r1102b1933],
38	1	CD	NUMBER	1	dep	113	SENT_383	[p11l1019t1895r1102b1933],
39	,	,	O	,	_	0	SENT_383	[p11l1019t1895r1102b1933],
40	virologic	JJ	O	virologic	dep	113	SENT_383	[p11l1114t1898r1253b1937],
41	failure	NN	O	failure	dep	113	SENT_383	[p11l1266t1898r1374b1933],
42	,	,	O	,	_	0	SENT_383	[p11l1266t1898r1374b1933],
43	change	NN	O	change	dep	113	SENT_383	[p11l1388t1898r1497b1937],
44	from	IN	O	from	dep	113	SENT_383	[p11l1510t1898r1586b1927],
45	baseline	NN	O	baseline	dep	113	SENT_383	[p11l1598t1898r1723b1927],
46	in	IN	O	in	dep	113	SENT_383	[p11l1736t1899r1766b1927],
47	log10	NN	O	log10	dep	113	SENT_383	[p11l1778t1898r1865b1937],
48	HIV	NN	MISC	hiv	dep	113	SENT_383	[p11l347t1949r422b1977],
49	RNA	NN	MISC	rna	dep	113	SENT_383	[p11l434t1949r524b1983],
50	,	,	O	,	_	0	SENT_383	[p11l434t1949r524b1983],
51	and	CC	O	and	dep	113	SENT_383	[p11l540t1948r596b1977],
52	various	JJ	O	various	dep	113	SENT_383	[p11l609t1949r721b1977],
53	mutations	NNS	O	mutation	dep	113	SENT_383	[p11l735t1949r891b1977],
54	associated	VBN	O	associate	dep	113	SENT_383	[p11l906t1948r1062b1977],
55	with	IN	O	with	dep	113	SENT_383	[p11l1075t1948r1145b1976],
56	resistance	NN	O	resistance	dep	113	SENT_383	[p11l1159t1949r1311b1977],
57	to	TO	O	to	dep	113	SENT_383	[p11l1326t1956r1356b1977],
58	raltegravir	NN	O	raltegravir	dep	113	SENT_383	[p11l1370t1947r1544b1986],
59	)	NN	O	)	dep	113	SENT_383	[p11l1370t1947r1544b1986],
60	following	VBG	DATE	follow	dep	113	SENT_383	[p11l1559t1948r1708b1986],
61	16	CD	DATE	16	dep	113	SENT_383	[p11l1725t1949r1758b1976],
62	Weeks	NNS	DATE	week	dep	113	SENT_383	[p11l1772t1947r1865b1977],
63	of	IN	O	of	dep	113	SENT_383	[p11l347t1998r382b2026],
64	treatment	NN	O	treatment	dep	113	SENT_383	[p11l395t2006r549b2026],
65	in	IN	O	in	dep	113	SENT_383	[p11l565t1999r596b2026],
66	combination	NN	O	combination	dep	113	SENT_383	[p11l613t1997r811b2026],
67	with	IN	O	with	dep	113	SENT_383	[p11l827t1997r897b2026],
68	optimized	VBN	O	optimize	dep	113	SENT_383	[p11l915t1997r1071b2036],
69	background	NN	O	background	dep	113	SENT_383	[p11l1088t1997r1274b2036],
70	therapy	NN	O	therapy	dep	113	SENT_383	[p11l1292t1997r1411b2036],
71	in	IN	O	in	dep	113	SENT_383	[p11l1427t1999r1457b2026],
72	two	CD	NUMBER	two	dep	113	SENT_383	[p11l1475t2006r1532b2026],
73	phase	NN	O	phase	dep	113	SENT_383	[p11l1549t1997r1636b2036],
74	III	CD	NUMBER	iii	dep	113	SENT_383	[p11l1654t1999r1694b2026],
75	studies	NNS	O	study	dep	113	SENT_383	[p11l1712t1997r1817b2026],
76	in	IN	O	in	dep	113	SENT_383	[p11l1835t1999r1865b2026],
77	treatment-experienced	JJ	O	treatment-experienced	dep	113	SENT_383	[p11l347t2047r703b2085],
78	patients	NNS	O	patient	dep	113	SENT_383	[p11l718t2049r849b2085],
79	,	,	O	,	_	0	SENT_383	[p11l718t2049r849b2085],
80	and	CC	O	and	dep	113	SENT_383	[p11l866t2047r922b2076],
81	patients	NNS	O	patient	dep	113	SENT_383	[p11l937t2049r1059b2085],
82	with	IN	O	with	dep	113	SENT_383	[p11l1074t2047r1143b2076],
83	the	DT	O	the	dep	113	SENT_383	[p11l1159t2047r1208b2076],
84	lowest	JJS	O	lowest	dep	113	SENT_383	[p11l1223t2047r1323b2076],
85	Cuough	JJ	MISC	cuough	dep	113	SENT_383	[p11l1338t2048r1436b2088],
86	values	NNS	O	value	dep	113	SENT_383	[p11l1452t2047r1547b2076],
87	(	RB	O	(	dep	113	SENT_383	[p11l1563t2047r1668b2083],
88	below	IN	O	below	dep	113	SENT_383	[p11l1563t2047r1668b2083],
89	the	DT	O	the	dep	113	SENT_383	[p11l1682t2047r1731b2076],
90	in	FW	O	in	dep	113	SENT_383	[p11l1747t2049r1777b2076],
91	vitro	FW	O	vitro	dep	113	SENT_383	[p11l1790t2049r1865b2076],
92	ICg5	NN	O	icg5	dep	113	SENT_383	[p11l347t2098r427b2133],
93	)	NN	O	)	dep	113	SENT_383	[p11l347t2098r427b2133],
94	had	VBD	O	have	dep	113	SENT_383	[p11l440t2097r496b2126],
95	a	DT	O	a	dep	113	SENT_383	[p11l509t2108r524b2126],
96	similar	JJ	O	similar	dep	113	SENT_383	[p11l537t2097r643b2126],
97	probability	NN	O	probability	dep	113	SENT_383	[p11l655t2097r829b2136],
98	of	IN	O	of	dep	113	SENT_383	[p11l840t2097r875b2126],
99	a	DT	O	a	dep	113	SENT_383	[p11l884t2108r898b2126],
100	successful	JJ	O	successful	dep	113	SENT_383	[p11l911t2097r1064b2126],
101	treatment	NN	O	treatment	dep	113	SENT_383	[p11l1077t2105r1232b2126],
102	outcome	NN	O	outcome	dep	113	SENT_383	[p11l1244t2105r1379b2126],
103	compared	VBN	O	compare	dep	113	SENT_383	[p11l1393t2097r1547b2135],
104	with	IN	O	with	dep	113	SENT_383	[p11l1559t2097r1629b2126],
105	the	DT	O	the	dep	113	SENT_383	[p11l1641t2097r1690b2126],
106	rest	NN	O	rest	dep	113	SENT_383	[p11l1703t2105r1761b2126],
107	of	IN	O	of	dep	113	SENT_383	[p11l1773t2097r1807b2126],
108	the	DT	O	the	dep	113	SENT_383	[p11l1816t2097r1865b2126],
109	study	NN	O	study	dep	113	SENT_383	[p11l347t2147r431b2185],
110	population	NN	O	population	dep	113	SENT_383	[p11l440t2147r610b2185],
111	(	CD	NUMBER	(	dep	113	SENT_383	[p11l621t2148r689b2183],
112	68	CD	NUMBER	68	dep	113	SENT_383	[p11l621t2148r689b2183],
113	)	NN	O	)	_	0	SENT_383	[p11l621t2148r689b2183],
114	.	.	O	.	_	0	SENT_383	[p11l621t2148r689b2183],

1	Some	DT	O	some	det	2	SENT_384	[p11l702t2148r788b2176],
2	relationships	NNS	O	relationship	nsubjpass	4	SENT_384	[p11l799t2147r999b2185],
3	were	VBD	O	be	auxpass	4	SENT_384	[p11l1008t2158r1083b2176],
4	observed	VBN	O	observe	_	0	SENT_384	[p11l1094t2147r1232b2176],
5	in	IN	O	in	_	0	SENT_384	[p11l1243t2148r1273b2175],
6	these	DT	O	these	det	7	SENT_384	[p11l1283t2147r1363b2176],
7	phase	NN	O	phase	prep_in	4	SENT_384	[p11l1373t2147r1460b2185],
8	III	CD	NUMBER	iii	num	9	SENT_384	[p11l1471t2148r1512b2175],
9	studies	NNS	O	study	dobj	4	SENT_384	[p11l1522t2147r1628b2176],
10	between	IN	O	between	_	0	SENT_384	[p11l1638t2147r1769b2176],
11	treatment	NN	O	treatment	nn	12	SENT_384	[p11l1779t2155r1864b2176, p11l346t2205r428b2226],
12	outcome	NN	O	outcome	prep_between	9	SENT_384	[p11l444t2205r580b2226],
13	and	CC	O	and	_	0	SENT_384	[p11l597t2197r653b2226],
14	the	DT	O	the	det	15	SENT_384	[p11l670t2196r718b2226],
15	average	NN	O	average	conj_and	9	SENT_384	[p11l736t2207r853b2235],
16	of	IN	O	of	_	0	SENT_384	[p11l870t2197r904b2226],
17	all	DT	O	all	prep_of	15	SENT_384	[p11l917t2196r953b2226],
18	collected	VBN	O	collect	partmod	17	SENT_384	[p11l970t2197r1109b2226],
19	raltegravir	NN	O	raltegravir	nn	21	SENT_384	[p11l1126t2197r1289b2235],
20	concentration	NN	O	concentration	nn	21	SENT_384	[p11l1306t2198r1523b2226],
21	data	NNS	O	datum	dobj	18	SENT_384	[p11l1540t2196r1604b2226],
22	for	IN	O	for	_	0	SENT_384	[p11l1621t2197r1666b2225],
23	a	DT	O	a	det	25	SENT_384	[p11l1683t2208r1698b2226],
24	particular	JJ	O	particular	amod	25	SENT_384	[p11l1714t2197r1866b2235],
25	patient	NN	O	patient	prep_for	21	SENT_384	[p11l347t2248r464b2285],
26	,	,	O	,	_	0	SENT_384	[p11l347t2248r464b2285],
27	using	VBG	O	use	partmod	18	SENT_384	[p11l478t2248r563b2285],
28	a	DT	O	a	det	31	SENT_384	[p11l575t2258r590b2275],
29	sparse	JJ	O	sparse	amod	31	SENT_384	[p11l604t2257r698b2285],
30	sampling	NN	O	sampling	nn	31	SENT_384	[p11l712t2246r854b2285],
31	scheme	NN	O	scheme	dobj	27	SENT_384	[p11l866t2247r981b2275],
32	where	WRB	O	where	advmod	40	SENT_384	[p11l994t2246r1089b2275],
33	one	CD	NUMBER	one	num	36	SENT_384	[p11l1104t2257r1160b2275],
34	pharmacokinetic	JJ	O	pharmacokinetic	amod	36	SENT_384	[p11l1173t2246r1435b2285],
35	(	NN	O	(	nn	36	SENT_384	[p11l1449t2247r1521b2283],
36	PK	NN	O	pk	nsubjpass	40	SENT_384	[p11l1449t2247r1521b2283],
37	)	NN	O	)	nn	38	SENT_384	[p11l1449t2247r1521b2283],
38	sample	NN	O	sample	dep	36	SENT_384	[p11l1536t2246r1643b2285],
39	was	VBD	O	be	auxpass	40	SENT_384	[p11l1656t2258r1712b2275],
40	collected	VBN	O	collect	advcl	4	SENT_384	[p11l1726t2246r1865b2275],
41	per	IN	O	per	_	0	SENT_384	[p11l347t2307r398b2335],
42	visit	NN	O	visit	prep_per	40	SENT_384	[p11l407t2298r479b2325],
43	.	.	O	.	_	0	SENT_384	[p11l407t2298r479b2325],

1	Because	IN	O	because	mark	7	SENT_385	[p11l492t2298r616b2325],
2	the	DT	O	the	det	5	SENT_385	[p11l627t2296r676b2325],
3	sparse	JJ	O	sparse	amod	5	SENT_385	[p11l687t2307r781b2335],
4	sampling	NN	O	sampling	nn	5	SENT_385	[p11l793t2296r935b2335],
5	scheme	NN	O	scheme	nsubj	7	SENT_385	[p11l945t2296r1060b2325],
6	is	VBZ	O	be	cop	7	SENT_385	[p11l1071t2298r1093b2325],
7	likely	JJ	O	likely	advcl	18	SENT_385	[p11l1104t2296r1190b2335],
8	to	TO	O	to	aux	9	SENT_385	[p11l1199t2305r1230b2325],
9	underestimate	VB	O	underestimate	xcomp	7	SENT_385	[p11l1240t2296r1464b2325],
10	peak	JJ	O	peak	amod	11	SENT_385	[p11l1475t2296r1548b2335],
11	concentrations	NNS	O	concentration	dobj	9	SENT_385	[p11l1557t2298r1797b2331],
12	,	,	O	,	_	0	SENT_385	[p11l1557t2298r1797b2331],
13	this	DT	O	this	det	16	SENT_385	[p11l1809t2296r1865b2325],
14	average	JJ	O	average	amod	16	SENT_385	[p11l347t2357r464b2385],
15	concentration	NN	O	concentration	nn	16	SENT_385	[p11l478t2348r695b2375],
16	parameter	NN	O	parameter	nsubj	18	SENT_385	[p11l708t2354r868b2384],
17	likely	JJ	O	likely	amod	16	SENT_385	[p11l880t2346r965b2385],
18	represents	VBZ	O	represent	_	0	SENT_385	[p11l976t2354r1136b2384],
19	something	NN	O	something	dobj	18	SENT_385	[p11l1150t2346r1315b2385],
20	in	IN	O	in	dep	18	SENT_385	[p11l1327t2348r1357b2375],
21	between	IN	O	between	_	0	SENT_385	[p11l1370t2346r1500b2375],
22	the	DT	O	the	det	27	SENT_385	[p11l1513t2346r1561b2375],
23	true	JJ	O	true	amod	27	SENT_385	[p11l1575t2354r1637b2375],
24	average	JJ	O	average	amod	27	SENT_385	[p11l1651t2357r1768b2385],
25	raltegravir	NN	O	raltegravir	nn	27	SENT_385	[p11l1781t2346r1864b2375, p11l347t2397r439b2434],
26	plasma	NN	O	plasma	nn	27	SENT_385	[p11l451t2396r559b2434],
27	concentration	NN	O	concentration	prep_between	18	SENT_385	[p11l572t2397r790b2425],
28	in	IN	O	in	_	0	SENT_385	[p11l802t2397r833b2424],
29	these	DT	O	these	det	30	SENT_385	[p11l846t2396r925b2425],
30	patients	NNS	O	patient	prep_in	27	SENT_385	[p11l939t2397r1061b2434],
31	and	CC	O	and	_	0	SENT_385	[p11l1075t2396r1130b2425],
32	the	DT	O	the	det	34	SENT_385	[p11l1144t2396r1192b2425],
33	trough	NN	O	trough	nn	34	SENT_385	[p11l1206t2396r1312b2434],
34	concentration	NN	O	concentration	conj_and	30	SENT_385	[p11l1325t2397r1551b2431],
35	,	,	O	,	_	0	SENT_385	[p11l1325t2397r1551b2431],
36	and	CC	O	and	cc	18	SENT_385	[p11l1566t2396r1630b2431],
37	,	,	O	,	_	0	SENT_385	[p11l1566t2396r1630b2431],
38	in	IN	O	in	dep	18	SENT_385	[p11l1644t2397r1675b2424],
39	light	NN	O	light	pobj	38	SENT_385	[p11l1687t2396r1760b2434],
40	of	IN	O	of	_	0	SENT_385	[p11l1773t2396r1807b2425],
41	the	DT	O	the	det	44	SENT_385	[p11l1816t2396r1865b2425],
42	considerable	JJ	O	considerable	amod	44	SENT_385	[p11l347t2445r543b2474],
43	interoccasion	NN	O	interoccasion	nn	44	SENT_385	[p11l552t2447r761b2474],
44	variability	NN	O	variability	prep_of	39	SENT_385	[p11l768t2445r927b2484],
45	in	IN	O	in	_	0	SENT_385	[p11l933t2447r963b2474],
46	the	DT	O	the	det	47	SENT_385	[p11l971t2445r1020b2474],
47	pharmacokinetics	NNS	O	pharmacokinetic	prep_in	44	SENT_385	[p11l1029t2445r1304b2483],
48	of	IN	O	of	_	0	SENT_385	[p11l1313t2445r1348b2474],
49	raltegravir	NN	O	raltegravir	prep_of	47	SENT_385	[p11l1352t2445r1515b2484],
50	(	CD	NUMBER	(	num	49	SENT_385	[p11l1524t2446r1592b2481],
51	41	CD	NUMBER	41	num	52	SENT_385	[p11l1524t2446r1592b2481],
52	)	NN	O	)	dep	49	SENT_385	[p11l1524t2446r1592b2481],
53	,	,	O	,	_	0	SENT_385	[p11l1524t2446r1592b2481],
54	it	PRP	O	it	nsubj	59	SENT_385	[p11l1602t2447r1624b2474],
55	may	MD	O	may	aux	59	SENT_385	[p11l1632t2456r1698b2484],
56	be	VB	O	be	cop	59	SENT_385	[p11l1704t2445r1740b2474],
57	a	DT	O	a	det	59	SENT_385	[p11l1749t2456r1764b2474],
58	better	JJR	O	better	amod	59	SENT_385	[p11l1772t2445r1866b2474],
59	measure	NN	O	measure	ccomp	18	SENT_385	[p11l347t2506r476b2524],
60	of	IN	O	of	_	0	SENT_385	[p11l486t2495r520b2524],
61	overall	JJ	O	overall	amod	62	SENT_385	[p11l526t2495r631b2524],
62	exposure	NN	O	exposure	prep_of	59	SENT_385	[p11l641t2506r778b2533],
63	to	TO	O	to	_	0	SENT_385	[p11l788t2503r819b2524],
64	raltegravir	NN	O	raltegravir	prep_to	62	SENT_385	[p11l829t2495r992b2534],
65	on	IN	O	on	_	0	SENT_385	[p11l1002t2506r1041b2524],
66	long-term	JJ	O	long-term	amod	67	SENT_385	[p11l1050t2495r1210b2534],
67	dosing	NN	O	dosing	prep_on	64	SENT_385	[p11l1219t2495r1323b2534],
68	than	IN	O	than	_	0	SENT_385	[p11l1331t2495r1401b2524],
69	Cmmgh	NNP	O	Cmmgh	prep_than	67	SENT_385	[p11l1411t2496r1509b2536],
70	because	IN	O	because	mark	72	SENT_385	[p11l1520t2495r1640b2524],
71	it	PRP	O	it	nsubj	72	SENT_385	[p11l1650t2497r1673b2524],
72	represented	VBD	O	represent	advcl	59	SENT_385	[p11l1681t2495r1865b2533],
73	sampling	NN	O	sampling	dobj	72	SENT_385	[p11l347t2545r489b2583],
74	on	IN	O	on	_	0	SENT_385	[p11l503t2556r542b2574],
75	more	JJR	O	more	amod	76	SENT_385	[p11l556t2556r637b2574],
76	occasions	NNS	O	occasion	prep_on	72	SENT_385	[p11l652t2546r807b2574],
77	.	.	O	.	_	0	SENT_385	[p11l652t2546r807b2574],

1	The	DT	O	the	det	5	SENT_386	[p11l822t2545r889b2574],
2	observed	VBN	O	observe	amod	5	SENT_386	[p11l904t2545r1042b2574],
3	pharmacokinetic/pharmacodynamic	JJ	O	pharmacokinetic/pharmacodynamic	amod	5	SENT_386	[p11l1056t2545r1622b2583],
4	(	NN	O	(	nn	5	SENT_386	[p11l1637t2546r1778b2581],
5	PK/PD	NN	O	pk/pd	nsubj	17	SENT_386	[p11l1637t2546r1778b2581],
6	)	CD	NUMBER	)	num	7	SENT_386	[p11l1637t2546r1778b2581],
7	relationships	NNS	O	relationship	advmod	17	SENT_386	[p11l1793t2545r1864b2574, p11l347t2595r488b2633],
8	for	IN	O	for	_	0	SENT_386	[p11l498t2595r543b2624],
9	raltegravir	NN	O	raltegravir	prep_for	7	SENT_386	[p11l551t2595r715b2633],
10	in	IN	O	in	_	0	SENT_386	[p11l723t2596r754b2623],
11	the	DT	O	the	det	12	SENT_386	[p11l763t2595r811b2624],
12	phase	NN	O	phase	prep_in	9	SENT_386	[p11l821t2595r908b2633],
13	III	CD	NUMBER	iii	num	14	SENT_386	[p11l917t2596r958b2623],
14	studies	NNS	O	study	dep	7	SENT_386	[p11l967t2595r1073b2624],
15	were	VBD	O	be	cop	17	SENT_386	[p11l1082t2606r1156b2624],
16	generally	RB	O	generally	advmod	17	SENT_386	[p11l1167t2595r1311b2633],
17	shallow	JJ	O	shallow	_	0	SENT_386	[p11l1319t2595r1437b2624],
18	for	IN	O	for	_	0	SENT_386	[p11l1445t2595r1490b2624],
19	patients	NNS	O	patient	prep_for	17	SENT_386	[p11l1499t2596r1621b2633],
20	with	IN	O	with	_	0	SENT_386	[p11l1630t2595r1700b2624],
21	additional	JJ	O	additional	amod	23	SENT_386	[p11l1709t2595r1865b2624],
22	active	JJ	O	active	amod	23	SENT_386	[p11l347t2646r436b2673],
23	agents	NNS	O	agent	prep_with	19	SENT_386	[p11l447t2653r545b2683],
24	in	IN	O	in	_	0	SENT_386	[p11l555t2646r586b2673],
25	their	PRP$	O	they	prep_in	17	SENT_386	[p11l596t2644r670b2673],
26	optimized	VBN	O	optimize	partmod	25	SENT_386	[p11l680t2644r837b2683],
27	background	NN	O	background	nn	28	SENT_386	[p11l847t2644r1033b2683],
28	therapies	NNS	O	therapy	dobj	26	SENT_386	[p11l1043t2645r1193b2683],
29	,	,	O	,	_	0	SENT_386	[p11l1043t2645r1193b2683],
30	and	CC	O	and	_	0	SENT_386	[p11l1205t2644r1261b2673],
31	did	VBD	O	do	aux	33	SENT_386	[p11l1272t2644r1320b2673],
32	not	RB	O	not	neg	33	SENT_386	[p11l1330t2653r1384b2673],
33	suggest	VB	O	suggest	conj_and	17	SENT_386	[p11l1393t2653r1509b2683],
34	a	DT	O	a	det	37	SENT_386	[p11l1518t2656r1533b2673],
35	threshold	NN	O	threshold	nn	37	SENT_386	[p11l1544t2644r1692b2673],
36	raltegravir	NN	O	raltegravir	nn	37	SENT_386	[p11l1702t2644r1866b2683],
37	concentration	NN	O	concentration	dobj	33	SENT_386	[p11l347t2696r565b2723],
38	known	VBN	O	know	partmod	37	SENT_386	[p11l576t2694r682b2723],
39	to	TO	O	to	aux	41	SENT_386	[p11l694t2703r724b2723],
40	be	VB	O	be	auxpass	41	SENT_386	[p11l736t2694r772b2723],
41	associated	VBN	O	associate	xcomp	38	SENT_386	[p11l785t2694r940b2723],
42	with	IN	O	with	_	0	SENT_386	[p11l951t2694r1021b2723],
43	reduced	VBN	O	reduce	amod	44	SENT_386	[p11l1032t2694r1157b2723],
44	efﬁcacy	NN	O	efﬁcacy	prep_with	41	SENT_386	[p11l1169t2694r1291b2733],
45	.	.	O	.	_	0	SENT_386	[p11l1169t2694r1291b2733],

1	Some	DT	O	some	det	3	SENT_387	[p11l1305t2695r1392b2723],
2	other	JJ	O	other	amod	3	SENT_387	[p11l1404t2694r1488b2723],
3	factors	NNS	O	factor	nsubj	21	SENT_387	[p11l1499t2694r1603b2723],
4	in	IN	O	in	_	0	SENT_387	[p11l1615t2696r1645b2723],
5	these	DT	O	these	det	6	SENT_387	[p11l1657t2694r1737b2723],
6	studies	NNS	O	study	prep_in	3	SENT_387	[p11l1749t2694r1864b2730],
7	,	,	O	,	_	0	SENT_387	[p11l1749t2694r1864b2730],
8	such	JJ	O	such	_	0	SENT_387	[p11l347t2744r417b2773],
9	as	IN	O	as	_	0	SENT_387	[p11l428t2755r456b2773],
10	baseline	NN	O	baseline	nn	12	SENT_387	[p11l467t2744r592b2773],
11	HIV	NN	O	hiv	nn	12	SENT_387	[p11l602t2745r678b2773],
12	RNA	NN	O	rna	prep_such_as	3	SENT_387	[p11l686t2745r770b2773],
13	and	CC	O	and	_	0	SENT_387	[p11l779t2744r834b2773],
14	naive	JJ	O	naive	amod	15	SENT_387	[p11l845t2747r926b2773],
15	use	NN	O	use	prep_such_as	3	SENT_387	[p11l936t2755r986b2773],
16	of	IN	O	of	_	0	SENT_387	[p11l997t2744r1032b2773],
17	darunavir	NN	O	darunavir	prep_of	15	SENT_387	[p11l1038t2744r1193b2779],
18	,	,	O	,	_	0	SENT_387	[p11l1038t2744r1193b2779],
19	were	VBD	O	be	cop	21	SENT_387	[p11l1204t2755r1279b2773],
20	more	RBR	O	more	advmod	21	SENT_387	[p11l1290t2755r1371b2773],
21	inﬂuential	JJ	O	inﬂuential	_	0	SENT_387	[p11l1382t2744r1541b2773],
22	on	IN	O	on	_	0	SENT_387	[p11l1552t2755r1591b2773],
23	efﬁcacy	NN	O	efﬁcacy	nn	24	SENT_387	[p11l1602t2744r1720b2783],
24	outcome	NN	O	outcome	prep_on	21	SENT_387	[p11l1729t2752r1865b2773],
25	than	IN	O	than	mark	29	SENT_387	[p11l347t2794r416b2823],
26	raltegravir	JJ	O	raltegravir	amod	28	SENT_387	[p11l427t2794r590b2832],
27	PK	NN	O	pk	nn	28	SENT_387	[p11l601t2795r653b2822],
28	parameters	NNS	O	parameter	nsubj	29	SENT_387	[p11l662t2802r835b2832],
29	(	VBP	O	(	advcl	21	SENT_387	[p11l847t2795r915b2830],
30	68	CD	NUMBER	68	number	31	SENT_387	[p11l847t2795r915b2830],
31	)	CD	NUMBER	)	dobj	29	SENT_387	[p11l847t2795r915b2830],
32	.	.	O	.	_	0	SENT_387	[p11l847t2795r915b2830],

1	Although	IN	O	although	mark	6	SENT_388	[p11l395t2844r544b2882],
2	short-term	JJ	O	short-term	amod	4	SENT_388	[p11l555t2844r725b2873],
3	monotherapy	NN	O	monotherapy	nn	4	SENT_388	[p11l735t2844r948b2882],
4	data	NNS	O	datum	nsubj	6	SENT_388	[p11l957t2844r1021b2873],
5	initially	RB	O	initially	advmod	6	SENT_388	[p11l1031t2844r1152b2882],
6	suggested	VBD	O	suggest	advcl	29	SENT_388	[p11l1161t2844r1313b2882],
7	the	DT	O	the	det	8	SENT_388	[p11l1324t2844r1372b2873],
8	importance	NN	O	importance	dobj	6	SENT_388	[p11l1383t2845r1562b2882],
9	of	IN	O	of	_	0	SENT_388	[p11l1573t2844r1607b2873],
10	Cmmgh	NNP	O	Cmmgh	prep_of	8	SENT_388	[p11l1615t2845r1713b2884],
11	for	IN	O	for	_	0	SENT_388	[p11l1725t2844r1771b2873],
12	raltegravir	NN	O	raltegravir	prep_for	6	SENT_388	[p11l1780t2844r1864b2873, p11l347t2895r444b2932],
13	,	,	O	,	_	0	SENT_388	[p11l1780t2844r1864b2873, p11l347t2895r444b2932],
14	extensive	JJ	O	extensive	amod	15	SENT_388	[p11l456t2895r597b2922],
15	analyses	NNS	O	analysis	dep	20	SENT_388	[p11l608t2893r733b2932],
16	in	IN	O	in	_	0	SENT_388	[p11l743t2895r773b2922],
17	longer	JJR	O	longer	prepc_in	15	SENT_388	[p11l782t2893r973b2932],
18	—	CD	NUMBER	—	num	19	SENT_388	[p11l782t2893r973b2932],
19	term	NN	O	term	dep	20	SENT_388	[p11l782t2893r973b2932],
20	phase	NN	O	phase	dep	29	SENT_388	[p11l982t2894r1069b2932],
21	II	CD	NUMBER	ii	num	20	SENT_388	[p11l1079t2895r1106b2922],
22	and	CC	O	and	_	0	SENT_388	[p11l1116t2893r1172b2922],
23	phase	NN	O	phase	dep	29	SENT_388	[p11l1181t2893r1269b2932],
24	III	CD	NUMBER	iii	num	26	SENT_388	[p11l1278t2895r1319b2922],
25	clinical	JJ	O	clinical	amod	26	SENT_388	[p11l1329t2893r1439b2922],
26	studies	NNS	O	study	nsubj	29	SENT_388	[p11l1450t2893r1555b2922],
27	have	VBP	O	have	aux	29	SENT_388	[p11l1565t2893r1636b2922],
28	not	RB	O	not	neg	29	SENT_388	[p11l1646t2902r1699b2922],
29	supported	VBN	O	support	_	0	SENT_388	[p11l1708t2893r1865b2932],
30	these	DT	O	these	det	32	SENT_388	[p11l347t2943r427b2972],
31	preliminary	JJ	O	preliminary	amod	32	SENT_388	[p11l438t2943r622b2982],
32	ﬁndings	NNS	O	ﬁndings	dobj	29	SENT_388	[p11l632t2943r765b2982],
33	.	.	O	.	_	0	SENT_388	[p11l632t2943r765b2982],

1	The	DT	O	the	det	4	SENT_389	[p11l777t2943r843b2972],
2	apparently	RB	O	apparently	advmod	3	SENT_389	[p11l855t2943r1021b2982],
3	complex	JJ	O	complex	amod	4	SENT_389	[p11l1031t2943r1162b2982],
4	relationship	NN	O	relationship	nsubj	13	SENT_389	[p11l1172t2943r1358b2982],
5	between	IN	O	between	_	0	SENT_389	[p11l1369t2943r1500b2972],
6	the	DT	O	the	det	8	SENT_389	[p11l1511t2943r1560b2972],
7	PK	NN	O	pk	nn	8	SENT_389	[p11l1571t2945r1623b2972],
8	target	NN	O	target	prep_between	4	SENT_389	[p11l1632t2951r1725b2982],
9	and	CC	O	and	_	0	SENT_389	[p11l1735t2943r1790b2972],
10	efﬁcacy	NN	O	efﬁcacy	prep_between	4	SENT_389	[p11l1802t2943r1864b2972, p11l347t3004r415b3032],
11	may	MD	O	may	aux	13	SENT_389	[p11l422t3004r488b3032],
12	also	RB	O	also	advmod	13	SENT_389	[p11l496t2993r555b3022],
13	be	VB	O	be	_	0	SENT_389	[p11l564t2993r609b3028],
14	,	,	O	,	_	0	SENT_389	[p11l564t2993r609b3028],
15	in	IN	O	in	_	0	SENT_389	[p11l619t2995r649b3022],
16	part	NN	O	part	prep_in	13	SENT_389	[p11l658t3001r729b3031],
17	,	,	O	,	_	0	SENT_389	[p11l658t3001r729b3031],
18	a	DT	O	a	det	19	SENT_389	[p11l740t3004r754b3022],
19	function	NN	O	function	npadvmod	31	SENT_389	[p11l764t2993r895b3022],
20	of	IN	O	of	_	0	SENT_389	[p11l905t2993r939b3022],
21	the	DT	O	the	det	23	SENT_389	[p11l944t2993r993b3022],
22	unique	JJ	O	unique	amod	23	SENT_389	[p11l1001t2995r1109b3031],
23	mechanism	NN	O	mechanism	prep_of	19	SENT_389	[p11l1118t2993r1296b3022],
24	of	IN	O	of	_	0	SENT_389	[p11l1305t2993r1339b3022],
25	action	NN	O	action	prep_of	23	SENT_389	[p11l1345t2995r1440b3022],
26	of	IN	O	of	_	0	SENT_389	[p11l1449t2993r1484b3022],
27	integrase	NN	O	integrase	nn	30	SENT_389	[p11l1488t2995r1629b3032],
28	strand	NN	O	strand	nn	30	SENT_389	[p11l1639t2993r1736b3022],
29	transfer	NN	O	transfer	nn	30	SENT_389	[p11l1745t2993r1866b3022],
30	inhibitors	NNS	O	inhibitor	prep_of	25	SENT_389	[p11l346t3043r499b3072],
31	relative	JJ	O	relative	advmod	13	SENT_389	[p11l511t3043r626b3072],
32	to	TO	O	to	_	0	SENT_389	[p11l639t3051r670b3072],
33	other	JJ	O	other	amod	35	SENT_389	[p11l683t3043r767b3072],
34	antiretroviral	JJ	O	antiretroviral	amod	35	SENT_389	[p11l779t3043r986b3072],
35	agents	NNS	O	agent	prep_to	31	SENT_389	[p11l998t3051r1105b3082],
36	.	.	O	.	_	0	SENT_389	[p11l998t3051r1105b3082],

1	As	IN	O	as	mark	4	SENT_390	[p11l1118t3044r1156b3072],
2	these	DT	O	these	det	3	SENT_390	[p11l1169t3043r1249b3072],
3	inhibitors	NNS	O	inhibitor	nsubj	4	SENT_390	[p11l1261t3043r1414b3072],
4	result	VBP	O	result	advcl	21	SENT_390	[p11l1426t3043r1515b3072],
5	in	IN	O	in	_	0	SENT_390	[p11l1526t3045r1556b3072],
6	a	DT	O	a	det	9	SENT_390	[p11l1569t3054r1584b3072],
7	functionally	RB	O	functionally	advmod	8	SENT_390	[p11l1596t3043r1785b3082],
8	irreversible	JJ	O	irreversible	amod	9	SENT_390	[p11l1795t3045r1864b3072, p11l345t3090r466b3119],
9	inhibition	NN	O	inhibition	prep_in	4	SENT_390	[p11l481t3090r637b3119],
10	of	IN	O	of	_	0	SENT_390	[p11l652t3090r686b3119],
11	the	DT	O	the	det	14	SENT_390	[p11l697t3090r745b3119],
12	HIV-1	NN	MISC	hiv-1	nn	14	SENT_390	[p11l760t3092r860b3119],
13	replication	NN	O	replication	nn	14	SENT_390	[p11l879t3090r1047b3129],
14	cycle	NN	O	cycle	prep_of	9	SENT_390	[p11l1062t3090r1148b3129],
15	,	,	O	,	_	0	SENT_390	[p11l1062t3090r1148b3129],
16	strand	NN	O	strand	nn	18	SENT_390	[p11l1164t3090r1261b3119],
17	transfer	NN	O	transfer	nn	18	SENT_390	[p11l1275t3090r1396b3119],
18	inhibitors	NNS	O	inhibitor	nsubj	21	SENT_390	[p11l1410t3090r1562b3119],
19	do	VBP	O	do	aux	21	SENT_390	[p11l1578t3090r1616b3119],
20	not	RB	O	not	neg	21	SENT_390	[p11l1631t3098r1684b3119],
21	have	VB	O	have	_	0	SENT_390	[p11l1698t3090r1768b3119],
22	to	TO	O	to	aux	24	SENT_390	[p11l1783t3098r1814b3119],
23	be	VB	O	be	cop	24	SENT_390	[p11l1829t3090r1865b3119],
24	present	JJ	DATE	present	xcomp	21	SENT_390	[p11l347t3149r463b3179],
25	continuously	RB	O	continuously	advmod	24	SENT_390	[p11l474t3140r677b3179],
26	during	IN	O	during	_	0	SENT_390	[p11l688t3140r792b3179],
27	the	DT	O	the	det	29	SENT_390	[p11l803t3140r851b3169],
28	infection	NN	O	infection	nn	29	SENT_390	[p11l863t3140r1003b3169],
29	process	NN	O	process	prep_during	24	SENT_390	[p11l1014t3151r1137b3179],
30	.	.	O	.	_	0	SENT_390	[p11l1014t3151r1137b3179],

1	Thus	RB	O	thus	advmod	19	SENT_391	[p11l1149t3140r1241b3176],
2	,	,	O	,	_	0	SENT_391	[p11l1149t3140r1241b3176],
3	maintaining	VBG	O	maintain	dep	19	SENT_391	[p11l1254t3142r1444b3179],
4	a	DT	O	a	det	7	SENT_391	[p11l1455t3151r1469b3169],
5	high	JJ	O	high	amod	7	SENT_391	[p11l1481t3140r1551b3179],
6	drug	NN	O	drug	nn	7	SENT_391	[p11l1563t3140r1636b3179],
7	concentration	NN	O	concentration	dobj	3	SENT_391	[p11l1648t3142r1865b3169],
8	throughout	IN	O	throughout	_	0	SENT_391	[p11l347t3188r527b3227],
9	the	DT	O	the	det	11	SENT_391	[p11l537t3188r586b3217],
10	dosing	NN	O	dosing	nn	11	SENT_391	[p11l598t3188r701b3227],
11	interval	NN	O	interval	prep_throughout	3	SENT_391	[p11l711t3188r838b3224],
12	,	,	O	,	_	0	SENT_391	[p11l711t3188r838b3224],
13	including	VBG	O	include	_	0	SENT_391	[p11l850t3188r999b3227],
14	trough	NN	O	trough	prep_including	19	SENT_391	[p11l1009t3188r1123b3227],
15	,	,	O	,	_	0	SENT_391	[p11l1009t3188r1123b3227],
16	could	MD	O	could	aux	19	SENT_391	[p11l1136t3188r1222b3217],
17	be	VB	O	be	cop	19	SENT_391	[p11l1233t3188r1268b3217],
18	less	RBR	O	less	advmod	19	SENT_391	[p11l1280t3188r1333b3217],
19	critical	JJ	O	critical	_	0	SENT_391	[p11l1345t3188r1451b3217],
20	for	IN	O	for	_	0	SENT_391	[p11l1463t3188r1508b3217],
21	efﬁcacy	NN	O	efﬁcacy	prep_for	19	SENT_391	[p11l1519t3188r1637b3227],
22	and	CC	O	and	_	0	SENT_391	[p11l1647t3188r1702b3217],
23	durability	NN	O	durability	conj_and	21	SENT_391	[p11l1714t3188r1867b3227],
24	than	IN	O	than	mark	27	SENT_391	[p11l347t3236r416b3266],
25	has	VBZ	O	have	aux	27	SENT_391	[p11l427t3236r476b3266],
26	been	VBN	O	be	auxpass	27	SENT_391	[p11l488t3236r562b3266],
27	observed	VBN	O	observe	advcl	19	SENT_391	[p11l574t3236r712b3266],
28	with	IN	O	with	_	0	SENT_391	[p11l722t3236r792b3266],
29	other	JJ	O	other	amod	31	SENT_391	[p11l803t3236r887b3266],
30	drug	NN	O	drug	nn	31	SENT_391	[p11l898t3236r971b3275],
31	classes	NNS	O	class	prep_with	27	SENT_391	[p11l982t3236r1090b3266],
32	.	.	O	.	_	0	SENT_391	[p11l982t3236r1090b3266],

1	CLINICAL	JJ	O	clinical	amod	2	SENT_392	[p11l347t3350r568b3382],
2	IMPLICATIONS	NNS	O	implication	_	0	SENT_392	[p11l580t3350r915b3382],

1	Efﬁcacy	NNP	O	Efﬁcacy	nn	6	SENT_393	[p11l346t3432r496b3475],
2	and	CC	O	and	_	0	SENT_393	[p11l508t3432r574b3464],
3	Future	NNP	DATE	Future	nn	6	SENT_393	[p11l587t3434r715b3464],
4	Directions	NNPS	MISC	Directions	nn	6	SENT_393	[p11l729t3434r927b3464],
5	Integrase	NNP	MISC	Integrase	nn	6	SENT_393	[p11l347t3496r491b3534],
6	inhibitors	NNS	O	inhibitor	nsubj	13	SENT_393	[p11l506t3495r659b3524],
7	in	IN	O	in	_	0	SENT_393	[p11l674t3497r704b3524],
8	combination	NN	O	combination	prep_in	6	SENT_393	[p11l720t3495r917b3524],
9	with	IN	O	with	_	0	SENT_393	[p11l931t3495r1001b3524],
10	optimized	VBN	O	optimize	prepc_with	8	SENT_393	[p11l1017t3495r1173b3534],
11	background	NN	O	background	nn	12	SENT_393	[p11l1189t3495r1374b3534],
12	therapy	NN	O	therapy	dobj	10	SENT_393	[p11l1390t3495r1509b3534],
13	provide	VBP	O	provide	_	0	SENT_393	[p11l1523t3495r1641b3534],
14	an	DT	O	a	det	16	SENT_393	[p11l1657t3506r1693b3524],
15	important	JJ	O	important	amod	16	SENT_393	[p11l1708t3497r1866b3534],
16	option	NN	O	option	dobj	13	SENT_393	[p11l347t3546r449b3584],
17	for	IN	O	for	_	0	SENT_393	[p11l465t3545r511b3574],
18	patients	NNS	O	patient	prep_for	16	SENT_393	[p11l526t3546r648b3584],
19	who	WP	O	who	nsubj	22	SENT_393	[p11l663t3545r729b3574],
20	are	VBP	O	be	cop	22	SENT_393	[p11l746t3556r793b3574],
21	treatment	NN	O	treatment	npadvmod	22	SENT_393	[p11l809t3553r963b3574],
22	experienced	JJ	O	experienced	rcmod	18	SENT_393	[p11l979t3545r1165b3584],
23	and	CC	O	and	_	0	SENT_393	[p11l1181t3545r1237b3574],
24	in	IN	O	in	rcmod	18	SENT_393	[p11l1252t3546r1282b3574],
25	whom	WP	O	whom	dobj	29	SENT_393	[p11l1297t3545r1395b3574],
26	current	JJ	DATE	current	amod	27	SENT_393	[p11l1411t3553r1527b3574],
27	therapy	NN	O	therapy	nsubj	29	SENT_393	[p11l1542t3545r1662b3584],
28	is	VBZ	O	be	cop	29	SENT_393	[p11l1675t3546r1698b3574],
29	unable	JJ	O	unable	pcomp	24	SENT_393	[p11l1714t3545r1818b3574],
30	to	TO	O	to	prep	29	SENT_393	[p11l1834t3553r1865b3574],

1	Annu	NNP	PERSON	Annu	_	0	SENT_394	[p12l56t1832r79b1912],
2	.	.	O	.	_	0	SENT_394	[p12l56t1832r79b1912],

1	Rev.	NNP	O	Rev.	nn	2	SENT_395	[p12l56t1761r79b1821],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_395	[p12l56t1602r79b1751],
3	.	.	O	.	_	0	SENT_395	[p12l56t1602r79b1751],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_396	[p12l56t1482r79b1591],
2	.	.	O	.	_	0	SENT_396	[p12l56t1482r79b1591],

1	2009.49:377	CD	NUMBER	2009.49:377	num	2	SENT_397	[p12l56t1237r80b1471],
2	-394	CD	NUMBER	-394	_	0	SENT_397	[p12l56t1237r80b1471],
3	.	.	O	.	_	0	SENT_397	[p12l56t1237r80b1471],

1	Downloaded	VBN	O	download	_	0	SENT_398	[p12l56t1057r79b1227],
2	from	IN	O	from	_	0	SENT_398	[p12l56t983r79b1048],
3	www	NN	O	www	prep_from	1	SENT_398	[p12l56t716r79b974],
4	.	.	O	.	_	0	SENT_398	[p12l56t716r79b974],

1	annua1review	NN	O	annua1review	nn	2	SENT_399	[p12l56t716r79b974],
2	s.	NN	O	s.	_	0	SENT_399	[p12l63t652r79b700],
3	or	CC	O	or	_	0	SENT_399	[p12l63t652r79b700],
4	g	NN	O	g	conj_or	2	SENT_399	[p12l63t622r86b637],
5	by	IN	O	by	_	0	SENT_399	[p12l89t1744r120b1776],
6	University	NNP	ORGANIZATION	University	prep_by	2	SENT_399	[p12l89t1595r120b1735],
7	of	IN	ORGANIZATION	of	_	0	SENT_399	[p12l89t1556r113b1585],
8	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	6	SENT_399	[p12l89t1410r113b1550],
9	-	:	O	-	_	0	SENT_399	[p12l103t1392r106b1401],
10	Madison	NNP	O	Madison	dep	2	SENT_399	[p12l89t1266r113b1382],
11	on	IN	O	on	_	0	SENT_399	[p12l97t1225r113b1257],
12	01/05/14	CD	DATE	01/05/14	prep_on	10	SENT_399	[p12l89t1091r113b1215],
13	.	.	O	.	_	0	SENT_399	[p12l89t1091r113b1215],

1	For	IN	O	for	_	0	SENT_400	[p12l90t1034r113b1081],
2	personal	JJ	O	personal	amod	3	SENT_400	[p12l89t914r120b1026],
3	use	NN	O	use	pobj	1	SENT_400	[p12l97t861r113b905],
4	only	RB	O	only	advmod	3	SENT_400	[p12l89t787r120b851],
5	.	.	O	.	_	0	SENT_400	[p12l89t787r120b851],

1	.	.	O	.	_	0	SENT_401	[p12l208t3107r231b3157],

1	org	NN	O	org	nn	2	SENT_402	[p12l208t3107r231b3157],
2	www.nnnnnlreview:.org	NN	O	www.nnnnnlreview:.org	_	0	SENT_402	[p12l1274t41r1547b71],
3	I	PRP	O	I	nsubj	4	SENT_402	[p12l1562t49r1571b59],
4	Emerging	VBG	O	emerge	rcmod	2	SENT_402	[p12l1586t41r1701b71],
5	Plmrmntology	NN	O	plmrmntology	dobj	4	SENT_402	[p12l1708t41r1866b71],
6	389	CD	NUMBER	389	num	5	SENT_402	[p12l1915t42r1959b70],

1	effectively	RB	O	effectively	advmod	2	SENT_403	[p12l584t80r744b119],
2	suppress	VB	O	suppress	_	0	SENT_403	[p12l755t91r886b119],
3	HIV	NN	MISC	hiv	nn	4	SENT_403	[p12l899t82r999b110],
4	—	NN	O	—	nsubj	8	SENT_403	[p12l899t82r999b110],
5	1	CD	NUMBER	1	number	6	SENT_403	[p12l899t82r999b110],
6	RNA	NN	ORGANIZATION	rna	amod	4	SENT_403	[p12l1015t81r1098b109],
7	1	CD	NUMBER	1	num	8	SENT_403	[p12l1108t80r1117b109],
8	replication	NN	O	replication	xcomp	2	SENT_403	[p12l1129t80r1298b119],
9	owing	VBG	O	owe	partmod	8	SENT_403	[p12l1310t82r1406b119],
10	to	TO	O	to	_	0	SENT_403	[p12l1417t89r1447b110],
11	drug	NN	O	drug	nn	12	SENT_403	[p12l1460t80r1533b119],
12	resistance	NN	O	resistance	prep_to	9	SENT_403	[p12l1544t82r1704b110],
13	.	.	O	.	_	0	SENT_403	[p12l1544t82r1704b110],

1	As	IN	O	as	_	0	SENT_404	[p12l1717t81r1755b110],
2	a	DT	O	a	det	5	SENT_404	[p12l1768t91r1782b110],
3	new	JJ	O	new	amod	5	SENT_404	[p12l1794t91r1859b110],
4	drug	NN	O	drug	nn	5	SENT_404	[p12l1870t80r1943b119],
5	class	NN	O	class	prep_as	9	SENT_404	[p12l1954t80r2032b116],
6	,	,	O	,	_	0	SENT_404	[p12l1954t80r2032b116],
7	it	PRP	O	it	nsubjpass	9	SENT_404	[p12l2045t82r2068b110],
8	is	VBZ	O	be	auxpass	9	SENT_404	[p12l2078t82r2101b110],
9	expected	VBN	O	expect	_	0	SENT_404	[p12l584t126r720b165],
10	that	IN	O	that	complm	14	SENT_404	[p12l732t126r794b155],
11	these	DT	O	these	det	12	SENT_404	[p12l804t126r884b155],
12	agents	NNS	O	agent	nsubj	14	SENT_404	[p12l897t134r995b165],
13	should	MD	O	should	aux	14	SENT_404	[p12l1007t126r1111b155],
14	have	VB	O	have	ccomp	9	SENT_404	[p12l1122t126r1193b155],
15	activity	NN	O	activity	dobj	14	SENT_404	[p12l1206t128r1319b165],
16	against	IN	O	against	_	0	SENT_404	[p12l1330t128r1439b165],
17	all	DT	O	all	det	20	SENT_404	[p12l1450t126r1486b155],
18	current	JJ	DATE	current	amod	20	SENT_404	[p12l1498t134r1614b155],
19	drug	NN	O	drug	nn	20	SENT_404	[p12l1625t126r1845b165],
20	—	NN	O	—	prep_against	15	SENT_404	[p12l1625t126r1845b165],
21	resistant	JJ	O	resistant	amod	23	SENT_404	[p12l1625t126r1845b165],
22	HIV-1	NN	O	hiv-1	nn	23	SENT_404	[p12l1855t127r1955b155],
23	variants	NNS	O	variant	dep	20	SENT_404	[p12l1969t128r2100b155],
24	.	.	O	.	_	0	SENT_404	[p12l1969t128r2100b155],

1	Raltegravir	NN	O	raltegravir	nsubj	4	SENT_405	[p12l584t172r759b211],
2	speciﬁcally	RB	O	speciﬁcally	advmod	4	SENT_405	[p12l769t172r941b211],
3	has	VBZ	O	have	aux	4	SENT_405	[p12l949t172r999b201],
4	demonstrated	VBN	O	demonstrate	_	0	SENT_405	[p12l1011t172r1225b201],
5	efﬁcacy	NN	O	efﬁcacy	dobj	4	SENT_405	[p12l1237t172r1355b211],
6	in	IN	O	in	_	0	SENT_405	[p12l1364t174r1394b201],
7	treatment	NN	O	treatment	npadvmod	9	SENT_405	[p12l1405t172r1761b211],
8	—	CD	NUMBER	—	num	7	SENT_405	[p12l1405t172r1761b211],
9	experienced	JJ	O	experienced	amod	10	SENT_405	[p12l1405t172r1761b211],
10	patients	NNS	O	patient	prep_in	4	SENT_405	[p12l1771t174r1894b211],
11	who	WP	O	who	nsubj	13	SENT_405	[p12l1904t172r1970b201],
12	are	VBP	O	be	aux	13	SENT_405	[p12l1982t183r2028b201],
13	failing	VBG	O	fail	rcmod	10	SENT_405	[p12l2039t172r2101b201, p12l583t220r634b257],
14	therapy	NN	O	therapy	dobj	13	SENT_405	[p12l645t218r764b257],
15	with	IN	O	with	_	0	SENT_405	[p12l773t218r843b247],
16	multidrug-resistant	JJ	O	multidrug-resistant	amod	18	SENT_405	[p12l854t218r1159b257],
17	HIIV-1	NN	O	hiiv-1	nn	18	SENT_405	[p12l1170t219r1284b247],
18	infection	NN	O	infection	prep_with	13	SENT_405	[p12l1299t218r1438b247],
19	in	IN	O	in	_	0	SENT_405	[p12l1449t220r1480b247],
20	both	CC	O	both	preconj	22	SENT_405	[p12l1491t218r1563b247],
21	the	DT	O	the	det	22	SENT_405	[p12l1575t218r1624b247],
22	phase	NN	O	phase	prep_in	18	SENT_405	[p12l1636t218r1723b257],
23	II	CD	NUMBER	ii	num	22	SENT_405	[p12l1734t219r1761b247],
24	and	CC	O	and	_	0	SENT_405	[p12l1773t218r1828b247],
25	phase	NN	O	phase	prep_in	18	SENT_405	[p12l1840t218r1927b257],
26	III	CD	NUMBER	iii	num	28	SENT_405	[p12l1939t219r1979b247],
27	clinical	JJ	O	clinical	amod	28	SENT_405	[p12l1991t218r2102b247],
28	trials	NNS	O	trial	nsubj	41	SENT_405	[p12l584t264r660b293],
29	with	IN	O	with	_	0	SENT_405	[p12l671t264r741b293],
30	increasing	VBG	O	increase	amod	31	SENT_405	[p12l752t265r912b303],
31	effectiveness	NN	O	effectiveness	prep_with	28	SENT_405	[p12l924t264r1119b293],
32	observed	VBN	O	observe	partmod	31	SENT_405	[p12l1132t264r1270b293],
33	when	WRB	O	when	advmod	34	SENT_405	[p12l1281t264r1366b293],
34	coadministered	VBN	O	coadminister	advcl	32	SENT_405	[p12l1378t264r1617b293],
35	in	IN	O	in	_	0	SENT_405	[p12l1629t265r1659b293],
36	combination	NN	O	combination	prep_in	34	SENT_405	[p12l1671t264r1868b293],
37	with	IN	O	with	_	0	SENT_405	[p12l1879t264r1948b293],
38	other	JJ	O	other	amod	40	SENT_405	[p12l1960t264r2044b293],
39	active	JJ	O	active	amod	40	SENT_405	[p12l2056t275r2101b293, p12l584t312r639b339],
40	agents	NNS	O	agent	prep_with	34	SENT_405	[p12l652t319r750b349],
41	(	VBP	O	(	dep	13	SENT_405	[p12l763t311r789b346],
42	3	CD	NUMBER	3	number	43	SENT_405	[p12l763t311r789b346],
43	7	CD	NUMBER	7	num	44	SENT_405	[p12l795t311r831b346],
44	)	NN	O	)	dobj	41	SENT_405	[p12l795t311r831b346],
45	.	.	O	.	_	0	SENT_405	[p12l795t311r831b346],

1	As	IN	O	as	_	0	SENT_406	[p12l844t311r882b339],
2	the	DT	O	the	det	4	SENT_406	[p12l894t310r943b339],
3	clinical	JJ	O	clinical	amod	4	SENT_406	[p12l955t310r1066b339],
4	success	NN	O	success	prep_as	22	SENT_406	[p12l1078t321r1188b339],
5	of	IN	O	of	_	0	SENT_406	[p12l1200t310r1235b339],
6	agents	NNS	O	agent	prep_of	4	SENT_406	[p12l1243t318r1341b349],
7	with	IN	O	with	_	0	SENT_406	[p12l1352t310r1422b339],
8	new	JJ	O	new	amod	9	SENT_406	[p12l1433t321r1498b339],
9	mechanisms	NNS	O	mechanism	prep_with	6	SENT_406	[p12l1508t310r1699b339],
10	of	IN	O	of	_	0	SENT_406	[p12l1712t310r1746b339],
11	action	NN	O	action	prep_of	9	SENT_406	[p12l1754t312r1857b345],
12	,	,	O	,	_	0	SENT_406	[p12l1754t312r1857b345],
13	including	VBG	O	include	_	0	SENT_406	[p12l1870t310r2019b349],
14	both	DT	O	both	preconj	16	SENT_406	[p12l2029t310r2102b339],
15	CCR5	NN	O	ccr5	nn	16	SENT_406	[p12l585t357r682b386],
16	antagonists	NNS	O	antagonist	prep_including	22	SENT_406	[p12l697t358r872b395],
17	and	CC	O	and	_	0	SENT_406	[p12l885t356r940b385],
18	integrase	NN	O	integrase	nn	19	SENT_406	[p12l952t358r1093b395],
19	inhibitors	NNS	O	inhibitor	conj_and	16	SENT_406	[p12l1105t356r1266b392],
20	,	,	O	,	_	0	SENT_406	[p12l1105t356r1266b392],
21	is	VBZ	O	be	auxpass	22	SENT_406	[p12l1279t358r1301b385],
22	established	VBN	O	establish	_	0	SENT_406	[p12l1314t356r1485b385],
23	it	PRP	O	it	nsubj	26	SENT_406	[p12l1497t358r1519b385],
24	will	MD	O	will	aux	26	SENT_406	[p12l1529t356r1586b385],
25	become	VB	O	become	cop	26	SENT_406	[p12l1598t356r1719b385],
26	important	JJ	O	important	ccomp	22	SENT_406	[p12l1731t358r1889b395],
27	to	TO	O	to	aux	28	SENT_406	[p12l1900t364r1931b385],
28	reevaluate	VB	O	reevaluate	xcomp	26	SENT_406	[p12l1943t356r2101b385],
29	the	DT	O	the	det	32	SENT_406	[p12l584t402r632b431],
30	current	JJ	DATE	current	amod	32	SENT_406	[p12l645t410r761b431],
31	long	JJ	O	long	amod	32	SENT_406	[p12l772t402r855b441],
32	—	NN	O	—	dobj	28	SENT_406	[p12l772t402r855b441],
33	and	CC	O	and	_	0	SENT_406	[p12l868t402r923b431],
34	short-term	JJ	O	short-term	amod	35	SENT_406	[p12l936t402r1106b431],
35	strategies	NNS	O	strategy	dobj	28	SENT_406	[p12l1118t403r1264b441],
36	in	IN	O	in	_	0	SENT_406	[p12l1276t403r1306b431],
37	HIV-1	NN	MISC	hiv-1	nn	39	SENT_406	[p12l1318t403r1418b431],
38	patient	NN	O	patient	nn	39	SENT_406	[p12l1434t403r1543b441],
39	management	NN	O	management	prep_in	28	SENT_406	[p12l1554t410r1757b441],
40	throughout	IN	O	throughout	_	0	SENT_406	[p12l1768t402r1948b441],
41	the	DT	O	the	det	42	SENT_406	[p12l1960t402r2008b431],
42	spectrum	NN	O	spectrum	prep_throughout	28	SENT_406	[p12l2021t413r2101b441, p12l584t457r661b478],
43	of	IN	O	of	_	0	SENT_406	[p12l675t448r709b478],
44	disease	NN	O	disease	prep_of	42	SENT_406	[p12l719t448r834b478],
45	.	.	O	.	_	0	SENT_406	[p12l719t448r834b478],

1	The	DT	O	the	det	2	SENT_407	[p12l849t448r915b478],
2	use	NN	O	use	nsubj	20	SENT_407	[p12l929t459r979b478],
3	of	IN	O	of	_	0	SENT_407	[p12l993t448r1027b478],
4	a	DT	O	a	det	6	SENT_407	[p12l1037t459r1052b478],
5	novel	JJ	O	novel	amod	6	SENT_407	[p12l1065t448r1150b478],
6	agent	NN	O	agent	prep_of	2	SENT_407	[p12l1164t456r1250b487],
7	such	JJ	O	such	_	0	SENT_407	[p12l1263t448r1333b478],
8	as	IN	O	as	_	0	SENT_407	[p12l1347t459r1375b478],
9	raltegravir	NN	O	raltegravir	prep_such_as	6	SENT_407	[p12l1389t448r1552b487],
10	as	IN	O	as	_	0	SENT_407	[p12l1566t459r1594b478],
11	part	NN	O	part	prep_as	9	SENT_407	[p12l1608t456r1671b487],
12	of	IN	O	of	_	0	SENT_407	[p12l1684t448r1719b478],
13	combination	NN	O	combination	nn	14	SENT_407	[p12l1729t448r1926b478],
14	therapy	NN	O	therapy	prep_of	11	SENT_407	[p12l1940t448r2060b487],
15	in	IN	O	in	_	0	SENT_407	[p12l2071t450r2102b477],
16	highly	RB	O	highly	advmod	17	SENT_407	[p12l583t498r684b537],
17	treatrnent-experienced	JJ	O	treatrnent-experienced	amod	18	SENT_407	[p12l694t498r1050b537],
18	patients	NNS	O	patient	prep_in	14	SENT_407	[p12l1063t500r1185b537],
19	may	MD	O	may	aux	20	SENT_407	[p12l1197t509r1263b537],
20	decrease	VB	O	decrease	_	0	SENT_407	[p12l1274t498r1405b527],
21	the	DT	O	the	det	22	SENT_407	[p12l1418t498r1467b527],
22	complexity	NN	O	complexity	dobj	20	SENT_407	[p12l1480t498r1652b537],
23	of	IN	O	of	_	0	SENT_407	[p12l1663t498r1698b527],
24	treatment	NN	O	treatment	prep_of	22	SENT_407	[p12l1706t506r1860b527],
25	with	IN	O	with	_	0	SENT_407	[p12l1870t498r1940b527],
26	improved	VBN	O	improve	amod	27	SENT_407	[p12l1952t498r2101b537],
27	efﬁcacy	NN	O	efﬁcacy	prep_with	20	SENT_407	[p12l584t544r706b583],
28	,	,	O	,	_	0	SENT_407	[p12l584t544r706b583],
29	better	JJR	O	better	amod	30	SENT_407	[p12l720t544r813b573],
30	safety	NN	O	safety	conj_and	27	SENT_407	[p12l826t544r919b583],
31	,	,	O	,	_	0	SENT_407	[p12l826t544r919b583],
32	and	CC	O	and	_	0	SENT_407	[p12l934t544r989b573],
33	tolerability	NN	O	tolerability	conj_and	27	SENT_407	[p12l1002t544r1179b583],
34	.	.	O	.	_	0	SENT_407	[p12l1002t544r1179b583],

1	However	RB	O	however	advmod	31	SENT_408	[p12l1193t546r1343b580],
2	,	,	O	,	_	0	SENT_408	[p12l1193t546r1343b580],
3	the	DT	O	the	det	6	SENT_408	[p12l1357t544r1406b573],
4	robust	JJ	O	robust	amod	6	SENT_408	[p12l1419t544r1520b573],
5	efﬁcacy	NN	O	efﬁcacy	nn	6	SENT_408	[p12l1532t544r1650b583],
6	phase	NN	O	phase	nsubj	31	SENT_408	[p12l1661t544r1748b583],
7	II	CD	NUMBER	ii	num	8	SENT_408	[p12l1761t546r1787b573],
8	study	NN	O	study	nsubj	19	SENT_408	[p12l1800t544r1885b583],
9	of	IN	O	of	_	0	SENT_408	[p12l1896t544r1930b573],
10	raltegravir	NN	O	raltegravir	prep_of	8	SENT_408	[p12l1939t544r2102b583],
11	in	IN	O	in	_	0	SENT_408	[p12l583t596r614b623],
12	combination	NN	O	combination	prep_in	10	SENT_408	[p12l629t594r826b623],
13	with	IN	O	with	_	0	SENT_408	[p12l839t594r909b623],
14	NRTIS	NN	ORGANIZATION	nrti	prep_with	12	SENT_408	[p12l923t595r1036b623],
15	in	IN	O	in	_	0	SENT_408	[p12l1050t596r1080b623],
16	treatment-naive	JJ	O	treatment-naive	amod	17	SENT_408	[p12l1095t597r1345b623],
17	patients	NNS	O	patient	prep_in	14	SENT_408	[p12l1360t596r1482b632],
18	also	RB	O	also	advmod	19	SENT_408	[p12l1498t594r1556b623],
19	suggests	VBZ	O	suggest	rcmod	6	SENT_408	[p12l1571t602r1700b633],
20	integrase	NN	O	integrase	nn	21	SENT_408	[p12l1714t596r1855b633],
21	inhibitors	NNS	O	inhibitor	nsubj	24	SENT_408	[p12l1870t594r2022b623],
22	may	MD	O	may	aux	24	SENT_408	[p12l2037t605r2103b633],
23	someday	RB	O	someday	advmod	24	SENT_408	[p12l584t658r721b697],
24	have	VB	O	have	ccomp	19	SENT_408	[p12l733t658r803b687],
25	a	DT	O	a	det	26	SENT_408	[p12l818t669r833b687],
26	role	NN	O	role	dobj	24	SENT_408	[p12l847t658r907b687],
27	in	IN	O	in	_	0	SENT_408	[p12l921t660r951b687],
28	ﬁrst-line	JJ	O	ﬁrst-line	amod	30	SENT_408	[p12l965t658r1099b687],
29	HAART	NN	O	haart	nn	30	SENT_408	[p12l1113t659r1249b687],
30	regimens	NNS	O	regimen	prep_in	26	SENT_408	[p12l1262t659r1404b697],
31	(	VBP	O	(	_	0	SENT_408	[p12l1420t659r1445b695],
32	3	CD	NUMBER	3	number	33	SENT_408	[p12l1420t659r1445b695],
33	8	CD	NUMBER	8	num	34	SENT_408	[p12l1451t659r1488b695],
34	)	NN	O	)	dobj	31	SENT_408	[p12l1451t659r1488b695],
35	.	.	O	.	_	0	SENT_408	[p12l1451t659r1488b695],

1	Larger	JJR	O	larger	amod	2	SENT_409	[p12l1503t659r1611b697],
2	studies	NNS	O	study	nsubjpass	17	SENT_409	[p12l1624t658r1730b687],
3	of	IN	O	of	_	0	SENT_409	[p12l1745t658r1779b687],
4	these	DT	O	these	det	5	SENT_409	[p12l1789t658r1869b687],
5	agents	NNS	O	agent	prep_of	2	SENT_409	[p12l1883t666r1981b697],
6	and	CC	O	and	_	0	SENT_409	[p12l1996t658r2052b687],
7	an	DT	O	a	det	8	SENT_409	[p12l2066t669r2102b687],
8	exploration	NN	O	exploration	conj_and	2	SENT_409	[p12l584t722r762b761],
9	of	IN	O	of	_	0	SENT_409	[p12l778t722r812b751],
10	the	DT	O	the	det	13	SENT_409	[p12l823t722r872b751],
11	sundry	JJ	O	sundry	amod	13	SENT_409	[p12l888t722r995b761],
12	combination	NN	O	combination	nn	13	SENT_409	[p12l1010t722r1207b751],
13	options	NNS	O	option	prep_of	8	SENT_409	[p12l1223t723r1339b761],
14	now	RB	DATE	now	advmod	15	SENT_409	[p12l1355t733r1422b751],
15	available	JJ	O	available	amod	13	SENT_409	[p12l1437t722r1570b751],
16	are	VBP	O	be	auxpass	17	SENT_409	[p12l1587t733r1633b751],
17	required	VBN	O	require	_	0	SENT_409	[p12l1649t722r1782b761],
18	to	TO	O	to	aux	19	SENT_409	[p12l1797t730r1828b751],
19	address	VB	O	address	xcomp	17	SENT_409	[p12l1845t722r1958b751],
20	the	DT	O	the	det	22	SENT_409	[p12l1975t722r2023b751],
21	best	JJS	O	best	amod	22	SENT_409	[p12l2039t722r2102b751],
22	approaches	NNS	O	approach	dobj	19	SENT_409	[p12l584t772r758b810],
23	for	IN	O	for	_	0	SENT_409	[p12l770t772r815b801],
24	including	VBG	O	include	prepc_for	19	SENT_409	[p12l824t771r973b810],
25	integrase	NN	O	integrase	nn	26	SENT_409	[p12l982t773r1124b810],
26	inhibitors	NNS	O	inhibitor	dobj	24	SENT_409	[p12l1134t772r1286b801],
27	in	IN	O	in	_	0	SENT_409	[p12l1297t773r1327b800],
28	an	DT	O	a	det	30	SENT_409	[p12l1338t782r1374b801],
29	overall	JJ	O	overall	amod	30	SENT_409	[p12l1385t772r1490b801],
30	strategy	NN	O	strategy	prep_in	24	SENT_409	[p12l1500t780r1625b810],
31	for	IN	O	for	_	0	SENT_409	[p12l1634t772r1679b801],
32	managing	VBG	O	manage	amod	34	SENT_409	[p12l1689t773r1844b810],
33	lifelong	JJ	O	lifelong	amod	34	SENT_409	[p12l1853t771r1974b810],
34	therapy	NN	O	therapy	prep_for	30	SENT_409	[p12l1983t772r2103b810],
35	for	IN	O	for	_	0	SENT_409	[p12l584t821r629b850],
36	HIV-1	NN	MISC	hiv-1	nn	38	SENT_409	[p12l639t823r740b850],
37	infected	JJ	O	infected	amod	38	SENT_409	[p12l754t821r879b850],
38	patients	NNS	O	patient	prep_for	34	SENT_409	[p12l890t823r1021b860],
39	.	.	O	.	_	0	SENT_409	[p12l890t823r1021b860],

1	Finally	RB	O	finally	advmod	26	SENT_410	[p12l634t871r747b910],
2	,	,	O	,	_	0	SENT_410	[p12l634t871r747b910],
3	given	VBN	O	give	prep	26	SENT_410	[p12l762t873r846b910],
4	the	DT	O	the	det	6	SENT_410	[p12l859t871r908b900],
5	continuing	VBG	O	continue	amod	6	SENT_410	[p12l923t873r1093b910],
6	success	NN	O	success	dep	3	SENT_410	[p12l1106t882r1216b900],
7	of	IN	O	of	_	0	SENT_410	[p12l1231t871r1265b900],
8	antiretroviral	JJ	O	antiretroviral	amod	9	SENT_410	[p12l1275t871r1481b900],
9	therapy	NN	O	therapy	prep_of	6	SENT_410	[p12l1495t871r1619b910],
10	,	,	O	,	_	0	SENT_410	[p12l1495t871r1619b910],
11	a	DT	O	a	det	13	SENT_410	[p12l1634t882r1649b900],
12	better	JJR	O	better	amod	13	SENT_410	[p12l1663t871r1756b900],
13	understanding	NN	O	understanding	nsubjpass	26	SENT_410	[p12l1768t871r1996b910],
14	of	IN	O	of	_	0	SENT_410	[p12l2009t871r2043b900],
15	the	DT	O	the	det	18	SENT_410	[p12l2052t871r2101b900],
16	potential	JJ	O	potential	amod	18	SENT_410	[p12l583t921r723b959],
17	pharmacologic	JJ	O	pharmacologic	amod	18	SENT_410	[p12l734t921r966b960],
18	implications	NNS	O	implication	prep_of	13	SENT_410	[p12l978t921r1169b959],
19	and	CC	O	and	_	0	SENT_410	[p12l1182t921r1237b950],
20	complications	NNS	O	complication	conj_and	13	SENT_410	[p12l1250t921r1467b959],
21	in	IN	O	in	_	0	SENT_410	[p12l1478t923r1509b950],
22	an	DT	O	a	det	24	SENT_410	[p12l1521t932r1557b950],
23	aging	VBG	O	age	amod	24	SENT_410	[p12l1569t923r1654b960],
24	population	NN	O	population	prep_in	20	SENT_410	[p12l1665t921r1835b959],
25	is	VBZ	O	be	auxpass	26	SENT_410	[p12l1846t923r1869b950],
26	needed	VBN	O	need	_	0	SENT_410	[p12l1880t921r2001b956],
27	,	,	O	,	_	0	SENT_410	[p12l1880t921r2001b956],
28	as	RB	O	as	advmod	30	SENT_410	[p12l2014t932r2042b950],
29	are	VBP	O	be	cop	30	SENT_410	[p12l2055t932r2101b950],
30	studies	NNS	O	study	dep	26	SENT_410	[p12l584t971r690b1000],
31	in	IN	O	in	_	0	SENT_410	[p12l704t972r735b999],
32	a	DT	O	a	det	33	SENT_410	[p12l750t982r764b1000],
33	variety	NN	O	variety	prep_in	30	SENT_410	[p12l777t972r886b1009],
34	of	IN	O	of	_	0	SENT_410	[p12l899t971r933b1000],
35	special	JJ	O	special	amod	36	SENT_410	[p12l944t971r1048b1009],
36	populations	NNS	O	population	prep_of	33	SENT_410	[p12l1062t971r1245b1009],
37	such	JJ	O	such	_	0	SENT_410	[p12l1260t971r1330b1000],
38	as	IN	O	as	_	0	SENT_410	[p12l1345t982r1373b1000],
39	hepatitis	NN	O	hepatitis	nn	41	SENT_410	[p12l1388t971r1520b1009],
40	C	NN	O	c	nn	41	SENT_410	[p12l1536t972r1562b1000],
41	virus	NN	O	virus	prep_such_as	36	SENT_410	[p12l1576t972r1651b1000],
42	(	CD	NUMBER	(	num	44	SENT_410	[p12l1667t971r1955b1007],
43	HCV	NN	O	hcv	nn	44	SENT_410	[p12l1667t971r1955b1007],
44	)	NN	O	)	nsubj	30	SENT_410	[p12l1667t971r1955b1007],
45	.	.	O	.	_	0	SENT_410	[p12l1667t971r1955b1007],

1	—	NN	O	—	_	0	SENT_411	[p12l1667t971r1955b1007],
2	.	.	O	.	_	0	SENT_411	[p12l1667t971r1955b1007],

1	coinfected	VBN	O	coinfect	_	0	SENT_412	[p12l1667t971r1955b1007],
2	patients	NNS	O	patient	dobj	1	SENT_412	[p12l1969t972r2100b1009],
3	,	,	O	,	_	0	SENT_412	[p12l1969t972r2100b1009],
4	ethnic	JJ	O	ethnic	amod	5	SENT_412	[p12l584t1021r681b1050],
5	minorities	NNS	O	minority	dobj	1	SENT_412	[p12l692t1022r860b1056],
6	,	,	O	,	_	0	SENT_412	[p12l692t1022r860b1056],
7	and	CC	O	and	_	0	SENT_412	[p12l874t1020r929b1050],
8	women	NNS	O	woman	dobj	1	SENT_412	[p12l940t1031r1063b1050],
9	.	.	O	.	_	0	SENT_412	[p12l940t1031r1063b1050],

1	In	IN	O	in	_	0	SENT_413	[p12l1076t1022r1110b1049],
2	addition	NN	O	addition	prep_in	21	SENT_413	[p12l1122t1021r1259b1056],
3	,	,	O	,	_	0	SENT_413	[p12l1122t1021r1259b1056],
4	an	DT	O	a	det	5	SENT_413	[p12l1273t1031r1308b1050],
5	exploration	NN	O	exploration	nsubj	21	SENT_413	[p12l1320t1020r1498b1059],
6	of	IN	O	of	_	0	SENT_413	[p12l1510t1021r1544b1050],
7	drug	NN	O	drug	nn	8	SENT_413	[p12l1552t1021r1625b1059],
8	penetration	NN	O	penetration	prep_of	5	SENT_413	[p12l1635t1022r1817b1059],
9	in	IN	O	in	_	0	SENT_413	[p12l1828t1022r1859b1049],
10	potential	JJ	O	potential	amod	12	SENT_413	[p12l1870t1020r2009b1059],
11	sanctuary	NN	O	sanctuary	nn	12	SENT_413	[p12l2021t1031r2101b1050, p12l584t1079r665b1109],
12	sites	NNS	O	site	prep_in	8	SENT_413	[p12l676t1072r750b1106],
13	,	,	O	,	_	0	SENT_413	[p12l676t1072r750b1106],
14	reservoirs	NNS	O	reservoir	prep_in	8	SENT_413	[p12l763t1072r923b1106],
15	,	,	O	,	_	0	SENT_413	[p12l763t1072r923b1106],
16	and	CC	O	and	_	0	SENT_413	[p12l937t1070r992b1099],
17	different	JJ	O	different	amod	19	SENT_413	[p12l1005t1070r1140b1099],
18	cell	NN	O	cell	nn	19	SENT_413	[p12l1151t1070r1204b1099],
19	types	NNS	O	type	prep_in	8	SENT_413	[p12l1215t1079r1295b1109],
20	is	VBZ	O	be	aux	21	SENT_413	[p12l1306t1072r1329b1099],
21	becoming	VBG	O	become	_	0	SENT_413	[p12l1341t1070r1496b1109],
22	an	DT	O	a	det	23	SENT_413	[p12l1507t1081r1543b1099],
23	area	NN	O	area	attr	21	SENT_413	[p12l1555t1081r1618b1099],
24	of	IN	O	of	_	0	SENT_413	[p12l1630t1070r1664b1099],
25	growing	VBG	O	grow	amod	26	SENT_413	[p12l1672t1072r1802b1109],
26	interest	NN	O	interest	prep_of	23	SENT_413	[p12l1812t1072r1931b1099],
27	for	IN	O	for	_	0	SENT_413	[p12l1942t1070r1987b1099],
28	HIV-1	NN	O	hiv-1	nn	29	SENT_413	[p12l1998t1072r2098b1099],
29	pathogenesis	NN	O	pathogenesis	prep_for	26	SENT_413	[p12l583t1120r793b1159],
30	.	.	O	.	_	0	SENT_413	[p12l583t1120r793b1159],

1	Although	IN	O	although	mark	11	SENT_414	[p12l807t1120r956b1159],
2	these	DT	O	these	det	3	SENT_414	[p12l969t1120r1049b1149],
3	data	NNS	O	datum	nsubjpass	11	SENT_414	[p12l1064t1120r1128b1149],
4	for	IN	O	for	_	0	SENT_414	[p12l1141t1120r1187b1149],
5	integrase	NN	O	integrase	nn	6	SENT_414	[p12l1200t1122r1341b1159],
6	inhibitors	NNS	O	inhibitor	prep_for	3	SENT_414	[p12l1354t1120r1506b1149],
7	in	IN	O	in	_	0	SENT_414	[p12l1520t1122r1550b1149],
8	particular	JJ	O	particular	prep_in	6	SENT_414	[p12l1564t1120r1715b1159],
9	are	VBP	O	be	auxpass	11	SENT_414	[p12l1729t1131r1775b1149],
10	currently	RB	DATE	currently	advmod	11	SENT_414	[p12l1790t1120r1934b1159],
11	limited	VBN	O	limit	advcl	14	SENT_414	[p12l1946t1120r2065b1156],
12	,	,	O	,	_	0	SENT_414	[p12l1946t1120r2065b1156],
13	it	PRP	O	it	nsubj	14	SENT_414	[p12l2080t1122r2103b1149],
14	is	VBZ	O	be	_	0	SENT_414	[p12l583t1172r606b1199],
15	in	IN	O	in	_	0	SENT_414	[p12l620t1172r651b1199],
16	general	JJ	O	general	amod	18	SENT_414	[p12l665t1170r779b1209],
17	an	DT	O	a	det	18	SENT_414	[p12l794t1181r830b1199],
18	area	NN	O	area	prep_in	14	SENT_414	[p12l844t1181r908b1199],
19	that	WDT	O	that	nsubjpass	24	SENT_414	[p12l922t1170r984b1199],
20	has	VBZ	O	have	aux	24	SENT_414	[p12l997t1170r1046b1199],
21	not	RB	O	not	neg	24	SENT_414	[p12l1060t1178r1114b1199],
22	been	VBN	O	be	auxpass	24	SENT_414	[p12l1127t1170r1201b1199],
23	extensively	RB	O	extensively	advmod	24	SENT_414	[p12l1216t1170r1387b1209],
24	studied	VBN	O	study	rcmod	18	SENT_414	[p12l1400t1170r1512b1199],
25	for	IN	O	for	_	0	SENT_414	[p12l1526t1170r1572b1199],
26	most	JJS	O	most	amod	28	SENT_414	[p12l1585t1178r1663b1199],
27	antiretroviral	JJ	O	antiretroviral	amod	28	SENT_414	[p12l1676t1170r1883b1199],
28	agents	NNS	O	agent	prep_for	24	SENT_414	[p12l1897t1178r2004b1209],
29	.	.	O	.	_	0	SENT_414	[p12l1897t1178r2004b1209],

1	With	IN	O	with	_	0	SENT_415	[p12l2019t1170r2102b1199],
2	the	DT	O	the	det	4	SENT_415	[p12l584t1220r632b1249],
3	new	JJ	O	new	amod	4	SENT_415	[p12l644t1231r709b1249],
4	options	NNS	O	option	prep_with	33	SENT_415	[p12l720t1221r836b1258],
5	available	JJ	O	available	amod	4	SENT_415	[p12l849t1220r982b1249],
6	for	IN	O	for	_	0	SENT_415	[p12l995t1220r1040b1249],
7	the	DT	O	the	det	8	SENT_415	[p12l1052t1220r1100b1249],
8	treatment	NN	O	treatment	prep_for	5	SENT_415	[p12l1113t1228r1267b1249],
9	of	IN	O	of	_	0	SENT_415	[p12l1279t1220r1313b1249],
10	HIV-1	NN	MISC	hiv-1	nn	11	SENT_415	[p12l1321t1221r1421b1249],
11	infection	NN	O	infection	prep_of	8	SENT_415	[p12l1436t1220r1584b1255],
12	,	,	O	,	_	0	SENT_415	[p12l1436t1220r1584b1255],
13	the	DT	O	the	det	14	SENT_415	[p12l1598t1220r1646b1249],
14	question	NN	O	question	nsubj	33	SENT_415	[p12l1659t1221r1792b1258],
15	of	IN	O	of	_	0	SENT_415	[p12l1805t1220r1839b1249],
16	whether	IN	O	whether	complm	23	SENT_415	[p12l1845t1220r1975b1249],
17	speciﬁc	NN	O	speciﬁc	nn	18	SENT_415	[p12l1987t1220r2102b1258],
18	drugs	NNS	O	drug	nsubj	23	SENT_415	[p12l584t1269r670b1308],
19	or	CC	O	or	_	0	SENT_415	[p12l683t1280r716b1298],
20	drug	NN	O	drug	nn	21	SENT_415	[p12l728t1269r801b1308],
21	classes	NNS	O	class	conj_or	18	SENT_415	[p12l813t1269r913b1298],
22	may	MD	O	may	aux	23	SENT_415	[p12l926t1280r992b1308],
23	offer	VB	O	offer	prepc_of	14	SENT_415	[p12l1003t1269r1077b1298],
24	advantages	NNS	O	advantage	dobj	23	SENT_415	[p12l1089t1269r1257b1308],
25	relative	JJ	O	relative	advmod	23	SENT_415	[p12l1270t1269r1384b1298],
26	to	TO	O	to	_	0	SENT_415	[p12l1397t1277r1428b1298],
27	these	DT	O	these	det	29	SENT_415	[p12l1440t1269r1520b1298],
28	pharmacologic	JJ	O	pharmacologic	amod	29	SENT_415	[p12l1532t1269r1765b1308],
29	features	NNS	O	feature	prep_to	25	SENT_415	[p12l1777t1269r1899b1298],
30	has	VBZ	O	have	aux	33	SENT_415	[p12l1911t1269r1960b1298],
31	now	RB	DATE	now	advmod	33	SENT_415	[p12l1973t1280r2040b1298],
32	become	VBN	O	become	cop	33	SENT_415	[p12l2051t1269r2101b1298, p12l584t1330r667b1348],
33	one	CD	NUMBER	one	_	0	SENT_415	[p12l680t1330r736b1348],
34	of	IN	O	of	_	0	SENT_415	[p12l750t1319r784b1348],
35	increasing	VBG	O	increase	amod	36	SENT_415	[p12l792t1321r953b1358],
36	relevance	NN	O	relevance	prep_of	33	SENT_415	[p12l964t1319r1110b1348],
37	with	IN	O	with	_	0	SENT_415	[p12l1122t1319r1192b1348],
38	potentially	RB	O	potentially	advmod	39	SENT_415	[p12l1204t1319r1374b1358],
39	important	JJ	O	important	amod	41	SENT_415	[p12l1384t1321r1543b1357],
40	clinical	JJ	O	clinical	amod	41	SENT_415	[p12l1555t1319r1665b1348],
41	consequences	NNS	O	consequence	prep_with	36	SENT_415	[p12l1678t1330r1890b1357],
42	that	WDT	O	that	nsubjpass	45	SENT_415	[p12l1903t1319r1965b1348],
43	must	MD	O	must	aux	45	SENT_415	[p12l1977t1327r2054b1348],
44	be	VB	O	be	auxpass	45	SENT_415	[p12l2066t1319r2101b1348],
45	explored	VBN	O	explore	rcmod	36	SENT_415	[p12l584t1369r718b1407],
46	for	IN	O	for	_	0	SENT_415	[p12l728t1369r774b1398],
47	integrase	NN	O	integrase	nn	48	SENT_415	[p12l782t1370r923b1407],
48	inhibitors	NNS	O	inhibitor	prep_for	45	SENT_415	[p12l933t1369r1085b1398],
49	as	RB	O	as	_	0	SENT_415	[p12l1095t1380r1123b1398],
50	well	RB	O	well	_	0	SENT_415	[p12l1132t1369r1197b1398],
51	as	IN	O	as	_	0	SENT_415	[p12l1206t1380r1235b1398],
52	all	DT	O	all	det	54	SENT_415	[p12l1245t1369r1281b1398],
53	other	JJ	O	other	amod	54	SENT_415	[p12l1290t1369r1374b1398],
54	antiretrovirals	NNS	O	antiretroviral	conj_and	33	SENT_415	[p12l1384t1369r1603b1398],
55	that	WDT	O	that	nsubj	58	SENT_415	[p12l1614t1369r1675b1398],
56	are	VBP	O	be	cop	58	SENT_415	[p12l1684t1380r1730b1398],
57	the	DT	O	the	det	58	SENT_415	[p12l1740t1369r1789b1398],
58	mainstay	NN	O	mainstay	rcmod	54	SENT_415	[p12l1799t1370r1939b1407],
59	of	IN	O	of	_	0	SENT_415	[p12l1947t1369r1981b1398],
60	current	JJ	DATE	current	amod	61	SENT_415	[p12l1987t1377r2103b1398],
61	therapy	NN	O	therapy	prep_of	58	SENT_415	[p12l584t1418r707b1457],
62	.	.	O	.	_	0	SENT_415	[p12l584t1418r707b1457],

1	DISCLOSURE	NN	O	disclosure	nn	2	SENT_416	[p12l584t1575r875b1606],
2	STATEMENT	NN	O	statement	_	0	SENT_416	[p12l888t1574r1172b1606],

1	All	DT	O	all	det	2	SENT_417	[p12l582t1643r628b1672],
2	authors	NNS	O	author	nsubjpass	11	SENT_417	[p12l639t1643r755b1672],
3	are	VBP	O	be	auxpass	4	SENT_417	[p12l767t1654r813b1672],
4	employed	VBN	O	employ	_	0	SENT_417	[p12l824t1643r976b1682],
5	by	IN	O	by	_	0	SENT_417	[p12l987t1643r1025b1682],
6	Merck	NNP	ORGANIZATION	Merck	agent	4	SENT_417	[p12l1033t1643r1138b1672],
7	and	CC	ORGANIZATION	and	_	0	SENT_417	[p12l1147t1643r1203b1672],
8	Co.	NNP	ORGANIZATION	Co.	agent	4	SENT_417	[p12l1214t1644r1268b1672],
9	and	CC	O	and	_	0	SENT_417	[p12l1281t1643r1337b1672],
10	were	VBD	O	be	auxpass	11	SENT_417	[p12l1346t1654r1421b1672],
11	involved	VBN	O	involve	conj_and	4	SENT_417	[p12l1432t1643r1564b1672],
12	in	IN	O	in	_	0	SENT_417	[p12l1574t1645r1605b1672],
13	the	DT	O	the	det	14	SENT_417	[p12l1615t1643r1664b1672],
14	discovery	NN	O	discovery	prep_in	11	SENT_417	[p12l1676t1643r1823b1682],
15	and	CC	O	and	_	0	SENT_417	[p12l1833t1643r1888b1672],
16	development	NN	O	development	conj_and	14	SENT_417	[p12l1900t1643r2103b1682],
17	of	IN	O	of	_	0	SENT_417	[p12l584t1693r618b1722],
18	raltegravir	NN	O	raltegravir	prep_of	14	SENT_417	[p12l625t1693r794b1732],
19	.	.	O	.	_	0	SENT_417	[p12l625t1693r794b1732],

1	LITERATURE	NN	O	literature	nsubj	2	SENT_418	[p12l583t1849r847b1878],
2	CITED	VBD	O	cite	_	0	SENT_418	[p12l859t1849r990b1878],

1	1	LS	NUMBER	1	_	0	SENT_419	[p12l619t1923r639b1947],
2	.	.	O	.	_	0	SENT_419	[p12l619t1923r639b1947],

1	Epidemiology	NNP	O	Epidemiology	_	0	SENT_420	[p12l658t1921r856b1956],
2	of	IN	O	of	_	0	SENT_420	[p12l865t1921r895b1947],
3	HIV/AIDS	NNPS	O	HIV/AIDS	prep_of	1	SENT_420	[p12l901t1921r1192b1947],
4	.	.	O	.	_	0	SENT_420	[p12l901t1921r1192b1947],

1	—	NN	O	—	_	0	SENT_421	[p12l901t1921r1192b1947],
2	.	.	O	.	_	0	SENT_421	[p12l901t1921r1192b1947],

1	United	NNP	LOCATION	United	nn	2	SENT_422	[p12l901t1921r1192b1947],
2	States	NNPS	LOCATION	States	_	0	SENT_422	[p12l1203t1922r1291b1953],
3	,	,	O	,	_	0	SENT_422	[p12l1203t1922r1291b1953],
4	1981-2005	CD	DATE	1981-2005	appos	2	SENT_422	[p12l1305t1922r1462b1947],
5	.	.	O	.	_	0	SENT_422	[p12l1305t1922r1462b1947],

1	2006	CD	DATE	2006	_	0	SENT_423	[p12l1474t1923r1548b1947],
2	.	.	O	.	_	0	SENT_423	[p12l1474t1923r1548b1947],

1	MM	NN	O	mm	nn	2	SENT_424	[p12l1558t1922r1624b1947],
2	WR	NN	O	wr	_	0	SENT_424	[p12l1625t1922r1675b1947],
3	55	CD	NUMBER	55	num	4	SENT_424	[p12l1687t1922r1716b1947],
4	(	NN	O	(	dep	2	SENT_424	[p12l1720t1922r1743b1954],
5	2	CD	NUMBER	2	number	6	SENT_424	[p12l1720t1922r1743b1954],
6	1	CD	NUMBER	1	num	7	SENT_424	[p12l1750t1922r1798b1954],
7	)	NN	O	)	dep	4	SENT_424	[p12l1750t1922r1798b1954],
8	:5	CD	NUMBER	:5	num	9	SENT_424	[p12l1750t1922r1798b1954],
9	89-92	CD	NUMBER	89-92	dep	2	SENT_424	[p12l1802t1923r1883b1947],
10	2	CD	NUMBER	2	dep	9	SENT_424	[p12l616t1969r639b1993],
11	.	.	O	.	_	0	SENT_424	[p12l616t1969r639b1993],

1	Palella	NNP	PERSON	Palella	_	0	SENT_425	[p12l658t1967r750b1993],
2	F	NN	O	f	nn	4	SENT_425	[p12l764t1968r794b2000],
3	]	CD	NUMBER	]	num	4	SENT_425	[p12l764t1968r794b2000],
4	Jr	NNP	O	Jr	dep	1	SENT_425	[p12l804t1968r840b2000],
5	,	,	O	,	_	0	SENT_425	[p12l804t1968r840b2000],
6	Delaney	NNP	ORGANIZATION	Delaney	nn	7	SENT_425	[p12l855t1967r971b2002],
7	KM	NNP	ORGANIZATION	KM	appos	4	SENT_425	[p12l983t1968r1046b1999],
8	,	,	O	,	_	0	SENT_425	[p12l983t1968r1046b1999],
9	Moorman	NNP	ORGANIZATION	Moorman	nn	10	SENT_425	[p12l1060t1968r1201b1993],
10	AC	NN	ORGANIZATION	ac	appos	4	SENT_425	[p12l1213t1968r1268b1999],
11	,	,	O	,	_	0	SENT_425	[p12l1213t1968r1268b1999],
12	Loveless	JJ	LOCATION	loveless	amod	13	SENT_425	[p12l1283t1967r1402b1993],
13	MO	NNP	LOCATION	MO	appos	4	SENT_425	[p12l1414t1968r1481b1999],
14	,	,	O	,	_	0	SENT_425	[p12l1414t1968r1481b1999],
15	Fuhrer	NNP	O	Fuhrer	nn	16	SENT_425	[p12l1496t1967r1624b2000],
16	]	NNP	O	]	appos	4	SENT_425	[p12l1496t1967r1624b2000],
17	,	,	O	,	_	0	SENT_425	[p12l1496t1967r1624b2000],
18	et	FW	O	et	nn	19	SENT_425	[p12l1639t1975r1665b1993],
19	al.	FW	O	al.	appos	4	SENT_425	[p12l1678t1967r1707b1993],
20	1998	CD	DATE	1998	dep	19	SENT_425	[p12l1725t1969r1797b1994],
21	.	.	O	.	_	0	SENT_425	[p12l1725t1969r1797b1994],

1	Declining	VBG	O	decline	amod	2	SENT_426	[p12l1812t1967r1951b2002],
2	morbidity	NN	O	morbidity	_	0	SENT_426	[p12l1963t1967r2103b2002],
3	and	CC	O	and	_	0	SENT_426	[p12l658t2013r708b2039],
4	mortality	NN	O	mortality	conj_and	2	SENT_426	[p12l717t2013r847b2047],
5	among	IN	O	among	_	0	SENT_426	[p12l855t2022r950b2047],
6	patients	NNS	O	patient	prep_among	4	SENT_426	[p12l959t2014r1067b2047],
7	with	IN	O	with	_	0	SENT_426	[p12l1076t2013r1138b2039],
8	advanced	JJ	O	advanced	amod	12	SENT_426	[p12l1148t2013r1275b2039],
9	human	JJ	O	human	amod	12	SENT_426	[p12l1284t2013r1381b2039],
10	immunodeﬁciency	NN	O	immunodeﬁciency	nn	12	SENT_426	[p12l1389t2013r1649b2047],
11	virus	NN	O	virus	nn	12	SENT_426	[p12l1656t2014r1723b2039],
12	infection	NN	O	infection	prep_with	6	SENT_426	[p12l1733t2013r1864b2039],
13	.	.	O	.	_	0	SENT_426	[p12l1733t2013r1864b2039],

1	HIV	NN	O	hiv	_	0	SENT_427	[p12l1874t2014r1941b2039],
2	Outpatient	NN	O	outpatient	nn	3	SENT_427	[p12l1949t2014r2103b2047],
3	Study	NN	O	study	dep	1	SENT_427	[p12l659t2058r745b2092],
4	.	.	O	.	_	0	SENT_427	[p12l659t2058r745b2092],

1	N.	NNP	O	N.	nn	2	SENT_428	[p12l755t2059r787b2084],
2	Engl	NNP	O	Engl	_	0	SENT_428	[p12l798t2059r866b2093],
3	.	.	O	.	_	0	SENT_428	[p12l798t2059r866b2093],

1	pa	NN	O	pa	_	0	SENT_429	[p12l874t2058r899b2092],
2	:	:	O	:	_	0	SENT_429	[p12l874t2058r899b2092],
3	F	NN	O	f	dep	1	SENT_429	[p12l874t2058r899b2092],
4	+	CC	O	+	_	0	SENT_429	[p12l874t2058r899b2092],
5	Med	NNP	O	Med	dep	1	SENT_429	[p12l910t2059r976b2084],
6	.	.	O	.	_	0	SENT_429	[p12l910t2059r976b2084],

1	338	CD	NUMBER	338	number	2	SENT_430	[p12l990t2059r1205b2090],
2	(	CD	NUMBER	(	_	0	SENT_430	[p12l990t2059r1205b2090],
3	13	CD	NUMBER	13	num	4	SENT_430	[p12l990t2059r1205b2090],
4	)	NN	O	)	dep	2	SENT_430	[p12l990t2059r1205b2090],
5	:853	CD	NUMBER	:853	number	6	SENT_430	[p12l990t2059r1205b2090],
6	—	CD	NUMBER	—	dep	2	SENT_430	[p12l990t2059r1205b2090],
7	60	CD	NUMBER	60	num	8	SENT_430	[p12l990t2059r1205b2090],
8	3	CD	NUMBER	3	dep	6	SENT_430	[p12l617t2105r639b2129],
9	.	.	O	.	_	0	SENT_430	[p12l617t2105r639b2129],

1	Autran	NN	PERSON	autran	nn	2	SENT_431	[p12l657t2104r754b2129],
2	B	NN	O	b	_	0	SENT_431	[p12l762t2104r790b2135],
3	,	,	O	,	_	0	SENT_431	[p12l762t2104r790b2135],
4	Carcelain	NNP	O	Carcelain	nn	5	SENT_431	[p12l800t2103r933b2129],
5	G	NNP	O	G	appos	2	SENT_431	[p12l941t2104r974b2135],
6	,	,	O	,	_	0	SENT_431	[p12l941t2104r974b2135],
7	Li	NNP	PERSON	Li	nn	8	SENT_431	[p12l984t2104r1014b2129],
8	TS	NN	O	t	appos	2	SENT_431	[p12l1022t2104r1073b2135],
9	,	,	O	,	_	0	SENT_431	[p12l1022t2104r1073b2135],
10	Blanc	NNP	PERSON	Blanc	nn	11	SENT_431	[p12l1083t2103r1160b2129],
11	C	NNP	O	C	appos	2	SENT_431	[p12l1169t2104r1199b2135],
12	,	,	O	,	_	0	SENT_431	[p12l1169t2104r1199b2135],
13	Mathez	NNP	PERSON	Mathez	nn	14	SENT_431	[p12l1207t2103r1314b2129],
14	D	NNP	O	D	appos	2	SENT_431	[p12l1322t2104r1356b2135],
15	,	,	O	,	_	0	SENT_431	[p12l1322t2104r1356b2135],
16	et	FW	O	et	nn	17	SENT_431	[p12l1365t2111r1391b2129],
17	al.	FW	O	al.	appos	2	SENT_431	[p12l1399t2103r1428b2129],
18	1997	CD	DATE	1997	dep	17	SENT_431	[p12l1441t2104r1512b2130],
19	.	.	O	.	_	0	SENT_431	[p12l1441t2104r1512b2130],

1	Positive	JJ	O	positive	amod	2	SENT_432	[p12l1522t2104r1632b2129],
2	effects	NNS	O	effect	_	0	SENT_432	[p12l1641t2103r1728b2129],
3	of	IN	O	of	_	0	SENT_432	[p12l1737t2103r1768b2129],
4	combined	JJ	O	combined	amod	6	SENT_432	[p12l1772t2103r1909b2129],
5	andretroviral	JJ	O	andretroviral	amod	6	SENT_432	[p12l1918t2103r2102b2129],
6	therapy	NN	O	therapy	prep_of	2	SENT_432	[p12l658t2148r765b2183],
7	on	IN	O	on	_	0	SENT_432	[p12l773t2158r808b2174],
8	CD4	NN	O	cd4	prep_on	2	SENT_432	[p12l819t2149r912b2177],
9	+	CC	O	+	_	0	SENT_432	[p12l819t2149r912b2177],
10	T	NN	O	t	nn	12	SENT_432	[p12l922t2149r948b2174],
11	cell	NN	O	cell	nn	12	SENT_432	[p12l957t2148r1004b2174],
12	homeostasis	NN	O	homeostasis	conj_+	8	SENT_432	[p12l1014t2148r1182b2174],
13	and	CC	O	and	_	0	SENT_432	[p12l1192t2148r1241b2174],
14	function	NN	O	function	prep_on	2	SENT_432	[p12l1252t2148r1368b2174],
15	in	IN	O	in	_	0	SENT_432	[p12l1378t2150r1405b2174],
16	advanced	JJ	O	advanced	amod	18	SENT_432	[p12l1415t2148r1542b2174],
17	HIV	NN	MISC	hiv	nn	18	SENT_432	[p12l1552t2149r1619b2174],
18	disease	NN	O	disease	prep_in	14	SENT_432	[p12l1627t2148r1729b2174],
19	.	.	O	.	_	0	SENT_432	[p12l1627t2148r1729b2174],

1	Silence	NN	O	silence	_	0	SENT_433	[p12l1741t2149r1830b2174],
2	277	CD	NUMBER	277	number	3	SENT_433	[p12l1840t2149r2091b2181],
3	(	CD	NUMBER	(	dep	1	SENT_433	[p12l1840t2149r2091b2181],
4	5322	CD	NUMBER	5322	num	5	SENT_433	[p12l1840t2149r2091b2181],
5	)	CD	NUMBER	)	dep	3	SENT_433	[p12l1840t2149r2091b2181],
6	:112	CD	NUMBER	:112	num	7	SENT_433	[p12l1840t2149r2091b2181],
7	—	NN	O	—	dep	1	SENT_433	[p12l1840t2149r2091b2181],
8	16	CD	NUMBER	16	number	9	SENT_433	[p12l1840t2149r2091b2181],
9	4	CD	NUMBER	4	dep	7	SENT_433	[p12l615t2195r639b2220],
10	.	.	O	.	_	0	SENT_433	[p12l615t2195r639b2220],

1	Pakker	NNP	O	Pakker	nn	2	SENT_434	[p12l658t2194r754b2220],
2	NG	NNP	O	NG	_	0	SENT_434	[p12l760t2195r823b2226],
3	,	,	O	,	_	0	SENT_434	[p12l760t2195r823b2226],
4	Notermans	NNP	PERSON	Notermans	nn	5	SENT_434	[p12l831t2195r989b2220],
5	DW	NNP	O	DW	appos	2	SENT_434	[p12l997t2195r1067b2226],
6	,	,	O	,	_	0	SENT_434	[p12l997t2195r1067b2226],
7	de	FW	PERSON	de	nn	10	SENT_434	[p12l1075t2194r1106b2220],
8	Boer	FW	PERSON	boer	nn	10	SENT_434	[p12l1114t2195r1180b2220],
9	R	NN	O	r	nn	10	SENT_434	[p12l1187t2195r1228b2226],
10	]	NN	O	]	appos	2	SENT_434	[p12l1187t2195r1228b2226],
11	,	,	O	,	_	0	SENT_434	[p12l1187t2195r1228b2226],
12	Roos	NNP	PERSON	Roos	nn	13	SENT_434	[p12l1237t2195r1306b2220],
13	MT	NNP	O	MT	appos	2	SENT_434	[p12l1312t2194r1377b2226],
14	,	,	O	,	_	0	SENT_434	[p12l1312t2194r1377b2226],
15	de	NNP	O	de	nn	17	SENT_434	[p12l1386t2194r1417b2220],
16	Wolf	NNP	O	Wolf	nn	17	SENT_434	[p12l1423t2194r1498b2220],
17	F	NN	O	f	appos	2	SENT_434	[p12l1501t2195r1527b2226],
18	,	,	O	,	_	0	SENT_434	[p12l1501t2195r1527b2226],
19	et	FW	O	et	nn	20	SENT_434	[p12l1536t2201r1561b2220],
20	al.	FW	O	al.	appos	2	SENT_434	[p12l1568t2194r1597b2220],
21	1998	CD	DATE	1998	dep	20	SENT_434	[p12l1609t2195r1680b2220],
22	.	.	O	.	_	0	SENT_434	[p12l1609t2195r1680b2220],

1	Biphasic	JJ	MISC	biphasic	amod	2	SENT_435	[p12l1689t2194r1806b2228],
2	kinetics	NNS	O	kinetics	_	0	SENT_435	[p12l1812t2194r1918b2220],
3	of	IN	O	of	_	0	SENT_435	[p12l1925t2194r1956b2220],
4	peripheral	JJ	O	peripheral	amod	7	SENT_435	[p12l1959t2194r2101b2228],
5	blood	NN	O	blood	nn	7	SENT_435	[p12l658t2239r737b2265],
6	T	NN	O	t	nn	7	SENT_435	[p12l750t2240r776b2264],
7	cells	NNS	O	cell	prep_of	2	SENT_435	[p12l789t2239r848b2265],
8	after	IN	O	after	_	0	SENT_435	[p12l862t2239r925b2265],
9	triple	JJ	O	triple	amod	11	SENT_435	[p12l938t2239r1012b2273],
10	combination	NN	O	combination	nn	11	SENT_435	[p12l1026t2239r1202b2265],
11	therapy	NN	O	therapy	prep_after	7	SENT_435	[p12l1215t2239r1321b2273],
12	in	IN	O	in	_	0	SENT_435	[p12l1333t2240r1360b2264],
13	HIV-1	NN	O	hiv-1	nn	14	SENT_435	[p12l1373t2240r1462b2265],
14	infection	NN	O	infection	prep_in	11	SENT_435	[p12l1478t2239r1609b2265],
15	:	:	O	:	_	0	SENT_435	[p12l1478t2239r1609b2265],
16	a	DT	O	a	det	17	SENT_435	[p12l1624t2249r1637b2265],
17	composite	NN	O	composite	dep	2	SENT_435	[p12l1651t2240r1793b2273],
18	of	IN	O	of	_	0	SENT_435	[p12l1807t2239r1837b2265],
19	redistribution	NN	O	redistribution	prep_of	17	SENT_435	[p12l1846t2239r2039b2265],
20	and	CC	O	and	_	0	SENT_435	[p12l2052t2239r2101b2265],
21	proliferation	NN	O	proliferation	prep_of	17	SENT_435	[p12l658t2284r841b2318],
22	.	.	O	.	_	0	SENT_435	[p12l658t2284r841b2318],

1	Nat	NN	PERSON	nat	_	0	SENT_436	[p12l851t2285r909b2310],
2	.	.	O	.	_	0	SENT_436	[p12l851t2285r909b2310],

1	Med	NNP	O	Med	_	0	SENT_437	[p12l919t2285r985b2310],
2	.	.	O	.	_	0	SENT_437	[p12l919t2285r985b2310],

1	4	CD	NUMBER	4	num	2	SENT_438	[p12l997t2285r1164b2316],
2	(	NN	O	(	_	0	SENT_438	[p12l997t2285r1164b2316],
3	2	CD	NUMBER	2	number	4	SENT_438	[p12l997t2285r1164b2316],
4	)	CD	NUMBER	)	dep	2	SENT_438	[p12l997t2285r1164b2316],
5	:208	CD	NUMBER	:208	num	6	SENT_438	[p12l997t2285r1164b2316],
6	—	NN	O	—	dep	2	SENT_438	[p12l997t2285r1164b2316],
7	14	CD	NUMBER	14	number	8	SENT_438	[p12l997t2285r1164b2316],
8	5	CD	NUMBER	5	dep	6	SENT_438	[p12l617t2330r639b2356],
9	.	.	O	.	_	0	SENT_438	[p12l617t2330r639b2356],

1	Wong	NNP	PERSON	Wong	_	0	SENT_439	[p12l657t2330r798b2364],
2	]	CD	NUMBER	]	num	1	SENT_439	[p12l657t2330r798b2364],
3	K	NNP	O	K	dep	1	SENT_439	[p12l657t2330r798b2364],
4	,	,	O	,	_	0	SENT_439	[p12l657t2330r798b2364],
5	Giinthard	NNP	O	Giinthard	nn	6	SENT_439	[p12l811t2329r947b2355],
6	HF	NN	O	hf	appos	3	SENT_439	[p12l958t2330r1014b2361],
7	,	,	O	,	_	0	SENT_439	[p12l958t2330r1014b2361],
8	Havlir	NNP	PERSON	Havlir	nn	9	SENT_439	[p12l1025t2329r1115b2355],
9	DV	NNP	O	DV	appos	3	SENT_439	[p12l1126t2330r1184b2361],
10	,	,	O	,	_	0	SENT_439	[p12l1126t2330r1184b2361],
11	Zhang	NNP	PERSON	Zhang	nn	12	SENT_439	[p12l1196t2329r1287b2364],
12	ZQ	NNP	O	ZQ	appos	3	SENT_439	[p12l1297t2329r1354b2361],
13	,	,	O	,	_	0	SENT_439	[p12l1297t2329r1354b2361],
14	Haase	NNP	PERSON	Haase	nn	15	SENT_439	[p12l1366t2330r1450b2355],
15	AT	NNP	O	AT	appos	3	SENT_439	[p12l1460t2330r1512b2361],
16	,	,	O	,	_	0	SENT_439	[p12l1460t2330r1512b2361],
17	et	FW	O	et	nn	18	SENT_439	[p12l1525t2337r1550b2355],
18	al.	FW	O	al.	appos	3	SENT_439	[p12l1561t2329r1590b2355],
19	1997	CD	DATE	1997	dep	18	SENT_439	[p12l1605t2330r1677b2356],
20	.	.	O	.	_	0	SENT_439	[p12l1605t2330r1677b2356],

1	Reduction	NN	O	reduction	_	0	SENT_440	[p12l1690t2329r1834b2355],
2	of	IN	O	of	_	0	SENT_440	[p12l1845t2329r1875b2355],
3	HIV-1	NN	O	hiv-1	prep_of	1	SENT_440	[p12l1882t2330r1971b2355],
4	in	IN	O	in	_	0	SENT_440	[p12l1985t2331r2012b2355],
5	blood	NN	O	blood	nn	8	SENT_440	[p12l2022t2329r2101b2355],
6	and	CC	O	and	_	0	SENT_440	[p12l658t2375r708b2401],
7	lymph	NN	O	lymph	nn	8	SENT_440	[p12l715t2375r804b2409],
8	nodes	NNS	O	node	prep_in	1	SENT_440	[p12l811t2375r892b2401],
9	following	VBG	O	follow	_	0	SENT_440	[p12l900t2375r1032b2409],
10	potent	JJ	O	potent	amod	12	SENT_440	[p12l1039t2382r1131b2409],
11	antiretroviral	JJ	O	antiretroviral	amod	12	SENT_440	[p12l1138t2375r1322b2401],
12	therapy	NN	O	therapy	prep_following	1	SENT_440	[p12l1330t2375r1436b2409],
13	and	CC	O	and	_	0	SENT_440	[p12l1443t2375r1492b2401],
14	the	DT	O	the	det	16	SENT_440	[p12l1500t2375r1544b2401],
15	virologic	JJ	O	virologic	amod	16	SENT_440	[p12l1551t2375r1674b2409],
16	correlates	NNS	O	correlate	prep_following	1	SENT_440	[p12l1682t2375r1817b2401],
17	of	IN	O	of	_	0	SENT_440	[p12l1825t2375r1856b2401],
18	treatment	NN	O	treatment	nn	19	SENT_440	[p12l1860t2382r1998b2401],
19	failure	NN	O	failure	prep_of	1	SENT_440	[p12l2005t2375r2100b2401],
20	.	.	O	.	_	0	SENT_440	[p12l2005t2375r2100b2401],

1	Proe	NNP	O	Proe	_	0	SENT_441	[p12l657t2421r719b2446],
2	.	.	O	.	_	0	SENT_441	[p12l657t2421r719b2446],

1	Natl.	NNP	O	Natl.	nn	2	SENT_442	[p12l731t2421r797b2446],
2	Acnd	NNP	O	Acnd	_	0	SENT_442	[p12l806t2421r878b2446],
3	.	.	O	.	_	0	SENT_442	[p12l806t2421r878b2446],

1	Sci	NNP	O	Sci	_	0	SENT_443	[p12l891t2421r933b2446],
2	.	.	O	.	_	0	SENT_443	[p12l891t2421r933b2446],

1	USA	NNP	O	USA	_	0	SENT_444	[p12l949t2421r1010b2446],
2	94	CD	NUMBER	94	num	1	SENT_444	[p12l1022t2421r1117b2452],
3	(	CD	NUMBER	(	number	4	SENT_444	[p12l1022t2421r1117b2452],
4	23	CD	NUMBER	23	num	5	SENT_444	[p12l1022t2421r1117b2452],
5	)	NN	O	)	dep	1	SENT_444	[p12l1022t2421r1117b2452],
6	:	:	O	:	_	0	SENT_444	[p12l1022t2421r1117b2452],
7	125	CD	NUMBER	125	number	8	SENT_444	[p12l1123t2421r1168b2446],
8	74-79	CD	NUMBER	74-79	dep	5	SENT_444	[p12l1173t2421r1255b2446],

1	Hnzndn	SYM	O	hnzndn	dep	3	SENT_445	[p12l583t2523r674b2545],
2	-	:	O	-	_	0	SENT_445	[p12l690t2531r700b2541],
3	Izvnmoto	NN	PERSON	izvnmoto	dep	5	SENT_445	[p12l714t2523r811b2545],
4	-	:	O	-	_	0	SENT_445	[p12l827t2531r836b2541],
5	Wenning	NN	PERSON	wenning	_	0	SENT_445	[p12l854t2523r956b2553],

1	.	.	O	.	_	0	SENT_446	[p12l397t2583r402b2587],

1	Zhang	NNP	PERSON	Zhang	nn	2	SENT_447	[p12l421t2562r512b2596],
2	ZQ	NNP	O	ZQ	_	0	SENT_447	[p12l525t2562r583b2593],
3	,	,	O	,	_	0	SENT_447	[p12l525t2562r583b2593],
4	Notermans	NNP	PERSON	Notermans	nn	5	SENT_447	[p12l597t2563r756b2588],
5	DW	NNP	O	DW	appos	2	SENT_447	[p12l770t2563r840b2593],
6	,	,	O	,	_	0	SENT_447	[p12l770t2563r840b2593],
7	Sedgewick	NNP	O	Sedgewick	nn	8	SENT_447	[p12l857t2562r1004b2596],
8	G	NNP	O	G	appos	2	SENT_447	[p12l1017t2563r1050b2593],
9	,	,	O	,	_	0	SENT_447	[p12l1017t2563r1050b2593],
10	Cavert	NNP	O	Cavert	nn	11	SENT_447	[p12l1066t2563r1160b2588],
11	W	NNP	O	W	appos	8	SENT_447	[p12l1172t2563r1215b2593],
12	,	,	O	,	_	0	SENT_447	[p12l1172t2563r1215b2593],
13	VI	NNP	O	VI	appos	2	SENT_447	[p12l1230t2562r1371b2596],
14	/	:	O	/	punct	20	SENT_447	[p12l1230t2562r1371b2596],
15	"	``	O	"	punct	17	SENT_447	[p12l1230t2562r1371b2596],
16	ietgrefe	NN	O	ietgrefe	nn	17	SENT_447	[p12l1230t2562r1371b2596],
17	S	NN	O	s	dep	20	SENT_447	[p12l1387t2563r1410b2593],
18	,	,	O	,	_	0	SENT_447	[p12l1387t2563r1410b2593],
19	et	FW	O	et	nn	20	SENT_447	[p12l1426t2569r1452b2588],
20	al.	FW	O	al.	dep	13	SENT_447	[p12l1465t2562r1495b2588],
21	1998	CD	DATE	1998	dep	20	SENT_447	[p12l1513t2563r1585b2588],
22	.	.	O	.	_	0	SENT_447	[p12l1513t2563r1585b2588],

1	Kinetics	NNS	O	kinetics	_	0	SENT_448	[p12l1600t2563r1714b2588],
2	of	IN	O	of	_	0	SENT_448	[p12l1729t2562r1760b2588],
3	CD4	NN	O	cd4	prep_of	1	SENT_448	[p12l1771t2563r1864b2590],
4	+	CC	O	+	_	0	SENT_448	[p12l1771t2563r1864b2590],
5	T	NN	O	t	nn	7	SENT_448	[p12l420t2605r447b2629],
6	cell	NN	O	cell	nn	7	SENT_448	[p12l458t2604r505b2630],
7	repopulation	NN	O	repopulation	prep_of	1	SENT_448	[p12l517t2604r696b2638],
8	of	IN	O	of	_	0	SENT_448	[p12l708t2604r739b2630],
9	lymphoid	JJ	O	lymphoid	amod	10	SENT_448	[p12l746t2604r879b2638],
10	tissues	NNS	O	tissue	prep_of	1	SENT_448	[p12l892t2605r980b2630],
11	after	IN	O	after	_	0	SENT_448	[p12l993t2604r1056b2630],
12	treatment	NN	O	treatment	prep_after	10	SENT_448	[p12l1068t2611r1205b2630],
13	of	IN	O	of	_	0	SENT_448	[p12l1216t2604r1247b2630],
14	HIV-1	NN	O	hiv-1	nn	15	SENT_448	[p12l1255t2605r1344b2630],
15	infection	NN	O	infection	prep_of	1	SENT_448	[p12l1358t2604r1490b2630],
16	.	.	O	.	_	0	SENT_448	[p12l1358t2604r1490b2630],

1	Proe	NNP	O	Proe	_	0	SENT_449	[p12l1502t2605r1564b2630],
2	.	.	O	.	_	0	SENT_449	[p12l1502t2605r1564b2630],

1	Nntl	NN	O	nntl	_	0	SENT_450	[p12l1578t2605r1644b2630],
2	.	.	O	.	_	0	SENT_450	[p12l1578t2605r1644b2630],

1	Aend	NNP	O	Aend	_	0	SENT_451	[p12l1655t2605r1727b2630],
2	.	.	O	.	_	0	SENT_451	[p12l1655t2605r1727b2630],

1	Sci	NNP	O	Sci	_	0	SENT_452	[p12l1742t2605r1784b2630],
2	.	.	O	.	_	0	SENT_452	[p12l1742t2605r1784b2630],

1	USA	NNP	ORGANIZATION	USA	_	0	SENT_453	[p12l1802t2605r1864b2630],
2	95	CD	NUMBER	95	number	3	SENT_453	[p12l422t2647r621b2678],
3	(	CD	NUMBER	(	dep	1	SENT_453	[p12l422t2647r621b2678],
4	3	CD	NUMBER	3	num	5	SENT_453	[p12l422t2647r621b2678],
5	)	NN	O	)	dep	3	SENT_453	[p12l422t2647r621b2678],
6	:1154	CD	NUMBER	:1154	number	7	SENT_453	[p12l422t2647r621b2678],
7	—	CD	NUMBER	—	dep	1	SENT_453	[p12l422t2647r621b2678],
8	59	CD	NUMBER	59	dep	7	SENT_453	[p12l422t2647r621b2678],
9	.	.	O	.	_	0	SENT_453	[p12l397t2710r402b2714],

1	Mocroft	NNP	O	Mocroft	nn	2	SENT_454	[p12l420t2688r538b2714],
2	A	NNP	O	A	_	0	SENT_454	[p12l544t2689r574b2720],
3	,	,	O	,	_	0	SENT_454	[p12l544t2689r574b2720],
4	Ledergerber	NNP	O	Ledergerber	nn	5	SENT_454	[p12l584t2688r759b2723],
5	B	NNP	O	B	appos	2	SENT_454	[p12l768t2689r795b2720],
6	,	,	O	,	_	0	SENT_454	[p12l768t2689r795b2720],
7	Katlama	NNP	PERSON	Katlama	nn	8	SENT_454	[p12l805t2688r921b2714],
8	C	NNP	PERSON	C	appos	2	SENT_454	[p12l931t2689r961b2720],
9	,	,	O	,	_	0	SENT_454	[p12l931t2689r961b2720],
10	Kirk	NNP	PERSON	Kirk	nn	11	SENT_454	[p12l971t2688r1035b2714],
11	O	NNP	PERSON	O	appos	2	SENT_454	[p12l1043t2689r1076b2720],
12	,	,	O	,	_	0	SENT_454	[p12l1043t2689r1076b2720],
13	Reiss	NNP	PERSON	Reiss	nn	14	SENT_454	[p12l1087t2689r1157b2714],
14	P	NN	O	p	appos	2	SENT_454	[p12l1166t2689r1194b2720],
15	,	,	O	,	_	0	SENT_454	[p12l1166t2689r1194b2720],
16	et	FW	O	et	nn	17	SENT_454	[p12l1204t2696r1230b2714],
17	al.	FW	O	al.	appos	2	SENT_454	[p12l1238t2688r1267b2714],
18	2003	CD	DATE	2003	dep	17	SENT_454	[p12l1278t2690r1352b2715],
19	.	.	O	.	_	0	SENT_454	[p12l1278t2690r1352b2715],

1	Decline	NN	O	decline	_	0	SENT_455	[p12l1363t2688r1471b2714],
2	in	IN	O	in	_	0	SENT_455	[p12l1480t2690r1507b2714],
3	the	DT	O	the	det	7	SENT_455	[p12l1516t2688r1559b2714],
4	AIDS	NN	MISC	aid	nn	7	SENT_455	[p12l1567t2689r1646b2714],
5	and	CC	O	and	_	0	SENT_455	[p12l1656t2688r1706b2714],
6	death	NN	O	death	conj_and	4	SENT_455	[p12l1715t2688r1791b2714],
7	rates	NNS	O	rate	prep_in	1	SENT_455	[p12l1799t2696r1864b2714],
8	in	IN	O	in	_	0	SENT_455	[p12l421t2732r448b2756],
9	the	DT	O	the	det	11	SENT_455	[p12l458t2731r501b2757],
10	EuroSIDA	NN	MISC	eurosida	nn	11	SENT_455	[p12l511t2732r663b2757],
11	study	NN	O	study	prep_in	7	SENT_455	[p12l672t2731r752b2765],
12	:	:	O	:	_	0	SENT_455	[p12l672t2731r752b2765],
13	an	DT	O	a	det	15	SENT_455	[p12l764t2741r796b2757],
14	observational	JJ	O	observational	amod	15	SENT_455	[p12l806t2731r991b2757],
15	study	NN	O	study	dep	1	SENT_455	[p12l1001t2731r1082b2765],
16	.	.	O	.	_	0	SENT_455	[p12l1001t2731r1082b2765],

1	Lancet	NNP	O	Lancet	_	0	SENT_456	[p12l1092t2732r1180b2757],
2	362	CD	NUMBER	362	num	1	SENT_456	[p12l1189t2732r1422b2763],
3	(	CD	NUMBER	(	number	4	SENT_456	[p12l1189t2732r1422b2763],
4	9377	CD	NUMBER	9377	num	6	SENT_456	[p12l1189t2732r1422b2763],
5	)	CD	NUMBER	)	number	6	SENT_456	[p12l1189t2732r1422b2763],
6	:22	CD	NUMBER	:22	dep	1	SENT_456	[p12l1189t2732r1422b2763],
7	—	NN	O	—	nn	9	SENT_456	[p12l1189t2732r1422b2763],
8	29	CD	NUMBER	29	num	9	SENT_456	[p12l1189t2732r1422b2763],
9	UNAIDS	NNP	ORGANIZATION	UNAIDS	dep	6	SENT_456	[p12l421t2777r564b2803],
10	.	.	O	.	_	0	SENT_456	[p12l421t2777r564b2803],

1	2006	CD	DATE	2006	_	0	SENT_457	[p12l576t2777r693b2811],
2	.	.	O	.	_	0	SENT_457	[p12l576t2777r693b2811],

1	_	NN	O	_	_	0	SENT_458	[p12l576t2777r693b2811],
2	7t	NN	O	7t	dep	1	SENT_458	[p12l576t2777r693b2811],
3	.	.	O	.	_	0	SENT_458	[p12l576t2777r693b2811],

1	UNProgmmme	NN	O	unprogmmme	_	0	SENT_459	[p12l709t2778r919b2812],
2	HIV/AIDS	NN	O	hiv/aids	dep	1	SENT_459	[p12l928t2777r1084b2803],
3	.	.	O	.	_	0	SENT_459	[p12l928t2777r1084b2803],

1	Global	JJ	O	global	amod	2	SENT_460	[p12l1098t2777r1183b2803],
2	Fnctt	NN	O	fnctt	_	0	SENT_460	[p12l1189t2778r1256b2803],
3	and	CC	O	and	_	0	SENT_460	[p12l1264t2777r1314b2803],
4	Figuret	NN	O	figuret	conj_and	2	SENT_460	[p12l1320t2778r1424b2812],
5	.	.	O	.	_	0	SENT_460	[p12l1320t2778r1424b2812],

1	Geneva	NNP	LOCATION	Geneva	_	0	SENT_461	[p12l1436t2777r1548b2803],
2	:	:	O	:	_	0	SENT_461	[p12l1436t2777r1548b2803],
3	WHO	WP	O	who	dep	1	SENT_461	[p12l1559t2777r1651b2803],
4	.	.	O	.	_	0	SENT_461	[p12l397t2841r402b2845],

1	Nolan	NNP	PERSON	Nolan	nn	2	SENT_462	[p12l421t2819r509b2845],
2	D	NNP	PERSON	D	_	0	SENT_462	[p12l520t2820r554b2851],
3	,	,	O	,	_	0	SENT_462	[p12l520t2820r554b2851],
4	Reiss	NNP	PERSON	Reiss	nn	5	SENT_462	[p12l566t2820r637b2845],
5	P	NN	PERSON	p	appos	2	SENT_462	[p12l648t2820r675b2851],
6	,	,	O	,	_	0	SENT_462	[p12l648t2820r675b2851],
7	Mallal	NNP	O	Mallal	nn	8	SENT_462	[p12l686t2819r775b2845],
8	S.	NNP	O	S.	appos	2	SENT_462	[p12l788t2820r811b2845],
9	2005	CD	DATE	2005	dep	8	SENT_462	[p12l824t2820r898b2845],
10	.	.	O	.	_	0	SENT_462	[p12l824t2820r898b2845],

1	Adverse	JJ	O	adverse	amod	2	SENT_463	[p12l909t2819r1020b2845],
2	effects	NNS	O	effect	_	0	SENT_463	[p12l1032t2819r1120b2845],
3	of	IN	O	of	_	0	SENT_463	[p12l1132t2819r1162b2845],
4	antiretroviral	JJ	O	antiretroviral	amod	5	SENT_463	[p12l1170t2819r1353b2845],
5	therapy	NN	O	therapy	prep_of	2	SENT_463	[p12l1364t2819r1471b2854],
6	for	IN	O	for	_	0	SENT_463	[p12l1480t2819r1521b2845],
7	HIV	NN	O	hiv	nn	8	SENT_463	[p12l1531t2820r1598b2845],
8	infection	NN	O	infection	prep_for	5	SENT_463	[p12l1606t2819r1737b2845],
9	:	:	O	:	_	0	SENT_463	[p12l1606t2819r1737b2845],
10	a	DT	O	a	det	11	SENT_463	[p12l1750t2829r1763b2845],
11	review	NN	O	review	dep	2	SENT_463	[p12l1774t2821r1866b2845],
12	of	IN	O	of	_	0	SENT_463	[p12l422t2862r452b2888],
13	selected	VBN	O	select	amod	14	SENT_463	[p12l458t2862r568b2888],
14	topics	NNS	O	topic	prep_of	11	SENT_463	[p12l578t2863r667b2896],
15	.	.	O	.	_	0	SENT_463	[p12l578t2863r667b2896],

1	Expert	NN	O	expert	_	0	SENT_464	[p12l677t2863r766b2896],
2	Opin	NN	PERSON	opin	dep	1	SENT_464	[p12l776t2863r845b2896],
3	.	.	O	.	_	0	SENT_464	[p12l776t2863r845b2896],

1	Drug	NN	O	drug	nn	2	SENT_465	[p12l857t2863r930b2897],
2	Snf	NN	O	snf	_	0	SENT_465	[p12l939t2862r989b2897],
3	4	CD	NUMBER	4	num	4	SENT_465	[p12l999t2863r1164b2894],
4	(	NN	O	(	dep	2	SENT_465	[p12l999t2863r1164b2894],
5	2	CD	NUMBER	2	number	6	SENT_465	[p12l999t2863r1164b2894],
6	)	CD	NUMBER	)	dep	4	SENT_465	[p12l999t2863r1164b2894],
7	:20	CD	NUMBER	:20	num	8	SENT_465	[p12l999t2863r1164b2894],
8	l	NN	O	l	tmod	4	SENT_465	[p12l999t2863r1164b2894],
9	—	CD	NUMBER	—	number	10	SENT_465	[p12l999t2863r1164b2894],
10	18	CD	NUMBER	18	dep	2	SENT_465	[p12l999t2863r1164b2894],
11	Shet	NNP	O	Shet	nn	12	SENT_465	[p12l422t2905r484b2931],
12	A	NNP	O	A	dep	10	SENT_465	[p12l493t2906r522b2936],
13	,	,	O	,	_	0	SENT_465	[p12l493t2906r522b2936],
14	Berry	NNP	PERSON	Berry	nn	15	SENT_465	[p12l535t2906r613b2939],
15	L	NNP	PERSON	L	appos	2	SENT_465	[p12l622t2906r651b2936],
16	,	,	O	,	_	0	SENT_465	[p12l622t2906r651b2936],
17	Mohri	NNP	PERSON	Mohri	nn	18	SENT_465	[p12l662t2905r752b2931],
18	H	NNP	PERSON	H	appos	2	SENT_465	[p12l763t2906r798b2936],
19	,	,	O	,	_	0	SENT_465	[p12l763t2906r798b2936],
20	Mehandru	NNP	O	Mehandru	nn	21	SENT_465	[p12l809t2905r957b2931],
21	S	NNP	O	S	appos	2	SENT_465	[p12l968t2906r992b2936],
22	,	,	O	,	_	0	SENT_465	[p12l968t2906r992b2936],
23	Chung	NNP	PERSON	Chung	nn	24	SENT_465	[p12l1004t2905r1100b2939],
24	C	NNP	PERSON	C	appos	2	SENT_465	[p12l1111t2906r1142b2936],
25	,	,	O	,	_	0	SENT_465	[p12l1111t2906r1142b2936],
26	et	FW	O	et	nn	27	SENT_465	[p12l1154t2912r1180b2931],
27	al.	FW	O	al.	appos	2	SENT_465	[p12l1190t2905r1219b2931],
28	2006	CD	DATE	2006	dep	27	SENT_465	[p12l1232t2906r1306b2930],
29	.	.	O	.	_	0	SENT_465	[p12l1232t2906r1306b2930],

1	Tracking	VBG	O	track	_	0	SENT_466	[p12l1318t2905r1443b2939],
2	the	DT	O	the	det	3	SENT_466	[p12l1453t2905r1497b2931],
3	prevalence	NN	O	prevalence	dobj	1	SENT_466	[p12l1507t2905r1655b2939],
4	of	IN	O	of	_	0	SENT_466	[p12l1667t2905r1697b2931],
5	transmitted	JJ	O	transmitted	amod	7	SENT_466	[p12l1704t2905r1865b2931],
6	antiretroviral	JJ	O	antiretroviral	amod	7	SENT_466	[p12l421t2947r605b2973],
7	drug	NN	O	drug	prep_of	3	SENT_466	[p12l615t2947r680b2981],
8	resistant	JJ	O	resistant	dep	9	SENT_466	[p12l688t2948r806b2973],
9	HIV-1	NN	O	hiv-1	amod	7	SENT_466	[p12l814t2948r913b2973],
10	:	:	O	:	_	0	SENT_466	[p12l814t2948r913b2973],
11	a	DT	DURATION	a	det	12	SENT_466	[p12l925t2957r938b2973],
12	decade	NN	DURATION	decade	dep	9	SENT_466	[p12l948t2947r1042b2973],
13	of	IN	O	of	_	0	SENT_466	[p12l1052t2947r1082b2973],
14	experience	NN	O	experience	prep_of	12	SENT_466	[p12l1089t2948r1243b2981],
15	.	.	O	.	_	0	SENT_466	[p12l1089t2948r1243b2981],

1	OF	IN	O	of	mark	4	SENT_467	[p12l1250t2947r1275b2981],
2	+	CC	O	+	cc	4	SENT_467	[p12l1250t2947r1275b2981],
3	Acqnln	NNP	MISC	Acqnln	nn	4	SENT_467	[p12l1284t2948r1377b2981],
4	Immune	NNP	MISC	Immune	_	0	SENT_467	[p12l1388t2948r1498b2973],
5	Deﬁc	NNP	MISC	Deﬁc	dep	4	SENT_467	[p12l1507t2947r1578b2981],
6	.	.	O	.	_	0	SENT_467	[p12l1507t2947r1578b2981],

1	Syndn	NNP	O	Syndn	_	0	SENT_468	[p12l1591t2948r1670b2981],
2	41	CD	NUMBER	41	number	3	SENT_468	[p12l1682t2948r1793b2979],
3	(	CD	NUMBER	(	dep	1	SENT_468	[p12l1682t2948r1793b2979],
4	4	CD	NUMBER	4	num	5	SENT_468	[p12l1682t2948r1793b2979],
5	)	NN	O	)	dep	3	SENT_468	[p12l1682t2948r1793b2979],
6	:43	CD	NUMBER	:43	num	9	SENT_468	[p12l1682t2948r1793b2979],
7	9-46	CD	NUMBER	9-46	num	9	SENT_468	[p12l1798t2949r1864b2973],
8	Richman	NNP	PERSON	Richman	nn	9	SENT_468	[p12l422t2989r547b3015],
9	DD	NNP	O	DD	dep	1	SENT_468	[p12l557t2990r618b3021],
10	,	,	O	,	_	0	SENT_468	[p12l557t2990r618b3021],
11	Morton	NNP	ORGANIZATION	Morton	nn	12	SENT_468	[p12l628t2990r738b3015],
12	SC	NNP	ORGANIZATION	SC	appos	9	SENT_468	[p12l749t2990r797b3021],
13	,	,	O	,	_	0	SENT_468	[p12l749t2990r797b3021],
14	Wrin	NNP	LOCATION	Wrin	nn	15	SENT_468	[p12l808t2990r883b3015],
15	T	NN	LOCATION	t	appos	9	SENT_468	[p12l891t2990r924b3021],
16	,	,	O	,	_	0	SENT_468	[p12l891t2990r924b3021],
17	Hellmann	NNP	ORGANIZATION	Hellmann	nn	18	SENT_468	[p12l935t2989r1076b3015],
18	N	NNP	ORGANIZATION	N	appos	9	SENT_468	[p12l1086t2990r1121b3021],
19	,	,	O	,	_	0	SENT_468	[p12l1086t2990r1121b3021],
20	Berry	NNP	PERSON	Berry	nn	21	SENT_468	[p12l1133t2990r1211b3024],
21	S	NNP	O	S	appos	9	SENT_468	[p12l1221t2990r1244b3021],
22	,	,	O	,	_	0	SENT_468	[p12l1221t2990r1244b3021],
23	et	FW	O	et	nn	24	SENT_468	[p12l1256t2996r1281b3015],
24	al.	FW	O	al.	appos	9	SENT_468	[p12l1291t2989r1320b3015],
25	2004	CD	DATE	2004	dep	24	SENT_468	[p12l1332t2991r1406b3015],
26	.	.	O	.	_	0	SENT_468	[p12l1332t2991r1406b3015],

1	The	DT	O	the	det	2	SENT_469	[p12l1417t2989r1476b3015],
2	prevalence	NN	O	prevalence	_	0	SENT_469	[p12l1486t2989r1634b3024],
3	of	IN	O	of	_	0	SENT_469	[p12l1644t2989r1675b3015],
4	antiretroviral	JJ	O	antiretroviral	amod	6	SENT_469	[p12l1681t2989r1865b3015],
5	drug	NN	O	drug	nn	6	SENT_469	[p12l422t3032r487b3066],
6	resistance	NN	O	resistance	prep_of	2	SENT_469	[p12l495t3033r631b3058],
7	in	IN	O	in	_	0	SENT_469	[p12l640t3033r667b3057],
8	the	DT	O	the	det	10	SENT_469	[p12l677t3032r720b3058],
9	United	NNP	LOCATION	United	nn	10	SENT_469	[p12l730t3032r828b3058],
10	States	NNPS	LOCATION	States	prep_in	2	SENT_469	[p12l840t3033r928b3058],
11	.	.	O	.	_	0	SENT_469	[p12l840t3033r928b3058],

1	AIDS	NNP	O	AIDS	_	0	SENT_470	[p12l936t3032r1018b3057],
2	18	CD	NUMBER	18	num	1	SENT_470	[p12l1029t3033r1258b3064],
3	(	CD	NUMBER	(	number	4	SENT_470	[p12l1029t3033r1258b3064],
4	10	CD	NUMBER	10	num	5	SENT_470	[p12l1029t3033r1258b3064],
5	)	NN	O	)	dep	1	SENT_470	[p12l1029t3033r1258b3064],
6	:1393	CD	NUMBER	:1393	num	7	SENT_470	[p12l1029t3033r1258b3064],
7	—	NN	O	—	dep	5	SENT_470	[p12l1029t3033r1258b3064],
8	401	CD	NUMBER	401	num	11	SENT_470	[p12l1029t3033r1258b3064],
9	Little	JJ	O	little	amod	11	SENT_470	[p12l421t3074r498b3100],
10	S	NN	O	s	nn	11	SENT_470	[p12l510t3075r546b3106],
11	]	NN	O	]	dep	1	SENT_470	[p12l510t3075r546b3106],
12	,	,	O	,	_	0	SENT_470	[p12l510t3075r546b3106],
13	Holte	NNP	PERSON	Holte	nn	14	SENT_470	[p12l557t3074r638b3100],
14	S	NNP	O	S	appos	11	SENT_470	[p12l650t3075r673b3106],
15	,	,	O	,	_	0	SENT_470	[p12l650t3075r673b3106],
16	Routy	NNP	O	Routy	nn	18	SENT_470	[p12l685t3075r819b3109],
17	]	CD	NUMBER	]	num	18	SENT_470	[p12l685t3075r819b3109],
18	P	NN	O	p	appos	11	SENT_470	[p12l685t3075r819b3109],
19	,	,	O	,	_	0	SENT_470	[p12l685t3075r819b3109],
20	Daar	NNP	PERSON	Daar	nn	21	SENT_470	[p12l831t3075r900b3100],
21	ES	NN	O	e	appos	11	SENT_470	[p12l910t3075r958b3106],
22	,	,	O	,	_	0	SENT_470	[p12l910t3075r958b3106],
23	Markowitz	NNP	PERSON	Markowitz	nn	24	SENT_470	[p12l968t3074r1121b3100],
24	M	NNP	O	M	appos	11	SENT_470	[p12l1129t3075r1169b3106],
25	,	,	O	,	_	0	SENT_470	[p12l1129t3075r1169b3106],
26	et	FW	O	et	nn	27	SENT_470	[p12l1181t3081r1206b3100],
27	al.	FW	O	al.	appos	11	SENT_470	[p12l1216t3074r1246b3100],
28	2002	CD	DATE	2002	dep	27	SENT_470	[p12l1258t3075r1332b3100],
29	.	.	O	.	_	0	SENT_470	[p12l1258t3075r1332b3100],

1	Antiretroviral-drug	JJ	O	antiretroviral-drug	amod	2	SENT_471	[p12l1343t3074r1615b3109],
2	resistance	NN	O	resistance	nsubj	6	SENT_471	[p12l1624t3075r1759b3100],
3	among	IN	O	among	_	0	SENT_471	[p12l1770t3083r1866b3109],
4	patients	NNS	O	patient	prep_among	2	SENT_471	[p12l421t3121r530b3154],
5	recently	RB	DATE	recently	advmod	6	SENT_471	[p12l540t3120r653b3154],
6	infected	VBN	O	infect	_	0	SENT_471	[p12l661t3120r773b3146],
7	with	IN	O	with	_	0	SENT_471	[p12l782t3120r844b3146],
8	HIV	NN	MISC	hiv	prep_with	6	SENT_471	[p12l853t3121r925b3146],
9	.	.	O	.	_	0	SENT_471	[p12l853t3121r925b3146],

1	N.	NNP	O	N.	nn	2	SENT_472	[p12l935t3121r967b3146],
2	Engl	NNP	O	Engl	_	0	SENT_472	[p12l978t3121r1046b3155],
3	.	.	O	.	_	0	SENT_472	[p12l978t3121r1046b3155],

1	Med	NNP	O	Med	_	0	SENT_473	[p12l1090t3121r1156b3146],
2	.	.	O	.	_	0	SENT_473	[p12l1090t3121r1156b3146],

1	347	CD	NUMBER	347	number	2	SENT_474	[p12l1170t3121r1217b3146],
2	(	CD	NUMBER	(	_	0	SENT_474	[p12l1221t3121r1369b3152],
3	6	CD	NUMBER	6	num	4	SENT_474	[p12l1221t3121r1369b3152],
4	)	NN	O	)	dep	2	SENT_474	[p12l1221t3121r1369b3152],
5	:385	CD	NUMBER	:385	number	6	SENT_474	[p12l1221t3121r1369b3152],
6	—	CD	NUMBER	—	dep	2	SENT_474	[p12l1221t3121r1369b3152],
7	94	CD	NUMBER	94	dep	6	SENT_474	[p12l1221t3121r1369b3152],

1	Annu	NNP	PERSON	Annu	_	0	SENT_475	[p13l55t3565r78b3645],
2	.	.	O	.	_	0	SENT_475	[p13l55t3565r78b3645],

1	Rev.	NNP	O	Rev.	nn	2	SENT_476	[p13l55t3495r78b3554],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_476	[p13l55t3336r78b3484],
3	.	.	O	.	_	0	SENT_476	[p13l55t3336r78b3484],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_477	[p13l55t3216r78b3325],
2	.	.	O	.	_	0	SENT_477	[p13l55t3216r78b3325],

1	2009.49:377	CD	NUMBER	2009.49:377	num	2	SENT_478	[p13l55t2971r79b3204],
2	-394	CD	NUMBER	-394	_	0	SENT_478	[p13l55t2971r79b3204],
3	.	.	O	.	_	0	SENT_478	[p13l55t2971r79b3204],

1	Downloaded	VBN	O	download	_	0	SENT_479	[p13l55t2790r78b2960],
2	from	IN	O	from	_	0	SENT_479	[p13l55t2717r78b2781],
3	www.annua1reviews.org	NN	O	www.annua1reviews.org	prep_from	1	SENT_479	[p13l55t2384r85b2708],
4	by	IN	O	by	_	0	SENT_479	[p13l88t3478r119b3510],
5	University	NNP	ORGANIZATION	University	dep	9	SENT_479	[p13l88t3329r119b3469],
6	of	IN	ORGANIZATION	of	_	0	SENT_479	[p13l88t3290r112b3319],
7	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	5	SENT_479	[p13l88t3144r112b3284],
8	-	:	O	-	_	0	SENT_479	[p13l102t3125r105b3134],
9	Madison	NNP	O	Madison	prep_by	1	SENT_479	[p13l88t2999r112b3115],
10	on	IN	O	on	_	0	SENT_479	[p13l96t2958r112b2990],
11	01/05/14	CD	DATE	01/05/14	prep_on	1	SENT_479	[p13l88t2825r112b2949],
12	.	.	O	.	_	0	SENT_479	[p13l88t2825r112b2949],

1	For	IN	O	for	_	0	SENT_480	[p13l89t2768r112b2814],
2	personal	JJ	O	personal	amod	3	SENT_480	[p13l88t2647r119b2759],
3	use	NN	O	use	pobj	1	SENT_480	[p13l96t2594r112b2638],
4	only	RB	O	only	advmod	3	SENT_480	[p13l88t2520r119b2584],
5	.	.	O	.	_	0	SENT_480	[p13l88t2520r119b2584],

1	Annu	NNP	PERSON	Annu	_	0	SENT_481	[p13l201t1137r224b1217],
2	.	.	O	.	_	0	SENT_481	[p13l201t1137r224b1217],

1	Rev.	NNP	O	Rev.	nn	2	SENT_482	[p13l201t1067r224b1126],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_482	[p13l201t907r224b1056],
3	.	.	O	.	_	0	SENT_482	[p13l201t907r224b1056],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_483	[p13l201t787r224b896],
2	.	.	O	.	_	0	SENT_483	[p13l201t787r224b896],

1	2009.49:377	CD	NUMBER	2009.49:377	num	2	SENT_484	[p13l201t542r225b775],
2	-394	CD	NUMBER	-394	_	0	SENT_484	[p13l201t542r225b775],
3	.	.	O	.	_	0	SENT_484	[p13l201t542r225b775],

1	Downloaded	VBN	O	download	_	0	SENT_485	[p13l201t361r224b531],
2	from	IN	O	from	_	0	SENT_485	[p13l201t288r224b352],
3	wwwannualreviews	NNS	O	wwwannualreview	prep_from	1	SENT_485	[p13l201t8r224b279],
4	by	IN	O	by	_	0	SENT_485	[p13l234t1050r265b1082],
5	University	NNP	ORGANIZATION	University	dep	9	SENT_485	[p13l234t900r265b1040],
6	of	IN	ORGANIZATION	of	_	0	SENT_485	[p13l234t861r258b890],
7	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	5	SENT_485	[p13l234t715r258b855],
8	-	:	O	-	_	0	SENT_485	[p13l248t696r251b705],
9	Madison	NNP	O	Madison	prep_by	1	SENT_485	[p13l234t571r258b686],
10	on	IN	O	on	_	0	SENT_485	[p13l242t529r258b561],
11	01/05/14	CD	DATE	01/05/14	prep_on	1	SENT_485	[p13l234t396r258b520],
12	.	.	O	.	_	0	SENT_485	[p13l234t396r258b520],

1	For	IN	O	for	_	0	SENT_486	[p13l235t339r258b385],
2	personal	JJ	O	personal	amod	3	SENT_486	[p13l234t218r265b330],
3	use	NN	O	use	pobj	1	SENT_486	[p13l242t166r258b209],
4	only	RB	O	only	advmod	3	SENT_486	[p13l234t91r265b156],
5	.	.	O	.	_	0	SENT_486	[p13l234t91r265b156],

1	Grant	NNP	O	Grant	nn	2	SENT_487	[p13l422t13r506b37],
2	RM	NN	O	rm	_	0	SENT_487	[p13l517t13r578b43],
3	,	,	O	,	_	0	SENT_487	[p13l517t13r578b43],
4	Hecht	NNP	PERSON	Hecht	nn	5	SENT_487	[p13l591t12r679b37],
5	FM	NNP	O	FM	appos	2	SENT_487	[p13l690t13r748b43],
6	,	,	O	,	_	0	SENT_487	[p13l690t13r748b43],
7	Wannerdam	NNP	O	Wannerdam	nn	8	SENT_487	[p13l760t12r938b37],
8	M	NNP	O	M	appos	2	SENT_487	[p13l947t13r987b43],
9	,	,	O	,	_	0	SENT_487	[p13l947t13r987b43],
10	Liu	NNP	ORGANIZATION	Liu	nn	11	SENT_487	[p13l1000t13r1049b37],
11	L	NNP	ORGANIZATION	L	appos	2	SENT_487	[p13l1060t13r1089b43],
12	,	,	O	,	_	0	SENT_487	[p13l1060t13r1089b43],
13	Liegler	NNP	ORGANIZATION	Liegler	nn	14	SENT_487	[p13l1102t11r1203b46],
14	T	NN	ORGANIZATION	t	appos	2	SENT_487	[p13l1214t12r1246b43],
15	,	,	O	,	_	0	SENT_487	[p13l1214t12r1246b43],
16	et	FW	O	et	nn	17	SENT_487	[p13l1260t19r1285b37],
17	al.	FW	O	al.	appos	2	SENT_487	[p13l1297t12r1326b37],
18	2002	CD	DATE	2002	dep	17	SENT_487	[p13l1339t13r1414b37],
19	.	.	O	.	_	0	SENT_487	[p13l1339t13r1414b37],

1	Time	NNP	O	Time	_	0	SENT_488	[p13l1426t12r1502b37],
2	trends	NNS	O	trend	dobj	7	SENT_488	[p13l1515t12r1601b37],
3	in	IN	O	in	_	0	SENT_488	[p13l1613t13r1640b37],
4	primary	JJ	O	primary	amod	6	SENT_488	[p13l1651t13r1762b46],
5	HIV-1	NN	O	hiv-1	nn	6	SENT_488	[p13l1772t13r1862b37],
6	drug	NN	O	drug	prep_in	2	SENT_488	[p13l422t57r487b92],
7	resistance	NN	O	resistance	dep	1	SENT_488	[p13l495t59r631b83],
8	among	IN	O	among	prep	7	SENT_488	[p13l641t67r736b92],
9	recently	RB	DATE	recently	dep	8	SENT_488	[p13l745t57r859b92],
10	infected	VBN	O	infect	rcmod	9	SENT_488	[p13l867t57r978b83],
11	persons	NNS	O	person	dobj	10	SENT_488	[p13l988t67r1101b91],
12	.	.	O	.	_	0	SENT_488	[p13l988t67r1101b91],
13	]	SYM	O	]	dep	1	SENT_488	[p13l1108t58r1203b91],

1	AI\/IA	NN	O	ai\/ia	_	0	SENT_489	[p13l1108t58r1203b91],
2	288	CD	NUMBER	288	num	1	SENT_489	[p13l1214t58r1413b89],
3	(	NN	O	(	nn	9	SENT_489	[p13l1214t58r1413b89],
4	2	CD	NUMBER	2	num	9	SENT_489	[p13l1214t58r1413b89],
5	)	CD	NUMBER	)	num	9	SENT_489	[p13l1214t58r1413b89],
6	:181	CD	NUMBER	:181	num	9	SENT_489	[p13l1214t58r1413b89],
7	-88	CD	NUMBER	-88	num	9	SENT_489	[p13l1214t58r1413b89],
8	Hanna	NNP	PERSON	Hanna	nn	9	SENT_489	[p13l421t102r515b127],
9	GJ	NNP	PERSON	GJ	dep	1	SENT_489	[p13l529t102r574b133],
10	,	,	O	,	_	0	SENT_489	[p13l529t102r574b133],
11	Hirsch	NNP	PERSON	Hirsch	nn	12	SENT_489	[p13l588t101r684b127],
12	MS.	NNP	O	MS.	appos	9	SENT_489	[p13l695t102r753b127],
13	2004	CD	DATE	2004	num	12	SENT_489	[p13l767t103r842b127],
14	.	.	O	.	_	0	SENT_489	[p13l767t103r842b127],

1	Antiretroviral	JJ	O	antiretroviral	amod	2	SENT_490	[p13l855t101r1047b127],
2	therapy	NN	O	therapy	_	0	SENT_490	[p13l1060t101r1167b136],
3	for	IN	O	for	_	0	SENT_490	[p13l1178t101r1219b127],
4	human	JJ	O	human	amod	7	SENT_490	[p13l1231t101r1327b127],
5	immunodeﬁciency	NN	O	immunodeﬁciency	nn	7	SENT_490	[p13l1340t101r1600b136],
6	virus	NN	O	virus	nn	7	SENT_490	[p13l1610t103r1677b127],
7	infection	NN	O	infection	prep_for	2	SENT_490	[p13l1690t101r1821b127],
8	.	.	O	.	_	0	SENT_490	[p13l1690t101r1821b127],

1	In	IN	O	in	_	0	SENT_491	[p13l1835t102r1865b127],
2	Principlex	NNP	LOCATION	Principlex	prep_in	12	SENT_491	[p13l420t148r546b181],
3	and	CC	O	and	_	0	SENT_491	[p13l554t148r604b173],
4	Practice	NNP	O	Practice	conj_and	2	SENT_491	[p13l611t148r713b173],
5	of	IN	O	of	_	0	SENT_491	[p13l723t147r752b181],
6	Infectionr	NNP	O	Infectionr	nn	7	SENT_491	[p13l753t147r876b181],
7	Direasec	NNP	O	Direasec	prep_of	2	SENT_491	[p13l885t148r996b178],
8	,	,	O	,	_	0	SENT_491	[p13l885t148r996b178],
9	6th	JJ	ORDINAL	6th	amod	10	SENT_491	[p13l1008t147r1053b173],
10	ed.	NN	O	ed.	appos	7	SENT_491	[p13l1064t147r1111b178],
11	,	,	O	,	_	0	SENT_491	[p13l1064t147r1111b178],
12	ed	VBN	O	ed	_	0	SENT_491	[p13l1123t147r1162b173],
13	.	.	O	.	_	0	SENT_491	[p13l1123t147r1162b173],

1	GL	NNP	O	GL	nn	2	SENT_492	[p13l1174t148r1222b173],
2	Mandell	NNP	PERSON	Mandell	_	0	SENT_492	[p13l1232t147r1356b178],
3	,	,	O	,	_	0	SENT_492	[p13l1232t147r1356b178],
4	JE	NNP	PERSON	JE	nn	5	SENT_492	[p13l1364t148r1402b179],
5	Bennett	NNP	PERSON	Bennett	appos	2	SENT_492	[p13l1412t148r1529b178],
6	,	,	O	,	_	0	SENT_492	[p13l1412t148r1529b178],
7	R	NNP	O	R	nn	8	SENT_492	[p13l1541t148r1564b172],
8	Dolin	NNP	PERSON	Dolin	appos	2	SENT_492	[p13l1574t147r1662b178],
9	,	,	O	,	_	0	SENT_492	[p13l1574t147r1662b178],
10	1	CD	NUMBER	1	num	11	SENT_492	[p13l1677t148r1786b179],
11	(	NN	O	(	appos	8	SENT_492	[p13l1677t148r1786b179],
12	2	CD	NUMBER	2	number	13	SENT_492	[p13l1677t148r1786b179],
13	)	CD	NUMBER	)	dep	2	SENT_492	[p13l1677t148r1786b179],
14	:165	CD	NUMBER	:165	num	15	SENT_492	[p13l1677t148r1786b179],
15	5-78	CD	NUMBER	5-78	dep	13	SENT_492	[p13l1791t148r1863b173],
16	.	.	O	.	_	0	SENT_492	[p13l1791t148r1863b173],

1	Philadelphia	NNP	LOCATION	Philadelphia	_	0	SENT_493	[p13l421t193r602b227],
2	:	:	O	:	_	0	SENT_493	[p13l421t193r602b227],
3	Elsevier	NNP	ORGANIZATION	Elsevier	nn	5	SENT_493	[p13l614t193r726b218],
4	Cleghorn	NNP	ORGANIZATION	Cleghorn	nn	5	SENT_493	[p13l422t237r555b271],
5	FR	NN	ORGANIZATION	fr	dep	1	SENT_493	[p13l566t238r616b268],
6	,	,	O	,	_	0	SENT_493	[p13l566t238r616b268],
7	Reitz	NNP	PERSON	Reitz	nn	9	SENT_493	[p13l628t238r701b262],
8	MS	NN	PERSON	m	nn	9	SENT_493	[p13l710t238r760b262],
9	Jr	NNP	PERSON	Jr	appos	5	SENT_493	[p13l768t238r803b269],
10	,	,	O	,	_	0	SENT_493	[p13l768t238r803b269],
11	Popovic	NNP	PERSON	Popovic	nn	12	SENT_493	[p13l815t238r928b271],
12	M	NNP	O	M	appos	5	SENT_493	[p13l938t238r977b268],
13	,	,	O	,	_	0	SENT_493	[p13l938t238r977b268],
14	Gallo	NNP	O	Gallo	nn	15	SENT_493	[p13l990t237r1067b262],
15	RC	NNP	O	RC	appos	5	SENT_493	[p13l1078t238r1133b262],
16	.	.	O	.	_	0	SENT_493	[p13l1078t238r1133b262],

1	2007	CD	DATE	2007	_	0	SENT_494	[p13l1145t238r1220b263],
2	.	.	O	.	_	0	SENT_494	[p13l1145t238r1220b263],

1	Human	JJ	O	human	amod	2	SENT_495	[p13l1232t238r1339b262],
2	immunodeﬁciency	NN	O	immunodeﬁciency	_	0	SENT_495	[p13l1350t237r1610b271],
3	viruses	NNS	O	virus	dep	2	SENT_495	[p13l1618t238r1720b262],
4	.	.	O	.	_	0	SENT_495	[p13l1618t238r1720b262],

1	In	IN	O	in	_	0	SENT_496	[p13l1733t238r1763b262],
2	Principles	NNS	O	principle	prep_in	12	SENT_496	[p13l1773t238r1864b262, p13l417t283r467b316],
3	and	CC	O	and	_	0	SENT_496	[p13l476t283r526b308],
4	Practice	NN	O	practice	conj_and	2	SENT_496	[p13l534t284r636b308],
5	of	IN	O	of	_	0	SENT_496	[p13l647t283r676b317],
6	Infectious	JJ	O	infectious	amod	7	SENT_496	[p13l679t283r801b317],
7	Direaxer	NN	O	direaxer	prep_of	2	SENT_496	[p13l811t284r922b314],
8	,	,	O	,	_	0	SENT_496	[p13l811t284r922b314],
9	6th	JJ	ORDINAL	6th	amod	10	SENT_496	[p13l935t282r980b308],
10	ed.	NN	O	ed.	appos	7	SENT_496	[p13l992t282r1040b314],
11	,	,	O	,	_	0	SENT_496	[p13l992t282r1040b314],
12	ed	VBN	O	ed	_	0	SENT_496	[p13l1053t282r1092b308],
13	.	.	O	.	_	0	SENT_496	[p13l1053t282r1092b308],

1	GL	NNP	O	GL	nn	2	SENT_497	[p13l1105t283r1153b308],
2	Mandell	NNP	PERSON	Mandell	_	0	SENT_497	[p13l1164t282r1288b314],
3	,	,	O	,	_	0	SENT_497	[p13l1164t282r1288b314],
4	RG	NNP	PERSON	RG	nn	5	SENT_497	[p13l1301t283r1351b308],
5	Douglas	NNP	PERSON	Douglas	appos	2	SENT_497	[p13l1363t282r1485b317],
6	,	,	O	,	_	0	SENT_497	[p13l1363t282r1485b317],
7	JE	NNP	PERSON	JE	nn	8	SENT_497	[p13l1494t284r1532b315],
8	Bennett	NNP	PERSON	Bennett	appos	2	SENT_497	[p13l1543t284r1661b314],
9	,	,	O	,	_	0	SENT_497	[p13l1543t284r1661b314],
10	2	CD	NUMBER	2	number	11	SENT_497	[p13l1674t283r1863b315],
11	(	CD	NUMBER	(	appos	2	SENT_497	[p13l1674t283r1863b315],
12	3	CD	NUMBER	3	num	13	SENT_497	[p13l1674t283r1863b315],
13	)	NN	O	)	dep	11	SENT_497	[p13l1674t283r1863b315],
14	:2119	CD	NUMBER	:2119	number	15	SENT_497	[p13l1674t283r1863b315],
15	—	CD	NUMBER	—	dep	2	SENT_497	[p13l1674t283r1863b315],
16	33	CD	NUMBER	33	dep	15	SENT_497	[p13l1674t283r1863b315],
17	.	.	O	.	_	0	SENT_497	[p13l1674t283r1863b315],

1	Philadelphia	NNP	LOCATION	Philadelphia	_	0	SENT_498	[p13l421t328r602b362],
2	:	:	O	:	_	0	SENT_498	[p13l421t328r602b362],
3	Elsevier	NNP	O	Elsevier	dep	1	SENT_498	[p13l614t328r725b354],
4	.	.	O	.	_	0	SENT_498	[p13l397t393r402b398],

1	Johnson	NNP	ORGANIZATION	Johnson	nn	2	SENT_499	[p13l417t372r536b404],
2	AA	NNP	ORGANIZATION	AA	_	0	SENT_499	[p13l548t373r600b403],
3	,	,	O	,	_	0	SENT_499	[p13l548t373r600b403],
4	Marchand	NNP	PERSON	Marchand	nn	5	SENT_499	[p13l614t372r758b398],
5	C	NNP	O	C	appos	2	SENT_499	[p13l772t373r803b404],
6	,	,	O	,	_	0	SENT_499	[p13l772t373r803b404],
7	Marchand	NNP	PERSON	Marchand	nn	8	SENT_499	[p13l817t372r960b398],
8	C	NNP	O	C	appos	2	SENT_499	[p13l975t373r1006b403],
9	,	,	O	,	_	0	SENT_499	[p13l975t373r1006b403],
10	Pommier	NNP	O	Pommier	nn	11	SENT_499	[p13l1021t373r1152b398],
11	Y.	NNP	O	Y.	appos	2	SENT_499	[p13l1164t373r1193b398],
12	2004	CD	DATE	2004	dep	11	SENT_499	[p13l1209t374r1283b398],
13	.	.	O	.	_	0	SENT_499	[p13l1209t374r1283b398],

1	HIV-1	NN	MISC	hiv-1	nn	3	SENT_500	[p13l1299t373r1388b398],
2	integrase	NN	O	integrase	nn	3	SENT_500	[p13l1404t373r1530b406],
3	inhibitors	NNS	O	inhibitor	_	0	SENT_500	[p13l1544t372r1686b398],
4	:	:	O	:	_	0	SENT_500	[p13l1544t372r1686b398],
5	a	DT	DURATION	a	det	6	SENT_500	[p13l1702t382r1715b398],
6	decade	NN	DURATION	decade	dep	3	SENT_500	[p13l1730t372r1823b398],
7	of	IN	O	of	_	0	SENT_500	[p13l1838t372r1868b398],
8	research	NN	O	research	prep_of	6	SENT_500	[p13l421t418r537b444],
9	and	CC	O	and	_	0	SENT_500	[p13l547t418r596b444],
10	two	CD	NUMBER	two	num	11	SENT_500	[p13l606t425r657b444],
11	drugs	NNS	O	drug	dep	3	SENT_500	[p13l668t418r744b452],
12	in	IN	O	in	_	0	SENT_500	[p13l753t419r780b443],
13	clinical	JJ	O	clinical	amod	14	SENT_500	[p13l791t418r889b444],
14	trial	NN	O	trial	prep_in	11	SENT_500	[p13l898t418r961b444],
15	.	.	O	.	_	0	SENT_500	[p13l898t418r961b444],

1	Cur	NN	O	cur	_	0	SENT_501	[p13l974t419r1040b443],
2	}	CD	NUMBER	}	num	1	SENT_501	[p13l974t419r1040b443],
3	:	:	O	:	_	0	SENT_501	[p13l974t419r1040b443],
4	722p	CD	NUMBER	722p	dep	1	SENT_501	[p13l1054t419r1102b452],
5	.	.	O	.	_	0	SENT_501	[p13l1054t419r1102b452],

1	Med	NNP	O	Med	_	0	SENT_502	[p13l1113t419r1179b443],
2	.	.	O	.	_	0	SENT_502	[p13l1113t419r1179b443],

1	Chem	NNP	O	Chem	_	0	SENT_503	[p13l1193t419r1273b443],
2	.	.	O	.	_	0	SENT_503	[p13l1193t419r1273b443],

1	4	CD	NUMBER	4	number	2	SENT_504	[p13l1285t419r1415b450],
2	(	CD	NUMBER	(	num	3	SENT_504	[p13l1285t419r1415b450],
3	l0	NN	O	l0	_	0	SENT_504	[p13l1285t419r1415b450],
4	)	CD	NUMBER	)	number	5	SENT_504	[p13l1285t419r1415b450],
5	:105	CD	NUMBER	:105	dep	3	SENT_504	[p13l1285t419r1415b450],
6	9-77	CD	NUMBER	9-77	num	8	SENT_504	[p13l1419t419r1484b444],
7	Pommier	NNP	O	Pommier	nn	8	SENT_504	[p13l421t463r552b488],
8	Y	NN	O	y	dep	5	SENT_504	[p13l562t463r591b493],
9	,	,	O	,	_	0	SENT_504	[p13l562t463r591b493],
10	Johnson	NNP	ORGANIZATION	Johnson	nn	14	SENT_504	[p13l600t462r718b494],
11	AA	NNP	ORGANIZATION	AA	nn	14	SENT_504	[p13l728t463r780b493],
12	,	,	O	,	_	0	SENT_504	[p13l728t463r780b493],
13	Marchand	NNP	PERSON	Marchand	appos	14	SENT_504	[p13l791t462r935b488],
14	C.	NNP	O	C.	appos	5	SENT_504	[p13l947t463r978b488],
15	2005	CD	DATE	2005	num	14	SENT_504	[p13l991t463r1056b488],
16	.	.	O	.	_	0	SENT_504	[p13l1061t483r1065b487],

1	Integrase	NN	O	integrase	nn	2	SENT_505	[p13l1078t463r1206b496],
2	inhibitors	NNS	O	inhibitor	nsubj	4	SENT_505	[p13l1217t462r1353b488],
3	to	TO	O	to	aux	4	SENT_505	[p13l1365t469r1392b488],
4	treat	VB	O	treat	_	0	SENT_505	[p13l1404t469r1468b488],
5	HIV/AIDS	NN	O	hiv/aids	dobj	4	SENT_505	[p13l1478t463r1643b488],
6	.	.	O	.	_	0	SENT_505	[p13l1478t463r1643b488],

1	Nat	NN	PERSON	nat	_	0	SENT_506	[p13l1655t463r1712b488],
2	.	.	O	.	_	0	SENT_506	[p13l1655t463r1712b488],

1	Rev.	NNP	O	Rev.	nn	3	SENT_507	[p13l1725t463r1780b488],
2	Drag	NNP	PERSON	Drag	nn	3	SENT_507	[p13l1793t463r1866b497],
3	Discov	NNP	PERSON	Discov	_	0	SENT_507	[p13l421t509r510b533],
4	.	.	O	.	_	0	SENT_507	[p13l421t509r510b533],

1	4	CD	NUMBER	4	_	0	SENT_508	[p13l522t508r686b540],
2	(	CD	NUMBER	(	number	3	SENT_508	[p13l522t508r686b540],
3	3	CD	NUMBER	3	dep	1	SENT_508	[p13l522t508r686b540],
4	)	NN	O	)	dep	3	SENT_508	[p13l522t508r686b540],
5	:236	CD	NUMBER	:236	number	6	SENT_508	[p13l522t508r686b540],
6	—	CD	NUMBER	—	dep	1	SENT_508	[p13l522t508r686b540],
7	48	CD	NUMBER	48	num	9	SENT_508	[p13l522t508r686b540],
8	Dayam	NN	ORGANIZATION	dayam	nn	9	SENT_508	[p13l421t553r521b586],
9	R	NN	ORGANIZATION	r	dep	6	SENT_508	[p13l531t553r560b583],
10	,	,	O	,	_	0	SENT_508	[p13l531t553r560b583],
11	Al-Mawsawi	NNP	ORGANIZATION	Al-Mawsawi	nn	12	SENT_508	[p13l570t551r744b577],
12	LQ	NNP	ORGANIZATION	LQ	appos	1	SENT_508	[p13l754t553r811b583],
13	,	,	O	,	_	0	SENT_508	[p13l754t553r811b583],
14	Neamati	NNP	O	Neamati	nn	15	SENT_508	[p13l822t553r943b577],
15	N.	NNP	O	N.	appos	1	SENT_508	[p13l952t553r988b577],
16	2007	CD	DATE	2007	dep	15	SENT_508	[p13l999t553r1074b578],
17	.	.	O	.	_	0	SENT_508	[p13l999t553r1074b578],

1	HIV-1	NN	MISC	hiv-1	nn	3	SENT_509	[p13l1085t553r1174b577],
2	integrase	NN	O	integrase	nn	3	SENT_509	[p13l1187t553r1312b586],
3	inhibitors	NNS	O	inhibitor	_	0	SENT_509	[p13l1322t551r1465b577],
4	:	:	O	:	_	0	SENT_509	[p13l1322t551r1465b577],
5	an	DT	O	a	det	8	SENT_509	[p13l1477t561r1509b577],
6	emerging	VBG	O	emerge	amod	8	SENT_509	[p13l1519t553r1652b586],
7	clinical	JJ	O	clinical	amod	8	SENT_509	[p13l1661t552r1759b577],
8	reality	NN	O	reality	dep	3	SENT_509	[p13l1769t552r1863b586],
9	.	.	O	.	_	0	SENT_509	[p13l1769t552r1863b586],

1	Drugs	NNS	O	drug	nn	3	SENT_510	[p13l421t598r503b632],
2	R	NN	O	r	nn	3	SENT_510	[p13l511t598r532b623],
3	D	NN	O	d	_	0	SENT_510	[p13l541t598r566b623],
4	8	CD	NUMBER	8	num	5	SENT_510	[p13l577t598r740b630],
5	(	NN	O	(	dep	3	SENT_510	[p13l577t598r740b630],
6	3	CD	NUMBER	3	num	7	SENT_510	[p13l577t598r740b630],
7	)	NN	O	)	dep	5	SENT_510	[p13l577t598r740b630],
8	:155	CD	NUMBER	:155	num	9	SENT_510	[p13l577t598r740b630],
9	-68	CD	NUMBER	-68	dep	3	SENT_510	[p13l577t598r740b630],
10	Deleted	JJ	O	deleted	amod	9	SENT_510	[p13l421t642r532b668],
11	in	IN	O	in	_	0	SENT_510	[p13l541t644r568b668],
12	proof	NN	O	proof	nn	14	SENT_510	[p13l578t643r657b677],
13	Hazuda	NNP	O	Hazuda	nn	14	SENT_510	[p13l421t686r529b712],
14	D.	NNP	O	D.	prep_in	10	SENT_510	[p13l538t688r571b712],
15	2006	CD	DATE	2006	num	14	SENT_510	[p13l581t688r656b712],
16	.	.	O	.	_	0	SENT_510	[p13l581t688r656b712],

1	Inhibitors	NNS	O	inhibitor	_	0	SENT_511	[p13l666t686r804b712],
2	of	IN	O	of	_	0	SENT_511	[p13l813t687r844b712],
3	human	JJ	O	human	amod	8	SENT_511	[p13l848t686r945b712],
4	immunodeﬁciency	NN	O	immunodeﬁciency	nn	8	SENT_511	[p13l953t687r1213b721],
5	virus	NN	O	virus	nn	8	SENT_511	[p13l1219t688r1286b712],
6	type	NN	O	type	nn	8	SENT_511	[p13l1295t694r1354b721],
7	I	CD	NUMBER	i	num	8	SENT_511	[p13l1363t688r1374b712],
8	integration	NN	O	integration	prep_of	1	SENT_511	[p13l1382t688r1544b721],
9	.	.	O	.	_	0	SENT_511	[p13l1382t688r1544b721],

1	Curr	NN	O	curr	_	0	SENT_512	[p13l1556t687r1622b712],
2	.	.	O	.	_	0	SENT_512	[p13l1556t687r1622b712],

1	Opin	NNP	PERSON	Opin	_	0	SENT_513	[p13l1635t687r1703b721],
2	.	.	O	.	_	0	SENT_513	[p13l1635t687r1703b721],

1	HI	NN	O	hus	nn	2	SENT_514	[p13l1714t688r1755b712],
2	V/AIDS	NN	O	v/aids	_	0	SENT_514	[p13l1756t687r1866b712],
3	1:2	CD	NUMBER	1:2	number	4	SENT_514	[p13l424t734r460b758],
4	12-17	CD	NUMBER	12-17	dep	2	SENT_514	[p13l467t733r547b758],
5	Chiu	NNP	O	Chiu	dep	4	SENT_514	[p13l422t776r491b802],
6	TK	NN	O	tk	dep	2	SENT_514	[p13l501t777r559b808],
7	,	,	O	,	_	0	SENT_514	[p13l501t777r559b808],
8	Davies	NNP	PERSON	Davies	nn	9	SENT_514	[p13l572t778r665b802],
9	DR.	NNP	O	DR.	appos	6	SENT_514	[p13l677t777r734b802],
10	2006	CD	DATE	2006	num	9	SENT_514	[p13l747t778r821b802],
11	.	.	O	.	_	0	SENT_514	[p13l747t778r821b802],

1	Structure	NN	O	structure	_	0	SENT_515	[p13l835t777r965b802],
2	and	CC	O	and	_	0	SENT_515	[p13l977t776r1026b802],
3	function	NN	O	function	conj_and	1	SENT_515	[p13l1038t776r1155b802],
4	of	IN	O	of	_	0	SENT_515	[p13l1166t776r1197b802],
5	HIV-1	NN	MISC	hiv-1	nn	6	SENT_515	[p13l1204t777r1293b802],
6	integrase	NN	O	integrase	prep_of	1	SENT_515	[p13l1308t778r1440b811],
7	:	:	O	:	_	0	SENT_515	[p13l1308t778r1440b811],
8	an	DT	O	a	nsubj	9	SENT_515	[p13l1454t786r1485b802],
9	update	VBP	O	update	dep	1	SENT_515	[p13l1496t776r1597b810],
10	.	.	O	.	_	0	SENT_515	[p13l1496t776r1597b810],

1	Front	NN	O	front	_	0	SENT_516	[p13l1609t777r1689b802],
2	.	.	O	.	_	0	SENT_516	[p13l1609t777r1689b802],

1	Med	NNP	O	Med	_	0	SENT_517	[p13l1701t777r1766b802],
2	.	.	O	.	_	0	SENT_517	[p13l1701t777r1766b802],

1	C/yem	NNP	O	C/yem	_	0	SENT_518	[p13l1782t777r1862b802],
2	.	.	O	.	_	0	SENT_518	[p13l1782t777r1862b802],

1	321-20	CD	NUMBER	321-20	num	3	SENT_519	[p13l423t824r514b848],
2	Chiu	NNP	O	Chiu	nn	3	SENT_519	[p13l422t866r491b892],
3	TK	NN	O	tk	_	0	SENT_519	[p13l496t866r554b897],
4	,	,	O	,	_	0	SENT_519	[p13l496t866r554b897],
5	Davies	NNP	PERSON	Davies	nn	6	SENT_519	[p13l562t867r655b892],
6	DR.	NNP	O	DR.	appos	3	SENT_519	[p13l662t867r719b891],
7	2004	CD	DATE	2004	dep	6	SENT_519	[p13l727t867r802b892],
8	.	.	O	.	_	0	SENT_519	[p13l727t867r802b892],

1	Structure	NN	O	structure	_	0	SENT_520	[p13l811t866r941b892],
2	and	CC	O	and	_	0	SENT_520	[p13l948t865r997b892],
3	function	NN	O	function	conj_and	1	SENT_520	[p13l1004t866r1121b892],
4	of	IN	O	of	_	0	SENT_520	[p13l1127t866r1158b892],
5	HIV-1	NN	MISC	hiv-1	nn	6	SENT_520	[p13l1160t867r1250b892],
6	integrase	NN	O	integrase	prep_of	1	SENT_520	[p13l1259t867r1392b900],
7	.	.	O	.	_	0	SENT_520	[p13l1259t867r1392b900],

1	Curr	NN	O	curr	_	0	SENT_521	[p13l1401t866r1467b892],
2	.	.	O	.	_	0	SENT_521	[p13l1401t866r1467b892],

1	Top	NNP	O	Top	_	0	SENT_522	[p13l1478t866r1526b900],
2	.	.	O	.	_	0	SENT_522	[p13l1478t866r1526b900],

1	Med	NNP	O	Med	_	0	SENT_523	[p13l1534t866r1599b892],
2	.	.	O	.	_	0	SENT_523	[p13l1534t866r1599b892],

1	Chem	NNP	O	Chem	_	0	SENT_524	[p13l1610t866r1690b892],
2	.	.	O	.	_	0	SENT_524	[p13l1610t866r1690b892],

1	4	CD	NUMBER	4	_	0	SENT_525	[p13l1699t866r1863b898],
2	(	CD	NUMBER	(	number	3	SENT_525	[p13l1699t866r1863b898],
3	9	CD	NUMBER	9	dep	1	SENT_525	[p13l1699t866r1863b898],
4	)	NN	O	)	dep	3	SENT_525	[p13l1699t866r1863b898],
5	:965	CD	NUMBER	:965	num	4	SENT_525	[p13l1699t866r1863b898],
6	-77	CD	NUMBER	-77	num	8	SENT_525	[p13l1699t866r1863b898],
7	Goldgur	NNP	O	Goldgur	nn	8	SENT_525	[p13l422t910r541b945],
8	Y	NN	O	y	dep	1	SENT_525	[p13l551t911r580b942],
9	,	,	O	,	_	0	SENT_525	[p13l551t911r580b942],
10	Dyda	NN	O	dyda	nn	11	SENT_525	[p13l593t910r667b945],
11	F	NN	O	f	appos	8	SENT_525	[p13l678t911r705b942],
12	,	,	O	,	_	0	SENT_525	[p13l678t911r705b942],
13	Hickman	NNP	ORGANIZATION	Hickman	nn	14	SENT_525	[p13l717t910r846b936],
14	AB	NNP	ORGANIZATION	AB	appos	8	SENT_525	[p13l856t911r907b942],
15	,	,	O	,	_	0	SENT_525	[p13l856t911r907b942],
16	Jenkins	NNP	PERSON	Jenkins	nn	17	SENT_525	[p13l915t910r1020b942],
17	TM	NNP	O	TM	appos	8	SENT_525	[p13l1031t911r1096b942],
18	,	,	O	,	_	0	SENT_525	[p13l1031t911r1096b942],
19	Craigie	NNP	ORGANIZATION	Craigie	nn	20	SENT_525	[p13l1109t911r1210b945],
20	R	NNP	ORGANIZATION	R	appos	8	SENT_525	[p13l1222t911r1251b942],
21	,	,	O	,	_	0	SENT_525	[p13l1222t911r1251b942],
22	Davies	NNP	PERSON	Davies	nn	23	SENT_525	[p13l1264t911r1356b936],
23	DR.	NNP	O	DR.	appos	8	SENT_525	[p13l1368t911r1425b936],
24	1998	CD	DATE	1998	dep	23	SENT_525	[p13l1441t912r1512b936],
25	.	.	O	.	_	0	SENT_525	[p13l1441t912r1512b936],

1	Three	CD	NUMBER	three	num	3	SENT_526	[p13l1524t910r1611b936],
2	new	JJ	O	new	amod	3	SENT_526	[p13l1622t920r1679b936],
3	structures	NNS	O	structure	_	0	SENT_526	[p13l1690t917r1826b936],
4	of	IN	O	of	_	0	SENT_526	[p13l1838t910r1868b936],
5	the	DT	O	the	det	7	SENT_526	[p13l421t956r465b982],
6	core	NN	O	core	nn	7	SENT_526	[p13l479t966r538b982],
7	domain	NN	O	domain	prep_of	3	SENT_526	[p13l552t956r656b982],
8	of	IN	O	of	_	0	SENT_526	[p13l670t956r700b982],
9	HIV-1	NN	MISC	hiv-1	nn	10	SENT_526	[p13l709t957r798b982],
10	integrase	NN	O	integrase	prep_of	7	SENT_526	[p13l815t957r947b990],
11	:	:	O	:	_	0	SENT_526	[p13l815t957r947b990],
12	an	DT	O	a	det	14	SENT_526	[p13l963t966r994b982],
13	active	JJ	O	active	amod	14	SENT_526	[p13l1008t957r1087b982],
14	site	NN	O	site	dep	3	SENT_526	[p13l1101t957r1147b982],
15	that	WDT	O	that	nsubj	16	SENT_526	[p13l1161t956r1216b982],
16	binds	VBZ	O	bind	rcmod	14	SENT_526	[p13l1228t956r1302b982],
17	magnesium	NN	O	magnesium	dobj	16	SENT_526	[p13l1315t957r1482b990],
18	.	.	O	.	_	0	SENT_526	[p13l1315t957r1482b990],

1	Proc	NNP	O	Proc	_	0	SENT_527	[p13l1496t957r1558b982],
2	.	.	O	.	_	0	SENT_527	[p13l1496t957r1558b982],

1	Natl.	NNP	O	Natl.	nn	2	SENT_528	[p13l1573t957r1639b982],
2	Acad	NNP	O	Acad	_	0	SENT_528	[p13l1652t957r1724b982],
3	.	.	O	.	_	0	SENT_528	[p13l1652t957r1724b982],

1	Sci	NNP	O	Sci	_	0	SENT_529	[p13l1740t957r1783b982],
2	.	.	O	.	_	0	SENT_529	[p13l1740t957r1783b982],

1	USA	NNP	ORGANIZATION	USA	_	0	SENT_530	[p13l1802t957r1864b982],
2	95	CD	NUMBER	95	num	1	SENT_530	[p13l422t1002r639b1034],
3	(	CD	NUMBER	(	number	4	SENT_530	[p13l422t1002r639b1034],
4	16	CD	NUMBER	16	dep	1	SENT_530	[p13l422t1002r639b1034],
5	)	NN	O	)	dep	4	SENT_530	[p13l422t1002r639b1034],
6	:9150	CD	NUMBER	:9150	num	5	SENT_530	[p13l422t1002r639b1034],
7	-54	CD	NUMBER	-54	num	9	SENT_530	[p13l422t1002r639b1034],
8	Dyda	NN	O	dyda	nn	9	SENT_530	[p13l421t1046r496b1080],
9	F	NN	O	f	dep	1	SENT_530	[p13l503t1047r529b1077],
10	,	,	O	,	_	0	SENT_530	[p13l503t1047r529b1077],
11	Hickman	NNP	ORGANIZATION	Hickman	nn	12	SENT_530	[p13l537t1046r666b1072],
12	AB	NNP	ORGANIZATION	AB	appos	9	SENT_530	[p13l672t1046r831b1078],
13	,	,	O	,	_	0	SENT_530	[p13l672t1046r831b1078],
14	Jenkins	NNP	PERSON	Jenkins	nn	15	SENT_530	[p13l672t1046r831b1078],
15	TM	NNP	O	TM	appos	9	SENT_530	[p13l837t1046r902b1077],
16	,	,	O	,	_	0	SENT_530	[p13l837t1046r902b1077],
17	Engelman	NNP	PERSON	Engelman	nn	18	SENT_530	[p13l910t1046r1053b1080],
18	A	NNP	O	A	appos	9	SENT_530	[p13l1058t1047r1088b1077],
19	,	,	O	,	_	0	SENT_530	[p13l1058t1047r1088b1077],
20	Craigie	NNP	ORGANIZATION	Craigie	nn	21	SENT_530	[p13l1096t1047r1198b1080],
21	R	NNP	ORGANIZATION	R	appos	9	SENT_530	[p13l1205t1047r1235b1077],
22	,	,	O	,	_	0	SENT_530	[p13l1205t1047r1235b1077],
23	Davies	NNP	PERSON	Davies	nn	24	SENT_530	[p13l1243t1047r1335b1072],
24	DR.	NNP	O	DR.	appos	9	SENT_530	[p13l1343t1047r1399b1071],
25	1994	CD	DATE	1994	dep	24	SENT_530	[p13l1411t1047r1482b1072],
26	.	.	O	.	_	0	SENT_530	[p13l1411t1047r1482b1072],

1	Crystal	NNP	O	Crystal	nn	2	SENT_531	[p13l1491t1046r1590b1080],
2	structure	NN	O	structure	_	0	SENT_531	[p13l1597t1053r1722b1072],
3	of	IN	O	of	_	0	SENT_531	[p13l1729t1046r1759b1072],
4	the	DT	O	the	det	6	SENT_531	[p13l1762t1046r1806b1072],
5	catalytic	JJ	O	catalytic	amod	6	SENT_531	[p13l1813t1053r1864b1072, p13l422t1091r495b1126],
6	domain	NN	O	domain	prep_of	2	SENT_531	[p13l502t1091r606b1117],
7	of	IN	O	of	_	0	SENT_531	[p13l612t1091r643b1117],
8	HIV-1	NN	MISC	hiv-1	nn	9	SENT_531	[p13l645t1092r734b1117],
9	integrase	NN	O	integrase	prep_of	6	SENT_531	[p13l744t1093r876b1126],
10	:	:	O	:	_	0	SENT_531	[p13l744t1093r876b1126],
11	similarity	NN	O	similarity	dep	2	SENT_531	[p13l884t1091r1016b1125],
12	to	TO	O	to	_	0	SENT_531	[p13l1021t1098r1048b1117],
13	other	JJ	O	other	amod	15	SENT_531	[p13l1055t1091r1130b1117],
14	polynucleotidyl	NN	O	polynucleotidyl	nn	15	SENT_531	[p13l1135t1091r1352b1126],
15	transferases	NNS	O	transferase	prep_to	11	SENT_531	[p13l1358t1091r1527b1117],
16	.	.	O	.	_	0	SENT_531	[p13l1358t1091r1527b1117],

1	Science	NNP	O	Science	_	0	SENT_532	[p13l1535t1092r1624b1117],
2	266	CD	NUMBER	266	num	1	SENT_532	[p13l1631t1092r1706b1123],
3	(	CD	NUMBER	(	number	4	SENT_532	[p13l1631t1092r1706b1123],
4	5	CD	NUMBER	5	dep	1	SENT_532	[p13l1631t1092r1706b1123],
5	193	CD	NUMBER	193	num	6	SENT_532	[p13l1713t1092r1866b1123],
6	)	NN	O	)	dep	4	SENT_532	[p13l1713t1092r1866b1123],
7	:1981	CD	NUMBER	:1981	num	11	SENT_532	[p13l1713t1092r1866b1123],
8	—	CD	NUMBER	—	num	11	SENT_532	[p13l1713t1092r1866b1123],
9	86	CD	NUMBER	86	num	11	SENT_532	[p13l422t1138r454b1162],
10	Hazuda	NNP	O	Hazuda	nn	11	SENT_532	[p13l421t1181r529b1207],
11	DJ	NNP	O	DJ	dep	1	SENT_532	[p13l540t1182r586b1214],
12	,	,	O	,	_	0	SENT_532	[p13l540t1182r586b1214],
13	Felock	NNP	PERSON	Felock	appos	11	SENT_532	[p13l599t1181r693b1207],
14	P	NN	PERSON	p	nn	19	SENT_532	[p13l703t1182r730b1213],
15	,	,	O	,	_	0	SENT_532	[p13l703t1182r730b1213],
16	VVlt	NN	O	vvlt	dep	19	SENT_532	[p13l742t1182r853b1207],
17	'	''	O	'	_	0	SENT_532	[p13l742t1182r853b1207],
18	I1	NN	O	i1	nn	19	SENT_532	[p13l742t1182r853b1207],
19	’	NN	O	’	dep	1	SENT_532	[p13l742t1182r853b1207],
20	1	CD	NUMBER	1	num	21	SENT_532	[p13l742t1182r853b1207],
21	€	NN	MONEY	€	dep	19	SENT_532	[p13l742t1182r853b1207],
22	1	CD	MONEY	1	number	23	SENT_532	[p13l742t1182r853b1207],
23	‘	CD	MONEY	‘	dep	1	SENT_532	[p13l742t1182r853b1207],
24	M	NN	O	m	dep	23	SENT_532	[p13l863t1182r902b1213],
25	,	,	O	,	_	0	SENT_532	[p13l863t1182r902b1213],
26	Wolfe	NNP	PERSON	Wolfe	nn	27	SENT_532	[p13l914t1181r999b1207],
27	A	NNP	O	A	appos	1	SENT_532	[p13l1010t1182r1039b1213],
28	,	,	O	,	_	0	SENT_532	[p13l1010t1182r1039b1213],
29	Stillmock	NNP	PERSON	Stillmock	nn	30	SENT_532	[p13l1053t1181r1186b1207],
30	K	NNP	PERSON	K	appos	1	SENT_532	[p13l1196t1182r1227b1213],
31	,	,	O	,	_	0	SENT_532	[p13l1196t1182r1227b1213],
32	et	FW	O	et	nn	33	SENT_532	[p13l1241t1188r1266b1207],
33	al.	FW	O	al.	appos	1	SENT_532	[p13l1277t1181r1306b1207],
34	2000	CD	DATE	2000	dep	33	SENT_532	[p13l1320t1183r1394b1207],
35	.	.	O	.	_	0	SENT_532	[p13l1320t1183r1394b1207],

1	Inhibitors	NNS	O	inhibitor	_	0	SENT_533	[p13l1407t1181r1545b1207],
2	of	IN	O	of	_	0	SENT_533	[p13l1557t1181r1587b1207],
3	strand	NN	O	strand	nn	4	SENT_533	[p13l1595t1181r1681b1207],
4	transfer	NN	O	transfer	prep_of	1	SENT_533	[p13l1693t1181r1800b1207],
5	that	WDT	O	that	nsubj	9	SENT_533	[p13l1811t1181r1866b1207],
6	prevent	VBP	O	prevent	rcmod	4	SENT_533	[p13l421t1230r527b1258],
7	integration	NN	O	integration	dobj	6	SENT_533	[p13l536t1225r691b1258],
8	and	CC	O	and	_	0	SENT_533	[p13l701t1223r750b1249],
9	inhibit	VBP	O	inhibit	rcmod	4	SENT_533	[p13l760t1223r853b1249],
10	HIV-1	NN	MISC	hiv-1	nn	11	SENT_533	[p13l862t1224r951b1249],
11	replication	NN	O	replication	dobj	9	SENT_533	[p13l964t1223r1114b1258],
12	in	IN	O	in	_	0	SENT_533	[p13l1123t1224r1150b1249],
13	cells	NNS	O	cell	prep_in	9	SENT_533	[p13l1160t1223r1226b1249],
14	.	.	O	.	_	0	SENT_533	[p13l1160t1223r1226b1249],

1	Science	NNP	O	Science	nn	9	SENT_534	[p13l1238t1224r1327b1249],
2	287	CD	NUMBER	287	num	9	SENT_534	[p13l1337t1224r1588b1256],
3	(	CD	NUMBER	(	num	9	SENT_534	[p13l1337t1224r1588b1256],
4	5453	CD	NUMBER	5453	num	9	SENT_534	[p13l1337t1224r1588b1256],
5	)	CD	NUMBER	)	num	9	SENT_534	[p13l1337t1224r1588b1256],
6	:646	CD	NUMBER	:646	num	9	SENT_534	[p13l1337t1224r1588b1256],
7	-50	CD	NUMBER	-50	num	9	SENT_534	[p13l1337t1224r1588b1256],
8	Espeseth	NNP	PERSON	Espeseth	nn	9	SENT_534	[p13l421t1266r545b1301],
9	AS	NNP	O	AS	_	0	SENT_534	[p13l558t1267r605b1298],
10	,	,	O	,	_	0	SENT_534	[p13l558t1267r605b1298],
11	Felock	NNP	PERSON	Felock	nn	12	SENT_534	[p13l620t1266r714b1292],
12	P	NN	PERSON	p	appos	9	SENT_534	[p13l726t1267r753b1298],
13	,	,	O	,	_	0	SENT_534	[p13l726t1267r753b1298],
14	Wolfe	NNP	PERSON	Wolfe	nn	15	SENT_534	[p13l767t1266r853b1292],
15	A	NNP	O	A	appos	9	SENT_534	[p13l865t1267r895b1298],
16	,	,	O	,	_	0	SENT_534	[p13l865t1267r895b1298],
17	Witmer	NNP	PERSON	Witmer	nn	18	SENT_534	[p13l908t1267r1020b1292],
18	M	NNP	O	M	appos	9	SENT_534	[p13l1032t1267r1071b1298],
19	,	,	O	,	_	0	SENT_534	[p13l1032t1267r1071b1298],
20	Grobler	NNP	PERSON	Grobler	nn	21	SENT_534	[p13l1086t1266r1199b1292],
21	J	NNP	PERSON	J	appos	9	SENT_534	[p13l1208t1267r1230b1299],
22	,	,	O	,	_	0	SENT_534	[p13l1208t1267r1230b1299],
23	et	FW	O	et	nn	24	SENT_534	[p13l1245t1274r1271b1292],
24	al.	FW	O	al.	appos	9	SENT_534	[p13l1284t1266r1313b1292],
25	2000	CD	DATE	2000	dep	24	SENT_534	[p13l1328t1268r1403b1292],
26	.	.	O	.	_	0	SENT_534	[p13l1328t1268r1403b1292],

1	HIV-1	NN	MISC	hiv-1	nn	3	SENT_535	[p13l1418t1267r1507b1292],
2	integrase	NN	O	integrase	nn	3	SENT_535	[p13l1523t1268r1648b1301],
3	inhibitors	NNS	O	inhibitor	nsubj	11	SENT_535	[p13l1662t1266r1797b1292],
4	that	WDT	O	that	nsubj	5	SENT_535	[p13l1811t1266r1866b1292],
5	compete	VBP	O	compete	rcmod	3	SENT_535	[p13l421t1316r539b1343],
6	with	IN	O	with	_	0	SENT_535	[p13l553t1309r615b1335],
7	the	DT	O	the	det	10	SENT_535	[p13l629t1309r673b1335],
8	target	NN	O	target	nn	10	SENT_535	[p13l687t1316r770b1343],
9	DNA	NN	O	dna	nn	10	SENT_535	[p13l783t1310r862b1334],
10	substrate	NN	O	substrate	prep_with	5	SENT_535	[p13l875t1309r999b1335],
11	deﬁne	VBP	O	deﬁne	_	0	SENT_535	[p13l1014t1309r1098b1335],
12	a	DT	O	a	det	16	SENT_535	[p13l1113t1319r1126b1335],
13	unique	JJ	O	unique	amod	16	SENT_535	[p13l1140t1310r1235b1343],
14	strand	NN	O	strand	nn	16	SENT_535	[p13l1250t1309r1336b1335],
15	transfer	NN	O	transfer	nn	16	SENT_535	[p13l1351t1309r1458b1335],
16	conformation	NN	O	conformation	dobj	11	SENT_535	[p13l1472t1309r1662b1335],
17	for	IN	O	for	_	0	SENT_535	[p13l1676t1309r1717b1335],
18	integrase	NN	O	integrase	prep_for	16	SENT_535	[p13l1730t1310r1863b1343],
19	.	.	O	.	_	0	SENT_535	[p13l1730t1310r1863b1343],

1	Proc	NNP	O	Proc	_	0	SENT_536	[p13l420t1352r482b1377],
2	.	.	O	.	_	0	SENT_536	[p13l420t1352r482b1377],

1	Natl.	NNP	O	Natl.	nn	2	SENT_537	[p13l494t1352r560b1377],
2	Acad	NNP	O	Acad	_	0	SENT_537	[p13l569t1352r641b1377],
3	.	.	O	.	_	0	SENT_537	[p13l569t1352r641b1377],

1	Sci	NNP	O	Sci	_	0	SENT_538	[p13l654t1352r696b1377],
2	.	.	O	.	_	0	SENT_538	[p13l654t1352r696b1377],

1	USA	NNP	ORGANIZATION	USA	nsubj	12	SENT_539	[p13l712t1352r774b1377],
2	97	CD	NUMBER	97	num	1	SENT_539	[p13l785t1352r1019b1383],
3	(	CD	NUMBER	(	num	5	SENT_539	[p13l785t1352r1019b1383],
4	21	CD	NUMBER	21	num	5	SENT_539	[p13l785t1352r1019b1383],
5	)	NN	O	)	dep	1	SENT_539	[p13l785t1352r1019b1383],
6	:11244	CD	NUMBER	:11244	number	7	SENT_539	[p13l785t1352r1019b1383],
7	—	CD	NUMBER	—	dep	1	SENT_539	[p13l785t1352r1019b1383],
8	49	CD	NUMBER	49	num	10	SENT_539	[p13l785t1352r1019b1383],
9	Wiskerchen	NN	O	wiskerchen	nn	10	SENT_539	[p13l420t1393r589b1419],
10	M	NN	O	m	dep	7	SENT_539	[p13l594t1394r633b1425],
11	,	,	O	,	_	0	SENT_539	[p13l594t1394r633b1425],
12	Muesing	VBG	O	muese	_	0	SENT_539	[p13l639t1394r763b1428],
13	MA	NNP	O	MA	dobj	12	SENT_539	[p13l767t1394r828b1419],
14	.	.	O	.	_	0	SENT_539	[p13l767t1394r828b1419],

1	1995	CD	DATE	1995	_	0	SENT_540	[p13l839t1394r911b1419],
2	.	.	O	.	_	0	SENT_540	[p13l839t1394r911b1419],

1	Human	JJ	O	human	amod	4	SENT_541	[p13l919t1394r1025b1419],
2	immunodeﬁciency	NN	O	immunodeﬁciency	nn	4	SENT_541	[p13l1031t1393r1291b1428],
3	virus	NN	O	virus	nn	4	SENT_541	[p13l1295t1394r1362b1419],
4	type	NN	O	type	_	0	SENT_541	[p13l1369t1401r1428b1428],
5	1	CD	NUMBER	1	num	6	SENT_541	[p13l1438t1395r1447b1419],
6	integrase	NN	O	integrase	dep	4	SENT_541	[p13l1457t1395r1589b1428],
7	:	:	O	:	_	0	SENT_541	[p13l1457t1395r1589b1428],
8	effects	NNS	O	effect	dep	4	SENT_541	[p13l1598t1393r1686b1419],
9	of	IN	O	of	_	0	SENT_541	[p13l1693t1393r1723b1419],
10	mutations	NNS	O	mutation	prep_of	8	SENT_541	[p13l1726t1395r1864b1419],
11	on	IN	O	on	_	0	SENT_541	[p13l421t1446r456b1462],
12	viral	JJ	O	viral	amod	13	SENT_541	[p13l467t1436r529b1462],
13	ability	NN	O	ability	prep_on	10	SENT_541	[p13l542t1436r629b1471],
14	to	TO	O	to	aux	15	SENT_541	[p13l640t1444r667b1462],
15	integrate	VB	O	integrate	infmod	8	SENT_541	[p13l680t1438r812b1471],
16	,	,	O	,	_	0	SENT_541	[p13l680t1438r812b1471],
17	direct	JJ	O	direct	amod	20	SENT_541	[p13l826t1436r907b1462],
18	viral	JJ	O	viral	amod	20	SENT_541	[p13l917t1436r978b1462],
19	gene	NN	O	gene	nn	20	SENT_541	[p13l991t1446r1056b1471],
20	expression	NN	O	expression	infmod	8	SENT_541	[p13l1069t1438r1214b1471],
21	from	IN	O	from	_	0	SENT_541	[p13l1227t1436r1294b1462],
22	unintegrated	JJ	O	unintegrated	amod	25	SENT_541	[p13l1306t1436r1485b1471],
23	viral	JJ	O	viral	amod	25	SENT_541	[p13l1496t1436r1558b1462],
24	DNA	NN	O	dna	nn	25	SENT_541	[p13l1571t1437r1650b1462],
25	templates	NNS	O	template	prep_from	20	SENT_541	[p13l1661t1436r1801b1471],
26	,	,	O	,	_	0	SENT_541	[p13l1661t1436r1801b1471],
27	and	CC	O	and	_	0	SENT_541	[p13l1815t1436r1865b1462],
28	sustain	VB	O	sustain	infmod	8	SENT_541	[p13l421t1480r516b1505],
29	viral	JJ	O	viral	amod	30	SENT_541	[p13l524t1479r586b1505],
30	propagation	NN	O	propagation	dobj	15	SENT_541	[p13l595t1480r764b1513],
31	in	IN	O	in	_	0	SENT_541	[p13l774t1480r801b1504],
32	primary	JJ	O	primary	amod	33	SENT_541	[p13l810t1480r922b1513],
33	cells	NNS	O	cell	prep_in	15	SENT_541	[p13l931t1479r1029b1513],
34	.	.	O	.	_	0	SENT_541	[p13l931t1479r1029b1513],

1	Viral	JJ	O	viral	_	0	SENT_542	[p13l1044t1480r1112b1505],
2	.	.	O	.	_	0	SENT_542	[p13l1044t1480r1112b1505],

1	69	CD	NUMBER	69	num	2	SENT_543	[p13l1125t1480r1307b1511],
2	(	NN	O	(	_	0	SENT_543	[p13l1125t1480r1307b1511],
3	1	CD	NUMBER	1	number	4	SENT_543	[p13l1125t1480r1307b1511],
4	)	CD	NUMBER	)	dep	2	SENT_543	[p13l1125t1480r1307b1511],
5	:376	CD	NUMBER	:376	dep	4	SENT_543	[p13l1125t1480r1307b1511],
6	-86	CD	NUMBER	-86	num	8	SENT_543	[p13l1125t1480r1307b1511],
7	Stevenson	NNP	PERSON	Stevenson	nn	8	SENT_543	[p13l422t1522r563b1547],
8	M	NN	O	m	dep	2	SENT_543	[p13l572t1522r611b1552],
9	,	,	O	,	_	0	SENT_543	[p13l572t1522r611b1552],
10	Stanwick	NNP	O	Stanwick	nn	11	SENT_543	[p13l624t1521r750b1547],
11	TL	NNP	O	TL	appos	8	SENT_543	[p13l758t1522r814b1552],
12	,	,	O	,	_	0	SENT_543	[p13l758t1522r814b1552],
13	Dempsey	NNP	PERSON	Dempsey	nn	14	SENT_543	[p13l826t1522r958b1555],
14	MP	NNP	O	MP	appos	2	SENT_543	[p13l965t1522r1026b1552],
15	,	,	O	,	_	0	SENT_543	[p13l965t1522r1026b1552],
16	Lamonica	NNP	PERSON	Lamonica	nn	17	SENT_543	[p13l1038t1522r1176b1547],
17	CA	NNP	O	CA	appos	2	SENT_543	[p13l1188t1522r1240b1547],
18	.	.	O	.	_	0	SENT_543	[p13l1188t1522r1240b1547],

1	1990	CD	DATE	1990	_	0	SENT_544	[p13l1255t1523r1327b1547],
2	.	.	O	.	_	0	SENT_544	[p13l1255t1523r1327b1547],

1	HIV-1	NN	O	hiv-1	nn	2	SENT_545	[p13l1339t1522r1428b1547],
2	replication	NN	O	replication	nsubjpass	4	SENT_545	[p13l1441t1521r1591b1555],
3	is	VBZ	O	be	auxpass	4	SENT_545	[p13l1601t1522r1621b1547],
4	controlled	VBN	O	control	_	0	SENT_545	[p13l1633t1521r1775b1547],
5	at	IN	O	at	_	0	SENT_545	[p13l1786t1528r1812b1547],
6	the	DT	O	the	det	7	SENT_545	[p13l1821t1521r1864b1547],
7	level	NN	O	level	prep_at	4	SENT_545	[p13l421t1563r484b1589],
8	of	IN	O	of	_	0	SENT_545	[p13l495t1563r525b1589],
9	T	NN	O	t	nn	11	SENT_545	[p13l530t1564r557b1589],
10	cell	NN	O	cell	nn	11	SENT_545	[p13l566t1563r613b1589],
11	activation	NN	O	activation	prep_of	7	SENT_545	[p13l623t1564r758b1589],
12	and	CC	O	and	_	0	SENT_545	[p13l768t1563r818b1589],
13	proviral	JJ	O	proviral	amod	14	SENT_545	[p13l828t1563r936b1598],
14	integration	NN	O	integration	prep_of	7	SENT_545	[p13l946t1565r1108b1598],
15	.	.	O	.	_	0	SENT_545	[p13l946t1565r1108b1598],

1	EIVIBO	NN	O	eivibo	_	0	SENT_546	[p13l1118t1564r1215b1589],
2	+	CC	O	+	_	0	SENT_546	[p13l1220t1564r1245b1598],
3	9	CD	NUMBER	9	num	4	SENT_546	[p13l1259t1564r1319b1596],
4	(	NN	O	(	conj_+	1	SENT_546	[p13l1259t1564r1319b1596],
5	5	CD	NUMBER	5	num	6	SENT_546	[p13l1259t1564r1319b1596],
6	)	NN	O	)	dep	4	SENT_546	[p13l1259t1564r1319b1596],
7	:	:	O	:	_	0	SENT_546	[p13l1259t1564r1319b1596],
8	15	CD	NUMBER	15	num	12	SENT_546	[p13l1325t1564r1353b1589],
9	5	CD	NUMBER	5	num	12	SENT_546	[p13l1358t1564r1371b1589],
10	1-60	CD	NUMBER	1-60	num	12	SENT_546	[p13l1377t1565r1440b1589],
11	Grobler	NNP	O	Grobler	nn	12	SENT_546	[p13l422t1606r534b1632],
12	JA	NNP	O	JA	dep	1	SENT_546	[p13l543t1607r588b1639],
13	,	,	O	,	_	0	SENT_546	[p13l543t1607r588b1639],
14	Stillmock	NNP	O	Stillmock	nn	15	SENT_546	[p13l603t1606r737b1632],
15	K	NNP	O	K	appos	12	SENT_546	[p13l748t1607r780b1638],
16	,	,	O	,	_	0	SENT_546	[p13l748t1607r780b1638],
17	Hu	NNP	PERSON	Hu	nn	18	SENT_546	[p13l794t1607r840b1632],
18	B	NNP	PERSON	B	appos	12	SENT_546	[p13l853t1607r881b1638],
19	,	,	O	,	_	0	SENT_546	[p13l853t1607r881b1638],
20	Witmer	NNP	PERSON	Witmer	nn	21	SENT_546	[p13l895t1607r1006b1632],
21	M	NNP	O	M	appos	12	SENT_546	[p13l1018t1607r1057b1638],
22	,	,	O	,	_	0	SENT_546	[p13l1018t1607r1057b1638],
23	Felock	NNP	PERSON	Felock	nn	24	SENT_546	[p13l1072t1606r1166b1632],
24	P	NN	PERSON	p	appos	12	SENT_546	[p13l1178t1607r1205b1638],
25	,	,	O	,	_	0	SENT_546	[p13l1178t1607r1205b1638],
26	et	FW	O	et	nn	27	SENT_546	[p13l1220t1614r1246b1632],
27	al.	FW	O	al.	appos	12	SENT_546	[p13l1259t1606r1288b1632],
28	2002	CD	DATE	2002	dep	27	SENT_546	[p13l1303t1608r1378b1632],
29	.	.	O	.	_	0	SENT_546	[p13l1303t1608r1378b1632],

1	Diketo	JJ	O	diketo	amod	4	SENT_547	[p13l1393t1606r1488b1632],
2	acid	NN	O	acid	nn	4	SENT_547	[p13l1503t1606r1557b1632],
3	inhibitor	NN	O	inhibitor	nn	4	SENT_547	[p13l1571t1606r1695b1632],
4	mechanism	NN	O	mechanism	_	0	SENT_547	[p13l1707t1606r1865b1632],
5	and	CC	O	and	_	0	SENT_547	[p13l421t1649r471b1675],
6	HIV-1	NN	O	hiv-1	nn	7	SENT_547	[p13l483t1650r572b1675],
7	integrase	NN	O	integrase	conj_and	4	SENT_547	[p13l586t1650r719b1683],
8	:	:	O	:	_	0	SENT_547	[p13l586t1650r719b1683],
9	implications	NNS	O	implication	dep	4	SENT_547	[p13l732t1649r902b1683],
10	for	IN	O	for	_	0	SENT_547	[p13l915t1649r955b1675],
11	metal	NN	O	metal	nn	12	SENT_547	[p13l966t1649r1043b1675],
12	binding	NN	O	binding	prep_for	9	SENT_547	[p13l1055t1649r1163b1683],
13	in	IN	O	in	_	0	SENT_547	[p13l1173t1650r1200b1674],
14	the	DT	O	the	det	16	SENT_547	[p13l1212t1649r1255b1675],
15	active	JJ	O	active	amod	16	SENT_547	[p13l1268t1650r1346b1675],
16	site	NN	O	site	prep_in	12	SENT_547	[p13l1359t1650r1405b1675],
17	of	IN	O	of	_	0	SENT_547	[p13l1417t1649r1448b1675],
18	phosphotransferase	NN	O	phosphotransferase	nn	19	SENT_547	[p13l1456t1649r1726b1683],
19	enzymes	NNS	O	enzyme	prep_of	16	SENT_547	[p13l1738t1659r1863b1683],
20	.	.	O	.	_	0	SENT_547	[p13l1738t1659r1863b1683],

1	Proc	NNP	O	Proc	_	0	SENT_548	[p13l420t1700r482b1725],
2	.	.	O	.	_	0	SENT_548	[p13l420t1700r482b1725],

1	Natl.	NNP	O	Natl.	nn	2	SENT_549	[p13l494t1700r560b1725],
2	Acad	NNP	O	Acad	_	0	SENT_549	[p13l569t1700r641b1725],
3	.	.	O	.	_	0	SENT_549	[p13l569t1700r641b1725],

1	Sci	NNP	O	Sci	_	0	SENT_550	[p13l654t1700r696b1725],
2	.	.	O	.	_	0	SENT_550	[p13l654t1700r696b1725],

1	USA	NNP	O	USA	_	0	SENT_551	[p13l712t1700r774b1725],
2	99	CD	NUMBER	99	num	1	SENT_551	[p13l785t1700r1001b1731],
3	(	CD	NUMBER	(	number	4	SENT_551	[p13l785t1700r1001b1731],
4	10	CD	NUMBER	10	num	5	SENT_551	[p13l785t1700r1001b1731],
5	)	NN	O	)	dep	1	SENT_551	[p13l785t1700r1001b1731],
6	:6661	CD	NUMBER	:6661	number	7	SENT_551	[p13l785t1700r1001b1731],
7	—	CD	NUMBER	—	dep	1	SENT_551	[p13l785t1700r1001b1731],
8	66	CD	NUMBER	66	dep	7	SENT_551	[p13l785t1700r1001b1731],

1	39a	NN	O	39a	_	0	SENT_552	[p13l584t3115r638b3140],
2	.	.	O	.	_	0	SENT_552	[p13l584t3115r638b3140],

1	42	CD	NUMBER	42	_	0	SENT_553	[p13l582t3567r613b3591],
2	a.	NN	O	a.	dep	1	SENT_553	[p13l618t3575r638b3591],
3	'	''	O	'	_	0	SENT_553	[p13l1273t1802r1506b1824],

1	www	NN	O	www	_	0	SENT_554	[p13l1273t1802r1506b1824],
2	.	.	O	.	_	0	SENT_554	[p13l1273t1802r1506b1824],

1	annnalrevie	NN	O	annnalrevie	_	0	SENT_555	[p13l1273t1802r1506b1824],
2	'	''	O	'	_	0	SENT_555	[p13l1273t1802r1506b1824],
3	wr	NN	O	wr	dep	1	SENT_555	[p13l1273t1802r1506b1824],
4	.	.	O	.	_	0	SENT_555	[p13l1273t1802r1506b1824],

1	org	NN	O	org	nn	2	SENT_556	[p13l1510t1810r1546b1832],
2	o	NN	O	o	_	0	SENT_556	[p13l1561t1810r1571b1820],
3	Emerging	VBG	O	emerge	dep	2	SENT_556	[p13l1586t1802r1701b1832],
4	Pharmacology	NNP	O	Pharmacology	nsubj	7	SENT_556	[p13l1707t1802r1865b1832],
5	3	CD	NUMBER	3	number	6	SENT_556	[p13l1915t1810r1928b1831],
6	9	CD	NUMBER	9	amod	4	SENT_556	[p13l1930t1810r1944b1831],
7	I	PRP	O	I	xcomp	3	SENT_556	[p13l1948t1810r1958b1824],

1	.	.	O	.	_	0	SENT_557	[p13l633t1862r638b1866],

1	Goldgur	NNP	MISC	Goldgur	nn	2	SENT_558	[p13l658t1841r777b1875],
2	Y	NN	O	y	_	0	SENT_558	[p13l783t1842r812b1872],
3	,	,	O	,	_	0	SENT_558	[p13l783t1842r812b1872],
4	Craigie	NNP	ORGANIZATION	Craigie	nn	5	SENT_558	[p13l821t1842r923b1875],
5	R	NNP	ORGANIZATION	R	appos	2	SENT_558	[p13l931t1842r960b1872],
6	,	,	O	,	_	0	SENT_558	[p13l931t1842r960b1872],
7	Cohen	NNP	PERSON	Cohen	nn	8	SENT_558	[p13l970t1841r1063b1867],
8	GH	NN	O	gh	appos	2	SENT_558	[p13l1071t1842r1133b1872],
9	,	,	O	,	_	0	SENT_558	[p13l1071t1842r1133b1872],
10	Fujiwara	NNP	PERSON	Fujiwara	nn	11	SENT_558	[p13l1142t1842r1262b1875],
11	T	NN	O	t	appos	2	SENT_558	[p13l1269t1841r1301b1872],
12	,	,	O	,	_	0	SENT_558	[p13l1269t1841r1301b1872],
13	Yoshinaga	NNP	PERSON	Yoshinaga	nn	14	SENT_558	[p13l1309t1841r1450b1875],
14	T	NN	PERSON	t	appos	2	SENT_558	[p13l1456t1841r1489b1872],
15	,	,	O	,	_	0	SENT_558	[p13l1456t1841r1489b1872],
16	et	FW	O	et	nn	17	SENT_558	[p13l1498t1848r1524b1867],
17	al.	FW	O	al.	appos	2	SENT_558	[p13l1531t1841r1560b1867],
18	1999	CD	DATE	1999	dep	17	SENT_558	[p13l1572t1842r1644b1867],
19	.	.	O	.	_	0	SENT_558	[p13l1572t1842r1644b1867],

1	Structure	NN	O	structure	_	0	SENT_559	[p13l1654t1842r1783b1867],
2	of	IN	O	of	_	0	SENT_559	[p13l1791t1841r1822b1867],
3	the	DT	O	the	det	7	SENT_559	[p13l1825t1841r1869b1867],
4	HIV-1	NN	MISC	hiv-1	nn	7	SENT_559	[p13l1876t1842r1965b1867],
5	integrase	NN	O	integrase	nn	7	SENT_559	[p13l1975t1842r2101b1875],
6	catalytic	JJ	O	catalytic	amod	7	SENT_559	[p13l658t1882r772b1916],
7	domain	NN	O	domain	prep_of	1	SENT_559	[p13l782t1882r886b1908],
8	complexed	VBN	O	complex	partmod	7	SENT_559	[p13l897t1882r1046b1916],
9	with	IN	O	with	_	0	SENT_559	[p13l1055t1882r1117b1908],
10	an	DT	O	a	det	11	SENT_559	[p13l1127t1892r1159b1908],
11	inhibitor	NN	O	inhibitor	prep_with	8	SENT_559	[p13l1169t1882r1299b1908],
12	:	:	O	:	_	0	SENT_559	[p13l1169t1882r1299b1908],
13	a	DT	O	a	det	14	SENT_559	[p13l1311t1892r1324b1908],
14	platform	NN	O	platform	dep	1	SENT_559	[p13l1334t1882r1456b1916],
15	for	IN	O	for	_	0	SENT_559	[p13l1466t1882r1506b1908],
16	antiviral	JJ	O	antiviral	amod	18	SENT_559	[p13l1516t1882r1629b1908],
17	drug	NN	O	drug	nn	18	SENT_559	[p13l1640t1882r1705b1916],
18	design	NN	O	design	prep_for	14	SENT_559	[p13l1715t1882r1811b1916],
19	.	.	O	.	_	0	SENT_559	[p13l1715t1882r1811b1916],

1	Proc	NNP	O	Proc	_	0	SENT_560	[p13l1821t1883r1883b1908],
2	.	.	O	.	_	0	SENT_560	[p13l1821t1883r1883b1908],

1	Natl.	NNP	O	Natl.	nn	2	SENT_561	[p13l1895t1883r1961b1908],
2	Acad	NNP	O	Acad	_	0	SENT_561	[p13l1971t1883r2043b1908],
3	.	.	O	.	_	0	SENT_561	[p13l1971t1883r2043b1908],

1	Sci	NNP	O	Sci	_	0	SENT_562	[p13l2056t1883r2099b1908],
2	.	.	O	.	_	0	SENT_562	[p13l2056t1883r2099b1908],

1	USA	NNP	ORGANIZATION	USA	_	0	SENT_563	[p13l661t1928r722b1953],
2	96	CD	NUMBER	96	number	3	SENT_563	[p13l733t1928r964b1959],
3	(	CD	NUMBER	(	dep	1	SENT_563	[p13l733t1928r964b1959],
4	23	CD	NUMBER	23	num	5	SENT_563	[p13l733t1928r964b1959],
5	)	NN	O	)	dep	3	SENT_563	[p13l733t1928r964b1959],
6	:13040	CD	NUMBER	:13040	num	10	SENT_563	[p13l733t1928r964b1959],
7	—	CD	NUMBER	—	num	10	SENT_563	[p13l733t1928r964b1959],
8	43	CD	NUMBER	43	num	10	SENT_563	[p13l733t1928r964b1959],
9	Hazuda	NNP	O	Hazuda	nn	10	SENT_563	[p13l657t1969r765b1995],
10	DJ	NNP	O	DJ	dep	1	SENT_563	[p13l775t1970r821b2002],
11	,	,	O	,	_	0	SENT_563	[p13l775t1970r821b2002],
12	Anthony	NNP	PERSON	Anthony	nn	14	SENT_563	[p13l831t1969r955b2004],
13	N	NNP	PERSON	N	nn	14	SENT_563	[p13l963t1970r1011b2002],
14	]	NN	O	]	appos	10	SENT_563	[p13l963t1970r1011b2002],
15	,	,	O	,	_	0	SENT_563	[p13l963t1970r1011b2002],
16	Gomez	NNP	PERSON	Gomez	nn	17	SENT_563	[p13l1023t1970r1125b1995],
17	RP	NNP	O	RP	appos	10	SENT_563	[p13l1135t1970r1185b2001],
18	,	,	O	,	_	0	SENT_563	[p13l1135t1970r1185b2001],
19	Jolly	JJ	O	jolly	amod	20	SENT_563	[p13l1192t1969r1261b2004],
20	SM	NN	O	sm	appos	10	SENT_563	[p13l1271t1970r1327b2001],
21	,	,	O	,	_	0	SENT_563	[p13l1271t1970r1327b2001],
22	WaiJS	NN	O	waij	appos	10	SENT_563	[p13l1337t1970r1441b2002],
23	,	,	O	,	_	0	SENT_563	[p13l1337t1970r1441b2002],
24	et	FW	O	et	nn	25	SENT_563	[p13l1453t1977r1479b1995],
25	al.	FW	O	al.	appos	10	SENT_563	[p13l1489t1969r1518b1995],
26	2004	CD	DATE	2004	dep	25	SENT_563	[p13l1530t1971r1604b1996],
27	.	.	O	.	_	0	SENT_563	[p13l1530t1971r1604b1996],

1	A	DT	O	a	det	3	SENT_564	[p13l1615t1970r1639b1995],
2	naphthyridine	NN	O	naphthyridine	nn	3	SENT_564	[p13l1647t1969r1844b2004],
3	carboxamide	NN	O	carboxamide	nsubj	4	SENT_564	[p13l1855t1969r2030b1995],
4	provides	VBZ	O	provide	_	0	SENT_564	[p13l2041t1979r2100b2004, p13l656t2012r726b2038],
5	evidence	NN	O	evidence	dobj	4	SENT_564	[p13l735t2012r855b2038],
6	for	IN	O	for	_	0	SENT_564	[p13l864t2012r905b2038],
7	discordant	JJ	O	discordant	amod	8	SENT_564	[p13l913t2012r1060b2038],
8	resistance	NN	O	resistance	prep_for	5	SENT_564	[p13l1067t2013r1203b2038],
9	between	IN	O	between	_	0	SENT_564	[p13l1211t2012r1327b2038],
10	mechanistically	RB	O	mechanistically	advmod	11	SENT_564	[p13l1336t2012r1551b2046],
11	identical	JJ	O	identical	amod	12	SENT_564	[p13l1558t2012r1677b2038],
12	inhibitors	NNS	O	inhibitor	prep_between	8	SENT_564	[p13l1686t2012r1821b2038],
13	of	IN	O	of	_	0	SENT_564	[p13l1831t2012r1861b2038],
14	HIV-1	NN	O	hiv-1	nn	15	SENT_564	[p13l1866t2013r1955b2038],
15	integrase	NN	O	integrase	prep_of	12	SENT_564	[p13l1967t2013r2100b2046],
16	.	.	O	.	_	0	SENT_564	[p13l1967t2013r2100b2046],

1	Proc	NNP	O	Proc	_	0	SENT_565	[p13l656t2055r718b2080],
2	.	.	O	.	_	0	SENT_565	[p13l656t2055r718b2080],

1	Natl.	NNP	O	Natl.	nn	2	SENT_566	[p13l730t2055r796b2080],
2	Acad	NNP	O	Acad	_	0	SENT_566	[p13l805t2055r877b2080],
3	.	.	O	.	_	0	SENT_566	[p13l805t2055r877b2080],

1	Sci	NNP	O	Sci	_	0	SENT_567	[p13l890t2055r933b2080],
2	.	.	O	.	_	0	SENT_567	[p13l890t2055r933b2080],

1	USA	NNP	LOCATION	USA	_	0	SENT_568	[p13l948t2055r1010b2080],
2	101	CD	NUMBER	101	num	1	SENT_568	[p13l1024t2055r1096b2086],
3	(	CD	NUMBER	(	number	4	SENT_568	[p13l1024t2055r1096b2086],
4	3	CD	NUMBER	3	dep	1	SENT_568	[p13l1024t2055r1096b2086],
5	1	CD	NUMBER	1	num	6	SENT_568	[p13l1103t2055r1149b2086],
6	)	NN	O	)	dep	4	SENT_568	[p13l1103t2055r1149b2086],
7	:1	CD	NUMBER	:1	num	13	SENT_568	[p13l1103t2055r1149b2086],
8	12	CD	NUMBER	12	num	13	SENT_568	[p13l1157t2056r1184b2079],
9	3	CD	NUMBER	3	num	13	SENT_568	[p13l1190t2056r1201b2080],
10	3-3	CD	NUMBER	3-3	num	13	SENT_568	[p13l1207t2056r1252b2080],
11	8	CD	NUMBER	8	num	13	SENT_568	[p13l1258t2056r1271b2080],
12	Fikkert	NNP	O	Fikkert	nn	13	SENT_568	[p13l657t2095r759b2121],
13	V	NNP	O	V	dep	1	SENT_568	[p13l771t2096r803b2126],
14	,	,	O	,	_	0	SENT_568	[p13l771t2096r803b2126],
15	Van	NNP	PERSON	Van	nn	17	SENT_568	[p13l817t2096r872b2121],
16	Maele	NNP	PERSON	Maele	nn	17	SENT_568	[p13l884t2095r971b2121],
17	B	NNP	PERSON	B	appos	13	SENT_568	[p13l985t2096r1013b2126],
18	,	,	O	,	_	0	SENT_568	[p13l985t2096r1013b2126],
19	Vercammen	NNP	PERSON	Vercammen	nn	20	SENT_568	[p13l1027t2096r1195b2121],
20	J	NNP	PERSON	J	appos	13	SENT_568	[p13l1205t2096r1228b2127],
21	,	,	O	,	_	0	SENT_568	[p13l1205t2096r1228b2127],
22	Hantson	NNP	O	Hantson	nn	23	SENT_568	[p13l1243t2096r1363b2121],
23	A	NNP	O	A	appos	13	SENT_568	[p13l1376t2096r1406b2126],
24	,	,	O	,	_	0	SENT_568	[p13l1376t2096r1406b2126],
25	Van	NNP	PERSON	Van	nn	27	SENT_568	[p13l1420t2096r1474b2121],
26	Remoortel	NNP	PERSON	Remoortel	nn	27	SENT_568	[p13l1489t2095r1638b2121],
27	B	NNP	PERSON	B	appos	13	SENT_568	[p13l1652t2096r1680b2126],
28	,	,	O	,	_	0	SENT_568	[p13l1652t2096r1680b2126],
29	et	FW	O	et	nn	30	SENT_568	[p13l1695t2103r1721b2121],
30	al.	FW	O	al.	appos	13	SENT_568	[p13l1735t2095r1764b2121],
31	2003	CD	DATE	2003	dep	30	SENT_568	[p13l1780t2097r1854b2121],
32	.	.	O	.	_	0	SENT_568	[p13l1780t2097r1854b2121],

1	Development	NN	O	development	_	0	SENT_569	[p13l1870t2095r2061b2129],
2	of	IN	O	of	_	0	SENT_569	[p13l2074t2095r2105b2121],
3	resistance	NN	O	resistance	prep_of	1	SENT_569	[p13l657t2142r792b2167],
4	against	IN	O	against	_	0	SENT_569	[p13l799t2142r897b2175],
5	diketo	NN	O	diketo	nn	6	SENT_569	[p13l903t2141r988b2167],
6	derivatives	NNS	O	derivative	prep_against	1	SENT_569	[p13l996t2141r1142b2167],
7	of	IN	O	of	_	0	SENT_569	[p13l1150t2141r1180b2167],
8	human	JJ	O	human	amod	11	SENT_569	[p13l1182t2141r1279b2167],
9	immunodeﬁciency	NN	O	immunodeﬁciency	nn	11	SENT_569	[p13l1285t2141r1545b2175],
10	virus	NN	O	virus	nn	11	SENT_569	[p13l1549t2142r1616b2167],
11	type	NN	O	type	prep_of	6	SENT_569	[p13l1623t2148r1682b2175],
12	1	CD	NUMBER	1	dep	1	SENT_569	[p13l1692t2143r1702b2166],
13	by	IN	O	by	dep	1	SENT_569	[p13l1711t2141r1745b2175],
14	progressive	JJ	O	progressive	amod	15	SENT_569	[p13l1750t2142r1907b2175],
15	accumulation	NN	O	accumulation	pobj	13	SENT_569	[p13l1915t2141r2101b2167],
16	of	IN	O	of	_	0	SENT_569	[p13l658t2183r688b2209],
17	integrase	NN	O	integrase	nn	18	SENT_569	[p13l694t2184r819b2217],
18	mutations	NNS	O	mutation	prep_of	15	SENT_569	[p13l829t2184r976b2209],
19	.	.	O	.	_	0	SENT_569	[p13l829t2184r976b2209],

1	MJ	NN	O	mj	_	0	SENT_570	[p13l982t2183r1007b2217],
2	+	CC	O	+	_	0	SENT_570	[p13l982t2183r1007b2217],
3	Viral	JJ	O	viral	conj_+	1	SENT_570	[p13l1023t2184r1091b2209],
4	.	.	O	.	_	0	SENT_570	[p13l1023t2184r1091b2209],

1	77	CD	NUMBER	77	num	2	SENT_571	[p13l1104t2184r1162b2215],
2	(	NN	O	(	_	0	SENT_571	[p13l1104t2184r1162b2215],
3	2	CD	NUMBER	2	number	4	SENT_571	[p13l1104t2184r1162b2215],
4	1	CD	NUMBER	1	num	5	SENT_571	[p13l1168t2184r1199b2215],
5	)	NN	O	)	dep	2	SENT_571	[p13l1168t2184r1199b2215],
6	:	:	O	:	_	0	SENT_571	[p13l1168t2184r1199b2215],
7	1	CD	NUMBER	1	number	8	SENT_571	[p13l1205t2185r1215b2208],
8	145	CD	NUMBER	145	dep	2	SENT_571	[p13l1222t2184r1267b2209],
9	9-70	CD	NUMBER	9-70	num	11	SENT_571	[p13l1271t2184r1337b2209],
10	Young	NNP	O	Young	nn	11	SENT_571	[p13l656t2225r746b2258],
11	SD	NN	O	sd	dep	8	SENT_571	[p13l755t2225r806b2250],
12	.	.	O	.	_	0	SENT_571	[p13l755t2225r806b2250],

1	2001	CD	DATE	2001	_	0	SENT_572	[p13l816t2226r891b2250],
2	.	.	O	.	_	0	SENT_572	[p13l816t2226r891b2250],

1	Inhibition	NN	O	inhibition	_	0	SENT_573	[p13l900t2224r1042b2250],
2	of	IN	O	of	_	0	SENT_573	[p13l1050t2224r1081b2250],
3	HIV-1	NN	MISC	hiv-1	nn	4	SENT_573	[p13l1085t2225r1174b2250],
4	integrase	NN	O	integrase	prep_of	1	SENT_573	[p13l1186t2225r1311b2258],
5	by	IN	O	by	_	0	SENT_573	[p13l1320t2224r1354b2258],
6	small	JJ	O	small	amod	7	SENT_573	[p13l1361t2224r1433b2250],
7	molecules	NNS	O	molecule	prep_by	4	SENT_573	[p13l1441t2224r1587b2250],
8	:	:	O	:	_	0	SENT_573	[p13l1441t2224r1587b2250],
9	the	DT	O	the	det	10	SENT_573	[p13l1597t2224r1640b2250],
10	potential	NN	O	potential	dep	1	SENT_573	[p13l1649t2224r1772b2258],
11	for	IN	O	for	_	0	SENT_573	[p13l1781t2224r1821b2250],
12	a	DT	O	a	det	14	SENT_573	[p13l1830t2234r1843b2250],
13	new	JJ	O	new	amod	14	SENT_573	[p13l1851t2234r1908b2250],
14	class	NN	O	class	prep_for	10	SENT_573	[p13l1916t2224r1977b2250],
15	of	IN	O	of	_	0	SENT_573	[p13l1987t2224r2017b2250],
16	AIDS	NNP	MISC	AIDS	nn	17	SENT_573	[p13l2021t2225r2100b2250],
17	chemotherapeutics	NNS	O	chemotherapeutic	prep_of	14	SENT_573	[p13l658t2266r928b2300],
18	.	.	O	.	_	0	SENT_573	[p13l658t2266r928b2300],

1	Curr	NNP	PERSON	Curr	nn	2	SENT_574	[p13l941t2267r1007b2292],
2	Opin	NNP	PERSON	Opin	_	0	SENT_574	[p13l1021t2267r1090b2300],
3	.	.	O	.	_	0	SENT_574	[p13l1021t2267r1090b2300],

1	Drug	NN	O	drug	_	0	SENT_575	[p13l1102t2267r1175b2301],
2	Discoz	NNP	O	Discoz	dep	1	SENT_575	[p13l1183t2267r1272b2292],
3	)	CD	NUMBER	)	num	2	SENT_575	[p13l1183t2267r1272b2292],
4	.	.	O	.	_	0	SENT_575	[p13l1183t2267r1272b2292],

1	Dev	NN	O	dev	_	0	SENT_576	[p13l1284t2267r1343b2292],
2	.	.	O	.	_	0	SENT_576	[p13l1284t2267r1343b2292],

1	4	CD	NUMBER	4	number	2	SENT_577	[p13l1355t2267r1520b2298],
2	(	CD	NUMBER	(	_	0	SENT_577	[p13l1355t2267r1520b2298],
3	4	CD	NUMBER	4	num	4	SENT_577	[p13l1355t2267r1520b2298],
4	)	NN	O	)	dep	2	SENT_577	[p13l1355t2267r1520b2298],
5	:402	CD	NUMBER	:402	num	8	SENT_577	[p13l1355t2267r1520b2298],
6	-10	CD	NUMBER	-10	num	8	SENT_577	[p13l1355t2267r1520b2298],
7	Hazuda	NNP	O	Hazuda	nn	8	SENT_577	[p13l657t2308r765b2334],
8	DJ	NNP	O	DJ	dep	2	SENT_577	[p13l774t2309r820b2340],
9	,	,	O	,	_	0	SENT_577	[p13l774t2309r820b2340],
10	Young	NNP	ORGANIZATION	Young	nn	11	SENT_577	[p13l829t2309r919b2342],
11	SD	NN	ORGANIZATION	sd	appos	8	SENT_577	[p13l929t2309r980b2339],
12	,	,	O	,	_	0	SENT_577	[p13l929t2309r980b2339],
13	Guare	NNP	ORGANIZATION	Guare	nn	14	SENT_577	[p13l991t2309r1078b2334],
14	JP	NNP	ORGANIZATION	JP	appos	8	SENT_577	[p13l1083t2309r1126b2340],
15	,	,	O	,	_	0	SENT_577	[p13l1083t2309r1126b2340],
16	Anthony	NNP	PERSON	Anthony	nn	17	SENT_577	[p13l1136t2308r1259b2342],
17	NJ	NNP	PERSON	NJ	appos	8	SENT_577	[p13l1267t2309r1315b2340],
18	,	,	O	,	_	0	SENT_577	[p13l1267t2309r1315b2340],
19	Gomez	NNP	PERSON	Gomez	nn	20	SENT_577	[p13l1326t2309r1428b2334],
20	RP	NNP	O	RP	appos	8	SENT_577	[p13l1437t2309r1487b2339],
21	,	,	O	,	_	0	SENT_577	[p13l1437t2309r1487b2339],
22	et	FW	O	et	nn	23	SENT_577	[p13l1498t2315r1523b2334],
23	al.	FW	O	al.	appos	8	SENT_577	[p13l1532t2308r1561b2334],
24	2004	CD	DATE	2004	dep	23	SENT_577	[p13l1572t2309r1647b2334],
25	.	.	O	.	_	0	SENT_577	[p13l1572t2309r1647b2334],

1	Integrase	NN	O	integrase	nn	2	SENT_578	[p13l1657t2309r1786b2342],
2	inhibitors	NNS	O	inhibitor	nsubj	6	SENT_578	[p13l1795t2308r1930b2334],
3	and	CC	O	and	_	0	SENT_578	[p13l1940t2308r1989b2334],
4	cellular	JJ	O	cellular	amod	5	SENT_578	[p13l1999t2308r2102b2334],
5	immunity	NN	O	immunity	nsubj	6	SENT_578	[p13l657t2351r794b2385],
6	suppress	VBP	O	suppress	_	0	SENT_578	[p13l803t2360r920b2384],
7	retroviral	JJ	O	retroviral	amod	8	SENT_578	[p13l930t2350r1060b2376],
8	replication	NN	O	replication	dobj	6	SENT_578	[p13l1070t2350r1220b2384],
9	in	IN	O	in	_	0	SENT_578	[p13l1230t2351r1256b2376],
10	rhesus	NN	O	rhesus	nn	11	SENT_578	[p13l1266t2350r1354b2376],
11	macaques	NNS	O	macaque	prep_in	8	SENT_578	[p13l1364t2360r1505b2385],
12	.	.	O	.	_	0	SENT_578	[p13l1364t2360r1505b2385],

1	Science	NNP	O	Science	_	0	SENT_579	[p13l1516t2351r1606b2376],
2	305	CD	NUMBER	305	num	1	SENT_579	[p13l1617t2351r1664b2376],
3	(	CD	NUMBER	(	dep	1	SENT_579	[p13l1668t2351r1692b2383],
4	5	CD	NUMBER	5	number	5	SENT_579	[p13l1668t2351r1692b2383],
5	683	CD	NUMBER	683	num	6	SENT_579	[p13l1695t2351r1780b2383],
6	)	NN	O	)	dep	3	SENT_579	[p13l1695t2351r1780b2383],
7	:5	CD	NUMBER	:5	number	8	SENT_579	[p13l1695t2351r1780b2383],
8	2	CD	NUMBER	2	dep	1	SENT_579	[p13l1783t2352r1796b2376],
9	8-3	CD	NUMBER	8-3	num	10	SENT_579	[p13l1801t2352r1847b2376],
10	2	CD	NUMBER	2	dep	8	SENT_579	[p13l1852t2352r1865b2376],
11	Little	JJ	O	little	amod	12	SENT_579	[p13l657t2394r734b2420],
12	S	NN	O	s	dep	1	SENT_579	[p13l748t2395r771b2425],
13	,	,	O	,	_	0	SENT_579	[p13l748t2395r771b2425],
14	Drusano	NNP	O	Drusano	nn	15	SENT_579	[p13l785t2395r905b2420],
15	G	NNP	O	G	conj_and	12	SENT_579	[p13l918t2395r951b2425],
16	,	,	O	,	_	0	SENT_579	[p13l918t2395r951b2425],
17	Schooley	NNP	PERSON	Schooley	nn	18	SENT_579	[p13l966t2394r1093b2428],
18	R	NNP	PERSON	R	conj_and	12	SENT_579	[p13l1104t2395r1133b2425],
19	,	,	O	,	_	0	SENT_579	[p13l1104t2395r1133b2425],
20	Haas	NNP	PERSON	Haas	nn	21	SENT_579	[p13l1146t2395r1215b2420],
21	D	NNP	O	D	conj_and	12	SENT_579	[p13l1228t2395r1262b2425],
22	,	,	O	,	_	0	SENT_579	[p13l1228t2395r1262b2425],
23	Kumar	NNP	PERSON	Kumar	nn	24	SENT_579	[p13l1275t2395r1373b2420],
24	P	NN	PERSON	p	conj_and	12	SENT_579	[p13l1384t2395r1411b2425],
25	,	,	O	,	_	0	SENT_579	[p13l1384t2395r1411b2425],
26	et	FW	O	et	nn	27	SENT_579	[p13l1425t2401r1451b2420],
27	al.	FW	O	al.	conj_and	12	SENT_579	[p13l1462t2394r1501b2425],
28	,	,	O	,	_	0	SENT_579	[p13l1462t2394r1501b2425],
29	and	CC	O	and	_	0	SENT_579	[p13l1514t2394r1564b2420],
30	Protocol	NNP	O	Protocol	nn	33	SENT_579	[p13l1576t2394r1697b2420],
31	004	CD	NUMBER	004	num	33	SENT_579	[p13l1710t2396r1760b2420],
32	Study	NNP	O	Study	nn	33	SENT_579	[p13l1773t2394r1853b2428],
33	Team	NNP	O	Team	dep	1	SENT_579	[p13l1863t2395r1947b2420],
34	.	.	O	.	_	0	SENT_579	[p13l1863t2395r1947b2420],

1	2005	CD	DATE	2005	_	0	SENT_580	[p13l1961t2395r2036b2420],
2	.	.	O	.	_	0	SENT_580	[p13l1961t2395r2036b2420],

1	Antiretroviral	JJ	O	antiretroviral	amod	2	SENT_581	[p13l2046t2395r2101b2419, p13l658t2440r803b2465],
2	eﬂfect	NN	O	eﬂfect	_	0	SENT_581	[p13l811t2440r876b2473],
3	of	IN	O	of	_	0	SENT_581	[p13l885t2440r914b2473],
4	L	NN	O	l	prep_of	2	SENT_581	[p13l915t2440r1084b2465],
5	—	CD	NUMBER	—	number	6	SENT_581	[p13l915t2440r1084b2465],
6	00087081	CD	NUMBER	00087081	num	7	SENT_581	[p13l915t2440r1084b2465],
7	o	NN	O	o	dep	2	SENT_581	[p13l1089t2441r1109b2470],
8	,	,	O	,	_	0	SENT_581	[p13l1089t2441r1109b2470],
9	a	DT	O	a	det	14	SENT_581	[p13l1121t2449r1136b2465],
10	novel	JJ	O	novel	amod	14	SENT_581	[p13l1146t2440r1214b2465],
11	HI	NN	MISC	hus	nn	14	SENT_581	[p13l1221t2440r1262b2465],
12	V-1	NN	MISC	v-1	nn	14	SENT_581	[p13l1263t2440r1306b2465],
13	integrase	NN	O	integrase	nn	14	SENT_581	[p13l1319t2441r1433b2474],
14	inhibitor	NN	O	inhibitor	appos	7	SENT_581	[p13l1443t2440r1557b2470],
15	,	,	O	,	_	0	SENT_581	[p13l1443t2440r1557b2470],
16	in	IN	O	in	_	0	SENT_581	[p13l1569t2441r1594b2465],
17	HI	NN	O	hus	nn	19	SENT_581	[p13l1604t2440r1644b2465],
18	V-1-infected	JJ	O	v-1-infected	amod	19	SENT_581	[p13l1646t2440r1803b2474],
19	patients	NNS	O	patient	prep_in	7	SENT_581	[p13l1807t2441r1917b2473],
20	.	.	O	.	_	0	SENT_581	[p13l1807t2441r1917b2473],

1	Presented	VBN	O	present	_	0	SENT_582	[p13l1928t2439r2067b2465],
2	at	IN	O	at	_	0	SENT_582	[p13l2077t2447r2102b2465],
3	12th	JJ	ORDINAL	12th	amod	4	SENT_582	[p13l660t2485r720b2511],
4	Conf	NN	O	conf	prep_at	1	SENT_582	[p13l730t2485r808b2511],
5	.	.	O	.	_	0	SENT_582	[p13l730t2485r808b2511],

1	Retrovir	NNP	O	Retrovir	_	0	SENT_583	[p13l819t2486r941b2511],
2	.	.	O	.	_	0	SENT_583	[p13l819t2486r941b2511],

1	Opport	NNP	O	Opport	_	0	SENT_584	[p13l953t2486r1063b2519],
2	.	.	O	.	_	0	SENT_584	[p13l953t2486r1063b2519],

1	Infect	VB	O	infect	_	0	SENT_585	[p13l1074t2485r1172b2516],
2	,	,	O	,	_	0	SENT_585	[p13l1074t2485r1172b2516],
3	Boston	NNP	LOCATION	Boston	nn	7	SENT_585	[p13l1183t2486r1288b2516],
4	,	,	O	,	_	0	SENT_585	[p13l1183t2486r1288b2516],
5	MA	NNP	O	MA	appos	7	SENT_585	[p13l1298t2486r1359b2516],
6	,	,	O	,	_	0	SENT_585	[p13l1298t2486r1359b2516],
7	Abstr	NNP	PERSON	Abstr	dep	1	SENT_585	[p13l1369t2485r1451b2511],
8	.	.	O	.	_	0	SENT_585	[p13l1369t2485r1451b2511],

1	161	CD	NUMBER	161	num	3	SENT_586	[p13l1465t2487r1509b2511],
2	DeJesus	NNP	PERSON	DeJesus	nn	3	SENT_586	[p13l657t2530r769b2561],
3	E	NNP	O	E	_	0	SENT_586	[p13l780t2530r809b2560],
4	,	,	O	,	_	0	SENT_586	[p13l780t2530r809b2560],
5	Berger	NNP	PERSON	Berger	nn	6	SENT_586	[p13l821t2530r916b2563],
6	D	NNP	O	D	appos	3	SENT_586	[p13l926t2530r960b2560],
7	,	,	O	,	_	0	SENT_586	[p13l926t2530r960b2560],
8	Markowitz	NNP	PERSON	Markowitz	nn	9	SENT_586	[p13l970t2528r1124b2554],
9	M	NNP	O	M	appos	3	SENT_586	[p13l1133t2530r1172b2560],
10	,	,	O	,	_	0	SENT_586	[p13l1133t2530r1172b2560],
11	Cohen	NNP	PERSON	Cohen	nn	12	SENT_586	[p13l1185t2528r1278b2554],
12	C	NNP	O	C	appos	3	SENT_586	[p13l1290t2529r1321b2560],
13	,	,	O	,	_	0	SENT_586	[p13l1290t2529r1321b2560],
14	Hawkins	NNP	PERSON	Hawkins	nn	15	SENT_586	[p13l1332t2528r1455b2554],
15	T	NN	O	t	appos	3	SENT_586	[p13l1465t2529r1498b2560],
16	,	,	O	,	_	0	SENT_586	[p13l1465t2529r1498b2560],
17	et	FW	O	et	nn	18	SENT_586	[p13l1511t2536r1536b2554],
18	al.	FW	O	al.	appos	3	SENT_586	[p13l1547t2528r1576b2554],
19	2006	CD	DATE	2006	dep	18	SENT_586	[p13l1589t2530r1663b2554],
20	.	.	O	.	_	0	SENT_586	[p13l1589t2530r1663b2554],

1	Antiviral	JJ	O	antiviral	amod	2	SENT_587	[p13l1674t2528r1797b2554],
2	activity	NN	O	activity	_	0	SENT_587	[p13l1808t2530r1913b2563],
3	,	,	O	,	_	0	SENT_587	[p13l1808t2530r1913b2563],
4	pharmacokinetics	NNS	O	pharmacokinetic	conj_and	2	SENT_587	[p13l1924t2528r2100b2563, p13l657t2576r744b2606],
5	,	,	O	,	_	0	SENT_587	[p13l1924t2528r2100b2563, p13l657t2576r744b2606],
6	and	CC	O	and	_	0	SENT_587	[p13l757t2574r806b2600],
7	dose	NN	O	dose	nn	8	SENT_587	[p13l817t2574r878b2600],
8	response	NN	O	response	conj_and	2	SENT_587	[p13l889t2584r1010b2608],
9	of	IN	O	of	_	0	SENT_587	[p13l1022t2574r1052b2600],
10	the	DT	O	the	det	13	SENT_587	[p13l1059t2574r1102b2600],
11	HIV-1	NN	MISC	hiv-1	nn	13	SENT_587	[p13l1113t2575r1202b2600],
12	integrase	NN	O	integrase	nn	13	SENT_587	[p13l1216t2576r1341b2609],
13	inhibitor	NN	O	inhibitor	prep_of	8	SENT_587	[p13l1352t2574r1475b2600],
14	GS-9137	NN	O	gs-9137	nn	16	SENT_587	[p13l1486t2575r1611b2600],
15	OTK-303	NN	O	otk-303	nn	16	SENT_587	[p13l1623t2575r1770b2606],
16	)	NN	O	)	dep	2	SENT_587	[p13l1623t2575r1770b2606],
17	in	IN	O	in	_	0	SENT_587	[p13l1781t2576r1807b2600],
18	treatment	NN	O	treatment	prep_in	16	SENT_587	[p13l1818t2576r2040b2600],
19	—	CD	NUMBER	—	dep	2	SENT_587	[p13l1818t2576r2040b2600],
20	naive	JJ	O	naive	amod	23	SENT_587	[p13l1818t2576r2040b2600],
21	and	CC	O	and	_	0	SENT_587	[p13l2052t2574r2101b2600],
22	treatment-experienced	JJ	O	treatment-experienced	conj_and	20	SENT_587	[p13l657t2620r974b2654],
23	patients	NNS	O	patient	dep	19	SENT_587	[p13l984t2621r1100b2654],
24	.	.	O	.	_	0	SENT_587	[p13l984t2621r1100b2654],

1	+	CC	O	+	dep	2	SENT_588	[p13l1107t2620r1132b2654],
2	Acqnir	NNP	O	Acqnir	_	0	SENT_588	[p13l1141t2621r1234b2654],
3	.	.	O	.	_	0	SENT_588	[p13l1141t2621r1234b2654],

1	Immune	JJ	O	immune	amod	2	SENT_589	[p13l1245t2621r1356b2646],
2	Deﬁc	NN	O	deﬁc	_	0	SENT_589	[p13l1365t2620r1436b2654],
3	.	.	O	.	_	0	SENT_589	[p13l1365t2620r1436b2654],

1	Syndr	NNP	O	Syndr	_	0	SENT_590	[p13l1449t2621r1528b2654],
2	.	.	O	.	_	0	SENT_590	[p13l1449t2621r1528b2654],

1	43:1	CD	NUMBER	43:1	num	2	SENT_591	[p13l1540t2621r1631b2646],
2	—	CD	NUMBER	—	_	0	SENT_591	[p13l1540t2621r1631b2646],
3	5	CD	NUMBER	5	num	5	SENT_591	[p13l1540t2621r1631b2646],
4	Grinsztejn	NN	O	grinsztejn	nn	5	SENT_591	[p13l658t2664r805b2698],
5	B	NN	O	b	dep	2	SENT_591	[p13l818t2665r845b2695],
6	,	,	O	,	_	0	SENT_591	[p13l818t2665r845b2695],
7	Nguyen	NNP	PERSON	Nguyen	nn	8	SENT_591	[p13l858t2665r971b2698],
8	B-Y	NNP	O	B-Y	appos	5	SENT_591	[p13l984t2665r1046b2695],
9	,	,	O	,	_	0	SENT_591	[p13l984t2665r1046b2695],
10	Katlama	NNP	PERSON	Katlama	nn	11	SENT_591	[p13l1060t2664r1176b2689],
11	C	NNP	O	C	appos	5	SENT_591	[p13l1189t2664r1220b2695],
12	,	,	O	,	_	0	SENT_591	[p13l1189t2664r1220b2695],
13	Gatell	NNP	O	Gatell	nn	14	SENT_591	[p13l1234t2663r1320b2689],
14	JM	NN	O	jm	appos	5	SENT_591	[p13l1328t2665r1383b2696],
15	,	,	O	,	_	0	SENT_591	[p13l1328t2665r1383b2696],
16	Lazzarin	NN	O	lazzarin	nn	17	SENT_591	[p13l1396t2665r1518b2689],
17	A	NN	O	a	appos	5	SENT_591	[p13l1529t2665r1558b2695],
18	,	,	O	,	_	0	SENT_591	[p13l1529t2665r1558b2695],
19	et	FW	O	et	nn	20	SENT_591	[p13l1572t2671r1598b2689],
20	al.	FW	O	al.	appos	5	SENT_591	[p13l1610t2663r1639b2689],
21	2007	CD	DATE	2007	dep	20	SENT_591	[p13l1654t2664r1728b2690],
22	.	.	O	.	_	0	SENT_591	[p13l1654t2664r1728b2690],

1	Safety	NN	O	safety	dep	14	SENT_592	[p13l1743t2664r1828b2698],
2	and	CC	O	and	_	0	SENT_592	[p13l1840t2663r1889b2689],
3	efﬁcacy	NN	O	efﬁcacy	dep	14	SENT_592	[p13l1902t2664r2007b2698],
4	of	IN	O	of	_	0	SENT_592	[p13l2018t2664r2049b2689],
5	the	DT	O	the	det	9	SENT_592	[p13l2057t2663r2101b2689],
6	HIV-1	NN	MISC	hiv-1	nn	9	SENT_592	[p13l657t2710r746b2735],
7	integrase	NN	O	integrase	nn	9	SENT_592	[p13l764t2711r889b2744],
8	inhibitor	NN	O	inhibitor	nn	9	SENT_592	[p13l904t2709r1028b2735],
9	raltegravir	NN	O	raltegravir	prep_of	1	SENT_592	[p13l1043t2709r1188b2744],
10	(	CD	NUMBER	(	num	11	SENT_592	[p13l1203t2710r1360b2742],
11	MK	NN	O	mk	dep	14	SENT_592	[p13l1203t2710r1360b2742],
12	—	CD	NUMBER	—	num	14	SENT_592	[p13l1203t2710r1360b2742],
13	05l8	CD	NUMBER	05l8	num	14	SENT_592	[p13l1203t2710r1360b2742],
14	)	NN	O	)	dep	19	SENT_592	[p13l1203t2710r1360b2742],
15	in	IN	O	in	_	0	SENT_592	[p13l1376t2711r1402b2735],
16	treatment	NN	O	treatment	prep_in	14	SENT_592	[p13l1417t2709r1734b2743],
17	—	CD	NUMBER	—	num	19	SENT_592	[p13l1417t2709r1734b2743],
18	experienced	JJ	O	experienced	amod	19	SENT_592	[p13l1417t2709r1734b2743],
19	patients	NNS	O	patient	dep	29	SENT_592	[p13l1749t2711r1857b2743],
20	with	IN	O	with	_	0	SENT_592	[p13l1872t2709r1934b2735],
21	multidrugresistant	JJ	O	multidrugresistant	amod	22	SENT_592	[p13l1949t2709r2100b2744, p13l657t2756r774b2781],
22	virus	NN	O	virus	prep_with	19	SENT_592	[p13l782t2756r857b2781],
23	:	:	O	:	_	0	SENT_592	[p13l782t2756r857b2781],
24	a	DT	O	a	det	29	SENT_592	[p13l868t2765r882b2781],
25	phase	NN	O	phase	nn	29	SENT_592	[p13l891t2755r969b2789],
26	II	CD	NUMBER	ii	num	29	SENT_592	[p13l979t2756r1002b2780],
27	randomised	JJ	O	randomised	amod	29	SENT_592	[p13l1012t2755r1175b2781],
28	controlled	JJ	O	controlled	amod	29	SENT_592	[p13l1185t2755r1328b2781],
29	trial	NN	O	trial	_	0	SENT_592	[p13l1338t2755r1401b2781],
30	.	.	O	.	_	0	SENT_592	[p13l1338t2755r1401b2781],

1	Lancet	NNP	O	Lancet	_	0	SENT_593	[p13l1411t2756r1499b2781],
2	369:1261	CD	NUMBER	369:1261	num	1	SENT_593	[p13l1509t2757r1686b2781],
3	—	CD	NUMBER	—	number	4	SENT_593	[p13l1509t2757r1686b2781],
4	69	CD	NUMBER	69	dep	1	SENT_593	[p13l1509t2757r1686b2781],
5	Markowitz	NNP	ORGANIZATION	Markowitz	dep	4	SENT_593	[p13l656t2799r809b2824],
6	M	NN	ORGANIZATION	m	dep	1	SENT_593	[p13l817t2800r856b2830],
7	,	,	O	,	_	0	SENT_593	[p13l817t2800r856b2830],
8	Nguyen	NNP	PERSON	Nguyen	nn	9	SENT_593	[p13l867t2800r980b2833],
9	B-Y	NNP	O	B-Y	appos	6	SENT_593	[p13l990t2800r1053b2830],
10	,	,	O	,	_	0	SENT_593	[p13l990t2800r1053b2830],
11	Gotuzzo	NNP	O	Gotuzzo	nn	12	SENT_593	[p13l1064t2800r1184b2824],
12	E	NNP	O	E	appos	6	SENT_593	[p13l1194t2800r1223b2830],
13	,	,	O	,	_	0	SENT_593	[p13l1194t2800r1223b2830],
14	Mendo	NNP	PERSON	Mendo	nn	15	SENT_593	[p13l1233t2799r1334b2824],
15	F	NN	O	f	appos	6	SENT_593	[p13l1344t2800r1371b2830],
16	,	,	O	,	_	0	SENT_593	[p13l1344t2800r1371b2830],
17	Ratanasuwan	NNP	O	Ratanasuwan	nn	18	SENT_593	[p13l1382t2800r1565b2824],
18	W	NNP	O	W	appos	6	SENT_593	[p13l1574t2800r1617b2830],
19	,	,	O	,	_	0	SENT_593	[p13l1574t2800r1617b2830],
20	et	FW	O	et	nn	21	SENT_593	[p13l1629t2806r1654b2824],
21	al.	FW	O	al.	appos	6	SENT_593	[p13l1663t2799r1693b2824],
22	2007	CD	DATE	2007	dep	21	SENT_593	[p13l1704t2800r1779b2825],
23	.	.	O	.	_	0	SENT_593	[p13l1704t2800r1779b2825],

1	Rapid	JJ	O	rapid	amod	5	SENT_594	[p13l1791t2799r1872b2833],
2	and	CC	O	and	_	0	SENT_594	[p13l1882t2799r1932b2824],
3	durable	JJ	O	durable	conj_and	1	SENT_594	[p13l1942t2799r2046b2824],
4	antiretroviral	JJ	O	antiretroviral	amod	5	SENT_594	[p13l2057t2808r2100b2824, p13l657t2844r808b2870],
5	effect	NN	O	effect	_	0	SENT_594	[p13l815t2844r892b2870],
6	of	IN	O	of	_	0	SENT_594	[p13l898t2844r929b2870],
7	the	DT	O	the	det	8	SENT_594	[p13l932t2844r975b2870],
8	HIV	NN	O	hiv	prep_of	5	SENT_594	[p13l982t2845r1056b2870],
9	-	:	O	-	_	0	SENT_594	[p13l982t2845r1056b2870],
10	1	CD	NUMBER	1	num	13	SENT_594	[p13l1062t2846r1071b2870],
11	integrase	NN	O	integrase	nn	13	SENT_594	[p13l1081t2846r1206b2879],
12	inhibitor	NN	O	inhibitor	nn	13	SENT_594	[p13l1213t2844r1337b2870],
13	raltegravir	NN	O	raltegravir	dep	5	SENT_594	[p13l1343t2844r1488b2879],
14	as	IN	O	as	_	0	SENT_594	[p13l1495t2854r1520b2870],
15	part	NN	O	part	prep_as	13	SENT_594	[p13l1527t2852r1584b2878],
16	of	IN	O	of	_	0	SENT_594	[p13l1590t2844r1620b2870],
17	combination	NN	O	combination	nn	18	SENT_594	[p13l1624t2844r1799b2870],
18	therapy	NN	O	therapy	prep_of	15	SENT_594	[p13l1806t2844r1913b2879],
19	in	IN	O	in	_	0	SENT_594	[p13l1918t2846r1945b2870],
20	treatmentnaive	JJ	O	treatmentnaive	amod	21	SENT_594	[p13l1952t2852r2100b2870, p13l657t2893r729b2916],
21	patients	NNS	O	patient	prep_in	18	SENT_594	[p13l736t2891r845b2924],
22	with	IN	O	with	_	0	SENT_594	[p13l852t2890r914b2916],
23	HIV	NN	MISC	hiv	nn	25	SENT_594	[p13l922t2891r988b2916],
24	-1	CD	NUMBER	-1	num	25	SENT_594	[p13l986t2892r1011b2915],
25	infection	NN	O	infection	prep_with	21	SENT_594	[p13l1021t2890r1152b2916],
26	.	.	O	.	_	0	SENT_594	[p13l1021t2890r1152b2916],

1	Results	NNS	O	result	_	0	SENT_595	[p13l1162t2890r1261b2916],
2	of	IN	O	of	_	0	SENT_595	[p13l1270t2890r1300b2916],
3	a	DT	O	a	det	6	SENT_595	[p13l1304t2900r1317b2916],
4	48-week	JJ	DURATION	48-week	amod	6	SENT_595	[p13l1325t2890r1443b2916],
5	controlled	JJ	O	controlled	amod	6	SENT_595	[p13l1450t2890r1593b2916],
6	study	NN	O	study	prep_of	1	SENT_595	[p13l1601t2890r1711b2924],
7	.	.	O	.	_	0	SENT_595	[p13l1601t2890r1711b2924],

1	Acquir	NNP	O	Acquir	_	0	SENT_596	[p13l1718t2891r1811b2924],
2	.	.	O	.	_	0	SENT_596	[p13l1718t2891r1811b2924],

1	Immune	JJ	O	immune	amod	2	SENT_597	[p13l1820t2891r1930b2916],
2	Deﬁc	NN	O	deﬁc	_	0	SENT_597	[p13l1938t2890r2009b2924],
3	.	.	O	.	_	0	SENT_597	[p13l1938t2890r2009b2924],

1	Synclr	NNP	O	Synclr	_	0	SENT_598	[p13l2019t2891r2098b2924],
2	.	.	O	.	_	0	SENT_598	[p13l2019t2891r2098b2924],

1	4-6	CD	NUMBER	4-6	_	0	SENT_599	[p13l657t2937r697b2962],
2	:	:	O	:	_	0	SENT_599	[p13l657t2937r697b2962],
3	12	CD	NUMBER	12	dep	8	SENT_599	[p13l703t2937r731b2961],
4	5	CD	NUMBER	5	num	5	SENT_599	[p13l736t2937r749b2962],
5	-3	CD	NUMBER	-3	dep	3	SENT_599	[p13l751t2937r781b2962],
6	3	CD	NUMBER	3	dep	8	SENT_599	[p13l787t2937r799b2962],
7	Wenrling	JJ	ORGANIZATION	wenrling	amod	8	SENT_599	[p13l656t2980r787b3013],
8	LA	NNP	ORGANIZATION	LA	dep	24	SENT_599	[p13l807t2980r858b3010],
9	,	,	O	,	_	0	SENT_599	[p13l807t2980r858b3010],
10	Anderson	NNP	PERSON	Anderson	nn	11	SENT_599	[p13l878t2979r1014b3005],
11	MS	NN	O	m	appos	8	SENT_599	[p13l1032t2980r1090b3010],
12	,	,	O	,	_	0	SENT_599	[p13l1032t2980r1090b3010],
13	Petry	NNP	PERSON	Petry	nn	14	SENT_599	[p13l1111t2980r1188b3013],
14	AS	NNP	O	AS	appos	8	SENT_599	[p13l1206t2980r1254b3010],
15	,	,	O	,	_	0	SENT_599	[p13l1206t2980r1254b3010],
16	Friedman	NNP	ORGANIZATION	Friedman	nn	17	SENT_599	[p13l1275t2979r1411b3005],
17	EJ	NNP	ORGANIZATION	EJ	appos	8	SENT_599	[p13l1431t2980r1472b3011],
18	,	,	O	,	_	0	SENT_599	[p13l1431t2980r1472b3011],
19	Kost	NNP	PERSON	Kost	nn	20	SENT_599	[p13l1493t2980r1559b3005],
20	JT	NNP	O	JT	appos	8	SENT_599	[p13l1574t2979r1623b3011],
21	,	,	O	,	_	0	SENT_599	[p13l1574t2979r1623b3011],
22	et	FW	O	et	nn	23	SENT_599	[p13l1645t2986r1671b3005],
23	al.	FW	O	al.	appos	8	SENT_599	[p13l1690t2979r1720b3005],
24	2007	CD	DATE	2007	dep	1	SENT_599	[p13l1742t2980r1816b3005],
25	.	.	O	.	_	0	SENT_599	[p13l1742t2980r1816b3005],

1	Raltegravir	NN	O	raltegravir	nn	3	SENT_600	[p13l1838t2979r1993b3013],
2	p	NN	O	p	nn	3	SENT_600	[p13l2014t2980r2100b3011],
3	я	NN	O	я	_	0	SENT_600	[p13l2014t2980r2100b3011],
4	+	CC	O	+	_	0	SENT_600	[p13l2014t2980r2100b3011],
5	dose	NN	O	dose	nn	6	SENT_600	[p13l658t3024r719b3050],
6	proportionality	NN	O	proportionality	dep	3	SENT_600	[p13l733t3024r947b3059],
7	and	CC	O	and	_	0	SENT_600	[p13l960t3025r1010b3050],
8	effect	NN	O	effect	dep	3	SENT_600	[p13l1024t3025r1101b3050],
9	of	IN	O	of	_	0	SENT_600	[p13l1114t3025r1145b3050],
10	food	NN	O	food	prep_of	3	SENT_600	[p13l1155t3025r1225b3050],
11	.	.	O	.	_	0	SENT_600	[p13l1155t3025r1225b3050],

1	47t/2	NN	O	47t/2	_	0	SENT_601	[p13l1240t3025r1300b3050],
2	Interrci	NN	O	interrcus	dep	1	SENT_601	[p13l1313t3026r1414b3050],
3	.	.	O	.	_	0	SENT_601	[p13l1313t3026r1414b3050],

1	Conf	NNP	O	Conf	_	0	SENT_602	[p13l1432t3025r1499b3059],
2	.	.	O	.	_	0	SENT_602	[p13l1432t3025r1499b3059],

1	AﬂtlmlLT0l7	NN	O	aﬂtlmllt0l7	_	0	SENT_603	[p13l1510t3025r1664b3050],
2	.	.	O	.	_	0	SENT_603	[p13l1510t3025r1664b3050],

1	Agent	NNP	O	Agent	_	0	SENT_604	[p13l1677t3025r1769b3059],
2	;	:	O	;	_	0	SENT_604	[p13l1677t3025r1769b3059],
3	C/yemot/yer	NNP	O	C/yemot/yer	nn	7	SENT_604	[p13l1783t3025r1925b3056],
4	,	,	O	,	_	0	SENT_604	[p13l1783t3025r1925b3056],
5	Chicago	NNP	LOCATION	Chicago	appos	7	SENT_604	[p13l1943t3025r2049b3059],
6	,	,	O	,	_	0	SENT_604	[p13l1943t3025r2049b3059],
7	Ill.	NNP	LOCATION	Ill.	dep	1	SENT_604	[p13l2064t3025r2098b3050],
8	(	CD	NUMBER	(	num	7	SENT_604	[p13l658t3070r759b3102],
9	Abstr	NNP	PERSON	Abstr	nn	11	SENT_604	[p13l658t3070r759b3102],
10	.	.	O	.	_	0	SENT_604	[p13l658t3070r759b3102],
11	)	NN	O	)	dep	7	SENT_604	[p13l658t3070r759b3102],

1	Iwamoto	NNP	PERSON	Iwamoto	nn	2	SENT_605	[p13l657t3115r780b3139],
2	M	NNP	O	M	_	0	SENT_605	[p13l793t3115r833b3145],
3	,	,	O	,	_	0	SENT_605	[p13l793t3115r833b3145],
4	Wenning	NNP	ORGANIZATION	Wenning	nn	5	SENT_605	[p13l848t3115r979b3148],
5	LA	NNP	ORGANIZATION	LA	appos	2	SENT_605	[p13l992t3115r1043b3145],
6	,	,	O	,	_	0	SENT_605	[p13l992t3115r1043b3145],
7	Petry	NNP	PERSON	Petry	nn	8	SENT_605	[p13l1059t3115r1135b3148],
8	AS	NNP	O	AS	appos	2	SENT_605	[p13l1147t3115r1195b3145],
9	,	,	O	,	_	0	SENT_605	[p13l1147t3115r1195b3145],
10	Laethem	NNP	O	Laethem	nn	11	SENT_605	[p13l1210t3114r1335b3139],
11	M	NNP	O	M	appos	2	SENT_605	[p13l1347t3115r1387b3145],
12	,	,	O	,	_	0	SENT_605	[p13l1347t3115r1387b3145],
13	De	NNP	ORGANIZATION	De	nn	15	SENT_605	[p13l1403t3115r1444b3139],
14	Smet	NNP	ORGANIZATION	Smet	nn	15	SENT_605	[p13l1460t3115r1531b3139],
15	M	NN	ORGANIZATION	m	appos	2	SENT_605	[p13l1543t3115r1582b3145],
16	,	,	O	,	_	0	SENT_605	[p13l1543t3115r1582b3145],
17	et	FW	O	et	nn	18	SENT_605	[p13l1598t3121r1624b3139],
18	al.	FW	O	al.	appos	2	SENT_605	[p13l1638t3114r1667b3139],
19	2008	CD	DATE	2008	dep	18	SENT_605	[p13l1683t3115r1758b3139],
20	.	.	O	.	_	0	SENT_605	[p13l1683t3115r1758b3139],

1	Safety	NN	O	safety	_	0	SENT_606	[p13l1775t3114r1863b3148],
2	,	,	O	,	_	0	SENT_606	[p13l1775t3114r1863b3148],
3	tolerability	NN	O	tolerability	conj_and	1	SENT_606	[p13l1879t3114r2036b3148],
4	,	,	O	,	_	0	SENT_606	[p13l1879t3114r2036b3148],
5	and	CC	O	and	_	0	SENT_606	[p13l2052t3114r2101b3139],
6	pharmacokinetics	NNS	O	pharmacokinetic	conj_and	1	SENT_606	[p13l657t3159r902b3193],
7	of	IN	O	of	_	0	SENT_606	[p13l911t3160r942b3185],
8	raltegravir	NN	O	raltegravir	prep_of	6	SENT_606	[p13l947t3159r1092b3194],
9	after	IN	O	after	_	0	SENT_606	[p13l1101t3160r1165b3185],
10	single	JJ	O	single	amod	13	SENT_606	[p13l1173t3159r1253b3194],
11	and	CC	O	and	_	0	SENT_606	[p13l1263t3159r1313b3185],
12	multiple	JJ	O	multiple	amod	13	SENT_606	[p13l1322t3159r1438b3193],
13	doses	NNS	O	dose	prep_after	8	SENT_606	[p13l1448t3159r1521b3185],
14	in	IN	O	in	_	0	SENT_606	[p13l1530t3161r1557b3185],
15	healthy	JJ	O	healthy	amod	16	SENT_606	[p13l1566t3159r1670b3194],
16	subjects	NNS	O	subject	prep_in	6	SENT_606	[p13l1678t3159r1793b3193],
17	.	.	O	.	_	0	SENT_606	[p13l1678t3159r1793b3193],

1	Clin	NNP	O	Clin	_	0	SENT_607	[p13l1806t3160r1866b3185],
2	.	.	O	.	_	0	SENT_607	[p13l1806t3160r1866b3185],

1	P/yarmacol	NN	O	p/yarmacol	_	0	SENT_608	[p13l1877t3160r2021b3185],
2	.	.	O	.	_	0	SENT_608	[p13l1877t3160r2021b3185],

1	Then	RB	O	then	advmod	7	SENT_609	[p13l2035t3160r2098b3185],
2	83:293	CD	NUMBER	83:293	num	7	SENT_609	[p13l658t3207r801b3231],
3	—	CD	NUMBER	—	num	7	SENT_609	[p13l658t3207r801b3231],
4	99	CD	NUMBER	99	num	7	SENT_609	[p13l658t3207r801b3231],
5	Merck	NNP	ORGANIZATION	Merck	nn	7	SENT_609	[p13l655t3252r740b3276],
6	d7	NNP	ORGANIZATION	d7	nn	7	SENT_609	[p13l751t3250r775b3276],
7	Co.	NNP	ORGANIZATION	Co.	_	0	SENT_609	[p13l785t3252r832b3282],
8	,	,	O	,	_	0	SENT_609	[p13l785t3252r832b3282],
9	Inc.	NNP	O	Inc.	appos	7	SENT_609	[p13l842t3252r888b3276],
10	2007	CD	DATE	2007	num	9	SENT_609	[p13l900t3252r974b3277],
11	.	.	O	.	_	0	SENT_609	[p13l900t3252r974b3277],

1	Raltegravir	NNP	O	Raltegravir	nn	2	SENT_610	[p13l985t3251r1141b3285],
2	Tablets	NNPS	O	Tablets	_	0	SENT_610	[p13l1148t3251r1249b3276],
3	FDA	NNP	O	FDA	nn	4	SENT_610	[p13l1258t3252r1329b3276],
4	Advis	NNPS	O	Advis	dep	2	SENT_610	[p13l1335t3251r1419b3276],
5	.	.	O	.	_	0	SENT_610	[p13l1335t3251r1419b3276],

1	Comm	NNP	O	Comm	_	0	SENT_611	[p13l1431t3252r1534b3276],
2	.	.	O	.	_	0	SENT_611	[p13l1431t3252r1534b3276],

1	Meet	NNP	O	Meet	_	0	SENT_612	[p13l1544t3252r1625b3276],
2	.	.	O	.	_	0	SENT_612	[p13l1544t3252r1625b3276],

1	Brieﬁng	NNP	O	Brieﬁng	nn	2	SENT_613	[p13l1636t3251r1749b3285],
2	Doc	NNP	O	Doc	_	0	SENT_613	[p13l1758t3252r1823b3276],
3	.	.	O	.	_	0	SENT_613	[p13l1758t3252r1823b3276],

1	(	NN	O	(	nn	3	SENT_614	[p13l1835t3251r2013b3285],
2	Background	NN	O	background	nn	3	SENT_614	[p13l1835t3251r2013b3285],
3	Package	NN	O	package	_	0	SENT_614	[p13l2022t3251r2100b3276, p13l657t3297r713b3330],
4	)	CD	NUMBER	)	num	7	SENT_614	[p13l2022t3251r2100b3276, p13l657t3297r713b3330],
5	Merck	NNP	ORGANIZATION	Merck	nn	7	SENT_614	[p13l655t3342r740b3367],
6	d7	NNP	ORGANIZATION	d7	nn	7	SENT_614	[p13l752t3341r777b3367],
7	Co.	NNP	ORGANIZATION	Co.	dep	3	SENT_614	[p13l788t3342r835b3373],
8	,	,	O	,	_	0	SENT_614	[p13l788t3342r835b3373],
9	Inc.	NNP	O	Inc.	appos	7	SENT_614	[p13l847t3343r892b3367],
10	2008	CD	DATE	2008	num	9	SENT_614	[p13l906t3343r981b3367],
11	.	.	O	.	_	0	SENT_614	[p13l906t3343r981b3367],

1	ISENTRESS	NNS	O	isentress	_	0	SENT_615	[p13l992t3342r1182b3367],
2	(	CD	NUMBER	(	num	5	SENT_615	[p13l1194t3342r1358b3376],
3	raltegravir	NN	O	raltegravir	nn	5	SENT_615	[p13l1194t3342r1358b3376],
4	)	NN	O	)	nn	5	SENT_615	[p13l1194t3342r1358b3376],
5	tablets	NNS	O	tablet	dep	1	SENT_615	[p13l1370t3342r1460b3367],
6	(	CD	NUMBER	(	dep	1	SENT_615	[p13l1472t3342r1639b3376],
7	prescribing	VBG	O	prescribe	partmod	1	SENT_615	[p13l1472t3342r1639b3376],
8	information	NN	O	information	dobj	7	SENT_615	[p13l1649t3342r1826b3374],
9	)	CD	NUMBER	)	num	12	SENT_615	[p13l1649t3342r1826b3374],
10	U.S.	NNP	LOCATION	U.S.	nn	12	SENT_615	[p13l1837t3343r1898b3367],
11	[	CD	NUMBER	[	num	12	SENT_615	[p13l1913t3342r2033b3373],
12	Product	NNP	O	Product	tmod	7	SENT_615	[p13l1913t3342r2033b3373],
13	Circular	JJ	O	circular	amod	14	SENT_615	[p13l2044t3343r2100b3367, p13l658t3387r743b3419],
14	]	NN	O	]	dep	12	SENT_615	[p13l2044t3343r2100b3367, p13l658t3387r743b3419],
15	.	.	O	.	_	0	SENT_615	[p13l2044t3343r2100b3367, p13l658t3387r743b3419],

1	V	NN	O	v	_	0	SENT_616	[p13l753t3387r925b3413],
2	‘	CD	NUMBER	‘	num	1	SENT_616	[p13l753t3387r925b3413],
3	/	:	O	/	punct	5	SENT_616	[p13l753t3387r925b3413],
4	hitehouse	NN	O	hitehouse	nn	5	SENT_616	[p13l753t3387r925b3413],
5	Station	NNP	O	Station	dep	1	SENT_616	[p13l936t3388r1042b3419],
6	,	,	O	,	_	0	SENT_616	[p13l936t3388r1042b3419],
7	NJ	NNP	O	NJ	appos	5	SENT_616	[p13l1053t3388r1100b3419],
8	.	.	O	.	_	0	SENT_616	[p13l1053t3388r1100b3419],

1	Kassahun	NNP	PERSON	Kassahun	nn	2	SENT_617	[p13l657t3431r790b3457],
2	K	NNP	PERSON	K	_	0	SENT_617	[p13l800t3432r832b3462],
3	,	,	O	,	_	0	SENT_617	[p13l800t3432r832b3462],
4	McIntosh	NNP	O	McIntosh	nn	5	SENT_617	[p13l842t3431r979b3457],
5	I	NNP	O	I	appos	2	SENT_617	[p13l989t3432r1008b3462],
6	,	,	O	,	_	0	SENT_617	[p13l989t3432r1008b3462],
7	Cui	NNP	PERSON	Cui	nn	8	SENT_617	[p13l1020t3432r1070b3457],
8	D	NNP	PERSON	D	appos	2	SENT_617	[p13l1081t3432r1115b3462],
9	,	,	O	,	_	0	SENT_617	[p13l1081t3432r1115b3462],
10	Hreniuk	NNP	O	Hreniuk	nn	11	SENT_617	[p13l1126t3431r1246b3457],
11	D	NNP	O	D	appos	2	SENT_617	[p13l1255t3432r1288b3462],
12	,	,	O	,	_	0	SENT_617	[p13l1255t3432r1288b3462],
13	Merschman	NNP	O	Merschman	nn	14	SENT_617	[p13l1299t3431r1466b3457],
14	S	NNP	O	S	appos	2	SENT_617	[p13l1477t3432r1500b3462],
15	,	,	O	,	_	0	SENT_617	[p13l1477t3432r1500b3462],
16	et	FW	O	et	nn	17	SENT_617	[p13l1513t3438r1538b3457],
17	al.	FW	O	al.	appos	2	SENT_617	[p13l1548t3431r1577b3457],
18	2007	CD	DATE	2007	dep	17	SENT_617	[p13l1589t3432r1664b3457],
19	.	.	O	.	_	0	SENT_617	[p13l1589t3432r1664b3457],

1	Metabolism	NN	O	metabolism	_	0	SENT_618	[p13l1674t3431r1842b3457],
2	and	CC	O	and	_	0	SENT_618	[p13l1853t3431r1902b3457],
3	disposition	NN	O	disposition	conj_and	1	SENT_618	[p13l1913t3431r2065b3465],
4	in	IN	O	in	_	0	SENT_618	[p13l2074t3432r2101b3456],
5	humans	NNS	O	human	prep_in	1	SENT_618	[p13l657t3477r765b3502],
6	of	IN	O	of	_	0	SENT_618	[p13l778t3477r809b3502],
7	raltegravir	NN	O	raltegravir	nn	10	SENT_618	[p13l817t3476r962b3511],
8	(	CD	NUMBER	(	num	10	SENT_618	[p13l975t3477r1140b3509],
9	MK-0518	NN	O	mk-0518	nn	10	SENT_618	[p13l975t3477r1140b3509],
10	)	NN	O	)	prep_of	5	SENT_618	[p13l975t3477r1140b3509],
11	,	,	O	,	_	0	SENT_618	[p13l975t3477r1140b3509],
12	an	DT	O	a	det	14	SENT_618	[p13l1154t3486r1186b3502],
13	anti-AIDS	JJ	O	anti-aids	amod	14	SENT_618	[p13l1198t3477r1343b3502],
14	drug	NN	O	drug	appos	1	SENT_618	[p13l1357t3477r1422b3511],
15	targeting	VBG	O	target	partmod	14	SENT_618	[p13l1433t3478r1560b3511],
16	the	DT	O	the	det	22	SENT_618	[p13l1571t3476r1615b3502],
17	human	JJ	O	human	amod	22	SENT_618	[p13l1627t3476r1724b3502],
18	immunodeﬁciency	NN	O	immunodeﬁciency	nn	22	SENT_618	[p13l1735t3476r1996b3511],
19	virus	NN	O	virus	nn	22	SENT_618	[p13l2005t3478r2072b3502],
20	1	CD	NUMBER	1	num	22	SENT_618	[p13l2088t3478r2098b3502],
21	integrase	NN	O	integrase	nn	22	SENT_618	[p13l657t3524r782b3556],
22	enzyme	NN	O	enzyme	dobj	15	SENT_618	[p13l793t3532r906b3556],
23	.	.	O	.	_	0	SENT_618	[p13l793t3532r906b3556],

1	Drug	NN	O	drug	_	0	SENT_619	[p13l917t3523r990b3557],
2	Metali	NNP	O	Metali	dep	1	SENT_619	[p13l997t3523r1087b3548],
3	.	.	O	.	_	0	SENT_619	[p13l997t3523r1087b3548],

1	Diaper	NN	O	diaper	_	0	SENT_620	[p13l1099t3523r1186b3556],
2	.	.	O	.	_	0	SENT_620	[p13l1099t3523r1186b3556],

1	35	CD	NUMBER	35	num	2	SENT_621	[p13l1200t3523r1230b3548],
2	:1657	CD	NUMBER	:1657	_	0	SENT_621	[p13l1235t3523r1358b3548],
3	—	NN	O	—	nn	5	SENT_621	[p13l1235t3523r1358b3548],
4	63	CD	NUMBER	63	num	5	SENT_621	[p13l1235t3523r1358b3548],
5	PetryAS	NNP	O	PetryAS	dep	2	SENT_621	[p13l657t3566r786b3600],
6	,	,	O	,	_	0	SENT_621	[p13l657t3566r786b3600],
7	Wenning	NNP	ORGANIZATION	Wenning	nn	8	SENT_621	[p13l794t3566r925b3600],
8	LA	NNP	ORGANIZATION	LA	appos	5	SENT_621	[p13l931t3566r982b3596],
9	,	,	O	,	_	0	SENT_621	[p13l931t3566r982b3596],
10	KostJT	NNP	O	KostJT	appos	5	SENT_621	[p13l991t3566r1155b3597],
11	,	,	O	,	_	0	SENT_621	[p13l991t3566r1155b3597],
12	Jin	NNP	PERSON	Jin	nn	13	SENT_621	[p13l991t3566r1155b3597],
13	B	NNP	PERSON	B	appos	5	SENT_621	[p13l1163t3566r1190b3597],
14	,	,	O	,	_	0	SENT_621	[p13l1163t3566r1190b3597],
15	Breidinger	NNP	ORGANIZATION	Breidinger	nn	16	SENT_621	[p13l1199t3565r1348b3600],
16	SA	NNP	ORGANIZATION	SA	appos	5	SENT_621	[p13l1356t3566r1402b3597],
17	,	,	O	,	_	0	SENT_621	[p13l1356t3566r1402b3597],
18	et	FW	O	et	nn	19	SENT_621	[p13l1411t3573r1436b3591],
19	al.	FW	O	al.	appos	5	SENT_621	[p13l1443t3565r1473b3591],
20	2008	CD	DATE	2008	dep	19	SENT_621	[p13l1482t3567r1556b3591],
21	.	.	O	.	_	0	SENT_621	[p13l1482t3567r1556b3591],

1	Raltegravir	NN	O	raltegravir	nn	3	SENT_622	[p13l1565t3565r1721b3600],
2	(	CD	NUMBER	(	num	3	SENT_622	[p13l1728t3566r1815b3597],
3	RAL	NN	O	ral	_	0	SENT_622	[p13l1728t3566r1815b3597],
4	)	CD	NUMBER	)	num	5	SENT_622	[p13l1728t3566r1815b3597],
5	pharmacokinetics	NNS	O	pharmacokinetic	dep	3	SENT_622	[p13l1822t3565r2067b3599],
6	in	IN	O	in	_	0	SENT_622	[p13l2074t3567r2101b3591],
7	individuals	NNS	O	individual	prep_in	5	SENT_622	[p13l657t3611r807b3637],
8	with	IN	O	with	_	0	SENT_622	[p13l816t3611r878b3637],
9	UGT1A1	NN	O	ugt1a1	nn	10	SENT_622	[p13l888t3612r1099b3637],
10	*	NN	O	*	prep_with	7	SENT_622	[p13l888t3612r1099b3637],
11	1	CD	NUMBER	1	dep	3	SENT_622	[p13l888t3612r1099b3637],
12	/	:	O	/	punct	14	SENT_622	[p13l888t3612r1099b3637],
13	*	CD	NUMBER	*	num	14	SENT_622	[p13l888t3612r1099b3637],
14	1	CD	NUMBER	1	dep	11	SENT_622	[p13l888t3612r1099b3637],
15	and	CC	O	and	_	0	SENT_622	[p13l1112t3611r1162b3637],
16	UGT1A1	NN	O	ugt1a1	dep	11	SENT_622	[p13l1172t3612r1419b3637],
17	*	CD	NUMBER	*	num	18	SENT_622	[p13l1172t3612r1419b3637],
18	28	CD	NUMBER	28	dep	14	SENT_622	[p13l1172t3612r1419b3637],
19	/	:	O	/	punct	14	SENT_622	[p13l1172t3612r1419b3637],
20	*	CD	NUMBER	*	number	21	SENT_622	[p13l1172t3612r1419b3637],
21	28	CD	NUMBER	28	num	22	SENT_622	[p13l1172t3612r1419b3637],
22	genotypes	NNS	O	genotype	dep	11	SENT_622	[p13l1430t3618r1577b3646],
23	.	.	O	.	_	0	SENT_622	[p13l1430t3618r1577b3646],

1	48t/J	NN	O	48t/j	_	0	SENT_623	[p13l1589t3612r1649b3637],
2	Interrci	NN	O	interrcus	dep	1	SENT_623	[p13l1658t3612r1759b3637],
3	.	.	O	.	_	0	SENT_623	[p13l1658t3612r1759b3637],

1	Conf	NNP	O	Conf	_	0	SENT_624	[p13l1773t3611r1840b3646],
2	.	.	O	.	_	0	SENT_624	[p13l1773t3611r1840b3646],

1	Antimicrob	NNP	PERSON	Antimicrob	_	0	SENT_625	[p13l1848t3612r2002b3637],
2	.	.	O	.	_	0	SENT_625	[p13l1848t3612r2002b3637],

1	Agents	NNS	O	agent	_	0	SENT_626	[p13l2011t3612r2103b3646],
2	Chemother	NNP	O	Chemother	nn	6	SENT_626	[p13l659t3654r811b3684],
3	,	,	O	,	_	0	SENT_626	[p13l659t3654r811b3684],
4	Washington	NNP	LOCATION	Washington	appos	6	SENT_626	[p13l821t3653r1000b3687],
5	,	,	O	,	_	0	SENT_626	[p13l821t3653r1000b3687],
6	DC	NNP	ORGANIZATION	DC	dep	1	SENT_626	[p13l1011t3654r1069b3679],
7	.	.	O	.	_	0	SENT_626	[p13l1011t3654r1069b3679],

1	(	NN	O	(	nn	2	SENT_627	[p13l1081t3653r1183b3685],
2	Abstr	NN	O	abstr	_	0	SENT_627	[p13l1081t3653r1183b3685],
3	.	.	O	.	_	0	SENT_627	[p13l1081t3653r1183b3685],
4	)	SYM	O	)	dep	2	SENT_627	[p13l1081t3653r1183b3685],

1	Iwamoto	NNP	PERSON	Iwamoto	nn	2	SENT_628	[p13l657t3696r780b3721],
2	M	NNP	O	M	_	0	SENT_628	[p13l789t3696r828b3727],
3	,	,	O	,	_	0	SENT_628	[p13l789t3696r828b3727],
4	Kassahun	NNP	PERSON	Kassahun	nn	5	SENT_628	[p13l839t3695r972b3721],
5	K	NNP	PERSON	K	appos	2	SENT_628	[p13l982t3696r1013b3727],
6	,	,	O	,	_	0	SENT_628	[p13l982t3696r1013b3727],
7	Troyer	NNP	PERSON	Troyer	nn	8	SENT_628	[p13l1023t3696r1119b3730],
8	MD	NNP	O	MD	appos	2	SENT_628	[p13l1127t3696r1194b3727],
9	,	,	O	,	_	0	SENT_628	[p13l1127t3696r1194b3727],
10	Hanley	NNP	PERSON	Hanley	nn	11	SENT_628	[p13l1205t3695r1308b3730],
11	WD	NNP	O	WD	appos	2	SENT_628	[p13l1315t3696r1386b3727],
12	,	,	O	,	_	0	SENT_628	[p13l1315t3696r1386b3727],
13	Lu	NNP	PERSON	Lu	nn	14	SENT_628	[p13l1397t3696r1437b3721],
14	P	NN	PERSON	p	appos	2	SENT_628	[p13l1446t3696r1473b3727],
15	,	,	O	,	_	0	SENT_628	[p13l1446t3696r1473b3727],
16	et	FW	O	et	nn	17	SENT_628	[p13l1485t3703r1510b3721],
17	al.	FW	O	al.	appos	2	SENT_628	[p13l1519t3695r1549b3721],
18	2008	CD	DATE	2008	dep	17	SENT_628	[p13l1560t3697r1635b3721],
19	.	.	O	.	_	0	SENT_628	[p13l1560t3697r1635b3721],

1	Lack	NN	O	lack	_	0	SENT_629	[p13l1646t3695r1715b3721],
2	of	IN	O	of	_	0	SENT_629	[p13l1723t3695r1754b3721],
3	a	DT	O	a	det	5	SENT_629	[p13l1760t3705r1773b3721],
4	pharmacokinetic	JJ	O	pharmacokinetic	amod	5	SENT_629	[p13l1783t3695r2015b3730],
5	effect	NN	O	effect	prep_of	1	SENT_629	[p13l2025t3695r2102b3721],
6	of	IN	O	of	_	0	SENT_629	[p13l658t3738r688b3764],
7	raltegravir	NN	O	raltegravir	prep_of	5	SENT_629	[p13l694t3738r839b3772],
8	on	IN	O	on	_	0	SENT_629	[p13l849t3748r884b3764],
9	midazolam	NN	O	midazolam	prep_on	5	SENT_629	[p13l893t3738r1053b3764],
10	:	:	O	:	_	0	SENT_629	[p13l893t3738r1053b3764],
11	in	IN	O	in	_	0	SENT_629	[p13l1064t3739r1091b3763],
12	vit1	NN	O	vit1	prep_in	9	SENT_629	[p13l1099t3739r1206b3764],
13	'	''	O	'	_	0	SENT_629	[p13l1099t3739r1206b3764],
14	o/in	FW	O	o/in	nn	16	SENT_629	[p13l1099t3739r1206b3764],
15	vivo	FW	O	vivo	nn	16	SENT_629	[p13l1214t3739r1272b3764],
16	correlation	NN	O	correlation	dep	5	SENT_629	[p13l1282t3738r1442b3764],
17	.	.	O	.	_	0	SENT_629	[p13l1282t3738r1442b3764],

1	`	``	O	`	_	0	SENT_630	[p13l1449t3738r1474b3772],
2	Pz	NN	O	pz	_	0	SENT_630	[p13l1449t3738r1474b3772],
3	+	CC	O	+	cc	4	SENT_630	[p13l1449t3738r1474b3772],
4	Clin	NN	O	clin	dep	2	SENT_630	[p13l1488t3739r1549b3763],
5	.	.	O	.	_	0	SENT_630	[p13l1488t3739r1549b3763],

1	P/aarmacol	NN	O	p/aarmacol	_	0	SENT_631	[p13l1560t3739r1705b3763],
2	.	.	O	.	_	0	SENT_631	[p13l1560t3739r1705b3763],

1	482209-14	CD	NUMBER	482209-14	_	0	SENT_632	[p13l1717t3739r1862b3764],
2	.	.	O	.	_	0	SENT_632	[p13l633t3801r638b3805],

1	Wenning	NNP	ORGANIZATION	Wenning	nn	2	SENT_633	[p13l656t3781r787b3814],
2	LA	NNP	ORGANIZATION	LA	_	0	SENT_633	[p13l800t3781r851b3811],
3	,	,	O	,	_	0	SENT_633	[p13l800t3781r851b3811],
4	Friedman	NNP	PERSON	Friedman	nn	5	SENT_633	[p13l865t3780r1001b3806],
5	EJ	NNP	O	EJ	appos	2	SENT_633	[p13l1014t3781r1055b3812],
6	,	,	O	,	_	0	SENT_633	[p13l1014t3781r1055b3812],
7	Kost	NNP	PERSON	Kost	nn	8	SENT_633	[p13l1069t3781r1136b3806],
8	JT	NNP	O	JT	appos	2	SENT_633	[p13l1144t3781r1192b3812],
9	,	,	O	,	_	0	SENT_633	[p13l1144t3781r1192b3812],
10	Breidinger	NNP	ORGANIZATION	Breidinger	nn	11	SENT_633	[p13l1207t3780r1356b3814],
11	SA	NNP	ORGANIZATION	SA	appos	2	SENT_633	[p13l1370t3781r1416b3811],
12	,	,	O	,	_	0	SENT_633	[p13l1370t3781r1416b3811],
13	Stek	NNP	PERSON	Stek	nn	14	SENT_633	[p13l1431t3780r1492b3806],
14	JE	NNP	O	JE	appos	2	SENT_633	[p13l1500t3781r1545b3812],
15	,	,	O	,	_	0	SENT_633	[p13l1500t3781r1545b3812],
16	et	FW	O	et	nn	17	SENT_633	[p13l1560t3787r1586b3806],
17	al.	FW	O	al.	appos	2	SENT_633	[p13l1598t3780r1628b3806],
18	2008	CD	DATE	2008	dep	17	SENT_633	[p13l1643t3782r1717b3806],
19	.	.	O	.	_	0	SENT_633	[p13l1643t3782r1717b3806],

1	Lack	NN	O	lack	_	0	SENT_634	[p13l1732t3780r1801b3806],
2	of	IN	O	of	_	0	SENT_634	[p13l1813t3780r1844b3806],
3	a	DT	O	a	det	5	SENT_634	[p13l1854t3790r1867b3806],
4	signiﬁcant	JJ	O	signiﬁcant	amod	5	SENT_634	[p13l1880t3780r2024b3814],
5	drug	NN	O	drug	prep_of	1	SENT_634	[p13l2037t3780r2102b3814],

1	Annu	NNP	PERSON	Annu	_	0	SENT_635	[p14l201t2219r224b2299],
2	.	.	O	.	_	0	SENT_635	[p14l201t2219r224b2299],

1	Rev.	NNP	O	Rev.	nn	2	SENT_636	[p14l201t2149r224b2208],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_636	[p14l201t1990r224b2138],
3	.	.	O	.	_	0	SENT_636	[p14l201t1990r224b2138],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_637	[p14l201t1869r224b1979],
2	.	.	O	.	_	0	SENT_637	[p14l201t1869r224b1979],

1	2009.49:3	CD	NUMBER	2009.49:3	num	2	SENT_638	[p14l201t1726r225b1858],
2	77-394	CD	NUMBER	77-394	_	0	SENT_638	[p14l201t1548r225b1649],
3	.	.	O	.	_	0	SENT_638	[p14l201t1548r225b1649],

1	Downloaded	VBN	O	download	_	0	SENT_639	[p14l201t1367r224b1538],
2	from	IN	O	from	_	0	SENT_639	[p14l201t1294r224b1358],
3	www.annualreviews.org	NN	O	www.annualreviews.org	nn	4	SENT_639	[p14l201t960r231b1285],
4	dison	NN	O	dison	prep_from	1	SENT_639	[p14l234t1578r258b1649],
5	on	IN	O	on	_	0	SENT_639	[p14l242t1536r258b1568],
6	01/05/14	CD	DATE	01/05/14	prep_on	4	SENT_639	[p14l234t1402r258b1526],
7	.	.	O	.	_	0	SENT_639	[p14l234t1402r258b1526],

1	For	IN	O	for	_	0	SENT_640	[p14l235t1345r258b1391],
2	personal	JJ	O	personal	amod	3	SENT_640	[p14l234t1225r265b1337],
3	use	NN	O	use	pobj	1	SENT_640	[p14l242t1172r258b1216],
4	only	RB	O	only	advmod	3	SENT_640	[p14l234t1097r265b1162],
5	.	.	O	.	_	0	SENT_640	[p14l234t1097r265b1162],

1	by	IN	O	by	dep	6	SENT_641	[p14l234t2132r265b2164],
2	University	NNP	ORGANIZATION	University	pobj	1	SENT_641	[p14l234t1983r265b2123],
3	of	IN	ORGANIZATION	of	_	0	SENT_641	[p14l234t1944r258b1973],
4	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	2	SENT_641	[p14l234t1797r258b1937],
5	-	:	O	-	_	0	SENT_641	[p14l248t1778r251b1787],
6	Ma	NNP	O	Ma	_	0	SENT_641	[p14l235t1724r258b1769],

1	46a	NN	O	46a	_	0	SENT_642	[p14l346t448r402b473],
2	.	.	O	.	_	0	SENT_642	[p14l346t448r402b473],

1	interaction	NN	O	interaction	_	0	SENT_643	[p14l657t11r809b36],
2	between	IN	O	between	_	0	SENT_643	[p14l819t10r935b36],
3	raltegravir	NN	O	raltegravir	prep_between	1	SENT_643	[p14l944t10r1089b44],
4	and	CC	O	and	_	0	SENT_643	[p14l1099t10r1148b36],
5	tenofovir	NN	O	tenofovir	prep_between	1	SENT_643	[p14l1159t10r1293b36],
6	.	.	O	.	_	0	SENT_643	[p14l1159t10r1293b36],

1	Antimieroh	NNP	PERSON	Antimieroh	_	0	SENT_644	[p14l1301t11r1455b36],
2	.	.	O	.	_	0	SENT_644	[p14l1301t11r1455b36],

1	Agent	NNP	O	Agent	_	0	SENT_645	[p14l1464t11r1555b45],
2	:	:	O	:	_	0	SENT_645	[p14l1464t11r1555b45],
3	Chemother	NNP	PERSON	Chemother	dep	1	SENT_645	[p14l1565t11r1708b36],
4	.	.	O	.	_	0	SENT_645	[p14l1565t11r1708b36],

1	5	CD	NUMBER	5	num	2	SENT_646	[p14l1722t11r1734b36],
2	2:325	CD	NUMBER	2:325	_	0	SENT_646	[p14l1738t11r1812b36],
3	3-5	CD	NUMBER	3-5	num	4	SENT_646	[p14l1816t11r1863b36],
4	8	CD	NUMBER	8	dep	2	SENT_646	[p14l1867t12r1881b36],

1	45	CD	NUMBER	45	_	0	SENT_647	[p14l597t53r638b78],
2	.	.	O	.	_	0	SENT_647	[p14l597t53r638b78],

1	Anderson	NNP	PERSON	Anderson	nn	2	SENT_648	[p14l656t52r791b78],
2	MS	NN	O	m	_	0	SENT_648	[p14l802t53r860b83],
3	,	,	O	,	_	0	SENT_648	[p14l802t53r860b83],
4	Kakuda	NNP	ORGANIZATION	Kakuda	nn	5	SENT_648	[p14l873t52r979b78],
5	TN	NN	ORGANIZATION	tn	appos	2	SENT_648	[p14l990t53r1052b83],
6	,	,	O	,	_	0	SENT_648	[p14l990t53r1052b83],
7	Miller	NNP	PERSON	Miller	nn	8	SENT_648	[p14l1064t52r1152b78],
8	JL	NNP	O	JL	appos	2	SENT_648	[p14l1160t53r1205b84],
9	,	,	O	,	_	0	SENT_648	[p14l1160t53r1205b84],
10	Simonts	NNP	O	Simonts	nn	11	SENT_648	[p14l1220t53r1332b78],
11	M	NNP	O	M	appos	2	SENT_648	[p14l1343t53r1382b83],
12	,	,	O	,	_	0	SENT_648	[p14l1343t53r1382b83],
13	Miller	NNP	PERSON	Miller	nn	14	SENT_648	[p14l1394t52r1483b78],
14	D	NNP	O	D	appos	2	SENT_648	[p14l1495t53r1528b83],
15	,	,	O	,	_	0	SENT_648	[p14l1495t53r1528b83],
16	et	FW	O	et	nn	17	SENT_648	[p14l1542t59r1568b78],
17	al.	FW	O	al.	appos	2	SENT_648	[p14l1579t52r1609b78],
18	2007	CD	DATE	2007	dep	17	SENT_648	[p14l1623t53r1697b78],
19	.	.	O	.	_	0	SENT_648	[p14l1623t53r1697b78],

1	Pharmacokinetic	JJ	O	pharmacokinetic	amod	2	SENT_649	[p14l1711t52r1947b78],
2	evaluation	NN	O	evaluation	_	0	SENT_649	[p14l1959t52r2101b78],
3	of	IN	O	of	_	0	SENT_649	[p14l658t94r688b120],
4	non-nucleoside	JJ	O	non-nucleoside	amod	9	SENT_649	[p14l696t94r911b120],
5	reverse	JJ	O	reverse	amod	9	SENT_649	[p14l924t103r1023b120],
6	transcriptase	NN	O	transcriptase	nn	9	SENT_649	[p14l1036t95r1212b128],
7	inhibitor	NN	O	inhibitor	nn	9	SENT_649	[p14l1225t94r1349b120],
8	(	NN	O	(	nn	9	SENT_649	[p14l1361t94r1498b126],
9	NNRTI	NN	ORGANIZATION	nnrtus	prep_of	2	SENT_649	[p14l1361t94r1498b126],
10	)	CD	NUMBER	)	num	11	SENT_649	[p14l1361t94r1498b126],
11	TMC125	NN	O	tmc125	dep	21	SENT_649	[p14l1510t94r1643b120],
12	and	CC	O	and	_	0	SENT_649	[p14l1658t94r1707b120],
13	integrase	NN	O	integrase	nn	15	SENT_649	[p14l1720t95r1845b128],
14	inhibitor	NN	O	inhibitor	nn	15	SENT_649	[p14l1858t94r1982b120],
15	(	NN	O	(	conj_and	11	SENT_649	[p14l1995t95r2100b126],
16	InSTI	NN	O	instus	dep	21	SENT_649	[p14l1995t95r2100b126],
17	)	CD	NUMBER	)	num	16	SENT_649	[p14l1995t95r2100b126],
18	raltegravir	NN	O	raltegravir	nn	21	SENT_649	[p14l657t136r802b171],
19	(	CD	NUMBER	(	num	21	SENT_649	[p14l816t137r903b169],
20	RAL	NN	O	ral	nn	21	SENT_649	[p14l816t137r903b169],
21	)	NN	O	)	dep	2	SENT_649	[p14l816t137r903b169],
22	in	IN	O	in	_	0	SENT_649	[p14l917t137r943b162],
23	healthy	JJ	O	healthy	amod	24	SENT_649	[p14l957t136r1060b171],
24	subjects	NNS	O	subject	prep_in	21	SENT_649	[p14l1073t136r1188b171],
25	.	.	O	.	_	0	SENT_649	[p14l1073t136r1188b171],

1	4th	JJ	ORDINAL	4th	amod	2	SENT_650	[p14l1203t137r1246b162],
2	Int	NN	O	int	_	0	SENT_650	[p14l1259t137r1304b162],
3	.	.	O	.	_	0	SENT_650	[p14l1259t137r1304b162],

1	AIDS	NNP	MISC	AIDS	nn	2	SENT_651	[p14l1317t137r1399b162],
2	Soc	NNP	O	Soc	_	0	SENT_651	[p14l1411t137r1458b162],
3	.	.	O	.	_	0	SENT_651	[p14l1411t137r1458b162],

1	Conf	NNP	O	Conf	_	0	SENT_652	[p14l1476t136r1543b171],
2	HIV	NN	O	hiv	nn	3	SENT_652	[p14l1556t137r1622b162],
3	Pathog	NN	O	pathog	dep	1	SENT_652	[p14l1629t137r1725b171],
4	.	.	O	.	_	0	SENT_652	[p14l1629t137r1725b171],

1	Treat	VB	O	treat	_	0	SENT_653	[p14l1743t137r1816b162],
2	.	.	O	.	_	0	SENT_653	[p14l1743t137r1816b162],

1	Prev.	NNP	O	Prev.	_	0	SENT_654	[p14l1832t137r1908b168],
2	,	,	O	,	_	0	SENT_654	[p14l1832t137r1908b168],
3	Sydney	NNP	LOCATION	Sydney	nn	5	SENT_654	[p14l1923t137r2017b171],
4	,	,	O	,	_	0	SENT_654	[p14l1923t137r2017b171],
5	Amt	NNP	O	Amt	appos	1	SENT_654	[p14l2031t137r2098b162],
6	.	.	O	.	_	0	SENT_654	[p14l2031t137r2098b162],

1	(	NN	O	(	nn	2	SENT_655	[p14l658t178r759b210],
2	Abstr	NN	O	abstr	_	0	SENT_655	[p14l658t178r759b210],
3	.	.	O	.	_	0	SENT_655	[p14l658t178r759b210],
4	)	SYM	O	)	dep	2	SENT_655	[p14l658t178r759b210],

1	46	CD	NUMBER	46	_	0	SENT_656	[p14l597t222r638b247],
2	.	.	O	.	_	0	SENT_656	[p14l597t222r638b247],

1	Anderson	NNP	PERSON	Anderson	nn	2	SENT_657	[p14l656t220r791b246],
2	MS	NN	O	m	_	0	SENT_657	[p14l799t221r857b252],
3	,	,	O	,	_	0	SENT_657	[p14l799t221r857b252],
4	Wenning	NNP	ORGANIZATION	Wenning	nn	5	SENT_657	[p14l867t221r998b255],
5	LA	NNP	ORGANIZATION	LA	appos	2	SENT_657	[p14l1006t221r1057b252],
6	,	,	O	,	_	0	SENT_657	[p14l1006t221r1057b252],
7	Moreau	NNP	PERSON	Moreau	nn	8	SENT_657	[p14l1066t221r1177b246],
8	A	NNP	O	A	appos	2	SENT_657	[p14l1185t221r1214b252],
9	,	,	O	,	_	0	SENT_657	[p14l1185t221r1214b252],
10	KostJT	NNP	O	KostJT	appos	2	SENT_657	[p14l1225t221r1343b253],
11	,	,	O	,	_	0	SENT_657	[p14l1225t221r1343b253],
12	Bieberdorf	NNP	O	Bieberdorf	nn	13	SENT_657	[p14l1354t220r1508b246],
13	FA	NNP	O	FA	appos	2	SENT_657	[p14l1513t221r1559b252],
14	,	,	O	,	_	0	SENT_657	[p14l1513t221r1559b252],
15	et	FW	O	et	nn	16	SENT_657	[p14l1570t228r1596b246],
16	al.	FW	O	al.	appos	2	SENT_657	[p14l1605t220r1634b246],
17	2007	CD	DATE	2007	dep	16	SENT_657	[p14l1645t221r1720b247],
18	.	.	O	.	_	0	SENT_657	[p14l1645t221r1720b247],

1	Effect	NN	O	effect	nsubj	10	SENT_658	[p14l1730t220r1815b246],
2	of	IN	O	of	_	0	SENT_658	[p14l1824t220r1854b246],
3	raltegravir	NN	O	raltegravir	nn	6	SENT_658	[p14l1859t220r2004b255],
4	(	CD	NUMBER	(	num	6	SENT_658	[p14l2014t221r2100b253],
5	RAL	NN	O	ral	nn	6	SENT_658	[p14l2014t221r2100b253],
6	)	NN	O	)	prep_of	1	SENT_658	[p14l2014t221r2100b253],
7	on	IN	O	on	_	0	SENT_658	[p14l658t273r692b289],
8	the	DT	O	the	det	9	SENT_658	[p14l704t263r747b289],
9	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	6	SENT_658	[p14l759t263r1003b297],
10	(	VBP	O	(	_	0	SENT_658	[p14l1016t264r1081b296],
11	PK	NN	O	pk	nn	12	SENT_658	[p14l1016t264r1081b296],
12	)	NN	O	)	dobj	10	SENT_658	[p14l1016t264r1081b296],
13	of	IN	O	of	_	0	SENT_658	[p14l1093t263r1124b289],
14	oral	JJ	O	oral	amod	15	SENT_658	[p14l1132t263r1185b289],
15	contraceptives	NNS	O	contraceptive	prep_of	12	SENT_658	[p14l1197t264r1403b297],
16	.	.	O	.	_	0	SENT_658	[p14l1197t264r1403b297],

1	47th	JJ	ORDINAL	47th	amod	2	SENT_659	[p14l1416t264r1476b289],
2	Interrei	NN	O	interreus	_	0	SENT_659	[p14l1487t264r1588b289],
3	.	.	O	.	_	0	SENT_659	[p14l1487t264r1588b289],

1	Conf	NNP	O	Conf	nn	2	SENT_660	[p14l1604t263r1671b298],
2	Antimieroh	NNP	O	Antimieroh	_	0	SENT_660	[p14l1680t264r1834b289],
3	.	.	O	.	_	0	SENT_660	[p14l1680t264r1834b289],

1	Agentx	NNP	PERSON	Agentx	nn	6	SENT_661	[p14l1845t264r1936b298],
2	Chemother	NNP	PERSON	Chemother	nn	6	SENT_661	[p14l1948t264r2099b295],
3	,	,	O	,	_	0	SENT_661	[p14l1948t264r2099b295],
4	Chicago	NNP	LOCATION	Chicago	appos	6	SENT_661	[p14l659t306r764b340],
5	,	,	O	,	_	0	SENT_661	[p14l659t306r764b340],
6	Ill.	NNP	LOCATION	Ill.	_	0	SENT_661	[p14l775t306r810b331],
7	(	CD	NUMBER	(	num	6	SENT_661	[p14l823t305r924b337],
8	Abstr	NNP	PERSON	Abstr	dep	6	SENT_661	[p14l823t305r924b337],
9	.	.	O	.	_	0	SENT_661	[p14l823t305r924b337],
10	)	NN	O	)	dep	6	SENT_661	[p14l823t305r924b337],

1	392	CD	NUMBER	392	num	4	SENT_662	[p14l487t416r530b437],
2	Hazuda	NN	O	hazuda	nn	4	SENT_662	[p14l582t408r674b430],
3	o	NN	O	o	nn	4	SENT_662	[p14l689t416r699b426],
4	Iwamato	NN	O	iwamato	_	0	SENT_662	[p14l713t408r810b430],
5	-	:	O	-	_	0	SENT_662	[p14l826t416r835b426],
6	Wenning	NN	PERSON	wenning	dep	4	SENT_662	[p14l854t408r955b438],

1	Iwamoto	NNP	PERSON	Iwamoto	nn	2	SENT_663	[p14l421t448r544b473],
2	M	NNP	O	M	_	0	SENT_663	[p14l551t448r590b478],
3	,	,	O	,	_	0	SENT_663	[p14l551t448r590b478],
4	Wenning	NNP	ORGANIZATION	Wenning	nn	5	SENT_663	[p14l598t448r729b481],
5	LA	NNP	ORGANIZATION	LA	appos	2	SENT_663	[p14l736t448r787b478],
6	,	,	O	,	_	0	SENT_663	[p14l736t448r787b478],
7	Moreau	NNP	PERSON	Moreau	nn	8	SENT_663	[p14l794t448r905b473],
8	AR	NNS	O	ar	appos	2	SENT_663	[p14l911t448r964b478],
9	,	,	O	,	_	0	SENT_663	[p14l911t448r964b478],
10	Hanley	NNP	PERSON	Hanley	nn	11	SENT_663	[p14l973t447r1076b481],
11	WD	NNP	O	WD	appos	2	SENT_663	[p14l1081t448r1152b478],
12	,	,	O	,	_	0	SENT_663	[p14l1081t448r1152b478],
13	Jin	NNP	PERSON	Jin	nn	14	SENT_663	[p14l1157t448r1200b479],
14	B	NNP	PERSON	B	appos	2	SENT_663	[p14l1207t448r1235b478],
15	,	,	O	,	_	0	SENT_663	[p14l1207t448r1235b478],
16	et	FW	O	et	nn	17	SENT_663	[p14l1244t454r1270b473],
17	al.	FW	O	al.	appos	2	SENT_663	[p14l1277t447r1306b473],
18	2008	CD	DATE	2008	dep	17	SENT_663	[p14l1315t448r1390b472],
19	.	.	O	.	_	0	SENT_663	[p14l1315t448r1390b472],

1	Omeprazole	NNP	O	Omeprazole	nsubj	2	SENT_664	[p14l1400t447r1571b481],
2	increases	VBZ	O	increase	_	0	SENT_664	[p14l1578t448r1702b473],
3	plasma	NN	O	plasma	nn	4	SENT_664	[p14l1710t447r1806b481],
4	levels	NNS	O	level	dobj	2	SENT_664	[p14l1813t447r1864b473, p14l422t488r456b514],
5	of	IN	O	of	_	0	SENT_664	[p14l465t488r495b514],
6	raltegravir	NN	O	raltegravir	nn	9	SENT_664	[p14l499t488r644b522],
7	(	CD	NUMBER	(	num	9	SENT_664	[p14l651t489r738b520],
8	RAL	NN	O	ral	nn	9	SENT_664	[p14l651t489r738b520],
9	)	NN	O	)	prep_of	4	SENT_664	[p14l651t489r738b520],
10	in	IN	O	in	_	0	SENT_664	[p14l746t489r773b513],
11	healthy	JJ	O	healthy	amod	12	SENT_664	[p14l780t488r883b522],
12	subjects	NNS	O	subject	prep_in	2	SENT_664	[p14l890t488r1006b522],
13	.	.	O	.	_	0	SENT_664	[p14l890t488r1006b522],

1	48th	JJ	ORDINAL	48th	amod	2	SENT_665	[p14l1014t489r1074b514],
2	Intersei	NN	O	interseus	_	0	SENT_665	[p14l1081t489r1182b514],
3	.	.	O	.	_	0	SENT_665	[p14l1081t489r1182b514],

1	Conf	NNP	O	Conf	nn	2	SENT_666	[p14l1193t488r1260b522],
2	Antimieroh	NNP	O	Antimieroh	_	0	SENT_666	[p14l1266t489r1419b514],
3	.	.	O	.	_	0	SENT_666	[p14l1266t489r1419b514],

1	Agentr	NN	MISC	agentr	_	0	SENT_667	[p14l1426t489r1518b523],
2	C	NN	O	c	nn	3	SENT_667	[p14l1525t489r1547b514],
3	hemother	NN	O	hemother	dep	1	SENT_667	[p14l1546t489r1667b514],
4	.	.	O	.	_	0	SENT_667	[p14l1546t489r1667b514],

1	,	,	O	,	_	0	SENT_668	[p14l1672t509r1677b519],
2	Washington	NNP	LOCATION	Washington	nsubj	4	SENT_668	[p14l1685t488r1864b522],
3	,	,	O	,	_	0	SENT_668	[p14l1685t488r1864b522],
4	DC	NNP	ORGANIZATION	DC	_	0	SENT_668	[p14l421t531r480b556],
5	.	.	O	.	_	0	SENT_668	[p14l421t531r480b556],

1	(	NN	O	(	nn	2	SENT_669	[p14l492t530r593b562],
2	Abstr	NN	O	abstr	_	0	SENT_669	[p14l492t530r593b562],
3	.	.	O	.	_	0	SENT_669	[p14l492t530r593b562],
4	)	SYM	O	)	dep	2	SENT_669	[p14l492t530r593b562],

1	Iwamoto	NNP	PERSON	Iwamoto	nn	2	SENT_670	[p14l421t573r544b598],
2	M	NNP	O	M	_	0	SENT_670	[p14l555t573r595b603],
3	,	,	O	,	_	0	SENT_670	[p14l555t573r595b603],
4	Wenning	NNP	ORGANIZATION	Wenning	nn	5	SENT_670	[p14l607t573r738b606],
5	LA	NNP	ORGANIZATION	LA	appos	2	SENT_670	[p14l749t573r800b603],
6	,	,	O	,	_	0	SENT_670	[p14l749t573r800b603],
7	Mistry	NNP	ORGANIZATION	Mistry	nn	8	SENT_670	[p14l812t573r907b606],
8	GC	NN	ORGANIZATION	gc	appos	2	SENT_670	[p14l918t573r977b603],
9	,	,	O	,	_	0	SENT_670	[p14l918t573r977b603],
10	Petty	NNP	O	Petty	nn	11	SENT_670	[p14l990t573r1066b606],
11	AS	NNP	O	AS	appos	2	SENT_670	[p14l1075t573r1123b603],
12	,	,	O	,	_	0	SENT_670	[p14l1075t573r1123b603],
13	Liou	NNP	PERSON	Liou	nn	14	SENT_670	[p14l1137t573r1203b598],
14	SY	NNP	PERSON	SY	appos	2	SENT_670	[p14l1216t573r1262b603],
15	,	,	O	,	_	0	SENT_670	[p14l1216t573r1262b603],
16	et	FW	O	et	nn	17	SENT_670	[p14l1276t579r1301b598],
17	al.	FW	O	al.	appos	2	SENT_670	[p14l1312t572r1342b598],
18	2008	CD	DATE	2008	dep	17	SENT_670	[p14l1356t573r1430b597],
19	.	.	O	.	_	0	SENT_670	[p14l1356t573r1430b597],

1	Atazanavir	NNP	O	Atazanavir	nsubj	3	SENT_671	[p14l1442t573r1591b598],
2	modestly	RB	O	modestly	advmod	3	SENT_671	[p14l1602t572r1730b606],
3	increases	VBZ	O	increase	_	0	SENT_671	[p14l1740t573r1864b598],
4	plasma	NN	O	plasma	nn	5	SENT_671	[p14l421t613r516b647],
5	levels	NNS	O	level	dobj	3	SENT_671	[p14l526t613r601b639],
6	of	IN	O	of	_	0	SENT_671	[p14l612t613r642b639],
7	raltegravir	NN	O	raltegravir	prep_of	5	SENT_671	[p14l648t613r794b647],
8	in	IN	O	in	_	0	SENT_671	[p14l803t614r830b638],
9	healthy	JJ	O	healthy	amod	10	SENT_671	[p14l839t613r943b647],
10	subjects	NNS	O	subject	prep_in	7	SENT_671	[p14l951t613r1067b647],
11	.	.	O	.	_	0	SENT_671	[p14l951t613r1067b647],

1	Clin	NNP	O	Clin	_	0	SENT_672	[p14l1080t614r1140b639],
2	.	.	O	.	_	0	SENT_672	[p14l1080t614r1140b639],

1	Infect	VB	O	infect	_	0	SENT_673	[p14l1152t613r1230b647],
2	.	.	O	.	_	0	SENT_673	[p14l1152t613r1230b647],

1	Dir	NN	O	dir	_	0	SENT_674	[p14l1242t614r1292b639],
2	.	.	O	.	_	0	SENT_674	[p14l1242t614r1292b639],

1	47	CD	NUMBER	47	_	0	SENT_675	[p14l1304t614r1344b639],
2	:	:	O	:	_	0	SENT_675	[p14l1304t614r1344b639],
3	1	CD	NUMBER	1	num	7	SENT_675	[p14l1350t615r1360b638],
4	3	CD	NUMBER	3	num	7	SENT_675	[p14l1366t615r1377b639],
5	7-40	CD	NUMBER	7-40	num	7	SENT_675	[p14l1383t614r1448b639],
6	Wenning	NNP	ORGANIZATION	Wenning	nn	7	SENT_675	[p14l420t656r551b690],
7	LA	NNP	ORGANIZATION	LA	dep	1	SENT_675	[p14l560t656r611b687],
8	,	,	O	,	_	0	SENT_675	[p14l560t656r611b687],
9	Hanley	NNP	PERSON	Hanley	nn	10	SENT_675	[p14l621t655r724b690],
10	W	NNP	O	W	appos	7	SENT_675	[p14l730t656r774b687],
11	,	,	O	,	_	0	SENT_675	[p14l730t656r774b687],
12	Stone	NNP	O	Stone	nn	13	SENT_675	[p14l785t656r892b688],
13	]	NNP	O	]	appos	7	SENT_675	[p14l785t656r892b688],
14	,	,	O	,	_	0	SENT_675	[p14l785t656r892b688],
15	Moreau	NNP	PERSON	Moreau	nn	16	SENT_675	[p14l900t656r1012b681],
16	A	NNP	O	A	appos	7	SENT_675	[p14l1019t656r1049b687],
17	,	,	O	,	_	0	SENT_675	[p14l1019t656r1049b687],
18	Kost	NNP	PERSON	Kost	nn	19	SENT_675	[p14l1059t656r1125b681],
19	JT	NNP	O	JT	appos	7	SENT_675	[p14l1129t656r1177b688],
20	,	,	O	,	_	0	SENT_675	[p14l1129t656r1177b688],
21	et	FW	O	et	nn	22	SENT_675	[p14l1188t663r1214b681],
22	al.	FW	O	al.	appos	7	SENT_675	[p14l1222t655r1252b681],
23	2006	CD	DATE	2006	dep	22	SENT_675	[p14l1263t657r1337b681],
24	.	.	O	.	_	0	SENT_675	[p14l1263t657r1337b681],

1	Effect	NN	O	effect	_	0	SENT_676	[p14l1348t655r1432b681],
2	of	IN	O	of	_	0	SENT_676	[p14l1441t655r1471b681],
3	tipranavir	NN	O	tipranavir	prep_of	1	SENT_676	[p14l1477t657r1612b690],
4	+	CC	O	+	_	0	SENT_676	[p14l1622t661r1645b684],
5	ritonavir	NN	O	ritonavir	nn	7	SENT_676	[p14l1654t657r1776b681],
6	(	CD	NUMBER	(	num	7	SENT_676	[p14l1785t656r1867b688],
7	TPV	NN	O	tpv	prep_of	1	SENT_676	[p14l1785t656r1867b688],
8	+	CC	O	+	_	0	SENT_676	[p14l422t703r445b726],
9	RTV	NN	O	rtv	nn	10	SENT_676	[p14l460t699r540b731],
10	)	NN	O	)	conj_+	7	SENT_676	[p14l460t699r540b731],
11	on	IN	O	on	_	0	SENT_676	[p14l555t708r590b724],
12	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	1	SENT_676	[p14l603t698r848b732],
13	of	IN	O	of	_	0	SENT_676	[p14l862t698r893b724],
14	MK-0518	NN	O	mk-0518	prep_of	12	SENT_676	[p14l902t699r1048b724],
15	.	.	O	.	_	0	SENT_676	[p14l902t699r1048b724],

1	46th	JJ	ORDINAL	46th	amod	2	SENT_677	[p14l1063t699r1123b724],
2	Interrei	NN	O	interreus	_	0	SENT_677	[p14l1136t699r1236b724],
3	.	.	O	.	_	0	SENT_677	[p14l1136t699r1236b724],

1	Conf	NNP	O	Conf	_	0	SENT_678	[p14l1254t698r1321b733],
2	on	IN	O	on	_	0	SENT_678	[p14l1336t708r1364b724],
3	Antimieroh	NNP	PERSON	Antimieroh	prep_on	1	SENT_678	[p14l1376t699r1529b724],
4	.	.	O	.	_	0	SENT_678	[p14l1376t699r1529b724],

1	Agents	NNS	O	agent	_	0	SENT_679	[p14l1543t699r1634b733],
2	Chemother	NNP	O	Chemother	nn	5	SENT_679	[p14l1648t699r1799b730],
3	,	,	O	,	_	0	SENT_679	[p14l1648t699r1799b730],
4	San	NNP	LOCATION	San	appos	5	SENT_679	[p14l1815t699r1864b724],
5	Franeixeo	NNP	LOCATION	Franeixeo	dep	1	SENT_679	[p14l420t741r545b771],
6	,	,	O	,	_	0	SENT_679	[p14l420t741r545b771],
7	CA	NNP	O	CA	nn	9	SENT_679	[p14l559t741r599b766],
8	(	NNP	O	(	nn	9	SENT_679	[p14l611t740r712b772],
9	Abstr	NNP	O	Abstr	appos	5	SENT_679	[p14l611t740r712b772],
10	.	.	O	.	_	0	SENT_679	[p14l611t740r712b772],
11	)	NN	O	)	dep	1	SENT_679	[p14l611t740r712b772],

1	Iwamoto	NNP	PERSON	Iwamoto	nn	2	SENT_680	[p14l421t783r544b808],
2	M	NNP	O	M	_	0	SENT_680	[p14l554t783r593b813],
3	,	,	O	,	_	0	SENT_680	[p14l554t783r593b813],
4	Wenning	NNP	ORGANIZATION	Wenning	nn	5	SENT_680	[p14l604t783r735b816],
5	LA	NNP	ORGANIZATION	LA	appos	2	SENT_680	[p14l744t783r795b813],
6	,	,	O	,	_	0	SENT_680	[p14l744t783r795b813],
7	Liou	NNP	PERSON	Liou	nn	8	SENT_680	[p14l807t783r874b808],
8	SY	NNP	PERSON	SY	appos	2	SENT_680	[p14l885t783r931b813],
9	,	,	O	,	_	0	SENT_680	[p14l885t783r931b813],
10	Kost	NNP	PERSON	Kost	nn	11	SENT_680	[p14l942t783r1008b808],
11	JT	NNP	O	JT	appos	2	SENT_680	[p14l1014t782r1062b814],
12	,	,	O	,	_	0	SENT_680	[p14l1014t782r1062b814],
13	Mangin	NNP	PERSON	Mangin	nn	14	SENT_680	[p14l1072t783r1183b816],
14	E	NNP	O	E	appos	2	SENT_680	[p14l1193t783r1222b813],
15	,	,	O	,	_	0	SENT_680	[p14l1193t783r1222b813],
16	et	FW	O	et	nn	17	SENT_680	[p14l1234t789r1259b808],
17	al.	FW	O	al.	appos	2	SENT_680	[p14l1269t782r1299b808],
18	2006	CD	DATE	2006	dep	17	SENT_680	[p14l1311t783r1385b807],
19	.	.	O	.	_	0	SENT_680	[p14l1311t783r1385b807],

1	Rifampin	NNP	O	Rifampin	nn	3	SENT_681	[p14l1397t782r1527b816],
2	(	CD	NUMBER	(	num	3	SENT_681	[p14l1538t783r1612b814],
3	RIF	NN	O	rif	nsubj	6	SENT_681	[p14l1538t783r1612b814],
4	)	CD	NUMBER	)	npadvmod	5	SENT_681	[p14l1538t783r1612b814],
5	modestly	RB	O	modestly	advmod	3	SENT_681	[p14l1623t782r1751b816],
6	reduces	VBZ	O	reduce	_	0	SENT_681	[p14l1759t782r1864b808],
7	plasma	NN	O	plasma	nn	8	SENT_681	[p14l421t824r516b858],
8	levels	NNS	O	level	dobj	6	SENT_681	[p14l526t824r601b850],
9	of	IN	O	of	_	0	SENT_681	[p14l612t824r643b850],
10	MK	NN	O	mk	prep_of	8	SENT_681	[p14l647t825r750b850],
11	—	CD	NUMBER	—	num	10	SENT_681	[p14l647t825r750b850],
12	05	CD	NUMBER	05	number	13	SENT_681	[p14l647t825r750b850],
13	18	CD	NUMBER	18	num	10	SENT_681	[p14l756t826r794b850],
14	.	.	O	.	_	0	SENT_681	[p14l756t826r794b850],

1	8th	JJ	ORDINAL	8th	amod	2	SENT_682	[p14l806t825r847b850],
2	Int	NN	O	int	_	0	SENT_682	[p14l857t825r902b850],
3	.	.	O	.	_	0	SENT_682	[p14l857t825r902b850],

1	Conga	NNP	O	Conga	_	0	SENT_683	[p14l916t825r996b859],
2	:	:	O	:	_	0	SENT_683	[p14l916t825r996b859],
3	Drug	NNP	O	Drug	nn	4	SENT_683	[p14l1009t825r1082b859],
4	Therapy	NN	O	therapy	dep	1	SENT_683	[p14l1091t825r1197b859],
5	in	IN	O	in	_	0	SENT_683	[p14l1207t826r1231b850],
6	HI	NNP	O	HI	nn	10	SENT_683	[p14l1241t825r1281b850],
7	Vlnfeetion	NNP	O	Vlnfeetion	nn	10	SENT_683	[p14l1283t824r1421b859],
8	(	CD	NUMBER	(	num	10	SENT_683	[p14l1434t825r1545b857],
9	HIV-8	NN	O	hiv-8	nn	10	SENT_683	[p14l1434t825r1545b857],
10	)	NN	O	)	prep_in	4	SENT_683	[p14l1434t825r1545b857],
11	.	.	O	.	_	0	SENT_683	[p14l1434t825r1545b857],

1	Glargow	NNP	O	Glargow	_	0	SENT_684	[p14l1560t825r1672b859],
2	,	,	O	,	_	0	SENT_684	[p14l1560t825r1672b859],
3	Scotl	NNP	O	Scotl	appos	1	SENT_684	[p14l1684t825r1750b850],
4	.	.	O	.	_	0	SENT_684	[p14l1684t825r1750b850],

1	(	NN	O	(	nn	2	SENT_685	[p14l1763t824r1864b857],
2	Abstr	NN	O	abstr	_	0	SENT_685	[p14l1763t824r1864b857],
3	.	.	O	.	_	0	SENT_685	[p14l1763t824r1864b857],
4	)	SYM	O	)	dep	2	SENT_685	[p14l1763t824r1864b857],

1	Lake	NNP	O	Lake	_	0	SENT_686	[p14l421t866r598b892],
2	.	.	O	.	_	0	SENT_686	[p14l421t866r598b892],

1	—	NN	O	—	_	0	SENT_687	[p14l421t866r598b892],
2	.	.	O	.	_	0	SENT_687	[p14l421t866r598b892],

1	Bakaar	JJ	O	bakaar	amod	2	SENT_688	[p14l421t866r598b892],
2	G	NN	O	g	_	0	SENT_688	[p14l607t867r640b898],
3	,	,	O	,	_	0	SENT_688	[p14l607t867r640b898],
4	Tom	NNP	PERSON	Tom	nn	5	SENT_688	[p14l650t867r715b892],
5	W	NNP	PERSON	W	appos	2	SENT_688	[p14l723t867r766b898],
6	,	,	O	,	_	0	SENT_688	[p14l723t867r766b898],
7	Lake	NNP	LOCATION	Lake	appos	5	SENT_688	[p14l776t866r953b892],
8	.	.	O	.	_	0	SENT_688	[p14l776t866r953b892],

1	—	NN	O	—	_	0	SENT_689	[p14l776t866r953b892],
2	.	.	O	.	_	0	SENT_689	[p14l776t866r953b892],

1	Bakaar	NN	ORGANIZATION	bakaar	nn	2	SENT_690	[p14l776t866r953b892],
2	D	NN	ORGANIZATION	d	_	0	SENT_690	[p14l962t867r995b898],
3	,	,	O	,	_	0	SENT_690	[p14l962t867r995b898],
4	Gupta	NNP	PERSON	Gupta	nn	5	SENT_690	[p14l1006t867r1093b901],
5	N	NNP	O	N	appos	2	SENT_690	[p14l1102t867r1138b898],
6	,	,	O	,	_	0	SENT_690	[p14l1102t867r1138b898],
7	Beidas	NNP	O	Beidas	nn	8	SENT_690	[p14l1148t866r1237b892],
8	S	NNP	O	S	appos	2	SENT_690	[p14l1248t867r1271b898],
9	,	,	O	,	_	0	SENT_690	[p14l1248t867r1271b898],
10	et	FW	O	et	nn	11	SENT_690	[p14l1282t874r1307b892],
11	al.	FW	O	al.	appos	2	SENT_690	[p14l1316t866r1345b892],
12	1988	CD	DATE	1988	dep	11	SENT_690	[p14l1359t868r1431b892],
13	.	.	O	.	_	0	SENT_690	[p14l1359t868r1431b892],

1	Gastropathy	NNP	PERSON	Gastropathy	_	0	SENT_691	[p14l1442t866r1616b901],
2	and	CC	O	and	_	0	SENT_691	[p14l1624t866r1673b892],
3	ketoconazole	NN	O	ketoconazole	nn	4	SENT_691	[p14l1682t866r1864b892],
4	malabsorption	NN	O	malabsorption	conj_and	1	SENT_691	[p14l421t909r622b943],
5	in	IN	O	in	_	0	SENT_691	[p14l631t910r658b934],
6	the	DT	O	the	det	9	SENT_691	[p14l668t909r711b935],
7	acquired	VBN	O	acquire	amod	9	SENT_691	[p14l722t909r840b943],
8	immunodeﬁciency	NN	O	immunodeﬁciency	nn	9	SENT_691	[p14l850t909r1110b943],
9	syndrome	NN	O	syndrome	prep_in	4	SENT_691	[p14l1119t909r1255b943],
10	(	CD	NUMBER	(	num	12	SENT_691	[p14l1266t910r1373b941],
11	AIDS	NNP	MISC	AIDS	nn	12	SENT_691	[p14l1266t910r1373b941],
12	)	NN	O	)	dep	9	SENT_691	[p14l1266t910r1373b941],
13	.	.	O	.	_	0	SENT_691	[p14l1266t910r1373b941],

1	Ann	NNP	PERSON	Ann	_	0	SENT_692	[p14l1381t909r1446b934],
2	.	.	O	.	_	0	SENT_692	[p14l1381t909r1446b934],

1	Intern	NNP	O	Intern	_	0	SENT_693	[p14l1457t910r1546b934],
2	.	.	O	.	_	0	SENT_693	[p14l1457t910r1546b934],

1	Med	NNP	O	Med	_	0	SENT_694	[p14l1557t910r1622b935],
2	.	.	O	.	_	0	SENT_694	[p14l1557t910r1622b935],

1	109:471	CD	NUMBER	109:471	num	2	SENT_695	[p14l1638t910r1793b935],
2	—	CD	NUMBER	—	_	0	SENT_695	[p14l1638t910r1793b935],
3	73	CD	NUMBER	73	num	5	SENT_695	[p14l1638t910r1793b935],
4	Ramanatl1an	NN	O	ramanatl1an	nn	5	SENT_695	[p14l422t950r596b976],
5	S	NN	O	s	dep	2	SENT_695	[p14l608t951r632b982],
6	,	,	O	,	_	0	SENT_695	[p14l608t951r632b982],
7	Mathias	NNP	ORGANIZATION	Mathias	nn	8	SENT_695	[p14l643t950r755b976],
8	AA	NNP	ORGANIZATION	AA	appos	5	SENT_695	[p14l765t951r817b982],
9	,	,	O	,	_	0	SENT_695	[p14l765t951r817b982],
10	Hinkle	NNP	PERSON	Hinkle	nn	11	SENT_695	[p14l829t950r925b976],
11	J	NNP	PERSON	J	appos	5	SENT_695	[p14l932t951r955b983],
12	,	,	O	,	_	0	SENT_695	[p14l932t951r955b983],
13	Kearney	NNP	PERSON	Kearney	nn	14	SENT_695	[p14l967t951r1085b985],
14	BP	NNP	O	BP	appos	5	SENT_695	[p14l1095t951r1143b976],
15	.	.	O	.	_	0	SENT_695	[p14l1095t951r1143b976],

1	2007	CD	DATE	2007	_	0	SENT_696	[p14l1156t951r1230b977],
2	.	.	O	.	_	0	SENT_696	[p14l1156t951r1230b977],

1	Clinical	JJ	O	clinical	amod	2	SENT_697	[p14l1243t950r1351b976],
2	pharmacology	NN	O	pharmacology	_	0	SENT_697	[p14l1362t950r1562b985],
3	of	IN	O	of	_	0	SENT_697	[p14l1572t950r1602b976],
4	the	DT	O	the	det	8	SENT_697	[p14l1609t950r1653b976],
5	HIV	NN	MISC	hiv	nn	8	SENT_697	[p14l1664t951r1730b976],
6	integrase	NN	O	integrase	nn	8	SENT_697	[p14l1739t951r1864b985],
7	inhibitor	NN	O	inhibitor	nn	8	SENT_697	[p14l421t996r545b1022],
8	elivitegravir	NN	O	elivitegravir	prep_of	2	SENT_697	[p14l555t996r727b1031],
9	.	.	O	.	_	0	SENT_697	[p14l555t996r727b1031],

1	I	PRP	O	I	_	0	SENT_698	[p14l740t998r752b1022],
2	1	CD	NUMBER	1	dep	1	SENT_698	[p14l758t998r769b1022],
3	th	DT	O	th	det	8	SENT_698	[p14l774t997r798b1022],
4	Eur	NNP	O	Eur	nn	8	SENT_698	[p14l808t997r861b1022],
5	AIDS	NNP	O	AIDS	nn	8	SENT_698	[p14l871t997r953b1022],
6	Conf	NNP	O	Conf	nn	8	SENT_698	[p14l963t997r1030b1030],
7	(	NNP	O	(	nn	8	SENT_698	[p14l1041t996r1142b1028],
8	Abstr	NNP	PERSON	Abstr	dep	2	SENT_698	[p14l1041t996r1142b1028],
9	.	.	O	.	_	0	SENT_698	[p14l1041t996r1142b1028],
10	)	NN	O	)	dep	1	SENT_698	[p14l1041t996r1142b1028],

1	Kawaguchi	NNP	PERSON	Kawaguchi	nn	2	SENT_699	[p14l421t1045r575b1080],
2	I	NNP	O	I	_	0	SENT_699	[p14l585t1046r603b1077],
3	,	,	O	,	_	0	SENT_699	[p14l585t1046r603b1077],
4	Ishikawa	NNP	PERSON	Ishikawa	nn	5	SENT_699	[p14l613t1045r734b1071],
5	T	NN	O	t	appos	2	SENT_699	[p14l742t1046r775b1077],
6	,	,	O	,	_	0	SENT_699	[p14l742t1046r775b1077],
7	Ishibashi	NNP	O	Ishibashi	nn	8	SENT_699	[p14l785t1045r909b1071],
8	M	NNP	O	M	appos	2	SENT_699	[p14l917t1046r956b1077],
9	,	,	O	,	_	0	SENT_699	[p14l917t1046r956b1077],
10	Irie	NNP	PERSON	Irie	nn	11	SENT_699	[p14l967t1046r1015b1071],
11	S	NNP	O	S	appos	2	SENT_699	[p14l1025t1046r1049b1077],
12	,	,	O	,	_	0	SENT_699	[p14l1025t1046r1049b1077],
13	Kakee	NNP	PERSON	Kakee	nn	14	SENT_699	[p14l1059t1045r1145b1071],
14	A.	NNP	O	A.	appos	2	SENT_699	[p14l1154t1046r1183b1071],
15	2006	CD	DATE	2006	dep	14	SENT_699	[p14l1194t1047r1268b1071],
16	.	.	O	.	_	0	SENT_699	[p14l1194t1047r1268b1071],

1	Safety	NN	O	safety	_	0	SENT_700	[p14l1280t1045r1365b1080],
2	and	CC	O	and	_	0	SENT_700	[p14l1373t1045r1422b1071],
3	pharmacokinetics	NNS	O	pharmacokinetic	conj_and	1	SENT_700	[p14l1431t1045r1676b1079],
4	of	IN	O	of	_	0	SENT_700	[p14l1686t1045r1716b1071],
5	single	JJ	O	single	amod	7	SENT_700	[p14l1722t1045r1802b1080],
6	oral	JJ	O	oral	amod	7	SENT_700	[p14l1812t1045r1864b1071],
7	dose	NN	O	dose	prep_of	1	SENT_700	[p14l422t1091r483b1117],
8	of	IN	O	of	_	0	SENT_700	[p14l495t1091r525b1117],
9	JTK-303	NN	O	jtk-303	prep_of	7	SENT_700	[p14l529t1092r717b1123],
10	/	:	O	/	punct	11	SENT_700	[p14l529t1092r717b1123],
11	GS	NN	O	g	dep	1	SENT_700	[p14l529t1092r717b1123],
12	9137	CD	DATE	9137	num	11	SENT_700	[p14l730t1092r805b1123],
13	,	,	O	,	_	0	SENT_700	[p14l730t1092r805b1123],
14	a	DT	O	a	det	18	SENT_700	[p14l818t1101r831b1117],
15	novel	JJ	O	novel	amod	18	SENT_700	[p14l842t1091r918b1117],
16	HIV	NN	MISC	hiv	nn	18	SENT_700	[p14l929t1092r996b1117],
17	integrase	NN	O	integrase	nn	18	SENT_700	[p14l1005t1092r1130b1126],
18	inhibitor	NN	O	inhibitor	appos	11	SENT_700	[p14l1142t1091r1271b1122],
19	,	,	O	,	_	0	SENT_700	[p14l1142t1091r1271b1122],
20	in	IN	O	in	_	0	SENT_700	[p14l1283t1092r1310b1117],
21	healthy	JJ	O	healthy	amod	22	SENT_700	[p14l1321t1091r1425b1125],
22	volunteers	NNS	O	volunteer	prep_in	1	SENT_700	[p14l1433t1091r1587b1117],
23	.	.	O	.	_	0	SENT_700	[p14l1433t1091r1587b1117],

1	13th	JJ	ORDINAL	13th	amod	2	SENT_701	[p14l1601t1092r1659b1117],
2	Canf	NN	O	canf	_	0	SENT_701	[p14l1673t1092r1740b1125],
3	Retravzr	NNP	O	Retravzr	nn	5	SENT_701	[p14l1751t1092r1862b1117],
4	Opportunivtie	NNP	O	Opportunivtie	nn	5	SENT_701	[p14l423t1138r596b1171],
5	Infect	NNP	O	Infect	dep	2	SENT_701	[p14l603t1137r681b1171],
6	.	.	O	.	_	0	SENT_701	[p14l603t1137r681b1171],

1	(	NN	O	(	nn	2	SENT_702	[p14l694t1137r795b1169],
2	Abstr	NN	O	abstr	_	0	SENT_702	[p14l694t1137r795b1169],
3	.	.	O	.	_	0	SENT_702	[p14l694t1137r795b1169],
4	)	SYM	O	)	dep	2	SENT_702	[p14l694t1137r795b1169],

1	Kearney	NNP	PERSON	Kearney	nn	2	SENT_703	[p14l421t1187r539b1220],
2	BP	NNP	O	BP	_	0	SENT_703	[p14l563t1187r611b1217],
3	,	,	O	,	_	0	SENT_703	[p14l563t1187r611b1217],
4	Mathias	NNP	PERSON	Mathias	nn	5	SENT_703	[p14l636t1186r748b1212],
5	A	NNP	PERSON	A	appos	2	SENT_703	[p14l772t1187r802b1217],
6	,	,	O	,	_	0	SENT_703	[p14l772t1187r802b1217],
7	Zhong	NNP	PERSON	Zhong	nn	8	SENT_703	[p14l828t1186r922b1220],
8	L	NNP	PERSON	L	appos	2	SENT_703	[p14l946t1187r975b1217],
9	,	,	O	,	_	0	SENT_703	[p14l946t1187r975b1217],
10	DeJesus	NNP	PERSON	DeJesus	nn	11	SENT_703	[p14l1001t1187r1113b1218],
11	E	NNP	O	E	appos	2	SENT_703	[p14l1138t1187r1167b1217],
12	,	,	O	,	_	0	SENT_703	[p14l1138t1187r1167b1217],
13	Markowitz	NNP	PERSON	Markowitz	nn	14	SENT_703	[p14l1191t1186r1345b1212],
14	M	NNP	O	M	appos	2	SENT_703	[p14l1367t1187r1407b1217],
15	,	,	O	,	_	0	SENT_703	[p14l1367t1187r1407b1217],
16	et	FW	O	et	nn	17	SENT_703	[p14l1434t1193r1459b1212],
17	al.	FW	O	al.	appos	2	SENT_703	[p14l1483t1186r1513b1211],
18	2006	CD	DATE	2006	dep	17	SENT_703	[p14l1539t1187r1614b1211],
19	.	.	O	.	_	0	SENT_703	[p14l1539t1187r1614b1211],

1	Pharmacokinetics/pharmacodynamics	NNS	O	pharmacokinetics/pharmacodynamics	_	0	SENT_704	[p14l1640t1186r1864b1212, p14l421t1231r738b1266],
2	of	IN	O	of	_	0	SENT_704	[p14l750t1232r780b1257],
3	GS	NN	O	g	prep_of	1	SENT_704	[p14l789t1232r913b1258],
4	—	CD	NUMBER	—	num	5	SENT_704	[p14l789t1232r913b1258],
5	9l37	CD	NUMBER	9l37	dep	1	SENT_704	[p14l789t1232r913b1258],
6	an	DT	O	a	det	9	SENT_704	[p14l927t1241r958b1257],
7	HIV	NN	MISC	hiv	nn	9	SENT_704	[p14l969t1233r1036b1257],
8	integrase	NN	O	integrase	nn	9	SENT_704	[p14l1045t1233r1170b1266],
9	inhibitor	NN	O	inhibitor	dep	5	SENT_704	[p14l1182t1231r1310b1257],
10	.	.	O	.	_	0	SENT_704	[p14l1182t1231r1310b1257],

1	7th	JJ	ORDINAL	7th	amod	2	SENT_705	[p14l1326t1232r1366b1257],
2	Int	NN	O	int	_	0	SENT_705	[p14l1376t1233r1422b1257],
3	.	.	O	.	_	0	SENT_705	[p14l1376t1233r1422b1257],

1	I/I/orlexhop	NNP	O	I/I/orlexhop	nn	2	SENT_706	[p14l1438t1232r1560b1266],
2	Clin	NNP	O	Clin	_	0	SENT_706	[p14l1573t1232r1634b1257],
3	.	.	O	.	_	0	SENT_706	[p14l1573t1232r1634b1257],

1	Pharmaeol	NNP	O	Pharmaeol	_	0	SENT_707	[p14l1647t1232r1791b1257],
2	.	.	O	.	_	0	SENT_707	[p14l1647t1232r1791b1257],

1	HIV	NN	O	hiv	_	0	SENT_708	[p14l1804t1233r1870b1257],
2	Therapy	NN	O	therapy	dep	1	SENT_708	[p14l423t1278r533b1312],
3	.	.	O	.	_	0	SENT_708	[p14l423t1278r533b1312],

1	(	NN	O	(	nn	2	SENT_709	[p14l547t1277r648b1310],
2	Abstr	NN	O	abstr	_	0	SENT_709	[p14l547t1277r648b1310],
3	.	.	O	.	_	0	SENT_709	[p14l547t1277r648b1310],
4	)	SYM	O	)	dep	2	SENT_709	[p14l547t1277r648b1310],

1	Ramanathan	NNP	PERSON	Ramanathan	nn	2	SENT_710	[p14l421t1325r596b1351],
2	S	NNP	PERSON	S	_	0	SENT_710	[p14l611t1326r635b1357],
3	,	,	O	,	_	0	SENT_710	[p14l611t1326r635b1357],
4	Shen	NNP	PERSON	Shen	nn	5	SENT_710	[p14l651t1325r720b1351],
5	G	NNP	PERSON	G	appos	2	SENT_710	[p14l735t1326r768b1357],
6	,	,	O	,	_	0	SENT_710	[p14l735t1326r768b1357],
7	Cheng	NNP	O	Cheng	nn	8	SENT_710	[p14l784t1325r878b1360],
8	A	NNP	O	A	appos	2	SENT_710	[p14l889t1326r919b1357],
9	,	,	O	,	_	0	SENT_710	[p14l889t1326r919b1357],
10	Kearney	NNP	PERSON	Kearney	nn	11	SENT_710	[p14l934t1327r1052b1360],
11	BP	NNP	O	BP	appos	2	SENT_710	[p14l1065t1327r1113b1351],
12	.	.	O	.	_	0	SENT_710	[p14l1065t1327r1113b1351],

1	2007	CD	DATE	2007	_	0	SENT_711	[p14l1129t1327r1204b1352],
2	.	.	O	.	_	0	SENT_711	[p14l1129t1327r1204b1352],

1	Pharmacokinetics	NNS	O	pharmacokinetic	_	0	SENT_712	[p14l1219t1325r1467b1351],
2	of	IN	O	of	_	0	SENT_712	[p14l1482t1326r1512b1351],
3	emtricitabine	NN	O	emtricitabine	prep_of	1	SENT_712	[p14l1523t1326r1715b1357],
4	,	,	O	,	_	0	SENT_712	[p14l1523t1326r1715b1357],
5	tenofovir	NN	O	tenofovir	conj_and	3	SENT_712	[p14l1731t1326r1863b1357],
6	,	,	O	,	_	0	SENT_712	[p14l1731t1326r1863b1357],
7	and	CC	O	and	_	0	SENT_712	[p14l422t1371r471b1397],
8	GS-9137	NN	MISC	gs-9137	conj_and	3	SENT_712	[p14l483t1372r608b1398],
9	following	VBG	O	follow	partmod	3	SENT_712	[p14l621t1371r753b1406],
10	coadministration	NN	O	coadministration	dobj	9	SENT_712	[p14l764t1371r1000b1397],
11	of	IN	O	of	prep	10	SENT_712	[p14l1011t1371r1042b1397],
12	emtricitabine/tenofovir	NN	O	emtricitabine/tenofovir	nn	14	SENT_712	[p14l1050t1371r1376b1397],
13	disoproxil	NN	O	disoproxil	nn	14	SENT_712	[p14l1388t1371r1525b1405],
14	fumarate	NN	O	fumarate	dep	11	SENT_712	[p14l1536t1371r1659b1397],
15	and	CC	O	and	_	0	SENT_712	[p14l1672t1371r1721b1397],
16	ritonavirboosted	JJ	O	ritonavirboosted	amod	17	SENT_712	[p14l1732t1373r1864b1397, p14l421t1417r530b1443],
17	GS-9137	NN	O	gs-9137	dep	11	SENT_712	[p14l541t1417r706b1451],
18	.	.	O	.	_	0	SENT_712	[p14l541t1417r706b1451],
19	]	SYM	O	]	dep	10	SENT_712	[p14l541t1417r706b1451],

1	.	.	O	.	_	0	SENT_713	[p14l541t1417r706b1451],

1	Aeqnir	NNP	O	Aeqnir	_	0	SENT_714	[p14l715t1418r808b1451],
2	.	.	O	.	_	0	SENT_714	[p14l715t1418r808b1451],

1	Immune	JJ	O	immune	amod	2	SENT_715	[p14l819t1418r929b1443],
2	Deﬁe	NN	O	deﬁe	_	0	SENT_715	[p14l939t1417r1010b1451],
3	.	.	O	.	_	0	SENT_715	[p14l939t1417r1010b1451],

1	Syndr	NNP	O	Syndr	_	0	SENT_716	[p14l1023t1418r1102b1451],
2	.	.	O	.	_	0	SENT_716	[p14l1023t1418r1102b1451],

1	45	CD	NUMBER	45	number	2	SENT_717	[p14l1114t1418r1146b1443],
2	:274	CD	NUMBER	:274	num	3	SENT_717	[p14l1150t1418r1258b1443],
3	—	NN	O	—	_	0	SENT_717	[p14l1150t1418r1258b1443],
4	79	CD	NUMBER	79	num	6	SENT_717	[p14l1150t1418r1258b1443],
5	Ramanathan	NNP	PERSON	Ramanathan	nn	6	SENT_717	[p14l421t1466r597b1492],
6	S	NN	PERSON	s	dep	3	SENT_717	[p14l608t1467r632b1497],
7	,	,	O	,	_	0	SENT_717	[p14l608t1467r632b1497],
8	Wright	NNP	PERSON	Wright	nn	9	SENT_717	[p14l643t1466r747b1500],
9	M	NNP	O	M	appos	6	SENT_717	[p14l755t1467r794b1497],
10	,	,	O	,	_	0	SENT_717	[p14l755t1467r794b1497],
11	West	NNP	LOCATION	West	nn	12	SENT_717	[p14l805t1467r878b1492],
12	S	NNP	LOCATION	S	appos	6	SENT_717	[p14l889t1467r912b1497],
13	,	,	O	,	_	0	SENT_717	[p14l889t1467r912b1497],
14	Kearney	NNP	PERSON	Kearney	nn	15	SENT_717	[p14l924t1467r1042b1500],
15	BP	NNP	O	BP	appos	6	SENT_717	[p14l1052t1467r1100b1492],
16	.	.	O	.	_	0	SENT_717	[p14l1052t1467r1100b1492],

1	2007	CD	DATE	2007	_	0	SENT_718	[p14l1112t1467r1187b1492],
2	.	.	O	.	_	0	SENT_718	[p14l1112t1467r1187b1492],

1	Pharmacokinetics	NNS	O	pharmacokinetic	nsubj	9	SENT_719	[p14l1199t1466r1454b1497],
2	,	,	O	,	_	0	SENT_719	[p14l1199t1466r1454b1497],
3	metabolism	NN	O	metabolism	appos	1	SENT_719	[p14l1466t1466r1628b1492],
4	and	CC	O	and	_	0	SENT_719	[p14l1639t1466r1688b1492],
5	excretion	NN	O	excretion	appos	1	SENT_719	[p14l1699t1467r1827b1492],
6	of	IN	O	of	_	0	SENT_719	[p14l1838t1466r1869b1492],
7	ritonavir	NN	O	ritonavir	prep_of	3	SENT_719	[p14l421t1512r663b1538],
8	—	CD	NUMBER	—	num	7	SENT_719	[p14l421t1512r663b1538],
9	boosted	VBD	O	boost	_	0	SENT_719	[p14l421t1512r663b1538],
10	GS-9137	NN	O	gs-9137	dobj	9	SENT_719	[p14l674t1513r807b1538],
11	.	.	O	.	_	0	SENT_719	[p14l674t1513r807b1538],

1	8th	JJ	ORDINAL	8th	amod	2	SENT_720	[p14l820t1513r861b1537],
2	Int	NN	O	int	_	0	SENT_720	[p14l870t1513r915b1537],
3	.	.	O	.	_	0	SENT_720	[p14l870t1513r915b1537],

1	Wbr/eshop	NNP	O	Wbr/eshop	nn	2	SENT_721	[p14l931t1513r1052b1546],
2	Clin	NNP	O	Clin	_	0	SENT_721	[p14l1064t1513r1125b1537],
3	.	.	O	.	_	0	SENT_721	[p14l1064t1513r1125b1537],

1	Pharmaeol	NNP	O	Pharmaeol	_	0	SENT_722	[p14l1136t1513r1280b1538],
2	.	.	O	.	_	0	SENT_722	[p14l1136t1513r1280b1538],

1	HIV	NN	O	hiv	_	0	SENT_723	[p14l1292t1513r1358b1538],
2	Therapy	NN	O	therapy	dep	1	SENT_723	[p14l1364t1513r1475b1546],
3	.	.	O	.	_	0	SENT_723	[p14l1364t1513r1475b1546],

1	(	NN	O	(	nn	2	SENT_724	[p14l1488t1512r1589b1544],
2	Abstr	NN	O	abstr	_	0	SENT_724	[p14l1488t1512r1589b1544],
3	.	.	O	.	_	0	SENT_724	[p14l1488t1512r1589b1544],
4	)	SYM	O	)	dep	2	SENT_724	[p14l1488t1512r1589b1544],

1	Ramanathan	NNP	PERSON	Ramanathan	nn	2	SENT_725	[p14l421t1561r597b1586],
2	S	NNP	O	S	_	0	SENT_725	[p14l613t1561r636b1592],
3	,	,	O	,	_	0	SENT_725	[p14l613t1561r636b1592],
4	West	NNP	LOCATION	West	nn	5	SENT_725	[p14l652t1562r724b1586],
5	S	NNP	LOCATION	S	appos	2	SENT_725	[p14l740t1561r763b1592],
6	,	,	O	,	_	0	SENT_725	[p14l740t1561r763b1592],
7	Abel	NNP	PERSON	Abel	nn	8	SENT_725	[p14l778t1560r843b1586],
8	S	NNP	O	S	appos	2	SENT_725	[p14l859t1561r883b1592],
9	,	,	O	,	_	0	SENT_725	[p14l859t1561r883b1592],
10	Enejosa	NNP	PERSON	Enejosa	nn	11	SENT_725	[p14l899t1562r1008b1595],
11	J	NNP	PERSON	J	appos	2	SENT_725	[p14l1019t1562r1041b1593],
12	,	,	O	,	_	0	SENT_725	[p14l1019t1562r1041b1593],
13	Kearney	NNP	PERSON	Kearney	nn	14	SENT_725	[p14l1058t1562r1176b1595],
14	BP	NNP	O	BP	appos	2	SENT_725	[p14l1190t1562r1238b1586],
15	.	.	O	.	_	0	SENT_725	[p14l1190t1562r1238b1586],

1	2007	CD	DATE	2007	_	0	SENT_726	[p14l1255t1562r1330b1587],
2	.	.	O	.	_	0	SENT_726	[p14l1255t1562r1330b1587],

1	Pharmacokinetics	NNS	O	pharmacokinetic	nsubj	6	SENT_727	[p14l1346t1561r1594b1586],
2	of	IN	O	of	_	0	SENT_727	[p14l1609t1561r1640b1586],
3	coadministered	JJ	O	coadministered	amod	5	SENT_727	[p14l1652t1560r1864b1586],
4	ritonavir	NN	O	ritonavir	nn	5	SENT_727	[p14l421t1606r663b1632],
5	—	NN	O	—	prep_of	1	SENT_727	[p14l421t1606r663b1632],
6	boosted	VBD	O	boost	_	0	SENT_727	[p14l421t1606r663b1632],
7	elvitegravir	NN	O	elvitegravir	dobj	6	SENT_727	[p14l674t1606r831b1641],
8	plus	CC	O	plus	prep	7	SENT_727	[p14l840t1606r896b1641],
9	maraviroc	NN	O	maraviroc	dep	8	SENT_727	[p14l906t1608r1052b1632],
10	.	.	O	.	_	0	SENT_727	[p14l906t1608r1052b1632],

1	47th	JJ	ORDINAL	47th	amod	2	SENT_728	[p14l1063t1607r1123b1632],
2	Intersei	NN	O	interseus	_	0	SENT_728	[p14l1132t1608r1233b1632],
3	.	.	O	.	_	0	SENT_728	[p14l1132t1608r1233b1632],

1	Conf	NNP	O	Conf	nn	2	SENT_729	[p14l1247t1607r1314b1641],
2	Antimitroh	NNP	O	Antimitroh	_	0	SENT_729	[p14l1321t1607r1475b1632],
3	.	.	O	.	_	0	SENT_729	[p14l1321t1607r1475b1632],

1	Agentt	NNP	PERSON	Agentt	nn	2	SENT_730	[p14l1484t1607r1576b1641],
2	Chemother	NNP	PERSON	Chemother	_	0	SENT_730	[p14l1586t1607r1728b1632],
3	.	.	O	.	_	0	SENT_730	[p14l1586t1607r1728b1632],

1	(	NN	O	(	nn	2	SENT_731	[p14l1741t1606r1842b1639],
2	Abstr	NN	O	abstr	_	0	SENT_731	[p14l1741t1606r1842b1639],
3	.	.	O	.	_	0	SENT_731	[p14l1741t1606r1842b1639],
4	)	SYM	O	)	dep	2	SENT_731	[p14l1741t1606r1842b1639],

1	Mathias	NNP	ORGANIZATION	Mathias	nn	2	SENT_732	[p14l420t1730r532b1756],
2	AA	NNP	ORGANIZATION	AA	_	0	SENT_732	[p14l540t1731r592b1761],
3	,	,	O	,	_	0	SENT_732	[p14l540t1731r592b1761],
4	Ramanathan	NNP	PERSON	Ramanathan	nn	5	SENT_732	[p14l602t1730r777b1756],
5	S	NNP	PERSON	S	appos	2	SENT_732	[p14l786t1731r810b1761],
6	,	,	O	,	_	0	SENT_732	[p14l786t1731r810b1761],
7	I-Iinkle	NNP	O	I-Iinkle	nn	8	SENT_732	[p14l820t1730r916b1756],
8	J	NNP	O	J	appos	2	SENT_732	[p14l921t1731r944b1762],
9	,	,	O	,	_	0	SENT_732	[p14l921t1731r944b1762],
10	Enejosa	NNP	O	Enejosa	nn	11	SENT_732	[p14l953t1731r1089b1764],
11	]	NNP	O	]	appos	2	SENT_732	[p14l953t1731r1089b1764],
12	,	,	O	,	_	0	SENT_732	[p14l953t1731r1089b1764],
13	Kearney	NNP	PERSON	Kearney	nn	14	SENT_732	[p14l1099t1731r1217b1764],
14	BP	NNP	O	BP	appos	2	SENT_732	[p14l1225t1731r1273b1755],
15	.	.	O	.	_	0	SENT_732	[p14l1225t1731r1273b1755],

1	2007	CD	DATE	2007	_	0	SENT_733	[p14l1283t1731r1358b1756],
2	.	.	O	.	_	0	SENT_733	[p14l1283t1731r1358b1756],

1	Effect	NN	O	effect	_	0	SENT_734	[p14l1368t1730r1453b1756],
2	of	IN	O	of	_	0	SENT_734	[p14l1461t1730r1491b1756],
3	atazanavir/r	NN	O	atazanavir/r	prep_of	1	SENT_734	[p14l1497t1731r1661b1756],
4	on	IN	O	on	_	0	SENT_734	[p14l1670t1739r1705b1756],
5	the	DT	O	the	det	7	SENT_734	[p14l1714t1730r1757b1756],
6	steadystate	NN	O	steadystate	nn	7	SENT_734	[p14l1766t1730r1864b1764, p14l421t1783r484b1802],
7	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	1	SENT_734	[p14l494t1776r739b1810],
8	of	IN	O	of	_	0	SENT_734	[p14l749t1776r780b1802],
9	elvitegravir	NN	O	elvitegravir	prep_of	1	SENT_734	[p14l786t1776r950b1810],
10	.	.	O	.	_	0	SENT_734	[p14l786t1776r950b1810],

1	47th	JJ	ORDINAL	47th	amod	2	SENT_735	[p14l961t1777r1021b1801],
2	Intersei	NN	O	interseus	_	0	SENT_735	[p14l1030t1777r1130b1801],
3	.	.	O	.	_	0	SENT_735	[p14l1030t1777r1130b1801],

1	Conf	NNP	O	Conf	nn	2	SENT_736	[p14l1145t1776r1212b1810],
2	Antimieroh	NNP	O	Antimieroh	_	0	SENT_736	[p14l1219t1776r1373b1801],
3	.	.	O	.	_	0	SENT_736	[p14l1219t1776r1373b1801],

1	Agent	NNP	O	Agent	_	0	SENT_737	[p14l1382t1776r1473b1811],
2	?	.	O	?	_	0	SENT_737	[p14l1382t1776r1473b1811],

1	Chemother	JJ	O	chemother	amod	3	SENT_738	[p14l1484t1777r1626b1801],
2	(	NN	O	(	nn	3	SENT_738	[p14l1639t1776r1740b1808],
3	Abstr	NN	O	abstr	_	0	SENT_738	[p14l1639t1776r1740b1808],
4	.	.	O	.	_	0	SENT_738	[p14l1639t1776r1740b1808],
5	)	SYM	O	)	dep	3	SENT_738	[p14l1639t1776r1740b1808],

1	Ramanathan	NNP	PERSON	Ramanathan	nn	2	SENT_739	[p14l421t1825r597b1850],
2	S	NNP	PERSON	S	_	0	SENT_739	[p14l610t1825r633b1856],
3	,	,	O	,	_	0	SENT_739	[p14l610t1825r633b1856],
4	Shen	NNP	PERSON	Shen	nn	5	SENT_739	[p14l648t1824r717b1850],
5	G	NNP	PERSON	G	appos	2	SENT_739	[p14l730t1825r763b1856],
6	,	,	O	,	_	0	SENT_739	[p14l730t1825r763b1856],
7	Hinkle	NNP	PERSON	Hinkle	nn	8	SENT_739	[p14l776t1825r873b1850],
8	J	NNP	PERSON	J	appos	2	SENT_739	[p14l882t1826r904b1857],
9	,	,	O	,	_	0	SENT_739	[p14l882t1826r904b1857],
10	Enejosa	NNP	O	Enejosa	nn	11	SENT_739	[p14l918t1826r1027b1859],
11	J	NNP	O	J	appos	2	SENT_739	[p14l1035t1826r1058b1857],
12	,	,	O	,	_	0	SENT_739	[p14l1035t1826r1058b1857],
13	Kearney	NNP	PERSON	Kearney	nn	14	SENT_739	[p14l1071t1826r1189b1859],
14	BP	NNP	O	BP	appos	2	SENT_739	[p14l1201t1826r1249b1850],
15	.	.	O	.	_	0	SENT_739	[p14l1201t1826r1249b1850],

1	2007	CD	DATE	2007	_	0	SENT_740	[p14l1263t1826r1338b1851],
2	.	.	O	.	_	0	SENT_740	[p14l1263t1826r1338b1851],

1	Pharmacokinetics	NNS	O	pharmacokinetic	nsubj	6	SENT_741	[p14l1351t1824r1599b1850],
2	of	IN	O	of	_	0	SENT_741	[p14l1612t1825r1643b1850],
3	coadministered	JJ	O	coadministered	amod	5	SENT_741	[p14l1652t1824r1864b1850],
4	ritonavir	NN	O	ritonavir	nn	5	SENT_741	[p14l421t1870r663b1896],
5	—	NN	O	—	prep_of	1	SENT_741	[p14l421t1870r663b1896],
6	boosted	VBD	O	boost	_	0	SENT_741	[p14l421t1870r663b1896],
7	elvitegravir	NN	O	elvitegravir	dobj	6	SENT_741	[p14l672t1870r829b1904],
8	and	CC	O	and	_	0	SENT_741	[p14l836t1870r886b1896],
9	zidovudine	NN	O	zidovudine	dobj	6	SENT_741	[p14l894t1870r1053b1901],
10	,	,	O	,	_	0	SENT_741	[p14l894t1870r1053b1901],
11	didanosine	NN	O	didanosine	conj_or	9	SENT_741	[p14l1063t1870r1220b1901],
12	,	,	O	,	_	0	SENT_741	[p14l1063t1870r1220b1901],
13	stavudine	NN	O	stavudine	conj_and	7	SENT_741	[p14l1229t1870r1367b1901],
14	,	,	O	,	_	0	SENT_741	[p14l1229t1870r1367b1901],
15	or	CC	O	or	_	0	SENT_741	[p14l1377t1880r1406b1896],
16	abacavir	NN	O	abacavir	conj_or	9	SENT_741	[p14l1414t1870r1564b1904],
17	.	.	O	.	_	0	SENT_741	[p14l1414t1870r1564b1904],

1	Acquir	NNP	O	Acquir	_	0	SENT_742	[p14l1571t1871r1664b1904],
2	.	.	O	.	_	0	SENT_742	[p14l1571t1871r1664b1904],

1	Immune	JJ	O	immune	amod	2	SENT_743	[p14l1673t1871r1783b1896],
2	Deﬁe	NN	O	deﬁe	_	0	SENT_743	[p14l1791t1870r1862b1904],
3	.	.	O	.	_	0	SENT_743	[p14l1791t1870r1862b1904],

1	Syndr	JJ	O	syndr	_	0	SENT_744	[p14l421t1916r500b1950],
2	462160-66	CD	NUMBER	462160-66	num	4	SENT_744	[p14l513t1917r657b1942],
3	Ramanathan	NN	PERSON	ramanathan	nn	4	SENT_744	[p14l421t1964r596b1990],
4	S	NN	PERSON	s	dep	1	SENT_744	[p14l606t1965r629b1996],
5	,	,	O	,	_	0	SENT_744	[p14l606t1965r629b1996],
6	Shen	NNP	PERSON	Shen	nn	7	SENT_744	[p14l640t1964r708b1990],
7	G	NNP	PERSON	G	appos	4	SENT_744	[p14l717t1965r750b1996],
8	,	,	O	,	_	0	SENT_744	[p14l717t1965r750b1996],
9	HinkleJ	NNP	O	HinkleJ	appos	4	SENT_744	[p14l760t1964r883b1997],
10	,	,	O	,	_	0	SENT_744	[p14l760t1964r883b1997],
11	Enejosa	NNP	O	Enejosa	nn	12	SENT_744	[p14l893t1966r1028b1999],
12	]	NNP	O	]	appos	4	SENT_744	[p14l893t1966r1028b1999],
13	,	,	O	,	_	0	SENT_744	[p14l893t1966r1028b1999],
14	Kearney	NNP	PERSON	Kearney	nn	15	SENT_744	[p14l1038t1966r1156b1999],
15	BP	NNP	O	BP	appos	4	SENT_744	[p14l1163t1966r1211b1990],
16	.	.	O	.	_	0	SENT_744	[p14l1163t1966r1211b1990],

1	2007	CD	DATE	2007	_	0	SENT_745	[p14l1221t1966r1296b1991],
2	.	.	O	.	_	0	SENT_745	[p14l1221t1966r1296b1991],

1	Effect	NN	O	effect	_	0	SENT_746	[p14l1306t1965r1390b1990],
2	of	IN	O	of	_	0	SENT_746	[p14l1398t1965r1428b1990],
3	atazanavir/r	NN	O	atazanavir/r	prep_of	1	SENT_746	[p14l1433t1966r1598b1990],
4	on	IN	O	on	_	0	SENT_746	[p14l1606t1974r1641b1990],
5	the	DT	O	the	det	9	SENT_746	[p14l1649t1964r1693b1990],
6	steady	JJ	O	steady	amod	9	SENT_746	[p14l1701t1964r1864b1999],
7	—	NN	O	—	nn	9	SENT_746	[p14l1701t1964r1864b1999],
8	state	NN	O	state	nn	9	SENT_746	[p14l1701t1964r1864b1999],
9	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	1	SENT_746	[p14l421t2010r665b2044],
10	of	IN	O	of	_	0	SENT_746	[p14l676t2010r706b2036],
11	elvitegravir	NN	O	elvitegravir	prep_of	9	SENT_746	[p14l713t2010r877b2045],
12	.	.	O	.	_	0	SENT_746	[p14l713t2010r877b2045],

1	8th	JJ	ORDINAL	8th	amod	2	SENT_747	[p14l889t2011r930b2036],
2	Int	NN	O	int	_	0	SENT_747	[p14l940t2011r985b2036],
3	.	.	O	.	_	0	SENT_747	[p14l940t2011r985b2036],

1	I/I/orkshop	NNP	O	I/I/orkshop	nn	2	SENT_748	[p14l1000t2011r1122b2044],
2	Clin	NNP	O	Clin	_	0	SENT_748	[p14l1134t2011r1194b2036],
3	.	.	O	.	_	0	SENT_748	[p14l1134t2011r1194b2036],

1	Pharmaeol	NNP	O	Pharmaeol	_	0	SENT_749	[p14l1206t2011r1350b2036],
2	.	.	O	.	_	0	SENT_749	[p14l1206t2011r1350b2036],

1	HIV	NN	O	hiv	nn	2	SENT_750	[p14l1361t2011r1427b2036],
2	Ther	NN	O	ther	_	0	SENT_750	[p14l1433t2011r1497b2036],
3	(	CD	NUMBER	(	dep	2	SENT_750	[p14l1511t2010r1612b2043],
4	Abstr	NNP	O	Abstr	nn	6	SENT_750	[p14l1511t2010r1612b2043],
5	.	.	O	.	_	0	SENT_750	[p14l1511t2010r1612b2043],
6	)	NN	O	)	dep	2	SENT_750	[p14l1511t2010r1612b2043],

1	Ramanathan	NNP	PERSON	Ramanathan	nn	2	SENT_751	[p14l422t2059r596b2085],
2	S	NNP	PERSON	S	_	0	SENT_751	[p14l610t2060r633b2090],
3	,	,	O	,	_	0	SENT_751	[p14l610t2060r633b2090],
4	Mathias	NNP	ORGANIZATION	Mathias	nn	5	SENT_751	[p14l645t2059r757b2085],
5	AA	NNP	ORGANIZATION	AA	appos	2	SENT_751	[p14l769t2060r820b2090],
6	,	,	O	,	_	0	SENT_751	[p14l769t2060r820b2090],
7	Shen	NNP	O	Shen	nn	8	SENT_751	[p14l835t2059r903b2085],
8	G	NNP	O	G	appos	2	SENT_751	[p14l916t2060r949b2090],
9	,	,	O	,	_	0	SENT_751	[p14l916t2060r949b2090],
10	Holmes	NNP	PERSON	Holmes	nn	11	SENT_751	[p14l963t2059r1072b2085],
11	C	NNP	O	C	appos	2	SENT_751	[p14l1086t2060r1116b2090],
12	,	,	O	,	_	0	SENT_751	[p14l1086t2060r1116b2090],
13	Kearney	NNP	PERSON	Kearney	nn	14	SENT_751	[p14l1130t2060r1248b2093],
14	BP	NNP	O	BP	appos	2	SENT_751	[p14l1259t2060r1307b2085],
15	.	.	O	.	_	0	SENT_751	[p14l1259t2060r1307b2085],

1	2007	CD	DATE	2007	_	0	SENT_752	[p14l1321t2060r1395b2085],
2	.	.	O	.	_	0	SENT_752	[p14l1321t2060r1395b2085],

1	Lack	NN	O	lack	nsubj	10	SENT_753	[p14l1409t2059r1478b2085],
2	of	IN	O	of	_	0	SENT_753	[p14l1489t2059r1520b2085],
3	clinically	RB	O	clinically	advmod	4	SENT_753	[p14l1528t2059r1653b2093],
4	relevant	JJ	O	relevant	amod	6	SENT_753	[p14l1664t2059r1776b2085],
5	drugdrug	NN	O	drugdrug	nn	6	SENT_753	[p14l1788t2059r1864b2093, p14l422t2105r487b2139],
6	interaction	NN	O	interaction	prep_of	1	SENT_753	[p14l497t2106r649b2131],
7	between	IN	O	between	_	0	SENT_753	[p14l661t2105r776b2131],
8	ritonavir	NN	O	ritonavir	prep_between	6	SENT_753	[p14l788t2105r1030b2131],
9	—	CD	NUMBER	—	num	8	SENT_753	[p14l788t2105r1030b2131],
10	boosted	VBD	O	boost	_	0	SENT_753	[p14l788t2105r1030b2131],
11	GS-9137	NN	O	gs-9137	nn	12	SENT_753	[p14l1042t2106r1167b2131],
12	(	NN	O	(	iobj	10	SENT_753	[p14l1181t2105r1357b2139],
13	elvitegravir	NN	O	elvitegravir	nn	14	SENT_753	[p14l1181t2105r1357b2139],
14	)	NN	O	)	dobj	10	SENT_753	[p14l1181t2105r1357b2139],
15	and	CC	O	and	_	0	SENT_753	[p14l1369t2105r1419b2131],
16	fosamprenavir/r	NN	O	fosamprenavir/r	dobj	10	SENT_753	[p14l1430t2105r1661b2139],
17	.	.	O	.	_	0	SENT_753	[p14l1430t2105r1661b2139],

1	4th	JJ	ORDINAL	4th	amod	2	SENT_754	[p14l1674t2106r1717b2131],
2	Int	NN	O	int	_	0	SENT_754	[p14l1728t2106r1773b2130],
3	.	.	O	.	_	0	SENT_754	[p14l1728t2106r1773b2130],

1	AIDS	NNP	MISC	AIDS	nn	2	SENT_755	[p14l1784t2106r1866b2130],
2	Soc	NNP	O	Soc	_	0	SENT_755	[p14l421t2151r468b2176],
3	.	.	O	.	_	0	SENT_755	[p14l421t2151r468b2176],

1	Conf	NNP	O	Conf	_	0	SENT_756	[p14l482t2151r549b2185],
2	HIV	NN	O	hiv	nn	5	SENT_756	[p14l559t2152r625b2176],
3	Canf	NN	O	canf	nn	5	SENT_756	[p14l631t2151r698b2185],
4	HI	NN	O	hus	nn	5	SENT_756	[p14l707t2152r748b2176],
5	VPathog	NN	O	vpathog	dep	1	SENT_756	[p14l749t2151r873b2185],
6	.	.	O	.	_	0	SENT_756	[p14l749t2151r873b2185],

1	Treat	VB	O	treat	_	0	SENT_757	[p14l887t2151r960b2176],
2	.	.	O	.	_	0	SENT_757	[p14l887t2151r960b2176],

1	Prev.	NNP	O	Prev.	_	0	SENT_758	[p14l972t2152r1047b2182],
2	,	,	O	,	_	0	SENT_758	[p14l972t2152r1047b2182],
3	Sydney	NNP	LOCATION	Sydney	nn	5	SENT_758	[p14l1059t2151r1154b2185],
4	,	,	O	,	_	0	SENT_758	[p14l1059t2151r1154b2185],
5	Aust	NNP	O	Aust	appos	1	SENT_758	[p14l1163t2151r1231b2176],
6	.	.	O	.	_	0	SENT_758	[p14l1163t2151r1231b2176],

1	(	NN	O	(	nn	2	SENT_759	[p14l1244t2150r1346b2183],
2	Abstr	NN	O	abstr	_	0	SENT_759	[p14l1244t2150r1346b2183],
3	.	.	O	.	_	0	SENT_759	[p14l1244t2150r1346b2183],
4	)	SYM	O	)	dep	2	SENT_759	[p14l1244t2150r1346b2183],

1	Mathias	NNP	ORGANIZATION	Mathias	nn	2	SENT_760	[p14l420t2199r532b2225],
2	AA	NNP	ORGANIZATION	AA	_	0	SENT_760	[p14l545t2200r597b2231],
3	,	,	O	,	_	0	SENT_760	[p14l545t2200r597b2231],
4	Shen	NNP	PERSON	Shen	nn	5	SENT_760	[p14l613t2199r681b2225],
5	G	NNP	PERSON	G	appos	2	SENT_760	[p14l695t2200r729b2231],
6	,	,	O	,	_	0	SENT_760	[p14l695t2200r729b2231],
7	Enejosa	NNP	O	Enejosa	nn	8	SENT_760	[p14l744t2200r852b2233],
8	J	NNP	O	J	appos	2	SENT_760	[p14l862t2200r884b2231],
9	,	,	O	,	_	0	SENT_760	[p14l862t2200r884b2231],
10	Sekar	NNP	O	Sekar	nn	11	SENT_760	[p14l901t2199r977b2225],
11	V	NNP	O	V	appos	2	SENT_760	[p14l989t2200r1021b2231],
12	,	,	O	,	_	0	SENT_760	[p14l989t2200r1021b2231],
13	Mack	NNP	PERSON	Mack	nn	14	SENT_760	[p14l1034t2199r1114b2225],
14	R	NNP	PERSON	R	appos	2	SENT_760	[p14l1127t2200r1156b2231],
15	,	,	O	,	_	0	SENT_760	[p14l1127t2200r1156b2231],
16	et	FW	O	et	nn	17	SENT_760	[p14l1171t2207r1197b2225],
17	al.	FW	O	al.	appos	2	SENT_760	[p14l1210t2199r1239b2225],
18	2007	CD	DATE	2007	dep	17	SENT_760	[p14l1255t2200r1329b2225],
19	.	.	O	.	_	0	SENT_760	[p14l1255t2200r1329b2225],

1	Lack	NN	O	lack	nsubj	8	SENT_761	[p14l1345t2199r1414b2225],
2	of	IN	O	of	_	0	SENT_761	[p14l1426t2199r1457b2225],
3	pharmacokinetic	JJ	O	pharmacokinetic	amod	4	SENT_761	[p14l1466t2199r1699b2233],
4	interaction	NN	O	interaction	prep_of	1	SENT_761	[p14l1713t2201r1865b2225],
5	between	IN	O	between	_	0	SENT_761	[p14l421t2244r537b2270],
6	ritonavir	NN	O	ritonavir	prep_between	4	SENT_761	[p14l547t2244r789b2270],
7	—	CD	NUMBER	—	num	6	SENT_761	[p14l547t2244r789b2270],
8	boosted	VBD	O	boost	_	0	SENT_761	[p14l547t2244r789b2270],
9	GS-9137	NN	O	gs-9137	nn	10	SENT_761	[p14l800t2245r924b2270],
10	(	NN	O	(	iobj	8	SENT_761	[p14l937t2244r1113b2279],
11	elvitegravir	NN	O	elvitegravir	nn	12	SENT_761	[p14l937t2244r1113b2279],
12	)	NN	O	)	dobj	8	SENT_761	[p14l937t2244r1113b2279],
13	and	CC	O	and	_	0	SENT_761	[p14l1124t2244r1174b2270],
14	darunavir/r	NN	O	darunavir/r	conj_and	12	SENT_761	[p14l1185t2244r1349b2270],
15	.	.	O	.	_	0	SENT_761	[p14l1185t2244r1349b2270],

1	4th	JJ	ORDINAL	4th	amod	2	SENT_762	[p14l1361t2245r1403b2270],
2	Int	NN	O	int	_	0	SENT_762	[p14l1413t2245r1458b2270],
3	.	.	O	.	_	0	SENT_762	[p14l1413t2245r1458b2270],

1	AIDS	NNP	MISC	AIDS	nn	2	SENT_763	[p14l1468t2245r1549b2270],
2	Soc	NNP	O	Soc	_	0	SENT_763	[p14l1558t2245r1605b2270],
3	.	.	O	.	_	0	SENT_763	[p14l1558t2245r1605b2270],

1	Conf	NNP	O	Conf	nn	2	SENT_764	[p14l1619t2245r1686b2279],
2	HI	NNP	O	HI	_	0	SENT_764	[p14l1696t2245r1737b2270],
3	VPa1	NN	O	vpa1	dep	2	SENT_764	[p14l1738t2245r1862b2279],
4	/	:	O	/	punct	2	SENT_764	[p14l1738t2245r1862b2279],
5	‘	CD	NUMBER	‘	num	6	SENT_764	[p14l1738t2245r1862b2279],
6	hag	NN	O	hag	dep	2	SENT_764	[p14l1738t2245r1862b2279],
7	.	.	O	.	_	0	SENT_764	[p14l1738t2245r1862b2279],

1	Treat	VB	O	treat	_	0	SENT_765	[p14l423t2291r496b2316],
2	.	.	O	.	_	0	SENT_765	[p14l423t2291r496b2316],

1	Prev	NNP	O	Prev	_	0	SENT_766	[p14l508t2291r574b2316],
2	.	.	O	.	_	0	SENT_766	[p14l508t2291r574b2316],

1	(	NN	O	(	nn	2	SENT_767	[p14l587t2290r688b2322],
2	Abstr	NN	O	abstr	_	0	SENT_767	[p14l587t2290r688b2322],
3	.	.	O	.	_	0	SENT_767	[p14l587t2290r688b2322],
4	)	SYM	O	)	dep	2	SENT_767	[p14l587t2290r688b2322],

1	Ramanathan	NNP	PERSON	Ramanathan	nn	2	SENT_768	[p14l421t2332r597b2358],
2	S	NNP	PERSON	S	_	0	SENT_768	[p14l605t2333r628b2364],
3	,	,	O	,	_	0	SENT_768	[p14l605t2333r628b2364],
4	SkillingtonJ	NNP	O	SkillingtonJ	appos	2	SENT_768	[p14l638t2332r816b2367],
5	,	,	O	,	_	0	SENT_768	[p14l638t2332r816b2367],
6	Plummet	NNP	O	Plummet	nn	7	SENT_768	[p14l825t2332r956b2358],
7	A	NNP	O	A	appos	2	SENT_768	[p14l961t2333r991b2364],
8	,	,	O	,	_	0	SENT_768	[p14l961t2333r991b2364],
9	HuiJ	NN	O	huij	appos	2	SENT_768	[p14l999t2333r1080b2365],
10	,	,	O	,	_	0	SENT_768	[p14l999t2333r1080b2365],
11	Shen	NNP	O	Shen	nn	12	SENT_768	[p14l1090t2332r1158b2358],
12	G	NNP	O	G	appos	2	SENT_768	[p14l1166t2333r1199b2364],
13	,	,	O	,	_	0	SENT_768	[p14l1166t2333r1199b2364],
14	et	FW	O	et	nn	15	SENT_768	[p14l1208t2340r1234b2358],
15	al.	FW	O	al.	appos	2	SENT_768	[p14l1241t2332r1270b2358],
16	2006	CD	DATE	2006	dep	15	SENT_768	[p14l1279t2334r1354b2358],
17	.	.	O	.	_	0	SENT_768	[p14l1279t2334r1354b2358],

1	Lack	NN	O	lack	nsubj	12	SENT_769	[p14l1363t2332r1432b2358],
2	of	IN	O	of	_	0	SENT_769	[p14l1438t2332r1468b2358],
3	clinically	RB	O	clinically	advmod	4	SENT_769	[p14l1472t2332r1597b2367],
4	relevant	JJ	O	relevant	amod	8	SENT_769	[p14l1603t2332r1715b2358],
5	drug	NN	O	drug	nn	8	SENT_769	[p14l1722t2332r1866b2367],
6	—	NN	O	—	nn	8	SENT_769	[p14l1722t2332r1866b2367],
7	drug	NN	O	drug	nn	8	SENT_769	[p14l1722t2332r1866b2367],
8	interaction	NN	O	interaction	prep_of	1	SENT_769	[p14l421t2376r573b2401],
9	between	IN	O	between	_	0	SENT_769	[p14l583t2375r699b2401],
10	ritonavir	NN	O	ritonavir	nn	11	SENT_769	[p14l708t2375r950b2401],
11	—	NN	O	—	prep_between	1	SENT_769	[p14l708t2375r950b2401],
12	boosted	VBD	O	boost	_	0	SENT_769	[p14l708t2375r950b2401],
13	GS	NN	O	g	iobj	12	SENT_769	[p14l961t2376r1086b2401],
14	—	CD	NUMBER	—	num	15	SENT_769	[p14l961t2376r1086b2401],
15	9l37	NN	O	9l37	dobj	12	SENT_769	[p14l961t2376r1086b2401],
16	and	CC	O	and	_	0	SENT_769	[p14l1097t2375r1147b2401],
17	emtricitabine	NN	O	emtricitabine	nn	20	SENT_769	[p14l1157t2375r1342b2401],
18	(	CD	NUMBER	(	num	20	SENT_769	[p14l1353t2376r1408b2407],
19	FT	NNP	O	FT	nn	20	SENT_769	[p14l1353t2376r1408b2407],
20	C	NNP	O	C	dobj	12	SENT_769	[p14l1409t2375r1584b2407],
21	)	CD	NUMBER	)	dep	20	SENT_769	[p14l1409t2375r1584b2407],
22	/	:	O	/	punct	25	SENT_769	[p14l1409t2375r1584b2407],
23	tenofovir	NN	O	tenofovir	nn	25	SENT_769	[p14l1409t2375r1584b2407],
24	disoproxil	NN	O	disoproxil	nn	25	SENT_769	[p14l1594t2375r1731b2409],
25	fumarate	NN	O	fumarate	dep	21	SENT_769	[p14l1741t2375r1864b2401],
26	(	CD	NUMBER	(	num	28	SENT_769	[p14l422t2421r522b2452],
27	TDF	NN	O	tdf	nn	28	SENT_769	[p14l422t2421r522b2452],
28	)	NN	O	)	dep	25	SENT_769	[p14l422t2421r522b2452],
29	.	.	O	.	_	0	SENT_769	[p14l422t2421r522b2452],

1	6th	JJ	ORDINAL	6th	amod	2	SENT_770	[p14l535t2421r575b2446],
2	Int	NN	O	int	_	0	SENT_770	[p14l585t2421r630b2446],
3	.	.	O	.	_	0	SENT_770	[p14l585t2421r630b2446],

1	AIDS	NNP	O	AIDS	nn	4	SENT_771	[p14l639t2421r721b2446],
2	Conf	NNP	O	Conf	nn	4	SENT_771	[p14l731t2420r798b2454],
3	(	NNP	O	(	nn	4	SENT_771	[p14l810t2420r911b2452],
4	Abstr	NNP	O	Abstr	_	0	SENT_771	[p14l810t2420r911b2452],
5	.	.	O	.	_	0	SENT_771	[p14l810t2420r911b2452],
6	)	NN	O	)	dep	4	SENT_771	[p14l810t2420r911b2452],

1	Ramanathan	NNP	PERSON	Ramanathan	nn	2	SENT_772	[p14l421t2462r597b2488],
2	S	NNP	O	S	_	0	SENT_772	[p14l609t2463r632b2493],
3	,	,	O	,	_	0	SENT_772	[p14l609t2463r632b2493],
4	West	NNP	LOCATION	West	nn	5	SENT_772	[p14l644t2463r717b2488],
5	S	NNP	LOCATION	S	appos	2	SENT_772	[p14l729t2463r752b2493],
6	,	,	O	,	_	0	SENT_772	[p14l729t2463r752b2493],
7	Kakuda	NNP	ORGANIZATION	Kakuda	nn	8	SENT_772	[p14l765t2462r871b2488],
8	T	NN	ORGANIZATION	t	appos	5	SENT_772	[p14l881t2462r914b2493],
9	,	,	O	,	_	0	SENT_772	[p14l881t2462r914b2493],
10	Mack	NNP	PERSON	Mack	nn	11	SENT_772	[p14l925t2462r1005b2488],
11	R	NNP	PERSON	R	appos	5	SENT_772	[p14l1016t2463r1045b2493],
12	,	,	O	,	_	0	SENT_772	[p14l1016t2463r1045b2493],
13	Holmes	NNP	PERSON	Holmes	nn	14	SENT_772	[p14l1057t2462r1167b2488],
14	C	NNP	O	C	appos	5	SENT_772	[p14l1180t2463r1210b2493],
15	,	,	O	,	_	0	SENT_772	[p14l1180t2463r1210b2493],
16	Kearney	NNP	PERSON	Kearney	nn	17	SENT_772	[p14l1223t2463r1341b2496],
17	BP	NNP	O	BP	appos	5	SENT_772	[p14l1352t2463r1400b2487],
18	.	.	O	.	_	0	SENT_772	[p14l1352t2463r1400b2487],

1	2007	CD	DATE	2007	_	0	SENT_773	[p14l1413t2463r1488b2488],
2	.	.	O	.	_	0	SENT_773	[p14l1413t2463r1488b2488],

1	Lack	NN	O	lack	nsubj	10	SENT_774	[p14l1501t2462r1570b2488],
2	of	IN	O	of	_	0	SENT_774	[p14l1580t2462r1611b2488],
3	clinically	RB	O	clinically	advmod	4	SENT_774	[p14l1619t2462r1743b2496],
4	relevant	JJ	O	relevant	amod	6	SENT_774	[p14l1753t2462r1866b2488],
5	drug	NN	O	drug	nn	6	SENT_774	[p14l422t2504r487b2538],
6	interactions	NNS	O	interaction	prep_of	1	SENT_774	[p14l498t2505r662b2530],
7	between	IN	O	between	_	0	SENT_774	[p14l674t2504r790b2530],
8	ritonavir	NN	O	ritonavir	prep_between	6	SENT_774	[p14l802t2504r1045b2530],
9	—	CD	NUMBER	—	num	8	SENT_774	[p14l802t2504r1045b2530],
10	boosted	VBD	O	boost	_	0	SENT_774	[p14l802t2504r1045b2530],
11	elvitegravir	NN	O	elvitegravir	dobj	10	SENT_774	[p14l1058t2504r1214b2538],
12	and	CC	O	and	_	0	SENT_774	[p14l1227t2504r1276b2530],
13	etravirine	NN	O	etravirine	dobj	10	SENT_774	[p14l1289t2505r1429b2530],
14	.	.	O	.	_	0	SENT_774	[p14l1289t2505r1429b2530],

1	47th	JJ	ORDINAL	47th	amod	2	SENT_775	[p14l1443t2505r1502b2530],
2	Intersei	NN	O	interseus	_	0	SENT_775	[p14l1514t2505r1615b2530],
3	.	.	O	.	_	0	SENT_775	[p14l1514t2505r1615b2530],

1	Conf	NNP	O	Conf	nn	2	SENT_776	[p14l1631t2504r1698b2538],
2	Antimieroh	NNP	O	Antimieroh	_	0	SENT_776	[p14l1709t2505r1862b2530],
3	.	.	O	.	_	0	SENT_776	[p14l1709t2505r1862b2530],

1	Agentt	NNP	PERSON	Agentt	nn	2	SENT_777	[p14l418t2546r509b2580],
2	Chemother	NNP	PERSON	Chemother	_	0	SENT_777	[p14l519t2546r661b2571],
3	.	.	O	.	_	0	SENT_777	[p14l519t2546r661b2571],

1	(	NN	O	(	nn	2	SENT_778	[p14l675t2545r776b2577],
2	Abstr	NN	O	abstr	_	0	SENT_778	[p14l675t2545r776b2577],
3	.	.	O	.	_	0	SENT_778	[p14l675t2545r776b2577],
4	)	SYM	O	)	dep	2	SENT_778	[p14l675t2545r776b2577],

1	Mathias	NNP	ORGANIZATION	Mathias	nn	2	SENT_779	[p14l420t2587r532b2613],
2	AA	NNP	ORGANIZATION	AA	_	0	SENT_779	[p14l542t2588r594b2618],
3	,	,	O	,	_	0	SENT_779	[p14l542t2588r594b2618],
4	West	NNP	LOCATION	West	nn	5	SENT_779	[p14l605t2588r678b2613],
5	S	NNP	LOCATION	S	appos	2	SENT_779	[p14l689t2588r712b2618],
6	,	,	O	,	_	0	SENT_779	[p14l689t2588r712b2618],
7	Enejosa	NNP	O	Enejosa	nn	8	SENT_779	[p14l725t2588r834b2621],
8	J	NNP	O	J	appos	2	SENT_779	[p14l840t2588r863b2619],
9	,	,	O	,	_	0	SENT_779	[p14l840t2588r863b2619],
10	Kearney	NNP	PERSON	Kearney	nn	11	SENT_779	[p14l875t2588r993b2621],
11	BP	NNP	O	BP	appos	2	SENT_779	[p14l1003t2588r1051b2612],
12	.	.	O	.	_	0	SENT_779	[p14l1003t2588r1051b2612],

1	2008	CD	DATE	2008	_	0	SENT_780	[p14l1064t2588r1139b2612],
2	.	.	O	.	_	0	SENT_780	[p14l1064t2588r1139b2612],

1	A	DT	O	a	det	3	SENT_781	[p14l1150t2588r1174b2612],
2	pharmacokinetic	JJ	O	pharmacokinetic	amod	3	SENT_781	[p14l1183t2587r1416b2621],
3	interaction	NN	O	interaction	_	0	SENT_781	[p14l1426t2588r1578b2613],
4	between	IN	O	between	_	0	SENT_781	[p14l1589t2587r1705b2613],
5	lopinavir/r	NN	O	lopinavir/r	prep_between	3	SENT_781	[p14l1716t2587r1865b2621],
6	and	CC	O	and	_	0	SENT_781	[p14l421t2629r471b2655],
7	elvitegravir	NN	O	elvitegravir	prep_between	3	SENT_781	[p14l481t2629r645b2663],
8	.	.	O	.	_	0	SENT_781	[p14l481t2629r645b2663],

1	47th	JJ	ORDINAL	47th	amod	2	SENT_782	[p14l656t2630r716b2655],
2	Intersei	NN	O	interseus	_	0	SENT_782	[p14l725t2630r826b2655],
3	.	.	O	.	_	0	SENT_782	[p14l725t2630r826b2655],

1	Conf	NNP	O	Conf	nn	2	SENT_783	[p14l840t2629r907b2663],
2	Antimieroh	NNP	O	Antimieroh	_	0	SENT_783	[p14l914t2630r1068b2655],
3	.	.	O	.	_	0	SENT_783	[p14l914t2630r1068b2655],

1	Agentr	NNP	PERSON	Agentr	nn	2	SENT_784	[p14l1077t2630r1169b2664],
2	Chemother	NNP	PERSON	Chemother	_	0	SENT_784	[p14l1178t2630r1321b2655],
3	.	.	O	.	_	0	SENT_784	[p14l1178t2630r1321b2655],

1	(	NN	O	(	nn	2	SENT_785	[p14l1334t2629r1435b2661],
2	Abstr	NN	O	abstr	_	0	SENT_785	[p14l1334t2629r1435b2661],
3	.	.	O	.	_	0	SENT_785	[p14l1334t2629r1435b2661],
4	)	SYM	O	)	dep	2	SENT_785	[p14l1334t2629r1435b2661],

1	Mathias	NNP	ORGANIZATION	Mathias	nn	2	SENT_786	[p14l420t2670r532b2696],
2	AA	NNP	ORGANIZATION	AA	_	0	SENT_786	[p14l544t2671r596b2702],
3	,	,	O	,	_	0	SENT_786	[p14l544t2671r596b2702],
4	Hinkle	NNP	PERSON	Hinkle	nn	5	SENT_786	[p14l610t2670r706b2696],
5	J	NNP	PERSON	J	appos	2	SENT_786	[p14l715t2671r738b2703],
6	,	,	O	,	_	0	SENT_786	[p14l715t2671r738b2703],
7	Enejosa	NNP	O	Enejosa	nn	8	SENT_786	[p14l752t2671r860b2705],
8	J	NNP	O	J	appos	2	SENT_786	[p14l869t2671r892b2703],
9	,	,	O	,	_	0	SENT_786	[p14l869t2671r892b2703],
10	Piliero	NNP	O	Piliero	nn	11	SENT_786	[p14l906t2670r999b2696],
11	PJ	NNP	O	PJ	appos	2	SENT_786	[p14l1012t2671r1052b2703],
12	,	,	O	,	_	0	SENT_786	[p14l1012t2671r1052b2703],
13	Kearney	NNP	PERSON	Kearney	nn	14	SENT_786	[p14l1066t2671r1184b2705],
14	BP	NNP	O	BP	appos	2	SENT_786	[p14l1196t2671r1244b2696],
15	.	.	O	.	_	0	SENT_786	[p14l1196t2671r1244b2696],

1	2007	CD	DATE	2007	_	0	SENT_787	[p14l1258t2671r1333b2697],
2	.	.	O	.	_	0	SENT_787	[p14l1258t2671r1333b2697],

1	Lack	NN	O	lack	nsubj	8	SENT_788	[p14l1347t2670r1416b2696],
2	of	IN	O	of	_	0	SENT_788	[p14l1428t2670r1458b2696],
3	pharmacokinetic	JJ	O	pharmacokinetic	amod	4	SENT_788	[p14l1468t2670r1700b2705],
4	interaction	NN	O	interaction	prep_of	1	SENT_788	[p14l1712t2672r1865b2696],
5	between	IN	O	between	_	0	SENT_788	[p14l421t2713r537b2739],
6	ritonavir	NN	O	ritonavir	prep_between	4	SENT_788	[p14l547t2713r789b2739],
7	—	CD	NUMBER	—	num	6	SENT_788	[p14l547t2713r789b2739],
8	boosted	VBD	O	boost	_	0	SENT_788	[p14l547t2713r789b2739],
9	GS-9137	NN	O	gs-9137	nn	10	SENT_788	[p14l800t2714r924b2739],
10	(	NN	O	(	iobj	8	SENT_788	[p14l936t2713r1113b2748],
11	elvitegravir	NN	O	elvitegravir	nn	12	SENT_788	[p14l936t2713r1113b2748],
12	)	NN	O	)	dobj	8	SENT_788	[p14l936t2713r1113b2748],
13	and	CC	O	and	_	0	SENT_788	[p14l1124t2713r1173b2739],
14	tipranavir/r	NN	O	tipranavir/r	conj_and	12	SENT_788	[p14l1183t2714r1351b2747],
15	.	.	O	.	_	0	SENT_788	[p14l1183t2714r1351b2747],

1	4th	JJ	ORDINAL	4th	amod	2	SENT_789	[p14l1362t2714r1404b2739],
2	Int	NN	O	int	_	0	SENT_789	[p14l1414t2714r1459b2739],
3	.	.	O	.	_	0	SENT_789	[p14l1414t2714r1459b2739],

1	AIDS	NNP	MISC	AIDS	nn	2	SENT_790	[p14l1469t2714r1550b2739],
2	Soc	NNP	O	Soc	_	0	SENT_790	[p14l1559t2714r1605b2739],
3	.	.	O	.	_	0	SENT_790	[p14l1559t2714r1605b2739],

1	Conf	NNP	O	Conf	nn	3	SENT_791	[p14l1620t2713r1687b2748],
2	HI	NNP	O	HI	nn	3	SENT_791	[p14l1697t2714r1737b2739],
3	VPathog	NNP	O	VPathog	_	0	SENT_791	[p14l1738t2714r1862b2748],
4	.	.	O	.	_	0	SENT_791	[p14l1738t2714r1862b2748],

1	Treat	VB	O	treat	_	0	SENT_792	[p14l423t2756r496b2781],
2	.	.	O	.	_	0	SENT_792	[p14l423t2756r496b2781],

1	Prev	NNP	O	Prev	_	0	SENT_793	[p14l508t2756r574b2781],
2	.	.	O	.	_	0	SENT_793	[p14l508t2756r574b2781],

1	(	NN	O	(	nn	2	SENT_794	[p14l587t2755r688b2787],
2	Abstr	NN	O	abstr	_	0	SENT_794	[p14l587t2755r688b2787],
3	.	.	O	.	_	0	SENT_794	[p14l587t2755r688b2787],
4	)	NN	O	)	dep	2	SENT_794	[p14l587t2755r688b2787],
5	'	''	O	'	_	0	SENT_794	[p14l1273t2858r1546b2888],

1	www.annualrevie'wr.org	NN	O	www.annualrevie'wr.org	nn	2	SENT_795	[p14l1273t2858r1546b2888],
2	o	NN	O	o	_	0	SENT_795	[p14l1561t2866r1571b2876],
3	Emerging	VBG	O	emerge	dep	2	SENT_795	[p14l1586t2858r1701b2888],
4	Pharmacology	NN	O	pharmacology	dobj	3	SENT_795	[p14l1707t2858r1865b2888],

1	66	CD	NUMBER	66	_	0	SENT_796	[p14l599t2897r639b2921],
2	.	.	O	.	_	0	SENT_796	[p14l599t2897r639b2921],

1	Ramanathan	NNP	PERSON	Ramanathan	nn	2	SENT_797	[p14l658t2896r833b2922],
2	S	NNP	PERSON	S	_	0	SENT_797	[p14l846t2897r870b2927],
3	,	,	O	,	_	0	SENT_797	[p14l846t2897r870b2927],
4	Lagan	NNP	LOCATION	Lagan	nn	5	SENT_797	[p14l883t2897r970b2930],
5	K	NNP	LOCATION	K	appos	2	SENT_797	[p14l981t2897r1012b2927],
6	,	,	O	,	_	0	SENT_797	[p14l981t2897r1012b2927],
7	Plummet	NNP	O	Plummet	nn	8	SENT_797	[p14l1025t2896r1156b2922],
8	A	NNP	O	A	appos	5	SENT_797	[p14l1166t2897r1196b2927],
9	,	,	O	,	_	0	SENT_797	[p14l1166t2897r1196b2927],
10	Hui	NNP	PERSON	Hui	nn	11	SENT_797	[p14l1209t2897r1263b2922],
11	J	NNP	PERSON	J	appos	5	SENT_797	[p14l1271t2897r1294b2928],
12	,	,	O	,	_	0	SENT_797	[p14l1271t2897r1294b2928],
13	Shen	NNP	O	Shen	nn	14	SENT_797	[p14l1308t2896r1377b2922],
14	G	NNP	O	G	appos	5	SENT_797	[p14l1389t2897r1422b2927],
15	,	,	O	,	_	0	SENT_797	[p14l1389t2897r1422b2927],
16	Cheng	NNP	O	Cheng	nn	17	SENT_797	[p14l1436t2896r1529b2930],
17	A	NNP	O	A	appos	5	SENT_797	[p14l1539t2897r1569b2927],
18	,	,	O	,	_	0	SENT_797	[p14l1539t2897r1569b2927],
19	Kearney	NNP	PERSON	Kearney	nn	20	SENT_797	[p14l1581t2897r1700b2930],
20	BP	NNP	O	BP	appos	5	SENT_797	[p14l1710t2897r1758b2921],
21	.	.	O	.	_	0	SENT_797	[p14l1710t2897r1758b2921],

1	2006	CD	DATE	2006	_	0	SENT_798	[p14l1772t2897r1847b2921],
2	.	.	O	.	_	0	SENT_798	[p14l1772t2897r1847b2921],

1	Lack	NN	O	lack	nsubj	11	SENT_799	[p14l1860t2896r1929b2922],
2	of	IN	O	of	_	0	SENT_799	[p14l1940t2896r1970b2922],
3	clinically	RB	O	clinically	advmod	4	SENT_799	[p14l1978t2896r2103b2930],
4	relevant	JJ	O	relevant	amod	6	SENT_799	[p14l658t2937r770b2963],
5	drug-drug	JJ	O	drug-drug	amod	6	SENT_799	[p14l782t2937r926b2971],
6	interaction	NN	O	interaction	prep_of	1	SENT_799	[p14l936t2938r1089b2963],
7	between	IN	O	between	_	0	SENT_799	[p14l1101t2937r1217b2963],
8	the	DT	O	the	det	10	SENT_799	[p14l1229t2937r1272b2963],
9	ritonavir	NN	O	ritonavir	nn	10	SENT_799	[p14l1284t2937r1526b2963],
10	—	NN	O	—	prep_between	6	SENT_799	[p14l1284t2937r1526b2963],
11	boosted	VBD	O	boost	_	0	SENT_799	[p14l1284t2937r1526b2963],
12	HIV	NN	MISC	hiv	nn	13	SENT_799	[p14l1538t2938r1605b2963],
13	integrase	NN	O	integrase	dep	11	SENT_799	[p14l1615t2938r1740b2971],
14	inhibitor	NN	O	inhibitor	nn	15	SENT_799	[p14l1752t2937r1876b2963],
15	GS-9137	NN	O	gs-9137	dep	13	SENT_799	[p14l1889t2938r2040b2963],
16	/	:	O	/	punct	13	SENT_799	[p14l1889t2938r2040b2963],
17	r	NN	O	r	dep	13	SENT_799	[p14l1889t2938r2040b2963],
18	and	CC	O	and	_	0	SENT_799	[p14l2052t2937r2101b2963],
19	zidovudine	NN	O	zidovudine	nn	22	SENT_799	[p14l659t2978r810b3004],
20	(	CD	NUMBER	(	num	22	SENT_799	[p14l821t2978r922b3011],
21	ZDV	NN	O	zdv	nn	22	SENT_799	[p14l821t2978r922b3011],
22	)	NN	O	)	dep	13	SENT_799	[p14l821t2978r922b3011],
23	.	.	O	.	_	0	SENT_799	[p14l821t2978r922b3011],

1	16th	JJ	ORDINAL	16th	amod	2	SENT_800	[p14l935t2979r993b3004],
2	Int	NN	O	int	_	0	SENT_800	[p14l1002t2979r1048b3004],
3	.	.	O	.	_	0	SENT_800	[p14l1002t2979r1048b3004],

1	AIDS	NNP	O	AIDS	nn	4	SENT_801	[p14l1057t2979r1139b3004],
2	Conf	NNP	O	Conf	nn	4	SENT_801	[p14l1149t2979r1216b3013],
3	(	NNP	O	(	nn	4	SENT_801	[p14l1228t2978r1329b3011],
4	Abstr	NNP	O	Abstr	_	0	SENT_801	[p14l1228t2978r1329b3011],
5	.	.	O	.	_	0	SENT_801	[p14l1228t2978r1329b3011],
6	)	NN	O	)	dep	4	SENT_801	[p14l1228t2978r1329b3011],

1	67	CD	NUMBER	67	_	0	SENT_802	[p14l599t3021r639b3046],
2	.	.	O	.	_	0	SENT_802	[p14l599t3021r639b3046],

1	Ramanathan	NNP	PERSON	Ramanathan	nn	2	SENT_803	[p14l658t3020r833b3046],
2	S	NNP	PERSON	S	_	0	SENT_803	[p14l847t3021r871b3051],
3	,	,	O	,	_	0	SENT_803	[p14l847t3021r871b3051],
4	Shen	NNP	PERSON	Shen	nn	5	SENT_803	[p14l886t3020r955b3046],
5	G	NNP	PERSON	G	appos	2	SENT_803	[p14l968t3021r1001b3051],
6	,	,	O	,	_	0	SENT_803	[p14l968t3021r1001b3051],
7	Hinkle	NNP	PERSON	Hinkle	nn	8	SENT_803	[p14l1015t3020r1111b3046],
8	J	NNP	PERSON	J	appos	2	SENT_803	[p14l1121t3021r1143b3052],
9	,	,	O	,	_	0	SENT_803	[p14l1121t3021r1143b3052],
10	Enejosa	NNP	O	Enejosa	nn	11	SENT_803	[p14l1157t3021r1266b3054],
11	J	NNP	O	J	appos	2	SENT_803	[p14l1275t3021r1297b3052],
12	,	,	O	,	_	0	SENT_803	[p14l1275t3021r1297b3052],
13	Kearney	NNP	PERSON	Kearney	nn	14	SENT_803	[p14l1311t3021r1430b3054],
14	BP	NNP	O	BP	appos	2	SENT_803	[p14l1442t3021r1490b3045],
15	.	.	O	.	_	0	SENT_803	[p14l1442t3021r1490b3045],

1	2007	CD	DATE	2007	_	0	SENT_804	[p14l1504t3021r1579b3046],
2	.	.	O	.	_	0	SENT_804	[p14l1504t3021r1579b3046],

1	Pharmacokinetic	JJ	O	pharmacokinetic	amod	2	SENT_805	[p14l1593t3020r1829b3046],
2	evaluation	NN	O	evaluation	nsubj	9	SENT_805	[p14l1842t3020r1984b3046],
3	of	IN	O	of	_	0	SENT_805	[p14l1997t3020r2028b3046],
4	drug	NN	O	drug	nn	5	SENT_805	[p14l2038t3020r2102b3054],
5	interactions	NNS	O	interaction	prep_of	2	SENT_805	[p14l658t3062r822b3087],
6	with	IN	O	with	_	0	SENT_805	[p14l834t3061r896b3087],
7	ritonavir	NN	O	ritonavir	nn	8	SENT_805	[p14l909t3061r1151b3087],
8	—	NN	O	—	prep_with	5	SENT_805	[p14l909t3061r1151b3087],
9	boosted	VBD	O	boost	_	0	SENT_805	[p14l909t3061r1151b3087],
10	HIV	NN	MISC	hiv	nn	11	SENT_805	[p14l1164t3062r1231b3087],
11	integrase	NN	O	integrase	iobj	9	SENT_805	[p14l1242t3062r1367b3095],
12	inhibitor	NN	O	inhibitor	nn	13	SENT_805	[p14l1380t3061r1504b3087],
13	GS	NN	O	g	dobj	9	SENT_805	[p14l1517t3062r1642b3087],
14	—	CD	NUMBER	—	num	18	SENT_805	[p14l1517t3062r1642b3087],
15	9l37	NN	O	9l37	nn	18	SENT_805	[p14l1517t3062r1642b3087],
16	(	NN	O	(	nn	18	SENT_805	[p14l1657t3061r1833b3095],
17	elvitegravir	NN	O	elvitegravir	nn	18	SENT_805	[p14l1657t3061r1833b3095],
18	)	NN	O	)	dep	13	SENT_805	[p14l1657t3061r1833b3095],
19	and	CC	O	and	_	0	SENT_805	[p14l1847t3061r1897b3087],
20	acid-reducing	JJ	O	acid-reducing	amod	21	SENT_805	[p14l1910t3061r2102b3095],
21	agents	NNS	O	agent	dep	13	SENT_805	[p14l658t3113r753b3141],
22	.	.	O	.	_	0	SENT_805	[p14l658t3113r753b3141],

1	8th	JJ	ORDINAL	8th	amod	2	SENT_806	[p14l766t3107r807b3132],
2	Int	NN	O	int	_	0	SENT_806	[p14l816t3107r861b3132],
3	.	.	O	.	_	0	SENT_806	[p14l816t3107r861b3132],

1	Wbrleshop	NNP	PERSON	Wbrleshop	nn	2	SENT_807	[p14l877t3107r998b3141],
2	Clin	NNP	PERSON	Clin	_	0	SENT_807	[p14l1010t3107r1070b3132],
3	.	.	O	.	_	0	SENT_807	[p14l1010t3107r1070b3132],

1	Pharmacol	NNP	O	Pharmacol	_	0	SENT_808	[p14l1082t3107r1226b3132],
2	.	.	O	.	_	0	SENT_808	[p14l1082t3107r1226b3132],

1	HIV	NN	O	hiv	nn	2	SENT_809	[p14l1238t3107r1304b3132],
2	Ther	NN	O	ther	_	0	SENT_809	[p14l1310t3107r1374b3132],
3	(	CD	NUMBER	(	dep	2	SENT_809	[p14l1387t3106r1488b3139],
4	Abstr	NNP	O	Abstr	nn	6	SENT_809	[p14l1387t3106r1488b3139],
5	.	.	O	.	_	0	SENT_809	[p14l1387t3106r1488b3139],
6	)	NN	O	)	dep	2	SENT_809	[p14l1387t3106r1488b3139],

1	68	CD	NUMBER	68	_	0	SENT_810	[p14l599t3149r639b3173],
2	.	.	O	.	_	0	SENT_810	[p14l599t3149r639b3173],

1	Wenning	VBG	PERSON	wenn	_	0	SENT_811	[p14l657t3149r788b3182],
2	L	NN	O	l	dobj	1	SENT_811	[p14l799t3149r828b3179],
3	,	,	O	,	_	0	SENT_811	[p14l799t3149r828b3179],
4	Nguyen	NNP	PERSON	Nguyen	nn	5	SENT_811	[p14l839t3149r953b3182],
5	B	NNP	PERSON	B	appos	2	SENT_811	[p14l964t3149r1027b3179],
6	.	.	O	.	_	0	SENT_811	[p14l964t3149r1027b3179],

1	—	NN	O	—	_	0	SENT_812	[p14l964t3149r1027b3179],
2	.	.	O	.	_	0	SENT_812	[p14l964t3149r1027b3179],

1	Y	NN	O	y	_	0	SENT_813	[p14l964t3149r1027b3179],
2	,	,	O	,	_	0	SENT_813	[p14l964t3149r1027b3179],
3	Sun	NNP	LOCATION	Sun	nn	4	SENT_813	[p14l1040t3149r1093b3174],
4	X	NNP	LOCATION	X	appos	1	SENT_813	[p14l1103t3149r1134b3179],
5	,	,	O	,	_	0	SENT_813	[p14l1103t3149r1134b3179],
6	Hwang	NNP	PERSON	Hwang	nn	7	SENT_813	[p14l1147t3149r1249b3182],
7	E	NNP	O	E	appos	1	SENT_813	[p14l1260t3149r1288b3179],
8	,	,	O	,	_	0	SENT_813	[p14l1260t3149r1288b3179],
9	Chen	NNP	O	Chen	nn	10	SENT_813	[p14l1302t3148r1377b3174],
10	Y	NN	O	y	appos	1	SENT_813	[p14l1387t3149r1417b3179],
11	,	,	O	,	_	0	SENT_813	[p14l1387t3149r1417b3179],
12	et	FW	O	et	nn	13	SENT_813	[p14l1430t3155r1456b3174],
13	al.	FW	O	al.	appos	1	SENT_813	[p14l1466t3148r1496b3174],
14	2008	CD	DATE	2008	dep	13	SENT_813	[p14l1509t3149r1583b3173],
15	.	.	O	.	_	0	SENT_813	[p14l1509t3149r1583b3173],

1	Pharmacokinetic/pharmacodynamic	JJ	O	pharmacokinetic/pharmacodynamic	amod	5	SENT_814	[p14l1596t3148r2102b3182],
2	(	NN	O	(	nn	5	SENT_814	[p14l659t3190r784b3221],
3	PK/PD	NN	O	pk/pd	nn	5	SENT_814	[p14l659t3190r784b3221],
4	)	NN	O	)	nn	5	SENT_814	[p14l659t3190r784b3221],
5	analyses	NNS	O	analysis	nsubj	16	SENT_814	[p14l800t3189r911b3223],
6	for	IN	O	for	_	0	SENT_814	[p14l926t3189r967b3215],
7	raltegravir	NN	O	raltegravir	prep_for	5	SENT_814	[p14l981t3189r1126b3223],
8	in	IN	O	in	_	0	SENT_814	[p14l1140t3190r1167b3214],
9	phase	NN	O	phase	prep_in	7	SENT_814	[p14l1182t3189r1259b3223],
10	II	CD	NUMBER	ii	num	9	SENT_814	[p14l1274t3190r1298b3214],
11	and	CC	O	and	_	0	SENT_814	[p14l1313t3189r1362b3215],
12	III	CD	NUMBER	iii	num	13	SENT_814	[p14l1377t3190r1413b3214],
13	studies	NNS	O	study	prep_for	5	SENT_814	[p14l1428t3189r1522b3215],
14	in	IN	O	in	_	0	SENT_814	[p14l1537t3190r1564b3214],
15	treatment	NN	O	treatment	prep_in	13	SENT_814	[p14l1579t3196r1716b3215],
16	experienced	VBD	O	experience	_	0	SENT_814	[p14l1731t3189r1896b3223],
17	HIV	NN	MISC	hiv	nn	19	SENT_814	[p14l1911t3190r1978b3215],
18	infected	JJ	O	infected	amod	19	SENT_814	[p14l1990t3189r2101b3215],
19	patients	NNS	O	patient	dobj	16	SENT_814	[p14l658t3231r774b3264],
20	.	.	O	.	_	0	SENT_814	[p14l658t3231r774b3264],

1	Presented	VBN	O	present	_	0	SENT_815	[p14l785t3231r909b3256],
2	at	IN	O	at	_	0	SENT_815	[p14l916t3237r943b3256],
3	9th	JJ	ORDINAL	9th	amod	4	SENT_815	[p14l951t3231r993b3256],
4	Int	NN	O	int	prep_at	1	SENT_815	[p14l1003t3231r1048b3256],
5	.	.	O	.	_	0	SENT_815	[p14l1003t3231r1048b3256],

1	Whrkshop	NNP	PERSON	Whrkshop	nn	2	SENT_816	[p14l1063t3231r1185b3264],
2	Clin	NNP	PERSON	Clin	_	0	SENT_816	[p14l1197t3231r1257b3256],
3	.	.	O	.	_	0	SENT_816	[p14l1197t3231r1257b3256],

1	Pharmaeol	NNP	O	Pharmaeol	_	0	SENT_817	[p14l1269t3231r1413b3256],
2	.	.	O	.	_	0	SENT_817	[p14l1269t3231r1413b3256],

1	HI	NN	O	hus	_	0	SENT_818	[p14l1425t3231r1465b3256],
2	VTher	NN	O	vther	dep	1	SENT_818	[p14l1467t3231r1560b3256],
3	.	.	O	.	_	0	SENT_818	[p14l1467t3231r1560b3256],

1	(	NN	O	(	nn	2	SENT_819	[p14l1574t3230r1675b3262],
2	Abstr	NN	O	abstr	_	0	SENT_819	[p14l1574t3230r1675b3262],
3	.	.	O	.	_	0	SENT_819	[p14l1574t3230r1675b3262],
4	)	SYM	O	)	dep	2	SENT_819	[p14l1574t3230r1675b3262],

1	V	NN	O	v	_	0	SENT_820	[p15l81t2845r85b2849],
2	,	,	O	,	_	0	SENT_820	[p15l81t2070r85b2074],
3	An	DT	O	a	det	4	SENT_820	[p15l56t1317r79b1357],
4	nu	NN	O	nu	appos	1	SENT_820	[p15l56t1207r79b1310],
5	.	.	O	.	_	0	SENT_820	[p15l56t1207r79b1310],

1	Rev.	NNP	O	Rev.	nn	2	SENT_821	[p15l56t1207r79b1310],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_821	[p15l56t1048r79b1196],
3	.	.	O	.	_	0	SENT_821	[p15l56t1048r79b1196],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_822	[p15l56t928r79b1037],
2	.	.	O	.	_	0	SENT_822	[p15l56t928r79b1037],

1	2009.49:3	CD	NUMBER	2009.49:3	num	2	SENT_823	[p15l56t785r80b917],
2	77-394	CD	NUMBER	77-394	_	0	SENT_823	[p15l56t679r80b779],
3	.	.	O	.	_	0	SENT_823	[p15l56t679r80b779],

1	Do	VB	O	do	aux	2	SENT_824	[p15l56t628r79b668],
2	wnloaded	VBN	O	wnload	_	0	SENT_824	[p15l56t452r79b582],
3	from	IN	O	from	_	0	SENT_824	[p15l56t379r79b443],
4	www.a11nualreviews.org	NN	O	www.a11nualreviews.org	nn	5	SENT_824	[p15l56t44r86b370],
5	Annu	NN	PERSON	annu	prep_from	2	SENT_824	[p15l81t3146r104b3225],
6	.	.	O	.	_	0	SENT_824	[p15l81t3146r104b3225],

1	Rev.	NNP	O	Rev.	nn	2	SENT_825	[p15l81t3075r104b3135],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_825	[p15l81t2915r104b3064],
3	.	.	O	.	_	0	SENT_825	[p15l81t2915r104b3064],

1	TOXICOI	NNP	O	TOXICOI	_	0	SENT_826	[p15l81t2795r104b2905],
2	.	.	O	.	_	0	SENT_826	[p15l81t2795r104b2905],

1	2009.49:377	CD	NUMBER	2009.49:377	num	2	SENT_827	[p15l81t2550r105b2784],
2	-394	CD	NUMBER	-394	_	0	SENT_827	[p15l81t2550r105b2784],
3	.	.	O	.	_	0	SENT_827	[p15l81t2550r105b2784],

1	Downloaded	VBN	O	download	_	0	SENT_828	[p15l81t2370r104b2539],
2	from	IN	O	from	_	0	SENT_828	[p15l81t2297r104b2361],
3	www.annualrev1ews.org	NN	O	www.annualrev1ews.org	prep_from	1	SENT_828	[p15l81t1964r111b2288],
4	/	:	O	/	punct	6	SENT_828	[p15l89t487r113b579],
5	05/14	CD	NUMBER	05/14	num	6	SENT_828	[p15l89t487r113b579],
6	_	NN	O	_	parataxis	1	SENT_828	[p15l89t487r113b579],
7	For	IN	O	for	dep	6	SENT_828	[p15l90t430r113b476],
8	personal	JJ	O	personal	amod	11	SENT_828	[p15l89t309r120b421],
9	use	NN	O	use	nn	11	SENT_828	[p15l97t256r113b300],
10	0n1y	NN	O	0n1y	nn	11	SENT_828	[p15l89t181r120b246],
11	_	NN	O	_	pobj	7	SENT_828	[p15l89t181r120b246],
12	by	IN	O	by	dep	6	SENT_828	[p15l89t1190r120b1222],
13	University	NNP	ORGANIZATION	University	pobj	12	SENT_828	[p15l89t1041r120b1181],
14	of	IN	ORGANIZATION	of	_	0	SENT_828	[p15l89t1002r113b1031],
15	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	13	SENT_828	[p15l89t856r113b996],
16	-	:	O	-	_	0	SENT_828	[p15l103t838r106b847],
17	Madison	NNP	O	Madison	dep	13	SENT_828	[p15l89t707r113b828],
18	on	IN	O	on	_	0	SENT_828	[p15l97t666r113b698],
19	01	CD	NUMBER	01	prep_on	17	SENT_828	[p15l89t627r113b657],

1	by	IN	O	by	dep	6	SENT_829	[p15l114t3058r145b3090],
2	University	NNP	ORGANIZATION	University	pobj	1	SENT_829	[p15l114t2908r145b3049],
3	of	IN	ORGANIZATION	of	_	0	SENT_829	[p15l114t2870r138b2899],
4	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	2	SENT_829	[p15l114t2723r138b2864],
5	-	:	O	-	_	0	SENT_829	[p15l128t2705r131b2713],
6	Madison	NNP	O	Madison	_	0	SENT_829	[p15l114t2579r138b2695],
7	on	IN	O	on	_	0	SENT_829	[p15l122t2537r138b2569],
8	01/05/14	CD	DATE	01/05/14	prep_on	6	SENT_829	[p15l114t2404r138b2528],
9	.	.	O	.	_	0	SENT_829	[p15l114t2404r138b2528],

1	For	IN	O	for	_	0	SENT_830	[p15l115t2347r138b2394],
2	personal	JJ	O	personal	amod	3	SENT_830	[p15l114t2227r145b2339],
3	use	NN	O	use	pobj	1	SENT_830	[p15l122t2174r138b2218],
4	only	RB	O	only	advmod	3	SENT_830	[p15l114t2100r145b2165],
5	.	.	O	.	_	0	SENT_830	[p15l114t2100r145b2165],

1	394	CD	NUMBER	394	_	0	SENT_831	[p15l488t1440r532b1461],
2	Haznda	NN	O	haznda	dep	1	SENT_831	[p15l583t1432r674b1454],
3	-	:	O	-	_	0	SENT_831	[p15l690t1440r699b1450],
4	Izoamoto	NN	PERSON	izoamoto	dep	1	SENT_831	[p15l714t1432r811b1454],
5	-	:	O	-	_	0	SENT_831	[p15l827t1440r836b1450],
6	Wenning	NN	PERSON	wenning	dep	4	SENT_831	[p15l854t1432r956b1462],

1	Contents	NNS	O	contents	_	0	SENT_832	[p15l230t1748r563b1812],

1	Autonomic	JJ	MISC	autonomic	amod	2	SENT_833	[p15l225t1943r422b1974],
2	Neurotransmission	NN	MISC	neurotransmission	_	0	SENT_833	[p15l433t1943r778b1974],
3	:	:	O	:	_	0	SENT_833	[p15l433t1943r778b1974],
4	60	CD	DURATION	60	num	5	SENT_833	[p15l793t1944r833b1974],
5	Years	NNS	DURATION	year	dep	2	SENT_833	[p15l844t1943r935b1974],
6	Since	IN	O	since	rcmod	5	SENT_833	[p15l950t1943r1042b1974],
7	Sir	NNP	O	Sir	nn	9	SENT_833	[p15l1056t1943r1104b1974],
8	Henry	NNP	PERSON	Henry	nn	9	SENT_833	[p15l1116t1943r1231b1985],
9	Dale	NNP	PERSON	Dale	pobj	6	SENT_833	[p15l1242t1942r1323b1974],

1	Geoﬁey	NNP	O	Geoﬁey	nn	2	SENT_834	[p15l279t1996r412b2038],
2	Bnrnxtock	NNP	O	Bnrnxtock	_	0	SENT_834	[p15l423t1996r583b2027],
3	. . . . .	FW	O	. . . . .	nn	17	SENT_834	[p15l665t2024r670b2029],[p15l607t2024r611b2029],
4	. . . . .	FW	O	. . . . .	nn	17	SENT_834	[p15l738t2024r742b2029],[p15l680t2024r684b2029],
5	. . . . .	FW	O	. . . . .	nn	17	SENT_834	[p15l810t2024r815b2029],[p15l752t2024r757b2029],
6	. . . . .	FW	O	. . . . .	nn	17	SENT_834	[p15l883t2024r888b2029],[p15l825t2024r829b2029],
7	. . . . .	FW	O	. . . . .	nn	17	SENT_834	[p15l956t2024r960b2029],[p15l898t2024r902b2029],
8	. . . . .	FW	O	. . . . .	nn	17	SENT_834	[p15l1028t2024r1033b2029],[p15l970t2024r975b2029],
9	. . . . .	FW	O	. . . . .	nn	17	SENT_834	[p15l1101t2024r1106b2029],[p15l1043t2024r1047b2029],
10	. . . . .	FW	O	. . . . .	nn	17	SENT_834	[p15l1174t2024r1178b2029],[p15l1116t2024r1120b2029],
11	. . . . .	FW	O	. . . . .	nn	17	SENT_834	[p15l1246t2024r1251b2029],[p15l1188t2024r1193b2029],
12	. . . . .	FW	O	. . . . .	nn	17	SENT_834	[p15l1319t2024r1324b2029],[p15l1261t2024r1265b2029],
13	. . . . .	FW	O	. . . . .	nn	17	SENT_834	[p15l1392t2024r1396b2029],[p15l1334t2024r1338b2029],
14	. . . . .	FW	O	. . . . .	nn	17	SENT_834	[p15l1464t2024r1469b2029],[p15l1406t2024r1411b2029],
15	. . . . .	FW	O	. . . . .	nn	17	SENT_834	[p15l1537t2024r1542b2029],[p15l1479t2024r1483b2029],
16	. . . . .	FW	O	. . . . .	nn	17	SENT_834	[p15l1610t2024r1614b2029],[p15l1552t2024r1556b2029],
17	. . . . .	FW	O	. . . . .	dep	2	SENT_834	[p15l1682t2024r1687b2029],[p15l1624t2024r1629b2029],
18	.	.	O	.	_	0	SENT_834	[p15l1697t2024r1716b2029],

1	.	.	O	.	_	0	SENT_835	[p15l1697t2024r1716b2029],

1	l	NN	O	l	_	0	SENT_836	[p15l1732t1997r1744b2027],

1	The	DT	O	the	det	2	SENT_837	[p15l226t2074r300b2106],
2	Role	NN	O	role	_	0	SENT_837	[p15l313t2074r393b2106],
3	of	IN	O	of	_	0	SENT_837	[p15l406t2074r444b2106],
4	Gfﬁy	NNP	O	Gfﬁy	nn	5	SENT_837	[p15l452t2075r537b2114],
5	Subunits	NNPS	O	Subunits	prep_of	2	SENT_837	[p15l551t2074r701b2106],
6	in	IN	O	in	_	0	SENT_837	[p15l714t2076r747b2106],
7	the	DT	O	the	det	8	SENT_837	[p15l760t2074r814b2106],
8	Organization	NNP	O	Organization	prep_in	2	SENT_837	[p15l827t2075r1067b2117],
9	,	,	O	,	_	0	SENT_837	[p15l827t2075r1067b2117],
10	Assembly	NNP	ORGANIZATION	Assembly	prep_in	2	SENT_837	[p15l1079t2074r1251b2117],
11	,	,	O	,	_	0	SENT_837	[p15l1079t2074r1251b2117],
12	and	CC	O	and	_	0	SENT_837	[p15l1266t2074r1327b2106],
13	Function	NN	O	function	conj_and	8	SENT_837	[p15l268t2129r427b2160],
14	of	IN	O	of	_	0	SENT_837	[p15l440t2128r478b2160],
15	GPCR	NNP	O	GPCR	nn	17	SENT_837	[p15l486t2129r606b2160],
16	Signaling	NN	O	signaling	nn	17	SENT_837	[p15l619t2128r782b2171],
17	Complexes	NNS	O	complex	prep_of	13	SENT_837	[p15l795t2128r986b2170],
18	Denisj	JJ	O	denisj	amod	19	SENT_837	[p15l276t2182r406b2224],
19	’	NN	O	’	dep	13	SENT_837	[p15l276t2182r406b2224],
20	.	.	O	.	_	0	SENT_837	[p15l276t2182r406b2224],

1	Dnpre	JJ	O	dnpre	amod	2	SENT_838	[p15l422t2183r533b2224],
2	’	NN	O	’	_	0	SENT_838	[p15l422t2183r533b2224],
3	,	,	O	,	_	0	SENT_838	[p15l422t2183r533b2224],
4	Melanie	NNP	PERSON	Melanie	nn	5	SENT_838	[p15l546t2183r680b2214],
5	Robitaille	NNP	PERSON	Robitaille	appos	2	SENT_838	[p15l690t2183r850b2221],
6	,	,	O	,	_	0	SENT_838	[p15l690t2183r850b2221],
7	R.	NNP	PERSON	R.	nn	9	SENT_838	[p15l864t2183r898b2214],
8	Victor	NNP	PERSON	Victor	nn	9	SENT_838	[p15l917t2183r1012b2214],
9	Relzoix	NNP	PERSON	Relzoix	appos	2	SENT_838	[p15l1020t2183r1127b2221],
10	,	,	O	,	_	0	SENT_838	[p15l1020t2183r1127b2221],
11	and	CC	O	and	_	0	SENT_838	[p15l1142t2183r1203b2214],
12	Yerence	NNP	PERSON	Yerence	nn	16	SENT_838	[p15l1215t2183r1331b2214],
13	E.	NNP	PERSON	E.	nn	16	SENT_838	[p15l1342t2183r1375b2214],
14	Hélzert	NNP	PERSON	Hélzert	nn	16	SENT_838	[p15l1389t2183r1503b2214],
15	.....	NNP	O	.....	nn	16	SENT_838	[p15l1523t2211r1672b2215],
16	.....	NNP	O	.....	conj_and	5	SENT_838	[p15l1523t2211r1672b2215],
17	.	.	O	.	_	0	SENT_838	[p15l1523t2211r1672b2215],

1	.	.	O	.	_	0	SENT_839	[p15l1682t2184r1744b2215],

1	.3	NN	NUMBER	.3	nn	2	SENT_840	[p15l1682t2184r1744b2215],
2	l	NN	O	l	_	0	SENT_840	[p15l1682t2184r1744b2215],

1	Pharmacology	NN	O	pharmacology	_	0	SENT_841	[p15l227t2261r480b2303],
2	of	IN	O	of	_	0	SENT_841	[p15l491t2261r529b2293],
3	Nicotine	NNP	O	Nicotine	prep_of	1	SENT_841	[p15l536t2262r700b2293],
4	:	:	O	:	_	0	SENT_841	[p15l536t2262r700b2293],
5	Addiction	NN	O	addiction	dep	1	SENT_841	[p15l713t2261r895b2300],
6	,	,	O	,	_	0	SENT_841	[p15l713t2261r895b2300],
7	Smoking	NN	O	smoking	appos	5	SENT_841	[p15l910t2261r1223b2303],
8	.	.	O	.	_	0	SENT_841	[p15l910t2261r1223b2303],

1	—	NN	O	—	_	0	SENT_842	[p15l910t2261r1223b2303],
2	.	.	O	.	_	0	SENT_842	[p15l910t2261r1223b2303],

1	Induced	VBN	O	induce	_	0	SENT_843	[p15l910t2261r1223b2303],
2	Disease	NN	O	disease	dobj	1	SENT_843	[p15l1236t2262r1377b2300],
3	,	,	O	,	_	0	SENT_843	[p15l1236t2262r1377b2300],
4	and	CC	O	and	_	0	SENT_843	[p15l1391t2261r1453b2293],
5	Therapeutics	NNP	PERSON	Therapeutics	nn	8	SENT_843	[p15l267t2315r498b2357],
6	Neal	NNP	PERSON	Neal	nn	8	SENT_843	[p15l275t2370r356b2401],
7	L.	NNP	PERSON	L.	nn	8	SENT_843	[p15l364t2370r396b2400],
8	Benowitz	NNP	PERSON	Benowitz	dobj	1	SENT_843	[p15l411t2370r560b2401],
9	. . . . .	FW	O	. . . . .	nn	24	SENT_843	[p15l636t2398r640b2402],[p15l578t2398r582b2402],
10	. . . . .	FW	O	. . . . .	nn	24	SENT_843	[p15l709t2398r713b2402],[p15l650t2398r655b2402],
11	. . . . .	FW	O	. . . . .	nn	24	SENT_843	[p15l781t2398r786b2402],[p15l723t2398r728b2402],
12	. . . . .	FW	O	. . . . .	nn	24	SENT_843	[p15l854t2398r858b2402],[p15l796t2398r800b2402],
13	. . . . .	FW	O	. . . . .	nn	24	SENT_843	[p15l927t2398r931b2402],[p15l869t2398r873b2402],
14	. . . . .	FW	O	. . . . .	nn	24	SENT_843	[p15l999t2398r1004b2402],[p15l941t2398r946b2402],
15	. . . . .	FW	O	. . . . .	nn	24	SENT_843	[p15l1072t2398r1076b2402],[p15l1014t2398r1018b2402],
16	. . . . .	FW	O	. . . . .	nn	24	SENT_843	[p15l1145t2398r1149b2402],[p15l1087t2398r1091b2402],
17	. . . . .	FW	O	. . . . .	nn	24	SENT_843	[p15l1217t2398r1222b2402],[p15l1159t2398r1164b2402],
18	. . . . .	FW	O	. . . . .	nn	24	SENT_843	[p15l1290t2398r1294b2402],[p15l1232t2398r1236b2402],
19	. . . . .	FW	O	. . . . .	nn	24	SENT_843	[p15l1363t2398r1367b2402],[p15l1304t2398r1309b2402],
20	. . . . .	FW	O	. . . . .	nn	24	SENT_843	[p15l1435t2398r1440b2402],[p15l1377t2398r1382b2402],
21	. . . . .	FW	O	. . . . .	nn	24	SENT_843	[p15l1508t2398r1512b2402],[p15l1450t2398r1454b2402],
22	. . . . .	FW	O	. . . . .	nn	24	SENT_843	[p15l1581t2398r1585b2402],[p15l1523t2398r1527b2402],
23	. . . . .	FW	O	. . . . .	nn	24	SENT_843	[p15l1653t2398r1658b2402],[p15l1595t2398r1600b2402],
24	. . .	FW	O	. . .	dep	8	SENT_843	[p15l1697t2370r1724b2402],[p15l1668t2398r1672b2402],
25	5	CD	NUMBER	5	number	26	SENT_843	[p15l1697t2370r1724b2402],
26	7	CD	NUMBER	7	amod	24	SENT_843	[p15l1730t2370r1747b2401],

1	Targeting	NN	O	targeting	nn	2	SENT_844	[p15l226t2448r398b2490],
2	Proteins	NNS	O	protein	_	0	SENT_844	[p15l408t2449r554b2480],
3	for	IN	O	for	_	0	SENT_844	[p15l567t2448r618b2480],
4	Destruction	NNP	O	Destruction	prep_for	2	SENT_844	[p15l630t2449r839b2480],
5	by	IN	O	by	_	0	SENT_844	[p15l851t2447r893b2490],
6	the	DT	O	the	det	8	SENT_844	[p15l904t2447r958b2480],
7	Ubiquitin	NNP	MISC	Ubiquitin	nn	8	SENT_844	[p15l971t2447r1142b2490],
8	System	NNP	MISC	System	prep_by	4	SENT_844	[p15l1156t2449r1288b2490],
9	:	:	O	:	_	0	SENT_844	[p15l1156t2449r1288b2490],
10	Implications	NNS	ORGANIZATION	implication	dep	2	SENT_844	[p15l268t2501r485b2543],
11	for	IN	ORGANIZATION	for	_	0	SENT_844	[p15l498t2501r548b2533],
12	Human	JJ	ORGANIZATION	human	amod	16	SENT_844	[p15l560t2502r693b2533],
13	Pathobiology	NN	ORGANIZATION	pathobiology	nn	16	SENT_844	[p15l705t2501r941b2544],
14	Alan	NNP	PERSON	Alan	nn	16	SENT_844	[p15l273t2555r354b2586],
15	L.	NNP	PERSON	L.	nn	16	SENT_844	[p15l366t2556r399b2586],
16	Schwartz	NNP	PERSON	Schwartz	prep_for	10	SENT_844	[p15l415t2555r566b2586],
17	and	CC	O	and	_	0	SENT_844	[p15l577t2556r639b2586],
18	Aaron	NNP	PERSON	Aaron	nn	29	SENT_844	[p15l645t2555r749b2586],
19	Clecbanover	NNP	PERSON	Clecbanover	nn	29	SENT_844	[p15l764t2555r960b2586],
20	. . . . .	NNP	O	. . . . .	nn	29	SENT_844	[p15l1028t2583r1033b2588],[p15l970t2583r975b2588],
21	. . . . .	NNP	O	. . . . .	nn	29	SENT_844	[p15l1101t2583r1106b2588],[p15l1043t2583r1047b2588],
22	. . . . .	NNP	O	. . . . .	nn	29	SENT_844	[p15l1174t2584r1178b2588],[p15l1116t2583r1120b2588],
23	. . . . .	NNP	O	. . . . .	nn	29	SENT_844	[p15l1246t2583r1251b2588],[p15l1188t2583r1193b2588],
24	. . . . .	NNP	O	. . . . .	nn	29	SENT_844	[p15l1319t2583r1324b2588],[p15l1261t2583r1265b2588],
25	. . . . .	NNP	O	. . . . .	nn	29	SENT_844	[p15l1392t2583r1396b2588],[p15l1334t2583r1338b2588],
26	. . . . .	NNP	O	. . . . .	nn	29	SENT_844	[p15l1464t2583r1469b2588],[p15l1406t2583r1411b2588],
27	. . . . .	NNP	O	. . . . .	nn	29	SENT_844	[p15l1537t2583r1542b2588],[p15l1479t2583r1483b2588],
28	. . . . .	NNP	O	. . . . .	nn	29	SENT_844	[p15l1610t2583r1614b2588],[p15l1552t2583r1556b2588],
29	. . . . .	NNP	O	. . . . .	conj_and	16	SENT_844	[p15l1682t2583r1687b2588],[p15l1624t2583r1629b2588],
30	.73	CD	NUMBER	.73	num	29	SENT_844	[p15l1697t2556r1745b2588],

1	Progress	NNP	O	Progress	_	0	SENT_845	[p15l227t2635r377b2676],
2	in	IN	O	in	_	0	SENT_845	[p15l390t2635r423b2665],
3	Genetic	JJ	O	genetic	amod	4	SENT_845	[p15l436t2634r574b2665],
4	Studies	NNS	O	study	prep_in	1	SENT_845	[p15l587t2633r711b2665],
5	of	IN	O	of	_	0	SENT_845	[p15l725t2633r763b2665],
6	Pain	NN	O	pain	prep_of	1	SENT_845	[p15l770t2635r848b2665],
7	and	CC	O	and	_	0	SENT_845	[p15l861t2633r923b2665],
8	Analgesia	NNP	PERSON	Analgesia	nn	11	SENT_845	[p15l934t2633r1100b2676],
9	Michael	NNP	PERSON	Michael	nn	11	SENT_845	[p15l275t2688r408b2719],
10	L.	NNP	PERSON	L.	nn	11	SENT_845	[p15l416t2689r449b2719],
11	LaCroz	NNP	PERSON	LaCroz	poss	13	SENT_845	[p15l463t2688r731b2719],
12	'	POS	O	'	_	0	SENT_845	[p15l463t2688r731b2719],
13	x	NN	O	x	prep_of	1	SENT_845	[p15l463t2688r731b2719],
14	.	.	O	.	_	0	SENT_845	[p15l463t2688r731b2719],

1	—	NN	O	—	_	0	SENT_846	[p15l463t2688r731b2719],
2	.	.	O	.	_	0	SENT_846	[p15l463t2688r731b2719],

1	Fralz	NNP	PERSON	Fralz	_	0	SENT_847	[p15l463t2688r731b2719],
2	's	POS	O	's	possessive	1	SENT_847	[p15l463t2688r731b2719],
3	/	:	O	/	punct	19	SENT_847	[p15l463t2688r731b2719],
4	9	CD	NUMBER	9	dep	19	SENT_847	[p15l463t2688r731b2719],
5	and	CC	O	and	_	0	SENT_847	[p15l743t2688r805b2719],
6	jeﬁey	NN	O	jeﬁey	dep	19	SENT_847	[p15l809t2688r922b2730],
7	S.	FW	PERSON	s.	nn	6	SENT_847	[p15l934t2688r963b2719],
8	Mogil	FW	PERSON	mogil	nn	6	SENT_847	[p15l977t2688r1077b2731],
9	.....	FW	O	.....	nn	6	SENT_847	[p15l1087t2716r1672b2721],
10	.....	FW	O	.....	nn	6	SENT_847	[p15l1087t2716r1672b2721],
11	.....	FW	O	.....	nn	6	SENT_847	[p15l1087t2716r1672b2721],
12	.....	FW	O	.....	nn	6	SENT_847	[p15l1087t2716r1672b2721],
13	.....	FW	O	.....	nn	6	SENT_847	[p15l1087t2716r1672b2721],
14	.....	FW	O	.....	nn	6	SENT_847	[p15l1087t2716r1672b2721],
15	.....	FW	O	.....	nn	6	SENT_847	[p15l1087t2716r1672b2721],
16	.....	FW	O	.....	nn	6	SENT_847	[p15l1087t2716r1672b2721],
17	. . .	FW	O	. . .	dep	6	SENT_847	[p15l1697t2688r1747b2721],[p15l1087t2716r1672b2721],
18	97	CD	NUMBER	97	num	19	SENT_847	[p15l1697t2688r1747b2721],
19	Lipid	NN	O	lipid	dep	20	SENT_847	[p15l227t2766r321b2809],
20	Mediators	NNS	O	mediator	dep	1	SENT_847	[p15l332t2766r511b2798],
21	in	IN	O	in	_	0	SENT_847	[p15l523t2768r557b2798],
22	Health	NNP	O	Health	prep_in	20	SENT_847	[p15l569t2766r690b2798],
23	and	CC	O	and	_	0	SENT_847	[p15l703t2766r764b2798],
24	Disease	NNP	O	Disease	prep_in	20	SENT_847	[p15l777t2768r917b2798],
25	:	:	O	:	_	0	SENT_847	[p15l777t2768r917b2798],
26	Enzymes	NNS	O	enzyme	dep	1	SENT_847	[p15l932t2768r1089b2809],
27	and	CC	O	and	_	0	SENT_847	[p15l1102t2766r1164b2798],
28	Receptors	NNS	O	receptor	dep	1	SENT_847	[p15l1177t2768r1350b2809],
29	as	IN	O	as	_	0	SENT_847	[p15l1364t2778r1395b2798],
30	Therapeutic	JJ	O	therapeutic	amod	31	SENT_847	[p15l267t2820r484b2863],
31	Targets	NNS	O	target	prep_as	26	SENT_847	[p15l495t2821r624b2863],
32	for	IN	O	for	_	0	SENT_847	[p15l637t2820r688b2853],
33	the	DT	O	the	det	34	SENT_847	[p15l699t2820r753b2853],
34	Regulation	NN	MISC	regulation	prep_for	31	SENT_847	[p15l766t2820r958b2863],
35	of	IN	MISC	of	_	0	SENT_847	[p15l970t2820r1008b2853],
36	Immunity	NN	MISC	immunity	prep_of	34	SENT_847	[p15l1016t2822r1191b2863],
37	and	CC	O	and	_	0	SENT_847	[p15l1203t2820r1264b2853],
38	Inﬂammation	NN	O	inﬂammation	prep_of	34	SENT_847	[p15l268t2874r506b2906],
39	Ya/eao	NN	O	ya/eao	dep	26	SENT_847	[p15l279t2929r371b2960],
40	S/annizu	FW	O	s/annizu	nn	39	SENT_847	[p15l384t2929r522b2960],
41	.....	FW	O	.....	nn	39	SENT_847	[p15l534t2957r1643b2962],
42	.....	FW	O	.....	nn	39	SENT_847	[p15l534t2957r1643b2962],
43	.....	FW	O	.....	nn	39	SENT_847	[p15l534t2957r1643b2962],
44	.....	FW	O	.....	nn	39	SENT_847	[p15l534t2957r1643b2962],
45	.....	FW	O	.....	nn	39	SENT_847	[p15l534t2957r1643b2962],
46	.....	FW	O	.....	nn	39	SENT_847	[p15l534t2957r1643b2962],
47	.....	FW	O	.....	nn	39	SENT_847	[p15l534t2957r1643b2962],
48	.....	FW	O	.....	nn	39	SENT_847	[p15l534t2957r1643b2962],
49	.....	FW	O	.....	nn	39	SENT_847	[p15l534t2957r1643b2962],
50	.....	FW	O	.....	nn	39	SENT_847	[p15l534t2957r1643b2962],
51	.....	FW	O	.....	nn	39	SENT_847	[p15l534t2957r1643b2962],
52	.....	FW	O	.....	nn	39	SENT_847	[p15l534t2957r1643b2962],
53	.....	FW	O	.....	nn	39	SENT_847	[p15l534t2957r1643b2962],
54	.....	FW	O	.....	nn	39	SENT_847	[p15l534t2957r1643b2962],
55	.....	FW	O	.....	dep	39	SENT_847	[p15l534t2957r1643b2962],
56	.	.	O	.	_	0	SENT_847	[p15l534t2957r1643b2962],

1	.	.	O	.	_	0	SENT_848	[p15l534t2957r1643b2962],

1	.	.	O	.	_	0	SENT_849	[p15l1653t2957r1672b2962],

1	.	.	O	.	_	0	SENT_850	[p15l1653t2957r1672b2962],

1	123	CD	NUMBER	123	_	0	SENT_851	[p15l1689t2930r1745b2960],

1	Sorting	VBG	O	sort	_	0	SENT_852	[p15l228t3008r358b3050],
2	out	RP	O	out	prt	1	SENT_852	[p15l370t3016r427b3039],
3	Astrocyte	NNP	O	Astrocyte	nn	4	SENT_852	[p15l437t3008r603b3050],
4	Physiology	NNP	O	Physiology	dobj	1	SENT_852	[p15l616t3007r810b3050],
5	from	IN	O	from	_	0	SENT_852	[p15l821t3007r905b3039],
6	Pharmacology	NNP	O	Pharmacology	prep_from	4	SENT_852	[p15l917t3007r1170b3050],

1	Todd	NNP	PERSON	Todd	nn	3	SENT_853	[p15l279t3062r354b3093],
2	A.	NNP	PERSON	A.	nn	3	SENT_853	[p15l360t3062r398b3093],
3	Flacco	NNP	PERSON	Flacco	_	0	SENT_853	[p15l413t3063r518b3100],
4	,	,	O	,	_	0	SENT_853	[p15l413t3063r518b3100],
5	Cendra	NNP	PERSON	Cendra	nn	6	SENT_853	[p15l535t3062r652b3093],
6	Agullaon	NNP	PERSON	Agullaon	conj_and	3	SENT_853	[p15l660t3062r808b3105],
7	,	,	O	,	_	0	SENT_853	[p15l660t3062r808b3105],
8	and	CC	O	and	_	0	SENT_853	[p15l823t3062r885b3093],
9	Ken	NNP	PERSON	Ken	nn	12	SENT_853	[p15l893t3063r957b3093],
10	D.	NNP	PERSON	D.	nn	12	SENT_853	[p15l970t3063r1008b3093],
11	McCarthy	NNP	PERSON	McCarthy	nn	12	SENT_853	[p15l1021t3062r1189b3104],
12	. . . . .	NNP	O	. . . . .	conj_and	3	SENT_853	[p15l1261t3090r1265b3095],[p15l1203t3090r1207b3095],
13	. . . . .	NNP	O	. . . . .	nn	17	SENT_853	[p15l1334t3090r1338b3095],[p15l1275t3090r1280b3095],
14	. . . . .	NNP	O	. . . . .	nn	17	SENT_853	[p15l1406t3090r1411b3095],[p15l1348t3090r1353b3095],
15	. . . . .	NNP	O	. . . . .	nn	17	SENT_853	[p15l1479t3090r1483b3095],[p15l1421t3090r1425b3095],
16	. . . . .	NNP	O	. . . . .	nn	17	SENT_853	[p15l1551t3090r1556b3095],[p15l1493t3090r1498b3095],
17	. . . . .	NNP	O	. . . . .	dep	12	SENT_853	[p15l1624t3090r1629b3095],[p15l1566t3090r1571b3095],
18	.	.	O	.	_	0	SENT_853	[p15l1639t3090r1643b3095],

1	.	.	O	.	_	0	SENT_854	[p15l1653t3090r1672b3095],

1	.	.	O	.	_	0	SENT_855	[p15l1653t3090r1672b3095],

1	151	CD	NUMBER	151	_	0	SENT_856	[p15l1689t3063r1744b3094],

1	Lithium	NN	O	lithium	poss	4	SENT_857	[p15l227t3140r392b3173],
2	’s	POS	O	’s	_	0	SENT_857	[p15l227t3140r392b3173],
3	Antisuicidal	NNP	O	Antisuicidal	nn	4	SENT_857	[p15l403t3140r610b3173],
4	Efﬁcacy	NNP	O	Efﬁcacy	_	0	SENT_857	[p15l622t3140r770b3183],
5	:	:	O	:	_	0	SENT_857	[p15l622t3140r770b3183],
6	Elucidation	NN	O	elucidation	dep	4	SENT_857	[p15l784t3140r987b3173],
7	of	IN	O	of	_	0	SENT_857	[p15l999t3140r1037b3173],
8	Neurobiological	JJ	O	neurobiological	amod	9	SENT_857	[p15l1043t3140r1330b3183],
9	Targets	NNS	O	target	prep_of	6	SENT_857	[p15l1341t3141r1470b3183],
10	Using	VBG	O	use	partmod	9	SENT_857	[p15l268t3195r374b3237],
11	Endophenotype	JJ	O	endophenotype	amod	15	SENT_857	[p15l385t3194r665b3237],
12	Strategies	NNS	O	strategy	nn	15	SENT_857	[p15l679t3195r848b3237],
13	Colleen	NNP	PERSON	Colleen	nn	15	SENT_857	[p15l279t3248r392b3279],
14	E.	NNP	PERSON	E.	nn	15	SENT_857	[p15l404t3249r437b3279],
15	Kovacxicx	NNP	PERSON	Kovacxicx	dobj	10	SENT_857	[p15l452t3249r604b3287],
16	,	,	O	,	_	0	SENT_857	[p15l452t3249r604b3287],
17	Irving	NNP	PERSON	Irving	nn	19	SENT_857	[p15l618t3249r724b3291],
18	I.	NNP	PERSON	I.	nn	19	SENT_857	[p15l733t3249r755b3279],
19	Gottexman	NNP	PERSON	Gottexman	dobj	10	SENT_857	[p15l773t3248r951b3287],
20	,	,	O	,	_	0	SENT_857	[p15l773t3248r951b3287],
21	and	CC	O	and	_	0	SENT_857	[p15l966t3248r1028b3279],
22	Todd	NNP	PERSON	Todd	nn	29	SENT_857	[p15l1040t3248r1115b3279],
23	D.	NNP	PERSON	D.	nn	29	SENT_857	[p15l1124t3249r1163b3279],
24	Gould	NNP	PERSON	Gould	nn	29	SENT_857	[p15l1181t3248r1279b3279],
25	. . . . .	NNP	O	. . . . .	nn	29	SENT_857	[p15l1348t3276r1353b3281],[p15l1290t3277r1294b3281],
26	. . . . .	NNP	O	. . . . .	nn	29	SENT_857	[p15l1421t3277r1425b3281],[p15l1363t3277r1367b3281],
27	. . . . .	NNP	O	. . . . .	nn	29	SENT_857	[p15l1493t3276r1498b3281],[p15l1435t3276r1440b3281],
28	. . . . .	NNP	O	. . . . .	nn	29	SENT_857	[p15l1566t3277r1571b3281],[p15l1508t3277r1512b3281],
29	. . . . .	NNP	O	. . . . .	dobj	10	SENT_857	[p15l1639t3277r1643b3281],[p15l1581t3277r1585b3281],
30	.	.	O	.	_	0	SENT_857	[p15l1653t3276r1672b3281],

1	.	.	O	.	_	0	SENT_858	[p15l1653t3276r1672b3281],

1	175	CD	NUMBER	175	_	0	SENT_859	[p15l1689t3248r1746b3280],

1	Global	JJ	O	global	_	0	SENT_860	[p15l228t3306r346b3339],
2	and	CC	O	and	_	0	SENT_860	[p15l359t3306r420b3338],
3	Site-Speciﬁc	NNP	O	Site-Speciﬁc	nn	5	SENT_860	[p15l434t3306r652b3349],
4	Quantitative	JJ	MISC	quantitative	amod	5	SENT_860	[p15l666t3307r883b3345],
5	Phosphoproteomics	NNS	MISC	phosphoproteomic	conj_and	1	SENT_860	[p15l896t3306r1253b3349],
6	:	:	O	:	_	0	SENT_860	[p15l896t3306r1253b3349],
7	Principles	NNS	O	principle	conj_and	1	SENT_860	[p15l1268t3306r1441b3349],
8	and	CC	O	and	_	0	SENT_860	[p15l269t3360r330b3392],
9	Applications	NNS	O	application	conj_and	1	SENT_860	[p15l342t3360r559b3403],
10	Boris	NNP	PERSON	Boris	nn	11	SENT_860	[p15l276t3415r359b3446],
11	Macek	NNP	PERSON	Macek	dep	7	SENT_860	[p15l367t3414r483b3453],
12	,	,	O	,	_	0	SENT_860	[p15l367t3414r483b3453],
13	Matt/alas	NNP	O	Matt/alas	nn	14	SENT_860	[p15l496t3415r647b3446],
14	Mann	NNP	PERSON	Mann	appos	11	SENT_860	[p15l655t3415r765b3453],
15	,	,	O	,	_	0	SENT_860	[p15l655t3415r765b3453],
16	and	CC	O	and	_	0	SENT_860	[p15l779t3415r841b3446],
17	jesper	NN	O	jesper	nn	21	SENT_860	[p15l845t3414r950b3456],
18	V	NN	O	v	nn	21	SENT_860	[p15l964t3415r994b3446],
19	Olsen	NNP	PERSON	Olsen	nn	21	SENT_860	[p15l1005t3414r1091b3446],
20	. . . . .	NNP	O	. . . . .	nn	21	SENT_860	[p15l1174t3443r1178b3447],[p15l1116t3443r1120b3447],
21	. . . . .	NNP	O	. . . . .	conj_and	1	SENT_860	[p15l1246t3443r1251b3447],[p15l1188t3443r1193b3447],
22	. . . . .	NNP	O	. . . . .	nn	27	SENT_860	[p15l1319t3443r1324b3447],[p15l1261t3443r1265b3447],
23	. . . . .	NNP	O	. . . . .	nn	27	SENT_860	[p15l1392t3443r1396b3447],[p15l1334t3443r1338b3447],
24	. . . . .	NNP	O	. . . . .	nn	27	SENT_860	[p15l1464t3443r1469b3447],[p15l1406t3443r1411b3447],
25	. . . . .	NNP	O	. . . . .	nn	27	SENT_860	[p15l1537t3443r1542b3447],[p15l1479t3443r1483b3447],
26	. . . . .	NNP	O	. . . . .	nn	27	SENT_860	[p15l1610t3443r1614b3447],[p15l1552t3443r1556b3447],
27	. . .	NNP	O	. . .	dep	21	SENT_860	[p15l1653t3443r1672b3447],[p15l1624t3443r1629b3447],
28	.	.	O	.	_	0	SENT_860	[p15l1653t3443r1672b3447],

1	199	CD	NUMBER	199	_	0	SENT_861	[p15l1689t3415r1748b3446],
2	Small	JJ	O	small	dep	1	SENT_861	[p15l228t3472r505b3505],
3	.	.	O	.	_	0	SENT_861	[p15l228t3472r505b3505],

1	—	NN	O	—	_	0	SENT_862	[p15l228t3472r505b3505],
2	.	.	O	.	_	0	SENT_862	[p15l228t3472r505b3505],

1	Molecule	NN	O	molecule	nn	2	SENT_863	[p15l228t3472r505b3505],
2	Inhibitors	NNS	O	inhibitor	_	0	SENT_863	[p15l517t3472r690b3505],
3	of	IN	O	of	_	0	SENT_863	[p15l703t3472r741b3505],
4	the	DT	O	the	det	5	SENT_863	[p15l749t3472r803b3505],
5	MDM2	NN	O	mdm2	prep_of	2	SENT_863	[p15l814t3474r947b3505],
6	—	CD	NUMBER	—	num	7	SENT_863	[p15l953t3474r1008b3515],
7	p5	NN	O	p5	dep	2	SENT_863	[p15l953t3474r1008b3515],
8	3	CD	NUMBER	3	num	9	SENT_863	[p15l1014t3474r1028b3505],
9	Protein	NN	O	protein	dep	7	SENT_863	[p15l1044t3474r1324b3505],
10	.	.	O	.	_	0	SENT_863	[p15l1044t3474r1324b3505],

1	—	NN	O	—	_	0	SENT_864	[p15l1044t3474r1324b3505],
2	.	.	O	.	_	0	SENT_864	[p15l1044t3474r1324b3505],

1	Protein	NN	O	protein	nn	2	SENT_865	[p15l1044t3474r1324b3505],
2	Interaction	NN	O	interaction	_	0	SENT_865	[p15l268t3528r462b3559],
3	to	TO	O	to	aux	4	SENT_865	[p15l475t3535r508b3559],
4	Reactivate	VB	O	reactivate	infmod	2	SENT_865	[p15l522t3528r701b3559],
5	p5	NN	O	p5	nn	7	SENT_865	[p15l713t3528r753b3569],
6	3	CD	NUMBER	3	num	7	SENT_865	[p15l759t3528r773b3559],
7	Function	NN	O	function	dobj	4	SENT_865	[p15l790t3528r957b3559],
8	:	:	O	:	_	0	SENT_865	[p15l790t3528r957b3559],
9	A	DT	O	a	det	11	SENT_865	[p15l970t3527r999b3558],
10	Novel	JJ	O	novel	amod	11	SENT_865	[p15l1009t3526r1116b3559],
11	Approach	NN	O	approach	dep	2	SENT_865	[p15l1127t3526r1298b3569],
12	for	IN	O	for	_	0	SENT_865	[p15l1310t3526r1361b3559],
13	Cancer	NN	O	cancer	nn	16	SENT_865	[p15l269t3581r394b3612],
14	Therapy	NN	O	therapy	nn	16	SENT_865	[p15l405t3580r558b3623],
15	Sanjeev	NNP	PERSON	Sanjeev	nn	16	SENT_865	[p15l277t3635r400b3676],
16	S/Jangary	NNP	O	S/Jangary	prep_for	11	SENT_865	[p15l413t3635r569b3677],
17	and	CC	O	and	_	0	SENT_865	[p15l580t3635r642b3666],
18	S/aaomeng	NNP	O	S/aaomeng	nn	30	SENT_865	[p15l652t3635r820b3677],
19	[	NNP	O	[	nn	30	SENT_865	[p15l834t3635r927b3677],
20	Vang	NNP	O	Vang	nn	30	SENT_865	[p15l834t3635r927b3677],
21	. . . . .	NNP	O	. . . . .	nn	30	SENT_865	[p15l999t3663r1004b3667],[p15l941t3663r946b3667],
22	. . . . .	NNP	O	. . . . .	nn	30	SENT_865	[p15l1072t3663r1076b3667],[p15l1014t3663r1018b3667],
23	. . . . .	NNP	O	. . . . .	nn	30	SENT_865	[p15l1145t3663r1149b3667],[p15l1087t3663r1091b3667],
24	. . . . .	NNP	O	. . . . .	nn	30	SENT_865	[p15l1217t3663r1222b3667],[p15l1159t3663r1164b3667],
25	. . . . .	NNP	O	. . . . .	nn	30	SENT_865	[p15l1290t3663r1294b3667],[p15l1232t3663r1236b3667],
26	. . . . .	NNP	O	. . . . .	nn	30	SENT_865	[p15l1363t3663r1367b3667],[p15l1304t3663r1309b3667],
27	. . . . .	NNP	O	. . . . .	nn	30	SENT_865	[p15l1435t3663r1440b3667],[p15l1377t3663r1382b3667],
28	. . . . .	NNP	O	. . . . .	nn	30	SENT_865	[p15l1508t3663r1512b3667],[p15l1450t3663r1454b3667],
29	. . . . .	NNP	O	. . . . .	nn	30	SENT_865	[p15l1581t3663r1585b3667],[p15l1523t3663r1527b3667],
30	. . . . .	NNP	O	. . . . .	conj_and	16	SENT_865	[p15l1653t3663r1672b3667],[p15l1595t3663r1600b3667],
31	.	.	O	.	_	0	SENT_865	[p15l1653t3663r1672b3667],

1	223	CD	NUMBER	223	_	0	SENT_866	[p15l1686t3636r1745b3666],

1	E	NN	O	e	_	0	SENT_867	[p15l1799t1537r1853b1622],

1	Annual	JJ	SET	annual	amod	2	SENT_868	[p15l1797t1670r1906b1696],
2	Review	NN	O	review	_	0	SENT_868	[p15l1915t1671r2026b1696],
3	of	IN	O	of	_	0	SENT_868	[p15l2035t1670r2069b1696],
4	Pharmacology	NNP	O	Pharmacology	prep_of	2	SENT_868	[p15l1798t1717r2015b1752],
5	and	CC	O	and	_	0	SENT_868	[p15l2024t1717r2078b1743],
6	Toxicology	NNP	O	Toxicology	conj_and	4	SENT_868	[p15l1797t1765r1966b1799],

1	Volume	NN	O	volume	_	0	SENT_869	[p15l1797t1835r1906b1861],
2	49	CD	NUMBER	49	num	1	SENT_869	[p15l1916t1837r1957b1867],
3	,	,	O	,	_	0	SENT_869	[p15l1916t1837r1957b1867],
4	2009	CD	DATE	2009	appos	1	SENT_869	[p15l1968t1837r2035b1862],

1	Annu	NNP	PERSON	Annu	_	0	SENT_870	[p16l56t1786r79b1867],
2	.	.	O	.	_	0	SENT_870	[p16l56t1786r79b1867],

1	Rev.	NNP	O	Rev.	nn	2	SENT_871	[p16l56t1715r79b1775],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_871	[p16l56t1556r79b1705],
3	.	.	O	.	_	0	SENT_871	[p16l56t1556r79b1705],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_872	[p16l56t1435r79b1545],
2	.	.	O	.	_	0	SENT_872	[p16l56t1435r79b1545],

1	2009.49:377	CD	NUMBER	2009.49:377	num	2	SENT_873	[p16l56t1187r80b1421],
2	-394	CD	NUMBER	-394	_	0	SENT_873	[p16l56t1187r80b1421],
3	.	.	O	.	_	0	SENT_873	[p16l56t1187r80b1421],

1	Downloaded	VBN	O	download	_	0	SENT_874	[p16l56t1006r79b1176],
2	from	IN	O	from	_	0	SENT_874	[p16l56t932r79b997],
3	www.annualreviews.org	NN	O	www.annualreviews.org	prep_from	1	SENT_874	[p16l56t601r86b924],
4	by	IN	O	by	_	0	SENT_874	[p16l89t1698r120b1731],
5	University	NNP	ORGANIZATION	University	dep	9	SENT_874	[p16l89t1549r120b1689],
6	of	IN	ORGANIZATION	of	_	0	SENT_874	[p16l89t1510r113b1539],
7	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	5	SENT_874	[p16l89t1360r113b1504],
8	-	:	O	-	_	0	SENT_874	[p16l103t1342r106b1351],
9	Madison	NNP	O	Madison	prep_by	1	SENT_874	[p16l89t1216r113b1332],
10	on	IN	O	on	_	0	SENT_874	[p16l97t1174r113b1206],
11	01/05/14	CD	DATE	01/05/14	prep_on	1	SENT_874	[p16l89t1040r113b1164],
12	.	.	O	.	_	0	SENT_874	[p16l89t1040r113b1164],

1	For	IN	O	for	_	0	SENT_875	[p16l90t983r113b1029],
2	personal	JJ	O	personal	amod	3	SENT_875	[p16l89t863r120b975],
3	use	NN	O	use	pobj	1	SENT_875	[p16l97t810r113b853],
4	only	RB	O	only	advmod	3	SENT_875	[p16l89t735r120b800],
5	.	.	O	.	_	0	SENT_875	[p16l89t735r120b800],

1	vi	LS	O	vi	_	0	SENT_876	[p16l511t2004r534b2025],

1	Epigenetics	NNS	MISC	epigenetic	_	0	SENT_877	[p16l584t50r796b91],
2	,	,	O	,	_	0	SENT_877	[p16l584t50r796b91],
3	DNA	NN	O	dna	nn	4	SENT_877	[p16l810t49r909b80],
4	Methylation	NN	O	methylation	conj_and	1	SENT_877	[p16l917t48r1143b91],
5	,	,	O	,	_	0	SENT_877	[p16l917t48r1143b91],
6	and	CC	O	and	_	0	SENT_877	[p16l1158t48r1219b80],
7	Chromatin	NNP	O	Chromatin	nn	9	SENT_877	[p16l1233t48r1425b80],
8	Modifying	NNP	O	Modifying	nn	9	SENT_877	[p16l1435t48r1622b91],
9	Drugs	NNPS	O	Drugs	conj_and	1	SENT_877	[p16l1633t50r1741b91],
10	Mox/ye	FW	O	mox/ye	nn	27	SENT_877	[p16l631t96r736b127],
11	Szyf	FW	O	szyf	nn	27	SENT_877	[p16l748t96r828b138],
12	. . . . .	FW	O	. . . . .	nn	27	SENT_877	[p16l891t124r896b129],[p16l833t124r837b129],
13	. . . . .	FW	O	. . . . .	nn	27	SENT_877	[p16l964t124r968b129],[p16l906t124r910b129],
14	. . . . .	FW	O	. . . . .	nn	27	SENT_877	[p16l1036t124r1041b129],[p16l978t124r983b129],
15	. . . . .	FW	O	. . . . .	nn	27	SENT_877	[p16l1109t124r1113b129],[p16l1051t124r1055b129],
16	. . . . .	FW	O	. . . . .	nn	27	SENT_877	[p16l1182t124r1186b129],[p16l1123t124r1128b129],
17	. . . . .	FW	O	. . . . .	nn	27	SENT_877	[p16l1254t124r1259b129],[p16l1196t124r1201b129],
18	. . . . .	FW	O	. . . . .	nn	27	SENT_877	[p16l1327t124r1331b129],[p16l1269t124r1273b129],
19	. . . . .	FW	O	. . . . .	nn	27	SENT_877	[p16l1400t124r1404b129],[p16l1341t124r1346b129],
20	. . . . .	FW	O	. . . . .	nn	27	SENT_877	[p16l1472t124r1477b129],[p16l1414t124r1419b129],
21	. . . . .	FW	O	. . . . .	nn	27	SENT_877	[p16l1545t124r1549b129],[p16l1487t124r1491b129],
22	. . . . .	FW	O	. . . . .	nn	27	SENT_877	[p16l1617t124r1622b129],[p16l1559t124r1564b129],
23	. . . . .	FW	O	. . . . .	nn	27	SENT_877	[p16l1690t124r1695b129],[p16l1632t124r1636b129],
24	. . . . .	FW	O	. . . . .	nn	27	SENT_877	[p16l1763t124r1767b129],[p16l1705t124r1709b129],
25	. . . . .	FW	O	. . . . .	nn	27	SENT_877	[p16l1835t124r1840b129],[p16l1777t124r1782b129],
26	. . . . .	FW	O	. . . . .	nn	27	SENT_877	[p16l1908t124r1913b129],[p16l1850t124r1854b129],
27	. . . . .	FW	O	. . . . .	dep	9	SENT_877	[p16l1981t124r1985b129],[p16l1923t124r1927b129],
28	.	.	O	.	_	0	SENT_877	[p16l1995t124r2000b129],

1	.	.	O	.	_	0	SENT_878	[p16l2010t124r2029b129],

1	.	.	O	.	_	0	SENT_879	[p16l2010t124r2029b129],

1	243	CD	NUMBER	243	_	0	SENT_880	[p16l2042t97r2101b128],
2	The	DT	O	the	det	4	SENT_880	[p16l583t174r656b207],
3	COXIB	NN	O	coxib	nn	4	SENT_880	[p16l670t175r804b207],
4	Experience	NN	O	experience	dep	1	SENT_880	[p16l818t176r1021b217],
5	:	:	O	:	_	0	SENT_880	[p16l818t176r1021b217],
6	A	DT	O	a	det	7	SENT_880	[p16l1034t175r1064b206],
7	Look	NN	O	look	dep	1	SENT_880	[p16l1074t174r1168b207],
8	in	IN	O	in	_	0	SENT_880	[p16l1178t176r1212b206],
9	the	DT	O	the	det	13	SENT_880	[p16l1224t174r1278b207],
10	Rearview	NNP	O	Rearview	nn	13	SENT_880	[p16l1291t176r1453b207],
11	lVIirror	NNP	O	lVIirror	nn	13	SENT_880	[p16l1462t176r1585b207],
12	Lawrence	NNP	O	Lawrence	nn	13	SENT_880	[p16l632t222r786b253],
13	S	NN	O	s	prep_in	7	SENT_880	[p16l793t221r824b263],
14	+	CC	O	+	_	0	SENT_880	[p16l793t221r824b263],
15	Marnett	NN	O	marnett	conj_+	13	SENT_880	[p16l838t222r979b253],
16	. . . . .	FW	O	. . . . .	nn	15	SENT_880	[p16l1051t250r1055b254],[p16l993t250r997b254],
17	. . . . .	FW	O	. . . . .	nn	15	SENT_880	[p16l1123t250r1128b254],[p16l1065t250r1070b254],
18	. . . . .	FW	O	. . . . .	nn	15	SENT_880	[p16l1196t250r1201b254],[p16l1138t250r1143b254],
19	. . . . .	FW	O	. . . . .	nn	15	SENT_880	[p16l1269t250r1273b254],[p16l1211t250r1215b254],
20	. . . . .	FW	O	. . . . .	nn	15	SENT_880	[p16l1341t250r1346b254],[p16l1283t250r1288b254],
21	. . . . .	FW	O	. . . . .	nn	15	SENT_880	[p16l1414t250r1419b254],[p16l1356t250r1360b254],
22	. . . . .	FW	O	. . . . .	nn	15	SENT_880	[p16l1487t250r1491b254],[p16l1429t250r1433b254],
23	. . . . .	FW	O	. . . . .	nn	15	SENT_880	[p16l1559t250r1564b254],[p16l1501t250r1506b254],
24	. . . . .	FW	O	. . . . .	nn	15	SENT_880	[p16l1632t250r1636b254],[p16l1574t250r1578b254],
25	. . . . .	FW	O	. . . . .	nn	15	SENT_880	[p16l1705t250r1709b254],[p16l1647t250r1651b254],
26	. . . . .	FW	O	. . . . .	nn	15	SENT_880	[p16l1777t250r1782b254],[p16l1719t250r1724b254],
27	. . . . .	FW	O	. . . . .	nn	15	SENT_880	[p16l1850t250r1854b254],[p16l1792t250r1796b254],
28	. . . . .	FW	O	. . . . .	nn	15	SENT_880	[p16l1923t250r1927b254],[p16l1864t250r1869b254],
29	. . . . .	FW	O	. . . . .	dep	15	SENT_880	[p16l1995t250r2000b254],[p16l1937t250r1942b254],
30	.	.	O	.	_	0	SENT_880	[p16l2010t250r2014b254],

1	.	.	O	.	_	0	SENT_881	[p16l2024t250r2029b254],

1	2	CD	NUMBER	2	number	2	SENT_882	[p16l2042t223r2059b252],
2	6	CD	NUMBER	6	nsubj	12	SENT_882	[p16l2064t223r2082b252],
3	5	CD	NUMBER	5	num	5	SENT_882	[p16l2087t222r2102b253],
4	Quantitative	JJ	O	quantitative	amod	5	SENT_882	[p16l585t300r802b338],
5	Disease	NN	O	disease	dep	2	SENT_882	[p16l815t300r956b338],
6	,	,	O	,	_	0	SENT_882	[p16l815t300r956b338],
7	Drug	NN	O	drug	conj_and	2	SENT_882	[p16l971t300r1072b342],
8	,	,	O	,	_	0	SENT_882	[p16l971t300r1072b342],
9	and	CC	O	and	_	0	SENT_882	[p16l1087t299r1148b331],
10	Trial	NNP	O	Trial	nn	11	SENT_882	[p16l1160t299r1243b331],
11	Models	NNS	O	model	conj_and	2	SENT_882	[p16l1254t299r1384b331],
12	fogarao	VBP	O	fogarao	_	0	SENT_882	[p16l628t352r758b395],
13	VS.	NNP	O	VS.	nn	14	SENT_882	[p16l775t352r832b383],
14	Gobburu	NNP	PERSON	Gobburu	dobj	12	SENT_882	[p16l850t352r989b383],
15	and	CC	O	and	_	0	SENT_882	[p16l1001t353r1063b383],
16	Lawrence	NNP	PERSON	Lawrence	nn	26	SENT_882	[p16l1071t352r1263b394],
17	Les/eo	NNP	O	Les/eo	nn	26	SENT_882	[p16l1278t352r1366b383],
18	. . . . .	NNP	O	. . . . .	nn	26	SENT_882	[p16l1443t380r1448b385],[p16l1385t380r1389b385],
19	. . . . .	NNP	O	. . . . .	nn	26	SENT_882	[p16l1516t380r1520b385],[p16l1458t380r1462b385],
20	. . . . .	NNP	O	. . . . .	nn	26	SENT_882	[p16l1588t380r1593b385],[p16l1530t380r1535b385],
21	. . . . .	NNP	O	. . . . .	nn	26	SENT_882	[p16l1661t380r1666b385],[p16l1603t380r1607b385],
22	. . . . .	NNP	O	. . . . .	nn	26	SENT_882	[p16l1734t380r1738b385],[p16l1676t380r1680b385],
23	. . . . .	NNP	O	. . . . .	nn	26	SENT_882	[p16l1806t380r1811b385],[p16l1748t380r1753b385],
24	. . . . .	NNP	O	. . . . .	nn	26	SENT_882	[p16l1879t380r1883b385],[p16l1821t380r1825b385],
25	. . . . .	NNP	O	. . . . .	nn	26	SENT_882	[p16l1952t380r1956b385],[p16l1894t380r1898b385],
26	. . . .	NNP	O	. . . .	conj_and	14	SENT_882	[p16l2010t380r2029b385],[p16l1966t380r1971b385],
27	.	.	O	.	_	0	SENT_882	[p16l2010t380r2029b385],

1	291	CD	NUMBER	291	num	2	SENT_883	[p16l2042t353r2101b384],
2	Immunodrugs	NNPS	O	Immunodrugs	_	0	SENT_883	[p16l583t430r841b473],
3	:	:	O	:	_	0	SENT_883	[p16l583t430r841b473],
4	Therapeutic	JJ	O	therapeutic	amod	6	SENT_883	[p16l854t430r1070b473],
5	VLP-Based	JJ	O	vlp-based	amod	6	SENT_883	[p16l1081t430r1285b462],
6	Vaccines	NNS	O	vaccine	dep	2	SENT_883	[p16l1295t432r1446b462],
7	for	IN	O	for	_	0	SENT_883	[p16l1459t430r1509b462],
8	Chronic	JJ	O	chronic	amod	9	SENT_883	[p16l1522t430r1666b462],
9	Diseases	NNS	O	disease	prep_for	6	SENT_883	[p16l1678t432r1825b462],

1	Gary	NNP	PERSON	Gary	nn	2	SENT_884	[p16l636t483r717b525],
2	T	NN	PERSON	t	_	0	SENT_884	[p16l731t483r760b515],
3	_	CD	NUMBER	_	num	4	SENT_884	[p16l768t483r917b526],
4	7ennings	NNS	O	7enning	dep	2	SENT_884	[p16l768t483r917b526],
5	and	CC	O	and	_	0	SENT_884	[p16l926t483r988b515],
6	Martin	NNP	PERSON	Martin	nn	8	SENT_884	[p16l996t484r1117b515],
7	F	NN	O	f	nn	8	SENT_884	[p16l1129t484r1156b515],
8	Bae/nnann	NN	O	bae/nnann	dep	2	SENT_884	[p16l1170t483r1341b515],
9	. . . . .	CD	NUMBER	. . . . .	number	10	SENT_884	[p16l1414t512r1418b516],[p16l1356t512r1360b516],
10	. . . . .	CD	NUMBER	. . . . .	dep	2	SENT_884	[p16l1487t512r1491b516],[p16l1429t512r1433b516],
11	. . . . .	CD	NUMBER	. . . . .	num	12	SENT_884	[p16l1559t512r1564b516],[p16l1501t512r1506b516],
12	. . . . .	CD	NUMBER	. . . . .	dep	10	SENT_884	[p16l1632t512r1636b516],[p16l1574t512r1578b516],
13	. . . . .	CD	NUMBER	. . . . .	number	14	SENT_884	[p16l1705t512r1709b516],[p16l1647t512r1651b516],
14	. . . . .	CD	NUMBER	. . . . .	dep	2	SENT_884	[p16l1777t512r1782b516],[p16l1719t512r1724b516],
15	. . . . .	CD	NUMBER	. . . . .	num	17	SENT_884	[p16l1850t512r1854b516],[p16l1792t512r1796b516],
16	. . . . .	CD	NUMBER	. . . . .	num	17	SENT_884	[p16l1923t512r1927b516],[p16l1864t512r1869b516],
17	. . . . .	NN	O	. . . . .	dep	14	SENT_884	[p16l1995t512r2000b516],[p16l1937t512r1941b516],
18	.	.	O	.	_	0	SENT_884	[p16l2010t512r2029b516],

1	.	.	O	.	_	0	SENT_885	[p16l2010t512r2029b516],

1	303	CD	NUMBER	303	_	0	SENT_886	[p16l2044t484r2101b515],

1	Akt/GSK3	NN	O	akt/gsk3	nn	2	SENT_887	[p16l582t561r767b594],
2	Signaling	NN	O	signaling	_	0	SENT_887	[p16l784t561r948b604],
3	in	IN	O	in	_	0	SENT_887	[p16l959t563r992b593],
4	the	DT	O	the	det	5	SENT_887	[p16l1005t561r1058b593],
5	Action	NNP	O	Action	prep_in	2	SENT_887	[p16l1070t562r1187b593],
6	of	IN	O	of	_	0	SENT_887	[p16l1199t561r1237b593],
7	Psychotropic	JJ	O	psychotropic	amod	8	SENT_887	[p16l1245t561r1473b604],
8	Drugs	NNS	O	drug	prep_of	5	SENT_887	[p16l1486t563r1593b604],
9	jean-Martin	JJ	PERSON	jean-martin	amod	10	SENT_887	[p16l628t616r845b658],
10	Beaulieu	NNP	PERSON	Beaulieu	dep	2	SENT_887	[p16l857t617r1005b655],
11	,	,	O	,	_	0	SENT_887	[p16l857t617r1005b655],
12	Raul	NNP	PERSON	Raul	nn	14	SENT_887	[p16l1019t617r1099b648],
13	R.	NNP	PERSON	R.	nn	14	SENT_887	[p16l1107t617r1141b647],
14	Gainetdinov	NNP	PERSON	Gainetdinov	conj_and	10	SENT_887	[p16l1158t617r1362b655],
15	,	,	O	,	_	0	SENT_887	[p16l1158t617r1362b655],
16	and	CC	O	and	_	0	SENT_887	[p16l1377t617r1439b648],
17	Marc	NNP	PERSON	Marc	nn	23	SENT_887	[p16l1446t617r1537b648],
18	G.	NNP	PERSON	G.	nn	23	SENT_887	[p16l1550t617r1585b647],
19	Caron	NNP	PERSON	Caron	nn	23	SENT_887	[p16l1603t617r1700b648],
20	. . . . .	NNP	O	. . . . .	nn	23	SENT_887	[p16l1777t645r1782b649],[p16l1719t645r1724b649],
21	. . . . .	NNP	O	. . . . .	nn	23	SENT_887	[p16l1850t645r1854b649],[p16l1792t645r1796b649],
22	. . . . .	NNP	O	. . . . .	nn	23	SENT_887	[p16l1923t645r1927b649],[p16l1864t645r1869b649],
23	. . . . .	NNP	O	. . . . .	conj_and	10	SENT_887	[p16l1995t645r2000b649],[p16l1937t645r1942b649],
24	.	.	O	.	_	0	SENT_887	[p16l2010t645r2029b649],

1	.	.	O	.	_	0	SENT_888	[p16l2010t645r2029b649],

1	327	CD	NUMBER	327	num	3	SENT_889	[p16l2044t617r2103b648],
2	Topical	JJ	O	topical	amod	3	SENT_889	[p16l583t692r711b735],
3	Microbicides	NNS	O	microbicide	nsubj	5	SENT_889	[p16l722t692r951b724],
4	to	TO	O	to	aux	5	SENT_889	[p16l964t701r998b724],
5	Prevent	VB	O	prevent	_	0	SENT_889	[p16l1010t694r1147b724],
6	HIV	NN	O	hiv	dobj	5	SENT_889	[p16l1158t693r1244b725],
7	:	:	O	:	_	0	SENT_889	[p16l1158t693r1244b725],
8	Clinical	JJ	O	clinical	amod	10	SENT_889	[p16l1259t692r1394b724],
9	Drug	NNP	O	Drug	nn	10	SENT_889	[p16l1407t694r1501b735],
10	Development	NNP	O	Development	nsubj	11	SENT_889	[p16l1512t692r1750b735],
11	Challenges	VBZ	O	challenge	parataxis	5	SENT_889	[p16l626t746r818b789],
12	Craig	NNP	PERSON	Craig	nn	13	SENT_889	[p16l636t801r729b844],
13	WHendrix	NNP	PERSON	WHendrix	dobj	11	SENT_889	[p16l742t802r939b840],
14	,	,	O	,	_	0	SENT_889	[p16l742t802r939b840],
15	Yingjun	NNP	PERSON	Yingjun	nn	16	SENT_889	[p16l956t801r1102b844],
16	Cao	NNP	PERSON	Cao	conj_and	13	SENT_889	[p16l1116t802r1184b839],
17	,	,	O	,	_	0	SENT_889	[p16l1116t802r1184b839],
18	and	CC	O	and	_	0	SENT_889	[p16l1198t802r1260b832],
19	Edward	NNP	PERSON	Edward	nn	26	SENT_889	[p16l1268t801r1434b843],
20	Fuc/as	NNP	O	Fuc/as	nn	26	SENT_889	[p16l1449t801r1542b832],
21	. . . . .	NNP	O	. . . . .	nn	26	SENT_889	[p16l1617t829r1622b834],[p16l1559t829r1564b834],
22	. . . . .	NNP	O	. . . . .	nn	26	SENT_889	[p16l1690t829r1695b834],[p16l1632t829r1636b834],
23	. . . . .	NNP	O	. . . . .	nn	26	SENT_889	[p16l1763t829r1767b834],[p16l1705t829r1709b834],
24	. . . . .	NNP	O	. . . . .	nn	26	SENT_889	[p16l1835t829r1840b834],[p16l1777t829r1782b834],
25	. . . . .	NNP	O	. . . . .	nn	26	SENT_889	[p16l1908t829r1913b834],[p16l1850t829r1854b834],
26	. . . . .	NNP	O	. . . . .	dobj	11	SENT_889	[p16l1981t829r1985b834],[p16l1923t829r1927b834],
27	.	.	O	.	_	0	SENT_889	[p16l1995t829r2000b834],

1	.	.	O	.	_	0	SENT_890	[p16l2010t829r2029b834],

1	.	.	O	.	_	0	SENT_891	[p16l2010t829r2029b834],

1	349	CD	NUMBER	349	_	0	SENT_892	[p16l2044t802r2104b833],

1	Emerging	VBG	O	emerge	amod	4	SENT_893	[p16l584t881r759b923],
2	Pharmacology	NNP	O	Pharmacology	dep	4	SENT_893	[p16l770t879r1031b923],
3	:	:	O	:	_	0	SENT_893	[p16l770t879r1031b923],
4	Inhibitors	NNS	O	inhibitor	nsubj	9	SENT_893	[p16l1045t879r1217b912],
5	of	IN	O	of	_	0	SENT_893	[p16l1231t880r1269b912],
6	Human	JJ	O	human	amod	8	SENT_893	[p16l1276t881r1410b912],
7	Immunodeﬁciency	NN	O	immunodeﬁciency	nn	8	SENT_893	[p16l1421t879r1750b923],
8	Virus	NN	O	virus	prep_of	4	SENT_893	[p16l623t935r717b965],
9	Integration	NN	O	integration	_	0	SENT_893	[p16l730t935r927b976],
10	Daria	NNP	PERSON	Daria	nn	11	SENT_893	[p16l633t989r731b1019],
11	Hazuda	NNP	PERSON	Hazuda	dobj	9	SENT_893	[p16l742t988r881b1026],
12	,	,	O	,	_	0	SENT_893	[p16l742t988r881b1026],
13	Marian	NNP	PERSON	Marian	nn	14	SENT_893	[p16l894t989r1022b1019],
14	Iwamoto	NNP	PERSON	Iwamoto	conj_and	11	SENT_893	[p16l1033t989r1180b1026],
15	,	,	O	,	_	0	SENT_893	[p16l1033t989r1180b1026],
16	and	CC	O	and	_	0	SENT_893	[p16l1195t988r1256b1019],
17	Larissa	NNP	PERSON	Larissa	nn	24	SENT_893	[p16l1265t989r1381b1019],
18	I/Venning	NNP	O	I/Venning	nn	24	SENT_893	[p16l1397t989r1542b1031],
19	. . . . .	NNP	O	. . . . .	nn	24	SENT_893	[p16l1617t1016r1622b1021],[p16l1559t1016r1564b1021],
20	. . . . .	NNP	O	. . . . .	nn	24	SENT_893	[p16l1690t1016r1695b1021],[p16l1632t1016r1636b1021],
21	. . . . .	NNP	O	. . . . .	nn	24	SENT_893	[p16l1763t1016r1767b1021],[p16l1705t1016r1709b1021],
22	. . . . .	NNP	O	. . . . .	nn	24	SENT_893	[p16l1835t1016r1840b1021],[p16l1777t1016r1782b1021],
23	. . . . .	NNP	O	. . . . .	nn	24	SENT_893	[p16l1908t1016r1913b1021],[p16l1850t1016r1854b1021],
24	. . . . .	NNP	O	. . . . .	conj_and	11	SENT_893	[p16l1981t1016r1985b1021],[p16l1923t1016r1927b1021],
25	.	.	O	.	_	0	SENT_893	[p16l1995t1016r2000b1021],

1	.	.	O	.	_	0	SENT_894	[p16l2010t1016r2029b1021],

1	.	.	O	.	_	0	SENT_895	[p16l2010t1016r2029b1021],

1	377	CD	NUMBER	377	_	0	SENT_896	[p16l2044t988r2103b1020],

1	The	DT	O	the	det	3	SENT_897	[p16l583t1066r656b1098],
2	TRPC	NNP	MISC	TRPC	nn	3	SENT_897	[p16l668t1067r786b1098],
3	Class	NNP	MISC	Class	_	0	SENT_897	[p16l800t1066r889b1098],
4	of	IN	MISC	of	_	0	SENT_897	[p16l903t1066r940b1098],
5	Ion	NNP	MISC	Ion	nn	6	SENT_897	[p16l948t1068r1007b1098],
6	Channels	NNPS	O	Channels	prep_of	3	SENT_897	[p16l1020t1066r1192b1098],
7	:	:	O	:	_	0	SENT_897	[p16l1020t1066r1192b1098],
8	A	DT	O	a	det	10	SENT_897	[p16l1205t1067r1235b1098],
9	Critical	JJ	O	critical	amod	10	SENT_897	[p16l1246t1066r1376b1098],
10	Review	NN	O	review	dep	3	SENT_897	[p16l1389t1068r1516b1098],
11	of	IN	O	of	_	0	SENT_897	[p16l1527t1066r1565b1098],
12	Their	PRP$	O	they	poss	13	SENT_897	[p16l1572t1066r1674b1098],
13	Roles	NNS	O	role	prep_of	10	SENT_897	[p16l1686t1066r1782b1098],
14	in	IN	O	in	_	0	SENT_897	[p16l1794t1068r1828b1098],
15	Slow	NNP	O	Slow	prep_in	13	SENT_897	[p16l627t1120r716b1160],
16	,	,	O	,	_	0	SENT_897	[p16l627t1120r716b1160],
17	Sustained	JJ	O	sustained	amod	18	SENT_897	[p16l731t1120r897b1152],
18	Increases	NNS	O	increase	appos	15	SENT_897	[p16l909t1122r1068b1152],
19	in	IN	O	in	_	0	SENT_897	[p16l1080t1122r1114b1152],
20	Intracellular	JJ	O	intracellular	amod	21	SENT_897	[p16l1126t1120r1341b1152],
21	Ca2	NN	O	ca2	prep_in	18	SENT_897	[p16l1354t1116r1438b1152],
22	+	CC	O	+	_	0	SENT_897	[p16l1354t1116r1438b1152],
23	Concentrations	NNS	O	concentration	appos	15	SENT_897	[p16l1454t1121r1723b1152],
24	Lutz	NNP	PERSON	Lutz	nn	25	SENT_897	[p16l632t1176r711b1206],
25	Birnbaumer	NNP	PERSON	Birnbaumer	dep	23	SENT_897	[p16l723t1175r923b1207],
26	. . . . .	FW	O	. . . . .	nn	40	SENT_897	[p16l993t1204r997b1208],[p16l935t1204r939b1208],
27	. . . . .	FW	O	. . . . .	nn	40	SENT_897	[p16l1065t1204r1070b1208],[p16l1007t1204r1012b1208],
28	. . . . .	FW	O	. . . . .	nn	40	SENT_897	[p16l1138t1204r1143b1208],[p16l1080t1204r1084b1208],
29	. . . . .	FW	O	. . . . .	nn	40	SENT_897	[p16l1211t1204r1215b1208],[p16l1153t1204r1157b1208],
30	. . . . .	FW	O	. . . . .	nn	40	SENT_897	[p16l1283t1204r1288b1208],[p16l1225t1204r1230b1208],
31	. . . . .	FW	O	. . . . .	nn	40	SENT_897	[p16l1356t1204r1360b1208],[p16l1298t1204r1302b1208],
32	. . . . .	FW	O	. . . . .	nn	40	SENT_897	[p16l1429t1204r1433b1208],[p16l1370t1204r1375b1208],
33	. . . . .	FW	O	. . . . .	nn	40	SENT_897	[p16l1501t1204r1506b1208],[p16l1443t1204r1448b1208],
34	. . . . .	FW	O	. . . . .	nn	40	SENT_897	[p16l1574t1204r1578b1208],[p16l1516t1204r1520b1208],
35	. . . . .	FW	O	. . . . .	nn	40	SENT_897	[p16l1647t1204r1651b1208],[p16l1588t1204r1593b1208],
36	. . . . .	FW	O	. . . . .	nn	40	SENT_897	[p16l1719t1204r1724b1208],[p16l1661t1204r1666b1208],
37	. . . . .	FW	O	. . . . .	nn	40	SENT_897	[p16l1792t1204r1796b1208],[p16l1734t1204r1738b1208],
38	. . . . .	FW	O	. . . . .	nn	40	SENT_897	[p16l1864t1204r1869b1208],[p16l1806t1204r1811b1208],
39	. . . . .	FW	O	. . . . .	nn	40	SENT_897	[p16l1937t1204r1942b1208],[p16l1879t1204r1883b1208],
40	. . . . .	FW	O	. . . . .	dep	23	SENT_897	[p16l2010t1204r2029b1208],[p16l1952t1204r1956b1208],
41	.	.	O	.	_	0	SENT_897	[p16l2010t1204r2029b1208],

1	395	CD	NUMBER	395	_	0	SENT_898	[p16l2044t1176r2102b1207],

1	Mycobacterial	JJ	O	mycobacterial	_	0	SENT_899	[p16l582t1253r833b1297],
2	Subversion	NN	O	subversion	dep	1	SENT_899	[p16l846t1253r1038b1286],
3	of	IN	O	of	_	0	SENT_899	[p16l1051t1254r1089b1286],
4	Chemotherapeutic	JJ	O	chemotherapeutic	amod	5	SENT_899	[p16l1097t1254r1424b1296],
5	Reagents	NNS	O	reagent	prep_of	2	SENT_899	[p16l1437t1255r1594b1297],
6	and	CC	O	and	_	0	SENT_899	[p16l1607t1254r1669b1286],
7	Host	NNP	ORGANIZATION	Host	nn	9	SENT_899	[p16l1681t1255r1768b1286],
8	Defense	NNP	ORGANIZATION	Defense	nn	9	SENT_899	[p16l626t1307r767b1340],
9	Tactics	NNPS	O	Tactics	conj_and	5	SENT_899	[p16l779t1308r909b1340],
10	:	:	O	:	_	0	SENT_899	[p16l779t1308r909b1340],
11	Challenges	NNS	O	challenge	dep	2	SENT_899	[p16l924t1307r1115b1351],
12	in	IN	O	in	_	0	SENT_899	[p16l1128t1309r1162b1339],
13	Tuberculosis	NN	O	tuberculosis	prep_in	11	SENT_899	[p16l1172t1307r1395b1340],
14	Drug	NNP	O	Drug	nn	17	SENT_899	[p16l1408t1309r1502b1351],
15	Development	NNP	O	Development	nn	17	SENT_899	[p16l1513t1307r1751b1350],
16	Liem	NNP	PERSON	Liem	nn	17	SENT_899	[p16l632t1363r717b1393],
17	Nguyen	NNP	PERSON	Nguyen	dep	1	SENT_899	[p16l727t1363r853b1405],
18	and	CC	O	and	_	0	SENT_899	[p16l866t1362r927b1393],
19	jean	NN	O	jean	nn	20	SENT_899	[p16l932t1362r1011b1404],
20	Pieterx	NN	O	pieterx	dep	1	SENT_899	[p16l1023t1363r1133b1393],
21	. . . . .	CD	NUMBER	. . . . .	number	22	SENT_899	[p16l1211t1390r1215b1395],[p16l1153t1390r1157b1395],
22	. . . . .	CD	NUMBER	. . . . .	dep	1	SENT_899	[p16l1283t1390r1288b1395],[p16l1225t1390r1230b1395],
23	. . . . .	CD	NUMBER	. . . . .	num	24	SENT_899	[p16l1356t1390r1360b1395],[p16l1298t1390r1302b1395],
24	. . . . .	CD	NUMBER	. . . . .	dep	22	SENT_899	[p16l1429t1390r1433b1395],[p16l1370t1390r1375b1395],
25	. . . . .	CD	NUMBER	. . . . .	number	26	SENT_899	[p16l1501t1390r1506b1395],[p16l1443t1390r1448b1395],
26	. . . . .	CD	NUMBER	. . . . .	dep	1	SENT_899	[p16l1574t1390r1578b1395],[p16l1516t1390r1520b1395],
27	. . . . .	CD	NUMBER	. . . . .	num	28	SENT_899	[p16l1647t1390r1651b1395],[p16l1588t1390r1593b1395],
28	. . . . .	CD	NUMBER	. . . . .	dep	26	SENT_899	[p16l1719t1390r1724b1395],[p16l1661t1390r1666b1395],
29	. . . . .	CD	NUMBER	. . . . .	number	30	SENT_899	[p16l1792t1390r1796b1395],[p16l1734t1390r1738b1395],
30	. . . . .	CD	NUMBER	. . . . .	dep	1	SENT_899	[p16l1864t1390r1869b1395],[p16l1806t1390r1811b1395],
31	. . . . .	CD	NUMBER	. . . . .	num	32	SENT_899	[p16l1937t1390r1942b1395],[p16l1879t1390r1883b1395],
32	. . . . .	NN	O	. . . . .	dep	30	SENT_899	[p16l2010t1390r2014b1395],[p16l1952t1390r1956b1395],
33	.	.	O	.	_	0	SENT_899	[p16l2024t1390r2029b1395],

1	427	CD	NUMBER	427	_	0	SENT_900	[p16l2041t1362r2103b1394],

1	Indexes	NNS	O	index	_	0	SENT_901	[p16l583t1468r728b1501],

1	Contributing	VBG	O	contribute	_	0	SENT_902	[p16l585t1558r816b1601],
2	Authors	NNS	O	author	dobj	1	SENT_902	[p16l826t1558r976b1597],
3	,	,	O	,	_	0	SENT_902	[p16l826t1558r976b1597],
4	Volumes	NNS	O	volume	appos	2	SENT_902	[p16l988t1558r1139b1590],
5	45-49	CD	NUMBER	45-49	num	6	SENT_902	[p16l1152t1559r1257b1590],
6	. . . . .	CD	NUMBER	. . . . .	dep	4	SENT_902	[p16l1327t1587r1331b1591],[p16l1269t1587r1273b1591],
7	. . . . .	FW	O	. . . . .	nn	16	SENT_902	[p16l1400t1587r1404b1591],[p16l1341t1587r1346b1591],
8	. . . . .	FW	O	. . . . .	nn	16	SENT_902	[p16l1472t1587r1477b1591],[p16l1414t1587r1419b1591],
9	. . . . .	FW	O	. . . . .	nn	16	SENT_902	[p16l1545t1587r1549b1591],[p16l1487t1587r1491b1591],
10	. . . . .	FW	O	. . . . .	nn	16	SENT_902	[p16l1617t1587r1622b1591],[p16l1559t1587r1564b1591],
11	. . . . .	FW	O	. . . . .	nn	16	SENT_902	[p16l1690t1587r1695b1591],[p16l1632t1587r1636b1591],
12	. . . . .	FW	O	. . . . .	nn	16	SENT_902	[p16l1763t1587r1767b1591],[p16l1705t1587r1709b1591],
13	. . . . .	FW	O	. . . . .	nn	16	SENT_902	[p16l1835t1587r1840b1591],[p16l1777t1587r1782b1591],
14	. . . . .	FW	O	. . . . .	nn	16	SENT_902	[p16l1908t1587r1913b1591],[p16l1850t1587r1854b1591],
15	. . . . .	FW	O	. . . . .	nn	16	SENT_902	[p16l1981t1587r1985b1591],[p16l1923t1587r1927b1591],
16	. . .	FW	O	. . .	dep	25	SENT_902	[p16l2024t1587r2029b1591],[p16l1995t1587r2000b1591],
17	45	CD	NUMBER	45	number	18	SENT_902	[p16l2041t1559r2081b1590],
18	5	CD	NUMBER	5	num	20	SENT_902	[p16l2087t1559r2102b1590],
19	Chapter	NN	O	chapter	nn	20	SENT_902	[p16l585t1637r727b1680],
20	Titles	NNS	O	title	dep	16	SENT_902	[p16l738t1637r849b1676],
21	,	,	O	,	_	0	SENT_902	[p16l738t1637r849b1676],
22	Volumes	NNS	O	volume	appos	20	SENT_902	[p16l861t1637r1013b1669],
23	45-49	CD	NUMBER	45-49	dep	25	SENT_902	[p16l1025t1638r1130b1669],
24	. . . . .	CD	NUMBER	. . . . .	num	25	SENT_902	[p16l1211t1666r1215b1671],[p16l1153t1666r1157b1671],
25	. . . . .	CD	NUMBER	. . . . .	dep	35	SENT_902	[p16l1283t1666r1288b1671],[p16l1225t1666r1230b1671],
26	. . . . .	CD	NUMBER	. . . . .	number	27	SENT_902	[p16l1356t1666r1360b1671],[p16l1298t1666r1302b1671],
27	. . . . .	CD	NUMBER	. . . . .	num	29	SENT_902	[p16l1429t1666r1433b1671],[p16l1370t1666r1375b1671],
28	. . . . .	CD	NUMBER	. . . . .	number	29	SENT_902	[p16l1501t1666r1506b1671],[p16l1443t1666r1448b1671],
29	. . . . .	CD	NUMBER	. . . . .	dep	25	SENT_902	[p16l1574t1666r1578b1671],[p16l1516t1666r1520b1671],
30	. . . . .	CD	NUMBER	. . . . .	number	31	SENT_902	[p16l1647t1666r1651b1671],[p16l1588t1666r1593b1671],
31	. . . . .	CD	NUMBER	. . . . .	num	33	SENT_902	[p16l1719t1666r1724b1671],[p16l1661t1666r1666b1671],
32	. . . . .	CD	NUMBER	. . . . .	number	33	SENT_902	[p16l1792t1666r1796b1671],[p16l1734t1666r1738b1671],
33	. . . . .	CD	NUMBER	. . . . .	dep	29	SENT_902	[p16l1864t1666r1869b1671],[p16l1806t1666r1811b1671],
34	. . . . .	CD	NUMBER	. . . . .	num	35	SENT_902	[p16l1937t1666r1942b1671],[p16l1879t1666r1883b1671],
35	. . . . .	NN	O	. . . . .	dep	2	SENT_902	[p16l2010t1666r2029b1671],[p16l1952t1666r1956b1671],
36	.	.	O	.	_	0	SENT_902	[p16l2010t1666r2029b1671],

1	458	CD	NUMBER	458	_	0	SENT_903	[p16l2041t1638r2103b1669],

1	Errata	NNP	O	Errata	_	0	SENT_904	[p16l583t1742r703b1773],

1	An	DT	O	a	det	3	SENT_905	[p16l582t1832r633b1863],
2	online	JJ	O	online	amod	3	SENT_905	[p16l644t1831r753b1864],
3	log	NN	O	log	nsubjpass	16	SENT_905	[p16l764t1831r819b1874],
4	of	IN	O	of	_	0	SENT_905	[p16l829t1831r867b1864],
5	corrections	NNS	O	correction	prep_of	3	SENT_905	[p16l874t1833r1068b1864],
6	to	TO	O	to	_	0	SENT_905	[p16l1080t1840r1114b1864],
7	Annual	JJ	SET	annual	amod	8	SENT_905	[p16l1121t1832r1249b1864],
8	Review	NN	O	review	prep_to	5	SENT_905	[p16l1256t1833r1371b1864],
9	of	IN	O	of	_	0	SENT_905	[p16l1383t1832r1419b1874],
10	Pharmacology	NNP	O	Pharmacology	nn	13	SENT_905	[p16l1420t1832r1645b1875],
11	and	CC	O	and	_	0	SENT_905	[p16l1655t1832r1717b1864],
12	Ybxicology	NNP	O	Ybxicology	conj_and	10	SENT_905	[p16l1727t1832r1886b1875],
13	articles	NNS	O	article	prep_of	8	SENT_905	[p16l1897t1831r2019b1864],
14	may	MD	O	may	aux	16	SENT_905	[p16l2030t1843r2103b1874],
15	be	VB	O	be	auxpass	16	SENT_905	[p16l584t1885r623b1917],
16	found	VBN	O	find	_	0	SENT_905	[p16l636t1885r737b1917],
17	at	IN	O	at	_	0	SENT_905	[p16l750t1894r782b1917],
18	http://pharmtox.annualreviews.org/errata.shtml	NN	O	http://pharmtox.annualreviews.org/errata.shtml	prep_at	16	SENT_905	[p16l792t1885r1630b1928],

1	Contents	NNS	O	contents	_	0	SENT_906	[p16l585t2003r682b2025],

